Citrus Sinensis ID: 025369
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | 2.2.26 [Sep-21-2011] | |||||||
| Q39193 | 361 | Serine/threonine-protein | yes | no | 0.948 | 0.667 | 0.866 | 1e-129 | |
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.917 | 0.643 | 0.922 | 1e-127 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.913 | 0.625 | 0.900 | 1e-124 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.952 | 0.668 | 0.864 | 1e-124 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.917 | 0.643 | 0.892 | 1e-124 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.909 | 0.639 | 0.867 | 1e-120 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.834 | 0.625 | 0.882 | 1e-111 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.834 | 0.625 | 0.877 | 1e-111 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.838 | 0.586 | 0.863 | 1e-111 | |
| Q9C958 | 361 | Serine/threonine-protein | no | no | 0.838 | 0.590 | 0.859 | 1e-110 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 461 bits (1186), Expect = e-129, Method: Compositional matrix adjust.
Identities = 221/255 (86%), Positives = 235/255 (92%), Gaps = 14/255 (5%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------- 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQ
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 236 -----VFIKP-CCHI 244
+ I P CCH+
Sbjct: 240 SIPDDIRISPECCHL 254
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 215/233 (92%), Positives = 223/233 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHD DRY+ VRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPK+FRKTIQ
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQ 233
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 209/232 (90%), Positives = 222/232 (95%)
Query: 4 DRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
DRA+LTVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRD+ T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 64 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 123
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
PAYIAPEVLL+ EYDGK ADVWSCGVTLYVM+VG YPFEDP+EPK+FRKTIQ
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQ 243
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-124, Method: Compositional matrix adjust.
Identities = 216/250 (86%), Positives = 230/250 (92%), Gaps = 8/250 (3%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI------QV 236
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI Q
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 237 FIKPCCHITP 246
I HI+P
Sbjct: 239 AIPDYVHISP 248
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-124, Method: Compositional matrix adjust.
Identities = 208/233 (89%), Positives = 223/233 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MD A+ + +D+PIMHDSDRYDFV+DIGSGNFGVARLM D+VTKELVAVKYIERG+KI
Sbjct: 1 MDPATNSPIMPIDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPE+LLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EP+D+RKTIQ
Sbjct: 181 TPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQ 233
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-120, Method: Compositional matrix adjust.
Identities = 203/234 (86%), Positives = 222/234 (94%), Gaps = 3/234 (1%)
Query: 3 MDRASLTVGP-AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK 61
M+RA+ GP M+MPIMHD DRY+ V++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 62 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 121
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
GTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQ 232
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1032), Expect = e-111, Method: Compositional matrix adjust.
Identities = 187/212 (88%), Positives = 203/212 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 186/212 (87%), Positives = 203/212 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 400 bits (1028), Expect = e-111, Method: Compositional matrix adjust.
Identities = 184/213 (86%), Positives = 203/213 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLM+ K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGVTLYVMLVG YPFED ++PK+FRKTIQ
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQ 214
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-110, Method: Compositional matrix adjust.
Identities = 183/213 (85%), Positives = 202/213 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGVTLYVMLVG YPFED ++PK+F+KTIQ
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQ 214
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | ||||||
| 255562649 | 362 | Serine/threonine-protein kinase SAPK10, | 0.917 | 0.643 | 0.961 | 1e-131 | |
| 449460610 | 363 | PREDICTED: serine/threonine-protein kina | 0.917 | 0.641 | 0.969 | 1e-131 | |
| 356563656 | 360 | PREDICTED: serine/threonine-protein kina | 0.917 | 0.647 | 0.944 | 1e-129 | |
| 224084266 | 362 | predicted protein [Populus trichocarpa] | 0.952 | 0.668 | 0.882 | 1e-129 | |
| 356511732 | 360 | PREDICTED: serine/threonine-protein kina | 0.917 | 0.647 | 0.939 | 1e-129 | |
| 297797685 | 361 | hypothetical protein ARALYDRAFT_920030 [ | 0.948 | 0.667 | 0.878 | 1e-129 | |
| 225470483 | 361 | PREDICTED: serine/threonine-protein kina | 0.917 | 0.645 | 0.935 | 1e-128 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.960 | 0.670 | 0.892 | 1e-128 | |
| 312282175 | 361 | unnamed protein product [Thellungiella h | 0.948 | 0.667 | 0.874 | 1e-128 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.933 | 0.652 | 0.919 | 1e-128 |
| >gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1215), Expect = e-131, Method: Compositional matrix adjust.
Identities = 224/233 (96%), Positives = 229/233 (98%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M+R+++TVGP MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MNRSAITVGPGMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICN GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNGGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQ 233
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460610|ref|XP_004148038.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] gi|449502711|ref|XP_004161721.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1214), Expect = e-131, Method: Compositional matrix adjust.
Identities = 226/233 (96%), Positives = 228/233 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA++TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK TKELVAVKYIERGDKI
Sbjct: 1 MDRATITVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKHTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILT THLAIVMEYASGGELFERI NAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTTTHLAIVMEYASGGELFERISNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQ 233
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563656|ref|XP_003550077.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1203), Expect = e-129, Method: Compositional matrix adjust.
Identities = 220/233 (94%), Positives = 228/233 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQ 233
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084266|ref|XP_002307247.1| predicted protein [Populus trichocarpa] gi|222856696|gb|EEE94243.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1202), Expect = e-129, Method: Compositional matrix adjust.
Identities = 225/255 (88%), Positives = 233/255 (91%), Gaps = 13/255 (5%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSDRYD VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC +GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKSGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLD SPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDDSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------- 235
TPAYIAPEVLLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLLRQEYDGKVADVWSCGVTLYVMLVGSYPFEDPAEPKDFRKTIQRVINVQY 240
Query: 236 -----VFIKP-CCHI 244
+ I P CCH+
Sbjct: 241 SIPDSILITPECCHL 255
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511732|ref|XP_003524577.1| PREDICTED: serine/threonine-protein kinase SAPK10-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-129, Method: Compositional matrix adjust.
Identities = 219/233 (93%), Positives = 227/233 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQ 233
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797685|ref|XP_002866727.1| hypothetical protein ARALYDRAFT_920030 [Arabidopsis lyrata subsp. lyrata] gi|297312562|gb|EFH42986.1| hypothetical protein ARALYDRAFT_920030 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-129, Method: Compositional matrix adjust.
Identities = 224/255 (87%), Positives = 235/255 (92%), Gaps = 14/255 (5%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP MDMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-MDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRF+EDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFNEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------- 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEP+D+RKTIQ
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRDYRKTIQRILSVKY 239
Query: 236 -----VFIKP-CCHI 244
+ I P CCH+
Sbjct: 240 SIPDDIRISPDCCHL 254
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470483|ref|XP_002264172.1| PREDICTED: serine/threonine-protein kinase SRK2I isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/233 (93%), Positives = 227/233 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR++L +GP MD+PIMHDSDRYDFVRDIGSGNFG+ARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRSTLALGPIMDLPIMHDSDRYDFVRDIGSGNFGIARLMRDKLTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC AGRF EDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKAGRFIEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVL+R EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQ
Sbjct: 181 TPAYIAPEVLMRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQ 233
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1191), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/250 (89%), Positives = 233/250 (93%), Gaps = 6/250 (2%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI------QV 236
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI Q
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 237 FIKPCCHITP 246
I HI+P
Sbjct: 241 SIPDYVHISP 250
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312282175|dbj|BAJ33953.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1189), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/255 (87%), Positives = 235/255 (92%), Gaps = 14/255 (5%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA ++ GP MDMPIMHDSDRYDFV+DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MDRAPVSSGP-MDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------- 235
TPAYIAPEVLLR +YDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQ
Sbjct: 180 TPAYIAPEVLLRQQYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 236 -----VFIKP-CCHI 244
+ I P CCH+
Sbjct: 240 SIPEDIRISPECCHL 254
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1189), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/237 (91%), Positives = 229/237 (96%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQ +K
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILK 237
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 254 | ||||||
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.913 | 0.642 | 0.927 | 2e-119 | |
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.952 | 0.668 | 0.864 | 3.2e-113 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.838 | 0.591 | 0.863 | 2.7e-100 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.838 | 0.590 | 0.859 | 4.4e-100 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.838 | 0.603 | 0.849 | 1e-98 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.854 | 0.632 | 0.820 | 4.1e-97 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.881 | 0.64 | 0.784 | 2.9e-96 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.838 | 0.628 | 0.798 | 1.5e-92 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.814 | 0.458 | 0.449 | 5.7e-43 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.803 | 0.458 | 0.451 | 7.3e-43 |
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 2.0e-119, Sum P(2) = 2.0e-119
Identities = 216/233 (92%), Positives = 228/233 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQ
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
|
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 216/250 (86%), Positives = 230/250 (92%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI------QV 236
TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI Q
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 237 FIKPCCHITP 246
I HI+P
Sbjct: 239 AIPDYVHISP 248
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 2.7e-100, P = 2.7e-100
Identities = 184/213 (86%), Positives = 201/213 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGVTLYVMLVGGYPFEDPD+P++FRKTIQ
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQ 214
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
Identities = 183/213 (85%), Positives = 202/213 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGVTLYVMLVG YPFED ++PK+F+KTIQ
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQ 214
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 181/213 (84%), Positives = 199/213 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+YD V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQ
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQ 214
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
Identities = 178/217 (82%), Positives = 200/217 (92%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ V+DIGSGNFGVA+L+RDK +KEL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCH++Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL EYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
DVWSCGVTLYVMLVG YPFEDP +PKDFRKTI +K
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILK 218
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 178/227 (78%), Positives = 201/227 (88%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RYD +RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL R EY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHIT-PFY 248
DVWSCGVTLYVMLVG YPFEDP++P++ R TIQ + H T P Y
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILS--VHYTIPDY 226
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 170/213 (79%), Positives = 190/213 (89%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y+ V+D+G GNFG+ARLMR+K T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y HA+Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
DVWSCGV LYVMLVG YPFEDP +P++FRKT+Q
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQ 214
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 5.7e-43, P = 5.7e-43
Identities = 97/216 (44%), Positives = 133/216 (61%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHP 79
+Y+ R IG G F + R+ T E VA+K +++ K+ E ++REI + ++HP
Sbjct: 23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
N+V+ EV+ + T + I++EY +GGELF++I N GR EDEAR +FQQLI V YCH+
Sbjct: 83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP--KSTVGTPAYIAPEVLLRHE 196
V HRDLK EN LLD LKI DFG S S + ++ GTP Y+APEVL
Sbjct: 143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRG 200
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
YDG AD+WSCGV LYV+L G PF+D + ++K
Sbjct: 201 YDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKK 236
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 7.3e-43, P = 7.3e-43
Identities = 98/217 (45%), Positives = 133/217 (61%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHP 79
+Y+ R IG G F + ++ T E VA+K ++R K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+VR EV+ + T + I++EY +GGELF++I GR SE EAR +F QLI GV YCH+
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRH 195
V HRDLK EN LLD LKI DFG S L Q K+T GTP Y+APEVL
Sbjct: 128 VYHRDLKPENLLLDSQG--NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHK 182
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y+G +AD+WSCGV LYV++ G PF++ D P + K
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSK 219
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8349 | 0.8346 | 0.6347 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8866 | 0.7992 | 0.6114 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8666 | 0.9488 | 0.6675 | yes | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8820 | 0.8346 | 0.6253 | N/A | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9227 | 0.9173 | 0.6436 | yes | no |
| Q7Y0B9 | SAPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9008 | 0.9133 | 0.6253 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_V000200 | hypothetical protein (362 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | gw1.186.8.1 | hypothetical protein (337 aa) | • | 0.455 | |||||||
 | fgenesh4_pg.C_scaffold_7275000001 | hypothetical protein (240 aa) | • | 0.417 | |||||||
 | gw1.57.100.1 | hypothetical protein (187 aa) | • | 0.408 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 254 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-73 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-45 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-41 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-41 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-40 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-38 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-36 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-36 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-35 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-35 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-35 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-35 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-34 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-34 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-33 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-33 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-33 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-29 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-29 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-26 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-25 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 2e-84
Identities = 91/229 (39%), Positives = 127/229 (55%), Gaps = 8/229 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ + +G G+FG L RDK T +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y H+ + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYPLF 251
D+WS GV LY +L G PF D+ + + KP P
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDI 223
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 5e-73
Identities = 88/206 (42%), Positives = 117/206 (56%), Gaps = 6/206 (2%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 81
Y+ +R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y H+ +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGK 200
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDE 226
DVWS GV LY +L G PF +
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENI 204
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-62
Identities = 83/188 (44%), Positives = 110/188 (58%), Gaps = 5/188 (2%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 88
+G G FG L RDK T + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 89 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y H+ + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 148 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 207 CGVTLYVM 214
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 3e-57
Identities = 74/228 (32%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y+ ++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 136
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
+ ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
Y+ K +D+WS G LY + +PFE + + K ++ P
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-52
Identities = 75/205 (36%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK-- 85
+G G+FG L DK T EL+AVK +E +E + +REI SL+HPNIVR+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
E L I +EY SGG L + G+ E R + +Q++ G++Y H+ + HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
K N L+D +K+ DFG +K S GTP ++APEV +R E G+ A
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEYGRAA 184
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEP 227
D+WS G T+ M G P+ + P
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-51
Identities = 81/212 (38%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y H++ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 147 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
WS GV LY ML G PF D + + K ++
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-48
Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IG G FG R K T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y H+ + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPK 228
AD+WS G+T + G P+ + K
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMK 204
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-45
Identities = 80/228 (35%), Positives = 133/228 (58%), Gaps = 23/228 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR----SLR 77
D ++F++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 78 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H++ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
+L Y GK D W+ G+ +Y ML G PF D + + + K ++ ++
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR 216
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-43
Identities = 71/242 (29%), Positives = 114/242 (47%), Gaps = 39/242 (16%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + IG G+F L ++K T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 173
H+ + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
+ S VGT Y++PE LL + GK +D+W+ G +Y ML G PF +E F+K
Sbjct: 176 RRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 234 IQ 235
++
Sbjct: 235 LK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-43
Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ Y + IG G G D+ T + VA+K + + E + EI+ + +HPNI
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V + + L L +VMEY GG L + I N R +E + + ++++ G+ Y H+ V
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ R +Y
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 198 DGKIADVWSCGVTLYVMLVGGYP--FEDP 224
K+ D+WS G+ M G P +P
Sbjct: 194 GPKV-DIWSLGIMCIEM-AEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 6e-43
Identities = 82/232 (35%), Positives = 121/232 (52%), Gaps = 21/232 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 79
Y +R +G G+FG L RD+ +LVA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 136
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 189
+ + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 190 EVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
EVLL Y +D+WS G+TLY +L G PFE +T+++ ++
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 72/207 (34%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y+ + +G G +GV RDK T E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCH+ +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR- 194
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPF 221
Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-41
Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 86
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+L +VMEY GG+L + N G ED AR + +++ + Y H+ + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
K D WS G LY LVG PF + F+ +
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 81/207 (39%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N LLD +KI DFG K +L ST GTP YIAPE+L Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFR 231
W+ GV LY ML G PFE DE + F+
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 79/209 (37%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 82
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
D W GV +Y M+ G PF + D K F
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 7e-39
Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
Y+ + IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 81 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 134
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 135 CH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 188
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
PE L YD K +D+WS G +Y + PF
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-39
Identities = 69/205 (33%), Positives = 112/205 (54%), Gaps = 9/205 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D + ++ +G+G FG L+RD++++ A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y H+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
K D W+ G+ +Y MLVG PF D
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD + +K+ DFG++K + + GTP Y+APE++L YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 207 CGVTLYVMLVGGYPFEDPDE 226
G+ LY +L G PF + DE
Sbjct: 178 LGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-38
Identities = 71/207 (34%), Positives = 107/207 (51%), Gaps = 16/207 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGD-KIDENVQREIINHRSLRHPNIVRFKEV 87
IG G FG + T EL+AVK I + D K + + E+ L+HPN+V++ V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHAMQVCHRDL 145
+ + I MEY SGG L E + GR DE R + QL+ G++Y H+ + HRD+
Sbjct: 68 EVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+ + G
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 201 I--ADVWSCGVTLYVMLVGGYPFEDPD 225
AD+WS G + M G P+ + D
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELD 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G G+ +D+ T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y HA
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-RHE 196
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L +
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 197 YDGKIADVWSCGVTLYVMLVGG 218
YD + D+W+ G +L G
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG DK T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFED 223
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-37
Identities = 82/226 (36%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L +Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
WS GV LY ML+G PF DE + F + P +P
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------LNDRPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-37
Identities = 69/199 (34%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEV 87
IG G FGV + T + VA+K I +E + +EI ++L+HPNIV++
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
I T L I++EYA G L + I G F E + Q++ G++Y H V HRD+K
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 148 ENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
N L DG +K+ DFG + K + + S VGTP ++APEV+ +D+
Sbjct: 128 ANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDI 182
Query: 205 WSCGVTLYVMLVGGYPFED 223
WS G T+ +L G P+ D
Sbjct: 183 WSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-37
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 7/202 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPN 80
++ +R IG G FG +++ + TK++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y H+ +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRD+K +N LLD + I DF + + ST GTP Y+APEVL R Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 201 IADVWSCGVTLYVMLVGGYPFE 222
D WS GVT Y L G P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+ + +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 201 IADVWSCGVTLYVMLVGGYPF--EDPDEP----KDFRKTIQ 235
+ D WS G LY L G PF P+E K +++T+Q
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-36
Identities = 77/230 (33%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 85
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD L DFG K + HS+ ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPD----------EPKDFRKTIQVFIKPCCHI 244
W G LY ML G PF D +P + I V H+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISV---SARHL 226
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-36
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRD 144
++IV+EY GG L + + G+ E + +Q++ G+ Y H + HRD
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125
Query: 145 LKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 126 IKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYA 180
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPK 228
AD+WS G+TL +G +PF P +P
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 76/205 (37%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDF 230
GV +Y M+ G PF + D + F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 80/208 (38%), Positives = 109/208 (52%), Gaps = 12/208 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 83
+G G+FG L K T EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +KI DFG K + ST GTP ++APEVL Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
D W GV +Y MLVG PF DE + F
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-35
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 83
IG G FG +R K T+ + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL + K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
D WS GV ++ M G PF D + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-35
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKY---IERGDKIDENVQREIINHRSLRHP 79
++Y+ + +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + G D R + QL+ ++YCH+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 193
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG 217
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 74/200 (37%), Positives = 108/200 (54%), Gaps = 19/200 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y+ ++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 192
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 193 -LRHEYDGKIADVWSCGVTL 211
+ YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 79/251 (31%), Positives = 112/251 (44%), Gaps = 45/251 (17%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RH 78
D ++ ++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 169
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 170 -SSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 225 DEPKDFRKTIQ 235
+ + K I
Sbjct: 234 TLQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 77/213 (36%), Positives = 114/213 (53%), Gaps = 11/213 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RH 78
++F+ +G G+FG L K T EL A+K I + D I D++V+ ++ R L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + + T L VMEY +GG+L I G+F E A F+ ++ G+ + H+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+ +RDLKL+N +LD +KI DFG K ++ + T GTP YIAPE++ Y
Sbjct: 121 GIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
GK D W+ GV LY ML G PF+ DE + F
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-35
Identities = 77/209 (36%), Positives = 107/209 (51%), Gaps = 7/209 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 80
+Y+ +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
K +D+W+ G LY + FE + P
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 74/210 (35%), Positives = 109/210 (51%), Gaps = 8/210 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 86
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVW 205
EN LLD + +CDFG K ++ +T GTP Y+APE+LL H Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ GV LY ML G PF D + + +RK +Q
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-35
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 81
Y + IG G +GV RDK+T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
++ +V L +V E+ +L++ I + R E + + QL+ G+++CH+ +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEY 197
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 198 DGKIADVWSCGVTLYVMLVG 217
D+WS G +L
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-35
Identities = 78/214 (36%), Positives = 114/214 (53%), Gaps = 8/214 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEY +GGELF + FSED RF+ +++S + Y H+ ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVW 205
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
GV +Y M+ G PF + D K F + IK
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-34
Identities = 71/195 (36%), Positives = 102/195 (52%), Gaps = 20/195 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 78
Y ++ +G G FG L R+K T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 136
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LLR
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 195 H-EYDGKIADVWSCG 208
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 74/213 (34%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 80
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 193
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
+ Y K AD+WS G + ML G +PF D +
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 72/249 (28%), Positives = 113/249 (45%), Gaps = 39/249 (15%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 135 CHAMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 177
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 178 -----------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+ +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNR 237
Query: 227 PKDFRKTIQ 235
+ F ++
Sbjct: 238 DETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-34
Identities = 78/206 (37%), Positives = 112/206 (54%), Gaps = 9/206 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDL 145
T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDF 230
W GV +Y M+ G PF + D K F
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-34
Identities = 77/217 (35%), Positives = 118/217 (54%), Gaps = 9/217 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L +I GRF E A F+ ++ G+ + H+
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ K+ GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
GK D W+ GV LY ML G PFE DE + F+ ++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 81/225 (36%), Positives = 118/225 (52%), Gaps = 17/225 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T HL VME+ +GG+L I + GRF A F+ +++ G+ + H+ + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
WS GV LY ML+G PF DE + F ++I+V TP YP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELF-ESIRV-------DTPHYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 72/201 (35%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 85
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K V + ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPD 225
W G LY ML G PF D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-33
Identities = 79/209 (37%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 82
R +G G+FG L R K + L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
D W+ GV LY ML G PFE +E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 6e-33
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 21/223 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + + VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+ V L IVMEY GG+L + R S + F Q+ G+ Y +
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 192
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
++ K +DVWS GV L+ + G + + ++
Sbjct: 177 KEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-33
Identities = 78/227 (34%), Positives = 120/227 (52%), Gaps = 17/227 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T +L VMEY +GG+L I + +F A F+ ++I G+ + H+ + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL +Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYPLF 251
WS GV LY ML+G PF DE + F ++I++ P YP +
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELF-QSIRM-------DNPCYPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-33
Identities = 75/217 (34%), Positives = 116/217 (53%), Gaps = 9/217 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L I G+F E +A F+ ++ G+ + H
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
GK D W+ GV LY ML G PF+ DE + F+ ++
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-33
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G+G+FG R+ + K T E A+K +++ + + + + +S L HP IV
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ ++E+ GGELF + AGRF D A+F+ +L+ Y H+ + +RDLK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
EN LLD +K+ DFG++K + + + GTP Y+APEV ++ + GK D W+
Sbjct: 146 PENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWT 200
Query: 207 CGVTLYVMLVGGYPFEDPDEP 227
GV LY + G PF D D P
Sbjct: 201 MGVLLYEFIAGYPPFFD-DTP 220
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-32
Identities = 73/207 (35%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDF 230
W+ GV +Y M+ G PFE +E F
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 70/210 (33%), Positives = 119/210 (56%), Gaps = 19/210 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y V+ IG G+FG A L++ K + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
++ HRD+K +N L DG+ +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
Y+ K +D+W+ G LY M + FE
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 25/245 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++ T L IVMEY G + + +I N +E+E Q + G+ Y H+ +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED-------------P----DEPKDFRKTIQVFIKPC 241
K AD+WS G+T M G P+ D P +P+ + F+K C
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 242 CHITP 246
P
Sbjct: 237 LVKDP 241
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 20/222 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + K VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
++ K +DVWS GV L+ + G ++ + ++
Sbjct: 177 EGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-32
Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 80
Y+ + IG G +G R+K T ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 81 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 193 L-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236
L Y ++ D+WS G L + +G F+ E + K ++
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 71/238 (29%), Positives = 105/238 (44%), Gaps = 24/238 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 84
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ + G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 205 WSCGVTLYVMLVGGYPFED----------------PDEPKDFRKTIQVFIKPCCHITP 246
WS G T+ M G P+ P P + FI C P
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 70/247 (28%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 80
+++ ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH-A 137
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + ++Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------------FRKTIQV 236
K +D+WS G++L + G +P+ ++P D F Q
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
Query: 237 FIKPCCH 243
F+ C
Sbjct: 236 FVNLCLI 242
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 70/202 (34%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRH---PNIVRFK 85
IG G +G + T +VA+K I D+ ++QRE+ LR PNI ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
L L I+MEYA GG + + AG +E ++++ + Y H + V HRD+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR-HEYDGKIAD 203
K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ YD K AD
Sbjct: 128 KAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK-AD 184
Query: 204 VWSCGVTLYVMLVGGYPFEDPD 225
+WS G+T+Y M G P+ D D
Sbjct: 185 IWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
Y +R +G G FG A L R LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLR 194
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 195 HEYDGKIADVWSCGVTLYVML 215
+Y+ K +D+W+ G LY +L
Sbjct: 176 VKYNFK-SDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 74/228 (32%), Positives = 112/228 (49%), Gaps = 29/228 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ ++ I +G +G L+R K T++ A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 180
+ HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDE 226
GTP YIAPEV+LR Y GK D W+ G+ LY LVG PF + P+E
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 72/213 (33%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRS 75
++ +D ++ IG G FG +L+R K +K++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 191
H+M HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 192 LLR---HEYDGKIADVWSCGVTLYVMLVGGYPF 221
L Y G+ D WS GV LY MLVG PF
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-31
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ L+I MEY GG + +++ G +E R + +Q++ GV Y H+ + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGK 200
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 201 IADVWSCGVTLYVMLVGGYPFED 223
ADVWS G T+ ML P+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-31
Identities = 72/207 (34%), Positives = 114/207 (55%), Gaps = 14/207 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
+Y+ +R +G G+FG A L++ + + A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRH 195
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFE 222
Y+ K +D+WS G LY + +PF+
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-31
Identities = 70/197 (35%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L R K ++ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL + YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 205 WSCGVTLYVMLVGGYPF 221
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 77/252 (30%), Positives = 111/252 (44%), Gaps = 39/252 (15%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 79
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y H+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLR 194
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFED----------------PDEPKDFRKTIQ--- 235
Y K+ D+WS G + M G P+ D P P D +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245
Query: 236 -VFIKPCCHITP 246
F+ C I P
Sbjct: 246 LDFLNACFTINP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 79/236 (33%), Positives = 120/236 (50%), Gaps = 21/236 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY+ ++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFY 248
Y+ K D+WS G LY + +PFE + + K Q + P I+P +
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNF 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 70/216 (32%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 80
RY+ ++ IGSG +GV DK T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 81 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 126
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 182
Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
T Y APE+LL Y I D+WS G +L
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-30
Identities = 72/200 (36%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G++G ++ + A+K ++ G K E+ EI S+ HPNI+ +KE
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHR 143
L L IVMEYA G+L + I + E E F QL+ G+ H ++ HR
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIA 202
DLK N LL +KI D G SK VL K+ +GTP Y+APEV Y K +
Sbjct: 128 DLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYK-S 182
Query: 203 DVWSCGVTLYVMLVGGYPFE 222
D+WS G LY M PFE
Sbjct: 183 DIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-30
Identities = 74/203 (36%), Positives = 102/203 (50%), Gaps = 30/203 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
D Y+ + I G +GV RDK T E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 76 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 128
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 186
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 187 IAPEVLL-RHEYDGKIADVWSCG 208
APE+LL EY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
++ + IG G+FGV + K K + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+++ H+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
Y+ K +DVW+ GV LY G +PF+ ++ K I+ P
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 71/219 (32%), Positives = 122/219 (55%), Gaps = 20/219 (9%)
Query: 31 IGSGNFGVARLMRDKVTKE----LVAVKYIERG-----DKIDENVQREIINHRSLRHPNI 81
+G G+FG L+R K+T L A+K +++ D++ ++R+I+ + HP I
Sbjct: 4 LGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ T L +++++ GG+LF R+ F+E++ +F+ +L + + H++ +
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGK 200
+RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ R + +
Sbjct: 121 YRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
AD WS GV ++ ML G PF+ KD ++T+ + +K
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 78/260 (30%), Positives = 117/260 (45%), Gaps = 60/260 (23%)
Query: 26 DF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLR----- 77
DF ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILAE 57
Query: 78 --HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLH 174
H + HRD+K +N LLD +K+ DFG
Sbjct: 118 HKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 175 SQPK------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
S+P STVGTP YIAPEV L+ Y K D WS GV +Y MLV
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLV 234
Query: 217 GGYPF--EDPDEPKDFRKTI 234
G PF ++P E +RK I
Sbjct: 235 GYPPFCSDNPQE--TYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 3e-29
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L + K+ + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V+++ +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
K EN LLD + + DFG K + S +T GTP Y+APEV+ + YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 205 WSCGVTLYVMLVGGYPFEDPD 225
W G LY ML G PF D
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-29
Identities = 75/241 (31%), Positives = 118/241 (48%), Gaps = 23/241 (9%)
Query: 13 AMDMPIMHDSDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQRE 69
A+ + + R IG G+ G+ + DK T VAVK ++ R + E + E
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE 66
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
++ R +HPNIV L L +VME+ GG L + I R +E++ ++
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125
Query: 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY 186
+S+ HA V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP +
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDP----------DEPKDFRKTIQ 235
+APEV+ R Y G D+WS G+ + M+ G P F +P + P + +
Sbjct: 182 MAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK 240
Query: 236 V 236
V
Sbjct: 241 V 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 52/272 (19%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSL 76
+D +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 193
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 194 RHEYDGKIA-----DVWSCGVTLYVMLVGGYPFED-------------------PDEPK- 228
DGK D WS GV Y M+ G PF + P++PK
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 229 --DFRKTIQV----------FIKPCCHITPFY 248
DF IQ + CCH PF+
Sbjct: 237 SSDFLDLIQSLLCGQKERLGYEGLCCH--PFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-28
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 136
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 193
+ + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS GV L+ + +G P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIV 82
++ I G FG L + + T + A+K +++ D I +N + R++ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + +L +VMEY +GG+ I G ED A+ + +++ GV H + H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174
Query: 203 DVWSCGVTLYVMLVGGYPF--EDPDE 226
D WS G ++ L G PF E PD
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 71/197 (36%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
IG G +G+ RD + E+VA+K + ER D I + REI +LRHPNIV KE
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKE 73
Query: 87 VILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ HL +VMEY L + + FSE + + QL+ G+ Y H +
Sbjct: 74 VV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYDGK 200
HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 131 HRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 201 IADVWSCGVTLYVMLVG 217
D+W+ G L +L
Sbjct: 189 AIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDEN------VQREIINHRSLR 77
++F+R +G+G+FG L K VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 198 DGKIADVWSCGVTLYVMLVGGYPF 221
GK AD W+ G+ +Y +LVG PF
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVR 83
V IG G +GV R+K+T E+VA+K I R D E V REI + L HPNIV+
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 84 FKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+VI T L +V E+ + F + + QL+ G+++CH+ +V H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYD 198
RDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL +Y
Sbjct: 124 RDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 199 GKIADVWSCGVTLYVML 215
D+WS G M+
Sbjct: 179 STAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 72/227 (31%), Positives = 103/227 (45%), Gaps = 20/227 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
D Y+ + IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 136
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 189
+ HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 190 EVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
EV+ H YD K AD+WS G+T + G P+ K T+Q
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G+G F RD T L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLRHE 196
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEV LR E
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGE 183
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPF 221
G+ DVWS G + M P+
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-27
Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RDLK EN LLD R I D G + + K GTP Y+APEVL YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKD 229
D ++ G TLY M+ G PF E +
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 27 FVRDIGSGNFGV---ARL-MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ +G G FG L + T+ VAVK ++ G ++ E E + L HPN
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IVR V L IV EY GG+L F R + + + + Q+ G+ Y +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPD 225
++ K +DVWS GV L+ + G P+
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMS 209
|
Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 90 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADV 204
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ + G AD+
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPK 228
WS G T+ M G PF + EP+
Sbjct: 195 WSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 69/203 (33%), Positives = 112/203 (55%), Gaps = 16/203 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D+Y+ V IG G +GV RD+VT E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 136
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 192
+ +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 193 LRHEYDGKIADVWSCGVTLYVML 215
L + D+WS G M+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLR 77
RY+ + +G G + V RDK T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 135
HPNI+ +V +++ +V E+ E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 191
H+ + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 192 LLRHEYDGKIADVWSCGV 209
L + G D+WS G
Sbjct: 174 LFGARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 79/269 (29%), Positives = 111/269 (41%), Gaps = 57/269 (21%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ IG G FG L+R T L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------SSVL 173
HRD+K +N L+D +K+ DFG Y K S +
Sbjct: 124 HRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 174 HSQPK----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ K S VGTP YIAPEVLLR Y ++ D WS GV LY MLVG
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 240
Query: 218 GYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
PF + K I + HI
Sbjct: 241 QPPFLADTPAETQLKVIN--WETTLHIPS 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
D ++ + ++G G FG + K T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ H+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 193
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 194 ---RHEYDGKIADVWSCGVTLYVM 214
+ YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-26
Identities = 76/225 (33%), Positives = 111/225 (49%), Gaps = 13/225 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++++ + +G G +GV R K TKE+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
Y GK D+WS G L L G P + D TIQ + P
Sbjct: 177 PY-GKAVDMWSVGCILG-ELSDGQPLFPGESEIDQLFTIQKVLGP 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVRFK 85
V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
++ + +++E+ GG L +F D AR Q++SG++Y H + HRD+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDI 194
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL---LRH-EYDGK 200
K N L++ A +KI DFG S+ P S+VGT AY++PE + L H YDG
Sbjct: 195 KPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252
Query: 201 IADVWSCGVTLYVMLVGGYPF 221
D+WS GV++ +G +PF
Sbjct: 253 AGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-26
Identities = 77/242 (31%), Positives = 118/242 (48%), Gaps = 25/242 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + AG F E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWS 206
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 207 CGVTLYVMLVGGYPFED---------------PDEPKDFRKTIQVFIKPCCHITP-FYPL 250
G+T + G P D P +F K + FI C + P F P
Sbjct: 187 LGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
Query: 251 FK 252
K
Sbjct: 247 AK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHP 79
RY + +IGSG +GV D + + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 80 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 190
H+ V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 191 VLLR-HEYDGKIADVWSCGVTLYVML 215
+LL EY I D+WS G ML
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
+ +R+IG G+FG RD T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 80 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
N + +K L +VMEY S ++ E + E E + G++Y H+
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---R 194
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 195 HEYDGKIADVWSCGVT 210
+YDGK DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGD-----KIDENV--QREIINH 73
++ +R +G+G +G L+R KV +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
R P +V T T L ++++Y +GGELF + F+E E R + +++ +
Sbjct: 61 VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV
Sbjct: 120 HLHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 192 LLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDE 226
+ K D WS GV + +L G PF E
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 74/265 (27%), Positives = 116/265 (43%), Gaps = 59/265 (22%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---- 77
+ ++ V IG G +G R K T +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 78 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 127
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 181 --VGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED--PD------ 225
+GTP ++APEV+ YD + +DVWS G+T + G P D P
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
Query: 226 ---------EPKDFRKTIQVFIKPC 241
P+++ K FI C
Sbjct: 231 PRNPPPTLKSPENWSKKFNDFISEC 255
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 64/182 (35%), Positives = 94/182 (51%), Gaps = 10/182 (5%)
Query: 67 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+R I+ +++HP IV T L +++EY SGGELF + G F ED A F+
Sbjct: 50 ERNIL--EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 185
++ + + H + +RDLK EN LLD +K+ DFG K S+ T GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHIT 245
Y+APE+L+R + GK D WS G +Y ML G PF + +KTI +K ++
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKGKLNLP 220
Query: 246 PF 247
P+
Sbjct: 221 PY 222
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 83
R IG G++ L+ K T+ + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 203 DVWSCGVTLYVMLVGGYPFE 222
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 81
Y + IG G F + + T + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 197 YDGKIADVWSCGVTLYVML 215
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 77
Y+ + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 78 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
GV + H+ ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVM 214
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHA 137
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CH+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL +
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 197 -YDGKIADVWSCGVTLYVMLVGGYP 220
Y I D+WS G + G P
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-25
Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENV--QREIINH 73
++ ++ +G+G +G L+R KVT +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I +
Sbjct: 61 VR-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE+
Sbjct: 120 HLHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
+ GK D WS G+ ++ +L G PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ YD V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E A+F+ +++ + H+
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPF 221
Y G+ D WS GV L+ MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 82/245 (33%), Positives = 117/245 (47%), Gaps = 41/245 (16%)
Query: 16 MPIMHDS-----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQR- 68
MP +D + Y+ ++ IG+G FG L++ K T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 69 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 121
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 122 RFFFQQLISGVSYCHAMQ-------VCHRDLKLENTLLDG---------------SPAPR 159
+QL+ ++YCH ++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLV 216
KI DFG SK+ + S S VGTP Y +PE+LL HE YD K +D+W+ G +Y +
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDK-SDMWALGCIIYELCS 238
Query: 217 GGYPF 221
G PF
Sbjct: 239 GKTPF 243
|
Length = 1021 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-25
Identities = 70/191 (36%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y V IG G +GV RDK+T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAM 138
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+V HRDLK +N L+D A LK+ DFG +++ V V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 198 DGKIADVWSCG 208
D+WS G
Sbjct: 177 YSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 9e-25
Identities = 76/209 (36%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D++D + IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 79 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 124
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 182
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
T Y PE+LL E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-24
Identities = 71/210 (33%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD-KIDENVQREIINH--RSLR 77
RY + +G G+FG L++DK L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 133
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
YD K +D+WS G LY M + FE
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-24
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G + R++ T E+VA+K I E G REI + L+H NIVR +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65
Query: 87 VILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
VI T L +V EY + + G + + F QL+ G+++CH +V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIA 202
LK +N L++ LK+ DFG +++ + + + V T Y AP+VLL Y I
Sbjct: 126 LKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI- 182
Query: 203 DVWSCGVTLYVMLVG 217
D+WS G + M+ G
Sbjct: 183 DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-24
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 8/201 (3%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIIN 72
D+ + + ++ ++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 191
Y H+ HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 192 LLRHEYDG--KIADVWSCGVT 210
G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 71/249 (28%), Positives = 106/249 (42%), Gaps = 40/249 (16%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFK 85
+ +G G G R K T + A+K I + + + RE+ ++S + P IV++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 86 EVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM 138
L + + I MEY GG L + I GR E + ++ G+SY H+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ HRD+K N LL +K+CDFG S V S + GT Y+APE + Y
Sbjct: 125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYS 181
Query: 199 GKIADVWSCGVTLYVMLVGGYPF-----------------------EDPDEPKDFRK--- 232
+DVWS G+TL + +PF E DEP + K
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 233 TIQVFIKPC 241
+ FIK C
Sbjct: 241 EFKDFIKQC 249
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ Y+ V+ IG G FG +L+R K T+++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E ARF+ +++ + H+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RHE---YDGKIADVWSCGVTLYVMLVGGYPF 221
Y G+ D WS GV LY MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-24
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 27 FVRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
F++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 193
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
++ +DVWS GVTLY + G P + P
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-24
Identities = 68/196 (34%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D TKE+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSC 207
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 208 GVTLYVMLVGGYPFED 223
G+T + G P D
Sbjct: 188 GITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 5e-24
Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + H Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFE-DPDE 226
D D W+ GV Y +L G +PF+ D DE
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-24
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 25/242 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWS 206
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 207 CGVTLYVMLVGGYPFED---------------PDEPKDFRKTIQVFIKPCCHITP-FYPL 250
G+T + G P + P ++ K ++ F++ C + P F P
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246
Query: 251 FK 252
K
Sbjct: 247 AK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-24
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K T+ + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 203 DVWSCGVTLYVMLVGGYPF------EDPDE 226
D W+ GV ++ M+ G PF ++PD+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 9e-24
Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQV 140
F + L L +VMEY +GG L + + DEA+ ++ + + + HA QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 198 DGKIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-23
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L ++I ME+ GG + + G E + +Q++ GV+Y H V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLRHE 196
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
Y G+ +D+WS G T++ M G P D
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-23
Identities = 63/195 (32%), Positives = 109/195 (55%), Gaps = 10/195 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L ++ME+ GG L + I + R +E++ + ++ + Y H+ V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 150 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 207 CGVTLYVMLVGGYPF 221
G+ + M+ G P+
Sbjct: 203 LGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-23
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K ++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 203 DVWSCGVTLYVMLVGGYPF----EDPD 225
D W+ GV ++ M+ G PF ++PD
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-23
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 199 GKIADVWSCGVT 210
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 4e-23
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-23
Identities = 64/191 (33%), Positives = 102/191 (53%), Gaps = 8/191 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ ++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L+ L I MEY GG L + G SE + + ++ + G++Y H+ H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG-- 199
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV + G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 200 KIADVWSCGVT 210
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-23
Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 199 GKIADVWSCGVT 210
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-23
Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRH 78
++RY ++ +G G FG+ RD++T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 79 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y H+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HE 196
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L +
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 197 YDGKIADVWSCGVTLYVMLVGG--YPFEDP------------DEPKDFRKTI 234
YD ++ D+WS G ML G +P +D P D TI
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-23
Identities = 60/212 (28%), Positives = 111/212 (52%), Gaps = 20/212 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDE-------NVQREIINH 73
++ ++ +G+G +G L+R KV + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T T L ++++Y +GGELF + RF E E + + +++ +
Sbjct: 61 IR-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 192 LLRHE--YDGKIADVWSCGVTLYVMLVGGYPF 221
+ + +D K D WS GV +Y +L G PF
Sbjct: 178 VRGGDGGHD-KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-23
Identities = 70/215 (32%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 25 YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI------------ERGDKIDENVQREII 71
Y + +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 127
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 128 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
PE++ Y G+ ADVW+ G LY M PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-22
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ R Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDP 224
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-22
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ + IG G F V + +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 134
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 189
H+ ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
E + + Y+ K +D+WS G LY M PF
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-22
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 83
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 199 GKIADVWSCGVT 210
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-22
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
++Y+ + IG G++GV R++ T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRHE 196
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 197 YDGKIADVWSCGVTLYVMLVG 217
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 43/252 (17%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 80
D ++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 178
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 179 ----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 223 DPDEPKDFRKTI 234
+ +RK +
Sbjct: 238 SETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
+ P + +Y+ + IG G FG R K TK++VA+K + + EN +
Sbjct: 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPIT 57
Query: 68 --REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG-RF 116
REI + L+H N+V E+ T +V E+ +L + N +F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH 174
+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++ L
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLS 172
Query: 175 SQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCG 208
K V T Y PE+LL G D+W G
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP 79
RY + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 191
H+ V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVG 217
+L + K D+WS G L ML
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-22
Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
G+ ADVWS T+ ML P+ +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-22
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 81
+ ++ + ++G G FG ++K T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 193
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 194 -RHEYDGKIADVWSCGVTLYVM 214
YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-21
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +AVK ++ + E + EI ++L H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D +K+ DFG SK + + KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
G+ AD+WS G T+ ML P+ +
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 42 MRDKVTKELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
R KE V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 101 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156
SGG+L ++I + F E E F Q++ + H+ ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 157 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 213
+K+ DFG+SK SV S GTP Y+APE+ R Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 214 MLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
+L PF+ P + + ++ + P
Sbjct: 264 LLTLHRPFKGPSQREIMQQVLYGKYDPF 291
|
Length = 478 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +SY H V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 207 CGVTLYVMLVGGYP-FEDP 224
G+ + M+ G P F +P
Sbjct: 204 LGIMVIEMIDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 70/196 (35%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 80
+Y ++ IG G +G+ ++ T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 81 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 193
H+ V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 194 R-HEYDGKIADVWSCG 208
EY I DVWS G
Sbjct: 182 NCSEYTTAI-DVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 67/244 (27%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 80
++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 178
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 179 --------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--E 222
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 223 DPDE 226
P E
Sbjct: 240 TPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-21
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDKIDENVQ----REIINHRSLR 77
++Y+ + +G G++G+ + K T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 135
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H+ + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG 217
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-21
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +S HA V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ R Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 207 CGVTLYVMLVGGYP-FEDP 224
G+ + M+ G P F +P
Sbjct: 202 LGIMVIEMVDGEPPYFNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-21
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
++ ++ + ++G G FG ++K T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ L I++E+ GG + + R +E + + +Q++ + Y H+M+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 193
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 194 --RHEYDGKIADVWSCGVTLYVM 214
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-21
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 206 SCGVTLYVMLVG 217
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-20
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L I MEY GG + +++ G +E R + +Q++ G+SY H+ + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED 223
G+ ADVWS G T+ ML P+ +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
+ D+G+GN G ++ T ++A K + G K +V+++I+ + H P IV
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVS 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCH 142
F L ++ + ME+ G L G + ++ G++Y + ++ H
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RD+K N L++ ++K+CDFG S +++S + VGT Y++PE + +Y K +
Sbjct: 128 RDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK-S 183
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKD 229
DVWS G+++ + +G +PF + D
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 73/246 (29%), Positives = 101/246 (41%), Gaps = 55/246 (22%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L R TK L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 142 HRDLKLENTLLD--------------------------GSPAPRLKICDFGYS------- 168
HRD+K +N L+D R DF
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 169 -----------KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
+++ H + S VGTP YIAPEVLLR Y ++ D WS GV LY ML
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEML 242
Query: 216 VGGYPF 221
VG PF
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-D--ENVQ------REI 70
H +Y+ ++ +G G +G+ D+ TKE+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 71 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 125
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
QL+ + Y H+ V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 181 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APE+LL K D+WS G L ML+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-20
Identities = 68/215 (31%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY +R +G G+ G+ D + VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 81 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 182
QL+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-20
Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + IG G +GV R+K T ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CH+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEY 197
+V HRDLK +N L+D +K+ DFG +++ + + + V T Y APEVLL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 198 DGKIADVWSCG 208
D+WS G
Sbjct: 179 YSTPVDIWSIG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ +D+WS G++L + +G YP PD
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ +D+WS G++L M +G YP PD
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-19
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 86
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCH 142
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 202 ADVWSCGVTLYVMLVGGYPF 221
D ++ GVTLY M+ PF
Sbjct: 179 -DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 78 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 188
Y H V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 189 PEVL--LRHEYDGKIADVWSCGVTLYVMLVG 217
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
SD ++ + IG G +G + +K AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 189
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 190 EVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 73/253 (28%), Positives = 104/253 (41%), Gaps = 63/253 (24%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 142 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 178
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 179 ---------------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
S VGTP YIAPEVLLR Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 212 YVMLVGGYPFEDP 224
+ MLVG PF P
Sbjct: 239 FEMLVGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 69/266 (25%), Positives = 115/266 (43%), Gaps = 59/266 (22%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDE----NVQREIINHRSL 76
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 169
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 170 --------SSVLHSQPK-------------STVGTPAYIAPEVLLRHEYDGKIADVWSCG 208
+ + S+ + STVGTP YIAPE+ L+ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 209 VTLYVMLVGGYPFEDPDEPKDFRKTI 234
++ L+G PF + + +RK I
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+D ++ + IG G +G + +K L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 81 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 190
+ + H ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 191 VL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
V+ + YD + DVWS G+T + G P D
Sbjct: 199 VIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-19
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 28 VRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
+R +G G+FG L + T E+VAVK ++R G + ++EI ++L H NI
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++K L ++MEY G L + + + + + F QQ+ G++Y H+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLLRH 195
HRDL N LLD +KI DFG +K+ + + + +P + A E L +
Sbjct: 128 YIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236
++ +DVWS GVTLY +L + P PK F + I
Sbjct: 186 KF-SYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIGP 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-19
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
V + IV EY S G C E RF QL+ G++Y + Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
+ K +DVW+ GV ++ V +G P+E + + K Q
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 83
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVC 141
+ THL +VM +GG+L I N G + R + Q+ G+ + H+M +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
+RD+K EN LLD RL D G + GT Y+APE+L Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKD----FRKTIQVFIK 239
D ++ G ++Y M+ G PF+D E R+T++ +K
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-19
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 26 DFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPN 80
+ + IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 81 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
I+ + + + L +V M Y S +L + G E F + +++ + Y H+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 189
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 190 EVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
EVL + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-19
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
DLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 200 KIADVWSCGVTLYVMLVGGYPF 221
AD +S G L+ +L G PF
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-19
Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 206 SCGVTLYVMLVG 217
G Y M G
Sbjct: 190 GVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 24 RYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIE----RGDKIDENVQREIINHRSLR 77
+Y+ IG G +G + K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 131
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 132 VSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 183
V Y H+ V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 184 PAYIAPEVLL--RHEYDGKIADVWSCG 208
Y APE+LL RH Y I D+W+ G
Sbjct: 179 IWYRAPELLLGARH-YTKAI-DIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-18
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYD 198
DLK N LLD R+ CDF K P ++VGT Y+APEVL + YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 199 GKIADVWSCGVTLYVMLVGGYPFE 222
AD +S G L+ +L G PF
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ + L+H NIV +++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G S + F Q++ G++YCH +V HRDLK
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY +I D+W
Sbjct: 133 QNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI-DMW 189
Query: 206 SCGVTLYVMLVG 217
G + M G
Sbjct: 190 GVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSL 76
D ++ ++ IG G FG +++ K T+ + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPF 221
PE+L E G D WS GV +Y ML G PF
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+ Y + +G G++ R K+T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 137
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RH 195
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 196 EYDGKIADVWSCGVTLYVMLVG 217
EY + D+W G Y M G
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-18
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + ++ VA+K ++ + +D +++ + + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ + L IV+E A G+L + I + E +F QL S V + H+ +V
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF 221
Y+ K +D+WS G LY M PF
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-18
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 9/213 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLR 77
+D Y+ + +G G++ + KV +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229
D+W G M+ G F + +D
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-18
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ + +E ++ EI + + H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 84 FKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + P H L +VME+ G + + + N ED + ++++ G+++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
HA +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
E YD + +D+WS G+T M G P D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-18
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 28 VRDIGSGNFGVARLMR-----DKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L R D T E VAVK + E G ++++EI R+L H N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 81 IVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K + + ++ME+ G L E + N + + + + Q+ G+ Y +
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLL 193
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L+
Sbjct: 128 RQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
+ ++ +DVWS GVTLY +L
Sbjct: 186 QSKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK------YIERGDKIDENVQREIINHRSL 76
D ++ ++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 135
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 189
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 190 EVLLRHEYDGK-----IADVWSCGVTLYVMLVGGYPF 221
E+L E DGK D WS GV +Y ML G PF
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-18
Identities = 52/148 (35%), Positives = 83/148 (56%), Gaps = 10/148 (6%)
Query: 94 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
+A+V++YA+ G+L + I + R F E EA F Q++ V + H+ + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 150 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ R Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
GV LY +L PF+ + + KT+
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTL 258
|
Length = 496 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-18
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDEN--VQREIINHRSLRHPNI 81
Y FVR +G G++G L+R + K+ V K R E ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 82 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHAM 138
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
Y+ K +DVW+ G +Y M + F D
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-18
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 36/255 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D + + ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 136 -HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 195 HEYDGKI-----ADVWSCGVTLYVMLVGGYPF------------------EDPDEPKDFR 231
+ +DVWS G+++ M +G YP+ + P P +
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 232 KTIQVFIKPCCHITP 246
Q F+ C + P
Sbjct: 236 DDAQDFVAKCLNKIP 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 132
+++ HP+++R K+ +++ +V+ + S +L+ + + D+A +Q++ G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
Y HA ++ HRD+K EN ++ ++ I D G ++ V+ GT APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPD 225
R +Y+ K AD+WS G+ L+ ML YP FEDP
Sbjct: 229 ARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-18
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 22/199 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 86
+G GN G +T+ ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 142
++I E+ GG L + +I GR + ++ G++Y ++++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + +Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 203 DVWSCGVTLYVMLVGGYPF 221
DVWS G++ + +G +P+
Sbjct: 175 DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----- 77
DRY + +GSG +G D T VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 78 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
++ G+ Y H+ + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-17
Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 34/248 (13%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 84 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFED----------PDEP------KDFRKT 233
E YD K +D+WS G+T M G P D P P K + K
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244
Query: 234 IQVFIKPC 241
Q FI+ C
Sbjct: 245 FQSFIESC 252
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRH 78
D + + + +IGSG G MR K T ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 79 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 135 C---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE 190
H V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPE 184
Query: 191 VL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
+ +YD + ADVWS G++L + G +P++
Sbjct: 185 RIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-17
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 27 FVRDIGSGNFGVARLMR-DKV---TKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
F++ +G GNFG L R D + T E+VAVK ++ + +REI +SL+H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHAM 138
V++K V + +L +VMEY G L + + R + + Q+ G+ Y +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEV 191
+ HRDL N L++ R+KI DFG +K + Q K V P + APE
Sbjct: 128 RYVHRDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPES 182
Query: 192 LLRHEYDGKIADVWSCGVTLY 212
L ++ +DVWS GV LY
Sbjct: 183 LTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-17
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + + VA+K I G +E+ E L HP +V+
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182
Query: 203 DVWSCGVTLY-VMLVGGYPFE 222
DVWS GV ++ V G PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFK 85
++G+GN GV + + + ++A K I +I ++ +II + H P IV F
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRD 144
+ ++I ME+ GG L + + AGR E+ ++ G++Y ++ HRD
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y + +D+
Sbjct: 126 VKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDI 181
Query: 205 WSCGVTLYVMLVGGYPFEDPDE 226
WS G++L M +G YP PD
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + VA+K ++ D +D + + I + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ L IV+E A G+L I + + E +F QL S + + H+ +V
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF 221
Y+ K +D+WS G LY M PF
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDKIDENVQREIINHRSLR---- 77
RY+ ++++G G +G+ R+ T E VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 78 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 125
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 180
Q++ G+ Y H+ V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 181 --VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-17
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSLRH 78
++ ++ IG G FG +++ K ++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 196 EYDGK-----IADVWSCGVTLYVMLVGGYPF 221
E DGK D WS GV +Y ML G PF
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-17
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
V++IGSG FG+ L + K VA+K I G +E+ E L HP
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + + +V E+ G L + + G+FS++ + G++Y +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV +
Sbjct: 121 VIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y K +DVWS GV ++ V G P+E+
Sbjct: 178 YSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 15/227 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
DRY ++ +GSG +G D+ T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
+ + D+WS G + ML G F+ D + ++V P
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-17
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPN 80
RY ++ +GSG +G DK T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ + D+WS G + ML G F+ D
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + K VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IV EY + G L + G+ + + + Y + HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIA 202
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 203 DVWSCGVTLYVMLVGG-YPFE 222
DVWS GV ++ + G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D + + VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
+L Y + D+WS G + M+ GG F D + K I+ PC
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + +G G++ ++ +LVA+K I K +E V RE + L+H N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISM--KTEEGVPFTAIREASLLKGLKHAN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV ++I T L V EY I + G R F QL+ G++Y H +
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYD 198
HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VLL +Y
Sbjct: 125 LHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 199 GKIADVWSCGVTLYVMLVG 217
+ D+W G ML G
Sbjct: 183 SAL-DIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-16
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 30 DIGSGNFGVARLMRDKVTKEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y + +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 193
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES-L 172
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
R +DVW GVTL+ M G E+P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYG---EEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 21/229 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
+L Y + D+WS G + ++ G F+ D + K I+ P
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P IV
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ +VMEY GG++ + G F E+ A + ++ + Y H + HR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK 169
DLK +N L+ S +K+ DFG SK
Sbjct: 129 DLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 29 RDIGSGNFGVAR--LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 81
+++G GNFG + K KE+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR V L +VME A G L + + + + Q+ G++Y +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLRHEY 197
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 198 DGKIADVWSCGVTLYVML-VGGYPFED 223
K +DVWS GVTL+ G P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-16
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 11/185 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG +M + VAVK ++ + E +LRHPN+V+ V+L
Sbjct: 14 IGKGEFG--DVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 91 PTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 207
N L+ K+ DFG +K + K V + APE L ++ K +DVWS
Sbjct: 132 NVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVWSF 185
Query: 208 GVTLY 212
G+ L+
Sbjct: 186 GILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSLR--- 77
+Y+ V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 78 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
G+ + HA + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 191 VLLRHEYDGKIADVWSCGVTLYVML 215
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 87 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 135
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPF 221
R YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 66/211 (31%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D Y+ + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 79 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 127
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 186
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
APEVLL + D+WS G M
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 13/226 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D ++ VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
+ + D+WS G + +L G F D ++ ++V P
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
R + S N G + + L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKI 201
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 202 ADVWSCGVTLYVML 215
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+RDLK EN LLD ++I D G + + VGT Y+APEVL Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDE 226
D W G +Y M+ G PF E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG+G+FGV T E VA+K + + + RE++ ++L H NI+ K+ T
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130
Query: 91 PT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
L +VME+ + + R N + + QL ++Y H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 138 MQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+CHRDLK +N L+D P LK+CDFG +K+ + + S + + Y APE++L
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQVFIKP 240
D+WS G + M++ GYP F + IQV P
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTP 290
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 17/228 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 80 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRDLK N ++ LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
L + + D+WS G + +L G F D + +++ P
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 69/263 (26%), Positives = 114/263 (43%), Gaps = 43/263 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
D + + ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 133
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 190
Y H+ + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 191 ---VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED----------------PDEPKD-F 230
L + YD K +DVWS G+T+ + G +P++ P P + F
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233
Query: 231 RKTIQVFIKPCC----HITPFYP 249
Q F+ C P YP
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 200 KIADVWSCGVTLYVMLVGGYPFE 222
D W+ G LY M+ G PF+
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-14
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 9/224 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
I+ V L + EL + +C + D R + Q++ G+ + H+
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
+ D+WS G + M+ F D + K I+ PC
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 27/233 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY ++ IGSG G+ D VT + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 78 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 128
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
+ G+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
PEV+L Y + D+WS G + M+ G F D + K I+ P
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 69/248 (27%), Positives = 98/248 (39%), Gaps = 51/248 (20%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------ 77
RYD +R IG G G L D V VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 78 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 124
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 125 -FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 167
F ++ + + Y H+ V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML +P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 225 DEPKDFRK 232
K RK
Sbjct: 234 ---KKGRK 238
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ +Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
D W G +Y M+ G PF E
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDE-----N 65
S+RY +G G +G D +T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 125
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 174
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 175 SQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
Q + S V T Y APE+L+ E D+WS G +L G F +E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
+Y+ V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 77 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRF 84
R +G G FG + + T ++ A K +E+ + +N + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
T L +V+ +GG+L I N G F E+ A F+ ++ G+ H ++ +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKI 201
RDLK EN LLD ++I D G + + + + VGT Y+APEV+ Y
Sbjct: 126 RDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 202 ADVWSCGVTLYVMLVGGYPFE 222
D W G +Y M+ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 85
R +GSG FG V L +++V VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR---VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHR 143
V + I+ E G L + + A Q+ G++Y HR
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDG 199
DL N L+ K+ DFG + K V L S K + APE +
Sbjct: 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGTFST 183
Query: 200 KIADVWSCGVTLY-VMLVGGYPFE 222
K +DVWS G+ LY + G P+
Sbjct: 184 K-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 28 VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
R +G+G FG V + TK VAVK ++ G E +E + LRH +V+
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHAM 138
V + IV EY S G L + + E + QL+ G++Y +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLLR 194
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 123 NYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 195 HEYDGKIADVWSCGVTLYVMLVGG---YP 220
+ K +DVWS G+ L ++ G YP
Sbjct: 179 GRFTIK-SDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 60/195 (30%), Positives = 90/195 (46%), Gaps = 23/195 (11%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
R IG G FGV + D + VA+K + + +N V RE+ +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 83 RFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ IL P H+ E EL + I + S D + F Q++ G+ Y H+
Sbjct: 63 SALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-- 193
+ HRD+K N L++ + LKICDFG ++ T V T Y APE+L+
Sbjct: 122 AGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 194 RHEYDGKIADVWSCG 208
RH Y + D+WS G
Sbjct: 180 RH-YTSAV-DIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-13
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR 77
D+ + IG+G FG R K+ +E+ VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 78 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ APE + ++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERG--DKIDENVQR 68
FV +G G FG L ++D K LVAVK + D E+ +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRFS 117
E+ L PNI R V L ++MEY G+L F + CN+ S
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177
+ Q+ SG+ Y ++ HRDL N L+ +KI DFG S++ L+S
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSD 184
Query: 178 KSTVG--TPAYI---APEVLLRHEYDGKIADVWSCGVTLYVML 215
V P I A E +L ++ K +DVW+ GVTL+ +L
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G +G A+ K KE A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEY-ALKQIE-GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 88 ILTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHA 137
L+ + + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIA 188
V HRDLK N L+ +G R+KI D G+++ L + P V T Y A
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRA 183
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVML 215
PE+LL + K D+W+ G +L
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-13
Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 43/227 (18%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
Y+ + +G G FG R T +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 79 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 124
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 178
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 179 --------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ V T Y PE+LL D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-12
Identities = 64/199 (32%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
IL L IVME S G L + GR + F + G+ Y + ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADV 204
N L+ S K+ DFG ++ + S P + APE L ++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 205 WSCGVTLYVMLVGG---YP 220
WS GV L+ + G YP
Sbjct: 181 WSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 53/186 (28%), Positives = 75/186 (40%), Gaps = 17/186 (9%)
Query: 47 TKELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 100
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APR 159
G L E + G E Q++ ++ H + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 160 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
K+ DFG + T +GTP Y APE LR E +D+++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIF 179
Query: 212 YVMLVG 217
L G
Sbjct: 180 LECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
IG G FG RL + VA+K ++ G DK + E HPNI+R +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCH 136
V+ + I+ EY G L F R E++ +F QL+ SG+ Y
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-YIAPE 190
M HRDL N L++ + K+ DFG S+ L ++T T P + APE
Sbjct: 124 EMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRWTAPE 178
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ + +DVWS G+ ++ VM G P+ D
Sbjct: 179 A-IAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-12
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
IG+G FG RL + VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 193
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-12
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 31 IGSGNFG-VAR-LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
IG+G FG V R +++ KE+ VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHE 196
RDL N L++ + K+ DFG S+ VL P+ T T + APE + +
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G +G + K K+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 89 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
L+ + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 189
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
E+LL + K D+W+ G +L
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-12
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 30 DIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
++GSGNFG + + + K +++ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDG 199
DL N LL KI DFG SK + + + K+ P + APE + +++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 200 KIADVWSCGVTLY 212
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-12
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 24 RYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----R 74
+ ++ +GSG FG V +KV K VA+K + ++ +EI++
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLR--EETSPKANKEILDEAYVMA 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 133
S+ HP++VR + L+ ++ + G L + + + + Q+ G+S
Sbjct: 65 SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPE 190
Y ++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+L Y K +DVWS GVT++ +M G P+E
Sbjct: 182 SILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-12
Identities = 62/215 (28%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFK 85
IG GNFG K VAVK R + ++ + L HPNIV+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + + IVME GG L + + + R ++L+ +G+ Y +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPAYIA 188
HRDL N L+ + LKI DFG Y+ S L P K T A
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------A 163
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
PE L Y + +DVWS G+ L+ G YP
Sbjct: 164 PEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 29 RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
R++G G+FG +A+ + + VA+K + + E E +N S
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCH 69
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF--------FFQ--- 126
++VR V+ T +VME + G+L + R R + F Q
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMAA 126
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 184
++ G++Y A + HRDL N ++ +KI DFG ++ + P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 185 A-YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
++APE L + K +DVWS GV L+ M
Sbjct: 185 VRWMAPESLKDGVFTTK-SDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-11
Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IVME GG+ + G R E + +G+ Y + HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEYDGKIA 202
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 203 DVWSCGVTLY-VMLVGGYPF 221
DVWS G+ L+ +G P+
Sbjct: 178 DVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 31 IGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK 85
IG G + L R K T E V V+ I +E V Q E+ + HPNIV ++
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L +V + + G + IC SE + Q ++ + Y H M HR
Sbjct: 66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125
Query: 144 DLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEV 191
+K + L +DG K+ G + V+H PK +V +++PEV
Sbjct: 126 SVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179
Query: 192 LLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 223
L ++ YD K +D++S G+T + G PF+D
Sbjct: 180 LQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-11
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 30 DIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
++GSGNFG + K+ K+ VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
RDL N LL KI DFG SK+ + + +S P + APE + ++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 199 GKIADVWSCGVTLYVML-VGGYPFE 222
+ +DVWS G+T++ G P++
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG L + K VAVK I + D + E LRH N+V+ VI+
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 91 P-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
L IV EY + G L + + + GR D F + + Y A HRDL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWS 206
N L+ S K+ DFG +K + S + T P + APE L ++ K +DVWS
Sbjct: 131 RNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWS 184
Query: 207 CGVTLY 212
G+ L+
Sbjct: 185 FGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 31 IGSGNFG------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 133
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 187
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 188 APEVLLRHEYDGKI---ADVWSCGVTLY-VMLVGGYPF 221
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 43/229 (18%)
Query: 23 DRYDFVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERGDKIDENV 66
R F +G G FG L M + K+ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 67 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 111
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 112 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
+ S F Q+ SG+ Y ++ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 172 VLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
L+S + A +++ E +L ++ +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 21 DSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
D +R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 189
+Y A HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
E L + + K +DVWS G+ L ++ G YP
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
R++G G FG L + + KELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 125
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
Q+ SG+ Y + HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY 212
++ PE ++ ++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 44/229 (19%)
Query: 31 IGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 83
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 126
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 173
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
S+ + V ++A E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ V+ +G+G FG V + TK VAVK ++ G + E ++L+H +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
VR V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE +
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 197 YDGKIADVWSCGVTLYVMLVGG---YP 220
+ K +DVWS G+ LY ++ G YP
Sbjct: 181 FTIK-SDVWSFGILLYEIVTYGKIPYP 206
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 13/169 (7%)
Query: 51 VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 110
VAVK ++ E +E + ++HPN+V+ V I+ E+ + G L + +
Sbjct: 34 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93
Query: 111 CNAGRFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
R + + Q+ S + Y HRDL N L+ +K+ DFG S
Sbjct: 94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLS 151
Query: 169 K-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
+ + H+ K + + APE L +++ K +DVW+ GV L+
Sbjct: 152 RLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SDVWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKY--IERGDKIDENVQREIINHRSLR 77
+ R IG G FG M + K VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLR 194
+ + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 20 HDSDRYDFVRDIGSGNFGV---ARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIIN 72
+ + ++VRDIG G FG AR + +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 112
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 113 AGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 170 --SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
S+ + ++ ++ PE + + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 85
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + IVME GG+ + R +DE + +QL+ +G++Y +
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 191 VLLRHEYDGKIADVWSCGVTLY 212
L Y + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 50 LVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK + R D + + + +EI L++PNI+R V ++ L ++ EY G+
Sbjct: 46 LVAVKML-RAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 106 L------------FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153
L F N S + Q+ SG+ Y ++ HRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 154 GSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
+KI DFG S+ S + V ++A E +L ++ +DVW+ GVT
Sbjct: 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVT 220
Query: 211 LYVMLV 216
L+ M
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 24 RYDFV--RDIGSGNFGVARLM--------RDKVTKELVAVKYI-ERGDKIDENVQREIIN 72
R++ V R++G G FG L +DK+ LVAVK + + D ++ RE
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDNARKDFHREAEL 60
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSED 119
+L+H +IV+F V + L +V EY G+L + + G ++
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
+ QQ+ +G+ Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRV 178
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
T+ ++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYG 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + +++ K A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 129
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 130 --SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L Y K +DVWS GV L+ ++ +GG P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVR 83
R +G+G FG + R ++ +EL VA+ + G DK E + H NIVR
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ VI + IV EY S G L F R + G+ + L SG+ Y M
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE 196
H+ L L++ KI F KS +++ KS V + APE + H
Sbjct: 130 HKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQYHH 184
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ ++ VM G P+ D
Sbjct: 185 FSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + ++ + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 127
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 30 DIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRF 84
+IG G N L R T LV V+ + + +E++ Q E++ RHPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 85 KEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR- 194
HR++K + L+ G L YS K+ V++ P+ + +++PE+L +
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 195 -HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+ Y+ K +D++S G+T + G PF+D
Sbjct: 184 LYGYNVK-SDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 60/284 (21%)
Query: 24 RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
R++F RD +G G FG + +DK KE V V D E ++
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 67
Query: 71 INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDE 120
++ + +H NI+ L +++EYAS G L E + A R +S D
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDI 126
Query: 121 AR-----FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
AR F+ L+S G+ Y + + HRDL N L+ + +KI DFG +
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLA 184
Query: 169 K--SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF--- 221
+ +++ + + + P ++APE L Y + +DVWS GV ++ + +GG P+
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGI 243
Query: 222 ------------EDPDEPKDFRKTIQVFIKPCCHITPFY-PLFK 252
D+P + + + ++ C H P + P FK
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 34/221 (15%)
Query: 29 RDIGSGNFG------VARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+IG+G FG R M V KEL A + + VQ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ----PYRELNHPN 56
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 135
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 192
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 193 LRHEYDGKIAD------VWSCGVTLYVMLVGGYPFEDPDEP 227
D D +WS GVT++ + F D+P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 27 FVRDIGSGNFG-VAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHP 79
F+ ++G G FG V + ++++ VA+K ++ K+ + ++E L+HP
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFFQ 126
NIV V ++ EY + G+L E + G S D + F
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 127 ---QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
Q+ +G+ Y + HRDL N L+ +KI DFG S+ S+ + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
+ ++ PE +L ++ + +D+WS GV L+
Sbjct: 187 LLPVRWMPPEAILYGKFTTE-SDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 17 PIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
P++ +D F IG GNFG AR+ +D + + A+K Y + D D + E
Sbjct: 2 PVLEWND-IKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 59
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
++ + HPNI+ +L + +EYA G L + + A
Sbjct: 60 VLC-KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
S + F + G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 176
Query: 174 HSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ K T+G P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 177 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 30 DIGSGNFG------VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIV 82
++G G FG L+ ++ K LVAVK + E + ++ QRE L+H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 83 RFKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQ 127
RF V L +V EY G+L F R G+ + + Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 185
+ SG+ Y ++ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTML 186
Query: 186 ---YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
++ PE +L ++ + +D+WS GV L+ + G
Sbjct: 187 PIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYG 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ +G+G FG V + TK VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 135
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 190
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
L + K +DVWS G+ L ++ G YP
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 74 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 117
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 174
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 225
+ ++A E L+ EY +DVWS GV L+ +M +G P+ + D
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREI-------INHRSLRH 78
+ +G G FG +L +D ++ VAVK + K+D + EI + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI--- 129
PN+++ V + L +++ + G+L + R + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 180
G+ Y HRDL N +L + +C DFG SK S + Q +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
+IA E L Y K +DVW+ GVT++ + G YP
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYP 217
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 24 RYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYIERGD-KIDENVQREIINHRS 75
R D V R++G G FG L + K LVAVK ++ ++ QRE +
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSED 119
L+H +IV+F V L +V EY G+L F R G
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
+ Q+ SG+ Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 181
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
T+ ++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYG 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 31 IGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG V + T+ VA+K ++ G E +E + LRH +V+ V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGVSYCHAMQVCHRDL 145
+ + IV EY S G L + + G + + Q+ SG++Y M HRDL
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
+ N L+ + K+ DFG ++ L + T A + APE L + K
Sbjct: 129 RAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 201 IADVWSCGVTLYVMLVGG---YP 220
+DVWS G+ L + G YP
Sbjct: 184 -SDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
V+ +GSG FG + + K VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRH 195
HRDL N L+ SP +KI DFG ++ +L K ++A E +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
++ + +DVWS GVT++ +M GG P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 12/220 (5%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
V+ +G+G FG + + VA+K +++G E E + L+HP +VR V
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ EY G L F + + + ++ Q+ G+++ HRDL
Sbjct: 70 V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
+ N L+ S KI DFG ++ + ++ + G + APE + + K +
Sbjct: 129 RAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-S 184
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
DVWS G+ L ++ G P+ P+ + + + P
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 55/273 (20%)
Query: 29 RDIGSGNFGVARLM------RDKVTKEL-VAVKYIERGDKIDENVQREIINHRSL----- 76
+ +G G FG + +DK K + VAVK + + D D+++ ++++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEMMKMIG 75
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 126
+H NI+ L +++EYAS G L E + A R +S D E + F+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 178
L+S G+ Y + + HRDL N L+ +KI DFG ++ + K
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKK 192
Query: 179 STVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF-------------- 221
+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
Query: 222 -EDPDEPKDFRKTIQVFIKPCCHITPFY-PLFK 252
D+P + + + ++ C H P P FK
Sbjct: 252 GHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 83
R IG G+FG L+ K AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 84 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVC 141
+ L +V+ Y G+L I + + + F Q+ G+ Y + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 225
++ K +DVWS GV L+ +M G P+ D D
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 43 RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
++ V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 163 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 220 PF 221
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 28 VRDIGSGNFG-----VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+R +G G FG + R + VAVK + D+ D ++ I++ H
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS--KFNH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQQLISG 131
NIVR V I++E +GG+L F R R S + F + + G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVGTPAYI 187
Y HRD+ N LL R+ KI DFG ++ + + + + ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
PE L + K DVWS GV L+ + GY
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGY 219
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+ +G+G FG V +K TK VAVK ++ G E E ++L+H +V+ V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ E+ + G L F + + + F Q+ G+++ HRDL
Sbjct: 70 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
+ N L+ S + KI DFG ++ K + + APE + + K
Sbjct: 129 RAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSFTIK 183
Query: 201 IADVWSCGVTLY-VMLVGGYPFEDPDEPKDFR 231
+DVWS G+ L ++ G P+ P+ R
Sbjct: 184 -SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 61/282 (21%)
Query: 23 DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIER-------GDKIDENV 66
DR + +G G FG + ++VTK VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSDATEKDLSDLISEME 75
Query: 67 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED--- 119
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 76 MMKMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 120 --EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
E + F+ L+S G+ Y + + HRDL N L+ +KI DFG ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARD 189
Query: 171 -SVLHSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF----- 221
+ K+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV 248
Query: 222 ----------EDPDEPKDFRKTIQVFIKPCCHITPFY-PLFK 252
D+P + + + ++ C H P P FK
Sbjct: 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 33/221 (14%)
Query: 31 IGSGNFG---VARL--MRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 81
+G G FG +A+ + ++ + LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 132
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 133 SYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 187
+ + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 188 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED-PDE 226
APE + ++ K +DVWS GV ++ V G PF DE
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE 225
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 31 IGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIV 82
+GSG FG + K VA+K I+ D+ +EI +H SL H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
R + + L +V + + G L + + + + Q+ G+ Y ++
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTP-AYIAPEVLLRHE 196
HR+L N LL S + ++I DFG + +L+ K S TP ++A E +L
Sbjct: 132 HRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 197 YDGKIADVWSCGVTLYVMLVGG 218
Y + +DVWS GVT++ M+ G
Sbjct: 188 YTHQ-SDVWSYGVTVWEMMSYG 208
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 17/179 (9%)
Query: 44 DKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 102
D T E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 163 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
C DFG + V + K GT A APE+L R Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 45/234 (19%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDENVQREI 70
DR + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 71 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 123
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 124 ----------FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
F Q+ G+ + + + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 174 HSQP---KSTVG-TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
H K+T G P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-07
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 9/177 (5%)
Query: 41 LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
L+ D T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-------ENVQREIINHRSLRHPNI 81
+ +G G FG +M ++ ++ +K + KI E+ E + + HPN+
Sbjct: 5 KTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 82 VRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQLI 129
+R V L +++ + G+L + R+ + ++ + F +
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
SG+ Y + HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDF 230
+IA E L Y K +DVWS GVT++ + G YP + E D+
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 31/234 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDEN----VQRE 69
+ F + +G+G FG +++ D V K VAVK ++ E + +
Sbjct: 35 NNLSFGKTLGAGAFG--KVVEATAYGLSKSDAVMK--VAVKMLKPTAHSSEREALMSELK 90
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
I++H H NIV + ++ EY G+L F R + ++ F Q
Sbjct: 91 IMSHLG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 185
+ G+++ + HRDL N LL + +KICDFG ++ + S K P
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 186 -YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD--FRKTIQ 235
++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 208 KWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 177
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
TV T APEVL Y + D+WS G+ ++
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 41/213 (19%)
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 126
+H NI+ V L +++EYA+ G L E + A R ++ D E + F+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFK 134
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQP 177
L+S G+ Y + + HRDL N L+ +KI DFG ++ + + +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKK 192
Query: 178 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF-------------- 221
S P ++APE L Y + +DVWS G+ ++ + +GG P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251
Query: 222 -EDPDEPKDFRKTIQVFIKPCCHITPFY-PLFK 252
D+P + + + ++ C H P P FK
Sbjct: 252 GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
F Q+ G+ + + HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 184 P----AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++APE + + Y ++DVWS G+ L+ + +GG P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 29 RDIGSGNFGVARL--MRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHAMQ 139
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 191
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 192 LLRHEYDG--------KIADVWSCGVTLYVML-VGGYPF 221
+ E G K ++VWS GVT++ + +G P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 9/108 (8%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 180
F Q+ +G+ + + HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEP 227
++APE + + Y ++DVWS G+ L+ + +GG P+ P+ P
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
++ +GSG FG + + K VA+K + K ++ + E S+ +P++
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
R + LT T + ++ + G L + + + + Q+ G++Y ++
Sbjct: 72 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRH 195
HRDL N L+ +KI DFG +K +L + K ++A E +L
Sbjct: 131 VHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
Y + +DVWS GVT++ +M G P++
Sbjct: 187 IYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ R+ + +G G FG D+ KE AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 82 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 132
RF + + H+ IVM +Y G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-L 244
Query: 133 SYCHA-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQP 177
Y H + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR- 302
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ V T Y +PEV+L + D+WS G +Y + G
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
V+ +GSG FG + + K VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLRHEY 197
HRDL N L+ SP +KI DFG ++ + G ++A E +L +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
+ +DVWS GVT++ +M G P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 46/226 (20%), Positives = 81/226 (35%), Gaps = 27/226 (11%)
Query: 43 RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
+ V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 103 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----- 152
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA-DVWSCGVTL 211
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 212 YVMLVGG-YPFE--DPDEPKDFRKTIQVFIKPCCHITPFYPLFKLI 254
+ G P E + F + P C L LI
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA-----ELANLI 237
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)
Query: 29 RDIGSGNFG------------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL 76
++IG+G FG VAR+ V KEL A K ++ +R L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARV----VVKELKA----NASSKEQNEFLQQGDPYRIL 52
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QLISGV 132
+HPNI++ + +V EY G+L + + Q ++ +GV
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAYIA 188
++ H H DL L N L +K+ D+G K + ++ V ++A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWLA 169
Query: 189 PEVLLRHEYDG-------KIADVWSCGVTLYVMLVGGYPFEDPDEP 227
PE L+ + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 170 PE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
P ++APE + Y + +DVWS GV L+ + +G P+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 29 RDIGSGNFGVAR---LMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 82
R +G G FG R L + + + VAVK ++ +++ RE + HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 83 RFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI------- 129
+ V L L I M + G+L + R E+ Q L+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
SG+ Y + HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L + Y +DVW+ GVT++ +M G P+
Sbjct: 180 KWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 31 IGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG + + TK VA+K ++ G + E +E + LRH +V V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70
Query: 90 TPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
+ + IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIA 202
N L+ + KI DFG ++ L + T A + APE L + K +
Sbjct: 131 ANILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 184
Query: 203 DVWSCGVTLYVMLVGG---YP 220
DVWS G+ L ++ G YP
Sbjct: 185 DVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 37/195 (18%)
Query: 50 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 106 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHAMQVCHRDL 145
L + ++ + E Q+ SG+ Y ++ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 201 IADVWSCGVTLYVML 215
+DVW+ GVTL+ +L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
P ++APE + Y + +DVWS GV L+ + +G P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+GTP Y+APE+LL + G D W+ GV L+ L G PF D
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND 582
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 49 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 107 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLEN 149
E + C++ + S D F Q+ +G+ Y + H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 150 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 206 SCGVTLY 212
S GV L+
Sbjct: 211 SFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 28/187 (14%)
Query: 49 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 105 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHAMQVCHRDLKLE 148
+L E + + G +D+ A F Q+ +G+ + + V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 149 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 206 SCGVTLY 212
S GV L+
Sbjct: 211 SYGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
P ++APE + Y + +DVWS GV L+ + +G P+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 13/92 (14%)
Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
A++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
Y K AD++S G+TLY L P+ +
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEALDYELPYNEE 107
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 176
+D RF Q + G+ + + HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 177 --PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
K P ++APE + Y + +DVWS G+ L+ + G YP
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYP 316
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 53 VKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112
VK I + I + EI + L+HPNIV+ + + ++ EY G L E + N
Sbjct: 720 VKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 113 AGRFSEDEARFFFQQLISGVS------YCH-AMQVCHRDLKLENTLLDGSPAPRLKICDF 165
E R +++ G++ +C + V +L E ++DG P L++
Sbjct: 777 LSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL--- 826
Query: 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220
S +L + K + + AY+APE + K +D++ G+ L +L G P
Sbjct: 827 --SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 181
F Q+ G+S+ + HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 182 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKD--FRKTIQ 235
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 23 DRYDFVRDIGSGNFGVAR--LMRDKVTKEL---VAVKYIERGDKIDENVQREIINHRSLR 77
++ +R++G G+FG+ RD + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 78 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 123
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 181 VGTPAYIAPEVLLRHEYDGKI---ADVWSCGVTLY 212
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.06 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.24 | |
| PLN02236 | 344 | choline kinase | 97.23 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.22 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.79 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.63 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.71 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.91 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.65 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.06 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.13 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=310.11 Aligned_cols=213 Identities=39% Similarity=0.633 Sum_probs=193.5
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.+...++|.+.+.||+|+|++||+++++.++..||||.+... ....+.+..|+.+|++++||||+.+++.+..++.+
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 344568999999999999999999999999999999988664 33456678999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CC---CceEEeccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKS 170 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~---~~~~l~df~~~~~ 170 (254)
++|||||+||+|..++...+.+++.+++.++.||+.|+++||+++|+||||||+|||++.. .. ..+||.|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999865 22 4699999999999
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 231 (254)
...+......+|++.|||||++....++.+ +|+||+|+++|+|++|+.||...+..+.+.
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 888888888899999999999998888777 999999999999999999999777655444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=300.59 Aligned_cols=213 Identities=36% Similarity=0.621 Sum_probs=192.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++++.||.|+||+||.|+.+.+++.||+|.+++.. .......+|..+|.+++||.|+++.-.|.+++.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 456889999999999999999999999999999999987643 3345678899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
|+|++|+.||.|...+++.+.+++..++.++.+|+.||+|||++||+||||||+|||++..|+ ++|+|||++......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999999998 999999999854444
Q ss_pred -CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHH
Q 025369 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234 (254)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 234 (254)
......+|++.|+|||++.+.+++.. .|+||||+++|+|++|.+||...+......++.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 34445599999999999999988666 999999999999999999999988766555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=313.53 Aligned_cols=221 Identities=37% Similarity=0.593 Sum_probs=200.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccC----CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.+|+.++.||+|||..+|.+++..+|+.||+|++.+ .....+.+.+|+++.++|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 789999999999999999999999999999999876 4567788999999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
|.|..++|..++....++++.+++.+++||+.++.|||+.+|+|||||..|+|++++.+ +|++|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999998899999999999999999999999999999999999999999988 999999999877654 555
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH--------------HHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT--------------IQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------------~~~~~~~~~~ 243 (254)
...+|++.|.|||++....+.-+ +||||+||+||.|+.|++||+..+-.+.+.++ -++++...++
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 67789999999999998888777 99999999999999999999987765555543 4466666666
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 255 ~~P 257 (592)
T KOG0575|consen 255 PNP 257 (592)
T ss_pred CCc
Confidence 666
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=298.00 Aligned_cols=225 Identities=31% Similarity=0.518 Sum_probs=201.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC--CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-eE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 94 (254)
.....++.+.++.||+|..|+||+++|+.++..+|+|.+.. .......+.+|++++++.+|||||.+++.|.+++ ..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 33455689999999999999999999999999999999844 3455677899999999999999999999999998 59
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
.++||||++|+|..++...+.+++..+..++.+++++|.|||+ .+|+||||||+|+|++..+. +||+|||++.....
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhh
Confidence 9999999999999999998999999999999999999999995 89999999999999998887 99999999876655
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------------------CChh-hHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------------------EPKD-FRK 232 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------------------~~~~-~~~ 232 (254)
. ......|+..|||||++.+..+... +||||||+.++|+..|+.||.... -++. +..
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 5 5567789999999999999998888 999999999999999999987641 1333 666
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.++.|+..|++.+|
T Consensus 310 ef~~FV~~CL~Kdp 323 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDP 323 (364)
T ss_pred HHHHHHHHHhcCCc
Confidence 79999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=300.10 Aligned_cols=208 Identities=39% Similarity=0.619 Sum_probs=185.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
..+.|.+.+.||+|+||.|-+|..+.+++.||+|++..... ......+|+++|++|+||+|+++.+++..+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 68899999999999999999999999999999999875321 1234579999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~~~~~l~df~~~~~~ 171 (254)
..|+|+||++||.|.+++..++.+.+..-+.+++|++.|+.|||++||+||||||+|||++.+ ...-+|+.|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999766 2234999999999987
Q ss_pred cccCCCCCccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
.........+|++.|.|||++.+.. .++.+.|+|||||++|-+++|.+||.+...+.
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 7777778889999999999997554 44556899999999999999999998766544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=300.45 Aligned_cols=233 Identities=29% Similarity=0.469 Sum_probs=207.3
Q ss_pred CCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEE
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEV 87 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (254)
.++...+++-..+.|+..++||+|.||.||+|++..+|+.||+|++.... ....-..+||.+|++|.||||+++.++
T Consensus 105 ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 105 GEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred ccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 45556777888899999999999999999999999999999999987653 334456799999999999999999999
Q ss_pred EEcC--CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 88 ILTP--THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 88 ~~~~--~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
..+. +.+|+|+||++. +|..++.+. -.|++.++.-+++|++.+|+|||.+|+.|||||.+|||+|.++. +||.|
T Consensus 185 vt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaD 261 (560)
T KOG0600|consen 185 VTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIAD 261 (560)
T ss_pred EEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEecc
Confidence 9887 689999999976 777777664 57999999999999999999999999999999999999998888 99999
Q ss_pred ccccccccccC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCcc
Q 025369 165 FGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCC 242 (254)
Q Consensus 165 f~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (254)
||+|....... .....+.+..|+|||.+.+...+..+.|+||.||++.||+.|+++|++.++.+++.++++-+..|+.
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 99998444433 3455667889999999999988888899999999999999999999999999999999999999998
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+..|
T Consensus 342 ~~W~ 345 (560)
T KOG0600|consen 342 DYWP 345 (560)
T ss_pred hccc
Confidence 8777
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=287.60 Aligned_cols=215 Identities=25% Similarity=0.462 Sum_probs=191.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+++|+.+.++|+|+||+||+.+++.||+.||||++..+.. ..+-..+|+.+|++++|+|+|.++++|.......+|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 5789999999999999999999999999999999876543 3355779999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-ccCC
Q 025369 99 EYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~ 176 (254)
||++. ++.+.++..+. .++..+..+++|++.|+.|+|+.+++||||||+|||++.++. +||||||+|+... .+..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence 99976 56666665543 889999999999999999999999999999999999998888 9999999998766 4555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (254)
...+..+.+|+|||.+.+...+.+..||||+||++.||++|.+.|++..+-+++..+...++.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~ 220 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN 220 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc
Confidence 567789999999999999776677699999999999999999999999998888888777665
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=300.08 Aligned_cols=228 Identities=32% Similarity=0.443 Sum_probs=206.8
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch--hHHHHHHHHhhcCC-CCCeeeeeEEEEcCC-
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLR-HPNIVRFKEVILTPT- 92 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 92 (254)
.....+++|.+.++||.|.||.||+|+...+++.||||+++.....- ---.+|+..|++++ ||||+++.+++.+..
T Consensus 4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 34567899999999999999999999999999999999987653332 33568999999998 999999999999987
Q ss_pred eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.+++||||++. +|.+++... ..+++..++.|++||+++|+++|+.|+.|||+||+|||+..... +||+|||+|+..
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev 160 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREV 160 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEeccccccccc
Confidence 99999999966 899888654 56999999999999999999999999999999999999986555 999999999998
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccccCCC
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
........++.+++|+|||++.....++.+.|||++||+++|+.+-++.|.+.++-+++.++++.+++|.++..|.
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 8888888999999999999998888777779999999999999999999999999999999999999999988774
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=276.64 Aligned_cols=212 Identities=33% Similarity=0.602 Sum_probs=193.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++++.||.|+||.|-+++.+.++..||+|.+.... ...+...+|..+|+.+.||.++++.+.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999887653 33456778999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||.+||.|.+++...+++++...+.++.+|+.||+|||+.+|++||+||+||++|.+|. +|+.|||+|++....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999999998 999999999865433
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
.-..+|++.|+|||.+...++... +|.||||+++|||+.|.+||........+.+++..
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~ 256 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG 256 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC
Confidence 556789999999999998888666 99999999999999999999998887777776543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=269.33 Aligned_cols=223 Identities=29% Similarity=0.446 Sum_probs=199.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+.+|...+.||+|.||+||+|++..+|+.||||++..... ..-...+|+..|+.++|+||+.++++|.+.+++.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 3689999999999999999999999999999999987543 3567889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||++. +|...+... ..++...+..++.+++.+++|||++.|.||||||.|+|++.++. +|+.|||+++........
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcc
Confidence 99965 787777544 46999999999999999999999999999999999999998888 999999999865543333
Q ss_pred C-CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccccCCC
Q 025369 178 K-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 178 ~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
. ...-+..|+|||.+.+...+....||||.||+++||+.|.+-|.+.++-+++..++..+.+|..+..|.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 2 336788999999999988777779999999999999999999999999999999999999999988883
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=291.76 Aligned_cols=212 Identities=33% Similarity=0.543 Sum_probs=187.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|+++++||+|+||.||+|+-+.||+.+|+|++.++. ......+.|-.+|....+|++|+++-.|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 457889999999999999999999999999999999998754 3345677788888888999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~- 173 (254)
||||||++||++..++...+.+++...+.++.+++.||+.+|+.|++||||||+|+|||..|+ +||+|||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999998 99999999732111
Q ss_pred ----------------------cCC-----C--------------------CCccCCCCccCccccccccCCCCcccHHH
Q 025369 174 ----------------------HSQ-----P--------------------KSTVGTPAYIAPEVLLRHEYDGKIADVWS 206 (254)
Q Consensus 174 ----------------------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 206 (254)
... . .+.+|++.|+|||++.+..+... .|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHH
Confidence 000 0 01248899999999999997666 99999
Q ss_pred HHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 207 CGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 207 lG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
|||+||||+.|.+||.+.+..+.++++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI 400 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKI 400 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999999999988777775
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=291.67 Aligned_cols=212 Identities=52% Similarity=0.860 Sum_probs=190.6
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----c--cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTP 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 91 (254)
....++|++++.||+|+||+|+.+.+..++..||+|++... . ...+.+.+|+..++.+. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 45678999999999999999999999999999999976553 1 23456778999999998 99999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CCCceEEeccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~~~~~l~df~~~~~ 170 (254)
..+++||||+.||+|.+.+.+.+++.+.+...+++|++.|++|||+.||+||||||+|++++.+ ++ +||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999988 65 99999999987
Q ss_pred c-cccCCCCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 171 S-VLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
. .........+|++.|+|||++.+.. +..+++|+||+|+++|.|++|..||...+.+..+.+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK 234 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 7 4556667889999999999999988 888889999999999999999999998665444444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=293.47 Aligned_cols=211 Identities=33% Similarity=0.532 Sum_probs=185.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
-..++|.+++.||+|+|++|++|++..+++.||||++.+..- ....+..|-..|..| .||+|++++-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 346799999999999999999999999999999998876432 224455677788888 899999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
|+|++|.++|+|.+++...+.+++...+.++.+|+.||+|||+.|||||||||+|||++++++ ++|.|||.|......
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChh
Confidence 999999999999999999999999999999999999999999999999999999999999998 999999988654443
Q ss_pred CCC--------------CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 175 SQP--------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 175 ~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
... ...+|+..|.+||.+.+...... +|+|+|||++|+|+.|.+||...++.-.++++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 222 23468889999999988877666 99999999999999999999998876666664
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=275.28 Aligned_cols=236 Identities=29% Similarity=0.377 Sum_probs=205.5
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
.......-..+.|+.+..|++|.||+||+|+++.+++.||+|+++.... ..-.-.+|+.+|.+++|||||.+.++..
T Consensus 66 ~~~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 66 QELLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred cccccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3335566677899999999999999999999999999999999876532 2234578999999999999999999987
Q ss_pred cC--CeEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 90 TP--THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 90 ~~--~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
.. +.+|+||+|++. +|.+.+..-+ ++...+++-++.|++.++.|||...|+||||||+|+|++..|. +|++|||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFG 222 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFG 222 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccc
Confidence 65 479999999966 8888887664 7999999999999999999999999999999999999998887 9999999
Q ss_pred ccccccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccccC
Q 025369 167 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 245 (254)
+|+....... .....-+..|+|||.+.+...++.+.|+||+||++.+|+++.+.|.+..+.+++.++++.+..|.....
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 9986544422 234456789999999999888877799999999999999999999999999999999999999999988
Q ss_pred CCcccc
Q 025369 246 PFYPLF 251 (254)
Q Consensus 246 p~~~~~ 251 (254)
|-+..+
T Consensus 303 pg~~~l 308 (419)
T KOG0663|consen 303 PGYSEL 308 (419)
T ss_pred CCcccc
Confidence 855543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=281.21 Aligned_cols=226 Identities=30% Similarity=0.502 Sum_probs=192.4
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeE-EEEcCC-
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILTPT- 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~- 92 (254)
......+|+|+++||.|.||.||+|.+..+|..+|.|.++... ...+....|+.+|++|+||||+++++ .+.+++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 4566778999999999999999999999999999999987543 33466789999999999999999998 444444
Q ss_pred eEEEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--eeecCCCCCcEEecCCCCCceEEec
Q 025369 93 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA--MQ--VCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~--i~h~di~p~nili~~~~~~~~~l~d 164 (254)
.+++|||++..|+|...+.. .+.+++..+|+++.|++.||..+|. .+ +.||||||.|||++.++. +||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeecc
Confidence 48999999999999888853 3459999999999999999999998 45 999999999999998887 99999
Q ss_pred ccccccccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------C
Q 025369 165 FGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------P 227 (254)
Q Consensus 165 f~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~ 227 (254)
||+++....... ..+.+|+++||+||.+.+.+++.+ +||||+||++|+|+.-+.||.+.+- .
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 999876554433 245679999999999999999777 9999999999999999999987542 2
Q ss_pred hhhHHHHHHhhcCccccCC
Q 025369 228 KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p 246 (254)
+.+...+..++..|.+.+|
T Consensus 251 ~~YS~~l~~li~~ci~vd~ 269 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDP 269 (375)
T ss_pred HHhhhHHHHHHHHHccCCc
Confidence 5566677777888877776
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=289.60 Aligned_cols=234 Identities=34% Similarity=0.491 Sum_probs=199.1
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc---hhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
......+.++..+.+.||+|+||+||++.+..+.. +|+|.+...... ...+.+|+.++++++||||+++++++..+
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45566677888999999999999999999984432 899988764332 45899999999999999999999999988
Q ss_pred C-eEEEEEEccCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecCCCCCcEEecCCC-CCceEEeccc
Q 025369 92 T-HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSP-APRLKICDFG 166 (254)
Q Consensus 92 ~-~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~di~p~nili~~~~-~~~~~l~df~ 166 (254)
. .+.+||||+++|+|..++.. ...++...+..++.+|+.++.|||+++ |+|+||||+|+|++.+. + +||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCc
Confidence 7 79999999999999999987 578999999999999999999999999 99999999999999886 5 9999999
Q ss_pred cccccccc-CCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------C
Q 025369 167 YSKSSVLH-SQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------P 227 (254)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~ 227 (254)
+++..... .......|+..|+|||++.+ ..++.+ +|+||||+++|+|++|..||..... +
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 98765544 33344678999999999984 456555 9999999999999999999987552 4
Q ss_pred hhhHHHHHHhhcCccccCCC-ccccc
Q 025369 228 KDFRKTIQVFIKPCCHITPF-YPLFK 252 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p~-~~~~~ 252 (254)
......+..+++.||..+|. .|-|.
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence 44677899999999999993 35443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=272.30 Aligned_cols=223 Identities=29% Similarity=0.405 Sum_probs=198.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCC-eeeeeEEEEcCC-----
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 92 (254)
+..|+.+++||+|.||+||+|+.+.+|..||+|++..... ......+|+.+++.++|+| |+.+.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 6789999999999999999999999999999999876543 4566789999999999999 999999998876
Q ss_pred -eEEEEEEccCccchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 93 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.+++|++|.+. +|..++.... .++...++.+++||+.|++|||+.||+||||||+|+++++++. +||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 78999999965 8888887665 4778899999999999999999999999999999999998777 99999999
Q ss_pred ccccccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccccCC
Q 025369 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~p 246 (254)
|...... ........+..|+|||++.+...+....||||+||+++||++++..|....+.++..++++.+.+|..+..|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 9855533 335666788899999999988666666999999999999999999999999999999999999999888777
Q ss_pred C
Q 025369 247 F 247 (254)
Q Consensus 247 ~ 247 (254)
.
T Consensus 247 ~ 247 (323)
T KOG0594|consen 247 G 247 (323)
T ss_pred C
Confidence 3
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=291.28 Aligned_cols=208 Identities=36% Similarity=0.629 Sum_probs=185.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch---hHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+++|.+.++||+|+||+||+++.+.+.+.||+|.+.+..+.. ..+.+|++++++++||||+.+++.|+....+|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 578999999999999999999999999999999987764443 55788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
||+.| +|..+++....++++.+..++++++.||.|||+.+|.|+|++|+||+++.++. +|++|||+|+........
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence 99977 99999999999999999999999999999999999999999999999998888 999999999866554333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
...-|++.|||||...+..++-. +|+|||||++||++.|++||........+..+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSI 212 (808)
T ss_pred eeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 23358999999999998888777 99999999999999999999775544444333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=276.30 Aligned_cols=223 Identities=34% Similarity=0.547 Sum_probs=190.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc-hhHHHHHHHHhhcCCCCCeeeeeEEEEcCC--eEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 98 (254)
..+|..++.||+|+||.||.+.+..++...|+|.+...+.. .+.+.+|+.+|++++||+||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 67899999999999999999999999999999988665322 466889999999999999999999744443 699999
Q ss_pred EccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccc---
Q 025369 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 173 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~--- 173 (254)
||+++|+|.+++.+.+ .+++..+..+++|++++|.|||++|++|+||||+|||++. ++. +||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999999887 7999999999999999999999999999999999999987 466 99999998876553
Q ss_pred -cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC-----------------CCChhhHHHHH
Q 025369 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-----------------DEPKDFRKTIQ 235 (254)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----------------~~~~~~~~~~~ 235 (254)
........+++.|+|||++.......+.+|||||||++.+|++|..||... ..+..+....+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 222345679999999999986433334599999999999999999999862 33555666788
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.|+..|...+|
T Consensus 254 ~Fl~~C~~~~p 264 (313)
T KOG0198|consen 254 DFLRKCFKRDP 264 (313)
T ss_pred HHHHHHhhcCc
Confidence 89999998888
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=288.64 Aligned_cols=214 Identities=33% Similarity=0.458 Sum_probs=195.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-C-----CCeeeeeEEEEcCCeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv 97 (254)
+|.|.+.||+|.||.|.++.+..+++.||||++++..........|+.+|..++ | -|+|+++++|...++.++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 899999999999999999999999999999999998888888888999999886 4 4799999999999999999
Q ss_pred EEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+|.+. .+|.+++..+. .++...++.++.||+.+|..||+.||||+||||+|||+.+-....+|++|||+++....
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-- 343 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-- 343 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--
Confidence 99984 59999998764 48899999999999999999999999999999999999887777899999999874432
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
..-.+..++.|+|||++.+.++..+ .|||||||+++||++|.+.|.+.++.+++..++..+..|.
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 2236778999999999999999888 9999999999999999999999999999999999888764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=276.35 Aligned_cols=220 Identities=31% Similarity=0.537 Sum_probs=188.7
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++.+..+++.+|+|.+.... ...+.+.+|+..++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 57999999999999999999999999999999886432 23356778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
||+++++|.+++.....+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999998764432 223
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCcccc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHI 244 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~ 244 (254)
...+++.|+|||.+.+.....+ +||||||+++|+|++|..||...+.... ....+.++++.|++.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCC
Confidence 3467889999999987776555 9999999999999999999977554322 233567888888888
Q ss_pred CCC
Q 025369 245 TPF 247 (254)
Q Consensus 245 ~p~ 247 (254)
+|.
T Consensus 236 dp~ 238 (291)
T cd05612 236 DRT 238 (291)
T ss_pred CHH
Confidence 874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=283.08 Aligned_cols=233 Identities=28% Similarity=0.441 Sum_probs=200.7
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+-.+.+.+++.++||+|.||.||.+.+..+ ..|++|.+....-..+++.+|+.++++|+|++|+++++++..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 666777778889999999999999999999843 4689999888777778899999999999999999999999998899
Q ss_pred EEEEEccCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++||||++.|+|.+++.. ...+...+.+.++.||+++++||+++++|||||..+||||+++.. +|++|||+|+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence 999999999999999986 456899999999999999999999999999999999999998887 9999999998322
Q ss_pred ccCCC--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 173 LHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 173 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
..... ...--...|+|||.+....++.+ +|+||||++|+||+| |+.||...+. |+..+..+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~v 433 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEV 433 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHH
Confidence 21111 11223457999999999999888 999999999999999 9999987553 55666679
Q ss_pred HHhhcCccccCC-Ccccc
Q 025369 235 QVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 235 ~~~~~~~~~~~p-~~~~~ 251 (254)
.++|+.||+.+| ..|.|
T Consensus 434 Y~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HHHHHHHhhCCcccCCCH
Confidence 999999999999 45544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=270.30 Aligned_cols=234 Identities=28% Similarity=0.439 Sum_probs=200.9
Q ss_pred CCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
.......+....++|++.+.||.|..++||+|+...++..||||++.... ...+.+++|+..++.++||||++++..|
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 45566778889999999999999999999999999999999999987653 3347889999999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
..++.+|+||+|+.+|++.+++...-+ +++..+..+.++++.||.|||++|.+|||||+.|||++++|. ++|+|||
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFg 171 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFG 171 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCce
Confidence 999999999999999999999976633 899999999999999999999999999999999999999998 9999999
Q ss_pred ccccccccCCC-----CCccCCCCccCcccc-ccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------
Q 025369 167 YSKSSVLHSQP-----KSTVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------- 226 (254)
Q Consensus 167 ~~~~~~~~~~~-----~~~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------- 226 (254)
++......... ....+++.|+|||++ ....-+..++||||||++..||.+|..||.....
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 76544333222 333689999999994 4444455569999999999999999999976442
Q ss_pred ----------ChhhHHHHHHhhcCccccCC
Q 025369 227 ----------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ----------~~~~~~~~~~~~~~~~~~~p 246 (254)
...+.+.+.+++..|++.||
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 23445578899999999998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=270.69 Aligned_cols=217 Identities=32% Similarity=0.496 Sum_probs=192.0
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--C---eEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAI 96 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~l 96 (254)
.=.|+..+.+|.|+||.||.+....+++.+|||++-.+.... -+|+.+++.+.||||+++.-+|... + +..+
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 347899999999999999999999999999999886655433 3688899999999999998888753 2 4568
Q ss_pred EEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 97 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
|+||++. +|...+.. +..++...++-+++||+.||.|||+.||+||||||+|+|+|.+.. .+||+|||.|+...
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLV 177 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeec
Confidence 9999965 88877763 567899999999999999999999999999999999999996633 49999999999998
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccc
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (254)
.+..+.++..++.|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+++..+++-++.|..+
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 88888999999999999999999888888999999999999999999999999999999999998887543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=279.16 Aligned_cols=224 Identities=30% Similarity=0.502 Sum_probs=192.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|++|.||++++..+++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 334689999999999999999999999999999999876432 2335678899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++|||+.+++|.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC-
Confidence 999999999999999988888999999999999999999999999999999999999998877 99999998864422
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~ 240 (254)
......+++.|+|||++.+.....+ +|+||||+++|+|++|..||...+... .+...+..++..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2233467889999999987776555 999999999999999999997654322 233457788888
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|-
T Consensus 249 ~L~~dP~ 255 (329)
T PTZ00263 249 LLQTDHT 255 (329)
T ss_pred HhhcCHH
Confidence 8888884
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=282.75 Aligned_cols=225 Identities=30% Similarity=0.532 Sum_probs=200.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
....+|...++||+|+.|.||.|....++..||+|.+.... .-.+-+.+|+.+++..+|+|||.+++.+...+.+|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 44578999999999999999999999999999999987653 34466889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
||++||+|.+.+.... +++.++..++++++.||++||.+||+|+|||.+||++..++. +||+|||++....... ..
T Consensus 350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCcc
Confidence 9999999999887664 899999999999999999999999999999999999998888 9999999876554443 55
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----------------CChhhHHHHHHhhcC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------------EPKDFRKTIQVFIKP 240 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------------~~~~~~~~~~~~~~~ 240 (254)
....|+++|||||++....+.++ .||||||++++||+-|.+||-..+ .++.+...+++|+..
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 66789999999999998888787 999999999999999999997533 355666689999999
Q ss_pred ccccCCCc
Q 025369 241 CCHITPFY 248 (254)
Q Consensus 241 ~~~~~p~~ 248 (254)
|++.|+..
T Consensus 506 cL~~dv~~ 513 (550)
T KOG0578|consen 506 CLVVDVEQ 513 (550)
T ss_pred Hhhcchhc
Confidence 99998843
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=275.58 Aligned_cols=226 Identities=36% Similarity=0.591 Sum_probs=187.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---------------cchhHHHHHHHHhhcCCCCCeeeee
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------------KIDENVQREIINHRSLRHPNIVRFK 85 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~ 85 (254)
..+.|++.+.||+|.||.|-+|++..+++.||+|++.+.. ...+...+|+.+++++.|||+|+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3678999999999999999999999999999999986421 1125788999999999999999999
Q ss_pred EEEEcC--CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 86 EVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 86 ~~~~~~--~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
++..++ +.+|+|+||+..|.+.+.-.....+++.+.++++++++.+|+|||.+||+||||||+|+|+++++. +||+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIs 252 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKIS 252 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEee
Confidence 998775 589999999998887654444444899999999999999999999999999999999999998887 9999
Q ss_pred ccccccccccc------CCCCCccCCCCccCcccccc---ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH---
Q 025369 164 DFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR--- 231 (254)
Q Consensus 164 df~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--- 231 (254)
|||++.....+ .......|++.|+|||.+.+ ..+...+.||||+|+++|.|+.|+.||-+....+.+.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99988644222 12234579999999999876 4456777999999999999999999998766544433
Q ss_pred -------------HHHHHhhcCccccCCCc
Q 025369 232 -------------KTIQVFIKPCCHITPFY 248 (254)
Q Consensus 232 -------------~~~~~~~~~~~~~~p~~ 248 (254)
+..+.+++.-++.||.-
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhh
Confidence 44666676667777743
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=278.27 Aligned_cols=206 Identities=29% Similarity=0.518 Sum_probs=177.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||+||++.+..+++.||+|.+.... .....+.+|+.+++.++|++|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999886432 22356778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
||+++++|.+++.....+++..+..++.|++.||+|||++||+||||+|+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998764321100
Q ss_pred ----------------------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 177 ----------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 177 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
.....+++.|+|||++.+..++.+ +|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 012357889999999987776655 999999999999999999998
Q ss_pred CCCCChhhH
Q 025369 223 DPDEPKDFR 231 (254)
Q Consensus 223 ~~~~~~~~~ 231 (254)
..+..+...
T Consensus 238 ~~~~~~~~~ 246 (363)
T cd05628 238 SETPQETYK 246 (363)
T ss_pred CCCHHHHHH
Confidence 766544333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=275.68 Aligned_cols=225 Identities=29% Similarity=0.456 Sum_probs=188.5
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccc-eeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.....++|++.+.||+|+||.||+|.+..++ ..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456789999999999999999999876554 68999987542 223456778999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++||||+.+++|.+++.....+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC
Confidence 99999999999999999988888999999999999999999999999999999999999988776 9999999886432
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFI 238 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~ 238 (254)
.......+++.|+|||++.+...+.. +|+||+|+++|+|++|..||...+.... +...+..++
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 183 --TRTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred --CCcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 22234568889999999987766555 9999999999999999999987654322 233456677
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
+.|++.+|.
T Consensus 260 ~~~l~~dp~ 268 (340)
T PTZ00426 260 KKLLSHDLT 268 (340)
T ss_pred HHHcccCHH
Confidence 777776663
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=264.45 Aligned_cols=218 Identities=32% Similarity=0.483 Sum_probs=192.0
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC---CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----C
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (254)
...+|...+.||.|++|.|+.+.+..+|+.||+|++.. ......+..+|+..|+.++|+||+.+.+++..+ +
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566668999999999999999999999999999863 233446778999999999999999999998762 4
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+|+|++++ +.+|...+..++.+++.-+..+++|++.+|.|+|+.+++|||+||.|++++.+.. +|++|||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 789999999 5589999999888999999999999999999999999999999999999988877 9999999998665
Q ss_pred c---cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 173 L---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 173 ~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
. ......+..+..|+|||.+.....++++.||||+||+++||++|++.|.+.+.-+++..++.-+..|.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 3 33335667889999999998888788889999999999999999999999999999999888877763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=271.02 Aligned_cols=210 Identities=40% Similarity=0.679 Sum_probs=193.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
-.+|++.+.||.|.||.|-+|.....|+.||||.+.++.. ..-.+++|+++++.|+||||+.++++|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3489999999999999999999999999999998876532 224578999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|||..+|.|.+++...+.+++.+.+.+++||+.|+.|+|+.+++|+||+.+|||+|++++ +|+.|||++.........
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 999999999999999999999999999999999999999999999999999999999988 999999998777777777
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
+..+|++-|.+||.+.+.++..+..|-||||+++|.|..|.+||.+.++...++++
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 88899999999999999999888899999999999999999999999986655554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=274.11 Aligned_cols=199 Identities=34% Similarity=0.534 Sum_probs=175.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..++..||+|.+.... .....+.+|+..++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999886432 22345778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
||+++++|.+++.....+++..++.++.|++.+|.|||+.|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998864432 334
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCH
Confidence 4568889999999987766555 9999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=265.31 Aligned_cols=221 Identities=26% Similarity=0.390 Sum_probs=185.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++|++++++.+.+.+++..+++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3789999999999999999999999999999876432 122456789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|...+... ..+++..++.++.|++.||+|||++|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998777543 35899999999999999999999999999999999999987776 999999998754433333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~~ 239 (254)
....++..|+|||++.+..++.. +|+||+|+++|+|++|..||...+.. ..+...+..++.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 44568889999999987777665 99999999999999999999765432 123345677888
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|+..+|.
T Consensus 238 ~~l~~~P~ 245 (285)
T cd05631 238 MLLTKNPK 245 (285)
T ss_pred HHhhcCHH
Confidence 88888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=272.43 Aligned_cols=217 Identities=35% Similarity=0.566 Sum_probs=183.6
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++++..+++.+|+|.+.... .......+|+..+++++||||+++.+.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999886532 22345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccCC
Q 025369 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 183 (254)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 183 (254)
+|.+.+.....+++..+..++.||+.||+|||+.||+||||+|+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999988776 99999998764322 2222344688
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCCCc
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p~~ 248 (254)
+.|+|||++.+..+..+ +|+||+|+++|+|++|..||...+... .+...+..++..|++.+|.-
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999987777655 999999999999999999997655322 23445677888888888743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=269.96 Aligned_cols=216 Identities=33% Similarity=0.565 Sum_probs=182.2
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++++..++..||+|.+.... .....+.+|+..++.++||||+++.+.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999876532 22345667899999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccCC
Q 025369 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 183 (254)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 183 (254)
+|...+.....+++..++.++.||+.||.|||++|++||||+|+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999988776 999999987643221 222334578
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCCC
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p~ 247 (254)
..|+|||++.+..+..+ +|+||||+++|+|++|..||...+... .+...+..++..|++.+|.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 89999999987776555 999999999999999999997665433 2334567788888888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=276.48 Aligned_cols=203 Identities=31% Similarity=0.524 Sum_probs=174.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 57999999999999999999999999999999875432 22345678999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
||+++++|.+++.....+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999998752211000
Q ss_pred ----------------------------------------------CCCccCCCCccCccccccccCCCCcccHHHHHHH
Q 025369 177 ----------------------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (254)
Q Consensus 177 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 210 (254)
.....+++.|+|||++.+..+..+ +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 001357888999999987776555 999999999
Q ss_pred HHHHHhCCCCCCCCCCCh
Q 025369 211 LYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 211 l~~l~~g~~pf~~~~~~~ 228 (254)
+|+|++|..||...+..+
T Consensus 238 l~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 238 MFECLIGWPPFCSENSHE 255 (377)
T ss_pred hhhhhcCCCCCCCCCHHH
Confidence 999999999997765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=275.51 Aligned_cols=201 Identities=33% Similarity=0.574 Sum_probs=174.6
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999886432 22345678999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
||+++++|.+++.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999988887 99999998754322110
Q ss_pred -------------------------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCC
Q 025369 177 -------------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219 (254)
Q Consensus 177 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 219 (254)
.....+++.|+|||++.+..++.+ +|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 011347889999999987776655 999999999999999999
Q ss_pred CCCCCCC
Q 025369 220 PFEDPDE 226 (254)
Q Consensus 220 pf~~~~~ 226 (254)
||...+.
T Consensus 238 Pf~~~~~ 244 (364)
T cd05599 238 PFCSDNP 244 (364)
T ss_pred CCCCCCH
Confidence 9976543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=262.11 Aligned_cols=217 Identities=29% Similarity=0.483 Sum_probs=181.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||.|++|.||++.+..++..||+|.+.... .....+.+|+..++.++||||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4678999999999999999999999999999999886432 23456778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-C
Q 025369 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 176 (254)
||+++ +|.+++.... .++...+..++.|++.||+|||++|++||||+|+||++++++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99976 8888876544 4789999999999999999999999999999999999988776 9999999876433222 1
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
.....++..|+|||.+.+......++|+||+|+++|+|++|..||...+..+....+...+..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2234567899999998765544555999999999999999999998877766666655554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=267.61 Aligned_cols=199 Identities=30% Similarity=0.496 Sum_probs=175.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++++..++..+++|.+.... .....+.+|+..+++++|||++++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4689999999999999999999999999999999886542 33467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++.....+++..+..++.+++.++.|||++ +++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998888899999999999999999999986 5999999999999988877 99999998764432 222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
....++..|+|||++.+...+.+ +|+||||+++|+|++|+.||..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCC
Confidence 34467889999999987776555 9999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.36 Aligned_cols=216 Identities=33% Similarity=0.558 Sum_probs=181.9
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++++..++..+|+|.+.... .....+.+|+..++.++||+|+++.+.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999886532 22345678899999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccCC
Q 025369 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 183 (254)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 183 (254)
+|...+.....+++.+++.++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999988888999999999999999999999999999999999999988776 999999987643221 222334588
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCCC
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p~ 247 (254)
+.|+|||.+.+..+..+ +|+||||+++|+|++|..||...+.... +...+..++..|++.+|.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 89999999987776555 9999999999999999999976554332 234567777788887774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=267.50 Aligned_cols=214 Identities=33% Similarity=0.547 Sum_probs=181.4
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||+|+||.||++.+..++..+|+|.+... ......+.+|+..++.++||||+++.+.+..++..++|+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999987642 22335567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccCCCC
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 185 (254)
.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999988776 999999987643222 22233468889
Q ss_pred ccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCCC
Q 025369 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p~ 247 (254)
|+|||.+.+..+..+ +|+||+|+++|+|++|..||...+.... +...+.+++..|+..+|.
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 999999987776555 9999999999999999999976544332 334567788888888883
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=277.53 Aligned_cols=224 Identities=37% Similarity=0.707 Sum_probs=200.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..+-|++++.||.|+.|.|-.|++..||+.+|||++... ......+.+|+.+++-+.|||++.++++|....++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 356799999999999999999999999999999998664 3445678899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|.||+++|.|.+++-..+++++.+...+++||+.++.|+|..+|+|||++|+|++++..++ +|++|||.|..-..+.-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999998888 99999999887777777
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~ 242 (254)
....||++.|.|||++.+..+...++||||-|++++.|++|..||.+.+.... +....+.++..-.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 78889999999999999999999999999999999999999999997664333 3334555555555
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+.||
T Consensus 248 ~VDp 251 (786)
T KOG0588|consen 248 DVDP 251 (786)
T ss_pred ccCc
Confidence 5555
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.48 Aligned_cols=201 Identities=33% Similarity=0.500 Sum_probs=173.7
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+.|++++.||+|+||+||+|.+..++..||+|.+.... .....+.+|+.+++.++|++|+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999886532 22356788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 175 (254)
||+++++|.+++.....+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999864221000
Q ss_pred ---------------------------------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHH
Q 025369 176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (254)
Q Consensus 176 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 210 (254)
......+++.|+|||.+.+..+..+ +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhH
Confidence 0012357889999999987776655 999999999
Q ss_pred HHHHHhCCCCCCCCCC
Q 025369 211 LYVMLVGGYPFEDPDE 226 (254)
Q Consensus 211 l~~l~~g~~pf~~~~~ 226 (254)
+|+|++|..||...+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (381)
T cd05626 238 LFEMLVGQPPFLAPTP 253 (381)
T ss_pred HHHHHhCCCCCcCCCH
Confidence 9999999999977554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=262.76 Aligned_cols=201 Identities=31% Similarity=0.511 Sum_probs=172.0
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|++|.||++++..++..+++|.+.... ...+.+.+|+..++.++||||+++.+++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 58999999999999999999999999999999886542 234567789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--C
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 177 (254)
|++++++..+......+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9998777655555567899999999999999999999999999999999999987776 99999998865432221 2
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
....++..|+|||++.+..++.. +|+||+|+++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 23457889999999987776554 9999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=274.70 Aligned_cols=201 Identities=36% Similarity=0.577 Sum_probs=176.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+..++.++|++++++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 58999999999999999999999999999999886532 33456778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 175 (254)
||+++++|.+++.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999886543322
Q ss_pred ---------------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 176 ---------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 176 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
......+++.|+|||.+.+..+... +||||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCH
Confidence 1223457889999999988766555 9999999999999999999977653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=249.13 Aligned_cols=212 Identities=34% Similarity=0.602 Sum_probs=192.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
-.+..++|++++.||.|.||.||.|+.+.++..+|+|++++++ .....+.+|+++.+.|+||||++++++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 4556889999999999999999999999999999999988754 234667889999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.|+++||...|++...+. ...++++...+.+++|++.|+.|+|.++++||||+|+|+|++..+. +++.|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeec
Confidence 999999999999999998 5567999999999999999999999999999999999999987777 999999988765
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
+ .......+++..|.+||...+...+.. .|+|++|++.|+++.|.+||.+....+.++++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI 234 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRI 234 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence 4 566677899999999999988888777 99999999999999999999998877777665
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=274.85 Aligned_cols=201 Identities=35% Similarity=0.546 Sum_probs=173.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++++..+++.||+|.+.... .....+.+|+.+++.++|++|+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999875432 23355778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc----
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~---- 174 (254)
||+++++|.+++.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 999999986421100
Q ss_pred ----------------------------------------CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHH
Q 025369 175 ----------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 214 (254)
Q Consensus 175 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 214 (254)
.......+++.|+|||++.+..+..+ +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00012357889999999987777655 9999999999999
Q ss_pred HhCCCCCCCCCC
Q 025369 215 LVGGYPFEDPDE 226 (254)
Q Consensus 215 ~~g~~pf~~~~~ 226 (254)
++|..||...+.
T Consensus 238 l~G~~Pf~~~~~ 249 (376)
T cd05598 238 LVGQPPFLADTP 249 (376)
T ss_pred hhCCCCCCCCCH
Confidence 999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=269.24 Aligned_cols=226 Identities=23% Similarity=0.389 Sum_probs=181.4
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (254)
+++..++|++.+.||+|+||.||++.+. .++..||+|.+.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4567789999999999999999999752 345689999886532 2235678899999999 8999999999887
Q ss_pred cCC-eEEEEEEccCccchHHHHHhc-------------------------------------------------------
Q 025369 90 TPT-HLAIVMEYASGGELFERICNA------------------------------------------------------- 113 (254)
Q Consensus 90 ~~~-~~~lv~~~~~~~~L~~~l~~~------------------------------------------------------- 113 (254)
..+ .++++|||+++++|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 654 688999999999999888642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC---CCCccCC
Q 025369 114 -------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGT 183 (254)
Q Consensus 114 -------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~ 183 (254)
.+++...+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++........ .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCC
Confidence 23677888999999999999999999999999999999987776 99999998864322211 1122345
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh----------------hhHHHHHHhhcCccccCC
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK----------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~p 246 (254)
..|+|||++.+..++.+ +||||||+++|+|++ |..||......+ .....+..++..||..+|
T Consensus 240 ~~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 240 LKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred ccccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 68999999987776665 999999999999997 999997654322 223457788889999888
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=266.75 Aligned_cols=221 Identities=33% Similarity=0.540 Sum_probs=183.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCC-CCeeeeeEEEEcCCeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 98 (254)
+|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+..|...+..+.| ++++.+.+.+.+.+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987643 2233456678888888876 56888999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~ 177 (254)
||+++++|.+.+.....+++..++.++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999988876 99999998754322 2222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~ 243 (254)
....++..|+|||++.+..+..+ +|+||+|+++|+|++|..||...+..+ .+......++..|+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 33457899999999987776555 999999999999999999997655332 233445567777777
Q ss_pred cCCC
Q 025369 244 ITPF 247 (254)
Q Consensus 244 ~~p~ 247 (254)
.+|.
T Consensus 238 ~~P~ 241 (324)
T cd05587 238 KHPA 241 (324)
T ss_pred cCHH
Confidence 7763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.85 Aligned_cols=201 Identities=36% Similarity=0.543 Sum_probs=173.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++++.||+|+||.||++++..++..+|+|.+.... .....+.+|+.+++.++|++|+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999886532 22356778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 175 (254)
||+++++|.+.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999864211000
Q ss_pred ---------------------------------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHH
Q 025369 176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210 (254)
Q Consensus 176 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 210 (254)
......+++.|+|||++.+..+... +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 0012357889999999987777655 999999999
Q ss_pred HHHHHhCCCCCCCCCC
Q 025369 211 LYVMLVGGYPFEDPDE 226 (254)
Q Consensus 211 l~~l~~g~~pf~~~~~ 226 (254)
+|+|++|..||...+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (382)
T cd05625 238 LYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHhCCCCCCCCCH
Confidence 9999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=274.67 Aligned_cols=212 Identities=36% Similarity=0.567 Sum_probs=186.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
.+...++|++.++||.|.||+|+++..+.+++.||||.+++.. ...+....|..++... +||.++.++..|..+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4677889999999999999999999999999999999988753 3445666777777666 5999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++|+||||+.||++. .+...+.+++..+..++..++.||.|||++||+|||||.+|||+|.+|+ +||.|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccC
Confidence 999999999999833 3345567999999999999999999999999999999999999999998 9999999997655
Q ss_pred -ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 173 -LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 173 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
.+......+|++.|+|||++.+..++.. .|+||||++||+|+.|..||.+.++++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 4556677799999999999988888666 99999999999999999999998886655543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=270.64 Aligned_cols=230 Identities=31% Similarity=0.497 Sum_probs=203.3
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.........|+..+.||+|.||.||++.+..+++.||+|++.... ...+++++|+.++..++++||.++++.+..+..
T Consensus 6 ~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 6 VLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred hhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 344455678899999999999999999999999999999987653 345789999999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++++|||+.||++.+.+.....+++..+..++++++.|+.|||.++.+|+||++.||++..++. ++|+|||++.....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeec
Confidence 9999999999999999998888899999999999999999999999999999999999998876 99999999875544
Q ss_pred cCCC-CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC---------------CChhhHHHHHHh
Q 025369 174 HSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---------------EPKDFRKTIQVF 237 (254)
Q Consensus 174 ~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------------~~~~~~~~~~~~ 237 (254)
.... ....|++.|||||++....++.+ +||||||++.++|.+|.+|+.... -+.++.+.+++|
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred hhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence 4333 56689999999999997778777 999999999999999999986533 234777889999
Q ss_pred hcCccccCCCc
Q 025369 238 IKPCCHITPFY 248 (254)
Q Consensus 238 ~~~~~~~~p~~ 248 (254)
+..|++.+|-.
T Consensus 243 V~~CL~k~P~~ 253 (467)
T KOG0201|consen 243 VEACLDKNPEF 253 (467)
T ss_pred HHHHhhcCccc
Confidence 99999999944
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=260.17 Aligned_cols=203 Identities=29% Similarity=0.474 Sum_probs=171.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++++..++..+|+|.+.... .......+|+..++.++|||++++.+++.++...++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3579999999999999999999999999999999886532 22345678999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
||+.+ +|.+.+... ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++. ++|+|||++...... ..
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99965 676666544 56899999999999999999999999999999999999988776 999999987543221 22
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.....++..|+|||++.+......++|+||+|+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 23345778999999987665555559999999999999999999987544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=271.26 Aligned_cols=203 Identities=29% Similarity=0.513 Sum_probs=175.5
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++.+..++..+|+|.+... ......+.+|+.++..++|++++++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999988642 223356778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
||+++++|.+++.....+++..+..++.|++.+|+|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998753321100
Q ss_pred ----------------------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 177 ----------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 177 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
.....+++.|+|||++.+..+... +|+|||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 012357889999999987777655 999999999999999999997
Q ss_pred CCCCCh
Q 025369 223 DPDEPK 228 (254)
Q Consensus 223 ~~~~~~ 228 (254)
..+...
T Consensus 238 ~~~~~~ 243 (360)
T cd05627 238 SETPQE 243 (360)
T ss_pred CCCHHH
Confidence 765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=264.20 Aligned_cols=220 Identities=34% Similarity=0.533 Sum_probs=181.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+|++.+.||+|+||.||++.+..++..+|+|.+.... ........|...+..+ .|++++++.+.+.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999876532 1223345566666666 5799999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~ 177 (254)
||+++++|...+.....+++..++.++.|++.||+|||+.|++||||+|+||++++++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999998877 99999998764322 2223
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~ 243 (254)
....+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+.... +...+..++..|++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 34567889999999987777655 9999999999999999999987654332 33445666777777
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 238 ~~p 240 (323)
T cd05616 238 KHP 240 (323)
T ss_pred cCH
Confidence 666
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=269.31 Aligned_cols=206 Identities=33% Similarity=0.501 Sum_probs=175.2
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.....++|++.+.||+|+||.||++++..+++.+|+|.+... ......+.+|+.+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 345678999999999999999999999999999999987542 1223457789999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||+|+||++++++. ++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceeccc
Confidence 99999999999999988654 5899999999999999999999999999999999999988877 99999998865432
Q ss_pred cC--CCCCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 174 HS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.. ......+++.|+|||++.+.. ....++|+||+|+++|+|++|..||...+.
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 21 123446889999999986543 234559999999999999999999977654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=269.82 Aligned_cols=223 Identities=33% Similarity=0.528 Sum_probs=196.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe-EEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 96 (254)
..++|.+++++|+|+||.++.++++..+..+++|.+... ........+|+.++++++||||+.+.+.|..++. .++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 368999999999999999999999999999999998754 3344577899999999999999999999999887 899
Q ss_pred EEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
||+|++||++.+.+... ..++++.++.++-|++.|+.|||+++|+||||++.|||++.++. ++|+|||+|+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCc
Confidence 99999999999998655 46999999999999999999999999999999999999998887 899999999987777
Q ss_pred C-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH---------------HHHhh
Q 025369 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT---------------IQVFI 238 (254)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---------------~~~~~ 238 (254)
. ......|++.|++||.+.+.++..+ +|||||||++|+|++-+++|...+-...+.++ ++.++
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 6 5566789999999999999999888 99999999999999999999987766555554 55556
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
+.+...+|
T Consensus 239 ~~~l~~~P 246 (426)
T KOG0589|consen 239 KSMLRKNP 246 (426)
T ss_pred HHHhhcCC
Confidence 66666665
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=265.63 Aligned_cols=223 Identities=29% Similarity=0.496 Sum_probs=183.2
Q ss_pred ceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCC-----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERG-----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
+|++++.||+|+||.||++++. .++..+|+|.+... ....+...+|+.+++.+ +|++++++.+++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 46889999987542 12234567789999999 589999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++|||+++++|.+.+.....+++..+..++.||+.||.|||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999988876 999999988653322
Q ss_pred CC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHH
Q 025369 175 SQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTI 234 (254)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~ 234 (254)
.. .....++..|+|||.+.+......++||||||+++|+|++|..||...... ..+...+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 21 223458889999999977654455599999999999999999999643221 1233446
Q ss_pred HHhhcCccccCCCc
Q 025369 235 QVFIKPCCHITPFY 248 (254)
Q Consensus 235 ~~~~~~~~~~~p~~ 248 (254)
..++..|++.+|.-
T Consensus 239 ~~li~~~l~~dp~~ 252 (332)
T cd05614 239 QDLLHKLLRKDPKK 252 (332)
T ss_pred HHHHHHHcCCCHHH
Confidence 77888888887743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=262.28 Aligned_cols=215 Identities=35% Similarity=0.552 Sum_probs=177.7
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhc-CCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++.+..++..||+|.+.... ...+....|...+.. .+||+|+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999876432 122334445555544 4899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988776 999999988643222 22234468
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p 246 (254)
+..|+|||++.+..+..+ +|+||||+++|+|++|..||...+... .+...+..++..|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 899999999987776655 999999999999999999998655322 234456788888888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=263.43 Aligned_cols=218 Identities=30% Similarity=0.481 Sum_probs=180.8
Q ss_pred eccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++.||+|+||.||++++. .+++.+|+|.+.... .....+.+|+.+++.++||||+++++.+..++.++++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 468899999876421 223456789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 178 (254)
|+++++|.+++.....+++..++.++.|++.+|+|||++|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999988776 999999987643222 2223
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCcccc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~ 244 (254)
...++..|+|||++.+.....+ +|+||||+++|+|++|..||...+... .+...+..++..|++.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 3468889999999987776555 999999999999999999997755322 2334567788888887
Q ss_pred CCCc
Q 025369 245 TPFY 248 (254)
Q Consensus 245 ~p~~ 248 (254)
+|.-
T Consensus 238 ~p~~ 241 (323)
T cd05584 238 NPSS 241 (323)
T ss_pred CHhH
Confidence 7743
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.78 Aligned_cols=200 Identities=31% Similarity=0.512 Sum_probs=174.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999876542 23456889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++.....+++..+..++.+++.++.|||+. +++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 9999999999998888899999999999999999999985 7999999999999987776 99999998754322 222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
....++..|+|||++.+.....+ +|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCc
Confidence 33457889999999977666555 99999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=264.45 Aligned_cols=191 Identities=31% Similarity=0.545 Sum_probs=165.8
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..||+|.+.... .....+.+|..+++.+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999886532 2234567788888888 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-ccCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 182 (254)
++|..++.....+++..++.++.|++.|+.|||++|++||||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988776 9999999876422 2222334468
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
+..|+|||++.+..++.+ +|+||||+++|+|++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcc
Confidence 889999999987776555 999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=266.03 Aligned_cols=217 Identities=35% Similarity=0.559 Sum_probs=181.3
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++.+..++..+|+|.+.... .......+|+..++.++||||+++.+.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999886532 22345667888999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
+|...+.....+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999999888889999999999999999999997 79999999999999998876 99999998764322 222233458
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCCCc
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p~~ 248 (254)
+..|+|||++.+..+..+ +|+||||+++|+|++|..||...+... .+...+..++..|++.+|.-
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 889999999987776555 999999999999999999997655432 23345677777788777743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=263.12 Aligned_cols=215 Identities=34% Similarity=0.537 Sum_probs=178.6
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..||+|.+... .........|...++.+ +||+++++++.+...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999987643 12234455677777665 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999988877 999999987643222 22233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p 246 (254)
++.|+|||++.+..+... +|+||||+++|+|++|..||...+..+. +...+.+++..|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 889999999987766555 9999999999999999999987654332 23345677777777777
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=257.51 Aligned_cols=221 Identities=26% Similarity=0.393 Sum_probs=184.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|++.+.||+|++|.||++.+..++..||+|.+.... .....+.+|+..++.++|++++++.+.+..++..+++|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999899999999886532 122345679999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+.+++|.+.+... ..+++..+..++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998887543 45899999999999999999999999999999999999987776 999999988654433333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~ 239 (254)
....++..|+|||++.+...+.. +|+||+|+++|+|++|..||...+... .+...+..++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 44567889999999977766555 999999999999999999998654322 23345677788
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|+..+|.
T Consensus 238 ~~l~~~P~ 245 (285)
T cd05605 238 QLLTKDPG 245 (285)
T ss_pred HHccCCHH
Confidence 88888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=262.10 Aligned_cols=220 Identities=35% Similarity=0.548 Sum_probs=180.3
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHH---hhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIIN---HRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~---l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
|++.+.||+|++|.||++.+..++..||+|.+.... ...+.+.+|... ++.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999886432 223445555544 4567899999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
|||+++++|...+.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999887754 46899999999999999999999999999999999999998876 999999987643222 22
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~ 242 (254)
.....++..|+|||.+.+..+..+ +|+||||+++|+|++|..||...+..+ .+...+..++..|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 234568889999999987766555 999999999999999999998755332 23345667888888
Q ss_pred ccCCCc
Q 025369 243 HITPFY 248 (254)
Q Consensus 243 ~~~p~~ 248 (254)
..+|.-
T Consensus 237 ~~dP~~ 242 (324)
T cd05589 237 RRNPER 242 (324)
T ss_pred hcCHhH
Confidence 877743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=262.73 Aligned_cols=199 Identities=33% Similarity=0.498 Sum_probs=167.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----CeEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 95 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 95 (254)
+|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+..++.++||||+++.+++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999987642 12234577899999999999999999988643 3579
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+|+||+. ++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 589999988888999999999999999999999999999999999999988877 9999999886432222
Q ss_pred CC----CCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 176 QP----KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 176 ~~----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.. ....++..|+|||++.+. .....++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11 234578899999998652 233445999999999999999999997644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=261.34 Aligned_cols=215 Identities=33% Similarity=0.512 Sum_probs=178.6
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhc-CCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++.+..++..||+|.+.... ........|...+.. .+||+++++++.+.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999999999999999886531 223445556666654 4899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..+..++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999988776 999999987643222 22234457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p 246 (254)
+..|+|||++.+..+..+ +|+||+|+++|+|++|..||...+.... +...+..+++.|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 889999999987776655 9999999999999999999976654332 23356678888888888
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.10 Aligned_cols=206 Identities=34% Similarity=0.517 Sum_probs=174.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.....++|++.+.||+|+||.||++++..++..+|+|.+.... .....+.+|..+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4456789999999999999999999999999999999875421 223456788999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCc
Confidence 99999999999999988654 5889999999999999999999999999999999999988777 99999999865432
Q ss_pred cC--CCCCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 174 HS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.. ......+++.|+|||++.... ....++|+||||+++|+|++|..||...+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 21 123446889999999986543 234559999999999999999999976553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=263.11 Aligned_cols=195 Identities=35% Similarity=0.611 Sum_probs=164.5
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|++|+||++.+..+++.||+|.+.... .....+.+|. ..++.++||||+++++.+...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999886432 1122333443 356788999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..++.++.||+.||.|||++|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988876 999999987643222 22233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
++.|+|||++.+..+..+ +|+||||+++|+|++|..||...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCH
Confidence 889999999987776555 9999999999999999999977553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=261.20 Aligned_cols=220 Identities=32% Similarity=0.525 Sum_probs=180.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........|...++.+. |++++++.+.+...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999876432 22234566777777775 577888999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
||+++++|.+.+.....+++.+++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998876 999999987643222 222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~ 243 (254)
....++..|+|||++.+..++.+ +|+||+|+++++|++|..||...+.... .......++..|++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 33457889999999987766555 9999999999999999999987654332 23344566666776
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 238 ~~p 240 (323)
T cd05615 238 KHP 240 (323)
T ss_pred cCH
Confidence 666
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=262.00 Aligned_cols=216 Identities=32% Similarity=0.512 Sum_probs=178.7
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..+|+|.+.... ...+....|..++..+ +||+|+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999876532 2224455677777655 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999998877 999999987643222 22233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhhcCccccCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFIKPCCHITPF 247 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~~~~~p~ 247 (254)
+..|+|||.+.+..+..+ +|+||||+++|+|++|..||...+..+.+ ...+..++..|++.+|.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 889999999987776555 99999999999999999999876543333 34556677777777773
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=269.44 Aligned_cols=215 Identities=29% Similarity=0.433 Sum_probs=177.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--------C
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------T 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~ 92 (254)
...+|++++.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|||++++.+++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4568999999999999999999999999999999875432 3345799999999999999998886432 2
Q ss_pred eEEEEEEccCccchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 93 HLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
.+++||||+++ ++.+++. ....+++..++.++.||+.||.|||+.||+||||+|+||+++.++. .++|+|||++
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccc
Confidence 46789999976 6666553 3456899999999999999999999999999999999999985542 3899999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
.............+++.|+|||++.+....+.++|+|||||++|+|++|.+||......+.+.++++.+..+
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 766555555556788999999998776544555999999999999999999999888877777776655443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=261.95 Aligned_cols=201 Identities=29% Similarity=0.496 Sum_probs=171.0
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++++..++..||+|.+... ......+.+|..+++.++|++|+++++.+.+++.+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5899999999999999999999999999999987642 122345778889999999999999999999999999999
Q ss_pred EccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++.. ...+++..+..++.||+.+|+|||++|++||||+|+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999976 456899999999999999999999999999999999999988776 999999987644332221
Q ss_pred --CCccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 178 --KSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 178 --~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
....+++.|+|||++.. ......++|+||+|+++|+|++|..||...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 22357889999999863 2333445999999999999999999997644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=244.58 Aligned_cols=237 Identities=27% Similarity=0.414 Sum_probs=196.3
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 91 (254)
+.-+...++||++.+.||+|||+.||++++-.+++.||+|++..+. ...+...+|++..++++|||+++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 4556788999999999999999999999999999999999987765 5567788999999999999999998876543
Q ss_pred ---CeEEEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEE
Q 025369 92 ---THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 92 ---~~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l 162 (254)
...|++++|+..|+|.+.+... ..+++.+++.++.+++++|++||+.. ++|+||||.||++.+++. .++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 3589999999999998888643 35999999999999999999999998 999999999999998777 899
Q ss_pred ecccccccccccCCCC----------CccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCC-------
Q 025369 163 CDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFED------- 223 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~----------~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~------- 223 (254)
+|||.+.......... ....+.-|+|||.+.-.. ..+.++|||||||++|.|+.|..||..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 9999876544433322 224678899999874332 224449999999999999999999953
Q ss_pred -----------CCCChhhHHHHHHhhcCccccCC-Ccccccc
Q 025369 224 -----------PDEPKDFRKTIQVFIKPCCHITP-FYPLFKL 253 (254)
Q Consensus 224 -----------~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~ 253 (254)
......+.+.+.++++.|.+.|| -.|.+++
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE 292 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence 12234478899999999999999 5666554
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=261.91 Aligned_cols=215 Identities=33% Similarity=0.533 Sum_probs=175.0
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..+++|.+.... .....+.+|. .+++.++||||+++.+.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999876432 1122333444 457889999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|...+.....+++..+..++.||+.+|.|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999988876 99999998764222 222233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~~~~~p 246 (254)
++.|+|||.+.+..+..+ +|+||||+++|+|++|..||...+..... ...+..++..|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 889999999987776555 99999999999999999999776533222 2235566666666666
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.02 Aligned_cols=215 Identities=31% Similarity=0.549 Sum_probs=174.5
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHH-HHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQRE-IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||+||++++..++..+++|.+.... .....+..| ...++.++|+||+++++.+...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999876432 111223333 3456788999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|.+.+.....+++..+..++.||+.||.|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999988776 99999998764322 222334468
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p 246 (254)
++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+. +...+..++..|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 899999999987776555 9999999999999999999976553322 23345556666666665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=262.48 Aligned_cols=216 Identities=30% Similarity=0.505 Sum_probs=177.8
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..+|+|.+.... .....+.+|+..+.++ +||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999886532 2234566777777666 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|...+.....+++..++.++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999999888888999999999999999999999999999999999999998877 99999998764322 222234467
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------------ChhhHHHHHHhhc
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------------PKDFRKTIQVFIK 239 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------------~~~~~~~~~~~~~ 239 (254)
+..|+|||++.+..+..+ +|+||||+++|+|++|..||..... +......+..+++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 889999999987776655 9999999999999999999952110 1122334567777
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|+..+|.
T Consensus 238 ~~L~~dP~ 245 (329)
T cd05618 238 SFLNKDPK 245 (329)
T ss_pred HHhcCCHH
Confidence 88887773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=264.53 Aligned_cols=205 Identities=34% Similarity=0.516 Sum_probs=173.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|++|.||++++..++..+|+|.+.... .....+.+|+.+++.++||+++++.+.+.+++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345689999999999999999999999999999999875421 2234467899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++++|.+++... .+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCC
Confidence 9999999999999988654 5889999999999999999999999999999999999988877 999999987654322
Q ss_pred C--CCCCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 175 S--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
. ......+++.|+|||.+.+.. ....++|+||||+++|+|++|..||...+.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 2 123346889999999986542 234559999999999999999999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=268.97 Aligned_cols=223 Identities=29% Similarity=0.448 Sum_probs=184.8
Q ss_pred CCceeEeccccCCcceEEEEEEEccc-ceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...|.+.+.||+|++|.||.|.+..+ +..+++|....... ....+.+|+..++.++||||+++++.+..++.+++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 45699999999999999999998877 78888887654332 23456789999999999999999999999999999999
Q ss_pred ccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
|+++++|.+.+.. ..++++..+..++.|++.+|+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887743 346899999999999999999999999999999999999988776 9999999987543222
Q ss_pred C---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHh
Q 025369 176 Q---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVF 237 (254)
Q Consensus 176 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~ 237 (254)
. .....+++.|+|||++.+..+..+ +|+||||+++|+|++|..||...+..+ .+...+..+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence 1 233458889999999987766555 999999999999999999997654322 233457778
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|+..+|.
T Consensus 303 i~~~L~~dP~ 312 (478)
T PTZ00267 303 LDPLLSKNPA 312 (478)
T ss_pred HHHHhccChh
Confidence 8888888873
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=258.97 Aligned_cols=215 Identities=33% Similarity=0.525 Sum_probs=177.3
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhc-CCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++++..++..||+|.+.... ........|...++. ++||+|+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999886531 222344556666665 5899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988778999999999999999999999999999999999999988776 999999987643222 22233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~~~~~p 246 (254)
+..|+|||++.+..++.+ +|+||+|+++|+|++|..||...+..+. +...+..++..|++.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence 889999999987776555 9999999999999999999976553222 23345677888888777
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=262.64 Aligned_cols=197 Identities=33% Similarity=0.578 Sum_probs=166.3
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||+||++.+..++..+++|.+.... .....+..|. .+++.++||||+++++.+..++.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999876432 1223334444 356788999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|...+.....+++..+..++.||+.||+|||+.|++||||+|+||++++++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998764322 222234468
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
+..|+|||++.+..+..+ +|+||||+++|+|++|..||...+..+
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~ 203 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAE 203 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHH
Confidence 889999999987777655 999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=256.21 Aligned_cols=224 Identities=24% Similarity=0.384 Sum_probs=180.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc----------------cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i 81 (254)
+..++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .....+.+|+..+++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 356899999999999999999998542 34479999876542 223567889999999999999
Q ss_pred eeeeEEEEcCCeEEEEEEccCccchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCeee
Q 025369 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHAMQVCH 142 (254)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h 142 (254)
+++++++.+.+..++++||+.+++|.+++.... .++...++.++.|++.||.|||+.|++|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999885431 3577889999999999999999999999
Q ss_pred cCCCCCcEEecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh--C
Q 025369 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--G 217 (254)
Q Consensus 143 ~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g 217 (254)
+||+|+||+++.++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ +
T Consensus 162 ~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 162 RDLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cCcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccC
Confidence 999999999988776 99999998864322211 122234678999999877776555 999999999999986 5
Q ss_pred CCCCCCCCCChh----------------------hHHHHHHhhcCccccCC
Q 025369 218 GYPFEDPDEPKD----------------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 218 ~~pf~~~~~~~~----------------------~~~~~~~~~~~~~~~~p 246 (254)
..||...+..+. ....+.+++..||..+|
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCc
Confidence 678865443221 23457788999999888
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=258.95 Aligned_cols=216 Identities=36% Similarity=0.563 Sum_probs=180.2
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||+||++.+..++..+|+|.+.... ........|..+++.+ +|||++++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999876432 2234456677777777 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999988876 99999998754222 222233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p~ 247 (254)
+..|+|||.+.+..+..+ +|+||||+++|+|++|..||...+... .+...+..+++.|++.+|.
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHH
Confidence 889999999988777665 999999999999999999997654322 2344567888888888873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=250.79 Aligned_cols=221 Identities=29% Similarity=0.443 Sum_probs=186.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
+.|++.+.||+|++|.||.+.+..++..+++|.+..... ....+.+|+..+++++|||++++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999998999999998764321 12457789999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
++|++++++|.+.+.....+++..+..++++++.++.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999987776 99999998764432211
Q ss_pred C----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hhhHHHHHH
Q 025369 177 P----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KDFRKTIQV 236 (254)
Q Consensus 177 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~ 236 (254)
. ....+...|+|||.+.+.....+ +|+||+|+++|+|++|+.||...+.. ......+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 22346678999999988775555 99999999999999999999664332 233456778
Q ss_pred hhcCccccCC
Q 025369 237 FIKPCCHITP 246 (254)
Q Consensus 237 ~~~~~~~~~p 246 (254)
++..|+..+|
T Consensus 239 li~~~l~~~p 248 (263)
T cd06625 239 FLRRTFVENA 248 (263)
T ss_pred HHHHHhhcCc
Confidence 8888888777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=262.05 Aligned_cols=222 Identities=29% Similarity=0.493 Sum_probs=181.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
....++|++.++||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|+||+++++++.+++.+++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 344678999999999999999999999999999999885432 234668899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
|+||+++++|... ...++..+..++.||+.||.|||+.|++|+||+|+||++++++. ++|+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMD 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccc
Confidence 9999999888542 23567888899999999999999999999999999999988776 9999999886543222
Q ss_pred CCCCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------ChhhHHH
Q 025369 176 QPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------PKDFRKT 233 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------~~~~~~~ 233 (254)
......++..|+|||++... .+...++||||||+++|+|++|+.||..... +......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 12344678899999987432 2233459999999999999999999974322 1223456
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|+..+|
T Consensus 304 l~~li~~~l~~~P 316 (353)
T PLN00034 304 FRHFISCCLQREP 316 (353)
T ss_pred HHHHHHHHccCCh
Confidence 7888999998888
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=258.83 Aligned_cols=213 Identities=40% Similarity=0.637 Sum_probs=189.2
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCC-CCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 92 (254)
.......|++.+.||+|.||.||.+....+|+.+|+|.+.+... ..+...+|+.+++.++ |||++.+.+++.+..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34456689999999999999999999999999999999876432 3468899999999998 999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC--CceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~--~~~~l~df~~~~~ 170 (254)
.+++|||++.||.|.+.+... .+++.....++.|++.++.|||+.|++|+|++|+|+|+..... +.++++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999998776 5999999999999999999999999999999999999975533 4699999999987
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
..........+|++.|+|||++....+... .|+||+|+++|.|++|.+||...+......+
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~ 249 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLA 249 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence 777556677789999999999988777677 9999999999999999999998776554444
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=261.02 Aligned_cols=201 Identities=29% Similarity=0.480 Sum_probs=170.6
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++++..+++.+|+|.+... ......+.+|..++..++|++|+.+.+.+.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987542 122344677888999999999999999999999999999
Q ss_pred EccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++.. ...+++..+..++.|++.+|+|||++|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457899999999999999999999999999999999999987776 999999987644322211
Q ss_pred --CCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 178 --KSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
....+++.|+|||++.+. .....++|+||+|+++|+|++|..||...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 224588899999998652 223344999999999999999999997544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=252.23 Aligned_cols=221 Identities=34% Similarity=0.599 Sum_probs=189.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++||||+++++++.+++..++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999999999999999876532 23456778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
||+++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999988776 999999987654332 33
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCcccc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~ 244 (254)
...++..|++||.+.+...... +|+||||+++++|++|..||...+... .+...+..+++.|+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccC
Confidence 4457788999999877665444 999999999999999999997655322 2234667888888888
Q ss_pred CCCc
Q 025369 245 TPFY 248 (254)
Q Consensus 245 ~p~~ 248 (254)
+|..
T Consensus 236 ~p~~ 239 (290)
T cd05580 236 DLTK 239 (290)
T ss_pred CHHH
Confidence 8743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.72 Aligned_cols=226 Identities=27% Similarity=0.454 Sum_probs=185.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.++|++.+.||+|+||.||++.... +..+++|.+.......+.+.+|+..+++++|||++++++++...+..+++|+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45789999999999999999998864 55789998776655567788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
+++++|.+++... ..+++..++.++.+++.+|.|||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 46899999999999999999999999999999999999987776 999999987643221111
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChhh---------------HHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF---------------RKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~---------------~~~~~~~~~~~ 241 (254)
....+...|+|||.+.+.....+ +|+||+|+++|+|++ |..||...+..+.. ...+..++..|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 12234457999999877666555 999999999999999 89999766543322 33467888889
Q ss_pred cccCC-Cccc
Q 025369 242 CHITP-FYPL 250 (254)
Q Consensus 242 ~~~~p-~~~~ 250 (254)
|..+| ..|-
T Consensus 238 ~~~~p~~Rps 247 (256)
T cd05114 238 WHEKPEGRPT 247 (256)
T ss_pred ccCCcccCcC
Confidence 99888 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=259.04 Aligned_cols=216 Identities=29% Similarity=0.486 Sum_probs=178.1
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|..++.++ +||+++.+++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999886532 2234567788888777 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 182 (254)
++|...+.....+++..++.++.|++.|++|||++|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999998888888999999999999999999999999999999999999988877 99999998764222 222234568
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------------ChhhHHHHHHhhcCc
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------------PKDFRKTIQVFIKPC 241 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------------~~~~~~~~~~~~~~~ 241 (254)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... +..+......++..|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 889999999987776555 9999999999999999999963221 112233466777777
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
+..+|.
T Consensus 238 L~~dP~ 243 (327)
T cd05617 238 LNKDPK 243 (327)
T ss_pred hccCHH
Confidence 777773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=262.16 Aligned_cols=231 Identities=24% Similarity=0.358 Sum_probs=185.1
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeee
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRF 84 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~ 84 (254)
.++....+..++|++++.||+|+||.||++.+ ..++..||+|.+.... ...+.+.+|+.+++.+ +||||+++
T Consensus 25 ~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred CCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 34455666778999999999999999999974 3456789999886532 2335677899999999 89999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhcC--------------------------------------------------
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNAG-------------------------------------------------- 114 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-------------------------------------------------- 114 (254)
++++.+++..++||||+++|+|.+++....
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 999999999999999999999988885421
Q ss_pred -------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 115 -------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 115 -------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.+++..+..++.||+.+|.|||+.|++||||+|+||++++++. ++|+|||++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~ 262 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR 262 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccce
Confidence 3677888999999999999999999999999999999987766 9999999886
Q ss_pred cccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh----------------h
Q 025369 170 SSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK----------------D 229 (254)
Q Consensus 170 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~----------------~ 229 (254)
........ .....+..|+|||.+.+..+..+ +|+||||+++++|++ |..||....... .
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence 44322211 11223457999999987776555 999999999999998 889987644322 2
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|++.+|
T Consensus 342 ~~~~l~~li~~cl~~dP 358 (375)
T cd05104 342 APSEMYDIMKSCWDADP 358 (375)
T ss_pred CCHHHHHHHHHHccCCh
Confidence 23457788888998888
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=251.13 Aligned_cols=224 Identities=24% Similarity=0.362 Sum_probs=183.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.++++|++.+.||+|+||.||++.+. ..+..+++|.+.... .....+.+|+..++.++|||++++.+++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 45789999999999999999999865 356789999887543 2234677899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++... ..+++..++.++.|++.|++|||++|++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999998764 56899999999999999999999999999999999999988776 99999997654322
Q ss_pred cCCC--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 174 HSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
.... ....++..|+|||.+.+..++.+ +|+||+|+++|++++ |..||...+. +......+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 1111 11223467999999877766555 999999999999875 9999975443 233445678
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
+++..||..+|
T Consensus 239 ~li~~c~~~~p 249 (266)
T cd05064 239 QLMLDCWQKER 249 (266)
T ss_pred HHHHHHcCCCc
Confidence 88889998888
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=263.02 Aligned_cols=217 Identities=30% Similarity=0.522 Sum_probs=181.2
Q ss_pred eccccCCcceEEEEEEEc---ccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
++.||+|+||.||++++. .++..+++|.+.... .......+|+..+++++||||+++++++..++.+++|+||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999873 578899999886532 12344667899999999999999999999999999999999
Q ss_pred CccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCc
Q 025369 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (254)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 180 (254)
.+++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999988776 999999987644332 222334
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------hhhHHHHHHhhcCccccCC
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~p 246 (254)
.++..|+|||.+.+.....+ +|+||||+++|+|++|..||...+.. ..+...+..++..|++.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 57889999999987766555 99999999999999999999765432 2234556788888888888
Q ss_pred C
Q 025369 247 F 247 (254)
Q Consensus 247 ~ 247 (254)
.
T Consensus 238 ~ 238 (318)
T cd05582 238 A 238 (318)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.89 Aligned_cols=194 Identities=22% Similarity=0.319 Sum_probs=168.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.+.||+|++|.||++.+..+++.||+|... .....+|+.++++++||||+++++++..+...++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3468999999999999999999999999999999643 34567899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc--CCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~--~~~~ 178 (254)
+. ++|..++.....++...++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...... ....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 85 588888887778999999999999999999999999999999999999988776 999999988542221 1222
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
...+++.|+|||++.+..+..+ +|+||||+++|+|++|..||..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCC
Confidence 3468899999999987766555 9999999999999999987653
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=262.97 Aligned_cols=202 Identities=32% Similarity=0.520 Sum_probs=172.2
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|+||.||++.+..++..+|+|.+..... ....+.+|+.+++.++|++++++.+.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999998865322 3355778899999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999988776 99999998865432221
Q ss_pred -CCCccCCCCccCcccccc-----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 177 -PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.....+++.|+|||.+.. ......++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 122357889999999863 22234459999999999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=253.53 Aligned_cols=214 Identities=27% Similarity=0.455 Sum_probs=177.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
...++|++.+.||+|+||.||++++..++..+++|.+.... .......+|+..+++++|+|++++++++..++..++|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 34688999999999999999999999999999999876432 2234567899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
+||+++ +|.+.+... ..++...+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcc
Confidence 999976 777776554 45889999999999999999999999999999999999988776 9999999876432222
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
......++..|+|||.+.+......++|+||||+++++|++|..||...+..+........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 220 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 1223456788999999876554455699999999999999999999887766555555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.61 Aligned_cols=212 Identities=27% Similarity=0.438 Sum_probs=175.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 92 (254)
...++|++.+.||+|+||.||++.+..++..+|+|.+... ......+.+|+..++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468999999999999999999999999999999988643 223456778999999999999999999986543
Q ss_pred --eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 --~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.++++|||+++ ++...+.. .++...+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccc
Confidence 57999999976 56555533 4788999999999999999999999999999999999988877 99999998865
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHh
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (254)
...........++..|+|||.+.+..+..+ +|+||||+++|+|++|..||...+..+.+.+.+..+
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 433333344567889999999988777666 999999999999999999999877655555444433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=258.81 Aligned_cols=202 Identities=27% Similarity=0.483 Sum_probs=170.6
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.++||+|+||.||++++..++..+++|.+... ......+.+|...+..++|++++++.+.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999987542 122234677888899999999999999999999999999
Q ss_pred EccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
||+++++|.+++.. ...+++..+..++.|++.+++|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999987776 99999998764322221
Q ss_pred -CCCccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 177 -PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.....+++.|+|||++.. ......++|+||||+++|+|++|+.||...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 123468899999999863 22334459999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=250.44 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=172.7
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++......++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 58999999999999999999999899999999875432 233557789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 178 (254)
|++++++..+......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888888777777999999999999999999999999999999999999988776 9999999876543332 122
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
...+...|+|||.+.+......++|+||+|+++++|++|..||...+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 334667899999987655445559999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=229.23 Aligned_cols=221 Identities=29% Similarity=0.489 Sum_probs=195.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.+|.-.++||+|.||+||++++..+.+.||+|.+...+ ....+..+|+-+++.++|+||++++++...+..+.+|++
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 56778899999999999999999999999999987653 344788999999999999999999999999999999999
Q ss_pred ccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 100 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
+|.. .|..+.. -++.++...++.++.|++.++.++|+.++.|+|++|+|.+++.++. +||.|||+++..... .-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9965 6766664 4578999999999999999999999999999999999999998887 999999998744332 233
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChhhHHHHHHhhcCccccCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~p 246 (254)
.....+..|++|.++.+...+....|+||.||++.++.. |.+.|.+.+.+++..+++..+..+..+..|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 445677899999999999888887999999999999997 888899999999999999999999888877
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=251.49 Aligned_cols=214 Identities=31% Similarity=0.426 Sum_probs=176.7
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||+|+||+||++.+..+++.+++|.+..... ..+.+..|+.+++.++|++++++.+++..++..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999998764321 224566799999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCCcc
Q 025369 107 FERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 181 (254)
Q Consensus 107 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 181 (254)
...+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877742 346899999999999999999999999999999999999987776 99999998765433222 22345
Q ss_pred CCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhhcCccc
Q 025369 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFIKPCCH 243 (254)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~~~~~~ 243 (254)
+++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...... ..+...+..++..|++
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 7889999999988776655 99999999999999999999754321 2234467778888888
Q ss_pred cCCC
Q 025369 244 ITPF 247 (254)
Q Consensus 244 ~~p~ 247 (254)
.+|.
T Consensus 238 ~~P~ 241 (280)
T cd05608 238 KDPE 241 (280)
T ss_pred CCHH
Confidence 8874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=250.34 Aligned_cols=212 Identities=29% Similarity=0.447 Sum_probs=171.8
Q ss_pred CceeEeccccCCcceEEEEEEEcc-cceeEEEEEccCCc---cchhHHHHHHHHhhcC---CCCCeeeeeEEEEc-----
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT----- 90 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 90 (254)
++|++.+.||+|+||.||++++.. ++..+|+|.+.... .......+|+..++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 46789999876432 2223455666666554 79999999999852
Q ss_pred CCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
...+++++|++++ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 3568999999964 888888654 34899999999999999999999999999999999999988776 999999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhh
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFI 238 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 238 (254)
.............++..|+|||.+.+..+..+ +|+||||+++|+|++|.+||...+..+.+.+++....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 65444433344567889999999977776555 9999999999999999999998887777766665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=250.04 Aligned_cols=220 Identities=27% Similarity=0.403 Sum_probs=184.4
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|+..+.||+|+||+||.+.+..+++.+|+|.+.... .....+.+|+..++.++|++++.+.+.+..++..+++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999999999999999876532 122346779999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|...+... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998887543 35899999999999999999999999999999999999987776 999999988654433333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~~ 239 (254)
....++..|+|||.+.+..+..+ +|+||+|+++++|++|..||...... ..+...+..++.
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 44568899999999977766555 99999999999999999999765432 123345677888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 238 ~~l~~~P 244 (285)
T cd05632 238 MLLTKDP 244 (285)
T ss_pred HHccCCH
Confidence 8888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=250.04 Aligned_cols=221 Identities=29% Similarity=0.506 Sum_probs=191.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
+|++.++||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|||++++.+.+..+...+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999886532 234678889999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
|+.+++|...+....++++..+..++.++++++.+||+.|++|+||+|+||++++++. ++|+|||++...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999988778999999999999999999999999999999999999988776 99999998876554444445
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~ 242 (254)
..+...|+|||.+.+.....+ +|+||+|+++|+|++|..||...+. +......+..++..|+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHc
Confidence 567788999999877776555 9999999999999999999987653 2234467778888888
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
..+|.
T Consensus 238 ~~~p~ 242 (258)
T cd05578 238 ERDPQ 242 (258)
T ss_pred cCChh
Confidence 88873
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=246.03 Aligned_cols=215 Identities=36% Similarity=0.597 Sum_probs=186.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC---CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
..+.|++.+.||+|.|++|++..+..+|+.+++|++.. +....+.+.+|+.+.+.|+||||+++.+...+.+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 46789999999999999999999999999999998753 234567899999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~ 176 (254)
+|++.|+.|..-+-..--+++..+-..++||++|+.|+|.+||+|||++|+|+++.... .+.+||+|||++.....+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999999976665555678899999999999999999999999999999999995333 33699999999987775555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
-....|++.|+|||++...++..+ +|||+-|+++|-|+.|.+||.+.+....+.++++.
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 566679999999999998888777 99999999999999999999987765555555443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=275.99 Aligned_cols=223 Identities=29% Similarity=0.398 Sum_probs=183.5
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++.++||+|++|.||++.+..+++.||+|.+.... ...+++.+|+..++.++|||++++++++.+++..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 479999999999999999999999999999999886532 2345678899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 98 MEYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
|+|++|++|.+++... ...+...++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence 9999999999988642 23456778899999999999999999999999999999988877 9999999
Q ss_pred ccccccccC-------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 025369 167 YSKSSVLHS-------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227 (254)
Q Consensus 167 ~~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 227 (254)
++....... ......+++.|+|||++.+...+.+ +|+||+|+++++|++|..||...+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 886541110 0112357889999999987776555 99999999999999999999764432
Q ss_pred h-----------------hhHHHHHHhhcCccccCCC
Q 025369 228 K-----------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ~-----------------~~~~~~~~~~~~~~~~~p~ 247 (254)
. .+...+..++..|+..+|.
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~ 274 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChh
Confidence 1 2234467777888888874
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=248.87 Aligned_cols=213 Identities=26% Similarity=0.413 Sum_probs=176.3
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||+|+||.||++++..+++.+++|.+.... ........|+.+++.++|||++++.+.+..+..++++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999875422 1223445689999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCC
Q 025369 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (254)
Q Consensus 107 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 184 (254)
.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88875443 4888999999999999999999999999999999999988776 9999999886554433333456788
Q ss_pred CccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------hhhHHHHHHhhcCccccC
Q 025369 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------KDFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------~~~~~~~~~~~~~~~~~~ 245 (254)
.|+|||++.+..++.. +|+||+|+++|+|++|..||...... ..+...+.+++..|++.+
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 9999999987776555 99999999999999999999754321 123345677788888877
Q ss_pred C
Q 025369 246 P 246 (254)
Q Consensus 246 p 246 (254)
|
T Consensus 238 P 238 (277)
T cd05607 238 P 238 (277)
T ss_pred H
Confidence 7
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=247.17 Aligned_cols=224 Identities=22% Similarity=0.346 Sum_probs=186.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
....+|++.+.||+|++|.||++.+..++..+++|.+.........+.+|+..++.++|++++++++++..++.+++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45678999999999999999999999899999999887665555678889999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|.+++... ..++...++.++.|++.++.+||++|++|+||+|+||++++++. ++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence 99999999998654 35889999999999999999999999999999999999987776 999999987654332221
Q ss_pred C--CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhc
Q 025369 178 K--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIK 239 (254)
Q Consensus 178 ~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~ 239 (254)
. ....+..|+|||.+.+...+.. +|+||||+++|+|++ |..||...+..+ .....+..++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1 1123457999999877776555 999999999999998 889986544322 23345777888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 240 ~cl~~~p 246 (263)
T cd05052 240 ACWQWNP 246 (263)
T ss_pred HHccCCc
Confidence 8888887
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=258.59 Aligned_cols=216 Identities=28% Similarity=0.463 Sum_probs=180.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 91 (254)
...++|++.+.||+|++|.||.+.+..+++.+++|.+... ......+.+|+..++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3468999999999999999999999999999999988653 22335677899999999999999999987643
Q ss_pred -CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..+++||||+++ ++...+.. .++...+..++.|++.||.+||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccc
Confidence 357999999966 66666643 4788999999999999999999999999999999999988776 99999999875
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
...........++..|+|||++.+..+..+ +|+||||+++|+|++|+.||...+..+.+.+.+..+..+|
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 444333344567889999999987776665 9999999999999999999998887777777766655544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=250.85 Aligned_cols=230 Identities=20% Similarity=0.209 Sum_probs=186.8
Q ss_pred CCCcccCCCceeEe--ccccCCcceEEEEEEEcccceeEEEEEccCCccc----hhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 15 DMPIMHDSDRYDFV--RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 15 ~~~~~~~~~~y~~~--~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
......+.++++.. ..|++|+++.||++.. +++.||+|.+...... .+.+.+|+..+++++||||+++++++
T Consensus 10 ~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 10 NDIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred CcceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 34444455566666 6889999999999988 5889999998765333 35567999999999999999999998
Q ss_pred Ec----CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEe
Q 025369 89 LT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 89 ~~----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
.+ ...+++++||+++++|.+++.....++......++.+++.++.+||+. +++|+||+|+||++++++. ++|+
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~ 165 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKII 165 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEc
Confidence 77 347899999999999999998888899999999999999999999985 8999999999999998876 9999
Q ss_pred cccccccccccCCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------- 228 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------- 228 (254)
|||++..... ......++..|+|||.+.+ ..+ +.++||||||+++|+|++|..||...+..+
T Consensus 166 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 166 CHGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242 (283)
T ss_pred ccchHhhhcc--ccccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9998764322 2233457788999999876 344 445999999999999999999998654322
Q ss_pred ---hhHHHHHHhhcCccccCC-Ccccc
Q 025369 229 ---DFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 229 ---~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
.....+..++..||+.+| .+|-+
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~ 269 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNI 269 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCH
Confidence 344568899999999999 44443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=246.89 Aligned_cols=220 Identities=36% Similarity=0.563 Sum_probs=185.5
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhH---HHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
|++++.||+|++|+||++++..++..+|+|.+......... ..+|+..+++++||+|+++.+++.+....+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999998876544333 345899999999999999999999999999999999
Q ss_pred CccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc-cccCCCCCc
Q 025369 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 180 (254)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~~~~~~ 180 (254)
.+++|.+++.....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999998888999999999999999999999999999999999999997776 999999987642 233344455
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---Chh------------------hHHHHHHhhc
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PKD------------------FRKTIQVFIK 239 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~------------------~~~~~~~~~~ 239 (254)
.++..|+|||.+........++|+||||+++++|++|..||..... ... ....+..++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 6788999999987344445559999999999999999999987621 110 1256777777
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|++.+|
T Consensus 239 ~~l~~~p 245 (260)
T PF00069_consen 239 KMLSKDP 245 (260)
T ss_dssp HHSSSSG
T ss_pred HHccCCh
Confidence 7777777
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=248.60 Aligned_cols=213 Identities=29% Similarity=0.450 Sum_probs=181.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.....+++++++.||.|.-|+||+++...++..+|+|++.+... ...+.+.|.++|+.+.||.++.++..+..+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44556789999999999999999999999999999999876432 23456678899999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.+++||||+||+|..+++.+ ..+++..++.++.+++.||+|||-.||++|||||+||||.++|+ +.|+||+++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccC
Confidence 99999999999999988765 45999999999999999999999999999999999999999998 999999986221
Q ss_pred cc---------------------------------cCC------------------------CCCccCCCCccCcccccc
Q 025369 172 VL---------------------------------HSQ------------------------PKSTVGTPAYIAPEVLLR 194 (254)
Q Consensus 172 ~~---------------------------------~~~------------------------~~~~~~~~~~~aPE~~~~ 194 (254)
.. ... ..+.+|+-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 000 001135668999999999
Q ss_pred ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 195 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
...... .|+|+||+++|||+.|.-||.+.+..+.+..+
T Consensus 310 ~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI 347 (459)
T KOG0610|consen 310 EGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI 347 (459)
T ss_pred CCCCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH
Confidence 999777 99999999999999999999988776655553
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.84 Aligned_cols=209 Identities=26% Similarity=0.394 Sum_probs=175.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----eEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (254)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999899999999875432 22356778999999999999999999998776 789
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+|++|+. ++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999996 478888877778999999999999999999999999999999999999998876 9999999886433221
Q ss_pred --CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHH
Q 025369 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (254)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 235 (254)
......++..|+|||.+.+......++|+||+|+++++|++|+.||...+..+++..+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 122335678899999988765545559999999999999999999988776655554443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=246.74 Aligned_cols=226 Identities=29% Similarity=0.428 Sum_probs=187.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|||++++.+.+..++.+++|+
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45678999999999999999999999899999999886543 23345778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
||+++++|.+++.....+++..+..++.|++.++.+||+.|++|+|++|+||++++++. ++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKR 163 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeeccccccc
Confidence 99999999999987778999999999999999999999999999999999999987776 9999999886543222 12
Q ss_pred CCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------hhhHHHHHH
Q 025369 178 KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------KDFRKTIQV 236 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------~~~~~~~~~ 236 (254)
....++..|+|||.+.. ......++|+||+|+++++|++|+.||...... ..+...+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 33457788999998743 222234599999999999999999998543211 123457888
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 244 li~~~l~~~P~ 254 (267)
T cd06646 244 FVKISLTKNPK 254 (267)
T ss_pred HHHHHhhCChh
Confidence 89999988883
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=256.15 Aligned_cols=199 Identities=27% Similarity=0.379 Sum_probs=172.3
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc-hhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-eEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~~ 99 (254)
.++|.-...||+|+||.||++..... ..+|||.+...... ..++.+|+..+.+++|||+++++|+|.+.+ ...+|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 45777778999999999999998844 88999987765544 566999999999999999999999999998 5999999
Q ss_pred ccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecCCCCCcEEecCCCCCceEEecccccccccc-
Q 025369 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~- 173 (254)
|++.|+|.+.+.... ++++..+.+|+.+++.||+|||+.. |+||||||+|||+|++.+ .||+|||+|...+.
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999997665 8999999999999999999999854 999999999999998888 89999999965443
Q ss_pred cCCCCCc-cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 174 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 174 ~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
....... .++.+|++||+......+.+ +||||+|+++.|+++|+.+....
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCC
Confidence 2222222 78899999999988666666 99999999999999999887653
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=261.05 Aligned_cols=216 Identities=34% Similarity=0.510 Sum_probs=175.1
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcC---CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
||+|+||+||++++..++..+|+|.+..... .......|...+... .||+|+++.+.+...+.+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999998754221 112233445555444 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 182 (254)
++|...+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999988776 999999987643222 22334568
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh---------------hHHHHHHhhcCccccCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~p~ 247 (254)
+..|+|||++.+......++|+||||+++|+|++|..||...+.... +...+..+++.|+..+|.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 88999999987655445559999999999999999999977554332 234566778888888774
Q ss_pred c
Q 025369 248 Y 248 (254)
Q Consensus 248 ~ 248 (254)
.
T Consensus 239 ~ 239 (330)
T cd05586 239 H 239 (330)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=266.51 Aligned_cols=224 Identities=29% Similarity=0.446 Sum_probs=184.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 92 (254)
...++|++.+.||+|+||+||++++..++..||+|.+.... .....+.+|+..+..++|++++++.+.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999999999999999886542 22345678899999999999999988765322
Q ss_pred ----eEEEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 93 ----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 93 ----~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
.+++|+||+++++|.+.+... ..+++..++.++.|++.+|.|||+.|++||||+|+||+++.++. ++|+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~D 186 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGD 186 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEe
Confidence 368999999999999888643 46899999999999999999999999999999999999988776 99999
Q ss_pred cccccccccc---CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------
Q 025369 165 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------- 226 (254)
Q Consensus 165 f~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------- 226 (254)
||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9998643322 11233468889999999987776555 9999999999999999999976443
Q ss_pred ChhhHHHHHHhhcCccccCC
Q 025369 227 PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~p 246 (254)
+..+...+..++..|+..+|
T Consensus 266 ~~~~~~~l~~li~~~L~~dP 285 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDP 285 (496)
T ss_pred CCCCCHHHHHHHHHHcccCh
Confidence 22334567788888888887
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=250.36 Aligned_cols=229 Identities=23% Similarity=0.401 Sum_probs=186.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccc-----eeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++.+.||+|++|.||++.....+ ..+++|.+.... .....+.+|+..++.++|||++++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34578999999999999999999976554 678999876432 23456788999999999999999999999888
Q ss_pred eEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC
Q 025369 93 HLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~ 156 (254)
..++++||+++++|.+++... ..++...++.++.|++.|+.+||+.|++|+||+|+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999998754 3478889999999999999999999999999999999998877
Q ss_pred CCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC-----
Q 025369 157 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP----- 227 (254)
Q Consensus 157 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~----- 227 (254)
. ++|+|||++....... ......++..|+|||.+.+...+.+ +|+||||+++|+|++ |..||......
T Consensus 162 ~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 162 T--VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred c--EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 6 9999999876432221 1123345678999999877766555 999999999999998 99998764432
Q ss_pred ----------hhhHHHHHHhhcCccccCC-Ccccc
Q 025369 228 ----------KDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 228 ----------~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
......+..++..||..+| -.|-+
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH
Confidence 2234567888999999888 44433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=257.73 Aligned_cols=216 Identities=27% Similarity=0.422 Sum_probs=179.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 91 (254)
...++|++.+.||+|+||.||.+.+..+++.+++|.+.... .......+|+..++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35689999999999999999999999999999999886532 2235667899999999999999999988643
Q ss_pred -CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
...+++|||+++ ++...+.. .++...++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCccccc
Confidence 357999999976 56666543 4788999999999999999999999999999999999988776 99999999875
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
...........++..|+|||.+.+..+..+ +|+||||+++|+|++|..||...+..+.+.+.+..+..+|
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 544433445567889999999987776665 9999999999999999999998876666666666555444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=247.59 Aligned_cols=221 Identities=27% Similarity=0.457 Sum_probs=184.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++++..++..+++|.+.... .....+.+|+..++.++|||++++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999875422 22345778999999999999999999999999999999
Q ss_pred EccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 99 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+|+++++|.+++.. ...+++..++.++.+++.|+.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999888753 344789999999999999999999999999999999999988776 999999987643322
Q ss_pred CC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------ChhhHHHHH
Q 025369 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------PKDFRKTIQ 235 (254)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------~~~~~~~~~ 235 (254)
.. .....+...|+|||.+.+.....+ +|+||+|+++++|++|+.||..... .......+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 21 123356778999999887776555 9999999999999999999864321 123445688
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
+++..||..+|
T Consensus 239 ~li~~cl~~~p 249 (267)
T cd08228 239 ELVSMCIYPDP 249 (267)
T ss_pred HHHHHHCCCCc
Confidence 99999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.34 Aligned_cols=223 Identities=34% Similarity=0.510 Sum_probs=188.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|||++++++.+.+.+.++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 5799999999999999999999998889999998865432 346788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCC
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 178 (254)
+++++|.+++... ..+++.+++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999988776 67999999999999999999999999999999999999998777 9999999876543322 222
Q ss_pred CccCCCCccCccccccc---cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------------ChhhHHHHHH
Q 025369 179 STVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------PKDFRKTIQV 236 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------------~~~~~~~~~~ 236 (254)
...+...|++||.+... ..+. ++|+||+|+++++|++|..||...+. ...+...+..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred cccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 33567789999998665 4544 49999999999999999999875431 1223456788
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 239 li~~~l~~~p~ 249 (262)
T cd06613 239 FIKKCLTKDPK 249 (262)
T ss_pred HHHHHcCCChh
Confidence 99999998883
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=259.99 Aligned_cols=226 Identities=24% Similarity=0.368 Sum_probs=181.5
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (254)
+.+..++|++++.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+..++.+ +|+||+++++.+.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 34667799999999999999999998643 33579999886542 2235677899999999 8999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhc--------------------------------------------------------
Q 025369 90 TPTHLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~-------------------------------------------------------- 113 (254)
.....+++|||+++++|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999888542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 114 --------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 114 --------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
.+++...++.++.|++.||.|||++|++||||+|+||++++++. ++|+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceee
Confidence 23677889999999999999999999999999999999987776 999999987643322111
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh----------------hHHHHHHhhc
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD----------------FRKTIQVFIK 239 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~----------------~~~~~~~~~~ 239 (254)
....++..|+|||++.+..++.+ +|+||||+++|+|++ |..||........ ....+..++.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK 349 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence 11223457999999977766555 999999999999997 9999976543221 2355778888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.||+.+|
T Consensus 350 ~cl~~dp 356 (374)
T cd05106 350 MCWNLEP 356 (374)
T ss_pred HHcCCCh
Confidence 8888888
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=249.35 Aligned_cols=221 Identities=26% Similarity=0.385 Sum_probs=183.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|++.+.||+|+||.||.+.+..+++.+++|.+..... ....+.+|+.+++.++|++++++.+.+.+.+..+++++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999998765321 12346679999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+.+++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999999888543 35899999999999999999999999999999999999987776 999999987654433333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~~ 239 (254)
....++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||...... ..+...+.+++.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 34567889999999987776555 99999999999999999999764321 112335677777
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|++.+|.
T Consensus 238 ~~l~~~p~ 245 (285)
T cd05630 238 MLLCKDPK 245 (285)
T ss_pred HHhhcCHH
Confidence 88887773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=248.41 Aligned_cols=199 Identities=30% Similarity=0.478 Sum_probs=167.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|||++++++++.+++..++|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999999999999876432 2235678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 974 787777543 45899999999999999999999999999999999999988877 99999998764322211
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.....+...|+|||.+.+......++|+||||+++++|++|+.||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1223457789999998766544555999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=245.21 Aligned_cols=222 Identities=26% Similarity=0.443 Sum_probs=183.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.++|++.+.||+|++|.||.+.... +..+++|.+.......+.+.+|+..++.++|||++++++++...+..++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46789999999999999999998764 44699998876555567788999999999999999999999988889999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
+.+++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|.||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999998764 46899999999999999999999999999999999999987776 999999987543222111
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~~~ 241 (254)
....+...|++||.+.+.....+ +|+||||+++|+|++ |..||......+ .....+..++..|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 11224467999999977666555 999999999999998 999987544322 2334677888889
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
|..+|
T Consensus 238 l~~~p 242 (256)
T cd05113 238 WHEKA 242 (256)
T ss_pred cCCCc
Confidence 98888
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=245.65 Aligned_cols=224 Identities=24% Similarity=0.380 Sum_probs=184.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
....++|+++++||+|++|.||++... ++..+++|.+.......+.+.+|+..++.++|+|++++.+.+...+..++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 356789999999999999999999876 5567999988765555678889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
||+++++|.+++... ..++...++.++.+++.+++|||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEY 158 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCce
Confidence 999999999988653 45788899999999999999999999999999999999988776 99999998865432211
Q ss_pred C--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhh
Q 025369 177 P--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFI 238 (254)
Q Consensus 177 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~ 238 (254)
. ....+...|+|||++.+.....+ +|+||||+++|+|++ |..||...+.. ......+..++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 12234557999999877666555 999999999999998 99999654321 22345677788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 238 ~~~l~~~p 245 (261)
T cd05072 238 KTCWKEKA 245 (261)
T ss_pred HHHccCCc
Confidence 88888877
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=275.10 Aligned_cols=233 Identities=31% Similarity=0.521 Sum_probs=187.0
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
.-.......++|++++.||.|+||+||++++..++..+++|.+.... .....+..|+.+++.++||||+++++++.+
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 33445566789999999999999999999999999999999876432 234567889999999999999999998865
Q ss_pred C--CeEEEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc-------CeeecCCCCCcEEecCC--
Q 025369 91 P--THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAM-------QVCHRDLKLENTLLDGS-- 155 (254)
Q Consensus 91 ~--~~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~-------~i~h~di~p~nili~~~-- 155 (254)
. ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 3 5789999999999999988652 5699999999999999999999984 49999999999999642
Q ss_pred -------------CCCceEEecccccccccccCCCCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCC
Q 025369 156 -------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 156 -------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
+...++|+|||++.............+++.|+|||++.+. .....++|||||||++|+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2334899999998755443334455688999999998643 23344599999999999999999999
Q ss_pred CCCCCChhh---------------HHHHHHhhcCccccCC
Q 025369 222 EDPDEPKDF---------------RKTIQVFIKPCCHITP 246 (254)
Q Consensus 222 ~~~~~~~~~---------------~~~~~~~~~~~~~~~p 246 (254)
...+....+ ...+..++..|+..+|
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCCh
Confidence 765433222 2346677777777777
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=257.21 Aligned_cols=223 Identities=36% Similarity=0.635 Sum_probs=198.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.+=|.+.+.||+|.|.+|-+|++..+|+.||||++.+. ......+.+|+..++-++|||||+++++......+|+|.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45689999999999999999999999999999998764 344567889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-CCCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|.-++|+|.+++..+. -+.+....++++||+.||.|+|+..++|+||||+||++- .-|- +||.|||++....++..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl--VKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL--VKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc--eEeeeccccccCCCcch
Confidence 9999999999997664 489999999999999999999999999999999998764 4444 99999999998899999
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~ 242 (254)
....+|+..|.|||.+.+..++.++.||||||+++|.|.+|++||+..+. +..+.+.++.+++.-+
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999989999999999999999999988665 4455556777777777
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
..+|
T Consensus 255 vRdP 258 (864)
T KOG4717|consen 255 VRDP 258 (864)
T ss_pred hcCc
Confidence 7776
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=249.01 Aligned_cols=224 Identities=28% Similarity=0.491 Sum_probs=187.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.....+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.+.|+|++++.+.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 345679999999999999999999999899999999876543 2346678899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
++|+++++|.+++.. ..++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccc
Confidence 999999999998865 35789999999999999999999999999999999999988776 99999998764332221
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIK 239 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~ 239 (254)
.....+...|+|||.+.+...... +|+||+|+++++|++|..||...+. +..+...+..++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 123357788999999877666555 9999999999999999999965432 2234456788888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 252 ~~l~~~p 258 (296)
T cd06654 252 RCLDMDV 258 (296)
T ss_pred HHCcCCc
Confidence 8888887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=245.91 Aligned_cols=221 Identities=33% Similarity=0.533 Sum_probs=185.3
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
+|++.+.||+|++|.||++.+..++..+++|.+... ....+.+.+|+..++.++|+|++++.+.+.+++.++++++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 689999999999999999999999999999987543 334466778999999999999999999999999999999999
Q ss_pred CccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CC
Q 025369 102 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (254)
Q Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 178 (254)
++++|.+++... ..+++..++.++.+++.++.+||+.|++|+||+|+||++++++. ++++|||.+........ ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 999998888643 35889999999999999999999999999999999999988776 99999998764432221 22
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhHHHHHHhhcCccc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~ 243 (254)
...++..|+|||++.+...... +|+||+|+++++|++|..||...+. +..+...+..++..|++
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 3457778999999877766555 9999999999999999999976542 22234457788888998
Q ss_pred cCCC
Q 025369 244 ITPF 247 (254)
Q Consensus 244 ~~p~ 247 (254)
.+|.
T Consensus 238 ~~P~ 241 (255)
T cd08219 238 RNPR 241 (255)
T ss_pred CCcc
Confidence 8883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=258.29 Aligned_cols=207 Identities=26% Similarity=0.437 Sum_probs=171.4
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
+++...+...++|++.+.||+|+||.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 5 ELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred HHhHHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 3444455567899999999999999999999999999999998865322 2345678999999999999999998875
Q ss_pred cC------CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 90 TP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 90 ~~------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
.. ...+++++++ +++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~ 160 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRIL 160 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEc
Confidence 43 3568999987 6688777653 46899999999999999999999999999999999999998877 9999
Q ss_pred cccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
|||++..... ......++..|+|||.+.+......++|+||||+++|+|++|..||...+
T Consensus 161 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 161 DFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999865432 23345678899999998775544555999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.71 Aligned_cols=197 Identities=29% Similarity=0.498 Sum_probs=171.5
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..+++++||||+++++.+..++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999876542 2235577899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
+++++|.+++.....+++..+..++.|++.++.|||+ .+++|+||+|+||++++++. ++|+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc-cccc
Confidence 9999999999888889999999999999999999997 58999999999999988776 999999987543222 2234
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
..++..|++||.+.+.....+ +|+||+|+++++|++|..||..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCC
Confidence 467789999999877665554 9999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=242.91 Aligned_cols=226 Identities=33% Similarity=0.501 Sum_probs=197.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---------cchhHHHHHHHHhhcC-CCCCeeeeeEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (254)
..++|.=.+.||.|..++|-+..++.++..+++|++.... ...+.-.+|+.+|+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3568888999999999999999999999999999875321 1124456789999887 79999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+.-+|+|++.++.|.|.+++.+.-.+++....++++|++++++|||.++|+|+||||+||+++++.+ ++|+|||+++.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~ 172 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQ 172 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeec
Confidence 9999999999999999999999999999999999999999999999999999999999999999888 99999999999
Q ss_pred ccccCCCCCccCCCCccCcccccc-----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCC------------------CC
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD------------------EP 227 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------------------~~ 227 (254)
...+......+|+++|.|||.+.. .+.+....|+|+.|++||.++.|.+||.... +.
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 999888889999999999998753 3334555899999999999999999997633 45
Q ss_pred hhhHHHHHHhhcCccccCCCc
Q 025369 228 KDFRKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p~~ 248 (254)
+++....+.++..|++.||.-
T Consensus 253 adis~~~KdLIsrlLqVdp~~ 273 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTK 273 (411)
T ss_pred hhccccHHHHHHHHHeeCchh
Confidence 566677888888888888844
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=251.65 Aligned_cols=225 Identities=25% Similarity=0.370 Sum_probs=180.3
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEccccee--EEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|+||.||+|.+..++.. +++|..... ......+.+|+..+.++ +|+|++++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999998776654 466665432 22335677899999999 89999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC
Q 025369 94 LAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~ 157 (254)
+++++||+++++|.+++.... .++..+++.++.|++.|++|||++|++||||+|+||++++++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999986442 4788999999999999999999999999999999999987776
Q ss_pred CceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh--------
Q 025369 158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK-------- 228 (254)
Q Consensus 158 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~-------- 228 (254)
++|+|||++.................|+|||.+.+.....+ +|+||||+++++|++ |..||...+..+
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 --AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred --EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999998753322222222233557999998876665555 999999999999998 999986543222
Q ss_pred -------hhHHHHHHhhcCccccCC
Q 025369 229 -------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -------~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|+..+|
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p 264 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKP 264 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCh
Confidence 233456778888888887
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=243.30 Aligned_cols=220 Identities=30% Similarity=0.505 Sum_probs=185.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|.+.+.||+|++|.+|++.+..++..+++|.+... ......+.+|+..++.++|||++++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999999999999999987643 23456678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
+++++|.+++... ..++...++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999998764 56899999999999999999999999999999999999988776 99999998764433221 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHhhcCcc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVFIKPCC 242 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~ 242 (254)
....+...|+|||++.+...+.+ +|+||||+++++|++|..||...+... .+...+..++..|+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence 22356788999999987776555 999999999999999999997655322 33446788888888
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+.+|
T Consensus 238 ~~~p 241 (256)
T cd08529 238 TKDY 241 (256)
T ss_pred cCCc
Confidence 8877
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=246.49 Aligned_cols=210 Identities=29% Similarity=0.444 Sum_probs=171.8
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcC---CCCCeeeeeEEEEcC-----C
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 92 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~ 92 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... .......+|+..++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6999999999999999999999999999999876432 2223455666666555 799999999988642 4
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..+++++++.+ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 57999999975 788877654 34899999999999999999999999999999999999988876 99999998865
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHh
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (254)
...........++..|+|||++.+.....+ +|+||+|+++|+|++|.+||......+...++...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 223 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh
Confidence 443333334457788999999987776555 999999999999999999998877766666665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.38 Aligned_cols=223 Identities=24% Similarity=0.349 Sum_probs=184.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.+.||+|++|.||++.+. .+..+++|.+.........+.+|+..+++++|+|++++++++...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34678999999999999999999876 45679999887665555678899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
++.+++|.+++.... .++...+..++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYE 159 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccc
Confidence 999999999987654 6899999999999999999999999999999999999998776 999999987654322111
Q ss_pred --CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhc
Q 025369 178 --KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIK 239 (254)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~ 239 (254)
........|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ......+..++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 11122357999999877766555 999999999999999 99999664432 233456777888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 239 ~~l~~~P 245 (261)
T cd05068 239 DCWKEDP 245 (261)
T ss_pred HHhhcCc
Confidence 8888887
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=249.94 Aligned_cols=222 Identities=26% Similarity=0.372 Sum_probs=179.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccce--eEEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~--~~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (254)
+++|++.+.||+|++|.||++....++. .+++|.+... ....+.+.+|+..++++ +|||++++++.+...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 4789999999999999999999876654 4677766532 22335678899999999 79999999999999899999
Q ss_pred EEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCce
Q 025369 97 VMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~ 160 (254)
+++|+++++|.+++.... .++...++.++.|++.|+++||+.|++|+||+|+||++++++. +
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~ 158 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--S 158 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--E
Confidence 999999999999986542 4788899999999999999999999999999999999987776 9
Q ss_pred EEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC------------
Q 025369 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP------------ 227 (254)
Q Consensus 161 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~------------ 227 (254)
+|+|||++.................|+|||++.+..++.+ +|+||||+++|+|++ |..||...+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~ 237 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM 237 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9999998753322212222223457999999877766555 999999999999997 99999764432
Q ss_pred ---hhhHHHHHHhhcCccccCC
Q 025369 228 ---KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+.+++..|++.+|
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p 259 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRP 259 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCCh
Confidence 2344567788888998888
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=266.58 Aligned_cols=225 Identities=27% Similarity=0.447 Sum_probs=187.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcCC-CCCeeeeeEEEEc----CC-
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEVILT----PT- 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~- 92 (254)
....+++|.+.|.+|||+.||+|++...+..||+|+.... ......+.+|+.+++.|+ |+|||.+++.... ++
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456899999999999999999999988788999987654 334577899999999996 9999999994321 12
Q ss_pred --eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEEeccc
Q 025369 93 --HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 93 --~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
.++++||||.|+.|.+++... ..|++.++++|++++++|+.+||..+ |+|||||-+|||++.+++ .||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccc
Confidence 568999999999999999743 44999999999999999999999987 999999999999998887 9999999
Q ss_pred ccccccccCCCC----------CccCCCCccCcccc---ccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------
Q 025369 167 YSKSSVLHSQPK----------STVGTPAYIAPEVL---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-------- 225 (254)
Q Consensus 167 ~~~~~~~~~~~~----------~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------- 225 (254)
.++......... ....++.|+|||.+ .+...+++ +|||+|||++|-||....||....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 886544433221 23478899999997 34555555 999999999999999999998752
Q ss_pred ----CChhhHHHHHHhhcCccccCCC
Q 025369 226 ----EPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 226 ----~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
....+...+..+|..|++.+|.
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcc
Confidence 2357788899999999999994
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=245.77 Aligned_cols=220 Identities=32% Similarity=0.540 Sum_probs=186.5
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++.+.+.++...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 57999999999999999999999999999999886543 2235677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 179 (254)
+++++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988765 7899999999999999999999999999999999999998777 999999988655433 22233
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh----------------hHHHHHHhhcCccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD----------------FRKTIQVFIKPCCH 243 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~ 243 (254)
..++..|++||.+.+...+.+ +|+||||+++|+|++|..||...+.... +...+..++..|+.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 456778999999987775555 9999999999999999999965432111 34457788888888
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 237 ~~p 239 (274)
T cd06609 237 KDP 239 (274)
T ss_pred CCh
Confidence 877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.68 Aligned_cols=220 Identities=35% Similarity=0.521 Sum_probs=185.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc----------hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
+|.+.+.||+|++|.||.|.+..++..+++|.+...... .+.+.+|+..++.++||+++++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999888999999987643221 2457789999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
.++++||+++++|.+++.....++...+..++.|++.++++||+.|++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999998765432
Q ss_pred cCC-------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhH
Q 025369 174 HSQ-------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFR 231 (254)
Q Consensus 174 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~ 231 (254)
... .....+...|+|||.+.+...... +|+||+|+++++|++|..||...+. +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence 111 112246778999999887766555 9999999999999999999976432 22345
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+..++..|++.+|
T Consensus 238 ~~~~~li~~~l~~~p 252 (267)
T cd06628 238 SEAIDFLEKTFEIDH 252 (267)
T ss_pred HHHHHHHHHHccCCc
Confidence 567888888888887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=245.59 Aligned_cols=226 Identities=29% Similarity=0.442 Sum_probs=186.3
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+...++|++.+.||+|++|.||+|.+..++..+++|.+..... ....+.+|+..++.++|||++++.+.+...+.++++
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3456799999999999999999999999999999998765432 234567899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
+||+++++|.+++...+.+++.+++.++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccc
Confidence 999999999999988888999999999999999999999999999999999999987776 999999987543322 12
Q ss_pred CCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------------hhHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------------DFRKTIQ 235 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------------~~~~~~~ 235 (254)
.....++..|+|||.+.. ......++|+||||+++|+|++|..||....... .+...+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 233457889999998742 2223445999999999999999999985433211 1234567
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 243 ~li~~~l~~~P 253 (267)
T cd06645 243 HFVKMALTKNP 253 (267)
T ss_pred HHHHHHccCCc
Confidence 78888888777
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.44 Aligned_cols=224 Identities=34% Similarity=0.528 Sum_probs=179.9
Q ss_pred eEeccccCCcceEEEEEEEc----ccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 26 DFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 26 ~~~~~l~~g~~g~v~~~~~~----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.+.+.||+|.||.||+|... ..+..|++|.+..... ..+.+.+|+..+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 56789999999999999998 4577899999865432 35788899999999999999999999998888999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc---
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 174 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~--- 174 (254)
|+++++|.+++... ..++...++.++.|++.|+.|||+++++|++|+++||+++.++. +||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999886 67999999999999999999999999999999999999998776 999999987654211
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhh
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFI 238 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~ 238 (254)
...........|+|||.+.+...+.+ +||||||++++++++ |..||...+. +......+..++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 11233346678999999877776455 999999999999999 7799876443 333455688999
Q ss_pred cCccccCC-Cccccc
Q 025369 239 KPCCHITP-FYPLFK 252 (254)
Q Consensus 239 ~~~~~~~p-~~~~~~ 252 (254)
..||..+| .+|-+.
T Consensus 239 ~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQ 253 (259)
T ss_dssp HHHT-SSGGGS--HH
T ss_pred HHHcCCChhhCcCHH
Confidence 99999998 455443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=246.92 Aligned_cols=212 Identities=27% Similarity=0.465 Sum_probs=177.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .......+|+..++.++||||+++++++..++..++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4678999999999999999999999999999999876432 23346778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
||+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99975 787777653 56899999999999999999999999999999999999988776 99999998764332221
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 235 (254)
.....++..|+|||.+.+......++|+||||+++++|++|.+||...+..+....+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~ 219 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 12334677899999987665555569999999999999999999988776655554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.41 Aligned_cols=223 Identities=26% Similarity=0.447 Sum_probs=183.1
Q ss_pred CCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+|.+.+.||+|++|.||++.+ ..++..+++|.+.... .....+.+|+..+++++|++++++.+++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467899999999999999999985 3345678899876543 3345688899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 95 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
++++||+++++|.+++...+ .+++..++.++.|++.||++||++|++||||+|+||++++++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999987543 3899999999999999999999999999999999999988776 99
Q ss_pred EecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-----------
Q 025369 162 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE----------- 226 (254)
Q Consensus 162 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~----------- 226 (254)
|+|||++........ .....+...|+|||.+.+.....+ +|+||||+++++|++ |..||.....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998764322211 122234567999999877666555 999999999999998 8999865432
Q ss_pred ----ChhhHHHHHHhhcCccccCC
Q 025369 227 ----PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ----~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|++.+|
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p 263 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREP 263 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCh
Confidence 22344568888999999888
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=248.58 Aligned_cols=201 Identities=28% Similarity=0.511 Sum_probs=171.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|||++++.+++..++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 579999999999999999999998899999998754322 33567789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 178 (254)
|++++++..+......++...++.++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888887766667899999999999999999999999999999999999988776 99999998764433221 12
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
...+...|+|||.+.+......++|+||||+++++|++|.+||...+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 23467789999998765544555999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=241.53 Aligned_cols=222 Identities=29% Similarity=0.495 Sum_probs=189.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
.++|++.+.||+|++|.||++.+..++..+++|.+..... .+.+.+|+..++.++|+|++++.+.+..+..+++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 5789999999999999999999998889999998865433 677889999999999999999999999999999999999
Q ss_pred CccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
++++|.+++.. ...+++..++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999875 356899999999999999999999999999999999999998876 9999999876543332 2233
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~ 242 (254)
..+...|++||++.+...+.+ +|+||+|+++++|++|..||..... +..+...+..++..|+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 346778999999877766555 9999999999999999999865332 2233456788999999
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
+.+|.
T Consensus 238 ~~~P~ 242 (256)
T cd06612 238 VKDPE 242 (256)
T ss_pred hcChh
Confidence 88883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=240.67 Aligned_cols=221 Identities=30% Similarity=0.507 Sum_probs=186.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++++.||.|++|.+|.+++..++..+++|.+... ......+.+|+..+++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999987643 23345677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999999765 45899999999999999999999999999999999999988776 9999999876443322 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh---------------hHHHHHHhhcCcc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------FRKTIQVFIKPCC 242 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~ 242 (254)
....++..|.|||.+.+...... +|+||||+++++|++|..||...+..+. ....+..++..|+
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence 33457789999999877766555 9999999999999999999976554332 2345777888888
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
..+|.
T Consensus 238 ~~~p~ 242 (256)
T cd08221 238 QQDPE 242 (256)
T ss_pred ccCcc
Confidence 87773
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=242.26 Aligned_cols=222 Identities=26% Similarity=0.438 Sum_probs=181.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..++.++|+|++++++++...+..++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3567999999999999999999886 466799998766555556788899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
+++++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999998654 46899999999999999999999999999999999999988776 999999987543221111
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~~~ 241 (254)
........|+|||.+.+.....+ +|+||||+++|+|++ |..||...+..+ .....+..++..|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11122347999999887776555 999999999999998 889986544322 2234577788888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 238 l~~~p 242 (256)
T cd05059 238 WHEKP 242 (256)
T ss_pred hcCCh
Confidence 87777
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=240.45 Aligned_cols=221 Identities=35% Similarity=0.555 Sum_probs=186.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++||+++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999886532 2345678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
+++++|.+++... ..+++..++.++.+++.++.+||++|++|+||+|+||++++++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999999764 35899999999999999999999999999999999999975543 37999999887654444434
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHhhcCccc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVFIKPCCH 243 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~ 243 (254)
...++..|+|||.+.+.....+ +|+||+|+++++|++|..||...+.+. .+...+..++..|+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 4567789999999877665555 999999999999999999997654322 234457778888888
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 239 ~~p 241 (256)
T cd08220 239 LDP 241 (256)
T ss_pred CCh
Confidence 777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=245.18 Aligned_cols=200 Identities=33% Similarity=0.554 Sum_probs=171.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|++|.||++.+..++..+++|.+... ....+.+.+|+..++.++|+|++++.+++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999987643 2334678899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC--CC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--~~ 177 (254)
|++++.+..+......+++..++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777766666667999999999999999999999999999999999999998776 9999999876544433 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
....+...|+|||.+.+....+.++|+||+|+++++|++|..||...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23456778999999988744455599999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=242.20 Aligned_cols=221 Identities=24% Similarity=0.361 Sum_probs=181.0
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.++||+|++|.||+|.+..+ ..+++|.+.......+.+.+|+..++.++|+|++++++.+. ....+++++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 457899999999999999999988755 45999988765555667889999999999999999999874 4567899999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
+++++|.+++... ..++...+..++.+++.+|++||+.|++|+||+|.||++++++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999999753 34788999999999999999999999999999999999988776 999999987644322211
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhcC
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIKP 240 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~~ 240 (254)
....++..|++||+..+...+.. +|+||||+++|+|++ |..||......+ ...+.+.+++..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 12234567999999877766555 999999999999999 888887654322 234567788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|++.+|
T Consensus 239 ~l~~~p 244 (262)
T cd05071 239 CWRKEP 244 (262)
T ss_pred HccCCc
Confidence 888887
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=245.75 Aligned_cols=220 Identities=30% Similarity=0.479 Sum_probs=177.8
Q ss_pred Cce-eEeccccCCcceEEEEEE----EcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcC--Ce
Q 025369 23 DRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (254)
Q Consensus 23 ~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (254)
++| ++.+.||+|+||+||++. ...++..+++|.+..... ....+.+|+..++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 566 999999999999998765 334678899998865432 346678899999999999999999987653 46
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
.+++|||+++++|.+++... .+++.+++.++.|++.++.+||++|++|+||+|+||++++++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999988764 5899999999999999999999999999999999999988776 99999998765433
Q ss_pred cCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------------
Q 025369 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------------- 226 (254)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------------- 226 (254)
... .....+...|++||.+.+...+.+ +|+||||+++++|++|..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 221 112234556999999877666555 9999999999999999988754321
Q ss_pred -------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..||+.+|
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p 265 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEA 265 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccCh
Confidence 11224578888999999888
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=241.77 Aligned_cols=221 Identities=30% Similarity=0.540 Sum_probs=189.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||+|++|.+|++.+..++..+++|.+..... ....+.+|+..+++++|++++++.+.+..++..+++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 479999999999999999999999999999998876542 456788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC-
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~- 178 (254)
+++++|.+++.....+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999888889999999999999999999999 99999999999999988776 9999999876544333322
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--C----------------Chh-hHHHHHHhhc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--E----------------PKD-FRKTIQVFIK 239 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~----------------~~~-~~~~~~~~~~ 239 (254)
...+...|+|||.+.+...+.. +|+||||+++|+|++|..||.... . +.. +...+..+++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 3456778999999877765555 999999999999999999997764 1 111 4456777888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 238 ~~l~~~p 244 (264)
T cd06623 238 ACLQKDP 244 (264)
T ss_pred HHccCCh
Confidence 8887776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=270.96 Aligned_cols=231 Identities=28% Similarity=0.446 Sum_probs=197.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
+..++.+..+.||+|.||+||+++-.. ....||||.++.... ...++++|++++..++|||||+++|+|..++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 456688889999999999999998653 456899998876543 4578999999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 93 HLAIVMEYASGGELFERICNAG----------R----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~----------~----~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
-+++|+||+..|+|.+|+.... + ++..+.+.++.||+.+++||-++.++||||-.+|.||.++-.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~- 641 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV- 641 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE-
Confidence 9999999999999999996432 2 788999999999999999999999999999999999988887
Q ss_pred ceEEecccccccccccCCCC---CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
||++|||+++......... ...-..+||+||.+..+.++++ +||||+|+++||+++ |..||.+..+
T Consensus 642 -VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 642 -VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred -EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999997654433222 2345679999999999999888 999999999999998 9999988665
Q ss_pred -------ChhhHHHHHHhhcCccccCC-Ccccccc
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP-FYPLFKL 253 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p-~~~~~~~ 253 (254)
++..+..+..+|..||+..| -.|-|++
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 44555679999999999999 6666654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=244.85 Aligned_cols=223 Identities=22% Similarity=0.360 Sum_probs=180.7
Q ss_pred CCCceeEeccccCCcceEEEEEEE----cccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
..++|++.+.||+|+||+||++.. ..++..+++|.+..... ....+.+|+..++.++|||++++.+++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 457899999999999999999985 34567899998865332 224677899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC
Q 025369 95 AIVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~ 157 (254)
++++||+++++|.+++... ..+++..+..++.+++.++.|||++|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999988532 23678889999999999999999999999999999999998776
Q ss_pred CceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-------
Q 025369 158 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE------- 226 (254)
Q Consensus 158 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~------- 226 (254)
++|+|||++........ .....+...|+|||++.+...... +|+||||+++++|++ |..||.....
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 163 --VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred --EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998865432211 122234557999999877666555 999999999999998 8899865432
Q ss_pred --------ChhhHHHHHHhhcCccccCC
Q 025369 227 --------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 --------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|+..+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGP 267 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 22334567788889998888
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=243.79 Aligned_cols=216 Identities=26% Similarity=0.472 Sum_probs=179.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..+++++|||++++++.+...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47899999999999999999999999999999876542 2335677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCc
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 180 (254)
+++++|..+ ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999888654 35788899999999999999999999999999999999998877 999999987644322 22334
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------------hhhHHHHHHh
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------------KDFRKTIQVF 237 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------------~~~~~~~~~~ 237 (254)
.++..|+|||.+.+.....+ +|+||||+++|+|++|..||...... ......+.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67789999999987776555 99999999999999999999642211 1123356778
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|++.+|
T Consensus 233 i~~~l~~~P 241 (279)
T cd06619 233 ITQCMRKQP 241 (279)
T ss_pred HHHHhhCCh
Confidence 888888887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=251.03 Aligned_cols=226 Identities=23% Similarity=0.392 Sum_probs=180.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (254)
+.++.++|++.+.||+|+||.||+|.... +++.|++|.+..... ..+.+.+|+..++++ +|+||+++++.+.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 45667899999999999999999997543 457899998865322 234567799999999 7999999999887
Q ss_pred cC-CeEEEEEEccCccchHHHHHhc-------------------------------------------------------
Q 025369 90 TP-THLAIVMEYASGGELFERICNA------------------------------------------------------- 113 (254)
Q Consensus 90 ~~-~~~~lv~~~~~~~~L~~~l~~~------------------------------------------------------- 113 (254)
.. ..++++++|+++++|.+++...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5678999999999999888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC---CCCccCCC
Q 025369 114 ------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP 184 (254)
Q Consensus 114 ------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~ 184 (254)
.+++...+..++.|++.++.|||++||+||||+|+||++++++. ++|+|||++........ .....+..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCc
Confidence 25788899999999999999999999999999999999997776 99999998865432221 12223456
Q ss_pred CccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh----------------hHHHHHHhhcCccccCC
Q 025369 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD----------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~p 246 (254)
.|+|||++.+..++.+ +||||||+++++|++ |..||......+. ....+..++..|++.+|
T Consensus 240 ~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 240 KWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred cccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 7999999988777666 999999999999998 9999976443222 23346677788888887
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=244.58 Aligned_cols=224 Identities=26% Similarity=0.390 Sum_probs=184.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|.+.+.||+|++|.||++.+.. ++..+++|.+...... .+.+.+|+..++.++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 35789999999999999999998743 4678999988654332 4678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 94 LAIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
.+++++|+++++|.+++...+ .+++..+..++.+++.++.+||++|++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-- 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--
Confidence 999999999999999987542 3788899999999999999999999999999999999988876
Q ss_pred eEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh-------
Q 025369 160 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK------- 228 (254)
Q Consensus 160 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~------- 228 (254)
++|+|||++........ .........|+|||.+.+.....+ +|+||||+++++|++ |..||...+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999998764322211 122234568999999987776555 999999999999998 999986544322
Q ss_pred --------hhHHHHHHhhcCccccCCC
Q 025369 229 --------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 --------~~~~~~~~~~~~~~~~~p~ 247 (254)
.....+..++..||..+|.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~ 266 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQ 266 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 3345678888899988883
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=245.26 Aligned_cols=225 Identities=28% Similarity=0.480 Sum_probs=188.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.....+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+..++..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 445689999999999999999999998899999999886543 3345677899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
++|+++++|.+++.. ..+++.++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccC
Confidence 999999999998865 45789999999999999999999999999999999999987776 99999998764332221
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIK 239 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~ 239 (254)
.....+...|++||.+.+...... +|+||+|+++|++++|..||...+. +..+...+..++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 223456778999999877666554 9999999999999999999965331 2334456788999
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|+..+|.
T Consensus 251 ~~l~~~p~ 258 (297)
T cd06656 251 RCLEMDVD 258 (297)
T ss_pred HHccCChh
Confidence 99998883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=259.89 Aligned_cols=208 Identities=26% Similarity=0.431 Sum_probs=169.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC------CCeeeeeEEEEcC-Ce
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-TH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~ 93 (254)
..++|++.+.||+|+||+||++.+..++..||+|++............|+..++.++| .+++.+.+++..+ ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3578999999999999999999999999999999986544444555667777766654 4588888888765 47
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCC--------------C
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA--------------P 158 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~--------------~ 158 (254)
+++|++++ +++|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+||+++.++. .
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 88999987 66888888888889999999999999999999998 59999999999999976542 1
Q ss_pred ceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
.+||+|||.+... ........++..|+|||++.+..+... +|||||||++|+|++|+.||...+..+.+..
T Consensus 286 ~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 286 RVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred eEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4899999976532 222334568899999999988777655 9999999999999999999987766544443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=246.84 Aligned_cols=222 Identities=31% Similarity=0.479 Sum_probs=184.7
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|++++++++.+.+....++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999998876432 2345778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
||+.+++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999998754 46899999999999999999999999999999999999988776 99999998754322111
Q ss_pred ------------------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 177 ------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 177 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.....++..|+|||.+.+...+.. +|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence 012245678999999987766555 9999999999999999999976553
Q ss_pred Chh----------------hHHHHHHhhcCccccCCC
Q 025369 227 PKD----------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 ~~~----------------~~~~~~~~~~~~~~~~p~ 247 (254)
... ....+.++++.|++.+|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 274 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPS 274 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHh
Confidence 322 245577788888877773
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=242.31 Aligned_cols=222 Identities=24% Similarity=0.390 Sum_probs=181.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.+.||+|++|.||++.+. .+..+++|.+.......+.+.+|+..+++++|++++++++++. .+..+++|+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 45789999999999999999999876 5566899988766555677889999999999999999999874 456789999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|.+++... ..++...++.++.+++.++.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccc
Confidence 99999999988653 35899999999999999999999999999999999999987766 999999988644322111
Q ss_pred --CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhc
Q 025369 178 --KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIK 239 (254)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~ 239 (254)
....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ......+..++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 11224457999999876666555 999999999999999 88998664432 223456778888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 238 ~~l~~~p 244 (260)
T cd05070 238 QCWKKDP 244 (260)
T ss_pred HHcccCc
Confidence 8888887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=245.86 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=170.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|+|++++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 58999999999999999999998899999998865432 234567899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
+||+ +++|.+++.... .+++..++.++.|+++||.+||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999997765 7999999999999999999999999999999999999998776 9999999876543322
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..........|+|||.+.+......++|+||||+++++|++|.+||...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 112234567799999886655555569999999999999999888765554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=245.06 Aligned_cols=196 Identities=30% Similarity=0.520 Sum_probs=165.8
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..+++++|+|++++++++.+.+.+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 6899999999999999999999999999999886432 2335677899999999999999999999999999999999
Q ss_pred cCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCC
Q 025369 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 178 (254)
+++ +|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 67776654 467899999999999999999999999999999999999988776 9999999876433221 112
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
...++..|+|||.+.+....+.++|+||||+++++|++|+.||.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 33467789999998776554555999999999999999988854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=244.72 Aligned_cols=225 Identities=28% Similarity=0.449 Sum_probs=185.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||.|++|.||++.+..++..+++|...... ...+.+.+|+..+++++|+|++++.+.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4578999999999999999999998889999999876543 233567789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
|+++++|.+++... ..+++..++.++.|++.++.|||++|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccccccc
Confidence 99999999998764 46899999999999999999999999999999999999988776 99999998754332221 2
Q ss_pred CCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHH
Q 025369 178 KSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQV 236 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~ 236 (254)
....++..|++||.+... .....++|+||||+++|+|++|..||...+. +..+...+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 233567789999987532 2223449999999999999999999976432 2234456778
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|++.+|.
T Consensus 241 li~~~l~~~p~ 251 (280)
T cd06611 241 FLKSCLVKDPD 251 (280)
T ss_pred HHHHHhccChh
Confidence 88888888883
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=243.44 Aligned_cols=224 Identities=29% Similarity=0.506 Sum_probs=187.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
....+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++++.+.....+++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 34568999999999999999999999999999999876532 33466788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
+|+++++|..++... .+++.++..++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccC
Confidence 999999999888654 5899999999999999999999999999999999999988776 99999998764332221 2
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhcC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~ 240 (254)
....+...|+|||.+.+.....+ +|+||||+++|+|++|..||...+. +..+...+..++..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 23356778999999877766555 9999999999999999999976432 12233457778888
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|+..+|.
T Consensus 252 ~l~~dp~ 258 (296)
T cd06655 252 CLEMDVE 258 (296)
T ss_pred HhhcChh
Confidence 8888873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=245.57 Aligned_cols=223 Identities=26% Similarity=0.487 Sum_probs=188.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++.+..++..+++|..... ......+.+|+..++.++|||++++++.+...+.+++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 467899999999999999999999989999999987543 233467888999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++...+.++...+..++.+++.++.|||+ .+++|+||+|+||++++++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence 999999999998887889999999999999999999997 58999999999999987776 99999998754322 222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------------------hhh
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------------------KDF 230 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------------------~~~ 230 (254)
....++..|+|||++.+.....+ +|+||+|++++++++|..||...... ..+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 33467889999999877766555 99999999999999999999754331 113
Q ss_pred HHHHHHhhcCccccCCC
Q 025369 231 RKTIQVFIKPCCHITPF 247 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p~ 247 (254)
...+.+++..|+..+|.
T Consensus 239 ~~~~~~li~~~l~~dp~ 255 (284)
T cd06620 239 PEDLRDFVDACLLKDPT 255 (284)
T ss_pred CHHHHHHHHHHhcCCcc
Confidence 34577788888888873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=253.16 Aligned_cols=227 Identities=25% Similarity=0.357 Sum_probs=183.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEccc-----ceeEEEEEccCCcc--chhHHHHHHHHhhcCC-CCCeeeeeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVI 88 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 88 (254)
....+.++|++++.||+|+||.||++.+... +..||+|.+..... ..+.+.+|+..++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 5666788999999999999999999987433 34699998865422 2356788999999996 99999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc-------------------------------------------------------
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA------------------------------------------------------- 113 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~------------------------------------------------------- 113 (254)
...+..++||||+++++|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999998887542
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe
Q 025369 114 -----------------------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (254)
Q Consensus 114 -----------------------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili 152 (254)
..++...+..++.|++.|+.|||+.+++|+||+|+||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136777889999999999999999999999999999999
Q ss_pred cCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC-
Q 025369 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP- 227 (254)
Q Consensus 153 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~- 227 (254)
++++. ++|+|||++........ .....++..|+|||.+.+..+..+ +||||||+++|+|++ |..||......
T Consensus 271 ~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 271 AQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred eCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 88776 99999998764332211 122335567999999877766555 999999999999997 88998654322
Q ss_pred ---------------hhhHHHHHHhhcCccccCC
Q 025369 228 ---------------KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---------------~~~~~~~~~~~~~~~~~~p 246 (254)
......+..++..||..+|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 381 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCH
Confidence 2334567888899999888
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=242.81 Aligned_cols=221 Identities=27% Similarity=0.448 Sum_probs=184.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++++.+..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999899999999875432 23356778999999999999999999999999999999
Q ss_pred EccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 99 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++++++|.+++.. ...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988863 345899999999999999999999999999999999999987776 999999987544322
Q ss_pred CC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------ChhhHHHHH
Q 025369 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------PKDFRKTIQ 235 (254)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------~~~~~~~~~ 235 (254)
.. .....+...|+|||.+.+...... +|+||+|+++++|++|..||..... .......+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22 123357788999999977776555 9999999999999999999864322 123456788
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 239 ~li~~~l~~~p 249 (267)
T cd08229 239 QLVNMCINPDP 249 (267)
T ss_pred HHHHHhcCCCc
Confidence 88888988888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=239.32 Aligned_cols=221 Identities=27% Similarity=0.470 Sum_probs=185.2
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|++++++++.+...+..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999875321 22456788999999999999999999999999999999
Q ss_pred EccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 99 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
||+++++|.+++.. ...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988864 244899999999999999999999999999999999999988776 999999987543322
Q ss_pred C-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------C-hhhHHHHH
Q 025369 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------P-KDFRKTIQ 235 (254)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~-~~~~~~~~ 235 (254)
. ......+...|.|||.+.+...... +|+||+|+++++|++|..||..... + ..+...+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2 1223456778999999877766555 9999999999999999999854321 1 13445788
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 239 ~~i~~cl~~~p 249 (267)
T cd08224 239 DLVSRCINPDP 249 (267)
T ss_pred HHHHHHcCCCc
Confidence 88999998888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=242.30 Aligned_cols=223 Identities=23% Similarity=0.408 Sum_probs=180.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce---eEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..++|++.+.||+|++|.||++....++. .+++|.+... ......+..|+..++.++|||++++.+++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45789999999999999999999876654 5999987653 223456888999999999999999999999889999
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++||+++++|.+++... +.++..+++.++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccC
Confidence 999999999999988754 56899999999999999999999999999999999999987766 999999987543322
Q ss_pred CCCCCc---c---CCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHH
Q 025369 175 SQPKST---V---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRK 232 (254)
Q Consensus 175 ~~~~~~---~---~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~ 232 (254)
...... . ....|++||.+.+.....+ +|+||+|++++++++ |..||...+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 221111 1 1346999999877776555 999999999999886 99999764432 22234
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..||..+|
T Consensus 239 ~~~~li~~~l~~~p 252 (269)
T cd05065 239 ALHQLMLDCWQKDR 252 (269)
T ss_pred HHHHHHHHHcCCCh
Confidence 57778888888877
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=244.39 Aligned_cols=221 Identities=32% Similarity=0.513 Sum_probs=183.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+..++.++|||++++++.+..++..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999876543 22345678999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 175 (254)
||+++++|.+++.....+++..+..++.+++.++.|||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999875311110
Q ss_pred -------------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------
Q 025369 176 -------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------- 228 (254)
Q Consensus 176 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------- 228 (254)
......+...|+|||.+.......+ +|+||||+++++|++|..||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0011235668999999877766555 999999999999999999997544322
Q ss_pred ---hhHHHHHHhhcCccccCC
Q 025369 229 ---DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ---~~~~~~~~~~~~~~~~~p 246 (254)
.....+..+++.|+..+|
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNP 258 (305)
T ss_pred ccccCCHHHHHHHHHHhccCh
Confidence 223446778888888777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=239.49 Aligned_cols=223 Identities=29% Similarity=0.472 Sum_probs=186.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||.|++|+||++....++..+++|.+.... .....+.+|+..++.++|++++++++.+..++.+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999998889999999876432 2346788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
+++++|.+.+... ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999998776 999999987654433222
Q ss_pred -----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------------hhHH
Q 025369 178 -----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------------DFRK 232 (254)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------------~~~~ 232 (254)
....++..|++||++......+.++|+||||+++++|++|..||...+... .+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 223467789999998776344455999999999999999999997644321 3345
Q ss_pred HHHHhhcCccccCCC
Q 025369 233 TIQVFIKPCCHITPF 247 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~ 247 (254)
.+..++..|++.+|.
T Consensus 239 ~~~~li~~~l~~~p~ 253 (267)
T cd06610 239 SFRKMISLCLQKDPS 253 (267)
T ss_pred HHHHHHHHHcCCChh
Confidence 678888888888883
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=243.17 Aligned_cols=226 Identities=28% Similarity=0.444 Sum_probs=184.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...++|+++++||+|++|.||++++..++..+++|...... ...+.+.+|+..++.++|+|++++.+.+..++.+++||
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 44678999999999999999999999999999999876543 23456778999999999999999999999999999999
Q ss_pred EccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
+|+++++|...+.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccc
Confidence 99999999887754 456899999999999999999999999999999999999987776 999999987543222 12
Q ss_pred CCCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQ 235 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~ 235 (254)
.....++..|+|||.+.+. .....++|+||||+++|+|++|..||...+. +..+...+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 2334567789999998532 2223449999999999999999999865431 122334677
Q ss_pred HhhcCccccCCC
Q 025369 236 VFIKPCCHITPF 247 (254)
Q Consensus 236 ~~~~~~~~~~p~ 247 (254)
.++..|+..+|.
T Consensus 247 ~li~~~l~~~p~ 258 (292)
T cd06644 247 DFLKTALDKHPE 258 (292)
T ss_pred HHHHHHhcCCcc
Confidence 788888888773
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=240.33 Aligned_cols=200 Identities=32% Similarity=0.472 Sum_probs=169.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (254)
.+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|||++++.+.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999875432 1224577899999999999999999988753 577
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++++|+++++|.+++.....++...++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999988878999999999999999999999999999999999999987776 999999987644321
Q ss_pred C----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
. ......+...|+|||.+.+...+.. +|+||+|+++++|++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccc
Confidence 1 1112346778999999877666555 999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=259.49 Aligned_cols=233 Identities=31% Similarity=0.473 Sum_probs=199.8
Q ss_pred CCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 9 ~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
......+..+....+...-++-||+|+.|-||+++.. ++.||||++. +...-+|.-|++|+|+||+.+.++|
T Consensus 110 e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 110 EHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred ehhhhhhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeee
Confidence 3444455566666677777889999999999999886 7789999653 3334578899999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
...-.|++|||||..|.|...+....++++..+..|..+|+.++.|||...|+|||||.-||||..+.. +||+|||-+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS 259 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTS 259 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccch
Confidence 999999999999999999999999999999999999999999999999999999999999999988777 999999987
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------CChhhHH
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------EPKDFRK 232 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------------~~~~~~~ 232 (254)
+........-..+|+..|||||++++.+-.++ .||||||+++|+|+||..||.+-+ .+....+
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence 65544444456679999999999988888777 999999999999999999997644 4677788
Q ss_pred HHHHhhcCccccCC-Cccccc
Q 025369 233 TIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 233 ~~~~~~~~~~~~~p-~~~~~~ 252 (254)
-++-+++.||..-| -.|-|+
T Consensus 339 GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHH
Confidence 89999999999877 444444
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=239.65 Aligned_cols=220 Identities=27% Similarity=0.427 Sum_probs=185.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.+.||+|++|.||++... ++.+++|.+.........+.+|+..++.++|+|++++++++.+.+..++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35679999999999999999999875 7889999887665545678889999999999999999999998889999999
Q ss_pred ccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|.+++.... .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD- 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc-
Confidence 999999999997665 6899999999999999999999999999999999999987776 99999998875532222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~~~ 241 (254)
.......|+|||++.......+ +|+||||++++++++ |..||...+.. ..+...+..++..|
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 2334567999999877666555 999999999999997 99998665422 12345677788888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 236 l~~~p 240 (256)
T cd05039 236 WELDP 240 (256)
T ss_pred hccCh
Confidence 88877
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=244.71 Aligned_cols=224 Identities=27% Similarity=0.415 Sum_probs=182.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccc----------------eeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----------------~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i 81 (254)
...++|++++.||+|+||.||++.+...+ ..+++|.+.... ...+.+.+|+..++.++|||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 35689999999999999999999876544 457899876543 234567889999999999999
Q ss_pred eeeeEEEEcCCeEEEEEEccCccchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
+++++++..++..+++++++.+++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997665 689999999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPD 225 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~ 225 (254)
++++++. ++|+|||++........ .....++..|+|||.+.+...... +|+||||+++|+|++ |..||...+
T Consensus 162 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9988866 99999998764332211 122234568999999877666555 999999999999998 678886644
Q ss_pred CChh----------------------hHHHHHHhhcCccccCC
Q 025369 226 EPKD----------------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ~~~~----------------------~~~~~~~~~~~~~~~~p 246 (254)
..+. ....+.+++..|+..+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 3221 12467888888888887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.26 Aligned_cols=229 Identities=26% Similarity=0.407 Sum_probs=187.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
+-...+...+++.||+|.||+||++.+.. .||||.+.... ...+.+++|+..+++-+|.||+-+.|++..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34455678899999999999999999974 38999887543 344778999999999999999999999988877
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~- 172 (254)
.+|+.+|+|.+|..++... .++...+.+.|++|+++++.|||.++|+|+|||..|||+.+++. |||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeee
Confidence 9999999999999988644 45899999999999999999999999999999999999988765 9999999975332
Q ss_pred --ccCCCCCccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------------Chh
Q 025369 173 --LHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------PKD 229 (254)
Q Consensus 173 --~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------------~~~ 229 (254)
...+.....+...|+|||+++.. ....+.+||||+|+++|||++|..||..... -..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 23333445678899999998632 3335559999999999999999999974332 224
Q ss_pred hHHHHHHhhcCccccCC-Cccccc
Q 025369 230 FRKTIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p-~~~~~~ 252 (254)
..+.+++++..||.-++ ..|.|.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~ 644 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFP 644 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHH
Confidence 45688999999998887 555544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=239.07 Aligned_cols=222 Identities=23% Similarity=0.393 Sum_probs=182.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.++||+|++|.||+|... ++..+++|.+.......+.+.+|+..++.++|+|++++.+++. .+..+++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45789999999999999999999876 5677999988776655678889999999999999999999864 456899999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
++.+++|.+++... ..++..++..++.+++.+|++||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcc
Confidence 99999999988653 35889999999999999999999999999999999999998876 99999998764432111
Q ss_pred -CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhc
Q 025369 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIK 239 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~ 239 (254)
.....+...|+|||++.......+ +|+||||++++++++ |..||...+..+ .....+..++.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112234567999999877666555 999999999999998 999997654322 22346788888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 238 ~~l~~~p 244 (260)
T cd05067 238 LCWKEKP 244 (260)
T ss_pred HHccCCh
Confidence 8888887
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=243.29 Aligned_cols=224 Identities=26% Similarity=0.428 Sum_probs=182.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
+.+.+|++.++||+|+||.||++.. ..++..+++|...... .....+.+|+..++.++|+||+++.+++.+.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4578899999999999999999974 2356688888776433 334678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 94 LAIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
.++++||+++++|.+++.... .+++..++.++.|++.|+.|||+.|++|+||+|+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~- 160 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC-
Confidence 999999999999999987643 3788999999999999999999999999999999999987776
Q ss_pred ceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
++|+|||++........ .....++..|+|||.+.+...+.+ +|+||||+++|+|++ |..||.....
T Consensus 161 -~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 161 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred -EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 99999998754322211 112224568999999877776555 999999999999998 8999865432
Q ss_pred -------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..||..+|
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P 265 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREP 265 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCh
Confidence 22344567889999999888
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=240.03 Aligned_cols=215 Identities=27% Similarity=0.434 Sum_probs=175.9
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
+.||+|++|.||++.+..++..+++|.+... ......+.+|+..++.++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4789999999999999989999999987543 22346688899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC---CccC
Q 025369 107 FERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182 (254)
Q Consensus 107 ~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~ 182 (254)
.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|.||+++.++. ++|+|||++.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99987643 5899999999999999999999999999999999999987776 9999999876433211111 1122
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~p 246 (254)
...|+|||.+.+.....+ +|+||||+++|+|++ |..||..... +......+..++..|++.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 356999999877776555 999999999999998 8888864332 22234567778888888887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=249.00 Aligned_cols=223 Identities=22% Similarity=0.361 Sum_probs=179.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccccee----EEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
...++|++.+.||+|+||.||++.+..++.. +++|.+.... ...+.+.+|+..++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3467899999999999999999987655553 8999876432 3346678899999999999999999998765 5
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++++|+++++|.+++... ..++...++.++.|++.||+|||++|++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEcccccccccc
Confidence 67899999999999988765 45889999999999999999999999999999999999988776 9999999987543
Q ss_pred ccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHH
Q 025369 173 LHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKT 233 (254)
Q Consensus 173 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~ 233 (254)
..... .....+..|++||.+.+...+.+ +|+||||+++|+|++ |..||......+ .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32221 11223457999999977776555 999999999999997 999987643221 22335
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..||..+|
T Consensus 240 ~~~li~~cl~~~p 252 (316)
T cd05108 240 VYMIMVKCWMIDA 252 (316)
T ss_pred HHHHHHHHccCCh
Confidence 6778888888887
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=241.17 Aligned_cols=226 Identities=29% Similarity=0.474 Sum_probs=185.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC-----
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT----- 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----- 92 (254)
+..+++|++.+.||+|++|.||++.+..++..+++|.+.......+.+.+|+..++++ .|+|++++++.+....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3457999999999999999999999998899999998877666667788999999998 7999999999987644
Q ss_pred -eEEEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 93 -HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.++++++|+++++|.+++.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCcc
Confidence 58999999999999988864 346899999999999999999999999999999999999988776 99999998
Q ss_pred ccccccc-CCCCCccCCCCccCcccccccc----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------
Q 025369 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------- 227 (254)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------- 227 (254)
+...... .......++..|+|||.+.... ....++|+||||+++++|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 7543222 2223345778899999875432 2234499999999999999999999754321
Q ss_pred --hhhHHHHHHhhcCccccCC
Q 025369 228 --KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~p 246 (254)
..+.+.+.+++..|+..+|
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp 260 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNY 260 (275)
T ss_pred chhhcCHHHHHHHHHHhhcCh
Confidence 1234467788888888888
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=244.86 Aligned_cols=228 Identities=23% Similarity=0.371 Sum_probs=184.8
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEE
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEV 87 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (254)
..+....++|++.+.||+|++|.||++.+. .++..+++|.+.... ...+.+.+|+..++++ +|+||+++++.
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 346677889999999999999999999752 345689999876542 2235678899999999 79999999999
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
+...+..++++||+.+++|.+++.... .++..+++.++.+++.++.|||+++++|+||+|+||++++++. ++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCC
Confidence 999999999999999999999987543 3899999999999999999999999999999999999987765 999999
Q ss_pred cccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh------------
Q 025369 166 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD------------ 229 (254)
Q Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~------------ 229 (254)
|++........ .....++..|+|||.+.+...+.+ +|+||+|+++++|++ |..||......+.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence 98764432221 112234567999999877776555 999999999999998 9999876443322
Q ss_pred ----hHHHHHHhhcCccccCC
Q 025369 230 ----FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ----~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|+..+|
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p 285 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADP 285 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCc
Confidence 23456678888888777
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=239.48 Aligned_cols=214 Identities=32% Similarity=0.523 Sum_probs=182.4
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|||++++.+.+.+++.+++++||.++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999899999999886532 2345688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCc
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 186 (254)
.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.............+...|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988878999999999999999999999999999999999999988776 999999988755444333444677889
Q ss_pred cCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--CChh----------------hHHHHHHhhcCccccCCC
Q 025369 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--EPKD----------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 187 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~----------------~~~~~~~~~~~~~~~~p~ 247 (254)
++||.+.+.....+ +|+||+|+++|+|++|..||...+ .... ....+..++..|+..+|.
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 99999877666555 999999999999999999997665 2111 234567888888888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=239.46 Aligned_cols=223 Identities=25% Similarity=0.411 Sum_probs=182.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..++|++.+.||+|+||.||+|.+... ...+++|...... .....+.+|+..++.++|||++++.+.+...+..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 467899999999999999999998643 4578999876532 22356778999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++||+++++|.+++... ..++...++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998664 46899999999999999999999999999999999999988776 999999988755311
Q ss_pred CCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHH
Q 025369 175 SQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQ 235 (254)
Q Consensus 175 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~ 235 (254)
... ........|+|||.+.+...+.+ +|+||||+++++|++ |..||...... ......+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 11233467999999877766555 999999999999998 99998654422 22345677
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
+++..|++.+|
T Consensus 239 ~li~~cl~~~p 249 (266)
T cd05033 239 QLMLDCWQKDR 249 (266)
T ss_pred HHHHHHcCCCc
Confidence 88888888887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=242.29 Aligned_cols=221 Identities=23% Similarity=0.349 Sum_probs=183.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|+++++||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++|+|++++++++.+....++++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4679999999999999999999987 88899998876544 456788899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
+++++|.+++... ..++...++.++.+++.|+.+||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccc
Confidence 9999999998753 45899999999999999999999999999999999999988776 999999987654322211
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh---------------hHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD---------------FRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~---------------~~~~~~~~~~~~ 241 (254)
....+...|++||.+.+.....+ +|+||||+++++|++ |..||...+..+. ....+..++..|
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred cCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 12234557999999877666555 999999999999998 8999976543322 234567777888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 241 l~~~p 245 (261)
T cd05148 241 WAAEP 245 (261)
T ss_pred cCCCc
Confidence 88887
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=241.46 Aligned_cols=225 Identities=22% Similarity=0.359 Sum_probs=183.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEccc-----ceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
....++|++.+.||+|++|.||++.+... +..+++|.+..... ....+.+|+..++.++|+|++++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 35678999999999999999999998643 47899998765432 234677899999999999999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 92 THLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
...++++||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~k 159 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EE
Confidence 99999999999999999986432 3677889999999999999999999999999999999998876 99
Q ss_pred EecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-----------
Q 025369 162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE----------- 226 (254)
Q Consensus 162 l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~----------- 226 (254)
|+|||++....... ......++..|+|||.+.+.....+ +|+||||+++|++++ |..||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 99999876433221 1122334568999999877666555 999999999999998 8999865432
Q ss_pred ----ChhhHHHHHHhhcCccccCC
Q 025369 227 ----PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ----~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|++.+|
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p 262 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNP 262 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCh
Confidence 23344667788888888887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=244.61 Aligned_cols=229 Identities=24% Similarity=0.394 Sum_probs=184.8
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEccc-----ceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 86 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (254)
+.......++|++.+.||+|++|.||++.+... ...+++|.+..... ....+.+|+..++.+ +|+|++++++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 445667788999999999999999999998643 37889998765322 234577899999999 8999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
++..++.+++++||+++++|..++... ..+++..++.++.|++.++.|||+.|++|+||+|+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998542 3588999999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
++++++. ++|+|||++........ .........|+|||++.+...+.+ +|+||||+++|++++ |..||.....
T Consensus 164 l~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 164 LVTEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEcCCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9988776 99999998764432211 111223457999999877766555 999999999999997 8899876443
Q ss_pred Ch---------------hhHHHHHHhhcCccccCC
Q 025369 227 PK---------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ~~---------------~~~~~~~~~~~~~~~~~p 246 (254)
.+ .....+..++..|+..+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 275 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVP 275 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 22 223467778888888888
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=242.01 Aligned_cols=228 Identities=27% Similarity=0.442 Sum_probs=185.0
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEE-----c
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----T 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~ 90 (254)
......++|++.+.||+|++|.||++.+..++..+++|...........+.+|+..++.+ +|+|++++++++. .
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 445578899999999999999999999999999999998766554556778899999998 6999999999874 3
Q ss_pred CCeEEEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 91 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
++.+++++||+++++|.+++.. ...+++..++.++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg 169 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFG 169 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCC
Confidence 4578999999999999888753 345888999999999999999999999999999999999988776 9999999
Q ss_pred ccccccccC-CCCCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------
Q 025369 167 YSKSSVLHS-QPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------- 228 (254)
Q Consensus 167 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------- 228 (254)
++....... ......++..|+|||.+... .....++|+||+|+++++|++|..||.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 876443221 22334577889999988532 223445999999999999999999986543211
Q ss_pred ----hhHHHHHHhhcCccccCC
Q 025369 229 ----DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ----~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|+..+|
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p 271 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDY 271 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCc
Confidence 223457888888888888
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=243.78 Aligned_cols=223 Identities=27% Similarity=0.409 Sum_probs=182.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+|.+.+.||+|++|.||++.+. .++..+++|.+..... ....+.+|+..+++++|+|++++.+++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4678999999999999999999854 2455688887755432 235688899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 95 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
++||||+++++|.+++.... .+++..++.++.|++.++.+||++|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 99999999999999996542 3788999999999999999999999999999999999988776
Q ss_pred ceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
++|+|||++........ .....+...|+|||.+.+.....+ +|+||||+++++|++ |..||...+.
T Consensus 162 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 162 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred -EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 99999998864332211 122345678999999887766555 999999999999998 9999855332
Q ss_pred -------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+.+++..|++.+|
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P 266 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREP 266 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccCh
Confidence 22334568888899999888
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=237.93 Aligned_cols=201 Identities=32% Similarity=0.494 Sum_probs=169.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--Ce
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (254)
+++|++++.||+|++|.||.+.+..++..+++|.+.... .....+.+|+..++.+.|++++++.+.+.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 368999999999999999999999999999999875322 1224677899999999999999999988764 46
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++++++|+++++|.+++.....+++..+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence 7899999999999999988778899999999999999999999999999999999999987776 99999998764322
Q ss_pred cC----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 174 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.. ......+...|+|||++.+...... +|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccc
Confidence 11 1122346778999999877665554 999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=239.99 Aligned_cols=221 Identities=29% Similarity=0.484 Sum_probs=183.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
+|+..+.||+|++|.||.+.+..++..+++|.+.... .....+.+|+..++.++|+|++++++++.+++.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999876432 123567889999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+++|+.+++|.+++....++++..++.++.|++.|+.+||++|++|+||+|.||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976543 389999998754432211
Q ss_pred -----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------hhhHH
Q 025369 177 -----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------KDFRK 232 (254)
Q Consensus 177 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------~~~~~ 232 (254)
.....++..|+|||.+.+...... +|+||+|+++++|++|..||...+.. +....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 112346778999999876665554 99999999999999999999654321 12334
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+.+++..|+..+|
T Consensus 239 ~~~~~i~~~l~~~p 252 (268)
T cd06630 239 GLRDVTLRCLELQP 252 (268)
T ss_pred HHHHHHHHHcCCCc
Confidence 56677778887777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=245.38 Aligned_cols=227 Identities=25% Similarity=0.400 Sum_probs=181.0
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKE 86 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (254)
......++|.+++.||+|+||.||.+++.. +...+++|.+.... .....+.+|+..++.+ +|+|++++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 445556899999999999999999998743 23469999886542 2234577899999999 7999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
++...+..+++++|+++++|.+++.... .++..+++.++.|++.+|+|||+.|++|+||+|+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997542 378889999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
++++++. ++|+|||++........ .........|+|||.+.+.....+ +|+||||+++|+|++ |..||...+.
T Consensus 172 ll~~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEcCCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9988776 99999998764432111 111223457999999877666555 999999999999998 8888865332
Q ss_pred ---------------ChhhHHHHHHhhcCccccCC
Q 025369 227 ---------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ---------------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|+..+|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCh
Confidence 22344567778888888777
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=240.57 Aligned_cols=224 Identities=20% Similarity=0.321 Sum_probs=179.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++.+.||+|++|.||.+.+.. ++..+++|.+..... ....+.+|+..++.++|+|++++++++..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 457899999999999999999998642 456799998754322 2345778999999999999999999999889
Q ss_pred eEEEEEEccCccchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 93 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
..++++||+++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||++++++. ++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l 160 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI 160 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEE
Confidence 9999999999999999886532 2567788999999999999999999999999999999997776 999
Q ss_pred ecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC-----------
Q 025369 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP----------- 227 (254)
Q Consensus 163 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~----------- 227 (254)
+|||++........ .....++..|+|||.+.+...+.. +|+||||+++++|++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99998754322211 112234567999999877666555 999999999999998 78888654432
Q ss_pred ----hhhHHHHHHhhcCccccCC
Q 025369 228 ----KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ----~~~~~~~~~~~~~~~~~~p 246 (254)
......+..++..|++.+|
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p 262 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNP 262 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCh
Confidence 2233457778888888887
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=238.78 Aligned_cols=221 Identities=31% Similarity=0.481 Sum_probs=185.8
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+|+..+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|++++++.+.+..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999998889999999875432 1335678899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
+||+++++|.+++....++++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999988776 999999987654443333
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------------hhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------DFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~ 241 (254)
....++..|++||.+........++|+||+|+++++|++|..||......+ .+...+..++..|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHH
Confidence 445677889999998666523444999999999999999999996644211 2334566778888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 239 l~~~p 243 (258)
T cd06632 239 LQRDP 243 (258)
T ss_pred hhcCc
Confidence 88777
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=245.08 Aligned_cols=230 Identities=24% Similarity=0.378 Sum_probs=183.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEc-------ccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeee
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRF 84 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~ 84 (254)
+..+....++|.+.+.||+|++|.||++++. .....+++|.+.... .....+.+|+..++.+ +||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 4556677889999999999999999999863 234578899876432 2234677899999999 69999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCC
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ 148 (254)
++++.+.+.+++++||+++++|.+++... ..++..++..++.|++.||.|||+.|++|+||+|+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 99999999999999999999999998653 24788899999999999999999999999999999
Q ss_pred cEEecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 025369 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP 224 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 224 (254)
||+++.++. ++|+|||++........ .........|+|||++.+...+.+ +|+||||+++|+|++ |..||...
T Consensus 164 Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 164 NVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eEEEcCCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCC
Confidence 999987776 99999998864432211 111223457999999877666555 999999999999999 88888654
Q ss_pred CCC---------------hhhHHHHHHhhcCccccCCC
Q 025369 225 DEP---------------KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 225 ~~~---------------~~~~~~~~~~~~~~~~~~p~ 247 (254)
+.. ......+..++..|+..+|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 278 (314)
T cd05099 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPT 278 (314)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 321 22234677888888888883
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=238.31 Aligned_cols=221 Identities=32% Similarity=0.511 Sum_probs=185.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|++++++++.+...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988899999998876543 456788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC--
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~-- 178 (254)
+++++|.+++.....+++..+..++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999988776 9999999876543332221
Q ss_pred ---CccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHH
Q 025369 179 ---STVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQ 235 (254)
Q Consensus 179 ---~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~ 235 (254)
...+...|++||++.+.. ....++|+||+|++++++++|..||...+... .....+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence 234677899999987665 23444999999999999999999997542211 1134567
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 239 ~li~~~l~~~p 249 (264)
T cd06626 239 DFLDRCLESDP 249 (264)
T ss_pred HHHHHHccCCc
Confidence 88888888777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=276.46 Aligned_cols=215 Identities=30% Similarity=0.472 Sum_probs=185.5
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC---C-ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---G-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~---~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.+...++|.+++.||+|+||.|.+++++.++..||.|++.+ . .....-+.+|-.++...+.+.|+.++-.|.++++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 45678899999999999999999999999999999998866 2 3344557778888888889999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+|+||+|++||+|..+++...++++..++.++..|+.||+.||+.|+|||||||+|||+|..|+ ++|.|||.+-.+..
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDA 227 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCC
Confidence 9999999999999999999999999999999999999999999999999999999999999998 99999997765554
Q ss_pred cCCC--CCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHH
Q 025369 174 HSQP--KSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234 (254)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 234 (254)
.+.. ...+|+|.|.+||++... ..+.+..|+||+|+++|+|+.|.-||....-.+.+.+++
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm 294 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM 294 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh
Confidence 3333 345799999999998532 334445999999999999999999998866655555554
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=240.74 Aligned_cols=226 Identities=23% Similarity=0.351 Sum_probs=182.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++.+.||+|++|.||++.+.. ++..+++|.+.... .....+.+|+..++.++|+|++++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345789999999999999999999987 67889999875432 22345788999999999999999999999888
Q ss_pred eEEEEEEccCccchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEec
Q 025369 93 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICD 164 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~d 164 (254)
..++++||+++++|.+++.... .+++..+..++.||+.+++|||+++++|+||+|+||+++.++. ..++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 8999999999999999987653 4889999999999999999999999999999999999986542 2489999
Q ss_pred ccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh-----------
Q 025369 165 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD----------- 229 (254)
Q Consensus 165 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~----------- 229 (254)
||++........ .........|+|||++.+...+.+ +|+||||+++++|++ |..||...+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 998765422111 112223457999999987776655 999999999999997 9999977554332
Q ss_pred ----hHHHHHHhhcCccccCC
Q 025369 230 ----FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ----~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|++.+|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCc
Confidence 22346678888888887
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=240.46 Aligned_cols=225 Identities=27% Similarity=0.455 Sum_probs=184.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC------C
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------T 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~ 92 (254)
...++|++.+.||+|++|.||++.+..+++.+++|.+.........+..|+..++.+ +|+|++++.+.+... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 356789999999999999999999999999999999876655566788899999888 699999999998753 4
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.+++++||+++++|.+++... ..+++..++.++.|++.++.|||+.+++|+||+|+||++++++. ++|+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCcee
Confidence 689999999999999998764 35899999999999999999999999999999999999998776 99999998764
Q ss_pred cccc-CCCCCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------Chh
Q 025369 171 SVLH-SQPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKD 229 (254)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~ 229 (254)
.... .......++..|+|||++.+. .....++|+||+|+++|+|++|..||...+. ...
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 3322 222334577889999998632 2233449999999999999999999864321 122
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
+...+.+++..|+..+|
T Consensus 241 ~~~~~~~li~~~l~~~p 257 (272)
T cd06637 241 WSKKFQSFIESCLVKNH 257 (272)
T ss_pred cCHHHHHHHHHHcCCCh
Confidence 34578888889998887
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=238.91 Aligned_cols=214 Identities=27% Similarity=0.390 Sum_probs=174.1
Q ss_pred ccccCCcceEEEEEEE--cccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~--~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
++||+|+||.||++.+ ..++..+++|.+..... ..+.+.+|+..++.++|+|++++++++. ....+++++|+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999864 45678999998765432 3456788999999999999999999875 4567899999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC----CC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 179 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~----~~ 179 (254)
++|.+++.....+++..+..++.|++.++.+||++|++|+||+|.||++++++. ++|+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCC
Confidence 999999988788999999999999999999999999999999999999988776 999999987654332221 11
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC---------------CChhhHHHHHHhhcCccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD---------------EPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~---------------~~~~~~~~~~~~~~~~~~ 243 (254)
..++..|+|||.+........ +|+||||+++|+|++ |..||.... .+......+..++..||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence 223468999998866655444 999999999999998 999997542 233455678888999998
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 237 ~~p 239 (257)
T cd05116 237 YGV 239 (257)
T ss_pred cCc
Confidence 887
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=239.41 Aligned_cols=219 Identities=29% Similarity=0.466 Sum_probs=181.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
+|++++.||+|+||.||++.+. ++..+++|.+..... ....+.+|+..++.++|+|++++.+++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5899999999999999999875 788899998764321 12457789999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc--
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-- 174 (254)
++||+++++|.+++....++++..+..++.|++.++++||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988778999999999999999999999999999999999999987776 999999987643211
Q ss_pred -----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHH
Q 025369 175 -----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRK 232 (254)
Q Consensus 175 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~ 232 (254)
.......++..|+|||.+.+...... +|+||||+++++|++|..||...+... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11123346778999999987766555 999999999999999999997544222 2334
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..|++.+|
T Consensus 237 ~~~~~i~~~l~~~p 250 (265)
T cd06631 237 AAIDFVTSCLTRDQ 250 (265)
T ss_pred HHHHHHHHHhcCCc
Confidence 56777888887777
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=240.97 Aligned_cols=214 Identities=31% Similarity=0.455 Sum_probs=179.4
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||+|++|+||++.+..+++.+++|.+.... .....+.+|+.+++.++||+++++.+.+...+.+++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999875432 2234456799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCC
Q 025369 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (254)
Q Consensus 107 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 184 (254)
.+++.... .+++..+..++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||.+.............+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987765 6899999999999999999999999999999999999988776 9999999876544333334455677
Q ss_pred CccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------ChhhHHHHHHhhcCccccCC
Q 025369 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 185 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------~~~~~~~~~~~~~~~~~~~p 246 (254)
.|++||.+.+...... +|+||+|+++++|++|..||..... +..+...+..++..|++.+|
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 8999999877775444 9999999999999999999976543 12234567788888888887
Q ss_pred C
Q 025369 247 F 247 (254)
Q Consensus 247 ~ 247 (254)
.
T Consensus 238 ~ 238 (277)
T cd05577 238 E 238 (277)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=240.25 Aligned_cols=224 Identities=28% Similarity=0.466 Sum_probs=183.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC-----CeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~ 94 (254)
..++|++.+.||+|++|.||++.+..++..+++|.+.........+.+|+..++++ +|||++++++++... +.+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 36889999999999999999999999999999998876555566778889999888 899999999998753 368
Q ss_pred EEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 95 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++|+||+++++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence 999999999999988753 356899999999999999999999999999999999999988776 99999998764
Q ss_pred ccccC-CCCCccCCCCccCccccccccC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------
Q 025369 171 SVLHS-QPKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------- 228 (254)
Q Consensus 171 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------- 228 (254)
..... ......+...|+|||.+..... ...++|+||+|+++++|++|..||...+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 43222 1223456778999998754331 2445999999999999999999987644322
Q ss_pred hhHHHHHHhhcCccccCC
Q 025369 229 DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|++.+|
T Consensus 258 ~~~~~l~~li~~~l~~~p 275 (291)
T cd06639 258 KWCRSFNHFISQCLIKDF 275 (291)
T ss_pred ccCHHHHHHHHHHhhcCh
Confidence 222356778888888887
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.75 Aligned_cols=223 Identities=23% Similarity=0.344 Sum_probs=183.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.++||+|++|.||++.+. .+..+++|.+.........+.+|+..++.++|++++++++++......+++++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45789999999999999999999976 45779999887766666788999999999999999999999998889999999
Q ss_pred ccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
++++++|.+++.... .++...+..++.+++.|+.+||++|++|+||+|+||++++++. ++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 999999999987653 5899999999999999999999999999999999999988876 99999998764432111
Q ss_pred -CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhc
Q 025369 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIK 239 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~ 239 (254)
.........|+|||.+.+...... +|+||+|++++++++ |..||...+... .....+.+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112223467999999877666555 999999999999998 999986644322 22345666777
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 239 ~~l~~~p 245 (261)
T cd05034 239 QCWDKDP 245 (261)
T ss_pred HHcccCc
Confidence 7777766
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=238.62 Aligned_cols=221 Identities=24% Similarity=0.362 Sum_probs=180.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.+.||+|++|.||++.+..+. .+++|.+.......+.+.+|+..++.++|++++++++++. .+..+++|+|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 3478999999999999999999887554 5899987765555677889999999999999999998875 4567899999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
+.+++|.+++... ..++...+..++.+++.||.|||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccc
Confidence 9999999998654 34788999999999999999999999999999999999988776 999999987644322111
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhcC
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIKP 240 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~~ 240 (254)
....++..|++||...+...+.. +|+||||+++|+|++ |..||...... ......+..++..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 12234567999998876665555 999999999999999 89998764332 2344567888888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 239 ~l~~~p 244 (260)
T cd05069 239 CWKKDP 244 (260)
T ss_pred HccCCc
Confidence 998888
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=241.89 Aligned_cols=220 Identities=30% Similarity=0.541 Sum_probs=186.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|++.+++++|||++++.+.+..++.+++++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47899999999999999999999999999999876643 2345678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
+++++|.+++... ..+++..++.++.|++.++.+||+ .|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9989999999876 778999999999999999999999 99999999999999998776 999999987544322221
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----C----------------Ch-hhHHHHHHh
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----E----------------PK-DFRKTIQVF 237 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~----------------~~-~~~~~~~~~ 237 (254)
...+...|++||.+.+.....+ +|+||+|+++++|++|..||...+ . +. .+...+..+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2567778999999877766555 999999999999999999996542 1 01 134457788
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|+..+|
T Consensus 237 i~~~l~~~p 245 (265)
T cd06605 237 VNLCLIKDP 245 (265)
T ss_pred HHHHcCCCc
Confidence 888988887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=239.90 Aligned_cols=221 Identities=31% Similarity=0.521 Sum_probs=185.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.|+..+.||.|++|.||.+.+..++..+++|.+.... .....+.+|+..++.+.|++++++.+.+.++..+++|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56889999999999999999999899999999876442 2345678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 179 (254)
+++++|.+++.. .++++.++..++.+++.++++||+.+++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999998865 46899999999999999999999999999999999999988776 99999998754433221 122
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhHHHHHHhhcCcccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKTIQVFIKPCCHI 244 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~ 244 (254)
..+...|.|||.+.+...+.. +|+||||+++++|++|..||...+. .......+..++..|++.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 346678999999877766555 9999999999999999999864331 223456688899999998
Q ss_pred CCC
Q 025369 245 TPF 247 (254)
Q Consensus 245 ~p~ 247 (254)
+|.
T Consensus 240 ~p~ 242 (277)
T cd06640 240 DPS 242 (277)
T ss_pred Ccc
Confidence 883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=238.56 Aligned_cols=220 Identities=29% Similarity=0.525 Sum_probs=183.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.+|++.+..++..+++|.+... ......+.+|+..+++++|+|++++.+.+...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999999999999987643 22335678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
+.+++|.+.+.... .+++.++..++.|++.++.+||++|++|+||+|+||+++.++. ++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999886543 5789999999999999999999999999999999999987776 999999987643322211
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------hhhHHHHHHhhcCcc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------KDFRKTIQVFIKPCC 242 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~ 242 (254)
....+...|+|||++.+.....+ +|+||+|+++++|++|..||...+.. ......+..++..|+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence 22346778999999877766555 99999999999999999998765432 233445778888888
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+.+|
T Consensus 238 ~~~p 241 (256)
T cd08218 238 KRNP 241 (256)
T ss_pred hCCh
Confidence 8887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.14 Aligned_cols=220 Identities=26% Similarity=0.410 Sum_probs=179.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 97 (254)
.....+|++.+.||+|++|.||++... +..+++|..... ...+.+.+|+..++.++|++++++.+++.. ++..+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 356789999999999999999999775 677899987543 334668889999999999999999997654 4678999
Q ss_pred EEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||+++++|.+++.... .+++..++.++.+++.++.+||++|++|+||+|+||++++++. ++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC
Confidence 99999999999987653 3788999999999999999999999999999999999988776 9999999876433222
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIK 239 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~ 239 (254)
........|+|||++.+...... +|+||||+++|+|++ |..||...+..+ .....+..++.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred --CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 22334567999999877666555 999999999999997 999987544322 22345788888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 234 ~~l~~~p 240 (256)
T cd05082 234 QCWHLDA 240 (256)
T ss_pred HHhcCCh
Confidence 8888887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=244.36 Aligned_cols=223 Identities=24% Similarity=0.388 Sum_probs=178.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEccc--------------ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeee
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVT--------------KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~--------------~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 84 (254)
..++|++.+.||+|+||.||++.+..+ ...+++|.+.... .....+.+|+..+++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 467999999999999999999987543 3358999876532 223567889999999999999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili 152 (254)
++++...+..+++|||+++++|.+++.... .++...++.++.+++.|+.|||+.|++|+||+|+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999885432 36788899999999999999999999999999999999
Q ss_pred cCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCC
Q 025369 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEP 227 (254)
Q Consensus 153 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 227 (254)
++++. ++|+|||++........ .....++..|+|||++.+...+.+ +|+||||+++++|++ |..||......
T Consensus 163 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 163 GNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred cCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 87776 99999998764332211 112234568999999877766555 999999999999998 66788654432
Q ss_pred hh----------------------hHHHHHHhhcCccccCC
Q 025369 228 KD----------------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ~~----------------------~~~~~~~~~~~~~~~~p 246 (254)
+. ....+.+++..|+..+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 280 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDI 280 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 21 23457788888888887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.36 Aligned_cols=232 Identities=25% Similarity=0.394 Sum_probs=196.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccce-----eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
...+.....++.+.||+|.||.||.+....... .|++|.+.... .....+.+|..+++.++||||+++++++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 445778899999999999999999999876544 38999887653 34467889999999999999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 90 TPTHLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
+....++++||+.+|+|.+++.+. ..++..+++.++.+|+++..||++++++||||..+|+|++.... +|+
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKI 843 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKI 843 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEE
Confidence 999999999999999999999876 24899999999999999999999999999999999999987755 999
Q ss_pred ecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC------------
Q 025369 163 CDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE------------ 226 (254)
Q Consensus 163 ~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~------------ 226 (254)
+|||+|+........ ....-...|||||.+.+..++++ +||||||+++||+++ |..||.+.+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 999999733322111 11234468999999999888888 999999999999999 9999988654
Q ss_pred ---ChhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 ---PKDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+......+.++|..||+.+| ..|-|
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccH
Confidence 44555678899999999999 44443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=256.34 Aligned_cols=234 Identities=26% Similarity=0.379 Sum_probs=196.0
Q ss_pred CCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccce---e-EEEEEccCCc----cchhHHHHHHHHhhcCCCCCee
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---L-VAVKYIERGD----KIDENVQREIINHRSLRHPNIV 82 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~-~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~ 82 (254)
.|+-...+...-++..+.++||+|+||.||+++....+. . ||+|....+. .....+.+|+++++.++||||+
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 566666777777888889999999999999999875422 3 8999877522 2345678899999999999999
Q ss_pred eeeEEEEcCCeEEEEEEccCccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
+++|+.....-+++|||+++||+|.+++..++. ++..+...++++.+.+|+|||+++++||||-.+|+|++.++. +|
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vK 302 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VK 302 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EE
Confidence 999999999999999999999999999998874 999999999999999999999999999999999999998776 89
Q ss_pred EecccccccccccCCCC-CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC------------
Q 025369 162 ICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP------------ 227 (254)
Q Consensus 162 l~df~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~------------ 227 (254)
++|||++.......... ..--...|+|||.+....++.+ +||||+|+++||+++ |..||......
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence 99999987554222222 2235679999999988876666 999999999999998 88899875543
Q ss_pred ----hhhHHHHHHhhcCccccCCC
Q 025369 228 ----KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ----~~~~~~~~~~~~~~~~~~p~ 247 (254)
......+..++..||..+|.
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~ 405 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPE 405 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChh
Confidence 33444677888899999984
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=240.15 Aligned_cols=212 Identities=28% Similarity=0.437 Sum_probs=179.3
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||+|.+..++..+++|.+.... .....+.+|+..+++++|+|++++++++..++..++|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6999999999999999999999899999999886543 2346788899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--C
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 177 (254)
+ +++|.+.+... ..+++.+++.++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 88999988653 56899999999999999999999999999999999999988776 99999998765443321 2
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhh
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFI 238 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 238 (254)
....++..|+|||.+.+......++|+||+|+++++|++|.+||...+....+.+.+..+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC
Confidence 3345778899999987665555669999999999999999888877776565555555443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=245.24 Aligned_cols=222 Identities=27% Similarity=0.493 Sum_probs=195.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..+-|.++++||+|+||.||+|.++.+|..+|+|.+.... ..+.+.+|+.++.+++.|++|++++.+.-...+|+||||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 3456889999999999999999999999999999987653 456778899999999999999999999999999999999
Q ss_pred cCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCC
Q 025369 101 ASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 178 (254)
|..|++.+++. .+.++++.++..+++..+.+|+|||...-+||||+..|||++.++. .||.|||++...-.. ...+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhC
Confidence 99999999885 4567999999999999999999999999999999999999998888 899999987643222 1224
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC-----------------CCCChhhHHHHHHhhcCc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED-----------------PDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-----------------~~~~~~~~~~~~~~~~~~ 241 (254)
...|++.|+|||++..-.+.+. +||||||++..+|..|++||.. ...++.+...+.++++.|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 5569999999999999999888 9999999999999999999965 224678888999999999
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+-..|
T Consensus 267 LiK~P 271 (502)
T KOG0574|consen 267 LIKKP 271 (502)
T ss_pred hcCCH
Confidence 98877
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=235.74 Aligned_cols=220 Identities=26% Similarity=0.484 Sum_probs=180.5
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 99 (254)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++|++++++.+.+.. .+.++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999899999999886532 233567789999999999999999988764 446799999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-C
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 176 (254)
|+++++|.+++... ..+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 99999999888753 45899999999999999999999999999999999999988776 9999999876443221 2
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh---------------hHHHHHHhhcCc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------FRKTIQVFIKPC 241 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~ 241 (254)
.....+...|+|||.+.+...+.+ +|+||+|+++++|++|..||...+.... ....+..++..|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 223356788999999887776655 9999999999999999999976543222 234466677777
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 238 l~~~p 242 (257)
T cd08223 238 LSKRP 242 (257)
T ss_pred hccCc
Confidence 77776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.25 Aligned_cols=223 Identities=28% Similarity=0.443 Sum_probs=183.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
+-|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++.+.+..++..++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999999999999999876543 33456778999999999999999999999999999999999
Q ss_pred CccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCC
Q 025369 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (254)
Q Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 179 (254)
++++|...+.. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 456899999999999999999999999999999999999987776 999999987543222 12233
Q ss_pred ccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhh
Q 025369 180 TVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFI 238 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~ 238 (254)
..++..|+|||++.. ......++|+||+|+++|+|++|+.||...+. +..+...+.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 457788999999742 22223459999999999999999999875432 223445688888
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..||..+|.
T Consensus 243 ~~~l~~~p~ 251 (282)
T cd06643 243 KKCLEKNVD 251 (282)
T ss_pred HHHccCChh
Confidence 899988883
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=245.98 Aligned_cols=196 Identities=26% Similarity=0.428 Sum_probs=161.8
Q ss_pred eEeccccCC--cceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 26 DFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 26 ~~~~~l~~g--~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+++++||+| ++++||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 67899999999999999999886542 2335677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. +++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence 9999999998653 45899999999999999999999999999999999999988776 89999975432211111
Q ss_pred ------CCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 177 ------PKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 177 ------~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
.....+...|+|||++.+. .....++|+||+|+++++|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1122345679999998764 2234459999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=237.77 Aligned_cols=214 Identities=28% Similarity=0.403 Sum_probs=175.3
Q ss_pred ccccCCcceEEEEEEEcccc---eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~---~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
++||+|++|.||++.....+ ..+++|.+..... ..+.+.+|+..++.+.|+|++++++++. .+.++++++|+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 7899998876543 4456788999999999999999999875 4567999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC----C
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 179 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~----~ 179 (254)
++|.+++.....+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999988776 9999999886543322211 1
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~ 243 (254)
..+...|+|||.+.+.....+ +|+||||+++|+|++ |..||...+. +......+.+++..|+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 112357999999877766555 999999999999998 9999976443 22334567788889988
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 237 ~~p 239 (257)
T cd05060 237 YRP 239 (257)
T ss_pred CCh
Confidence 888
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=242.49 Aligned_cols=224 Identities=25% Similarity=0.431 Sum_probs=179.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc----------------cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i 81 (254)
+..++|++.+.||+|+||.||++.+.. ++..+++|...... .....+.+|+..++.++|+|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 356789999999999999999986542 34578999876542 233567889999999999999
Q ss_pred eeeeEEEEcCCeEEEEEEccCccchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
+++++++...+..++++||+++++|.+++.... .++..+++.++.|++.|+.+||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986542 256778999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPD 225 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~ 225 (254)
++++++. ++|+|||++........ .........|++||...+..++.+ +|+||||+++|+|++ |..||...+
T Consensus 162 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 162 LVGKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEcCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9987766 99999998764432211 111223567999998877766555 999999999999998 778886543
Q ss_pred CCh----------------------hhHHHHHHhhcCccccCC
Q 025369 226 EPK----------------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ~~~----------------------~~~~~~~~~~~~~~~~~p 246 (254)
..+ .....+.+++..||..+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 222 233567788889998888
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=238.70 Aligned_cols=223 Identities=23% Similarity=0.369 Sum_probs=180.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce---eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..++|+..+.||+|++|.||++.+..++. .+++|...... ...+.+.+|+..++.++|+|++++.+++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45689999999999999999999876544 78899876542 23456788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++|||+++++|.+++... ..++..++..++.+++.|+++||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999998654 56899999999999999999999999999999999999987776 999999987644332
Q ss_pred CCCCC----ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHH
Q 025369 175 SQPKS----TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTI 234 (254)
Q Consensus 175 ~~~~~----~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~ 234 (254)
..... ......|++||.+.....+.+ +|+||||+++|+|++ |..||...+..+ .....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 22111 112346999999877666555 999999999999997 999997654322 223356
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
.+++..|+..+|
T Consensus 240 ~~li~~c~~~~p 251 (268)
T cd05063 240 YQLMLQCWQQDR 251 (268)
T ss_pred HHHHHHHcCCCc
Confidence 677778887777
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.04 Aligned_cols=197 Identities=30% Similarity=0.458 Sum_probs=163.9
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCC-CCCeeeeeEEEEcC--CeEEEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 99 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~~ 99 (254)
|++.+.||+|++|.||++.+..++..+++|.+..... ......+|+..++++. |+|++++++++.++ +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998765322 2223456788888885 99999999999987 88999999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|+++ ++.+.+.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||++++ +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777765 356899999999999999999999999999999999999987 44 9999999887554433334
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
...++..|+|||.+........++|+||+|+++++|++|..||...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 44577889999987655554556999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=250.57 Aligned_cols=232 Identities=25% Similarity=0.365 Sum_probs=186.2
Q ss_pred CCCCCCcccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc--chhHHHHHHHHhhcCC-CCCeee
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVR 83 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~ 83 (254)
...+..+..+.++|.+++.||+|+||.||++++. .++..||+|.+..... ..+.+.+|+..+.++. ||||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 26 LPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred CCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 3444457777889999999999999999999864 3456899999875422 2346778999999997 999999
Q ss_pred eeEEEEcCCeEEEEEEccCccchHHHHHhcC-------------------------------------------------
Q 025369 84 FKEVILTPTHLAIVMEYASGGELFERICNAG------------------------------------------------- 114 (254)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~------------------------------------------------- 114 (254)
+++.+..++..++|+||+++++|.+++....
T Consensus 106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 9999999999999999999999999885431
Q ss_pred -------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCC
Q 025369 115 -------------------------------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145 (254)
Q Consensus 115 -------------------------------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di 145 (254)
.++...+..++.|++.||.|||+.+++|+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl 265 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL 265 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence 2566678889999999999999999999999
Q ss_pred CCCcEEecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCC
Q 025369 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 221 (254)
Q Consensus 146 ~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf 221 (254)
+|+||++++++. ++|+|||++........ .....++..|++||.+.+...... +|+||||+++++|++ |..||
T Consensus 266 kp~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 266 AARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CcceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCC
Confidence 999999987766 99999998864322211 122345678999999987766555 999999999999998 88998
Q ss_pred CCCCCCh----------------hhHHHHHHhhcCccccCC
Q 025369 222 EDPDEPK----------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 222 ~~~~~~~----------------~~~~~~~~~~~~~~~~~p 246 (254)
......+ .....+.+++..||+.+|
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P 383 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 7644322 234567789999999888
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=242.71 Aligned_cols=228 Identities=21% Similarity=0.374 Sum_probs=182.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||.|++|.||++.+.. .+..+++|.+..... ..+.+.+|+..++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 45679999999999999999998754 357899998865432 23567789999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC
Q 025369 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~ 157 (254)
.+++++|+.+++|.+++... ..++...+..++.|++.||.|||+.|++||||+|.||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999999999888532 23788889999999999999999999999999999999987776
Q ss_pred CceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC------
Q 025369 158 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP------ 227 (254)
Q Consensus 158 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~------ 227 (254)
++|+|||++........ .....+++.|+|||++.+...... +|+||||+++++|++ |..||......
T Consensus 163 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 163 --VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred --eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998764322211 122234568999999877776555 999999999999998 88888654332
Q ss_pred ---------hhhHHHHHHhhcCccccCC-Ccccc
Q 025369 228 ---------KDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 228 ---------~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
......+..++..|++.+| ..|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 2344457788889999888 44433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=239.78 Aligned_cols=222 Identities=23% Similarity=0.387 Sum_probs=179.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
..++|++.+.||+|++|+||++.+..++. .|++|.+.... .....+.+|+..++.++|+|++++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 46799999999999999999999876665 47899876432 2345677889999999999999999998754 46
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++++++++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++. ++|+|||++.....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence 7899999999999998764 56899999999999999999999999999999999999987776 99999998865433
Q ss_pred cCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
.... ........|++||...+...+.+ +|+||||+++|+|++ |..||..... +......+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2221 12234567999999877766555 999999999999998 8899865332 22234556
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..||+.+|
T Consensus 241 ~~li~~~l~~dp 252 (279)
T cd05109 241 YMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHHcCCCh
Confidence 778888898887
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=248.93 Aligned_cols=192 Identities=26% Similarity=0.442 Sum_probs=163.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
...+|++.+.||+|++|.||++.+..++..+++|..... ....|+.+++.++|+||+++++++......++|+++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 345799999999999999999999999999999974332 235688999999999999999999999999999999
Q ss_pred cCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||+|+||+++.++. ++|+|||++...........
T Consensus 139 ~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 139 YSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred cCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccc
Confidence 965 77777754 456899999999999999999999999999999999999988777 99999998864433333334
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
..++..|+|||++.+..+..+ +|+||||+++|+|+++..++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCcc
Confidence 567889999999988777665 99999999999999855443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.70 Aligned_cols=216 Identities=31% Similarity=0.417 Sum_probs=183.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC------
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (254)
.+.-|..-+.||+|+||.||+++++.+|+.+|||.+... ....+..-+|++++++++|+|||++.++-....
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 356788899999999999999999999999999988763 345577889999999999999999999865433
Q ss_pred eEEEEEEccCccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec--CCCCCceEEecccc
Q 025369 93 HLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGY 167 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~--~~~~~~~~l~df~~ 167 (254)
.-.++||||.||+|...+... .-+++.+++.+..++..|+.|||+.||+||||||.||++. .++..-.||+|||+
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 457999999999999999643 3499999999999999999999999999999999999874 33454589999999
Q ss_pred cccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
|+.......-.+..|+..|.+||.......++...|.||+|+++|++.||..||.....+....+++-.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 998877777788889999999999876444455599999999999999999999887777654444333
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=233.32 Aligned_cols=221 Identities=33% Similarity=0.545 Sum_probs=188.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
+|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|++++++.+.+...+..+++++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58899999999999999999998899999998876543 45678899999999999999999999999999999999999
Q ss_pred ccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCcc
Q 025369 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181 (254)
Q Consensus 103 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 181 (254)
+++|.+++... ..+++..++.++.+++.++.+||+.|++||||+|+||++++++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57899999999999999999999999999999999999998776 9999999876554433234456
Q ss_pred CCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCcccc
Q 025369 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~ 244 (254)
+...|++||.+.+.....+ +|+||||+++++|++|..||...+... .+...+..++..|+..
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 7788999999877665445 999999999999999999987652211 1145678888888888
Q ss_pred CCC
Q 025369 245 TPF 247 (254)
Q Consensus 245 ~p~ 247 (254)
+|-
T Consensus 238 ~p~ 240 (253)
T cd05122 238 NPE 240 (253)
T ss_pred Chh
Confidence 873
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=241.32 Aligned_cols=221 Identities=26% Similarity=0.442 Sum_probs=181.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
++|++++.||+|++|.||++.+..++..+++|.+... ......+.+|+..+++++|+|++++++.+..++.+++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4799999999999999999999999999999987643 22235677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+++++|..++... ..+++..+..++.+++.++.|||+ .|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999998888763 368999999999999999999996 59999999999999988666 99999998754322 22
Q ss_pred CCCccCCCCccCccccccccC-----CCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKT 233 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~ 233 (254)
.....+...|+|||.+.+... ...++|+||+|+++++|++|..||...+.. ..+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 233456778999999855432 244599999999999999999999653322 123345
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|++.+|
T Consensus 238 ~~~li~~~l~~~p 250 (286)
T cd06622 238 AQDFVAKCLNKIP 250 (286)
T ss_pred HHHHHHHHcccCc
Confidence 6677788888777
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=234.71 Aligned_cols=220 Identities=35% Similarity=0.541 Sum_probs=190.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 98 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|++++++.+.+.+. +.+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999899999999876554 3456788999999999999999999999988 8999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
|++++++|.+++.....+++..++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988888999999999999999999999999999999999999998766 99999998765554432
Q ss_pred -CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----------------CChhhHHHHHHhh
Q 025369 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------------EPKDFRKTIQVFI 238 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------------~~~~~~~~~~~~~ 238 (254)
.....+...|.+||.+.+.....+ +|+||||+++++|++|..||...+ .+......+..++
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 344567789999999877765555 999999999999999999997654 1233456788888
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 238 ~~~l~~~p 245 (260)
T cd06606 238 RKCLRRDP 245 (260)
T ss_pred HHhCcCCh
Confidence 88888887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=239.30 Aligned_cols=201 Identities=29% Similarity=0.449 Sum_probs=166.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.++|++.+.||+|++|.||++.+..++..+++|.+.... .......+|+..++.++|+|++++.+++..+...++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999999899999999876542 223456789999999999999999999999999999999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
|+. +++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCC
Confidence 996 466666544 345788899999999999999999999999999999999988776 9999999876432221 12
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
....+...|+|||.+.+......++|+||||+++++|++|..||...+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 233467789999998765433445999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=238.07 Aligned_cols=205 Identities=30% Similarity=0.486 Sum_probs=171.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++.+.+.+.+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999999999999999886543 23456678999999999999999999999999999999999
Q ss_pred CccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 102 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 102 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
++ +|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 787777654 35899999999999999999999999999999999999987776 99999998754332211 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 231 (254)
....++..|++||.+.+......++|+||||+++++|++|..||...+..+...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 233456789999998765554555999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=248.45 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=168.2
Q ss_pred CCceeEeccccCCcceEEEEEEEc--ccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..+|++++.||.|++|.||++... .++..+++|.+... ....+|+.+++.++||||+++++.+......+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999764 35678999977543 334679999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
++. ++|..++.....+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++.........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 985 578888877788999999999999999999999999999999999999988776 999999988654332221
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
....++..|+|||++.+..+..+ +|+||||+++|+|++|+.||.....
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 23457889999999987777665 9999999999999999999976543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=238.98 Aligned_cols=222 Identities=31% Similarity=0.534 Sum_probs=184.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCC---CCCeeeeeEEEEcCCeEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 97 (254)
+.|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|+..++.++ ||+++++++++..+...+++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3688999999999999999999989999999987653 223456778888888886 99999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
+||+++++|.+++... .+++..++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccc
Confidence 9999999999888654 7899999999999999999999999999999999999998776 99999998765433322
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------------hhHHHHHHhhcC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------DFRKTIQVFIKP 240 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~ 240 (254)
.....+...|+|||.+.+......++|+||||+++|+|++|..||...+... .+...+..++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 2233577789999998765544555999999999999999999996543211 144567888889
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 238 ~l~~~p~ 244 (277)
T cd06917 238 CLDEEPK 244 (277)
T ss_pred HcCCCcc
Confidence 9988884
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=235.20 Aligned_cols=200 Identities=33% Similarity=0.505 Sum_probs=169.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (254)
.+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|++++++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 68999999999999999999999999999999874321 2224677899999999999999999998764 468
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++++||+++++|.+.+.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999988778899999999999999999999999999999999999987776 999999988644221
Q ss_pred C----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
. ......+...|+|||.+.+...+.+ +|+||||+++++|++|..||...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccC
Confidence 1 1122346778999999887666555 999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=235.40 Aligned_cols=222 Identities=22% Similarity=0.379 Sum_probs=180.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...++|++.+.||+|++|.||++.+. .+..+++|.+.......+.+.+|+.+++.++|++++++.+.+.. ...+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45789999999999999999999865 44568999877655455678889999999999999999999877 77899999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+++++|.+++... ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998753 34788889999999999999999999999999999999987776 999999987643322111
Q ss_pred --CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhc
Q 025369 178 --KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIK 239 (254)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~ 239 (254)
....+...|+|||++.......+ +|+||||++++++++ |..||...+... .....+..++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 11234467999999877665555 999999999999998 899997654322 22346777888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|++.+|
T Consensus 238 ~~l~~~p 244 (260)
T cd05073 238 RCWKNRP 244 (260)
T ss_pred HHcccCc
Confidence 8888888
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=234.48 Aligned_cols=222 Identities=26% Similarity=0.449 Sum_probs=183.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.++|++.+.||+|++|.||++.+. .+..+++|.+.........+.+|+..++.++||+++++++++......+++++|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999886 466799998876655567788999999999999999999999998999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--C
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 177 (254)
+.+++|.+++... ..+++..++.++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999988754 46889999999999999999999999999999999999987776 99999998754322111 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~~~ 241 (254)
.....+..|+|||.+.+.....+ +|+||||+++|+|++ |..||...... ....+.+..++..|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12224467999999877666554 999999999999998 99998754422 22344577788888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 238 l~~~p 242 (256)
T cd05112 238 WKERP 242 (256)
T ss_pred cccCh
Confidence 88887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=235.75 Aligned_cols=215 Identities=27% Similarity=0.454 Sum_probs=180.8
Q ss_pred ccccCCcceEEEEEEEccc---ceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|++|.||++.+... +..+++|.+...... .+.+.+|+..++.++|++++++++++.....++++++|+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4789999999999999865 889999988765433 46788899999999999999999999998999999999999
Q ss_pred cchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 104 ~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 67999999999999999999999999999999999999998876 999999988655433
Q ss_pred C---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 175 S---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 175 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
. ......+...|+|||.+.......+ +|+||+|+++++|++ |..||...+. +......+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 2233456778999999877765555 999999999999999 6899876543 223345577
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|++.+|
T Consensus 238 ~li~~~l~~~p 248 (262)
T cd00192 238 ELMLSCWQLDP 248 (262)
T ss_pred HHHHHHccCCc
Confidence 77778888777
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.61 Aligned_cols=219 Identities=21% Similarity=0.347 Sum_probs=175.2
Q ss_pred eeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe-----
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (254)
|++++.||+|+||.||.+....+ +..+++|.+..... ..+.+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987643 47899998865432 23467889999999999999999998876543
Q ss_pred -EEEEEEccCccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 94 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
.+++++|+++++|...+... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887433 25899999999999999999999999999999999999988776 9999999
Q ss_pred ccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh--------------
Q 025369 167 YSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK-------------- 228 (254)
Q Consensus 167 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~-------------- 228 (254)
++......... .....+..|++||.+.+.....+ +|+||||+++|+|++ |..||......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 88654332211 11223457999999876666555 999999999999999 889987654322
Q ss_pred -hhHHHHHHhhcCccccCC
Q 025369 229 -DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -~~~~~~~~~~~~~~~~~p 246 (254)
.....+.+++..|+..+|
T Consensus 238 ~~~~~~~~~li~~~l~~~p 256 (273)
T cd05035 238 EDCLDELYDLMYSCWRADP 256 (273)
T ss_pred cCCCHHHHHHHHHHcCCCh
Confidence 233467788888888888
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.54 Aligned_cols=220 Identities=24% Similarity=0.395 Sum_probs=177.1
Q ss_pred ceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ....+.+|+..++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58999999999999999998753 235688887764432 23567789999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe
Q 025369 97 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili 152 (254)
+++|+.+++|.+++... ..++...++.++.|++.+|++||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 247788999999999999999999999999999999999
Q ss_pred cCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--
Q 025369 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-- 226 (254)
Q Consensus 153 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-- 226 (254)
++++. ++|+|||++........ .........|+|||.+.+...+.. +|+||||+++++|++ |..||.....
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 87776 99999998764332221 122234567999999876666555 999999999999998 9999865432
Q ss_pred -------------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|++.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 22234567788888988888
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=239.42 Aligned_cols=223 Identities=22% Similarity=0.335 Sum_probs=176.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
+..++|++.+.||+|++|+||++.+..++. .+++|.+.... .....+..|+..++++.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 345799999999999999999999876665 46777764332 122456677778899999999999998754 45
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++++++++++|.+++... ..+++..++.++.|++.++.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceecc
Confidence 67899999999999999764 56899999999999999999999999999999999999987776 9999999886443
Q ss_pred ccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHH
Q 025369 173 LHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKT 233 (254)
Q Consensus 173 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~ 233 (254)
.... .....++..|++||.+.+..++.+ +|+||||+++|++++ |..||....... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 2221 112235568999999877766555 999999999999998 999997644221 22335
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..||..+|
T Consensus 240 ~~~li~~c~~~~p 252 (279)
T cd05111 240 VYMVMVKCWMIDE 252 (279)
T ss_pred HHHHHHHHcCCCc
Confidence 6677888888888
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=237.85 Aligned_cols=223 Identities=24% Similarity=0.396 Sum_probs=180.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccc---eeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
+.++|++.+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+..++.++|||++++.+++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4578999999999999999999886443 368899876532 23356788999999999999999999999889999
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++||+++++|.+++... ..++..+++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998765 46899999999999999999999999999999999999987776 999999987654332
Q ss_pred CCCC----CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHH
Q 025369 175 SQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTI 234 (254)
Q Consensus 175 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~ 234 (254)
.... .......|++||.+.+.....+ +|+||||++++++++ |..||...+..+ .....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence 2111 1112357999999977666555 999999999999886 999997654322 223456
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..|++.+|
T Consensus 239 ~~li~~~l~~~p 250 (267)
T cd05066 239 HQLMLDCWQKDR 250 (267)
T ss_pred HHHHHHHcccCc
Confidence 778888888777
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=237.08 Aligned_cols=222 Identities=32% Similarity=0.485 Sum_probs=183.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-----------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
+|.+.+.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+..++.++|++++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68999999999999999999998999999998753211 1245678999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++|+||+++++|.+.+.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999876433
Q ss_pred ccCC---CCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------------
Q 025369 173 LHSQ---PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------------- 228 (254)
Q Consensus 173 ~~~~---~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------------- 228 (254)
.... .....++..|+|||.+.... ....++|+||||++++++++|..||...+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 2211 12234677899999987654 23445999999999999999999986433211
Q ss_pred hhHHHHHHhhcCccccCCC
Q 025369 229 DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p~ 247 (254)
.+...+..++..|+..+|.
T Consensus 240 ~~~~~~~~li~~~l~~~p~ 258 (272)
T cd06629 240 NLSPVALDFLNACFTINPD 258 (272)
T ss_pred cCCHHHHHHHHHHhcCChh
Confidence 2245677888888888883
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=242.35 Aligned_cols=220 Identities=31% Similarity=0.510 Sum_probs=183.6
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.|+..+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+..++..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 46888899999999999999999899999999876432 2345688999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 179 (254)
+++++|.+++.. ..+++..++.++.+++.++.+||++|++|+||+|+||++++++. ++|+|||++........ ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999988764 46899999999999999999999999999999999999988776 99999998764432221 122
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------hhhHHHHHHhhcCcccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------KDFRKTIQVFIKPCCHI 244 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~ 244 (254)
..+...|+|||++.+.....+ +|+||||+++++|++|..||...... ......+..++..|+..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 346778999999987766555 99999999999999999998643321 12345678888889988
Q ss_pred CC
Q 025369 245 TP 246 (254)
Q Consensus 245 ~p 246 (254)
+|
T Consensus 240 ~p 241 (277)
T cd06642 240 DP 241 (277)
T ss_pred Cc
Confidence 88
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=237.69 Aligned_cols=204 Identities=31% Similarity=0.494 Sum_probs=168.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++++++.+....++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 68999999999999999999999899999999876542 223567789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 100 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
|+++ ++.+.+..... +++..++.++.||+.||++||++|++|+||+|+||+++.++. .++|+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 77777755433 578888999999999999999999999999999999985443 389999998864432221
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
.....+...|+|||.+.+......++|+||+|+++++|++|..||...+..+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1233456789999998765544555999999999999999999997655433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=238.33 Aligned_cols=200 Identities=32% Similarity=0.500 Sum_probs=168.5
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..+++++|||++++.+++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4899999999999999999999999999999876432 2235678899999999999999999999999999999999
Q ss_pred cCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 101 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
+. ++|.+++.. ...+++..++.++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 478887754 346899999999999999999999999999999999999998876 99999998764332221 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
....+...|+|||.+.+......++|+||||+++++|++|..||...+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 2234567899999987766545569999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=239.06 Aligned_cols=223 Identities=30% Similarity=0.477 Sum_probs=177.8
Q ss_pred CCCceeEeccccCCcceEEEEEEE----cccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcC--Ce
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (254)
...+|++.+.||+|+||.||.+.. ..++..+++|.+..... ....+.+|+..++.++|||++++.+++... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 356899999999999999999984 45688999998765432 245678899999999999999999987543 46
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
+++++||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||++++++. ++|+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCccccccc
Confidence 89999999999999998764 45899999999999999999999999999999999999987776 9999999887543
Q ss_pred ccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------------
Q 025369 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------------- 226 (254)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------------- 226 (254)
..... ........|+|||++.+.....+ +|+||||+++++|++|..++.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32221 11123345899999877666554 9999999999999998766432211
Q ss_pred ---------ChhhHHHHHHhhcCccccCC
Q 025369 227 ---------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ---------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..||..+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDP 267 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCCh
Confidence 11233568888999998888
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=238.78 Aligned_cols=212 Identities=33% Similarity=0.458 Sum_probs=176.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 96 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 96 (254)
.++|++.+.||+|++|.||+|.+..++..+++|.+..... ....+.+|+..+++++|||++++.+++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999998999999998865422 223456899999999999999999998877 88999
Q ss_pred EEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-
Q 025369 97 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 174 (254)
++||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence 9999975 8888887654 5899999999999999999999999999999999999998776 999999987654433
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
.......+...|+|||.+.+......++|+||+|+++++|++|..||...+..+...+....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 22233446778999999876655455599999999999999999999887776655555443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=240.10 Aligned_cols=227 Identities=23% Similarity=0.395 Sum_probs=182.4
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEc-------ccceeEEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKE 86 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (254)
......++|++.+.||+|+||.||+++.. ..+..+++|..... ......+.+|+..++.+ +|||++++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 35577889999999999999999999752 23457899987543 23345688899999999 8999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
.+...+..+++++|+++++|.+++... ..++..++..++.|++.|+.|||+.|++|+||+|+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998753 2367788999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
++++++. ++|+|||++......... ....+...|+|||++.+..++.+ +|+||||+++++|++ |..||...+.
T Consensus 169 li~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9987776 999999988654332211 12234467999999977666555 999999999999998 7888865443
Q ss_pred Ch---------------hhHHHHHHhhcCccccCC
Q 025369 227 PK---------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ~~---------------~~~~~~~~~~~~~~~~~p 246 (254)
.+ .....+..++..||..+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCh
Confidence 22 233467788888888887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=237.51 Aligned_cols=217 Identities=37% Similarity=0.610 Sum_probs=190.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch----hHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..+++|..++.||.|.||+|.+++.+.+++.||+|++++.-... ..-.-|-.+|+..+||.+..+.-.|.....++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45889999999999999999999999999999999987753222 23345778889999999999998999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 174 (254)
+||+|..||.|...++....+++...+.+...|+.||.|||+++|++||+|.+|.++|.+|+ +|+.|||+++.....
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccc
Confidence 99999999999999988888999999999999999999999999999999999999999998 999999998754443
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhc
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (254)
......+|++.|.|||++.++.+... .|+|.+|++||+|++|+.||.+.++...+.-++..-++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k 386 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK 386 (516)
T ss_pred ceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc
Confidence 44466789999999999988887666 99999999999999999999999997776665544443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=239.34 Aligned_cols=207 Identities=28% Similarity=0.437 Sum_probs=168.8
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.......++|++.+.||+|++|.||++.+..++..+++|.+.... .......+|+..+++++||+++++++++....
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 445567789999999999999999999999999999999875432 22334567999999999999999999987543
Q ss_pred --------eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 93 --------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 93 --------~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
..++|+||+.+ ++.+.+... ..+++.+++.++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~ 161 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLA 161 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEEC
Confidence 45999999965 777766554 36899999999999999999999999999999999999988776 9999
Q ss_pred cccccccccccCCC-----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 164 DFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 164 df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
|||++......... ....++..|+|||.+.+.....+++|+||+|+++++|++|..||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99987644322211 123456789999998765544555999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=237.13 Aligned_cols=224 Identities=20% Similarity=0.352 Sum_probs=178.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++.+.||+|++|.||++.... .+..+++|.+...... ...+.+|+..++.++|+|++++++++..++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 457899999999999999999987642 3557999987654322 235678899999999999999999999889
Q ss_pred eEEEEEEccCccchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 93 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
..+++|||+++++|.+++... ...+...+..++.|++.||.|||++|++|+||+|+||++++++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999999643 23466788999999999999999999999999999999987776 999
Q ss_pred ecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh----------
Q 025369 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------- 228 (254)
Q Consensus 163 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------- 228 (254)
+|||++........ .....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+..+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99998764322111 112234567999999877766555 999999999999998 788886544222
Q ss_pred -----hhHHHHHHhhcCccccCC
Q 025369 229 -----DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -----~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|++.+|
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p 262 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNP 262 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCh
Confidence 223567788888888877
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=234.82 Aligned_cols=220 Identities=35% Similarity=0.580 Sum_probs=182.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 98 (254)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 6899999999999999999999999999999876432 233557789999999999999999998764 45679999
Q ss_pred EccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 99 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH-----~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
||+++++|.+++.. ..++++..++.++.+++.+|.+|| +.+++|+||+|+||++++++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 356899999999999999999999 899999999999999988776 9999999877
Q ss_pred cccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhHHH
Q 025369 170 SSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKT 233 (254)
Q Consensus 170 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~~~ 233 (254)
....... .....+...|++||.+.+...+.. +|+||||+++++|++|..||...+. +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHH
Confidence 5544332 233457888999999877665545 9999999999999999999976532 2233455
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|+..+|
T Consensus 238 ~~~l~~~~l~~~p 250 (265)
T cd08217 238 LNEVIKSMLNVDP 250 (265)
T ss_pred HHHHHHHHccCCc
Confidence 6777778887777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=235.73 Aligned_cols=215 Identities=26% Similarity=0.370 Sum_probs=171.8
Q ss_pred ccccCCcceEEEEEEEcccce--eEEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~--~~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|++|.||++.+..++. .+++|.+... ....+.+.+|+..++++ +|||++++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999987765 4577876542 23345678899999999 799999999999999999999999999
Q ss_pred cchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 104 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 104 ~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
++|.+++.... .++..+++.++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986542 3788899999999999999999999999999999999987776 99999998
Q ss_pred cccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhH
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFR 231 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~ 231 (254)
+.................|+|||++.....+.+ +|+||||+++++|++ |..||...+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 753322222222233457999999876665555 999999999999997 99999654322 2233
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+..++..|+..+|
T Consensus 238 ~~~~~li~~~l~~~p 252 (270)
T cd05047 238 DEVYDLMRQCWREKP 252 (270)
T ss_pred HHHHHHHHHHcccCh
Confidence 457788888888887
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=238.47 Aligned_cols=223 Identities=28% Similarity=0.443 Sum_probs=178.6
Q ss_pred CCceeEeccccCCcceEEEEEEE----cccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--Ce
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (254)
..-|++.+.||+|++|.||++.. ..++..+++|.+.... .....+.+|+..++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34579999999999999999984 4568899999876542 2335688999999999999999999998875 57
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.++++||+++++|.+++... ..++...++.++.+++.+|.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccc
Confidence 89999999999999998665 35899999999999999999999999999999999999988776 9999999886543
Q ss_pred ccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC------------------------
Q 025369 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP------------------------ 224 (254)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------------------------ 224 (254)
..... ....+...|+|||.+.+.....+ +|+||||+++++|+++..|+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 32211 12335567999999877666555 99999999999999976654221
Q ss_pred ------CCChhhHHHHHHhhcCccccCCC
Q 025369 225 ------DEPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
+.+..+...+..++..|++.+|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 268 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPS 268 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcc
Confidence 11223445677888888888883
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=238.76 Aligned_cols=223 Identities=28% Similarity=0.494 Sum_probs=185.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...++|++.+.||+|++|.||++.+..++..+++|.+... ....+.+.+|+..++.++|||++++.+.+..++..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3458999999999999999999999888999999987543 233466788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
||+++++|.+++... .++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccc
Confidence 999999999988654 4788999999999999999999999999999999999988776 9999999765433222 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhhcC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFIKP 240 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~ 240 (254)
....+...|++||.+........ +|+||||++++++++|..||...+.. ..+...+..++..
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 23356778999999877666555 99999999999999999999654321 1233468889999
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
||..+|
T Consensus 252 ~l~~~p 257 (293)
T cd06647 252 CLEMDV 257 (293)
T ss_pred HccCCh
Confidence 998887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=243.40 Aligned_cols=211 Identities=28% Similarity=0.429 Sum_probs=175.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC------
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 91 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 91 (254)
..++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4689999999999999999999999999999999875432 2234567899999999999999999988643
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
...++|+||+.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999965 777777554 889999999999999999999999999999999999988876 999999998754
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHh
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (254)
..........++..|+|||.+.+.....+ +|+||||+++++|++|+.||...+....+.+.+..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 43333334456788999999987777655 999999999999999999998877666555554433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=237.45 Aligned_cols=198 Identities=33% Similarity=0.506 Sum_probs=167.5
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|++++++.+++.+++..+++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999899999999876542 22356778999999999999999999999999999999999
Q ss_pred CccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CC
Q 025369 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (254)
Q Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 178 (254)
+ ++|.+++.... .+++..++.++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........ ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58998887765 6899999999999999999999999999999999999998766 99999998764332211 12
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
...+...|+|||++.+......++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23456789999988765444455999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=235.26 Aligned_cols=202 Identities=31% Similarity=0.500 Sum_probs=169.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .......+|+..++.++|+||+++++++.+....++|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3578999999999999999999999899999999876532 22345668999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 99975 888888654 46899999999999999999999999999999999999988776 99999998754322111
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.....++..|+|||.+.+......++|+||+|+++++|++|..||...+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1222356789999998765544555999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=235.18 Aligned_cols=223 Identities=23% Similarity=0.374 Sum_probs=179.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
+...+|++.+.||+|+||.||++.+..++. .+++|....... ....+.+|+..++.++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 456899999999999999999999876554 588887765432 33567789999999999999999999887 78
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++++|+++++|.+.+... ..+++..++.++.|++.|++|||+.|++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCccccccc
Confidence 89999999999999998764 46899999999999999999999999999999999999987776 9999999886544
Q ss_pred ccCCCCC---ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh---------------hHHH
Q 025369 173 LHSQPKS---TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD---------------FRKT 233 (254)
Q Consensus 173 ~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~---------------~~~~ 233 (254)
....... ......|++||.+.......+ +|+||+|++++++++ |..||......+. ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 2222111 122457999999876666555 999999999999998 9999976543221 2234
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..||..+|
T Consensus 240 ~~~~~~~~l~~~p 252 (279)
T cd05057 240 VYMVLVKCWMIDA 252 (279)
T ss_pred HHHHHHHHcCCCh
Confidence 5667778887777
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=236.06 Aligned_cols=224 Identities=30% Similarity=0.529 Sum_probs=189.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
...+.|++.+.||+|++|.||.+.+..++..+++|.+.......+.+.+|+..++.++|+|++++++.+..++..+++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678999999999999999999999889999999887655445678889999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
|+++++|.+++.... .++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhh
Confidence 999999999998876 7999999999999999999999999999999999999987776 99999998654332211 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhhcC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFIKP 240 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~ 240 (254)
....+...|++||.+.+.....+ +|+||||+++|+|++|..||...+.. ..+...+..++..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 22345678999999877766555 99999999999999999998754321 1134567788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 253 ~l~~~p 258 (286)
T cd06614 253 CLVKDP 258 (286)
T ss_pred HhccCh
Confidence 888887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=236.35 Aligned_cols=224 Identities=22% Similarity=0.399 Sum_probs=182.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||+|+||.||+++... +...+++|.+..... ..+.+.+|+..+++++|+|++++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 45799999999999999999999753 356788997765432 34678899999999999999999999998889
Q ss_pred EEEEEEccCccchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 94 LAIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
.++++||+++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcc
Confidence 999999999999999997665 6899999999999999999999999999999999999988776 99999
Q ss_pred cccccccccc--CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------
Q 025369 165 FGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE--------------- 226 (254)
Q Consensus 165 f~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~--------------- 226 (254)
||++...... .......++..|++||.+.+...... +|+||||++++++++ |..||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9987533211 11122334567999999877666555 999999999999998 7888864322
Q ss_pred -ChhhHHHHHHhhcCccccCCC
Q 025369 227 -PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 -~~~~~~~~~~~~~~~~~~~p~ 247 (254)
+......+..++..|+..+|.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~ 261 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPK 261 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcc
Confidence 223445678888888888873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=248.08 Aligned_cols=206 Identities=41% Similarity=0.696 Sum_probs=191.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
....+.|.+.+.||.|.|++|..+++..++..||+|.+.+... ......+|+.+++.++||||++++.+...+..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3446789999999999999999999999999999999876532 2355789999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||..++.+.+++.+++...+.....+..|++.|++|||+++|+|+||+++|++++.+.+ ++|+|||++.......
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999998888 9999999998888888
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..+..++++-|.|||.+.+..+..+..|+||+|+++|.|++|..||.+.+-
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 889999999999999999999998889999999999999999999987553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=232.74 Aligned_cols=201 Identities=37% Similarity=0.558 Sum_probs=172.5
Q ss_pred cCCCceeEe-ccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEc----CCe
Q 025369 20 HDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTH 93 (254)
Q Consensus 20 ~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 93 (254)
...++|++- ++||-|-.|.|-...++.+++.+|+|.+.. ....++|+++.... .|+|||.+++++.. ...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 356678775 489999999999999999999999998733 35567788777555 79999999999864 347
Q ss_pred EEEEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEeccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 170 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~ 170 (254)
+.+|||.++||.|.+.++..+. +++.++..|++||..|+.|||+.+|.||||||+|+|... ..++.+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 7899999999999999987765 999999999999999999999999999999999999853 3345699999999998
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
..........+.+++|.|||++....+ .+..|+||+|++||-|++|.+||.+..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccC
Confidence 777777788889999999999866664 555999999999999999999998754
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=236.34 Aligned_cols=219 Identities=24% Similarity=0.395 Sum_probs=173.8
Q ss_pred eeEeccccCCcceEEEEEEEcccce--eEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC------Ce
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~--~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 93 (254)
+.+++.||+|++|.||++.+..++. .+++|.+.... ...+.+.+|+..++.++|+|++++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999999876664 58899876542 2335677899999999999999999987532 24
Q ss_pred EEEEEEccCccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 94 LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.+++++|+.+++|.+++... ..++...+..++.|++.+|.|||+.|++|+||+|+||++++++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 68999999999998887422 23789999999999999999999999999999999999987776 99999998
Q ss_pred cccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------Ch
Q 025369 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PK 228 (254)
Q Consensus 168 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~ 228 (254)
+........ ......+..|++||...+...+.+ +|+||||+++|+|++ |..||...+. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 865432211 122235568999999877766555 999999999999999 7889865432 22
Q ss_pred hhHHHHHHhhcCccccCC
Q 025369 229 DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..||+.+|
T Consensus 238 ~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred CCCHHHHHHHHHHcCCCc
Confidence 334567888889999888
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=239.63 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=165.7
Q ss_pred ceeEeccccCCcceEEEEEEEcc--cceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKV--TKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 95 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 95 (254)
+|++.++||+|++|.||++.+.. ++..+|+|.+... ....+...+|+.+++.++|||++++.+++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 68999999999999999999988 8899999988763 23346678899999999999999999999988 7899
Q ss_pred EEEEccCccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC----CCCCceEEeccc
Q 025369 96 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG----SPAPRLKICDFG 166 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~----~~~~~~~l~df~ 166 (254)
+|+|++++ ++.+.+... ..+++..++.++.|++.++.|||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999975 566655422 26899999999999999999999999999999999999987 554 9999999
Q ss_pred ccccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 167 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
++........ .....++..|+|||.+.+......++|+||||+++++|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 8764432222 12234677899999887655445559999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=236.37 Aligned_cols=225 Identities=27% Similarity=0.442 Sum_probs=182.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEc------CC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~ 92 (254)
...+.|++.+.||+|++|.||++.+..++..+++|.+.........+..|+..++++ +|+|++++.+.+.. .+
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 456899999999999999999999999999999998866555556678888888888 69999999999853 45
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.++++|||+++++|.+++... ..+++..++.++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhh
Confidence 789999999999999988654 34788889999999999999999999999999999999988776 99999998764
Q ss_pred cccc-CCCCCccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hh
Q 025369 171 SVLH-SQPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KD 229 (254)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~ 229 (254)
.... .......+...|+|||.+... .....++|+||||+++|+|++|..||...... ..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 3321 122334577889999987531 22334499999999999999999999653321 12
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
+...+.+++..||..+|
T Consensus 251 ~~~~~~~li~~cl~~~p 267 (282)
T cd06636 251 WSKKFIDFIEGCLVKNY 267 (282)
T ss_pred cCHHHHHHHHHHhCCCh
Confidence 34567888888998887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.64 Aligned_cols=213 Identities=27% Similarity=0.419 Sum_probs=170.4
Q ss_pred cccCCcceEEEEEEEc--ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccc
Q 025369 30 DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~ 105 (254)
.||+|+||.||.+.+. ..+..+++|...... ...+.+.+|+..++.++|++++++++++. ....++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998764 345678999876543 22356889999999999999999999875 457899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC----CCc
Q 025369 106 LFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 180 (254)
Q Consensus 106 L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 180 (254)
|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998875 456899999999999999999999999999999999999987776 999999987643222111 111
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhhcCcccc
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~ 244 (254)
.+...|+|||.+.....+.+ +|+||||+++|++++ |..||......+ .....+.+++..||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 22467999999876665555 999999999999996 999997654322 2245677889999988
Q ss_pred CC
Q 025369 245 TP 246 (254)
Q Consensus 245 ~p 246 (254)
+|
T Consensus 238 ~~ 239 (257)
T cd05115 238 KW 239 (257)
T ss_pred Ch
Confidence 88
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=230.29 Aligned_cols=220 Identities=32% Similarity=0.502 Sum_probs=186.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.+|++.+..++..+++|.+.... ...+.+.+|++.+++++|++++++.+++.+.+..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 6899999999999999999999889999999887654 2446788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 179 (254)
+++++|.+++.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999988766 99999998765443322 123
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHhhcCcccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~ 244 (254)
..+...|++||...+.... .++|+||+|+++++|++|..||...+... .....+..++..|+..
T Consensus 159 ~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred cccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhC
Confidence 4567789999998776644 44999999999999999999987544321 2334567777777777
Q ss_pred CC
Q 025369 245 TP 246 (254)
Q Consensus 245 ~p 246 (254)
+|
T Consensus 238 ~p 239 (254)
T cd06627 238 DP 239 (254)
T ss_pred Ch
Confidence 76
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=233.43 Aligned_cols=220 Identities=21% Similarity=0.244 Sum_probs=172.1
Q ss_pred ccccCCcceEEEEEEEcc------------cceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 29 RDIGSGNFGVARLMRDKV------------TKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~------------~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
+.||+|++|.||++.... ....+++|.+.... .....+.+|+..++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 22357888765543 23346778889999999999999999999988999
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC-----ceEEecccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSK 169 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~-----~~~l~df~~~~ 169 (254)
+++||+++++|..++... ..+++..++.++.||+.|++|||++|++|+||+|+||+++.++.. .++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999998888653 568999999999999999999999999999999999999755431 38999999875
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCh-------------hhHHHHH
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPK-------------DFRKTIQ 235 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~-------------~~~~~~~ 235 (254)
... ......++..|+|||.+.+....+.++||||||+++|+|+ .|..||......+ .....+.
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd05077 161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELA 237 (262)
T ss_pred ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHH
Confidence 432 2223446678999998875554455599999999999998 4888886544221 1235678
Q ss_pred HhhcCccccCC-Ccccc
Q 025369 236 VFIKPCCHITP-FYPLF 251 (254)
Q Consensus 236 ~~~~~~~~~~p-~~~~~ 251 (254)
.++..||+.+| -.|.+
T Consensus 238 ~li~~cl~~dp~~Rp~~ 254 (262)
T cd05077 238 DLMTHCMNYDPNQRPFF 254 (262)
T ss_pred HHHHHHcCCChhhCcCH
Confidence 89999999998 34433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=251.46 Aligned_cols=230 Identities=25% Similarity=0.455 Sum_probs=189.7
Q ss_pred CCCCCcccCCCce-eEeccccCCcceEEEEEEEcccceeEEEEEc-----cCCccchhHHHHHHHHhhcCCCCCeeeeeE
Q 025369 13 AMDMPIMHDSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86 (254)
Q Consensus 13 ~~~~~~~~~~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 86 (254)
........+.++| +...+||+|+|.+||+|-|..+|-.||=..+ .++....+++..|+.+|+.|+||||+++++
T Consensus 29 ~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~ 108 (632)
T KOG0584|consen 29 ESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYD 108 (632)
T ss_pred cccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeee
Confidence 3444555566777 4566999999999999999999888773322 234445588999999999999999999999
Q ss_pred EEEcCC--eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEE
Q 025369 87 VILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 87 ~~~~~~--~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l 162 (254)
.|.+.. .+.+|+|.+..|+|..++...+..+...+..|++||+.+|.|||++. |+|||||.+||||+.+ .+.+||
T Consensus 109 SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKI 187 (632)
T KOG0584|consen 109 SWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKI 187 (632)
T ss_pred heecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceee
Confidence 999865 48999999999999999999999999999999999999999999884 9999999999999844 347999
Q ss_pred ecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH----------
Q 025369 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK---------- 232 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---------- 232 (254)
+|+|+|......... +..|++.|||||... -.+ ....||||||.+|++|.|+..||..=.++.++.+
T Consensus 188 GDLGLAtl~r~s~ak-svIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 188 GDLGLATLLRKSHAK-SVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred cchhHHHHhhccccc-eeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 999999765544433 368999999999875 334 4449999999999999999999998777776666
Q ss_pred -------HHHHhhcCccccCC
Q 025369 233 -------TIQVFIKPCCHITP 246 (254)
Q Consensus 233 -------~~~~~~~~~~~~~p 246 (254)
..+++|..|...-.
T Consensus 265 l~kV~dPevr~fIekCl~~~~ 285 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLATKS 285 (632)
T ss_pred hhccCCHHHHHHHHHHhcCch
Confidence 36667777766533
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=237.04 Aligned_cols=199 Identities=34% Similarity=0.507 Sum_probs=168.7
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
|++.+.||+|++|+||++....+++.+++|.+..... ......+|+..+++++ |++++++++++.+++..++|+||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998899999998765422 2233456888999998 999999999999999999999999
Q ss_pred CccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
+++|.+.+.... .++...++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 668888887654 6899999999999999999999999999999999999998776 99999998875544444444
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..++..|+|||.+.+......++|+||||+++++|++|..||.....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 55777899999886655445569999999999999999999965543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=237.23 Aligned_cols=223 Identities=26% Similarity=0.445 Sum_probs=181.0
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||+|++|.||++.+.. ++..+++|.+..... ....+.+|+..++.+.||+++++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 46789999999999999999998753 578899998765432 23567789999999999999999999999889
Q ss_pred EEEEEEccCccchHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEE
Q 025369 94 LAIVMEYASGGELFERICNA----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nil 151 (254)
.++++||+++++|.+++... ..+++..++.++.+++.+|++||++|++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999999999998643 23678889999999999999999999999999999999
Q ss_pred ecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-
Q 025369 152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE- 226 (254)
Q Consensus 152 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~- 226 (254)
+++++. ++|+|||++........ .........|+|||.+.+..+..+ +|+||||+++|+|++ |..||.....
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 988776 99999998754322211 112234557999999877766555 999999999999997 8888865432
Q ss_pred --------------ChhhHHHHHHhhcCccccCC
Q 025369 227 --------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 --------------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|+..+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 273 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLP 273 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 22344568888889998888
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=235.20 Aligned_cols=221 Identities=26% Similarity=0.408 Sum_probs=175.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHH-HhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
++|++.+.||+|+||.||++.+..++..||+|.+..... ....+..|+. .++.+.|||++++++.+..++..+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 579999999999999999999999999999998865422 2234444554 4566789999999999999999999999
Q ss_pred ccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
|+++ +|.+++.. ...+++..++.++.|++.++.|||++ +++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9964 77766643 24689999999999999999999997 9999999999999988776 999999987654332
Q ss_pred CCCCCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHH
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTI 234 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~ 234 (254)
.......++..|+|||.+.+.. ....++|+||+|+++++|++|..||...... ..+...+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 2223345677899999886422 2234499999999999999999999653211 1234567
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..|+..+|
T Consensus 238 ~~li~~~l~~~p 249 (283)
T cd06617 238 QDFVNKCLKKNY 249 (283)
T ss_pred HHHHHHHccCCh
Confidence 788888888888
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=234.93 Aligned_cols=225 Identities=22% Similarity=0.281 Sum_probs=181.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcc----cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc-C
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-P 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 91 (254)
....++|++.+.||+|+||.||.+.+.. .+..+++|.+.... .....+.+|+..++.++|+|++++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567899999999999999999999875 35788898876432 224567789999999999999999998776 4
Q ss_pred CeEEEEEEccCccchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 92 THLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
...+++++++++++|.+++... ..+++.+++.++.+++.||+|||+.+++|+||+|+||++++++. ++++
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEEC
Confidence 6788999999989999988653 35889999999999999999999999999999999999987776 9999
Q ss_pred cccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC------------
Q 025369 164 DFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP------------ 227 (254)
Q Consensus 164 df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~------------ 227 (254)
|||++......... ....+...|+|||++.+.....+ +||||||++++++++ |..||...+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence 99998644322111 12234567999999877766555 999999999999998 99999754321
Q ss_pred ---hhhHHHHHHhhcCccccCC
Q 025369 228 ---KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~p 246 (254)
......+.+++..||..+|
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p 260 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDP 260 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCCh
Confidence 1223457788888888887
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=238.46 Aligned_cols=223 Identities=29% Similarity=0.449 Sum_probs=181.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.....+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|||++++.+++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 3445779999999999999999999998899999998754321 224577899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++|+||+.+ ++.+.+.. ...+++..+..++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC
Confidence 999999975 66666653 456899999999999999999999999999999999999988876 99999998754322
Q ss_pred cCCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHHHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKTIQ 235 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~ 235 (254)
.....+...|+|||.+.+ ......++|+||+|+++|+|++|..||...+. ...+.+.+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 223456778999998753 22234459999999999999999999865331 123455688
Q ss_pred HhhcCccccCCC
Q 025369 236 VFIKPCCHITPF 247 (254)
Q Consensus 236 ~~~~~~~~~~p~ 247 (254)
.++..||..+|.
T Consensus 245 ~li~~~l~~~p~ 256 (307)
T cd06607 245 NFVDSCLQKIPQ 256 (307)
T ss_pred HHHHHHhcCChh
Confidence 899999998883
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=242.22 Aligned_cols=201 Identities=32% Similarity=0.485 Sum_probs=168.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----C
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (254)
..++|++.+.||+|++|+||++.+..++..|++|.+... ......+.+|+..++.++|+|++++.+++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357899999999999999999999999999999987643 22234567899999999999999999987654 3
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..+++++|+. ++|.+++.....+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccC
Confidence 5799999996 588888888888999999999999999999999999999999999999988776 9999999886543
Q ss_pred cc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 173 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 173 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
.. .......++..|+|||.+........++|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 32 12223456778999999865433445599999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=242.86 Aligned_cols=225 Identities=23% Similarity=0.392 Sum_probs=176.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEEEEc
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (254)
-+..++|++.+.||+|+||+||++.+ ..+++.||+|.+.... .....+.+|+..+.++ +|+|++++++.+..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 35678999999999999999999984 3467889999886532 2234677899999999 68999999998865
Q ss_pred C-CeEEEEEEccCccchHHHHHhc--------------------------------------------------------
Q 025369 91 P-THLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (254)
Q Consensus 91 ~-~~~~lv~~~~~~~~L~~~l~~~-------------------------------------------------------- 113 (254)
. ...++++||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4678999999999999888542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC---CCC
Q 025369 114 -----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKS 179 (254)
Q Consensus 114 -----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~ 179 (254)
..++...+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCC
Confidence 12577788889999999999999999999999999999987776 99999998764322211 111
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh----------------hHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD----------------FRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~----------------~~~~~~~~~~~~~ 242 (254)
..++..|+|||.+.+..+..+ +|+||||+++++|++ |..||........ ....+..++..||
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl 319 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 319 (343)
T ss_pred CCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence 223457999999877766555 999999999999997 8999876443222 1234566777788
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+.+|
T Consensus 320 ~~~p 323 (343)
T cd05103 320 HGEP 323 (343)
T ss_pred cCCh
Confidence 8777
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=234.28 Aligned_cols=215 Identities=29% Similarity=0.421 Sum_probs=170.5
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHh---hcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.||+|+||.||++.+..++..+++|.+..... ......++...+ ....|++++.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999998999999998765321 112233343333 34478999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccC
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 182 (254)
+++|.+++.....+++..+..++.|++.|+++||+.|++|+||+|+||++++++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999987776 999999987543222 2233457
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhhcCccccC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~ 245 (254)
+..|+|||.+........++|+||+|+++++|++|..||...... +.+...+..++..|+..+
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence 889999999865443344599999999999999999999654321 122345667777788777
Q ss_pred CC
Q 025369 246 PF 247 (254)
Q Consensus 246 p~ 247 (254)
|.
T Consensus 238 p~ 239 (279)
T cd05633 238 VS 239 (279)
T ss_pred HH
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=230.23 Aligned_cols=220 Identities=32% Similarity=0.568 Sum_probs=186.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++.++.++|+|++++.+.+......++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 6899999999999999999999899999999886643 3445678899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 101 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 101 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
+++++|.+.+... ..++...++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988764 66899999999999999999999999999999999999987776 9999999876443332
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHhhcC
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVFIKP 240 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~ 240 (254)
......++..|+|||...+...... +|+||+|+++++|++|..||...+... .....+..++..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 2233457778999999877766555 999999999999999999997664322 233566777778
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 238 ~l~~~p 243 (258)
T cd08215 238 LLQKDP 243 (258)
T ss_pred HcCCCh
Confidence 888777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.07 Aligned_cols=216 Identities=33% Similarity=0.536 Sum_probs=186.2
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccC-CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHH
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 108 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (254)
+||.|.||+||.+++..+....|||-+.. .....+-+.+|+.+.+.|+|.|||++.+.+..++.+-+.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 68999999999999999999999998764 34556778999999999999999999999988898899999999999999
Q ss_pred HHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCCCCCccCCC
Q 025369 109 RICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTP 184 (254)
Q Consensus 109 ~l~~~-~~~--~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~ 184 (254)
++... +++ .+.+...+.+||+++|.|||++.|+|||||-+||+|+.-. +-+|++|||-+++... .+......|+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS-GvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS-GVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc-ceEEecccccchhhccCCccccccccch
Confidence 99877 456 7888999999999999999999999999999999997433 3499999998765433 33334556899
Q ss_pred CccCcccccc-ccCCCCcccHHHHHHHHHHHHhCCCCCCC-----------------CCCChhhHHHHHHhhcCccccCC
Q 025369 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFED-----------------PDEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 185 ~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~-----------------~~~~~~~~~~~~~~~~~~~~~~p 246 (254)
.|||||++.. ...+.+++|||||||++.+|.||++||.. ...++.+....+.|+..|.+++|
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~ 820 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDP 820 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence 9999999854 44557779999999999999999999965 33467788889999999999998
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=235.25 Aligned_cols=200 Identities=32% Similarity=0.405 Sum_probs=163.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCe-----
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 93 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 93 (254)
++|++.+.||+|++|.||++.+..++..|++|...... .....+.+|+..++.+. |+|++++.+++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 57999999999999999999999999999999876532 22356778999999995 6999999999887654
Q ss_pred EEEEEEccCccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccc
Q 025369 94 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 167 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~ 167 (254)
.+++++|+++ +|.+++... ..+++..++.++.||+.+|.|||++|++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999986 787777542 34799999999999999999999999999999999999987 554 99999998
Q ss_pred ccccccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
+...... .......+.+.|+|||.+.+......++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 7643222 222233457789999988665544555999999999999999999997644
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=232.98 Aligned_cols=220 Identities=30% Similarity=0.505 Sum_probs=181.0
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 98 (254)
++|+..+.||.|++|.||.+.+..++..+++|.+..... ....+.+|++.++.++||||+++++++.+. +.+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 579999999999999999999998999999998865432 346688999999999999999999988654 4789999
Q ss_pred EccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 99 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
||+++++|.+++.. ...++...+..++.+++.+|.|||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345889999999999999999999999999999999999987776 999999987543322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----C----------------------h
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----P----------------------K 228 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~----------------------~ 228 (254)
.. ....+...|++||.+.+..++.. +|+||||+++|+|++|..||..... + .
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 21 23346778999999877776555 9999999999999999999976521 0 1
Q ss_pred hhHHHHHHhhcCccccCC
Q 025369 229 DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|+..+|
T Consensus 237 ~~~~~~~~li~~~l~~~p 254 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDP 254 (287)
T ss_pred chHHHHHHHHHHHcCCCc
Confidence 123456788888888887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=237.53 Aligned_cols=196 Identities=29% Similarity=0.410 Sum_probs=157.5
Q ss_pred eccccCCcceEEEEEEEc--ccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeEEEEEEccCc
Q 025369 28 VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 103 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 103 (254)
+++||+|+||+||++.+. .++..+++|.+.... ......+|+..++.++||||+++.+++.. +..++++++|+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999975 467889999876543 34567789999999999999999999865 3568999999855
Q ss_pred cchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC--CCCceEEeccccccccc
Q 025369 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 172 (254)
Q Consensus 104 ~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~--~~~~~~l~df~~~~~~~ 172 (254)
+|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||++... ..+.++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777776432 248899999999999999999999999999999999999432 22349999999886543
Q ss_pred ccC----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 173 LHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 173 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
... ......+++.|+|||++.+....+.++|+||+|+++++|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 221 12234567889999999876655566999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=236.82 Aligned_cols=215 Identities=32% Similarity=0.486 Sum_probs=176.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (254)
...++|++.+.||+|++|.||++.+..++..|++|.+..... ......+|+..+++++|+|++++.+++.+. +.+
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 357899999999999999999999999999999998764322 223456799999999999999999998765 568
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++|+||+.+ +|.+++... ..+++.+++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCC
Confidence 999999965 787777653 56899999999999999999999999999999999999988776 99999998765433
Q ss_pred cC-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHh
Q 025369 174 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237 (254)
Q Consensus 174 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 237 (254)
.. ..........|+|||.+.+......++|+||+|+++|+|++|..||...+..+.+......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~ 225 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 21 11222346679999998765555556999999999999999999998877766655555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=241.48 Aligned_cols=199 Identities=33% Similarity=0.489 Sum_probs=164.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----CeE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 94 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 94 (254)
.++|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+..++.++|+|++++.+++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57999999999999999999999999999999988642 23345677899999999999999999887654 357
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++++++.+ ++.+.+.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999965 77766643 46899999999999999999999999999999999999988777 999999987643322
Q ss_pred CCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 175 SQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 175 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
... ....++..|+|||.+.+....+.++|+||+|+++++|++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211 22356778999998766544455599999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.11 Aligned_cols=192 Identities=22% Similarity=0.294 Sum_probs=163.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
...+|.+.+.||+|++|.||++.+..++..|++|.. ......+|+.++++++|+||+++++++..++..++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~-----~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAG-----WYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecc-----cccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 355899999999999999999999999999999953 223456899999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC--
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 177 (254)
+. ++|..++... ..++..+++.++.|++.+|.|||++||+|+||||+||+++.++. ++|+|||++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence 95 5777777554 46999999999999999999999999999999999999987776 999999988644322111
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCC
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
....++..|+|||++.+..+..+ +|+||||+++|+|++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCc
Confidence 22357889999999988776555 99999999999999987654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=231.82 Aligned_cols=214 Identities=20% Similarity=0.210 Sum_probs=173.0
Q ss_pred ccccCCcceEEEEEEEcccc----------eeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 29 RDIGSGNFGVARLMRDKVTK----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~----------~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+.||+|+||.||++.+..++ ..+++|...........+.+|+..++.++|||++++++++.. ...++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357788766554446778899999999999999999999888 7789999
Q ss_pred EccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC-----ceEEeccccccccc
Q 025369 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 172 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~-----~~~l~df~~~~~~~ 172 (254)
||+++++|.+++.... .++...+..++.|++.+|.|||++|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999998766 78999999999999999999999999999999999999876621 49999999876543
Q ss_pred ccCCCCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh-------------hHHHHHHh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD-------------FRKTIQVF 237 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~-------------~~~~~~~~ 237 (254)
. .....+...|+|||++.+. .....++|+||||+++++|++ |..||...+.... ....+..+
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANL 236 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHH
Confidence 2 2233456679999998766 233445999999999999999 5777765532111 11467788
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|+..+|
T Consensus 237 i~~~l~~~p 245 (259)
T cd05037 237 INQCWTYDP 245 (259)
T ss_pred HHHHhccCh
Confidence 888888877
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=237.41 Aligned_cols=199 Identities=33% Similarity=0.502 Sum_probs=168.2
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..+++++|++++++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999998999999998765432 3456778999999999999999999999999999999999
Q ss_pred CccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 102 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
++ ++.+.+.. ..++++..++.++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 77777765 467899999999999999999999999999999999999997776 9999999876544332 2223
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..+...|+|||.+.+....+.++|+||||+++++|++|+.||...+.
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34667899999987764445559999999999999999999966543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=232.84 Aligned_cols=217 Identities=28% Similarity=0.414 Sum_probs=177.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.+.||+|++|.||.+.. ++..+++|..... ...+.+.+|+..++.++|||++++.+.+..+ ..+++++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 457899999999999999998864 5778999987543 3446788899999999999999999998654 47899999
Q ss_pred cCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
+.+++|.+++.... .++...++.++.|++.|+.+||+.|++||||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999987653 4789999999999999999999999999999999999987776 999999987643222 12
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhcCcc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIKPCC 242 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~~~~ 242 (254)
.......|+|||.+.+.....+ +|+||||+++++|++ |..||...+.. ......+..++..|+
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 2334567999999876666555 999999999999998 99998765432 223345778888888
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
..+|
T Consensus 235 ~~~p 238 (254)
T cd05083 235 ETEP 238 (254)
T ss_pred CCCh
Confidence 8887
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=234.94 Aligned_cols=222 Identities=27% Similarity=0.490 Sum_probs=179.9
Q ss_pred ceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
+|++.+.||.|++|.||.+.+. .++..+++|.+.... ...+...+|+..++.+ +|++|+++.+.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999985 478899999876432 2335677899999999 589999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++++||+++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999988776 999999987644322
Q ss_pred C--CCCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHH
Q 025369 175 S--QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKT 233 (254)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~ 233 (254)
. ......+...|++||.+.... ....++|+||+|+++|+|++|..||...... ......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence 1 112334678899999986532 2344599999999999999999999643221 122344
Q ss_pred HHHhhcCccccCCC
Q 025369 234 IQVFIKPCCHITPF 247 (254)
Q Consensus 234 ~~~~~~~~~~~~p~ 247 (254)
+..++..|+..+|.
T Consensus 239 ~~~ll~~~l~~~p~ 252 (290)
T cd05613 239 AKDIIQRLLMKDPK 252 (290)
T ss_pred HHHHHHHHhcCCHH
Confidence 66777777777774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=233.43 Aligned_cols=220 Identities=32% Similarity=0.514 Sum_probs=179.7
Q ss_pred ceeEeccccCCcceEEEEEEEcc-cceeEEEEEccCCc-----------cchhHHHHHHHHhh-cCCCCCeeeeeEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD-----------KIDENVQREIINHR-SLRHPNIVRFKEVILT 90 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~~-----------~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~ 90 (254)
.|++.+.||+|++|.||++.+.. .+..+++|.+.... .....+.+|+..++ .++|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67889999765321 12234556777775 4799999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 91 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
++..++++||+++++|.+.+.. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887743 3468999999999999999999996 68999999999999988776 999999
Q ss_pred cccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------Chh
Q 025369 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKD 229 (254)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~ 229 (254)
|.+.............+...|++||.+.+.....+ +|+||||+++|+|++|..||...+. ...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 98865444333344557788999999987666455 9999999999999999999865432 113
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|+..+|
T Consensus 238 ~~~~l~~li~~cl~~~p 254 (269)
T cd08528 238 YSEDVTDVITSCLTPDA 254 (269)
T ss_pred CCHHHHHHHHHHCCCCC
Confidence 45678888899999888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.87 Aligned_cols=214 Identities=29% Similarity=0.428 Sum_probs=174.7
Q ss_pred ccccCCcceEEEEEEEcc-cc--eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKV-TK--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~-~~--~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|++|.||++.+.. .+ ..+++|.+..... ..+.+.+|+..+++++|+|++++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 23 3589998766543 44678889999999999999999999988 889999999999
Q ss_pred cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC----C
Q 025369 104 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 177 (254)
Q Consensus 104 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~----~ 177 (254)
++|.+++.... .+++..++.++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999997764 6899999999999999999999999999999999999988876 99999998765433211 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh----------------hhHHHHHHhhcC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK----------------DFRKTIQVFIKP 240 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~----------------~~~~~~~~~~~~ 240 (254)
....+...|+|||.+.+...... +|+||||+++++|++ |..||...+..+ .....+..++..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 12335668999999877776555 999999999999998 999986543322 233566778888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 237 ~l~~~p 242 (257)
T cd05040 237 CWAHNP 242 (257)
T ss_pred HCCCCc
Confidence 888887
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=230.84 Aligned_cols=219 Identities=29% Similarity=0.420 Sum_probs=180.6
Q ss_pred eeEeccccCCcceEEEEEEEcccc----eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~----~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
+++.+.||.|++|.||++.+...+ ..+++|.+..... ....+.+|+..++.++|+|++++++++.+.+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 367889999999999999998766 8899998866543 3567888999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+++++++|.+++..... +++..++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999976554 899999999999999999999999999999999999988776 99999998765443311
Q ss_pred CC--CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHHHHHhh
Q 025369 177 PK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKTIQVFI 238 (254)
Q Consensus 177 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~~~~~~ 238 (254)
.. ...++..|++||.+.+.....+ +|+||||+++++|++ |..||...+... .....+.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 11 1225578999999866555555 999999999999998 788887544322 2344566777
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 238 ~~~l~~~p 245 (258)
T smart00219 238 LQCWAEDP 245 (258)
T ss_pred HHHCcCCh
Confidence 88888777
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=231.72 Aligned_cols=213 Identities=31% Similarity=0.481 Sum_probs=173.0
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCccch----hHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~----~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
+.||+|++|.||+|.+..++..+++|.+....... .....|. ...+..+|+|++++++.+..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999899999999886542211 2223333 334556899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 183 (254)
++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++..... .....+.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999988776 99999998764322 2334567
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcCccccC
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~~~~~~ 245 (254)
..|++||.+.+.... .++|+||+|+++++|++|..||...+... .....+..++..|+..+
T Consensus 157 ~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 157 PDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred cCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 789999998777654 44999999999999999999996644322 23455677777777777
Q ss_pred CC
Q 025369 246 PF 247 (254)
Q Consensus 246 p~ 247 (254)
|.
T Consensus 236 p~ 237 (260)
T cd05611 236 PA 237 (260)
T ss_pred HH
Confidence 73
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=233.00 Aligned_cols=208 Identities=32% Similarity=0.518 Sum_probs=175.2
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--CeEEEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 99 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~ 99 (254)
|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|+|++++.+++... +..+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999889999999987652 3345677899999999999999999999988 88999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
|+++ +|.+++... ..+++..++.++.+++.|+.+||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888888665 57899999999999999999999999999999999999998776 99999998765443321
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 235 (254)
.........|+|||.+.+......++|+||||+++++|++|..||...+.+....+...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22334567899999887655445569999999999999999999988776655555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=232.51 Aligned_cols=192 Identities=31% Similarity=0.450 Sum_probs=158.7
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCccc----hhHHHHHH---HHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~----~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.||+|++|.||++.+..+++.|++|.+...... .....++. ..++...||+++.+.+.+.++...++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999989999999987653211 11222332 33445679999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccC
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 182 (254)
+++|...+.....+++..++.++.|++.++.|||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999999988888999999999999999999999999999999999999988776 999999987643322 2234467
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
+..|+|||.+.+......++|+||+|+++++|++|..||...
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 889999999875543344599999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=238.06 Aligned_cols=221 Identities=28% Similarity=0.464 Sum_probs=181.2
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.+.|.....||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+..++..++++||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 356777889999999999999999899999999875532 2345677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 179 (254)
+++++|.+++.. ..+++..++.++.+++.++.+||++|++|+||+|+||++++++. ++|+|||++........ ...
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCce
Confidence 999999988754 46899999999999999999999999999999999999988776 99999998754322221 123
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh-----------------hHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----------------FRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~ 242 (254)
..++..|+|||.+.+...+.. +|+||+|+++++|++|..||...+.... ....+..++..|+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 356788999999877666555 9999999999999999999976543221 2234566777777
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
..+|
T Consensus 257 ~~~P 260 (292)
T cd06658 257 VREP 260 (292)
T ss_pred cCCh
Confidence 7776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=239.19 Aligned_cols=225 Identities=24% Similarity=0.389 Sum_probs=178.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 88 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (254)
.....+|++++.||+|+||.||.+.+.. .+..+++|.+.... ...+.+.+|+..++++ +||||+++++.+
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3444689999999999999999998643 22368999776432 2335678899999999 799999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili 152 (254)
..++..+++++|+++++|.+++.... .++..++..++.|++.|+.|||++|++|+||+|+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999986532 36778889999999999999999999999999999999
Q ss_pred cCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh
Q 025369 153 DGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (254)
Q Consensus 153 ~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 228 (254)
+.++. ++|+|||++......... ........|+|||++.+..+..+ +|+||||+++++|++ |..||...+..+
T Consensus 168 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 TEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred cCCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 87776 999999987644322111 11223457999999987776665 999999999999998 888886644322
Q ss_pred ---------------hhHHHHHHhhcCccccCC
Q 025369 229 ---------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ---------------~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|++.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVP 277 (334)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 223356677888888777
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=235.73 Aligned_cols=215 Identities=20% Similarity=0.241 Sum_probs=171.9
Q ss_pred ccccCCcceEEEEEEEcccce-------eEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 29 RDIGSGNFGVARLMRDKVTKE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~-------~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.||+|+||.||++.+...+. .+++|...... ...+.+.+|+..++.+.|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999865443 37777765432 2345678899999999999999999999998889999999
Q ss_pred cCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC------ceEEecccccccccc
Q 025369 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 173 (254)
Q Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~------~~~l~df~~~~~~~~ 173 (254)
+++++|.+++.... .+++..++.++.|++.++.|||++|++|+||+|+||+++.++.. .++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999997654 58999999999999999999999999999999999999876542 379999998754322
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC-CCCCCCCCCh-------------hhHHHHHHhhc
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPK-------------DFRKTIQVFIK 239 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~-------------~~~~~~~~~~~ 239 (254)
.....++..|+|||.+.+......++|+||||+++|+|++|. .||...+... .....+..++.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLIN 237 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHH
Confidence 223456678999999977554455599999999999999985 6665433321 22245778899
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|++.+|
T Consensus 238 ~~l~~~p 244 (258)
T cd05078 238 QCMDYEP 244 (258)
T ss_pred HHhccCh
Confidence 9999888
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=235.25 Aligned_cols=221 Identities=32% Similarity=0.518 Sum_probs=184.5
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 97 (254)
++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|...+++++ |+|++++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 58999999999999999999999999999999876532 22356778899999998 99999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
|+++.+++|.+++.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999988776 99999998764432221
Q ss_pred --------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------
Q 025369 177 --------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------- 228 (254)
Q Consensus 177 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------- 228 (254)
.....+...|++||...+...... +|+||||++++++++|..||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 111235678999999877665444 999999999999999999997655322
Q ss_pred ------hhHHHHHHhhcCccccCC
Q 025369 229 ------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ------~~~~~~~~~~~~~~~~~p 246 (254)
.+.+.+..++..|+..+|
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCH
Confidence 233456677777777766
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=232.13 Aligned_cols=220 Identities=30% Similarity=0.533 Sum_probs=181.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+-|++.+.||.|++|.||++.+..++..+++|...... .....+.+|+..++.++|||++++++.+..+..+++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 35788999999999999999998899999999875432 2235677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
+++++|.+++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988765 46899999999999999999999999999999999999987776 9999999875432221 1122
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh---------------hhHHHHHHhhcCcccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~ 244 (254)
..+...|++||.+.+...... +|+||+|+++++|++|..||....... .....+..++..|+..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 346778999999876665555 999999999999999999987543211 2335677888888888
Q ss_pred CC
Q 025369 245 TP 246 (254)
Q Consensus 245 ~p 246 (254)
+|
T Consensus 240 ~p 241 (277)
T cd06641 240 EP 241 (277)
T ss_pred Ch
Confidence 87
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=229.48 Aligned_cols=214 Identities=26% Similarity=0.389 Sum_probs=174.0
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
+.||+|++|.||++... ++..+++|.+.... .....+.+|+..++.++|||++++.+++...+..++++||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 67889999876543 2234677899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC--CccCC
Q 025369 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGT 183 (254)
Q Consensus 107 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~ 183 (254)
.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||++++++. ++|+|||++.......... .....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988654 45789999999999999999999999999999999999987776 9999999875432221111 12334
Q ss_pred CCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCccccCC
Q 025369 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~p 246 (254)
..|+|||++.+.....+ +|+||||++++++++ |..||..... +..+...+..++..|+..+|
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 57999999877666555 999999999999998 9999865432 22344677888888888888
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=230.60 Aligned_cols=219 Identities=34% Similarity=0.539 Sum_probs=184.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.+|++.+..++..+++|.+.... .....+.+|+..++.++|+|++++.+++.+....+++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999876532 2335667889999999999999999999999999999999
Q ss_pred cCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 101 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 101 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+++++|.+++.. ...+++..++.++.+++.|+.+||+.|++|+||+|.||++++++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999988865 346899999999999999999999999999999999999998766 999999988655443 2
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------hhhHHHHHHhhcCc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------KDFRKTIQVFIKPC 241 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~ 241 (254)
.....+...|++||.+.+.....+ +|+||+|+++++|++|..||...+.. ......+..++..|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 333457788999999877666555 99999999999999999999765532 22334567777788
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 237 l~~~p 241 (256)
T cd08530 237 LQVKP 241 (256)
T ss_pred cCCCc
Confidence 87776
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=236.09 Aligned_cols=201 Identities=31% Similarity=0.502 Sum_probs=168.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc----cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEc--CC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT--PT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 92 (254)
...+|++.+.||+|++|.||++.... ++..+++|.+..... ....+.+|+..++.++|+|++++.+++.. ..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 35678999999999999999998653 478999998876554 35678899999999999999999999887 55
Q ss_pred eEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++++||+++++|.+++.... .++...++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEccccccccc
Confidence 7899999999999999997654 5899999999999999999999999999999999999988776 999999988654
Q ss_pred cccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 172 VLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 172 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
...... ........|++||.+.+...... +|+||||+++++|++|..|+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccc
Confidence 422111 11233456999999877766555 99999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.27 Aligned_cols=209 Identities=29% Similarity=0.447 Sum_probs=173.7
Q ss_pred CCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
.++....+...++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+.+|+..++.++|+||+++.+++
T Consensus 4 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 4556666777899999999999999999999999999999999875432 2335677899999999999999999998
Q ss_pred EcCC------eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 89 LTPT------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 89 ~~~~------~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
.... .+++|++++ +++|..++.. ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++. ++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl 159 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKI 159 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEE
Confidence 7543 468999998 6688877754 46899999999999999999999999999999999999987776 999
Q ss_pred ecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
+|||++..... ......++..|++||.+.+....+.++|+||||++++++++|..||...+.
T Consensus 160 ~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 160 LDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred eeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998764322 223345677899999987644445559999999999999999999976554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=232.75 Aligned_cols=213 Identities=34% Similarity=0.529 Sum_probs=178.0
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|+|++++.+.+..++..+++++++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999889999999886543 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC---------C
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---------P 177 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---------~ 177 (254)
.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998877 99999998765433321 1
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh----------------HHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----------------RKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~ 241 (254)
....+...|++||...+...... +|+||||++++++++|..||...+..+.. ...+..++..|
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 23346778999999877765444 99999999999999999999754432211 44567777777
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
++.+|
T Consensus 238 l~~~p 242 (265)
T cd05579 238 LVPDP 242 (265)
T ss_pred hcCCH
Confidence 77776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=230.44 Aligned_cols=198 Identities=30% Similarity=0.471 Sum_probs=169.7
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
+.||+|+++.|--...-.++..||||++.+... ...+..+|++.+... .|+||+.++++|.++..+|+|||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999888888999999999977643 457788999999888 599999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEeccccccccccc--------CCC
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH--------SQP 177 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~~--------~~~ 177 (254)
.+.+.....+++.+..++.++|+.||.+||++||.|||+||+|||-.+ +....+||+||++....... ++.
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 999999999999999999999999999999999999999999999753 33346999999986432222 122
Q ss_pred CCccCCCCccCccccc----cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
...+|+..|||||+.. ...++.+..|.||||+++|-|++|.+||.+...
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 3346888999999853 345667789999999999999999999987543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=232.02 Aligned_cols=196 Identities=26% Similarity=0.345 Sum_probs=156.4
Q ss_pred ccccCCcceEEEEEEEc--ccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++... .++..+++|.+..... ....+.+|+..++.++|||++++++.+.+....++|+||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999864 3556789998765432 2246778999999999999999999999888999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---C
Q 025369 105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 176 (254)
Q Consensus 105 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~---~ 176 (254)
+|.+++.... ..+...+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999986432 3566778889999999999999999999999999999988776 9999999875332211 1
Q ss_pred CCCccCCCCccCcccccccc------CCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
.....++..|+|||.+.+.. ..+.++|+||||+++++|++ |..||...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 11233566799999986432 12445999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=230.72 Aligned_cols=219 Identities=27% Similarity=0.507 Sum_probs=174.9
Q ss_pred CCceeEeccc--cCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhc-CCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDI--GSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l--~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++.+.+ |+|+||.||++.+..++..+++|.+........ |...... .+|+|++++++.+..++.+++|+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 3577787777 999999999999999999999998765432111 2222221 27999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
||+++++|.+++.....+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++. .++|+|||++.... ...
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~ 164 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPS 164 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCc
Confidence 99999999999988878999999999999999999999999999999999999987771 39999999875432 222
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~ 240 (254)
...++..|+|||++.+.....+ +|+||+|+++++|++|..||....... .....+..++..
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS 243 (267)
T ss_pred cCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence 3457788999999987776555 999999999999999999997543221 133456667777
Q ss_pred ccccCCCcc
Q 025369 241 CCHITPFYP 249 (254)
Q Consensus 241 ~~~~~p~~~ 249 (254)
|++.+|..+
T Consensus 244 ~l~~~p~~R 252 (267)
T PHA03390 244 MLKYNINYR 252 (267)
T ss_pred HhccChhhC
Confidence 777776433
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.19 Aligned_cols=221 Identities=33% Similarity=0.557 Sum_probs=182.7
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999999999999999875532 2345677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
+++++|.+++.... .+++..+..++.+++.++.+||+.+++|+||+|+||++++++. .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886543 4789999999999999999999999999999999999987654 3699999987654332221
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh---------------hHHHHHHhhcCcc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------FRKTIQVFIKPCC 242 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~ 242 (254)
....++..|+|||.+.+.....+ +|+||+|+++++|++|..||...+.... ....+..++..|+
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 22346778999999877666555 9999999999999999999976543222 2345777778888
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
..+|
T Consensus 239 ~~~p 242 (257)
T cd08225 239 KVSP 242 (257)
T ss_pred ccCh
Confidence 7777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=243.59 Aligned_cols=227 Identities=26% Similarity=0.356 Sum_probs=180.3
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEc
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (254)
...+......|+++++||+||.+.||+|.....+ .|++|++... ....+.+.+|+..|.+| .|.+|+.++++-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 3445566778999999999999999999987544 4566655442 33457789999999999 57999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++.+|+||||- ..+|..++..... .....++.+++||+.|+.++|+.||||.||||.|+++-+ |. +||+|||.|.
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~--LKLIDFGIA~ 507 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GR--LKLIDFGIAN 507 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-ee--EEeeeechhc
Confidence 99999999985 4589999987754 444688999999999999999999999999999998853 33 8999999988
Q ss_pred cccccCCC---CCccCCCCccCccccccccCC----------CCcccHHHHHHHHHHHHhCCCCCCCCC-----------
Q 025369 170 SSVLHSQP---KSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPD----------- 225 (254)
Q Consensus 170 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~----------~~~~Di~slG~~l~~l~~g~~pf~~~~----------- 225 (254)
........ ...+|++.||+||++...... .+++|||||||++|+|+-|+.||..-.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 76655444 345799999999998654332 334999999999999999999996522
Q ss_pred --C----ChhhHH-HHHHhhcCccccCC
Q 025369 226 --E----PKDFRK-TIQVFIKPCCHITP 246 (254)
Q Consensus 226 --~----~~~~~~-~~~~~~~~~~~~~p 246 (254)
+ ++.-.. .+..+++.|+..+|
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDP 615 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCc
Confidence 1 111111 28899999999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=236.17 Aligned_cols=216 Identities=25% Similarity=0.389 Sum_probs=172.9
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC---
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--- 91 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 91 (254)
.....++|++.+.||+|++|.||++.+..++..+++|.+.... .......+|+..++.++|+||+++.+++...
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 3455789999999999999999999999999999999875432 2234567899999999999999999987543
Q ss_pred -----CeEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 92 -----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 92 -----~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
..++++++|+.+ ++...+.. ...+++..++.++.|++++|.+||++|++|+||+|+||++++++. ++|+||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~df 159 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADF 159 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcC
Confidence 346999999865 56665543 457999999999999999999999999999999999999998877 999999
Q ss_pred cccccccccCCCC------------CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 166 GYSKSSVLHSQPK------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 166 ~~~~~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
|++.......... ...++..|+|||.+.+......++|+||+|+++++|++|.+||...+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9876433222111 1134567999998876554455599999999999999999999877776655554
Q ss_pred HHH
Q 025369 234 IQV 236 (254)
Q Consensus 234 ~~~ 236 (254)
...
T Consensus 240 ~~~ 242 (311)
T cd07866 240 FKL 242 (311)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=237.80 Aligned_cols=221 Identities=27% Similarity=0.469 Sum_probs=181.0
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
...|.....||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.+.|||++++++.+..++..+++++|
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 345666778999999999999999889999999875432 2345677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
+++++|..++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccc
Confidence 999999887654 46899999999999999999999999999999999999988776 9999999875332221 1223
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~ 242 (254)
..++..|+|||.+.+.....+ +|+||+|+++++|++|..||...+..+ .+...+..++..|+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 457789999999977766555 999999999999999999986544221 22335677777777
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
+.+|
T Consensus 256 ~~~P 259 (297)
T cd06659 256 TREP 259 (297)
T ss_pred cCCc
Confidence 7776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=230.93 Aligned_cols=223 Identities=26% Similarity=0.357 Sum_probs=178.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...++|++.+.||+|++|.||++.+... ...+++|...... ...+.+.+|+..++.++|||++++++++.+ +..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 3467899999999999999999987543 4468889776543 234568889999999999999999998865 456
Q ss_pred EEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++++|+++++|.+++.... .++...++.++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~ 159 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLED 159 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccc
Confidence 79999999999999997654 5899999999999999999999999999999999999987776 99999998764433
Q ss_pred cCCC--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHH
Q 025369 174 HSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQ 235 (254)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~ 235 (254)
.... ........|+|||.+.......+ +|+||||++++++++ |..||...+.. ......+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 2111 12223457999999876666555 999999999999996 99999665432 23345677
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 239 ~li~~~l~~~P 249 (270)
T cd05056 239 SLMTKCWAYDP 249 (270)
T ss_pred HHHHHHcCCCh
Confidence 78888888887
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=239.62 Aligned_cols=201 Identities=32% Similarity=0.478 Sum_probs=167.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC--CeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 94 (254)
..++|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|+..++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467999999999999999999999988999999987542 22334566799999999 999999999998654 368
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++|+||+++ +|..++... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSEL 160 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccc
Confidence 999999975 888888665 7888999999999999999999999999999999999998887 999999987644332
Q ss_pred CC------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 175 SQ------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 175 ~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.. .....++..|+|||.+.+......++|+||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223467789999988765544556999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=237.58 Aligned_cols=214 Identities=24% Similarity=0.378 Sum_probs=176.4
Q ss_pred CCCceeE-eccccCCcceEEEEEEEcccceeEEEEEccCCccch---------------hHHHHHHHHhhcCCCCCeeee
Q 025369 21 DSDRYDF-VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 21 ~~~~y~~-~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~ 84 (254)
..++|.. .+.||+|++|+||++.+..++..+++|.+....... ..+.+|+..++.++|+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3678875 577999999999999999999999999876532221 246789999999999999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
.+++..++..++++|++. ++|.+++.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d 162 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD 162 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence 999999999999999996 489999988778999999999999999999999999999999999999988876 99999
Q ss_pred ccccccccc---------------cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh
Q 025369 165 FGYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (254)
Q Consensus 165 f~~~~~~~~---------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 229 (254)
||.+..... ........++..|+|||.+.+......++|+||||+++++|++|..||...+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998754331 01111223566899999987655545569999999999999999999988877665
Q ss_pred hHHHHHHh
Q 025369 230 FRKTIQVF 237 (254)
Q Consensus 230 ~~~~~~~~ 237 (254)
..++...+
T Consensus 243 ~~~i~~~~ 250 (335)
T PTZ00024 243 LGRIFELL 250 (335)
T ss_pred HHHHHHHh
Confidence 55554443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=227.87 Aligned_cols=214 Identities=27% Similarity=0.380 Sum_probs=175.3
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
++||+|++|.||++.+.. ++.+++|.+..... ....+.+|+..++.++|++++++++++...+..+++++++.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 478999999999999987 89999998765433 345788899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC---CCccC
Q 025369 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 182 (254)
Q Consensus 107 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 182 (254)
.+++... ..++...+..++.+++.++.+||+++++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 9988654 46889999999999999999999999999999999999988776 999999987644321111 11223
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCccccCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~p 246 (254)
...|+|||.+.+...... +|+||||+++++|++ |..||..... ++.....+..++..|+..+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 456999999877666555 999999999999998 8888865432 22334567778888888877
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=232.53 Aligned_cols=217 Identities=27% Similarity=0.414 Sum_probs=174.3
Q ss_pred ccccCCcceEEEEEEEcccc------eeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 29 RDIGSGNFGVARLMRDKVTK------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~------~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.||+|++|.||++++.... ..+++|.+.... .....+.+|+..++.++||||+++++++......+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986543 678999775542 3345678899999999999999999999998999999999
Q ss_pred cCccchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC---CCceEEeccccccc
Q 025369 101 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 170 (254)
Q Consensus 101 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~---~~~~~l~df~~~~~ 170 (254)
+++++|.+++... ..++..++..++.+++.++.|||+.+++|+||+|+||+++.++ ...++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988642 2378899999999999999999999999999999999998765 11499999998764
Q ss_pred ccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhH
Q 025369 171 SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFR 231 (254)
Q Consensus 171 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~ 231 (254)
...... .........|+|||.+.+.....+ +|+||||+++|+|++ |..||...+. +....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 432211 112234568999999987776555 999999999999998 9999865432 22344
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+.+++..|+..+|
T Consensus 240 ~~~~~li~~~l~~~p 254 (269)
T cd05044 240 DKIYQLMTNCWAQDP 254 (269)
T ss_pred HHHHHHHHHHcCCCc
Confidence 567889999999888
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=231.43 Aligned_cols=200 Identities=31% Similarity=0.477 Sum_probs=165.0
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcC---CCCCeeeeeEEEEcCCe-----
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 93 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 93 (254)
|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++++ .|++++++.+++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999998864322 223455676666555 69999999999987765
Q ss_pred EEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.+++++++.+ +|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 8999999975 7888876643 4899999999999999999999999999999999999998866 999999987655
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
..........+...|+|||.+.+.....+ +|+||+|+++++|++|.+||......+
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHH
Confidence 43333334456778999999987776665 999999999999999999987655433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=236.04 Aligned_cols=223 Identities=22% Similarity=0.363 Sum_probs=177.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
+..++|++.+.||+|++|.||++.+..++. .+++|.+..... ....+.+|+..++.++|||++++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 456889999999999999999999876665 468887654322 223577899999999999999999998654 4
Q ss_pred EEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++++++++++|.+++.... .+++..++.++.|++.+|.|||++|++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence 678899999999999887654 5889999999999999999999999999999999999987776 9999999886543
Q ss_pred ccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHH
Q 025369 173 LHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKT 233 (254)
Q Consensus 173 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~ 233 (254)
..... .....+..|++||.+.+.....+ +|+||||+++|+|++ |..||...... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 22221 12234568999999876666555 999999999999997 88998654321 122345
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..||..+|
T Consensus 240 ~~~li~~c~~~~p 252 (303)
T cd05110 240 VYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHHHcCCCh
Confidence 6777888888877
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=228.45 Aligned_cols=223 Identities=31% Similarity=0.478 Sum_probs=178.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
+.......||+|++|.||++.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++++..++..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 333344589999999999999998899999998765432 3456889999999999999999999999999999999999
Q ss_pred CccchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-C
Q 025369 102 SGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (254)
Q Consensus 102 ~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 177 (254)
++++|.+++... ..+ +...+..++.|++.++.+||++|++|+||+|+||+++.+.. .++|+|||++........ .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCCCcc
Confidence 999999998764 445 78888999999999999999999999999999999975332 499999998764432211 2
Q ss_pred CCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~ 239 (254)
....+...|+|||.+.+.. ....++|+||+|+++++|++|..||..... +......+..++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 2334678899999986543 234459999999999999999999865332 1223346778888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 247 ~~l~~~p 253 (268)
T cd06624 247 RCFEPDP 253 (268)
T ss_pred HHcCCCc
Confidence 8888887
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=238.63 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=172.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc----CCeEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 95 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 95 (254)
++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++|||++++.+++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999886532 234567789999999999999999988763 35789
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+|++|+. ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence 9999995 589988887778999999999999999999999999999999999999998877 9999999875433222
Q ss_pred CC-----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 176 QP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 176 ~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
.. ....++..|++||.+.+.....+++|+||+|+++|+|++|..||...+....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 11 2235677899999987654445559999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.86 Aligned_cols=215 Identities=32% Similarity=0.483 Sum_probs=181.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----eEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (254)
+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999999889999999886542 23467888999999999999999999988764 789
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
++++|+.+ +|.+++.....+++..++.++.+++.+|.+||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 99999974 88888887778999999999999999999999999999999999999988866 9999999887554433
Q ss_pred ----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 176 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 176 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
......++..|+|||.+.+......++|+||+|+++++|++|..||...+..+.+..+...+..+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 123345677899999998774445559999999999999999999998887666666555544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=249.66 Aligned_cols=217 Identities=31% Similarity=0.529 Sum_probs=188.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch----hHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..|.-++.||.|+||-||.|++..+.+.||||++..+.... .++.+|+..|+++.|||.+.+.+.+..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 36788899999999999999999999999999987654332 56788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|||-| +..+++.-. .++.+.++..|+.+.+.+|.|||+.+.+|+|||..|||+++.+. +||+|||.+... ...
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APA 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cch
Confidence 99955 788888655 57899999999999999999999999999999999999998888 999999987533 445
Q ss_pred CCccCCCCccCccccc---cccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------CChhhHHHHHHhh
Q 025369 178 KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------EPKDFRKTIQVFI 238 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------------~~~~~~~~~~~~~ 238 (254)
++..|+++|||||++. .+.++.+ .||||||++.++|.-.++|+.+.+ ....+...++.|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 6788999999999974 4566677 999999999999999999976533 2446778899999
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|++.-|
T Consensus 259 d~CLqKip 266 (948)
T KOG0577|consen 259 DSCLQKIP 266 (948)
T ss_pred HHHHhhCc
Confidence 99998776
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=231.46 Aligned_cols=214 Identities=22% Similarity=0.264 Sum_probs=168.7
Q ss_pred cccCCcceEEEEEEEcc------------------------cceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeee
Q 025369 30 DIGSGNFGVARLMRDKV------------------------TKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~------------------------~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 84 (254)
.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999987532 123578887754332 23567788899999999999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-----C
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----P 158 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-----~ 158 (254)
++++..+...++||||+++++|..++.. .+.++...+..++.|++.|++|||++|++|+||+|+||++++.+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999988865 456899999999999999999999999999999999999975432 2
Q ss_pred ceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCh---------
Q 025369 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPK--------- 228 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~--------- 228 (254)
.++++|||++..... .....++..|+|||.+.+......++|+||||+++|+++ +|..||......+
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 238 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH 238 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc
Confidence 379999997653321 122345677999999876554455599999999999985 6889987643321
Q ss_pred ----hhHHHHHHhhcCccccCC
Q 025369 229 ----DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ----~~~~~~~~~~~~~~~~~p 246 (254)
.....+..+++.||+.+|
T Consensus 239 ~~~~~~~~~~~~li~~cl~~~p 260 (274)
T cd05076 239 RLPEPSCKELATLISQCLTYEP 260 (274)
T ss_pred CCCCCCChHHHHHHHHHcccCh
Confidence 112357788899999888
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=229.94 Aligned_cols=220 Identities=30% Similarity=0.486 Sum_probs=182.0
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
.+|...+.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+..++.++|++++++++.+..++..+++++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 467777899999999999999988899999998754332 2345778999999999999999999999999999999999
Q ss_pred CccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCCc
Q 025369 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (254)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 180 (254)
++++|.+++.. .+++...++.++.|++.++++||+.|++||||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998877 56899999999999999999999999999999999999988776 9999999765432221 12233
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCccc
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCCH 243 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~ 243 (254)
.++..|+|||.+.+.....+ +|+||+|+++++|++|..||...+... .....+..++..|+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 57788999999877766555 999999999999999999986533211 133467788888887
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 255 ~~p 257 (285)
T cd06648 255 RDP 257 (285)
T ss_pred cCh
Confidence 777
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=221.65 Aligned_cols=216 Identities=23% Similarity=0.441 Sum_probs=187.8
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCC--eE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~ 94 (254)
.+...++|++.+++|+|.++.||.+....+++.+++|.+++- ....+.+|+.+|..|. ||||+++.++..++. ..
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 345788999999999999999999999989999999987653 2367889999999996 999999999998864 56
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
.+++|+.+..+...+- +.++...+..++++++.||.|+|++||.|||++|+|++++.... +++|+|||+|....++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCC
Confidence 8999999876554433 45889999999999999999999999999999999999985554 7999999999988888
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCC-CCCCCChhhHHHHHHhhc
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTIQVFIK 239 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~ 239 (254)
.+.+....+..|--||.+.+.+.+....|+|||||+++.|+..+.|| .+.++.+++-++.+.++.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 88888899999999999999888777789999999999999988775 677788888887776654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=233.45 Aligned_cols=222 Identities=25% Similarity=0.365 Sum_probs=177.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|+..+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..+.++. |+|++++++++..++..++++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 467888999999999999999999999999999886542 23456778888898886 999999999999999999999
Q ss_pred EccCccchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 99 EYASGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 99 ~~~~~~~L~~~l---~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
+++.. ++.++. . ....+++..+..++.+++.+++|||+. +++||||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhc
Confidence 99854 444332 2 235689999999999999999999975 9999999999999988776 9999999886544
Q ss_pred ccCCCCCccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------------hhh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------------KDF 230 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------------~~~ 230 (254)
.........++..|+|||++.+. ...+.++|+||+|+++++|++|..||...... ..+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 33333344577889999998766 23444599999999999999999998653210 113
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+.+++..|+..+|
T Consensus 240 ~~~l~~li~~~l~~~p 255 (288)
T cd06616 240 SPSFVNFINLCLIKDE 255 (288)
T ss_pred CHHHHHHHHHHccCCh
Confidence 4457788888888887
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=232.84 Aligned_cols=217 Identities=32% Similarity=0.498 Sum_probs=174.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 92 (254)
...++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34679999999999999999999999899999999886432 23356678999999999999999999987654
Q ss_pred ------eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 93 ------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 93 ------~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
.++++++|+++ ++...+... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcc
Confidence 78999999976 666666543 46899999999999999999999999999999999999988777 999999
Q ss_pred cccccccccCC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhc
Q 025369 166 GYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239 (254)
Q Consensus 166 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (254)
|++........ .........|++||.+.+......++|+||+|+++++|++|..||...+..+......+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 98764433221 112234667999998866544445599999999999999999999877665555554444333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=231.64 Aligned_cols=202 Identities=17% Similarity=0.174 Sum_probs=154.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCccch--h----------HHHHHHHHhhcCCCCCeeee
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~ 84 (254)
...++|++.+.||+|+||.||++.+..+ +..+++|......... + ....+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457999999999999999999998876 6677777543222110 1 11123344566789999999
Q ss_pred eEEEEcCC----eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCce
Q 025369 85 KEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (254)
Q Consensus 85 ~~~~~~~~----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~ 160 (254)
++.+.... ..+++++++.. ++.+.+......++..++.++.|++.+++|||+.+++||||||+||+++.++. +
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--G 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--E
Confidence 98765543 34677777643 66666666555788899999999999999999999999999999999987766 9
Q ss_pred EEecccccccccccC--------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 161 KICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 161 ~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
+|+|||++....... ......+++.|+|||++.+..++.+ +|+||||+++++|++|..||....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999986543211 1122358889999999887776555 999999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=234.13 Aligned_cols=200 Identities=31% Similarity=0.509 Sum_probs=166.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 95 (254)
...++|++.+.||.|++|.||++.+..++..+++|.+... ......+.+|+..++.++|||++++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3578999999999999999999999999999999987532 2334667789999999999999999999876 45788
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
++++|+ +++|..++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||.+.... .
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~--~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQD--P 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccC--C
Confidence 999998 5588877754 35788889999999999999999999999999999999987776 9999999876432 2
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
......+...|++||.+.+......++|+||+|+++++|++|..||...+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334567789999998664444556999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=238.12 Aligned_cols=208 Identities=26% Similarity=0.435 Sum_probs=171.8
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
+|........++|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|+..++.++|+|++++.+++.
T Consensus 5 ~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred hhccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 45555556688999999999999999999999999999999987643 222355667999999999999999998876
Q ss_pred cCCe------EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 90 TPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 90 ~~~~------~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
.... .++|++++ +++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++. ++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~ 160 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKIL 160 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEc
Confidence 5543 89999998 5689888765 46899999999999999999999999999999999999988776 9999
Q ss_pred cccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
|||++..... ......++..|+|||.+.+......++|+||||++++++++|..||...+.
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 161 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred cccccccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9998764432 223345677899999986644445559999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=230.70 Aligned_cols=200 Identities=34% Similarity=0.537 Sum_probs=170.2
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+..|+..++.++|++++++.+++.+.+..+++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999988764 333456778999999999999999999999999999999999
Q ss_pred CccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
++ +|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||++++++. ++|+|||++....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 75 899999776 57999999999999999999999999999999999999988776 9999999876443322 2223
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 227 (254)
......|+|||.+.+......++|+||||++++++++|..||...+..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 345667999999877644455599999999999999999999776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=231.79 Aligned_cols=228 Identities=27% Similarity=0.384 Sum_probs=180.6
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
.......++|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..+... .|+|++++++++.+..
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 3445678999999999999999999999998899999999865432 234455666656555 5999999999999999
Q ss_pred eEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..+++++|+.+ ++.+++.. ...+++..+..++.+++.++.|||+ .|++|+||+|+||++++++. ++|+|||++..
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGR 164 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchh
Confidence 99999999854 66666654 3468999999999999999999997 59999999999999987776 99999998765
Q ss_pred ccccCCCCCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hh
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KD 229 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~ 229 (254)
...........+...|+|||.+.+.. ..+.++|+||||+++++|++|..||...... ..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 43333333345677899999986543 2334499999999999999999999652211 12
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
+...+..++..|+..+|
T Consensus 245 ~~~~l~~li~~~l~~~p 261 (296)
T cd06618 245 FSPDFCSFVDLCLTKDH 261 (296)
T ss_pred CCHHHHHHHHHHccCCh
Confidence 34567888888888887
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=233.37 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=155.9
Q ss_pred eccccCCcceEEEEEEEcc--cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeEEEEEEccCc
Q 025369 28 VRDIGSGNFGVARLMRDKV--TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 103 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~--~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 103 (254)
+.+||+|+||.||++++.. ++..+++|.+.... ....+.+|+..++.++|||++++.+++.. +...+++++|+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 4689999999999999754 56789999876543 34567789999999999999999999864 4578999999865
Q ss_pred cchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC--CCCceEEeccccccccc
Q 025369 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 172 (254)
Q Consensus 104 ~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~--~~~~~~l~df~~~~~~~ 172 (254)
+|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++..+ ..+.++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 676666421 247889999999999999999999999999999999999432 22349999999986443
Q ss_pred ccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.... .....++..|+|||.+.+....+.++|+||+|+++|+|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 2211 1233567889999998776555566999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=226.24 Aligned_cols=214 Identities=37% Similarity=0.589 Sum_probs=180.1
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
||+|++|.||.+.+..++..+++|.+..... ..+.+.+|+..++.++|++++++++.+..+...+++++++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999998765432 335678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCccCCCC
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 185 (254)
.+++.....+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......+...
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988888999999999999999999999999999999999999988776 999999987654333 12234456778
Q ss_pred ccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccccCCC
Q 025369 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~p~ 247 (254)
|++||...+...... +|+||||++++++++|..||...+... .....+..+++.|+..+|.
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 999999877666555 999999999999999999997655322 2234567777788877773
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=235.62 Aligned_cols=212 Identities=26% Similarity=0.435 Sum_probs=172.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
........++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+..+++++|+||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 33445567999999999999999999999998999999998865321 235577899999999999999999987643
Q ss_pred ------CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 92 ------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 92 ------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
...+++++++ +++|.+++... .+++..++.++.|++.|+.|||+.|++|+||+|+||++++++. ++|+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~df 164 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDF 164 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecc
Confidence 3467888876 67888777543 5899999999999999999999999999999999999998876 999999
Q ss_pred cccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
|++.... .......++..|+|||.+.+......++|+||+|+++++|++|..||...+......+
T Consensus 165 g~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 165 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred ccccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9876432 2223345677899999987644444559999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=227.62 Aligned_cols=215 Identities=27% Similarity=0.382 Sum_probs=168.1
Q ss_pred ccccCCcceEEEEEEEcc---cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CCeEEEEEEccC
Q 025369 29 RDIGSGNFGVARLMRDKV---TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYAS 102 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~---~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~~~~ 102 (254)
+.||+|+||.||++.+.. .+..+++|.+.... ...+.+.+|+..++.++|||++++++++.. ++..+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34678999875432 223567789999999999999999998764 556789999999
Q ss_pred ccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-----C
Q 025369 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 176 (254)
Q Consensus 103 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-----~ 176 (254)
+++|.+++... ...+...+..++.+++.|+.|||+.+++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998764 34677888999999999999999999999999999999988776 9999999876432211 1
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhC-CCCCCCCCC---------------ChhhHHHHHHhhcC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE---------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~---------------~~~~~~~~~~~~~~ 240 (254)
.....++..|+|||.+.+.....+ +|+||||+++++|++| .+||...+. +......+..++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112234567999999877766555 9999999999999995 566654221 22344667888889
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
||..+|
T Consensus 238 cl~~~p 243 (262)
T cd05058 238 CWHPKP 243 (262)
T ss_pred HcCCCh
Confidence 998888
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=235.43 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=164.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 91 (254)
...++|.+.+.||+|++|.||+|.+..++..+++|.+... ......+.+|+..++.++|+|++++.+++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 3467999999999999999999999989999999987643 22335577899999999999999999998754
Q ss_pred -CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..++++++|+.. ++..... ..+++..+..++.|++.|+.+||+.|++||||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~ 166 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARH 166 (342)
T ss_pred CceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcC
Confidence 356899999864 6665542 35899999999999999999999999999999999999988776 99999998764
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.. .......++..|+|||.+.+....+.++|+||||+++++|++|+.||...+
T Consensus 167 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 167 AD--AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CC--CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 222234566789999998765444555999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=247.48 Aligned_cols=197 Identities=25% Similarity=0.411 Sum_probs=153.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce-eEEE------------------EEccCCccchhHHHHHHHHhhcCCCCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-LVAV------------------KYIERGDKIDENVQREIINHRSLRHPNI 81 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-~~~l------------------K~~~~~~~~~~~~~~e~~~l~~l~h~~i 81 (254)
..++|++.+.||+|+||+||++....... ..+. |.+.........+.+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987643221 1111 2122222233557789999999999999
Q ss_pred eeeeEEEEcCCeEEEEEEccCccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC
Q 025369 82 VRFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (254)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~ 156 (254)
+++++++.+.+..+++++++.+ ++..++... .......++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999855 666665432 2234667888999999999999999999999999999998877
Q ss_pred CCceEEecccccccccccCC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCC
Q 025369 157 APRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 157 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
. ++|+|||++........ .....++..|+|||++.+..+... +||||||+++|+|++|..++
T Consensus 305 ~--vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 K--IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred C--EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCC
Confidence 6 99999999865433222 123468899999999988776555 99999999999999987543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=235.74 Aligned_cols=201 Identities=33% Similarity=0.447 Sum_probs=164.0
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcC---------
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--------- 91 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 91 (254)
.++|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 5899999999999999999999999999999998765432 345678899999999999999998776543
Q ss_pred -----CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 92 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 92 -----~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
...++++||+++ +|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 357899999964 88877754 46899999999999999999999999999999999999975443 38999999
Q ss_pred ccccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 167 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.+........ .....++..|+|||.+.+......++|+||||+++++|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764422211 1223456789999987654444555999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=227.33 Aligned_cols=229 Identities=27% Similarity=0.366 Sum_probs=189.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 92 (254)
.-..|++.+.||+|.||.||+|..+.++. .+|+|+++.+ .....+.-+|+.+++.++|+|++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34689999999999999999996654433 6899988765 3456788899999999999999999999987 77
Q ss_pred eEEEEEEccCccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC--CCCceEEecc
Q 025369 93 HLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDF 165 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~--~~~~~~l~df 165 (254)
.++++++|.+. +|..++.-+ ..++...+..+++||++++.|||++=+.||||||.||++..+ ..+++|++|+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999966 777777432 358999999999999999999999999999999999999755 2356999999
Q ss_pred cccccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC---------CChhhHH
Q 025369 166 GYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---------EPKDFRK 232 (254)
Q Consensus 166 ~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~~~~~ 232 (254)
|+++.....-. ......+..|+|||.+.+...++++.|+|+.||++.||++-.+.|...+ ..++..+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99875443222 2233467789999999999999999999999999999999999996544 3467888
Q ss_pred HHHHhhcCccccCCCccc
Q 025369 233 TIQVFIKPCCHITPFYPL 250 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~~~~ 250 (254)
++..+..|..+..|...-
T Consensus 261 If~vLG~Pt~~~Wp~lkk 278 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKK 278 (438)
T ss_pred HHHHcCCCccccchhhhh
Confidence 999999998887775443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=225.71 Aligned_cols=196 Identities=23% Similarity=0.365 Sum_probs=154.9
Q ss_pred ccccCCcceEEEEEEEcc--cceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~--~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++.... ....+++|....... ....+.+|+..++.++|+||+++++.+.....++++|||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999996532 455788887654322 2345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---C
Q 025369 105 ELFERICNAGR-----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 176 (254)
Q Consensus 105 ~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~---~ 176 (254)
+|.+++..... .++..+..++.|++.+++|||++|++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 99999876432 467788899999999999999999999999999999998776 9999999875432211 1
Q ss_pred CCCccCCCCccCccccccc------cCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
.....+...|+|||++... .....++|+||||+++|+|++ |..||.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 1222345679999987532 233455999999999999999 7888876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=229.66 Aligned_cols=219 Identities=28% Similarity=0.464 Sum_probs=178.2
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
...|+..+.||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|+|++++.+++.++...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3458899999999999999999998999999998764322 224577899999999999999999999999999999
Q ss_pred EEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+||+.+ ++.+.+.. ..++++.++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.... .
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~ 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---P 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---C
Confidence 999976 66666643 456899999999999999999999999999999999999988776 9999999865332 2
Q ss_pred CCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~~~~ 238 (254)
.....++..|+|||.+.. ......++|+||+|+++++|++|..||...+. ...+...+..++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 233457778999999742 22234459999999999999999999865432 123445577888
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 258 ~~~l~~~p 265 (317)
T cd06635 258 DSCLQKIP 265 (317)
T ss_pred HHHccCCc
Confidence 88888887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=226.80 Aligned_cols=219 Identities=23% Similarity=0.383 Sum_probs=172.5
Q ss_pred eeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC------
Q 025369 25 YDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 92 (254)
|++.+.||+|++|.||+|... .++..+++|.+.... ...+.+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357889999886532 23356778999999999999999999886532
Q ss_pred eEEEEEEccCccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 93 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
..+++++|+.+++|..++... ..++...++.++.|++.+++|||+.|++|+||+|+||++++++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 246888999999998876432 24788899999999999999999999999999999999987776 9999999
Q ss_pred ccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh--------------
Q 025369 167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK-------------- 228 (254)
Q Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~-------------- 228 (254)
++........ .........|++||.+.....+.+ +|+||||+++|+|++ |..||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 8765432221 112234467999999877766555 999999999999999 888886544322
Q ss_pred -hhHHHHHHhhcCccccCC
Q 025369 229 -DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -~~~~~~~~~~~~~~~~~p 246 (254)
.....+.+++..|+..+|
T Consensus 238 ~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred CCCCHHHHHHHHHHcCCCh
Confidence 233567778888888887
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=235.46 Aligned_cols=206 Identities=31% Similarity=0.450 Sum_probs=183.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.+...+.|+.-++||.||||.||-.+-..||+.||.|.+.+. .....-..+|-.+|.+++.+.||.+--.+.....
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 445577889999999999999999999999999999977542 1223445678889999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+++|+..++||+|.-.+.+.+ -+++.....++.+|+-+|++||+.+|++||+||+|||+|+.|+ ++|+|+|+|+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEec
Confidence 999999999999988887665 5999999999999999999999999999999999999999988 999999999988
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..+.......|+.+|||||++.+..++.. .|+|||||++|+|+.|+.||....+
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhh
Confidence 88888888899999999999988886555 8999999999999999999977554
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.31 Aligned_cols=225 Identities=29% Similarity=0.485 Sum_probs=192.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.+.+.|.|...||.|+||.||+|.++.++...|-|.+.-. ....+++.-|+.+|..+.||+|+++++.+..++.+|++.
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3467899999999999999999999998888888877543 334467778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 176 (254)
+||.||-+..++-.- ..+++.++..+++|++.||.|||+++|+|+||+..|||+..+|. ++|.|||++..... ...
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhh
Confidence 999999888777554 56999999999999999999999999999999999999999998 99999998653322 233
Q ss_pred CCCccCCCCccCccccc-----cccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----------------CChhhHHHH
Q 025369 177 PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------------EPKDFRKTI 234 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------------~~~~~~~~~ 234 (254)
.....|+++|||||+.. +.++++. +||||||+++++|..+.+|-...+ .+..+...+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 45668999999999964 4455566 999999999999999999965533 366778889
Q ss_pred HHhhcCccccCCC
Q 025369 235 QVFIKPCCHITPF 247 (254)
Q Consensus 235 ~~~~~~~~~~~p~ 247 (254)
.++++.|+..+|-
T Consensus 266 ~DfLk~cL~Knp~ 278 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPR 278 (1187)
T ss_pred HHHHHHHHhcCCc
Confidence 9999999999884
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=268.25 Aligned_cols=228 Identities=32% Similarity=0.461 Sum_probs=196.2
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.-+|+-+..||+|.||.||-+.+..+|+..|+|.+.-. ......+.+|..++..++|||++.++++-.+....++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44888999999999999999999999999999976543 334466789999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 176 (254)
|||++|+|.+.+...+-.++.....+..|++.++.|||+.|||||||||.||+++.++- +|++|||.|.......+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcC
Confidence 99999999999998888888888889999999999999999999999999999998886 99999999876555432
Q ss_pred ---CCCccCCCCccCccccccccC--CCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHHHH
Q 025369 177 ---PKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKTIQ 235 (254)
Q Consensus 177 ---~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~ 235 (254)
.+...|++-|||||++.+... ...++|||||||++.||.||+.||...++ |+.+...-.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 244569999999999965542 23348999999999999999999977554 445666788
Q ss_pred HhhcCccccCCCcccc
Q 025369 236 VFIKPCCHITPFYPLF 251 (254)
Q Consensus 236 ~~~~~~~~~~p~~~~~ 251 (254)
+|+..|++.||.-+++
T Consensus 1472 dFle~Cl~~dP~~Rw~ 1487 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWT 1487 (1509)
T ss_pred HHHHHHHhcCchhhhH
Confidence 9999999999976554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=239.94 Aligned_cols=201 Identities=37% Similarity=0.636 Sum_probs=176.0
Q ss_pred ceeEe--ccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 24 RYDFV--RDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 24 ~y~~~--~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
=|+|. +.||+|-||+||-+++..+|+.||||.+.+. ....+.+++|+.+|..+.||+|+.+.-.|+.....|+||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 35543 6899999999999999999999999988653 344577899999999999999999999999999999999
Q ss_pred EccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|.+.|.-|.-+++ +.+.+++.....+..||+.||.|||-++|+|+||||+|||+.+ +..+.+||||||+|+.......
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9997755555554 4467999999999999999999999999999999999999953 3445699999999998877777
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.....|++.|.|||++++..+... .|+||.|+++|.-++|..||...+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCcc
Confidence 788899999999999999988766 899999999999999999997654
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=231.60 Aligned_cols=196 Identities=23% Similarity=0.308 Sum_probs=158.8
Q ss_pred eccccCC--cceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 28 VRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 28 ~~~l~~g--~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
...||.| ++|+||.+++..+++.|++|.+..... ..+.+.+|+.+++.++||||+++++++..++..+++++|+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 889999999999999999998765432 23567889999999999999999999999999999999999
Q ss_pred ccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC---
Q 025369 103 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 177 (254)
Q Consensus 103 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~--- 177 (254)
++++.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence 99999988764 34899999999999999999999999999999999999988776 999999754322111111
Q ss_pred -----CCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 178 -----KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
....+...|++||++.+.. ....++|+||+|+++++|++|..||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 1112345699999987642 23445999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=229.17 Aligned_cols=217 Identities=29% Similarity=0.455 Sum_probs=176.8
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|...++||+|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|+|++++.+++.+....++++|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47777889999999999999998999999998764322 22456789999999999999999999999999999999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|+.+ ++.+.+.. ..++++.+++.++.|++.++.|||+.|++|+||+|+||++++++. ++|+|||++... ....
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~~ 175 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPAN 175 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCCC
Confidence 9965 66666654 456899999999999999999999999999999999999987776 999999987532 2223
Q ss_pred CccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hhhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KDFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~~~ 240 (254)
...++..|+|||.+.. ......++|+||||+++++|++|..||...+.. ..+...+..++..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 4457788999999743 232344599999999999999999998664321 1233457888888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|++.+|
T Consensus 256 ~l~~~P 261 (313)
T cd06633 256 CLQKIP 261 (313)
T ss_pred HccCCh
Confidence 888887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=244.16 Aligned_cols=213 Identities=30% Similarity=0.484 Sum_probs=192.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++.+++..||-||||.|=++..+.....+|+|.+++.+ ...+.+..|-+++..+..|.|++++..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44568888999999999999999988776678888877643 44466777888888899999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
++||.|-||.+...+...+.+++.+...++..+++|++|||++||++|||||+|.+++.+|- +||.|||+|+....+.
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999998888 9999999999888888
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHH
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 235 (254)
..-..+|++.|.|||.+.+..++.. .|.||||+++++|++|.+||...+....+..+++
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred ceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 8888899999999999999998777 9999999999999999999999887666665544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=228.46 Aligned_cols=219 Identities=28% Similarity=0.457 Sum_probs=177.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.|....+||+|++|.||++....++..+++|.+.... .....+.+|+..++.++|+|++++.+.+..++..++++||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 4444578999999999999999999999999875432 234567789999999999999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCCcc
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 181 (254)
+++|.+++.. ..+++..++.++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 9999887654 46899999999999999999999999999999999999988776 9999999875433221 122345
Q ss_pred CCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCcccc
Q 025369 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCCHI 244 (254)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~ 244 (254)
++..|++||.+.+.....+ +|+||+|+++++|++|..||...+... .....+..++..|+..
T Consensus 178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 6778999999876665544 999999999999999999987543221 1233466677777777
Q ss_pred CC
Q 025369 245 TP 246 (254)
Q Consensus 245 ~p 246 (254)
+|
T Consensus 257 ~P 258 (292)
T cd06657 257 DP 258 (292)
T ss_pred Cc
Confidence 76
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=230.14 Aligned_cols=209 Identities=29% Similarity=0.447 Sum_probs=169.6
Q ss_pred ceeEeccccCCcceEEEEEEEccc--ceeEEEEEccCCc---cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC----Ce
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVT--KELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 93 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 93 (254)
+|++.+.||+|++|.||++.+..+ +..+++|.+.... .....+.+|+..++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8899999876432 2235567899999988 599999999875432 45
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++++++++. ++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||++++++. ++|+|||++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788888885 589998888888999999999999999999999999999999999999988876 99999998864332
Q ss_pred cCC-----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHH
Q 025369 174 HSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235 (254)
Q Consensus 174 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 235 (254)
... .....++..|+|||.+.+......++|+||+|+++++|++|..||...+....+.+.+.
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 211 12235778899999887654445559999999999999999999987765554444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=230.49 Aligned_cols=221 Identities=27% Similarity=0.441 Sum_probs=179.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
....|+..+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++|++++++.+++..+...++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3456888999999999999999999899999999875421 223456789999999999999999999999999999
Q ss_pred EEEccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 97 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
|+||+.+ ++.+.+. ...++++..+..++.+++.++.+||+.+++|+||+|+||++++++. ++|+|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~-- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC--
Confidence 9999965 6766664 3456899999999999999999999999999999999999988776 99999998764322
Q ss_pred CCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHHHHHh
Q 025369 176 QPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKTIQVF 237 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~~~ 237 (254)
.....++..|+|||.+.+ ......++|+||||+++++|++|..||...+. ...+...+..+
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 223456778999999753 22234459999999999999999999865432 12344567888
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|+..+|.
T Consensus 247 i~~cl~~~P~ 256 (308)
T cd06634 247 VDSCLQKIPQ 256 (308)
T ss_pred HHHHhhCCcc
Confidence 9999988883
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=227.84 Aligned_cols=221 Identities=30% Similarity=0.517 Sum_probs=178.2
Q ss_pred ceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
+|++.+.||+|++|.||++.+. .++..+++|.+.... ...+.+.+|+..++++ +|++++++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 457789999875432 2335567899999999 589999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++|++|+++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999987778999999999999999999999999999999999999987776 999999987643322
Q ss_pred CC--CCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHH
Q 025369 175 SQ--PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKT 233 (254)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~ 233 (254)
.. .....+...|++||.+.+.. ....++|+||+|+++++|++|..||...... ..+...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence 21 12234678899999986654 2344499999999999999999999643221 112345
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+.+++..|+..+|
T Consensus 239 l~~li~~~l~~~p 251 (288)
T cd05583 239 ARDFIQKLLEKDP 251 (288)
T ss_pred HHHHHHHHhcCCH
Confidence 6777777777777
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=229.85 Aligned_cols=189 Identities=28% Similarity=0.443 Sum_probs=155.0
Q ss_pred cceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHH
Q 025369 35 NFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 111 (254)
Q Consensus 35 ~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~ 111 (254)
+.+.+|++++..++..+|+|.+... ......+.+|+..++.++|+||+++++++...+..+++++|+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456677777778999999988654 2334678899999999999999999999999999999999999999999987
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC--------CCCcc
Q 025369 112 NA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 181 (254)
Q Consensus 112 ~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~ 181 (254)
.. ..+++..+..+++|++.||.|||+++++|+||+|+||+++.++. ++++||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 54 45889999999999999999999999999999999999987776 99999997754332211 12223
Q ss_pred CCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 182 GTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 182 ~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
+...|+|||.+... .....++|+||+|+++++|++|..||....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 55679999998654 223445999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=220.06 Aligned_cols=207 Identities=21% Similarity=0.272 Sum_probs=169.0
Q ss_pred CcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHHhc
Q 025369 34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 113 (254)
Q Consensus 34 g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~ 113 (254)
|.++.||++++..+++.+++|.+..... ..++...+....|||++++++++.+....+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999998865432 223444455567999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccc
Q 025369 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193 (254)
Q Consensus 114 ~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 193 (254)
..+++..+..++.|++.++.+||++|++|+||+|+||+++.++. ++++|||.+...... .........|+|||...
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999988776 999999976433221 22334456799999987
Q ss_pred cccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------CChhhHHHHHHhhcCccccCCCcc
Q 025369 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------EPKDFRKTIQVFIKPCCHITPFYP 249 (254)
Q Consensus 194 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------~~~~~~~~~~~~~~~~~~~~p~~~ 249 (254)
+...+.. +|+||+|+++++|++|..|+.... .+..+...+..++..|++.+|..+
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 6666555 999999999999999998765322 233455677888889998888543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=223.51 Aligned_cols=219 Identities=31% Similarity=0.525 Sum_probs=175.8
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC------ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+|.+.+.||+|++|.||++.+..++..+++|..... .........|+..++.++|||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999877666666655431 12223456788899999999999999999988899999
Q ss_pred EEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+||+++++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++++ . ++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-L--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-C--EeecccCceeecCC
Confidence 999999999888753 3568999999999999999999999999999999999999743 3 89999998764432
Q ss_pred cCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhHHHHHHh
Q 025369 174 HSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKTIQVF 237 (254)
Q Consensus 174 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~~~~~~~ 237 (254)
... .....++..|++||.+.+.....+ +|+||+|+++++|++|..||..... +......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 222 223346778999999876666555 9999999999999999999864322 23344567778
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|+..+|
T Consensus 237 i~~~l~~~p 245 (260)
T cd08222 237 MQSMLNKDP 245 (260)
T ss_pred HHHHhcCCh
Confidence 888888777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=238.28 Aligned_cols=200 Identities=29% Similarity=0.456 Sum_probs=175.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhH---------HHHHHHHhhcCC---CCCeeeeeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---------VQREIINHRSLR---HPNIVRFKEVI 88 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~---------~~~e~~~l~~l~---h~~i~~~~~~~ 88 (254)
...+|...+.+|+|+||.|+.+.++.+...|++|.+++..-..+. +-.|+.++..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 345799999999999999999999999999999998775432222 225899998886 99999999999
Q ss_pred EcCCeEEEEEEccC-ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 89 LTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 89 ~~~~~~~lv~~~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
++++++|++||--. |-+|.+++.-++.+++.+...|++|++.++++||++||+|||||-+||.++.+|. +||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccc
Confidence 99999999999774 6689999999999999999999999999999999999999999999999988887 99999998
Q ss_pred cccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
+.....+ .-....|+..|.|||++.+..+-.+..|||+||+++|.+.....||.+
T Consensus 717 aa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7543332 234567999999999999999988889999999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=221.88 Aligned_cols=221 Identities=27% Similarity=0.396 Sum_probs=186.3
Q ss_pred CCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC---CccchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
..|..++....++|+-+.++|+|.||.||+|+.+.+++.|++|++.. .........+|+.+|..++|+|++.++++|
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 35667788889999999999999999999999999999999987654 233456678999999999999999998887
Q ss_pred Ec--------CCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 89 LT--------PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 89 ~~--------~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
.. ...+++||++|+. +|..++.+. ..++..++.+++.+++++|.|+|...|+|||+++.|++++.++.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-- 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-- 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--
Confidence 53 2358999999965 788888765 67999999999999999999999999999999999999998888
Q ss_pred eEEecccccccccccCCC-----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHH
Q 025369 160 LKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234 (254)
Q Consensus 160 ~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 234 (254)
++|.|||+++........ .....+..|++||.+.+...+.+..|+|..||++.+|++|.+.++..++..++.-+-
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 999999998644332222 122347789999999988888777999999999999999999999999877766553
Q ss_pred H
Q 025369 235 Q 235 (254)
Q Consensus 235 ~ 235 (254)
.
T Consensus 243 ~ 243 (376)
T KOG0669|consen 243 Q 243 (376)
T ss_pred H
Confidence 3
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=215.09 Aligned_cols=224 Identities=29% Similarity=0.414 Sum_probs=180.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 95 (254)
..+.++.+++..||+|..|.|++++...++...|||.+..... ...++...+.+..... .|+||+.+++|..+...+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 4556677888999999999999999999999999999876543 2355666666665554 799999999999999999
Q ss_pred EEEEccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 96 IVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+.||.+.. -+..++. ..+++++..+-++...++.||.||-++ ||+|||+||+|||+|+.|+ +||||||.+.+...
T Consensus 168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeec
Confidence 99998743 3344443 345689999999999999999999865 8999999999999999998 99999999998888
Q ss_pred cCCCCCccCCCCccCccccccc---cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRK 232 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~ 232 (254)
+.......|-+.|+|||.+... .++.. +|+||||++++||.||+.||..-+.+ ..+..
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP 323 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence 8888888899999999998644 33444 99999999999999999999873321 12444
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.++.|+..|+..|+
T Consensus 324 ~F~~fv~~CL~kd~ 337 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDH 337 (391)
T ss_pred HHHHHHHHHhhcCc
Confidence 56666666666654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=216.59 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=153.4
Q ss_pred ccccCCcceEEEEEEEccc--ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVT--KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~--~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+.||+|+||.||++..... ...+++|.+.... ...+.+.+|+..++.++|||++++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999975433 3356677655432 23456788889999999999999999999989999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc---CCC
Q 025369 105 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 177 (254)
Q Consensus 105 ~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~~~ 177 (254)
+|.+++... ...+...++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999998754 23567778899999999999999999999999999999987776 999999986432111 112
Q ss_pred CCccCCCCccCcccccccc------CCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 226 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 226 (254)
....++..|+|||++.... ..+.++|+||||+++++|++ |..||...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2345677899999875321 12345999999999999997 5678865443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=232.82 Aligned_cols=230 Identities=24% Similarity=0.363 Sum_probs=189.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc----ceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~----~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
...+...+.+.||.|-||.||.+....- .-.||||..+.. ....+.+..|..+++.+.||||++++|++.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3444556678999999999999987532 346889988763 3446789999999999999999999999865 46
Q ss_pred EEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.|+|||.++.|.|+.++..+. .++...+..+++||..|+.|||+.+++||||-.+||+|..... +||+|||+++...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~e 542 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLE 542 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhcc
Confidence 899999999999999997664 5889999999999999999999999999999999999998887 9999999987654
Q ss_pred ccCCCCC--ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 173 LHSQPKS--TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 173 ~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
...-... ..-...|+|||.+.-..+++. +|+|-||++||++++ |..||....+ ++..+-.+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred ccchhhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 4333222 224557999999877777666 999999999999997 9999976432 55667788
Q ss_pred HHhhcCccccCC-Ccccccc
Q 025369 235 QVFIKPCCHITP-FYPLFKL 253 (254)
Q Consensus 235 ~~~~~~~~~~~p-~~~~~~~ 253 (254)
..++..||..+| -.|.|.+
T Consensus 622 YslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred HHHHHHHhccCcccCCcHHH
Confidence 899999999999 5555543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=226.75 Aligned_cols=215 Identities=33% Similarity=0.568 Sum_probs=181.6
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhH----HHHHHHHhhcC-CCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSL-RHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~----~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (254)
+....+|..+.+||.|+||.|.++..+.+.+.||||++++.-...++ -..|-++|.-. +-|.++.++..|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 55567899999999999999999999999999999998765322211 12233444333 45778888888888889
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+|+||||+.||+|-..+++-+.+.+.....++.+|+-+|-+||++||++|||+.+||+++.+++ +||.|||.+.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999998888 99999998865443
Q ss_pred c-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHH
Q 025369 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQV 236 (254)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 236 (254)
. ......+|++.|+|||.+...++.-. .|+||+|+++|+|+.|++||...++++.++.++..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 3 34456689999999999987777555 99999999999999999999999998888876543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=240.50 Aligned_cols=147 Identities=30% Similarity=0.454 Sum_probs=133.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++.+.||.|+||.||++.+..+++.||+|++..... ....+.+|+..++.++|++|+++++.+...+.+++
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999998865322 23567788999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
||||+.+++|.+++.....+++..++.++.||+.||+|||+.||+|+||+|+|||++.++. ++|+|||++.
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999999999999988778999999999999999999999999999999999999987776 9999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=232.29 Aligned_cols=219 Identities=32% Similarity=0.488 Sum_probs=181.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...+.|.+...+|.|+|+.+-...+..++..+++|++.... ....+|+ ..+..-+|||+++..+++.++.+.|+||
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 45789999999999999999999999999999999987652 2233455 3445558999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-CCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|.+.|+.+.+.+...+.+. .++..|+++|+.|++|||++|++|||++|.|||++ +.++ ++|+|||.++..... .
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--C 470 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--h
Confidence 9999988888887766655 77788999999999999999999999999999994 6665 999999988755444 3
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------hhhHHHHHHhhcCcccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------KDFRKTIQVFIKPCCHI 244 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------~~~~~~~~~~~~~~~~~ 244 (254)
...+.+..|.|||++....++.. +|+||||+++|+|++|..||...... +.+...-+.+++.+++.
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~ 549 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQV 549 (612)
T ss_pred cccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccC
Confidence 44567789999999986666555 99999999999999999999887766 33344567778888888
Q ss_pred CCC
Q 025369 245 TPF 247 (254)
Q Consensus 245 ~p~ 247 (254)
+|.
T Consensus 550 dP~ 552 (612)
T KOG0603|consen 550 DPA 552 (612)
T ss_pred Chh
Confidence 873
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=242.34 Aligned_cols=227 Identities=24% Similarity=0.395 Sum_probs=192.6
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccc---eeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
..-.+.+..+|.++||.|.||.|+.++.+..+ ..||||.++.. .+...++..|+.++-+..||||+.+.++....
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 33456788999999999999999999987654 48999998765 34456788999999999999999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.-.++|+||++.|+|..|+..+ ++++.-++.-+.+.|+.++.||-+.|++||||..+||||+.+-. +|++|||+++.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceee
Confidence 9999999999999999999766 67999999999999999999999999999999999999987766 99999999985
Q ss_pred ccccCCCCC-c---cCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChhhH--------------
Q 025369 171 SVLHSQPKS-T---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR-------------- 231 (254)
Q Consensus 171 ~~~~~~~~~-~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~-------------- 231 (254)
......... . --..+|.|||.+.-..+++. +|+||+|++|||.++ |..||.+..+.+-+.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence 544432111 1 12468999999988888777 999999999999997 999999877655444
Q ss_pred -HHHHHhhcCccccCC
Q 025369 232 -KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 -~~~~~~~~~~~~~~p 246 (254)
..+.+++.-||+.+-
T Consensus 860 P~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDR 875 (996)
T ss_pred cHHHHHHHHHHHHHHh
Confidence 457888888888764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=230.57 Aligned_cols=202 Identities=35% Similarity=0.543 Sum_probs=174.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
-+-|...+.||-|+||.|.+++...+...||.|.+.+.+- .....+.|-.+|.....+.+|+++-.|.+..++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457888999999999999999999999999998866432 234567788899999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+|++||++-+++...+-|.+...+.++.++..|+++.|+.|++||||||+|||||.+|+ +||.|||++.......+.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999999998 999999997422211000
Q ss_pred C-------------------------------------------CccCCCCccCccccccccCCCCcccHHHHHHHHHHH
Q 025369 178 K-------------------------------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 214 (254)
Q Consensus 178 ~-------------------------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 214 (254)
. ...|+..|+|||++....+..- .|+||.|+++++|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 0 1136778999999988888666 9999999999999
Q ss_pred HhCCCCCCCCCC
Q 025369 215 LVGGYPFEDPDE 226 (254)
Q Consensus 215 ~~g~~pf~~~~~ 226 (254)
+.|++||...+.
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999977553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=201.14 Aligned_cols=212 Identities=26% Similarity=0.370 Sum_probs=170.9
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
+-...++..-+..||+|++|.|-+.++..+|...|+|.+... .....+...|+.+..+. ..|.++.+++....++..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344556667778999999999999999999999999988653 22334555666665443 689999999999999999
Q ss_pred EEEEEccCccchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 95 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++.||.++. ||..+- ...+.+++..+-+++..++.|+.+||++ .++|||+||+|||++.++. +|+||||.+.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccce
Confidence 999999854 665443 4557799999999999999999999976 8999999999999999888 9999999887
Q ss_pred cccccCCCCCccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
....+.......|-.-|+|||.+.. ..++.+ +|+||||+++.||.+++.||.+...+-+..+.
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 6555444444567778999999753 244455 99999999999999999999988776544333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=222.32 Aligned_cols=215 Identities=27% Similarity=0.412 Sum_probs=180.5
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----eEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 95 (254)
+.+=-+.||.|+||+||.+.+..+|+.+++|++.+- -....++.+|+.+|+..+|.|++...++..... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 444567899999999999999999999999987542 233467889999999999999999988876543 457
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+++|.+.. +|..++-+.+.++..-++-+.+||+.+|.|||+.+|.||||||.|.+++.+.. +|++|||+++......
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 88888754 78888888888999999999999999999999999999999999999987776 9999999987544433
Q ss_pred CC--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 176 QP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
.. .....+.+|+|||.+.+...++.+.||||.||++.|++.++..|+....-+++.-+..-+.++.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 22 2335677999999999998888889999999999999999999999888777777776666654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=218.86 Aligned_cols=228 Identities=26% Similarity=0.356 Sum_probs=182.0
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC--CCCCeeeeeEEEEcC--
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL--RHPNIVRFKEVILTP-- 91 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~-- 91 (254)
...+......++.+.||+|.||.||++.+. |+.||||+|... ...+..+|.++.... +|+||+.+++.=..+
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 345566778999999999999999999997 889999988654 446777888887654 999999998764322
Q ss_pred --CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----c---CeeecCCCCCcEEecCCCCCceE
Q 025369 92 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-----M---QVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 92 --~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-----~---~i~h~di~p~nili~~~~~~~~~ 161 (254)
..+|+|++|.+.|||.+++.. ..++.+...+++..++.+|++||. + .|.|||||..||+|.+++. +-
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~ 356 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CC 356 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EE
Confidence 378999999999999999988 468999999999999999999993 2 3999999999999998888 99
Q ss_pred EecccccccccccC-----CCCCccCCCCccCccccccccC-----CCCcccHHHHHHHHHHHHh----CC------CCC
Q 025369 162 ICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLV----GG------YPF 221 (254)
Q Consensus 162 l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~----g~------~pf 221 (254)
+.|+|+|.+..... ..+..+|+.+|||||++..... +.+.+||||||.++||+.. |. +||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997665543 2345579999999999865432 2445899999999999864 22 677
Q ss_pred CCCC--------------------------CChhhHHHHHHhhcCccccCCCccc
Q 025369 222 EDPD--------------------------EPKDFRKTIQVFIKPCCHITPFYPL 250 (254)
Q Consensus 222 ~~~~--------------------------~~~~~~~~~~~~~~~~~~~~p~~~~ 250 (254)
.+.- ......+.+.++++.||..+|-.++
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 5411 1223344688999999999996554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=220.67 Aligned_cols=207 Identities=31% Similarity=0.447 Sum_probs=177.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC--CC----eeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PN----IVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h--~~----i~~~~~~~~~~~~ 93 (254)
...++|++++.+|+|.||.|....+..++..+|||++..-.+..+...-|++.+.++.+ |+ ++.+.++|...++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 44789999999999999999999999999999999998877788888889999999942 33 6777777888999
Q ss_pred EEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC---------------
Q 025369 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--------------- 156 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~--------------- 156 (254)
.++|+|.+ |.|+.+++.++ .+++-..+..+++|+++++.+||+.+++|.||||+||++.++.
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 99999988 66999999765 4689999999999999999999999999999999999984211
Q ss_pred ---CCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh
Q 025369 157 ---APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (254)
Q Consensus 157 ---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 230 (254)
...++++|||.|.... ........+..|+|||++.+.+++.+ .|+||+||++.|+++|...|+..++.+.+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred cCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1248999999876332 22245568889999999999999999 99999999999999999999988866655
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=229.79 Aligned_cols=231 Identities=23% Similarity=0.351 Sum_probs=199.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.+..+.....+||.|-||.||.+.++.-.-.||||.++.+.-..+++.+|+.+++.++|||+|+++++|..+--+|+|+|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34456677889999999999999999999999999998877778999999999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|+..|+|.+++.+. ..++.-.+++++.||..|++||..++++||||-.+|.||.++.. +|+.|||+++.+......
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCcee
Confidence 99999999999765 34777888999999999999999999999999999999987776 999999998765443332
Q ss_pred CCc--cCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCC---------------CCChhhHHHHHHhhc
Q 025369 178 KST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP---------------DEPKDFRKTIQVFIK 239 (254)
Q Consensus 178 ~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~---------------~~~~~~~~~~~~~~~ 239 (254)
... --...|.|||.+..+.+..+ +|+|+||+++|++.+ |..||..- +.++.......+++.
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 221 12457999999999999888 999999999999998 88999763 356777778999999
Q ss_pred CccccCC-Ccccccc
Q 025369 240 PCCHITP-FYPLFKL 253 (254)
Q Consensus 240 ~~~~~~p-~~~~~~~ 253 (254)
.||+=.| ..|.|.+
T Consensus 501 aCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAE 515 (1157)
T ss_pred HHhcCCcccCccHHH
Confidence 9999888 6666654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=227.37 Aligned_cols=227 Identities=26% Similarity=0.410 Sum_probs=190.4
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
...-++.++..++++||+|.||.|-...... +..||+|....... ...++.+|+..|.+|+||||+.++++|..+..
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3445677899999999999999999888763 68999999877543 24679999999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+.+++||++.|+|.+++..+ +.........++.||+.+++||.+.+++|||+.++|+|++.+.+ +|++|||.++..
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~l 687 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNL 687 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCccccccc
Confidence 99999999999999999877 33456667789999999999999999999999999999988887 999999988755
Q ss_pred cccCCCC---CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh--CCCCCCCCCC--------------------
Q 025369 172 VLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDE-------------------- 226 (254)
Q Consensus 172 ~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~-------------------- 226 (254)
..+.... ...-..+|+|+|.+..+.++++ +|+|++|+++||+++ ...||.+...
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 4433321 2235579999999999999888 999999999999864 8899977554
Q ss_pred --ChhhHHHHHHhhcCccccCC
Q 025369 227 --PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 --~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+.+++.+||..+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es 788 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRES 788 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhh
Confidence 33445567788889998765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=229.43 Aligned_cols=226 Identities=29% Similarity=0.523 Sum_probs=193.5
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEc-----
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----- 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----- 90 (254)
..+...+.|++.+.+|.|.+|.||++++..++...|+|+........+++..|.++++.. .|||++.+++++.-
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 456667899999999999999999999999999999999988888889999999999888 68999999999863
Q ss_pred CCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
++.+|+|||||.+||..+++.+. ..+.+..+..|++.++.++.+||...++|+||+-.|||++.++. +||+|||++
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvS 170 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVS 170 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeee
Confidence 46899999999999999999765 46889999999999999999999999999999999999988877 999999987
Q ss_pred ccccc-cCCCCCccCCCCccCcccccccc-----CCCCcccHHHHHHHHHHHHhCCCCCCC-----------------CC
Q 025369 169 KSSVL-HSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFED-----------------PD 225 (254)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~-----------------~~ 225 (254)
..... ........|++.|||||++...+ ++.. +|+||||++.++|-.|.+|+-+ ..
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 54333 34445667999999999986543 3344 8999999999999999999855 22
Q ss_pred CChhhHHHHHHhhcCccccC
Q 025369 226 EPKDFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~ 245 (254)
.++.+.+.+..++..|+..+
T Consensus 250 rp~kWs~~FndFIs~cL~Kd 269 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKD 269 (953)
T ss_pred chhhHHHHHHHHHHHHHhhc
Confidence 36677778888888887655
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-30 Score=203.35 Aligned_cols=196 Identities=42% Similarity=0.700 Sum_probs=170.3
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
|.+.+.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+..+++++|++++++++.+......++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999998889999999876543 45678889999999999999999999998889999999999
Q ss_pred ccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC--CCCC
Q 025369 103 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 179 (254)
Q Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--~~~~ 179 (254)
+++|.+++..... ++...++.++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9899999987766 899999999999999999999999999999999999987765 9999999876554432 2234
Q ss_pred ccCCCCccCcccc-ccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 180 TVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 180 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
..+...|++||.+ ....... ++|+|+||+++++|++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 4567789999998 4444444 59999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=246.51 Aligned_cols=186 Identities=23% Similarity=0.313 Sum_probs=154.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
.+...+.||+|+||.||++.+..++..||+|.+..... ...+|+..+++++||||+++++++.++...++||||+++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999988999999998764332 223468888999999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCc
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 180 (254)
++|.+++.. +++..+..++.+++.|++||| +.+++||||+|+||+++.+...++. ++...... .....
T Consensus 768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~---~~~~~~~~---~~~~~ 838 (968)
T PLN00113 768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC---TDTKC 838 (968)
T ss_pred CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE---eccccccc---cCCCc
Confidence 999999853 788999999999999999999 6699999999999999877763333 44322111 11223
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
.++..|+|||++.+..++.+ +||||+|+++|||++|+.||.
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCC
Confidence 56789999999887776665 999999999999999999984
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=228.42 Aligned_cols=233 Identities=26% Similarity=0.428 Sum_probs=195.0
Q ss_pred CCCCCCCCcccCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeee
Q 025369 10 VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 10 ~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~ 84 (254)
.+|..+.--.+..++.++.+.||+|+||+|+++.+... --.||||.+..... .-+++.+|+..+.+|+|+|++++
T Consensus 97 ~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 97 ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEE
Confidence 45556666666778999999999999999999998753 23678998766433 45789999999999999999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
+++..+ .-..+|+|.++.|+|.+.+.. ...+-...++.++.||+.++.||..+++|||||-.+|+++..... +|+
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI 253 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKI 253 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eee
Confidence 999987 677899999999999999976 345888999999999999999999999999999999999987655 999
Q ss_pred ecccccccccccCCCC----CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC------------
Q 025369 163 CDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD------------ 225 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~------------ 225 (254)
+|||+.+......+.. ...-...|.|||.+.-..++.. +|+|++|+++|||++ |..||.+..
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE 332 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence 9999987655444332 1223457999999998888777 999999999999998 889997643
Q ss_pred ---CChhhHHHHHHhhcCccccCC
Q 025369 226 ---EPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ---~~~~~~~~~~~~~~~~~~~~p 246 (254)
.++...+.+..+++.||.-.|
T Consensus 333 rLpRPk~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCc
Confidence 456667789999999999887
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=206.39 Aligned_cols=209 Identities=42% Similarity=0.663 Sum_probs=177.8
Q ss_pred cceEEEEEEEcccceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHHh
Q 025369 35 NFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112 (254)
Q Consensus 35 ~~g~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~ 112 (254)
++|.||++.+..++..+++|.+...... .+.+.+|+..+++++|++++++.+.+......+++++++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999988999999988765332 47888999999999999999999999999999999999998899999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCcccc
Q 025369 113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (254)
Q Consensus 113 ~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 192 (254)
...++...++.++.+++.++.+||+.+++|+||+|.||++++++. ++++|||.+.............+...|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 766899999999999999999999999999999999999988766 999999988765554444556678889999998
Q ss_pred ccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHHHHHhhcCccccCC
Q 025369 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 193 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~~~~~p 246 (254)
.+...+.+ +|+||+|++++++++|..||........ ....+..++..|+..+|
T Consensus 159 ~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 159 LGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred ccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 86666664 9999999999999999999976322221 44567778888888777
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=210.80 Aligned_cols=204 Identities=30% Similarity=0.526 Sum_probs=177.5
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEc
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (254)
.-.....++|.++++||+|+|.+|..++.+.+.+.||+|++++. +...+..+.|-.+.... +||.++-+...|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34455678999999999999999999999999999999987653 34445566666555444 78999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++.+|+|.||.+||+|--.+....+++++-.+.+...|..||.|||++||+++|+|..||+++..++ +||.|+|.++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhc
Confidence 9999999999999999877888888999999999999999999999999999999999999998888 99999998764
Q ss_pred c-cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 171 S-VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
. ..+......++++.|.|||.+++..+.-. .|+|+||++|++|+.|+.||.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcc
Confidence 3 33445566789999999999998888666 999999999999999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=211.01 Aligned_cols=219 Identities=26% Similarity=0.392 Sum_probs=190.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC---
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--- 91 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 91 (254)
......||..++.+|.|.. .|..|-+...++.+++|+..... ....+..+|...++.++|+|+++++.++.-.
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 4455679999999999998 78889999999999999876532 2336678899999999999999999998754
Q ss_pred ---CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 92 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 92 ---~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
...|+|||++.. +|...+.. .++=..+..+.+|++.++.+||+.||+||||+|+||++..+.. +|+.|||++
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhh
Confidence 367999999955 88877763 4677889999999999999999999999999999999988887 999999999
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccc
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (254)
...........+..+..|+|||++.+.++.+. .||||+||++.+|+.|+..|.+.+.-+++.++...+..++..
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 87666656667788999999999999997777 999999999999999999999999999999999988887643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=217.55 Aligned_cols=190 Identities=27% Similarity=0.345 Sum_probs=157.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhh--cCCCCCeeeeeEEEEcCC----eEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HLA 95 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~~----~~~ 95 (254)
....++.+++|+|.||.||+|+.. ++.||||++...+. +++..|-++.+ .++|+||+.+++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456778999999999999999886 58999999866433 55666655554 558999999998876554 899
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------cCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------MQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~---------~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
+|++|.+.|+|.+++..+ .++.....+++..++++|+|||+ ..|+|||||.+||||..|.. ..|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccc
Confidence 999999999999999876 47999999999999999999995 35999999999999998988 9999999
Q ss_pred ccccccccCCC---CCccCCCCccCccccccccCCC-----CcccHHHHHHHHHHHHhCC
Q 025369 167 YSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG-----KIADVWSCGVTLYVMLVGG 218 (254)
Q Consensus 167 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~ 218 (254)
+|-+....... ....|+.+|||||++.+...-. ++.||||+|.++|||+++-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 99766544332 3356899999999987654333 3479999999999999854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=213.81 Aligned_cols=211 Identities=29% Similarity=0.435 Sum_probs=172.1
Q ss_pred CCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhh-cCCCCCeeeeeEEE
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHR-SLRHPNIVRFKEVI 88 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~-~l~h~~i~~~~~~~ 88 (254)
|.-+....+..++.+-+..||.|.||+|+++.++.+|+..|||.+.... ....++..|..... .-+.|+||++++..
T Consensus 53 p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 53 PDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred CCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 3344555667778888999999999999999999999999999987643 34455666666554 44789999999999
Q ss_pred EcCCeEEEEEEccCccchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEE
Q 025369 89 LTPTHLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l 162 (254)
..++..|+.||.++- |+..+- -....++++.+-.+.-..+.||.||-+. +|+|||+||+|||++..|. +||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKL 209 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--Eee
Confidence 999999999999854 554332 1334689999999999999999999754 8999999999999998888 999
Q ss_pred ecccccccccccCCCCCccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
||||.+.....+.......|-.-|+|||.+.... ++.+ +|+||||++++|+.+|..||...+.
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH
Confidence 9999887666555556667888999999986443 4455 9999999999999999999987654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=236.01 Aligned_cols=191 Identities=32% Similarity=0.480 Sum_probs=154.6
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc----------
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 90 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 90 (254)
++|+.++.||+||||.||+++++-+|+.||||++... ......+.+|+..+.+|+|||+++++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678899999999999999999999999999998765 4455778899999999999999987333210
Q ss_pred --------------------------------------------------------------------------------
Q 025369 91 -------------------------------------------------------------------------------- 90 (254)
Q Consensus 91 -------------------------------------------------------------------------------- 90 (254)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeEEEEEEccCccchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCe
Q 025369 91 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQV 140 (254)
Q Consensus 91 ---------------------~--------~~~~lv~~~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~LH~~~i 140 (254)
+ ..+|+.|+||+..++.+++..+... .....|+++++|++|+.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1257888999887777777665443 578899999999999999999999
Q ss_pred eecCCCCCcEEecCCCCCceEEeccccccccc----c---------------cCCCCCccCCCCccCcccccccc--CCC
Q 025369 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----L---------------HSQPKSTVGTPAYIAPEVLLRHE--YDG 199 (254)
Q Consensus 141 ~h~di~p~nili~~~~~~~~~l~df~~~~~~~----~---------------~~~~~~~~~~~~~~aPE~~~~~~--~~~ 199 (254)
+||||||.|||+++++. +||+|||++.... . ........|+.-|.|||.+.+.. .+.
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999997777 9999999986511 0 00112335777899999997766 455
Q ss_pred CcccHHHHHHHHHHHH
Q 025369 200 KIADVWSCGVTLYVML 215 (254)
Q Consensus 200 ~~~Di~slG~~l~~l~ 215 (254)
.+.||||||++++||+
T Consensus 797 ~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML 812 (1351)
T ss_pred chhhhHHHHHHHHHHh
Confidence 5599999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=229.35 Aligned_cols=233 Identities=25% Similarity=0.437 Sum_probs=190.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 86 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (254)
.+....++.++.+.||+|.||.|+++.-.. ....||+|....... ..+.+..|+.+++.+ .|+|++.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 555666677888899999999999998541 256789998775433 346788999999988 5999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
.+...+..++|.||+..|+|.+++...+ .++..+++.+++||+.+++||++.+++||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999899999999999999999998766 388999999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccCCCC--Ccc--CCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCC-
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHSQPK--STV--GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP- 224 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~- 224 (254)
++..+.. +|++|||+++......... ... -...|+|||.+....++.+ +|+||+|+++||+++ |..||..-
T Consensus 450 Li~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9988866 9999999997433322221 111 3557999999999777666 999999999999999 88999862
Q ss_pred ---------------CCChhhHHHHHHhhcCccccCC-Cccccc
Q 025369 225 ---------------DEPKDFRKTIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 225 ---------------~~~~~~~~~~~~~~~~~~~~~p-~~~~~~ 252 (254)
..|......+..+++.||+.+| ..|-|.
T Consensus 527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 2344555577899999999888 455443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=218.94 Aligned_cols=206 Identities=27% Similarity=0.392 Sum_probs=178.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC------CCeeeeeEEEEcCCeEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~l 96 (254)
++|.+....|+|-||+|..|.+..-+..||||++.+.......=+.|+++|++|+. -|++.++..|.+.+++++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 47888889999999999999999999999999998776666666789999999953 478999999999999999
Q ss_pred EEEccCccchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 97 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
|+|-+ ..+|.+.+...+. +....+..+++|++.||..|-..|++|.||+|.||||++..+ .+||||||.|... .
T Consensus 512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~-~ 588 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFA-S 588 (752)
T ss_pred Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccc-c
Confidence 99988 4589999977654 778889999999999999999999999999999999997766 5999999987543 2
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
..+...+..+..|.|||.+.+.++..+ .|+||.||++|++.+|+..|++.+.-.++.-
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 333345567889999999999999999 9999999999999999999999888555443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=214.26 Aligned_cols=211 Identities=30% Similarity=0.422 Sum_probs=172.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch--------hHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
+.-+++|-++..||.|||+.||+|-+-...+.||+|+-.....+. ...-+|..+.+.|.||.||++++++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345789999999999999999999999999999999865543333 233468888999999999999999875
Q ss_pred -CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CeeecCCCCCcEEecC-CCCCceEEeccc
Q 025369 91 -PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDG-SPAPRLKICDFG 166 (254)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~h~di~p~nili~~-~~~~~~~l~df~ 166 (254)
...++-|.|||+|.+|.-++..+.-+++.+.+.|+.||++||.||.+. .|+|-||+|.|||+-+ ...+.+|+.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 567889999999999999999999999999999999999999999976 5999999999998753 334579999999
Q ss_pred ccccccccCCC--------CCccCCCCccCcccccccc---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh
Q 025369 167 YSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (254)
Q Consensus 167 ~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 229 (254)
++..+...... ....|+.+|++||.+.-.. -.+.+.|+||.|+++|+++.|+.||...-....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 98765443222 2235778899999875442 224458999999999999999999987554433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=199.57 Aligned_cols=214 Identities=27% Similarity=0.445 Sum_probs=172.2
Q ss_pred CCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEE-
Q 025369 10 VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV- 87 (254)
Q Consensus 10 ~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~- 87 (254)
.=|..++......+.|.|.++||+|.||.+-++++..++..+++|.+........++.+|...--.| .|.||+.-+++
T Consensus 11 ~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 11 LIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred ccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 3455566677778999999999999999999999999999999999988777788899998877777 47999987766
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
|...+.+++++||++.|+|.+-+...+ +.+.....++.|++.||++||+++++|||||.+||||-+.+.-++||+|||.
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 445578899999999999988776543 6788889999999999999999999999999999999655555899999998
Q ss_pred cccccccCCCCCccCCCCccCccccccccC----CCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
+.... ......-....|.+||....... ..+.+|+|.||++++.+++|..||+....
T Consensus 170 t~k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 170 TRKVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred ccccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 75332 11112223456888887643321 23348999999999999999999986444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=224.29 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=190.9
Q ss_pred ccCCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCC--ccchhHHHHHHHHhhcCCCC
Q 025369 6 ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHRSLRHP 79 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~ 79 (254)
+++...+.............+..++||+|+||+||++.+-..++ .|++|.+... .....++.+|+-.+.++.||
T Consensus 679 apS~~~~n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHp 758 (1177)
T KOG1025|consen 679 APSGFAANLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHP 758 (1177)
T ss_pred ccccccchhhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCc
Confidence 34444444444455555667778899999999999999865544 6778876554 33467889999999999999
Q ss_pred CeeeeeEEEEcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
|++++++++.... ..+|++|+++|+|.+++..+ .++.....+.|.+||++++.|||+++++||||-.+||||.....
T Consensus 759 nl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h- 836 (1177)
T KOG1025|consen 759 NLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH- 836 (1177)
T ss_pred hHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe-
Confidence 9999999997765 78899999999999999765 56999999999999999999999999999999999999998887
Q ss_pred ceEEecccccccccccCCCCCc---cCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
+|+.|||++.........-.. ...+.|+|-|.+....+... +|+||+|+++||++| |..||.....
T Consensus 837 -vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 837 -VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred -EEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 999999998765544333222 24567999999888888666 999999999999998 9999977543
Q ss_pred -------ChhhHHHHHHhhcCccccCC-Cccccc
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p-~~~~~~ 252 (254)
+......+--++-.||-.|+ -.|.|+
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHH
Confidence 33333355566667787776 334443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=217.91 Aligned_cols=201 Identities=18% Similarity=0.208 Sum_probs=141.4
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEccc----ceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEE-----
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV----- 87 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~----~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~----- 87 (254)
......++|++.+.||+|+||.||++.+..+ +..+++|.+...... +....+ .++...+.++..+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3445678999999999999999999999988 899999986543221 111111 1122122222211111
Q ss_pred -EEcCCeEEEEEEccCccchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCeeecCCC
Q 025369 88 -ILTPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (254)
Q Consensus 88 -~~~~~~~~lv~~~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~ 146 (254)
...+..+++|++|+.+++|.+++..... .....+..++.|++.+|+|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2345678999999999999988864321 1233466799999999999999999999999
Q ss_pred CCcEEecCC-CCCceEEeccccccccccc--CCCCCccCCCCccCccccccccCC---------------------CCcc
Q 025369 147 LENTLLDGS-PAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYD---------------------GKIA 202 (254)
Q Consensus 147 p~nili~~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~ 202 (254)
|+||+++++ +. ++|+|||++...... .......+++.|+|||.+...... +.++
T Consensus 283 P~NILl~~~~~~--~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCCCCc--EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999853 44 999999998644322 222345678899999976432211 2236
Q ss_pred cHHHHHHHHHHHHhCCCCCC
Q 025369 203 DVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 203 Di~slG~~l~~l~~g~~pf~ 222 (254)
||||+||++|+|+++..++.
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999998766543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=209.38 Aligned_cols=203 Identities=21% Similarity=0.272 Sum_probs=148.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEc----------------ccceeEEEEEccCCccc---------------hhHH
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK----------------VTKELVAVKYIERGDKI---------------DENV 66 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~----------------~~~~~~~lK~~~~~~~~---------------~~~~ 66 (254)
.++..++|++.++||+|+||+||++... ..++.|+||.+...... .+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3567999999999999999999998652 23467999987543211 1122
Q ss_pred HHHHHHhhcCCCCCe-----eeeeEEEEc--------CCeEEEEEEccCccchHHHHHhcC-------------------
Q 025369 67 QREIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG------------------- 114 (254)
Q Consensus 67 ~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~~~~~~~~L~~~l~~~~------------------- 114 (254)
..|+..+.+++|.++ +++++++.. .+..++|+||+++++|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 335566666766543 556666543 356799999999999988885321
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC--ccCCCCcc
Q 025369 115 -----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYI 187 (254)
Q Consensus 115 -----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~ 187 (254)
.++...++.++.|++.++.|||+.+++|+||+|+||+++.++. ++|+|||++........... ...++.|+
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCccee
Confidence 2355678889999999999999999999999999999988776 99999998864433222221 23467899
Q ss_pred CccccccccC---------------------CCCcccHHHHHHHHHHHHhCCC-CCC
Q 025369 188 APEVLLRHEY---------------------DGKIADVWSCGVTLYVMLVGGY-PFE 222 (254)
Q Consensus 188 aPE~~~~~~~---------------------~~~~~Di~slG~~l~~l~~g~~-pf~ 222 (254)
+||.+..... .....|+||+|+++++|++|.. ||.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9998754321 1123699999999999999875 664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=184.50 Aligned_cols=197 Identities=42% Similarity=0.662 Sum_probs=165.2
Q ss_pred ccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHH
Q 025369 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 108 (254)
Q Consensus 31 l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~ 108 (254)
||+|.+|.+|++....+++.+++|.+..... ..+.+.+|+..++.++|++++++.+++......+++++++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999988899999998876544 24678899999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccccC-CCCCccCCCC
Q 025369 109 RICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 185 (254)
Q Consensus 109 ~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 185 (254)
++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98776 56899999999999999999999999999999999999987 555 9999999876443322 1233457778
Q ss_pred ccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccccCC
Q 025369 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 186 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~p 246 (254)
|.+||............|+|++|++++++ ..+.+++..|+..+|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------PELKDLIRKMLQKDP 202 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-----------------HHHHHHHHHHhhCCc
Confidence 99999987763334449999999999999 556666666666665
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=197.12 Aligned_cols=133 Identities=26% Similarity=0.406 Sum_probs=117.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-----C---CCeeeeeEEEEcC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILTP 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~~ 91 (254)
+..++|.+.++||=|.|++||++++..+++.||+|+++...-..+....||.+|++++ | .+||++++.|...
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 3448999999999999999999999999999999999888778888899999998873 2 5699999999863
Q ss_pred ----CeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEec
Q 025369 92 ----THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLD 153 (254)
Q Consensus 92 ----~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~ 153 (254)
.++++|+|++ |.+|..++... +-++...+++|++|++.+|.|||.+ ||+|.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4889999999 66888888654 4589999999999999999999965 999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=211.84 Aligned_cols=226 Identities=31% Similarity=0.465 Sum_probs=187.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+...++|++.+.+|+|.+|.||++++..+++..++|.++.... ....+++|+.+++..+||||+.+++.+.....+|++
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 3668999999999999999999999999999999999887543 345678899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 176 (254)
||||.+|+|.+.-...+++++.++...++..+.++.|||++|-+|||||-.||++++.+. ++|.|||.+..... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999998888 99999998653322 233
Q ss_pred CCCccCCCCccCccccc--cccCCCCcccHHHHHHHHHHHHhCCCCCCC-------------------CCCChhhHHHHH
Q 025369 177 PKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFED-------------------PDEPKDFRKTIQ 235 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-------------------~~~~~~~~~~~~ 235 (254)
.....|+++|+|||+.. ....+...+|+|++|+...++-.-++|... ..+...+...+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 45667999999999852 223334449999999999998766655322 223445555666
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.|++.+.-.+|
T Consensus 249 ~fvK~altknp 259 (829)
T KOG0576|consen 249 NFVKGALTKNP 259 (829)
T ss_pred HHHHHHhcCCC
Confidence 66666665555
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=208.55 Aligned_cols=192 Identities=30% Similarity=0.370 Sum_probs=156.3
Q ss_pred eEeccccCCcce-EEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 26 DFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 26 ~~~~~l~~g~~g-~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
.-.+++|.|+.| .||++... ++.||||.+-.. ..+..++|+..|+.. .||||++++..-.+....|+..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 334678889887 67777665 789999976443 335678899999888 799999999998889999999999955
Q ss_pred cchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC---CCCCceEEecccccccccccCC
Q 025369 104 GELFERICNAG-R---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 104 ~~L~~~l~~~~-~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~---~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+|.+++.... . ......+....|++.++++||+.+|+||||+|+||||+. ++..+++|+|||+++....+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999998741 1 111445778999999999999999999999999999976 4555799999999987766555
Q ss_pred CC----CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 025369 177 PK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFED 223 (254)
Q Consensus 177 ~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 223 (254)
.- ...|+-+|+|||++.......+ .|||||||++|+.++ |..||.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCc
Confidence 43 3368889999999987776555 999999999999998 4799976
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=176.56 Aligned_cols=211 Identities=24% Similarity=0.291 Sum_probs=170.2
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC-CCeeeeeEEEEcCCeEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 96 (254)
...-.++|+++++||+|+||.+|.+..-.+|+.||+|.- .+..-...+..|..+.+.|++ .+|..+.-++.+..+-++
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~E-s~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLE-SSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEee-cccCCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 344578999999999999999999999999999999954 434444556678888888876 777777777778888899
Q ss_pred EEEccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC-ceEEeccccccccccc
Q 025369 97 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~-~~~l~df~~~~~~~~~ 174 (254)
||+.+ |.+|.++.. -+..++..+++-++-|++.-++|+|.++++|+||||+|.+..-+.+. ++.|+|||+++....-
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99988 668877774 34569999999999999999999999999999999999998543322 6999999999754432
Q ss_pred C--------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH
Q 025369 175 S--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (254)
Q Consensus 175 ~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 231 (254)
. ......|+..|.+-....+...+.. +|+-|+|+++.++--|..||++.......+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 2 2233457788888888877776666 999999999999999999999877644433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=191.49 Aligned_cols=214 Identities=27% Similarity=0.409 Sum_probs=175.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcc---cceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
.++...+.|.+.++||+|.|++||++.+.. .++.|++|.+.... ...++..|+++|..+ .+.|++++.+.+..++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 356678899999999999999999999987 78899999886542 446788999999999 5799999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
...+|+||++.....++... ++..++..+++.++.||.++|++||+||||||.|++.+.... +-.|+|||++....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYD 184 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHH
Confidence 99999999998888887765 578999999999999999999999999999999999986555 57999999975111
Q ss_pred ccC--------------C-C------------------------------CCccCCCCccCccccccccCCCCcccHHHH
Q 025369 173 LHS--------------Q-P------------------------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSC 207 (254)
Q Consensus 173 ~~~--------------~-~------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 207 (254)
... . . ....|+++|+|||++...+..+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 0 011378899999999888887777999999
Q ss_pred HHHHHHHHhCCCCCCCC-CCChhhHHHHH
Q 025369 208 GVTLYVMLVGGYPFEDP-DEPKDFRKTIQ 235 (254)
Q Consensus 208 G~~l~~l~~g~~pf~~~-~~~~~~~~~~~ 235 (254)
|+++..++++..||-.. ++-+.+.++..
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHH
Confidence 99999999999997544 34344444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=185.39 Aligned_cols=201 Identities=27% Similarity=0.287 Sum_probs=163.5
Q ss_pred ceeEeccccCCcceEEEEEEEcccc-eeEEEEEccCCccc-hhHHHHHHHHhhcCC----CCCeeeeeEEE-EcCCeEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 96 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~lK~~~~~~~~-~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 96 (254)
+|++.+.||+|+||.||.+.+..++ ..+|+|........ ...+..|..++..+. .+++..+++.+ ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 9999999999999999999998764 67888876554222 226777888888886 36899999998 46778899
Q ss_pred EEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-C--CceEEecccccc--
Q 025369 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 169 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~--~~~~l~df~~~~-- 169 (254)
||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||+|.|+.+.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99987 77999988544 4699999999999999999999999999999999999998654 1 359999999997
Q ss_pred cccccC--------C-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 170 SSVLHS--------Q-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 170 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
...... . .....|+..|.++....+...... +|+||+++++.++..|..||.....
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccc
Confidence 321111 1 112338889999999988888666 9999999999999999999977664
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=189.26 Aligned_cols=233 Identities=19% Similarity=0.252 Sum_probs=185.9
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
..+....|+++...+.+|.||.||.+.+.. +.+.+.+|.++... -....+..|..++..+.|||++.+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 345566789999999999999999996543 23355667665542 23356778888999999999999999987
Q ss_pred cC-CeEEEEEEccCccchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCce
Q 025369 90 TP-THLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (254)
Q Consensus 90 ~~-~~~~lv~~~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~ 160 (254)
+. ...++++++...++|..++.. .+.++..++..++.|++.|++|||+.|++|.||-.+|.++++.-. +
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--V 435 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--V 435 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--E
Confidence 65 456888999988999999971 134788889999999999999999999999999999999987755 9
Q ss_pred EEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC-----------
Q 025369 161 KICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD----------- 225 (254)
Q Consensus 161 ~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~----------- 225 (254)
||+|-.+++...+.... ........|++||.+....++.. +|+||||+++|||++ |+.||.+-+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99999888755443322 23345678999999998888777 999999999999998 999997655
Q ss_pred ----CChhhHHHHHHhhcCccccCC-Cccccc
Q 025369 226 ----EPKDFRKTIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 226 ----~~~~~~~~~~~~~~~~~~~~p-~~~~~~ 252 (254)
.+.+.+..+-..+..||...| ..|.|.
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence 355666778888999999888 455443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=173.17 Aligned_cols=208 Identities=24% Similarity=0.317 Sum_probs=172.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
--.|+++++||.|.||+++.+.+.-+++.||||. .+.......++.|....+.|. .++|...+-+...+-+-.+|+|.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3489999999999999999999999999999994 444445567788888888885 58998888877777777899998
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC---ceEEecccccccccc---
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVL--- 173 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~---~~~l~df~~~~~~~~--- 173 (254)
+ |.||.++..-. ..|+..+++.++.|++.-++++|++.+++|||||+|+||...++. .+.++|||+|+....
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 8 66898888654 469999999999999999999999999999999999999754432 489999999864433
Q ss_pred -----cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 174 -----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 174 -----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
..+..+..|+.+||+=.-..+...+.. .|+-|||-++++++-|..||+....+....+
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 233344468889999988888887777 9999999999999999999998776554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=181.48 Aligned_cols=163 Identities=17% Similarity=0.101 Sum_probs=124.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcc-cceeEEEEEccCC------ccchhHHHHHHHHhhcCCCCCeee-eeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~ 89 (254)
.+...++|++.+.||+|+||+||+|.+.. ++..+|+|..... ......+.+|+.++++++|+++++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 45567899999999999999999999876 6777899976432 112456889999999999999885 443
Q ss_pred cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCC-CCCcEEecCCCCCceEEeccccc
Q 025369 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di-~p~nili~~~~~~~~~l~df~~~ 168 (254)
.+..++||||++|++|.. .. +.. ...++.+++++|.+||++||+|||| ||+||+++.++. ++|+|||++
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA 159 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLA 159 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccc
Confidence 245799999999988863 21 111 1467889999999999999999999 999999987665 999999998
Q ss_pred ccccccCCCC---------CccCCCCccCccccc
Q 025369 169 KSSVLHSQPK---------STVGTPAYIAPEVLL 193 (254)
Q Consensus 169 ~~~~~~~~~~---------~~~~~~~~~aPE~~~ 193 (254)
.......... ...+.+.|.+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 7543322111 123556688888764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=161.64 Aligned_cols=171 Identities=15% Similarity=0.147 Sum_probs=128.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhH----------HHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
.-.++|++.+.+|.|++|.||.+.+ ++..+++|.+.......+. +.+|+..+.++.|+++..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4478999999999999999999766 4667999988654322222 578888999999999999988866
Q ss_pred cC--------CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 90 TP--------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 90 ~~--------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
.. +..+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|.|+++++++ ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EE
Confidence 43 34789999999999987632 333 2456999999999999999999999999998665 89
Q ss_pred EecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHH
Q 025369 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215 (254)
Q Consensus 162 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 215 (254)
|+|||........... ...+....+.. ++|+||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-----------d~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-----------DRIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-----------HHHHHHhHhcc-cccccceeEeehHHH
Confidence 9999976433111110 01223333443 489999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=157.69 Aligned_cols=137 Identities=20% Similarity=0.191 Sum_probs=107.6
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccc---------------------------hhHHHHHHHHhhcCCCCC
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 80 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 80 (254)
.+.||+|++|.||+|.+. +|+.||+|++...... ......|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999988654211 012234888999998777
Q ss_pred eeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeecCCCCCcEEecCCCCCc
Q 025369 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~i~h~di~p~nili~~~~~~~ 159 (254)
+.....+... ..++||||++++++.........++...+..++.|++.++.++ |+.|++||||+|+||++++ + .
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 6544433222 2389999999877765544456789999999999999999999 7999999999999999973 3 4
Q ss_pred eEEeccccccc
Q 025369 160 LKICDFGYSKS 170 (254)
Q Consensus 160 ~~l~df~~~~~ 170 (254)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=195.59 Aligned_cols=148 Identities=17% Similarity=0.191 Sum_probs=110.2
Q ss_pred hcCCC-CCeeeeeEEE-------EcCCeEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecC
Q 025369 74 RSLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144 (254)
Q Consensus 74 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~d 144 (254)
+.+.| +||+.+.+.+ .+...++.++|+. +++|.+++.. ...+++.+++.+++||+.||+|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 44455 4666666665 2234567778887 5599999965 34689999999999999999999999999999
Q ss_pred CCCCcEEecCCC-----------------CCceEEecccccccccccC-----------------CCCCccCCCCccCcc
Q 025369 145 LKLENTLLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPE 190 (254)
Q Consensus 145 i~p~nili~~~~-----------------~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE 190 (254)
|||+|||++..+ ...++++|||++....... ......+++.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999996422 2246777777764321100 001124567799999
Q ss_pred ccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 191 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
++.+..+..+ +|||||||++|+|++|..|+..
T Consensus 186 ~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 186 EDNGSSSNCA-SDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhccCCCCch-hhhhhHHHHHHHHhhCCCchhh
Confidence 9988777555 9999999999999999988754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-21 Score=159.27 Aligned_cols=198 Identities=41% Similarity=0.664 Sum_probs=166.8
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCC-CeeeeeEEEEcCCeEEEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~~ 99 (254)
|.+.+.||.|+++.||.+.+. ..+++|.+..... ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999998 6788888765432 356788899999999988 79999999977778899999
Q ss_pred ccCccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 100 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
++.++++.+++.... .++......++.+++.++.++|+.+++|+|++|+|++++..+. .+++.|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776664 7999999999999999999999999999999999999987662 38999999876433332
Q ss_pred ------CCCCccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 176 ------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 176 ------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
......++..|.+||.+.+. .......|+||+|++++++++|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 23556788999999999874 3445559999999999999999999777664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=153.25 Aligned_cols=139 Identities=18% Similarity=0.139 Sum_probs=109.5
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCccc---------------------------hhHHHHHHHHhhcCCCC
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP 79 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ 79 (254)
+.+.||+|++|.||+|.+. +|+.||+|.+...... .....+|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999988 8999999987654211 12235788889999898
Q ss_pred CeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCC
Q 025369 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~ 158 (254)
++.....+.... .++||||++|+++.........++......++.+++.++.++|+ .|++|+||+|.||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 876555544333 48999999887554433334567888999999999999999999 9999999999999998 444
Q ss_pred ceEEecccccccc
Q 025369 159 RLKICDFGYSKSS 171 (254)
Q Consensus 159 ~~~l~df~~~~~~ 171 (254)
++|+|||++...
T Consensus 156 -~~liDFG~a~~~ 167 (190)
T cd05145 156 -PYIIDVSQAVEL 167 (190)
T ss_pred -EEEEEcccceec
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=183.00 Aligned_cols=198 Identities=23% Similarity=0.296 Sum_probs=161.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHH-HHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.....+|.|.+.||+|+||.||.|.+.. ++.+|||+-.+...+.--+-.++ ..|+-.--+.|..+...+...+.-++|
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3457799999999999999999999986 99999998766554432222211 222211236777777777778888999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-----CCCCCceEEeccccccccc
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-----GSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-----~~~~~~~~l~df~~~~~~~ 172 (254)
++|.+.|+|.+++.....+++..++.++.|++..++.||..+||||||||+|.++. +.+...++|+|||.+..+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999999999888899999999999999999999999999999999999984 2334459999999987655
Q ss_pred ccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC
Q 025369 173 LHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218 (254)
Q Consensus 173 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 218 (254)
...+. ...+++-.+-++|...+..+++. .|.|.++.+++.|++|+
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK 900 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence 54443 34457778999999999999888 99999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=149.52 Aligned_cols=186 Identities=17% Similarity=0.158 Sum_probs=135.5
Q ss_pred eEeccccCCcceEEEEEEEcccceeEEEEEccCCccchh-----HHHHHHHHhhcCCC-CCeeeeeEEEEcCCeEEEEEE
Q 025369 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----NVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 26 ~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~-----~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.+...|++|+||+|+.+.. .+..++.+.+........ .+.+|+.+++++.| +++++++++ +..+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999997766 467777777766555433 57889999999954 788888885 34689999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCC-CCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di-~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
|+.|.+|...... ....++.+++.++.++|++|++|+|| +|.||+++.++. ++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHH
Confidence 9999888654321 12357789999999999999999999 799999987766 999999998643322210
Q ss_pred ---C----------CccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 178 ---K----------STVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 178 ---~----------~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
. .....+.+++|+...-.. .+-...+.++.|+.+|.++|++.++.+..+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 011455666666543222 221225788999999999999988765443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=147.65 Aligned_cols=128 Identities=25% Similarity=0.341 Sum_probs=101.9
Q ss_pred cchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccC
Q 025369 104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (254)
Q Consensus 104 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 182 (254)
|+|.+++.. ...+++.+++.++.|++.||.|||+.+ +|+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 578888876 456999999999999999999999998 999999988776 777 9987543221 2257
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------------hhhHH--HHHHhh
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------------KDFRK--TIQVFI 238 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------------~~~~~--~~~~~~ 238 (254)
++.|+|||++.+..+..+ +||||+|+++|+|++|..||...... ..+.. .+..++
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 789999999988777655 99999999999999999999654321 11222 477788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 146 ~~cl~~~p 153 (176)
T smart00750 146 RVCASRLP 153 (176)
T ss_pred HHHHhccc
Confidence 88888887
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=152.22 Aligned_cols=196 Identities=22% Similarity=0.221 Sum_probs=126.4
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCC----------CCeeeeeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH----------PNIVRFKEVIL 89 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~ 89 (254)
....++.||.|+++.||.+++..+++.+++|.+.... ...+.+++|......+.+ -.++...+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5677889999999999999999999999999875432 223455566555544322 22333333332
Q ss_pred c------------CC-----eEEEEEEccCccchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhcCeeecCC
Q 025369 90 T------------PT-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDL 145 (254)
Q Consensus 90 ~------------~~-----~~~lv~~~~~~~~L~~~l~---~~~~----~~~~~~~~~~~~i~~~l~~LH~~~i~h~di 145 (254)
. .+ +.+++|+...+ +|..++. .... ........+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 12 23677777744 7766653 2222 223334566789999999999999999999
Q ss_pred CCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccccc-------cCCCCcccHHHHHHHHHHHHhCC
Q 025369 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-------EYDGKIADVWSCGVTLYVMLVGG 218 (254)
Q Consensus 146 ~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~ 218 (254)
+|+|++++.+|. +.|+||+...+....... ......|.+||..... ...+.+.|.|+||+++|.|+|+.
T Consensus 172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999998887 999999865543322221 3334678999976432 12344589999999999999999
Q ss_pred CCCCCC
Q 025369 219 YPFEDP 224 (254)
Q Consensus 219 ~pf~~~ 224 (254)
.||...
T Consensus 248 lPf~~~ 253 (288)
T PF14531_consen 248 LPFGLS 253 (288)
T ss_dssp -STCCC
T ss_pred CCCCCC
Confidence 999753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=149.31 Aligned_cols=220 Identities=20% Similarity=0.369 Sum_probs=179.1
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccC---CccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..+.+...+..+|.+...|..|+++++.+ .++.|++.. ......++.+|.-.|+-..||||+++++.|..+-+..
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34556677788999999999999999844 456665543 3455677888999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 96 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
++..|++.++|...+.+... .+..+..+++.+++.++.|||+.. |----++...+++|++-+.++...|--++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--- 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--- 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---
Confidence 99999999999999976643 677889999999999999999874 44457899999999999877777774332
Q ss_pred cccCCCCCccCCCCccCccccccccCC--CCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKT 233 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~ 233 (254)
.+......++.|++||.+...+.+ ..++|+|||++++|++-+...||.+... +..+...
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 233445678899999999877654 3458999999999999999999987553 5566778
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+.++++-|-..||
T Consensus 418 m~klm~icmnedp 430 (448)
T KOG0195|consen 418 MNKLMNICMNEDP 430 (448)
T ss_pred HHHHHHHHhcCCC
Confidence 8999999988888
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=145.59 Aligned_cols=139 Identities=17% Similarity=0.091 Sum_probs=109.6
Q ss_pred ceeEeccccCCcceEEEEEE-EcccceeEEEEEccCCccc-------------------------hhHHHHHHHHhhcCC
Q 025369 24 RYDFVRDIGSGNFGVARLMR-DKVTKELVAVKYIERGDKI-------------------------DENVQREIINHRSLR 77 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~-~~~~~~~~~lK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 77 (254)
-|++.+.||+|++|.||+|. +..++..||+|.+...... .....+|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6678999999988643210 123467899998887
Q ss_pred CCC--eeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecCCCCCcEEecC
Q 025369 78 HPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDG 154 (254)
Q Consensus 78 h~~--i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~di~p~nili~~ 154 (254)
+.+ +.++++. +..++||||+++.++.................++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3344432 234899999999887665544555677778899999999999999999 99999999999998
Q ss_pred CCCCceEEecccccc
Q 025369 155 SPAPRLKICDFGYSK 169 (254)
Q Consensus 155 ~~~~~~~l~df~~~~ 169 (254)
++. ++|+|||.+.
T Consensus 184 ~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 DGK--VVIIDVSQSV 196 (237)
T ss_pred CCC--EEEEEChhhh
Confidence 444 9999999765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=138.09 Aligned_cols=134 Identities=19% Similarity=0.229 Sum_probs=104.2
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcC-----CCCCeeeeeEEEEcCC---e-EEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---H-LAI 96 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~l 96 (254)
-.+.||+|++|.||. +..++.. ++|+.... ....+.+.+|+..++.+ .||||+++++++..+. . +.+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6555554 68877653 22346789999999999 5799999999998763 3 337
Q ss_pred EEEc--cCccchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCeeecCCCCCcEEecCC--CCCceEEeccc
Q 025369 97 VMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFG 166 (254)
Q Consensus 97 v~~~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~i~h~di~p~nili~~~--~~~~~~l~df~ 166 (254)
|+|| ..+++|.+++... .+++. ..++.+++.++ +|||+.+|+|+||+|+||+++.. +...++|+|++
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 4468999999764 45555 35677888777 99999999999999999999753 33359999944
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-21 Score=168.74 Aligned_cols=202 Identities=34% Similarity=0.600 Sum_probs=160.5
Q ss_pred CCce-eEeccccCCcceEEEEEEEcccceeEEEEEcc----CCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 22 SDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----RGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 22 ~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~----~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..+| .-...+|.|.+|.++.+........+..|.+. .... ....+..|..+-+.+.|++++.......+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4556 56678899999988888776665555555443 1111 11224456666678899999887777766655
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
..-.|||+++ +|..++.....++..++.-++.|++.++.|+|+.|+.|+|++++|+++..++. ++++|||.+.....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRY 472 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeecc
Confidence 5555999999 99999988888999999999999999999999999999999999999998887 99999998765444
Q ss_pred cCCC-----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 174 HSQP-----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 174 ~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
..+. ....++.-|.|||.+.+..+.+...|+||.|+++..|.+|+.||.....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 3332 3346888899999999999999999999999999999999999965443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-21 Score=171.50 Aligned_cols=194 Identities=25% Similarity=0.400 Sum_probs=149.6
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHH--hhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.|...+.||++.|=+|.++++. .| .+++|++.+... ..+.+.+.++- .+.+++||.+++.-+-..+...|+|.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7899999999999999999887 33 488998866542 22333333322 455589999999888777777888988
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
|.. .+|.+.++-.+-+..-+.+.|+.|++.|+..+|+.||+|||||.+|||+..=. .+.|.||..-+......++..
T Consensus 102 yvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCcc
Confidence 884 49999998877788899999999999999999999999999999999997544 489999986544333333322
Q ss_pred c--------cCCCCccCcccccccc---------C-CCCcccHHHHHHHHHHHHh-CCCCCC
Q 025369 180 T--------VGTPAYIAPEVLLRHE---------Y-DGKIADVWSCGVTLYVMLV-GGYPFE 222 (254)
Q Consensus 180 ~--------~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 222 (254)
. .....|.|||++.... . -.++.||||+||+++|+++ |++||.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2 2344699999986532 1 2445899999999999998 788884
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-19 Score=136.79 Aligned_cols=133 Identities=22% Similarity=0.206 Sum_probs=110.1
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCcc---------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
+.||+|++|.||++.+ .+..+++|....... ......+|+..+..+.|+++.....++.+.+..+++|+
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6789999999999987 566788887543221 11346678899999999998887777777788899999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
|++|.+|.+++..... ....++.+++.++.++|+.|++|+|++|.||+++ ++. ++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999998865432 7889999999999999999999999999999998 443 89999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=157.20 Aligned_cols=186 Identities=30% Similarity=0.485 Sum_probs=153.4
Q ss_pred cccCCcceEEEEEEE---cccceeEEEEEccCCcc---chhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 30 DIGSGNFGVARLMRD---KVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~---~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.+|+|.+|.|+.++. ...+..++.|..++... .......|-.++...+ ||.++++...+..++..+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368899998887764 34577788887654321 1123344566666665 8999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccC
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 182 (254)
++.+...+.....+++.....+...++.+++.+|+.+++|+|+|++||+++.+|+ +++.|||+++...... ..++
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~---~~cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEK---IACG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhh---hccc
Confidence 9999888888888999999999999999999999999999999999999998888 9999999876443222 2288
Q ss_pred CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
+..|+|||.+. ..... .|.||+|.++++|++|..||..
T Consensus 156 t~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch
Confidence 99999999987 33344 8999999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=141.31 Aligned_cols=145 Identities=31% Similarity=0.464 Sum_probs=111.0
Q ss_pred CCCCeeeeeEEEEc---------------------------CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHH
Q 025369 77 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129 (254)
Q Consensus 77 ~h~~i~~~~~~~~~---------------------------~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 129 (254)
+||||+.+.+.|.+ +..+|+||..++. +|..++.... .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999998777653 2357899998855 8988886653 46777888999999
Q ss_pred HHHHHHHhcCeeecCCCCCcEEe--cCCCCCceEEecccccccccc-----c--CCCCCccCCCCccCcccccccc----
Q 025369 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-----H--SQPKSTVGTPAYIAPEVLLRHE---- 196 (254)
Q Consensus 130 ~~l~~LH~~~i~h~di~p~nili--~~~~~~~~~l~df~~~~~~~~-----~--~~~~~~~~~~~~~aPE~~~~~~---- 196 (254)
+++.|||++|+.|+|+|.+||++ ++|+.+.+++.|||++-.... . ......-|....+|||.....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 567777899999997532111 1 1111223566789999874332
Q ss_pred -CCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 197 -YDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 197 -~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
....++|.|+.|.+.||++....||..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccc
Confidence 123349999999999999999999977
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=130.66 Aligned_cols=129 Identities=21% Similarity=0.197 Sum_probs=102.8
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCc-c--------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGD-K--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.||+|++|.||++.. ++..+++|...... . ....+.+|+..++.+.++++.....++...+..+++|+|
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 46778888754321 1 114466799999999888766666566667777899999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++|++|.+.+..... .++.+++.++.+||+.|++|+|++|.||+++ ++ +++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 999999887754321 7899999999999999999999999999998 44 499999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=153.79 Aligned_cols=188 Identities=31% Similarity=0.512 Sum_probs=138.5
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
......++|...+.+..|++|-||.++++.+...++.| +++... +.+. ++.....|.+
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfv--------------- 134 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFV--------------- 134 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCcce---------------
Confidence 45567889999999999999999999999999999995 333221 1111 2222222322
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
| |+=...+.+-++++.. ++.+++|||+.||+|+|++|+|.+|..-++ +|+.|||+++.......
T Consensus 135 v------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 135 V------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred e------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhcc
Confidence 2 2223334443444332 288999999999999999999999988887 99999999764443322
Q ss_pred C----------------CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 177 P----------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 177 ~----------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
. ...++++.|+|||++....+.-+ .|+|+||+++|+++-|..||...+.++.+...+...+.-
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 2 23368999999999988887666 999999999999999999999998877777766666654
Q ss_pred ccc
Q 025369 241 CCH 243 (254)
Q Consensus 241 ~~~ 243 (254)
...
T Consensus 278 pE~ 280 (1205)
T KOG0606|consen 278 PEE 280 (1205)
T ss_pred ccc
Confidence 444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=130.67 Aligned_cols=133 Identities=22% Similarity=0.257 Sum_probs=103.1
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-----------------------chhHHHHHHHHhhcCCCCC-
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN- 80 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~- 80 (254)
|.+.+.||+|++|.||++.+. +++.+++|.+..... .......|...+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999886 789999997654220 0123456788888887764
Q ss_pred -eeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 81 -IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 81 -i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
+...++ .+..+++|||+++++|...... .....++.+++.++.++|+.|++|+||+|.||++++++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~-- 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK-- 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--
Confidence 333333 2345899999999888765321 345678899999999999999999999999999987665
Q ss_pred eEEeccccccc
Q 025369 160 LKICDFGYSKS 170 (254)
Q Consensus 160 ~~l~df~~~~~ 170 (254)
++|+|||.+..
T Consensus 164 ~~liDfg~~~~ 174 (198)
T cd05144 164 IYIIDWPQMVS 174 (198)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-17 Score=146.14 Aligned_cols=134 Identities=21% Similarity=0.168 Sum_probs=106.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEcc-CC---c-----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RG---D-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~-~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.|...+.||+|++|+||++...... +++|... .. . ...+++.+|+..++.++|+++.....+...+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456889999999999998876433 3333321 11 1 1124577899999999999998887777777778
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++||||+++++|.+++. ....++.+++.++.+||+.|++|||++|+||+++ ++. ++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence 99999999999988774 3567899999999999999999999999999993 443 89999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=122.93 Aligned_cols=134 Identities=21% Similarity=0.248 Sum_probs=92.8
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCccchhH-------------------------HHHHHHHhhcCCCCC-
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN- 80 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~-------------------------~~~e~~~l~~l~h~~- 80 (254)
+.+.||+|++|.||.+.+. ++..|++|.+......... ...|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 7889999987653221111 123444444443332
Q ss_pred -eeeeeEEEEcCCeEEEEEEccCccchH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCC
Q 025369 81 -IVRFKEVILTPTHLAIVMEYASGGELF-ERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 81 -i~~~~~~~~~~~~~~lv~~~~~~~~L~-~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~ 157 (254)
+.++++. ...+++++|++++.+. ..+.... .......++.+++.++.++|+ .|++|+||+|+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 3333332 2458999999884321 1111110 116678899999999999999 9999999999999998 544
Q ss_pred CceEEeccccccc
Q 025369 158 PRLKICDFGYSKS 170 (254)
Q Consensus 158 ~~~~l~df~~~~~ 170 (254)
++++|||.+..
T Consensus 153 --~~liDfg~a~~ 163 (187)
T cd05119 153 --VYIIDVPQAVE 163 (187)
T ss_pred --EEEEECccccc
Confidence 99999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.2e-16 Score=122.19 Aligned_cols=132 Identities=20% Similarity=0.242 Sum_probs=98.6
Q ss_pred cccc-CCcceEEEEEEEcccceeEEEEEccCCc--------------cchhHHHHHHHHhhcCCCCCe--eeeeEEEEcC
Q 025369 29 RDIG-SGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 91 (254)
Q Consensus 29 ~~l~-~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 91 (254)
..|| .||.|++|.+... +..++||.+.... .......+|+..+..+.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3466 7888888888775 6778888774311 122457789999999988775 5666654332
Q ss_pred C----eEEEEEEccCc-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 92 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 92 ~----~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
. ..++|+++++| .+|.+++... ++++.. +.+++.++.+||++||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 22599999987 6888877543 455443 568999999999999999999999999987665 9999999
Q ss_pred ccc
Q 025369 167 YSK 169 (254)
Q Consensus 167 ~~~ 169 (254)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-16 Score=113.61 Aligned_cols=131 Identities=24% Similarity=0.265 Sum_probs=108.2
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC--CCeeeeeEEEEcCCeEEEEEEccCcc
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
+++.|++|.++.||++.... ..+++|....... ...+.+|+..++.+++ ..+++++......+..+++++|+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999864 6789998765443 5678889999998876 58888888887778899999999887
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++... +......++.+++.++..+|.. +++|+|++|.||++++.+. ++++||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 66543 4566677889999999999985 7999999999999987554 9999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=130.22 Aligned_cols=149 Identities=25% Similarity=0.375 Sum_probs=123.7
Q ss_pred hhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCe-eecCCCCCcE
Q 025369 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQV-CHRDLKLENT 150 (254)
Q Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i-~h~di~p~ni 150 (254)
++.+.|.|+.++++.+.++..++.|.+|+..|+|.+.+.. ...++......++++++.++.|||...| .||.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 4568888889999999999999998765 9999999999
Q ss_pred EecCCCCCceEEeccccccccccc---CCCCCccCCCCccCccccccccC------CCCcccHHHHHHHHHHHHhCCCCC
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
+++..-. +||.|||+....... ...........|.|||.+..... ....+|+||+|++++++++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9987777 999999987544321 11112224557999999876421 344589999999999999999999
Q ss_pred CC
Q 025369 222 ED 223 (254)
Q Consensus 222 ~~ 223 (254)
..
T Consensus 159 ~~ 160 (484)
T KOG1023|consen 159 DL 160 (484)
T ss_pred cc
Confidence 76
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.9e-16 Score=129.93 Aligned_cols=119 Identities=29% Similarity=0.401 Sum_probs=101.3
Q ss_pred CeEEEEEEccCccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 92 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
.++++.|++|...+|.+|+.... ..+......++.|++.+++| +|.+|+|++|.||+...+.. ++++|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 35789999999999999997543 35677788899999999999 99999999999999987776 899999987
Q ss_pred ccccccC-------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh
Q 025369 169 KSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216 (254)
Q Consensus 169 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 216 (254)
....... ......++..|++||++.+..+..+ .||||||+++++++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH
Confidence 5444433 3445578999999999999999777 999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.5e-16 Score=134.99 Aligned_cols=205 Identities=34% Similarity=0.538 Sum_probs=164.0
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-cceeEEEEEccCCc---cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 95 (254)
....|.+.+.||+|.++.+-.+.... ....++.|.+.... ........|....+.+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 68899999999999999888887743 34455666554432 23344555777777776 999999999999999999
Q ss_pred EEEEccCccchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 96 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 96 lv~~~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
+..++..++++...+ .... ..+....-.+..|+..++.|+| ..++.|+|++|+|.+++..+. .++..|||+|....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999999898888877 4443 5677788889999999999999 999999999999999988772 38999999986554
Q ss_pred c-c---CCCCCccC-CCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 173 L-H---SQPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 173 ~-~---~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
. . ......++ ++.|.|||...+..+..+..|+||.|+++.-+++|..|+.....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 4 1 12233457 89999999998876666669999999999999999999876554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-13 Score=118.68 Aligned_cols=166 Identities=19% Similarity=0.259 Sum_probs=128.0
Q ss_pred EEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHH
Q 025369 42 MRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 120 (254)
Q Consensus 42 ~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~ 120 (254)
+..+.++..+.+..+..... ..+...+.+..++.++||||+++++.+...+..|+|+|.+. .|...+.+. +...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~ 105 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEE 105 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHH
Confidence 44556677777776665543 23557788899999999999999999999999999999885 455556553 4778
Q ss_pred HHHHHHHHHHHHHHHH-hcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-CCCccCCCCccCccccccccCC
Q 025369 121 ARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYD 198 (254)
Q Consensus 121 ~~~~~~~i~~~l~~LH-~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~ 198 (254)
+...++||+.||.+|| +.+++|++|+-..|+|+..|. .+|++|.++........ .........|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 8999999999999997 668999999999999998888 99999997754433332 22223344567777654333
Q ss_pred CCcccHHHHHHHHHHHHhC
Q 025369 199 GKIADVWSCGVTLYVMLVG 217 (254)
Q Consensus 199 ~~~~Di~slG~~l~~l~~g 217 (254)
-. .|.|.||+++++++.|
T Consensus 182 ~s-~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WS-IDSWGLGCLIEELFNG 199 (690)
T ss_pred cc-hhhhhHHHHHHHHhCc
Confidence 12 5999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-13 Score=103.13 Aligned_cols=136 Identities=14% Similarity=0.146 Sum_probs=96.1
Q ss_pred eccccCCcceEEEEEEEcc------cceeEEEEEccC--------------Ccc---------ch----hHHHHHHHHhh
Q 025369 28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIER--------------GDK---------ID----ENVQREIINHR 74 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~------~~~~~~lK~~~~--------------~~~---------~~----~~~~~e~~~l~ 74 (254)
...||.|..+.||.+.... .+..+|+|+..- ... .. .+..+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999998754 357899997631 100 01 12337888888
Q ss_pred cCCC--CCeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeecCCCCCcEE
Q 025369 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTL 151 (254)
Q Consensus 75 ~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~i~h~di~p~nil 151 (254)
++.. -.+++++++ ...++||||+.+..+....-....++..+...+..+++.++..| |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8854 345555543 45688999997643322111222355666777889999999998 8999999999999999
Q ss_pred ecCCCCCceEEeccccccc
Q 025369 152 LDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 152 i~~~~~~~~~l~df~~~~~ 170 (254)
+++ + ++.++|||.+..
T Consensus 158 ~~~-~--~v~iIDF~qav~ 173 (197)
T cd05146 158 WHD-G--KVWFIDVSQSVE 173 (197)
T ss_pred EEC-C--cEEEEECCCcee
Confidence 974 3 389999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=103.69 Aligned_cols=127 Identities=19% Similarity=0.246 Sum_probs=93.2
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee-eeeEEEEcCCeEEEEEEccCccch
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
.+.++.|..+.+|+++.. +..+++|.............+|+..++.+.+.+++ +++.. .....++||++++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 457888999999999875 77899998755443334567888888888654443 34443 23345799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCe-----eecCCCCCcEEecCCCCCceEEecccccc
Q 025369 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 107 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i-----~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
... . ........+++.++..||+.++ +|||++|.||+++ ++. ++++||+.+.
T Consensus 79 ~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 79 LTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred ccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence 543 0 1123456789999999999885 9999999999998 333 8999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.3e-13 Score=96.99 Aligned_cols=143 Identities=17% Similarity=0.098 Sum_probs=110.5
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCC---------ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
....+.||+.+.|+.+... |+.++||.-+.. .-...+..+|+..+.++.--+|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5778899999999888775 778888854321 12235667899999888766777777777788888999
Q ss_pred EEccCc-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC-ceEEecccccccc
Q 025369 98 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSS 171 (254)
Q Consensus 98 ~~~~~~-~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~-~~~l~df~~~~~~ 171 (254)
|||++| .++.+++.... +........+++++-+.+.-||..+++||||+.+||++.+++.. .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 47777776553 23344447899999999999999999999999999999877764 2489999987643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-12 Score=96.09 Aligned_cols=129 Identities=22% Similarity=0.199 Sum_probs=99.5
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCC----ccc-----hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..+++|+.+.++.+... |..+++|.-.+. +.. .++-.+|+.++.++.--++....-+..++....++|+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999998664 445677743221 111 1445678889988877777777777778888899999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
|.+|..|.+.+... ...++..+-..+.-||..||+|||++++|+++..+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99998898888665 245666777777889999999999999999997554 8999999876
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-12 Score=112.15 Aligned_cols=137 Identities=18% Similarity=0.177 Sum_probs=91.9
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCccch-----------------------------------h------HHH
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----------------------------------E------NVQ 67 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~-----------------------------------~------~~~ 67 (254)
+.||+|+.|.||+|+.. +|+.||||+..+.-... . ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 68999999875431000 0 122
Q ss_pred HHHHHhhcC----CCCCeeeeeEEE-EcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCe
Q 025369 68 REIINHRSL----RHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHAMQV 140 (254)
Q Consensus 68 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~LH~~~i 140 (254)
+|+..+.++ ++..-+.+-.++ ...+..++||||++|.+|.+..... ...+ ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 233333333 222222222232 2344569999999999998776432 1122 3445556655 4678899999
Q ss_pred eecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 141 ~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+|+|++|.||++++++. ++++|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 99999999999987766 999999987644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.2e-13 Score=114.28 Aligned_cols=142 Identities=23% Similarity=0.313 Sum_probs=92.0
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-----------------------------------cchhHH
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------------------------KIDENV 66 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----------------------------------~~~~~~ 66 (254)
...|.. +.||+|+.|.|+.|+...+|+.||||+..+.- .....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 79999999999999999889999999876431 001112
Q ss_pred HH------HHHHhhcC----CCCCeeeeeEEEEc-CCeEEEEEEccCccchHHHH--HhcC----CCCHHHHHHHHHHHH
Q 025369 67 QR------EIINHRSL----RHPNIVRFKEVILT-PTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQQLI 129 (254)
Q Consensus 67 ~~------e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~~~~~~~~L~~~l--~~~~----~~~~~~~~~~~~~i~ 129 (254)
.+ |+....++ .+...+.+-.++.+ .+..++||||++|+++.+.- ...+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 22 33233222 23333444444433 45678999999999987642 2222 1223333333333
Q ss_pred HHHHHHHhcCeeecCCCCCcEEecCCC--CCceEEecccccccc
Q 025369 130 SGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 171 (254)
Q Consensus 130 ~~l~~LH~~~i~h~di~p~nili~~~~--~~~~~l~df~~~~~~ 171 (254)
+...|++|+|++|.||+++.++ .++++++|||.+...
T Consensus 276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3468999999999999998766 224999999987544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-10 Score=91.18 Aligned_cols=129 Identities=14% Similarity=0.045 Sum_probs=90.5
Q ss_pred EEEEEEcccceeEEEEEccCCcc------------chhHHHHHHHHhhcCCCCCee--eeeEEEEc-----CCeEEEEEE
Q 025369 39 ARLMRDKVTKELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIVME 99 (254)
Q Consensus 39 v~~~~~~~~~~~~~lK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~~ 99 (254)
|+++.. .|+.+.+|....... ......+|...+..+...+|. .++.+... ....++|++
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 444433 466788886533221 111367888888777544443 33444432 234689999
Q ss_pred ccCcc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-----CCCCceEEecccccc
Q 025369 100 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 169 (254)
Q Consensus 100 ~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-----~~~~~~~l~df~~~~ 169 (254)
++++. +|.+++.. ..+.+......++.+++..+..||+.|++|+|++++||+++. ++..++.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99875 78888753 344567778899999999999999999999999999999975 234469999999653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.9e-11 Score=91.49 Aligned_cols=139 Identities=19% Similarity=0.261 Sum_probs=98.4
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCC--eeeeeEEEEcC---CeEEEEEEcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPN--IVRFKEVILTP---THLAIVMEYA 101 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~---~~~~lv~~~~ 101 (254)
+.|+.|..+.+|++.... |..+++|....... ....+..|...++.+.+.+ +.+++.+.... +..+++++++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568899999999998753 57899998765433 3566788999998886644 45666665543 2568999999
Q ss_pred CccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 025369 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (254)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------------------------------------- 137 (254)
+|.++...+.. ..++......++.+++.++..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 98877654421 234555555666666666666652
Q ss_pred ------------cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 138 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 ------------~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..++|||+.|.||+++.++...+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34799999999999987422237899998654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.6e-12 Score=106.27 Aligned_cols=199 Identities=21% Similarity=0.169 Sum_probs=151.7
Q ss_pred CCCceeEeccccC--CcceEEEEEEE--cccceeEEEEEccC---CccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 21 DSDRYDFVRDIGS--GNFGVARLMRD--KVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~--g~~g~v~~~~~--~~~~~~~~lK~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
....+.+.+.+|. |.+|.+|.++. ..++..+++|.-.. ......+-.+++.....+ .|++.++....+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456778888999 99999999999 88899999997322 122334445666666666 5899999888888899
Q ss_pred eEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLIS----GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~----~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
..++-+|.+. .++..+..... -++...++....+... |+.++|..+++|-|++|.||+...+.. ..+++|||+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~ 269 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGL 269 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcce
Confidence 9999999985 46666655443 3788889999999999 999999999999999999999987732 389999998
Q ss_pred cccccccCCCC-Cc-----cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 168 SKSSVLHSQPK-ST-----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 168 ~~~~~~~~~~~-~~-----~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
........... .. .+...|++||...+.. ...+|+|++|.++.+-.++..+...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccC
Confidence 76444433221 11 4667899999875444 4448999999999998887655443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-11 Score=97.27 Aligned_cols=174 Identities=18% Similarity=0.300 Sum_probs=121.7
Q ss_pred HHHhhcCCCCCeeeeeEEEEcCC-----eEEEEEEccCccchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC-
Q 025369 70 IINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQ- 139 (254)
Q Consensus 70 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~- 139 (254)
...+..+-|.|+++++.+|.+.. ...++++|+..+++..++.+.. .+......+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34456667999999999987643 4678899999999999997543 4777788899999999999999884
Q ss_pred -eeecCCCCCcEEecCCCCCceEEeccccc--cc---ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHH
Q 025369 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYS--KS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 213 (254)
Q Consensus 140 -i~h~di~p~nili~~~~~~~~~l~df~~~--~~---~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~ 213 (254)
|+|+++..+.|++..++. +|++.-.-. .. .....+...+.+.++|.+||.=...+...+ +|||++|.+..+
T Consensus 198 piihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHH
Confidence 999999999999987765 555432211 10 000111123346778999997544444455 899999999999
Q ss_pred HHhCCCCCCCCCC----ChhhHH--------HHHHhhcCccccCC
Q 025369 214 MLVGGYPFEDPDE----PKDFRK--------TIQVFIKPCCHITP 246 (254)
Q Consensus 214 l~~g~~pf~~~~~----~~~~~~--------~~~~~~~~~~~~~p 246 (254)
|..+..--...+. +..+.. .-+.++++|++..|
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEP 319 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCC
Confidence 9887644222221 112221 24567889999888
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.3e-09 Score=91.70 Aligned_cols=166 Identities=19% Similarity=0.242 Sum_probs=123.6
Q ss_pred ceEEEEEEEcccceeEEEEEccCCccc-hhHHHHHHHHhhcCCCCCeeeeeEEEE----cCCeEEEEEEccCc-cchHHH
Q 025369 36 FGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVIL----TPTHLAIVMEYASG-GELFER 109 (254)
Q Consensus 36 ~g~v~~~~~~~~~~~~~lK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~~~~~~-~~L~~~ 109 (254)
..+.|++....+|..|++|++...... ....-.-.+.++++.|.|++++.+++. ++..+.+|++|+++ .+|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 468999999999999999998432211 123345678899999999999999987 35688999999975 466655
Q ss_pred HHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 110 ICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 110 l~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
-..+ ...++..+|.++.|+..||.++|+.|+...-|.|.+|+++.+. +++++..|........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCC
Confidence 4322 2367899999999999999999999999999999999997555 4888876654332222
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 220 (254)
. -+-+.+ ..+.|.--||.++..|.+|..-
T Consensus 447 ~-------------~~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 P-------------TEPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred C-------------CcchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 1 011111 1227999999999999998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.2e-10 Score=83.98 Aligned_cols=122 Identities=26% Similarity=0.291 Sum_probs=77.9
Q ss_pred EEEEEEEcccceeEEEEEccCC--------------c-------------cchhHHHHHHHHhhcCCCCC--eeeeeEEE
Q 025369 38 VARLMRDKVTKELVAVKYIERG--------------D-------------KIDENVQREIINHRSLRHPN--IVRFKEVI 88 (254)
Q Consensus 38 ~v~~~~~~~~~~~~~lK~~~~~--------------~-------------~~~~~~~~e~~~l~~l~h~~--i~~~~~~~ 88 (254)
.||.|... .+..+|+|+.... . ....+..+|...|.++...+ +++++++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 37888775 5778999976421 0 01145678999999997664 4555544
Q ss_pred EcCCeEEEEEEccC--ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 89 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 89 ~~~~~~~lv~~~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~-LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
. ...+||||++ |..+..+.... ++......+..+++..+.. +|..|++|||+++.||+++++ . +.++||
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred -e--CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 2 3379999998 65665443322 1234556677778775444 689999999999999999866 3 999999
Q ss_pred cccc
Q 025369 166 GYSK 169 (254)
Q Consensus 166 ~~~~ 169 (254)
|.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-09 Score=81.76 Aligned_cols=135 Identities=10% Similarity=0.083 Sum_probs=98.9
Q ss_pred cCCcceEEEEEEEcccceeEEEEEccCC-------ccchhHHHHHHHHhhcCCCCC--eeeeeEEEE---cC--CeEEEE
Q 025369 32 GSGNFGVARLMRDKVTKELVAVKYIERG-------DKIDENVQREIINHRSLRHPN--IVRFKEVIL---TP--THLAIV 97 (254)
Q Consensus 32 ~~g~~g~v~~~~~~~~~~~~~lK~~~~~-------~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~--~~~~lv 97 (254)
++||.|-|+...... ..+-+|...+. +.....+.+|+..+..+...+ ++++. ++. .+ -..++|
T Consensus 27 ~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 448888889887653 36778876521 234577889999998885433 33333 222 12 245899
Q ss_pred EEccCc-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 98 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 98 ~~~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++-+++ .+|.+++... .+.+......++.+++.++..||+.|+.|+|+.+.||+++.++...+.++||.-+.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5888887653 34678888899999999999999999999999999999986554469999998554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-10 Score=87.46 Aligned_cols=132 Identities=20% Similarity=0.229 Sum_probs=98.8
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCC--------------------c---cchhHHHHHHHHhhcCCCC--
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------------------D---KIDENVQREIINHRSLRHP-- 79 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--------------------~---~~~~~~~~e~~~l~~l~h~-- 79 (254)
+.++.+||.|..|.||.+.+. .|..+++|.-... . ......++|...|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999998 6888999963210 0 1123456788888888654
Q ss_pred CeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
.+++.+++ +...+||++.+|..|...- ++......++..|+.-+.-+-..|++|||+++-||++++++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 56666643 4568999999987765432 235555666777777777777999999999999999998877
Q ss_pred eEEeccccc
Q 025369 160 LKICDFGYS 168 (254)
Q Consensus 160 ~~l~df~~~ 168 (254)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.5e-11 Score=101.12 Aligned_cols=200 Identities=21% Similarity=0.200 Sum_probs=143.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEc-ccceeEEEEEccCCccc-hhH--HHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKI-DEN--VQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~lK~~~~~~~~-~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
......++..+..||.|.++.++...-. .++..|++|-..+.-.. .++ -..|+.+...+ .|.+.+.....|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 5566778999999999999988887655 56778888866543211 111 12344444444 5778888777777777
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++--||+.++++.....-...+++..++.+..|++.++.++|+..++|.|++|.||++..++ ...+++||+++.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLA 418 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccc
Confidence 7779999998887766665555688899999999999999999999999999999999998764 237999999876522
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCC
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 219 (254)
. ...........|-..|.+........+.|++|||..+.+..++..
T Consensus 419 ~-~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 F-SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred e-ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 1 111122223233235555444444555999999999999888763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.5e-09 Score=87.22 Aligned_cols=190 Identities=14% Similarity=0.124 Sum_probs=123.1
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeee----eeEEE--EcCC-eEEEEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKEVI--LTPT-HLAIVME 99 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~--~~~~-~~~lv~~ 99 (254)
.+..||+|+.+.+|-+... +.. +-|++.....-.+. +.-..+-+.-.||-+-. ..... .+.+ ...++|+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh--hch-hheeecCCCchHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4678999999998866443 222 34544333221111 11112222234443222 11111 1222 3678888
Q ss_pred ccCcc-chHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 100 YASGG-ELFERIC------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 100 ~~~~~-~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++. .+..+.. +.+...+..+.+.++.++.+...||..|.+-||++++|+++++++. ++|+|-+.-....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~ 168 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINA 168 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeecc
Confidence 87664 2333322 2234778889999999999999999999999999999999988876 9999866433333
Q ss_pred ccCCCCCccCCCCccCccccc-----cccCCCCcccHHHHHHHHHHHHhC-CCCCCC
Q 025369 173 LHSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVG-GYPFED 223 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~ 223 (254)
.+.......+...|.+||.-. +..-..+ .|.|.||+++++++.| +.||.+
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCc
Confidence 444445557889999999753 3344455 8999999999999985 899865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.6e-11 Score=105.97 Aligned_cols=212 Identities=26% Similarity=0.353 Sum_probs=153.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch----hHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
+...+.+.+.+-+.+|.++.++.++-..++.....|.....+... ++...+-..+-.-.+|.++...-.+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 456778889999999999999999888888666666543332221 1111111111112335555444444445678
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~- 173 (254)
+++++++.+++|...+.+.+..+.+-.......+.+++++||...+.|+|++|.|.+...++. .++.||+.......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLI 957 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccc
Confidence 999999999999999988887787788888889999999999999999999999999988887 78888873211000
Q ss_pred ---------------------------cCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 174 ---------------------------HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 174 ---------------------------~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
..+ .....+++.|.+||...+...... +|+|+.|.++++.++|.+||.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCC
Confidence 000 011236778999999988888777 899999999999999999998
Q ss_pred CCCCChhhHHH
Q 025369 223 DPDEPKDFRKT 233 (254)
Q Consensus 223 ~~~~~~~~~~~ 233 (254)
.......+..+
T Consensus 1037 a~tpq~~f~ni 1047 (1205)
T KOG0606|consen 1037 AETPQQIFENI 1047 (1205)
T ss_pred Ccchhhhhhcc
Confidence 88776555443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-09 Score=82.01 Aligned_cols=107 Identities=19% Similarity=0.205 Sum_probs=81.8
Q ss_pred hhHHHHHHHHhhcCCCCCe--eeeeEEEEcC----CeEEEEEEccCcc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 025369 63 DENVQREIINHRSLRHPNI--VRFKEVILTP----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYC 135 (254)
Q Consensus 63 ~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~----~~~~lv~~~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~L 135 (254)
.....+|...+..+...+| ++++.+.... ...+++++++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3456778877777754333 3444444432 2458999999874 7888887755577788899999999999999
Q ss_pred HhcCeeecCCCCCcEEecCCC-CCceEEecccccc
Q 025369 136 HAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 169 (254)
Q Consensus 136 H~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~ 169 (254)
|++|++|+|+++.|||++.++ ..++.++||+.+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998775 3359999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.7e-08 Score=74.28 Aligned_cols=136 Identities=15% Similarity=0.146 Sum_probs=87.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchh----------HHHHHHHHhhcC---CCCCeeeeeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----------NVQREIINHRSL---RHPNIVRFKE 86 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~----------~~~~e~~~l~~l---~h~~i~~~~~ 86 (254)
+..++|.+.+.+.......|.+... ++..+++|.........+ ...+.+....++ .-.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3467889999998877666555544 578899997654321111 112223222233 2222222222
Q ss_pred E-----EEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 87 V-----ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 87 ~-----~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
+ +......++++||++|..|.+... +++ .+...+.+++..||+.|+.|||.+|.|+++++++ ++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EE
Confidence 2 222356679999999988765432 222 2445677888999999999999999999998554 89
Q ss_pred Eeccccc
Q 025369 162 ICDFGYS 168 (254)
Q Consensus 162 l~df~~~ 168 (254)
++|++..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-09 Score=92.43 Aligned_cols=94 Identities=20% Similarity=0.366 Sum_probs=69.9
Q ss_pred HHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC----------CccCCCCccCccccc
Q 025369 125 FQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLL 193 (254)
Q Consensus 125 ~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~aPE~~~ 193 (254)
+.+.+.++.++|. .+++|++|.|++|.++..+. .|++.|+++.......... .......|.+||.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3345599999995 58999999999999998887 9999999765433311111 112456899999998
Q ss_pred cccCCCCcccHHHHHHHHHHHHh-CCCCC
Q 025369 194 RHEYDGKIADVWSCGVTLYVMLV-GGYPF 221 (254)
Q Consensus 194 ~~~~~~~~~Di~slG~~l~~l~~-g~~pf 221 (254)
....... +|+||+|+++|.+.. |...+
T Consensus 183 ~~~~~~~-sd~fSlG~li~~i~~~gk~i~ 210 (700)
T KOG2137|consen 183 GTTNTPA-SDVFSLGVLIYTIYNGGKSII 210 (700)
T ss_pred ccccccc-ccceeeeeEEEEEecCCcchh
Confidence 7555444 999999999999985 44444
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-07 Score=72.79 Aligned_cols=133 Identities=18% Similarity=0.163 Sum_probs=87.4
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCc--------------------c-----chhHHHHHHHHhhcCCCCC--
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------------K-----IDENVQREIINHRSLRHPN-- 80 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------------------~-----~~~~~~~e~~~l~~l~h~~-- 80 (254)
...|++|..+.||.|... ++..+|+|++..+. . ...+..+|...|+++.-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 347788999999999874 67889999875311 0 1123446777777774433
Q ss_pred eeeeeEEEEcCCeEEEEEEccCccch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCC
Q 025369 81 IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 81 i~~~~~~~~~~~~~~lv~~~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~ 158 (254)
+.+.+.+. .-.++||++..... .-.+.. .++...+...+..++++.+.-|-. .+++||||+.-|||+. ++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 33444332 33789999854311 101110 123333566677788888888776 8999999999999998 444
Q ss_pred ceEEecccccc
Q 025369 159 RLKICDFGYSK 169 (254)
Q Consensus 159 ~~~l~df~~~~ 169 (254)
+.++||+-+.
T Consensus 205 -p~iID~~QaV 214 (268)
T COG1718 205 -PYIIDVSQAV 214 (268)
T ss_pred -EEEEECcccc
Confidence 8999999665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-06 Score=67.50 Aligned_cols=71 Identities=17% Similarity=0.175 Sum_probs=52.9
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEEEEcCCeEEEEEEccCcc
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~~~~~~ 104 (254)
..|++|..+.+|+. .+..+++|..... .......+|...++.+...+ +.+++.+....+...++|++++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999973 2446788876543 34466788999998886544 356777777777788999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.8e-06 Score=64.33 Aligned_cols=78 Identities=18% Similarity=0.185 Sum_probs=53.6
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEEEE---cCCeEEEEEEccC
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVIL---TPTHLAIVMEYAS 102 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~~~~~lv~~~~~ 102 (254)
++.++.|..+.+|.+.... ..+++|..... .....+.+|...++.+.... +..++.... .....++++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678889999999999875 47899976544 44566777888877774332 344554332 2345799999999
Q ss_pred ccchHH
Q 025369 103 GGELFE 108 (254)
Q Consensus 103 ~~~L~~ 108 (254)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 877666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.9e-06 Score=77.08 Aligned_cols=79 Identities=19% Similarity=0.207 Sum_probs=56.2
Q ss_pred EeccccCCcceEEEEEEEcccc--eeEEEEEccCCc--cchhHHHHHHHHhhcCC-CCCe--eeeeEEEEcC---CeEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 96 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~--~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~l 96 (254)
-+++++.|.+..+|.+.....+ ..+++|+..... .....+.+|...++.+. |.++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888999999998876432 467888765432 22356889999999885 6665 6667776654 45789
Q ss_pred EEEccCccc
Q 025369 97 VMEYASGGE 105 (254)
Q Consensus 97 v~~~~~~~~ 105 (254)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.3e-06 Score=65.30 Aligned_cols=75 Identities=12% Similarity=0.049 Sum_probs=50.4
Q ss_pred cccCCcc-eEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEccCccchH
Q 025369 30 DIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 107 (254)
Q Consensus 30 ~l~~g~~-g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (254)
.|..|.. ..||++... +..+++|...... .....+|+..++.+. +--+.+++.....++..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4455555 688988764 3678888765443 345667888877763 233556666666666778999999987765
Q ss_pred H
Q 025369 108 E 108 (254)
Q Consensus 108 ~ 108 (254)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.1e-06 Score=74.52 Aligned_cols=137 Identities=20% Similarity=0.185 Sum_probs=88.4
Q ss_pred ccccCCcceEEEEEEEcccceeEEEEEccCCc-----------------------------------cchhHHH------
Q 025369 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------------------------KIDENVQ------ 67 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----------------------------------~~~~~~~------ 67 (254)
+.|+.++-|.|++|+..+ |+.||||+..++- ...+.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 577889999999999984 9999999864310 0001122
Q ss_pred HHHHHhhcC-----CCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHH-HHHHHhcCe
Q 025369 68 REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG-VSYCHAMQV 140 (254)
Q Consensus 68 ~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~-l~~LH~~~i 140 (254)
+|.....++ ..+.+.-..-++...+..+++|||++|..+.+...-. ..++...+.. .++.+ +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~---~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE---LLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH---HHHHHHHHHHHhcCc
Confidence 233222222 2344444444444566779999999998887774222 3345444333 33332 233445899
Q ss_pred eecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 141 ~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.|+|..|.||+++.++. +.+.|||.....
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCcceecC
Confidence 99999999999998876 999999976543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-05 Score=61.28 Aligned_cols=129 Identities=21% Similarity=0.205 Sum_probs=90.8
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCc-----------------cchhHHHHHHHHhhcCC------CCCeeee
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 84 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~ 84 (254)
...||+|+.-.+|.--+. ...+||+..... .......+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999998865443 346788766544 22345566666665555 6889999
Q ss_pred eEEEEcCCeEEEEEEccCc------cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 85 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
+|+...+-...+|+|.... .+|.+++... .+++ . +...+-+-..+|-+.+|+.+|++|.||++.....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999998888888887632 3677777444 3555 3 33344455678889999999999999999755543
Q ss_pred --ceEEec
Q 025369 159 --RLKICD 164 (254)
Q Consensus 159 --~~~l~d 164 (254)
+++|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 478888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.5e-06 Score=61.45 Aligned_cols=129 Identities=19% Similarity=0.191 Sum_probs=91.9
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeee-eeEEEEcCCeEEEEEEccC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~~~~~ 102 (254)
.-++.+.|+.|..|.||.+.+. +..+++| +...++....+..|+++|..++..++.+ ++.+.. .++.|+|..
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~K-vrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALK-VRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEE-EecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 4456789999999999999886 5578888 4555667788999999999887766543 444322 234599999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCC--CcEEecCCCCCceEEecccccc
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p--~nili~~~~~~~~~l~df~~~~ 169 (254)
|-+|.++.... + .+-...+++...-|-..||-|+.|+- .||++++. . +.|+||..|.
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~--~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-D--VYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-c--EEEEEccchh
Confidence 98887655432 2 23344566666667888999999974 45555433 3 8999999765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.9e-05 Score=56.57 Aligned_cols=135 Identities=19% Similarity=0.284 Sum_probs=91.7
Q ss_pred CCCCCCCcccCCCceeEeccccCCcc-eEEEEEEEcccceeEEEEEcc---CCc-------------------cchhHHH
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNF-GVARLMRDKVTKELVAVKYIE---RGD-------------------KIDENVQ 67 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~-g~v~~~~~~~~~~~~~lK~~~---~~~-------------------~~~~~~~ 67 (254)
+..+..++.....+++.++.||.|.. |.||+++-. |..||+|.+. ... ...+.+.
T Consensus 25 ~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 25 PGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 44555566666689999999999999 999999876 7799999822 110 1123455
Q ss_pred HHHHHhhcCC---CCCe--eeeeEEEEcC------------------CeEEEEEEccCccchHHHHHhcCCCCHHHHHHH
Q 025369 68 REIINHRSLR---HPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFF 124 (254)
Q Consensus 68 ~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (254)
.|.+...+|+ +.++ ++++++..-. -...+|-||.+... .++...
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~---- 169 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD---- 169 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----
Confidence 6666666553 4555 8888876421 12356777665432 223333
Q ss_pred HHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 125 ~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
+.+|.+-+.-+|+.||+-+|+++.|.. + =+|+|||.
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~ 205 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSS 205 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc---C----CEEEeccc
Confidence 345666667799999999999999986 2 38999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.9e-07 Score=78.95 Aligned_cols=186 Identities=22% Similarity=0.261 Sum_probs=133.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC-eeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~ 100 (254)
...|....-++.++++.+++.+...+.... .+.+... ....-++++|.+++||| .+...+-+..+...++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 456677888899999999999988776654 5555333 44556889999999999 55555555566788999999
Q ss_pred cCcc-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 101 ASGG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 101 ~~~~-~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
+.++ +..... ...-.+...+...+.+.-+..++++|+..-+|+| ||+..+.. .++.+|+............
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccc
Confidence 8765 221111 1111244455666677778889999988767887 77765433 6999999876555554456
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 220 (254)
...+.+.+++||+...+..... .|.|++|.-..++--|-+|
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCC
Confidence 6678899999999888887766 7999999766666556655
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.4e-05 Score=61.65 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=43.3
Q ss_pred ccccCCcce-EEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCC---CeeeeeEEEEcC---CeEEEEEEcc
Q 025369 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 101 (254)
Q Consensus 29 ~~l~~g~~g-~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~~~~ 101 (254)
+.++.|+.. .||.+. ..+++|.... ......+.+|...+..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666665 588762 2477886443 33455788899888777532 233344333222 2347899999
Q ss_pred Cccch
Q 025369 102 SGGEL 106 (254)
Q Consensus 102 ~~~~L 106 (254)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.8e-05 Score=65.20 Aligned_cols=139 Identities=18% Similarity=0.147 Sum_probs=85.1
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCc--------------------------------cchhHHHHHHHHhh-
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------------------------KIDENVQREIINHR- 74 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------------------------------~~~~~~~~e~~~l~- 74 (254)
.+.|+..+.+.|++|+.+. |+.||||+.+++- ...+.+..|+...+
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3578889999999999985 9999999754310 00111222222222
Q ss_pred ---------cCCCCC---eeeeeEEEEc-CCeEEEEEEccCccchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 025369 75 ---------SLRHPN---IVRFKEVILT-PTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139 (254)
Q Consensus 75 ---------~l~h~~---i~~~~~~~~~-~~~~~lv~~~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 139 (254)
.+.|-+ -+.+=.++.+ ....+++|||++|..+.+.- .+. .++...+..-+.+... +-+=..|
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhcC
Confidence 222333 2223333333 35679999999997665443 332 3566544443333222 2234678
Q ss_pred eeecCCCCCcEEecCC--CCCceEEeccccccc
Q 025369 140 VCHRDLKLENTLLDGS--PAPRLKICDFGYSKS 170 (254)
Q Consensus 140 i~h~di~p~nili~~~--~~~~~~l~df~~~~~ 170 (254)
++|+|-.|.||++..+ +...+.+.|+|+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 9999999999999854 344699999998653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-05 Score=62.95 Aligned_cols=137 Identities=19% Similarity=0.205 Sum_probs=92.9
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCC-----------------------c----cchhHHHHHHHHhhcCCCC
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----------------------D----KIDENVQREIINHRSLRHP 79 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-----------------------~----~~~~~~~~e~~~l~~l~h~ 79 (254)
+-..|+.|....||.|... +|..+|||+++-+ + -..-+...|+..|+++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4567889999999998776 6777999986410 0 0113455688888888776
Q ss_pred CeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecCCCCCcEEecCCCCC
Q 025369 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~di~p~nili~~~~~~ 158 (254)
+|.-..-+.. ...+|||+++.......-.-...+++...+..+-.+++.-+.-|- ..++||.||+--|+|+.++
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG--- 301 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG--- 301 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---
Confidence 6544333322 234789999864322211122235777777777777877777774 5689999999999999643
Q ss_pred ceEEecccccc
Q 025369 159 RLKICDFGYSK 169 (254)
Q Consensus 159 ~~~l~df~~~~ 169 (254)
++.++|.+-+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 38999988553
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00018 Score=56.60 Aligned_cols=75 Identities=15% Similarity=0.249 Sum_probs=46.5
Q ss_pred eccccCCcceEEEEEEEcc-cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEEEccCccc
Q 025369 28 VRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 105 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~ 105 (254)
.+.|..|-...+|++.... .+..+++|.........-...+|...++.+...++ ++++... ++ .++++|++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEeeCCCc
Confidence 3567777778999997653 35678899765433322334567888887754443 3333322 22 47999998765
Q ss_pred h
Q 025369 106 L 106 (254)
Q Consensus 106 L 106 (254)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0015 Score=55.29 Aligned_cols=75 Identities=19% Similarity=0.105 Sum_probs=51.7
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccC------C--ccchhHHHHHHHHhhcCC---CCCeeeeeEEEEcCCeEEE
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER------G--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~------~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 96 (254)
.+.||.|....||++.+...++.++||.-.. . ....++...|...|+.+. ...+++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4678999999999999975446899997431 1 123456677777777652 2345566655 5566789
Q ss_pred EEEccCcc
Q 025369 97 VMEYASGG 104 (254)
Q Consensus 97 v~~~~~~~ 104 (254)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.8e-06 Score=67.74 Aligned_cols=130 Identities=15% Similarity=0.159 Sum_probs=90.0
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--------------------c---chhHHHHHHHHhhcCCCCC-
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------------K---IDENVQREIINHRSLRHPN- 80 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------------------~---~~~~~~~e~~~l~~l~h~~- 80 (254)
+.++.+||-|..+.+|++.+. .|...++|.-.... + +.-+..+|...++.|.-..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567899999999999999887 57778888532111 0 0112345666666664322
Q ss_pred -eeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 81 -IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 81 -i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
+++.+ +.+...+||+++.|-+|.....- .....+...+...+.-|-..|++|||.+-=||++.+++.
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-- 240 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-- 240 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence 22333 33456789999988777654322 233445667777788899999999999999999997776
Q ss_pred eEEecccc
Q 025369 160 LKICDFGY 167 (254)
Q Consensus 160 ~~l~df~~ 167 (254)
++++||--
T Consensus 241 i~vIDFPQ 248 (465)
T KOG2268|consen 241 IVVIDFPQ 248 (465)
T ss_pred EEEeechH
Confidence 99999963
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.6e-05 Score=57.77 Aligned_cols=96 Identities=15% Similarity=0.079 Sum_probs=74.7
Q ss_pred HHHHHHhhcCCC-CCeeeeeEEEEcCCeEEEEEEccCccchHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 025369 67 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 139 (254)
Q Consensus 67 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~ 139 (254)
..|..+++.+++ +++++++|+|. .+++.|+...+++.. .+..-...++..+..++.++++.+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 69999999983 367888887655432 11122245889999999999999999987 34
Q ss_pred eeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 140 i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
+.-+|++++|+-+++++. ++++|.+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v 109 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDV 109 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhc
Confidence 888999999999997776 999999854
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00011 Score=58.62 Aligned_cols=132 Identities=14% Similarity=0.090 Sum_probs=73.6
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCccch-hHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEEEccCccchH
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 107 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~L~ 107 (254)
.+..|-.+.+|++.. ++..+++|......... -...+|...++.+...++ .+++... + -++|++|++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 455677778998873 46678888654432221 235678888887754333 2333332 2 26899999875542
Q ss_pred H--------------HHH---hc----CCCCHHH-HHHHHHHH---------HHHHHHHHh--------cCeeecCCCCC
Q 025369 108 E--------------RIC---NA----GRFSEDE-ARFFFQQL---------ISGVSYCHA--------MQVCHRDLKLE 148 (254)
Q Consensus 108 ~--------------~l~---~~----~~~~~~~-~~~~~~~i---------~~~l~~LH~--------~~i~h~di~p~ 148 (254)
. .+. .. .+++... +..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 111 00 1112111 11111111 111222221 24899999999
Q ss_pred cEEecCCCCCceEEeccccccc
Q 025369 149 NTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~ 170 (254)
||++++++ +.++||+.+..
T Consensus 157 Nil~~~~~---~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC---CEEEeccccCc
Confidence 99998655 68999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00023 Score=58.01 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=78.4
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEE------EEcCCeEEEEEE
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVME 99 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~~ 99 (254)
.+.+..|....+|++... +..+++|.... ...+.+..|+..+..+...+ +.+++.. ...++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777877899988654 34688997754 23455667777777664332 3333321 123456689999
Q ss_pred ccCccchHH-----------HHH----hcCCCCH--------H--HH--H--------HHHHHHHHHHHHHHh-------
Q 025369 100 YASGGELFE-----------RIC----NAGRFSE--------D--EA--R--------FFFQQLISGVSYCHA------- 137 (254)
Q Consensus 100 ~~~~~~L~~-----------~l~----~~~~~~~--------~--~~--~--------~~~~~i~~~l~~LH~------- 137 (254)
+++|..+.. .+. ....+.. . .. . .....+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998755311 110 0000000 0 00 0 011112233444432
Q ss_pred cCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 138 ~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.+++|||+.|.|+++++++. +.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhcC
Confidence 46999999999999987543 57999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00024 Score=66.18 Aligned_cols=152 Identities=22% Similarity=0.278 Sum_probs=107.0
Q ss_pred HHHHHHhhcCCCCCeeeeeEEEEcCCeE----EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeee
Q 025369 67 QREIINHRSLRHPNIVRFKEVILTPTHL----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142 (254)
Q Consensus 67 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h 142 (254)
.-|+..+....|+|+..++.+....-.. .+..+++...++...+.+-...+..+++.+..+...++.++|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 3466777888999999999988765322 344677888889999998889999999999999999999999996666
Q ss_pred cCCCCC---cEEecCCCCCceEEe--cccccccccccCCCCCccCCCCccCccccccccCCC-CcccHHHHHHHHHHHHh
Q 025369 143 RDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG-KIADVWSCGVTLYVMLV 216 (254)
Q Consensus 143 ~di~p~---nili~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~~Di~slG~~l~~l~~ 216 (254)
.-+..+ +..++..+. +..+ ||+.+.................+.++|....+.... ...|+|++|.....+..
T Consensus 310 v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred eEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 655555 333333333 4444 777655444333333344555677777665444322 22699999999999988
Q ss_pred CCCC
Q 025369 217 GGYP 220 (254)
Q Consensus 217 g~~p 220 (254)
|..+
T Consensus 388 ~~~i 391 (1351)
T KOG1035|consen 388 GEDI 391 (1351)
T ss_pred cCcc
Confidence 7744
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00035 Score=57.21 Aligned_cols=74 Identities=12% Similarity=0.136 Sum_probs=45.0
Q ss_pred ccccCCcceEEEEEEEcc------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEEEcc
Q 025369 29 RDIGSGNFGVARLMRDKV------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~~------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~ 101 (254)
+.+..|-...+|++.... .++.+++|.............+|...++.+...++ .+++..+. + ..|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 455656667889887653 25788999865544333455677777777754333 33444432 2 3578887
Q ss_pred Cccch
Q 025369 102 SGGEL 106 (254)
Q Consensus 102 ~~~~L 106 (254)
+|.++
T Consensus 80 ~G~~l 84 (302)
T cd05156 80 PSRTL 84 (302)
T ss_pred CCCcC
Confidence 76554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0017 Score=53.33 Aligned_cols=140 Identities=19% Similarity=0.169 Sum_probs=78.1
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEE------EEcCCeEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 96 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~l 96 (254)
....+.++.|....+|++... +..+++|..... ...+.+..+...+..|...+ +.+++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 444667777777889998754 346888876442 22344556666666664322 2333321 112356789
Q ss_pred EEEccCccchH-----------HHHH---h-cCCCCH-------HHHH----------------HHHHHHHHHHHHHH--
Q 025369 97 VMEYASGGELF-----------ERIC---N-AGRFSE-------DEAR----------------FFFQQLISGVSYCH-- 136 (254)
Q Consensus 97 v~~~~~~~~L~-----------~~l~---~-~~~~~~-------~~~~----------------~~~~~i~~~l~~LH-- 136 (254)
+++|++|..+. ..+. . ...++. ...+ .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999874321 1111 0 000000 0000 00112233444453
Q ss_pred -----hcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 137 -----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 137 -----~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..+++|||+++.|+++++++. ..++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 368999999999999987653 6899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.01 Score=49.39 Aligned_cols=72 Identities=18% Similarity=0.144 Sum_probs=46.8
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccC-------C-ccchhHHHHHHHHhhcCC--CCC-eeeeeEEEEcCCeEEEEE
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIER-------G-DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~-------~-~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv~ 98 (254)
.||.|....||++.+...++.++||.-.. + +...++..-|...|+... .|. +++++. .++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57889999999999864446899996321 1 223355666777776653 243 344433 4666677899
Q ss_pred EccCc
Q 025369 99 EYASG 103 (254)
Q Consensus 99 ~~~~~ 103 (254)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0028 Score=52.32 Aligned_cols=74 Identities=11% Similarity=0.047 Sum_probs=42.0
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeE------EEEcCCeEEEEEE
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 99 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~~ 99 (254)
.+.++.|....+|.+... +..+++|.+.. ...+.+..+...+..|...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 455667777789998765 33688997652 22233444455554442212 222222 1123456789999
Q ss_pred ccCccc
Q 025369 100 YASGGE 105 (254)
Q Consensus 100 ~~~~~~ 105 (254)
+++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0086 Score=50.52 Aligned_cols=77 Identities=18% Similarity=0.143 Sum_probs=50.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccC------C-ccchhHHHHHHHHhhcCC--CCC-eeeeeEEEEcCCe
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------G-DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTH 93 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~------~-~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~ 93 (254)
.++ .+.||.|....||++.+...++.++||.-.. + +...++..-|...|+... .|. +++++. .++..
T Consensus 31 ~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~ 107 (409)
T PRK12396 31 GLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM 107 (409)
T ss_pred cce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH
Confidence 344 6788999999999999854456799996321 1 223466667777777653 243 444443 35666
Q ss_pred EEEEEEccCc
Q 025369 94 LAIVMEYASG 103 (254)
Q Consensus 94 ~~lv~~~~~~ 103 (254)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 6778887754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0038 Score=51.85 Aligned_cols=79 Identities=14% Similarity=0.155 Sum_probs=44.8
Q ss_pred CceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee-eeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 98 (254)
+..++....| |=...+|++..... +..|++|.........-.-.+|...++.+...++- +++.++ .++ ++.
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~ 89 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ 89 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence 4555544444 66678898875432 33788997655433222335677777777554443 445444 222 477
Q ss_pred EccCccch
Q 025369 99 EYASGGEL 106 (254)
Q Consensus 99 ~~~~~~~L 106 (254)
+|+++.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88766544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0042 Score=51.90 Aligned_cols=139 Identities=17% Similarity=0.192 Sum_probs=76.0
Q ss_pred EeccccCCcceEEEEEEEcc----cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee-eeeEEEEcCCeEEEEEEcc
Q 025369 27 FVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~----~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~~~~ 101 (254)
-.+.+..|-...+|++.... .+..+++|.........-...+|...++.+...++. ++++.+.. + .+.+|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 34455557778999987532 246789997755432222236677777777544443 34444422 2 478888
Q ss_pred CccchHHH----------HH-------hcC-C----CC-HHHHHHHHHH-----------------HHHHHHHHH-----
Q 025369 102 SGGELFER----------IC-------NAG-R----FS-EDEARFFFQQ-----------------LISGVSYCH----- 136 (254)
Q Consensus 102 ~~~~L~~~----------l~-------~~~-~----~~-~~~~~~~~~~-----------------i~~~l~~LH----- 136 (254)
++.++... +. ... + .. ...+..+..+ +...+..|.
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 76554211 10 000 0 11 1122222211 111122221
Q ss_pred ---hcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 137 ---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 137 ---~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
...++|+|+++.||+++++. ..+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhccc
Confidence 23589999999999997533 2499999997753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.037 Score=47.03 Aligned_cols=73 Identities=16% Similarity=0.180 Sum_probs=48.8
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccC-----Cc---cchhHHHHHHHHhhcCC---CCCeeeeeEEEEcCCeEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 95 (254)
..+.||.|....||++.+. ++.++||.-.. +. ...++...|...|+.+. ...+++++.++. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999999874 45689997542 11 13344555666666553 246667777665 4457
Q ss_pred EEEEccCc
Q 025369 96 IVMEYASG 103 (254)
Q Consensus 96 lv~~~~~~ 103 (254)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999966
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0033 Score=50.78 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.9
Q ss_pred CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 139 ~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.++|||++|.||++++++. -.-++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986432 24699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0051 Score=50.28 Aligned_cols=107 Identities=12% Similarity=0.055 Sum_probs=72.3
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC---CCeeeeeEEEEcC---CeEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIV 97 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv 97 (254)
+-.-.+.|+.|..+.+|...... + .+.+|.. ........+..|...++.+.. -.+.++++++..+ +.-++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 44456789999999999996542 3 4667763 322234577888888888743 3567777776543 567999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 138 (254)
||++++.++.+. ..+......+..++++++..||+.
T Consensus 92 mE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 92 LERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999998776541 123444555666777777778864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.008 Score=49.27 Aligned_cols=145 Identities=13% Similarity=0.099 Sum_probs=80.1
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccC-C--ccchhHHHHHHHHhhcCCCCCe--eeeeEEEEcCC--eEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-G--DKIDENVQREIINHRSLRHPNI--VRFKEVILTPT--HLAI 96 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~-~--~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~--~~~l 96 (254)
...+++....|-...+|..... ++.++++ ... . ........+|...++.+.---+ ...++.|.++. ..|.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 3445555555555566666554 7778888 332 1 2234556677777777644232 33444444443 5589
Q ss_pred EEEccCccch------------------HHHHHhc--------CC------CCHHHHHHHHHHH--------------HH
Q 025369 97 VMEYASGGEL------------------FERICNA--------GR------FSEDEARFFFQQL--------------IS 130 (254)
Q Consensus 97 v~~~~~~~~L------------------~~~l~~~--------~~------~~~~~~~~~~~~i--------------~~ 130 (254)
||+|.+|..+ .+++..- .. ....++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999887211 1111100 00 0111122221111 22
Q ss_pred HHHHHHh--------cCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 131 GVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 131 ~l~~LH~--------~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
...+|++ ..++|||+++.|+++++++. +-+.||+.+....+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence 2445542 24899999999999987776 89999998764433
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.043 Score=45.13 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.5
Q ss_pred CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 139 ~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
+++|||+.++|+++++++. +.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999987765 8999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.053 Score=44.47 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.2
Q ss_pred cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 ~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.+++|||+.+.|++++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 47899999999999976 33 8999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.073 Score=44.14 Aligned_cols=69 Identities=14% Similarity=0.074 Sum_probs=41.1
Q ss_pred cceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe--ee---eeE--EEEcCCeEEEEEEccCcc
Q 025369 35 NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI--VR---FKE--VILTPTHLAIVMEYASGG 104 (254)
Q Consensus 35 ~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~---~~~--~~~~~~~~~lv~~~~~~~ 104 (254)
....||.+... ++..+++|...........+..|+..+..|....+ +. ..+ +...++..+.++++.+|.
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 34568888764 45568899775444455667777777766632221 11 111 122345678889988764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0056 Score=47.32 Aligned_cols=30 Identities=33% Similarity=0.678 Sum_probs=19.2
Q ss_pred cCeeecCCCCCcEEe-cCCCCCceEEecccccc
Q 025369 138 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 ~~i~h~di~p~nili-~~~~~~~~~l~df~~~~ 169 (254)
..+.|+|+.+.||++ +.++. ++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~--~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGE--VKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSC--EEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCe--EEEecHHHHh
Confidence 358999999999999 44554 9999999765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.013 Score=48.64 Aligned_cols=83 Identities=24% Similarity=0.241 Sum_probs=59.2
Q ss_pred CCeeeeeEEEEcC-CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCC
Q 025369 79 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP 156 (254)
Q Consensus 79 ~~i~~~~~~~~~~-~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~ 156 (254)
++..+..-+-.++ .+.|++|++- |+++...- ....+++..++++.+..++-+..+ ..-|+|+.-.||+++ +|
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 3333333333233 3568888875 44543211 135678889999999999888865 699999999999998 66
Q ss_pred CCceEEecccccc
Q 025369 157 APRLKICDFGYSK 169 (254)
Q Consensus 157 ~~~~~l~df~~~~ 169 (254)
+ +.|+||.+++
T Consensus 359 n--vtLIDfklsR 369 (488)
T COG5072 359 N--VTLIDFKLSR 369 (488)
T ss_pred c--eEEEEeeeee
Confidence 6 9999999876
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.033 Score=47.17 Aligned_cols=79 Identities=9% Similarity=0.006 Sum_probs=44.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccc-e-----eEEEEEccCCccchhHHHHHHHHhhcCCCCCee-eeeEEEEcCCeEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTK-E-----LVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLA 95 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~-~-----~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~ 95 (254)
+..++. .|..|-...+|++...... . .|+++.........-+-.+|..+++.+...++. ++++.+. -+
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 344554 5555777899999754321 2 244443322222222335678888888665554 4444442 25
Q ss_pred EEEEccCccch
Q 025369 96 IVMEYASGGEL 106 (254)
Q Consensus 96 lv~~~~~~~~L 106 (254)
++.+|++|.++
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 88888887654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.068 Score=43.44 Aligned_cols=76 Identities=11% Similarity=0.065 Sum_probs=46.9
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC---CCCeeeeeEEEEcCCeEEEEEEcc
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYA 101 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~ 101 (254)
.+-.+.++.|....+|.+. .+++.+.+|.-. ......+..|...|+.|. .-.+++++.+....+.-++++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4456678889999999987 467788899654 233456777888887773 345778888887777779999998
Q ss_pred Ccc
Q 025369 102 SGG 104 (254)
Q Consensus 102 ~~~ 104 (254)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 755
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.59 Score=45.00 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.5
Q ss_pred cCeeecCCCCCcEEecCCCCCceE-Eecccccc
Q 025369 138 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 169 (254)
Q Consensus 138 ~~i~h~di~p~nili~~~~~~~~~-l~df~~~~ 169 (254)
.+++|+|+++.||+++.++..++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 469999999999999876532354 99999765
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.2 Score=43.42 Aligned_cols=79 Identities=15% Similarity=0.026 Sum_probs=44.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcc--------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee-eeeEEEEcCC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~ 92 (254)
.++. -.+.|..|-.-.+|++.... .++.|++++.-......-.-.+|...++.+...++- ++++.+.
T Consensus 105 ~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--- 180 (442)
T PTZ00296 105 EDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS--- 180 (442)
T ss_pred cccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC---
Confidence 3455 45566667777888887542 146788997755432222334566666666543433 3444432
Q ss_pred eEEEEEEccCccc
Q 025369 93 HLAIVMEYASGGE 105 (254)
Q Consensus 93 ~~~lv~~~~~~~~ 105 (254)
-+.+.+|++|.+
T Consensus 181 -gg~I~efi~g~~ 192 (442)
T PTZ00296 181 -GGRIEEWLYGDP 192 (442)
T ss_pred -CCEEEEeeCCcc
Confidence 245778887653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.0032 Score=60.94 Aligned_cols=150 Identities=16% Similarity=0.136 Sum_probs=101.3
Q ss_pred HHHHhhcCCCCCeeeeeEEEEcC--CeEEEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc---C
Q 025369 69 EIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAM---Q 139 (254)
Q Consensus 69 e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~ 139 (254)
|....+.+.|+++.....-.... ...+..+.++.+|.+.+.+.++ ++....-+.....+.+....-+|+. |
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 44445666888876655444332 2446778888888888888654 2334444444444435555555533 2
Q ss_pred --eeecCCCCCcEEecCCCCCceEEecccccc-cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh
Q 025369 140 --VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216 (254)
Q Consensus 140 --i~h~di~p~nili~~~~~~~~~l~df~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 216 (254)
-+|.++++.|.++..+.+ ++++++|+.+ ..+.........+++.|+.|+....-....+ +|+|..|+.+|....
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSD 1435 (2724)
T ss_pred ccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhc
Confidence 678999999999987776 9999999987 3333333345567778888888766666555 999999999999887
Q ss_pred CCCCC
Q 025369 217 GGYPF 221 (254)
Q Consensus 217 g~~pf 221 (254)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77665
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.24 Score=38.57 Aligned_cols=113 Identities=15% Similarity=0.075 Sum_probs=64.5
Q ss_pred CcceEEEEEEEcccceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCccchHHHHH
Q 025369 34 GNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 111 (254)
Q Consensus 34 g~~g~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~ 111 (254)
++.++.-+++.+. | ...+|++...+.. ..-+..+..++.++ -+|+++..- ..-.+.++.|+|.....
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-----
Confidence 3444544444443 3 3455555544332 23345556665544 245555521 33356788888853211
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 112 NAGRFSEDEARFFFQQLISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 112 ~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.....+. -=+.+|.-.|+ .+.+|||.+|+||+-|..|. +||.|=+.
T Consensus 142 ----~~~N~i~----agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 142 ----NFSNFIT----AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred ----chhHHHH----HhHHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 1111111 11355666784 36999999999999999988 99999763
|
The function of this family is unknown. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.075 Score=42.76 Aligned_cols=46 Identities=26% Similarity=0.351 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHHHHHhc--CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 122 RFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 122 ~~~~~~i~~~l~~LH~~--~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
...+..+-.++.-.+.. -++|+|+.|.|++.++.+. ++|+||..|.
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~--l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG--LFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCc--EEEEecccCC
Confidence 33445555555555544 5899999999999987555 9999999775
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.18 Score=38.49 Aligned_cols=33 Identities=21% Similarity=0.233 Sum_probs=25.7
Q ss_pred hcCeeecCCCCCcEEecCCCCC---ceEEecccccc
Q 025369 137 AMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 169 (254)
Q Consensus 137 ~~~i~h~di~p~nili~~~~~~---~~~l~df~~~~ 169 (254)
...++|||+.+.|+++..++.+ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 3469999999999999754432 48999998664
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.091 Score=39.67 Aligned_cols=29 Identities=24% Similarity=0.393 Sum_probs=24.3
Q ss_pred CeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 139 ~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
-.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 379999999999997554 78999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 254 | ||||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-129 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-124 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-124 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-124 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-123 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-121 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-43 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-42 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-42 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-41 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-41 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-41 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-41 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-41 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-40 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-40 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-40 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-40 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-40 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-39 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-39 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-39 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-35 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-35 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-34 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-34 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-34 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-34 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-34 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-34 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-33 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-32 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-31 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-31 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-31 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-31 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-31 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-30 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-30 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-30 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-30 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-30 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-28 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-28 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-27 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-27 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-27 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-26 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-26 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-26 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-25 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-24 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-23 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-23 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-23 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-23 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-23 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-22 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-21 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-20 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-18 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-05 |
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 420 bits (1081), Expect = e-149
Identities = 214/233 (91%), Positives = 226/233 (96%), Gaps = 1/233 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQ
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-121
Identities = 83/241 (34%), Positives = 132/241 (54%), Gaps = 13/241 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTI--QVFIKPCCHIT 245
PE+L R E+ + DVWSCG+ L ML G P++ P + +++ + ++ P I
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 246 P 246
Sbjct: 236 S 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 341 bits (877), Expect = e-119
Identities = 83/241 (34%), Positives = 132/241 (54%), Gaps = 13/241 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTI--QVFIKPCCHIT 245
PE+L R E+ + DVWSCG+ L ML G P++ P + +++ + ++ P I
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 246 P 246
Sbjct: 236 S 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-91
Identities = 94/214 (43%), Positives = 120/214 (56%), Gaps = 8/214 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ ++T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G D+WSCGV LY +L G PF+D P F+K
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 2e-90
Identities = 84/213 (39%), Positives = 122/213 (57%), Gaps = 7/213 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
Y ++ IG GNF +L R +T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ +YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
DVWS GV LY ++ G PF+ + + +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-89
Identities = 92/214 (42%), Positives = 122/214 (57%), Gaps = 8/214 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ + ++T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G D+WS GV LY +L G PF+D P F+K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-88
Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 8/215 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ DVWS G +Y +LVG PFE + + +
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-88
Identities = 94/214 (43%), Positives = 127/214 (59%), Gaps = 9/214 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G+FG +L T++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G DVWSCG+ LYVMLVG PF+D P F+K
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 3e-87
Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 8/215 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ DVWS G +Y +LVG PFE + + +
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 3e-86
Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLR 77
+Y +G G++G + + D T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 78 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 133
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 190
Y H+ + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ + G D+WS GVTLY + G YPFE + K F
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 253 bits (650), Expect = 5e-85
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 9/216 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
+ + +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y H+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ R
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ + +DVWS G Y +L+G PF+ K
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 4e-84
Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--------VQREIINHR 74
+Y +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 131
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 188
V +CH V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
PE + H Y G+ A VWS G+ LY M+ G PFE +E
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 5e-84
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIINHR 74
+Y + +GSG FG DK + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 75 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
+ Y G ++WS GVTLY ++ PF + +E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-83
Identities = 73/221 (33%), Positives = 116/221 (52%), Gaps = 8/221 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
D +D R +G G FG L R+K K ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
K D+W GV Y LVG PF+ P + R+ + V +K
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-83
Identities = 79/245 (32%), Positives = 114/245 (46%), Gaps = 43/245 (17%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------------- 58
+Y +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 59 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 114
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 169
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 170 SSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
++L +TVGTPA++APE L R + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 228 KDFRK 232
K
Sbjct: 247 CLHSK 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 7e-83
Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 8/221 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
K D+WS GV Y LVG PFE + +++ +V
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-82
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--------NVQREIINHR 74
Y +G G FG + VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 75 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 129
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 186
+ + +CH+ V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
PE + RH+Y A VWS G+ LY M+ G PFE E
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-80
Identities = 66/225 (29%), Positives = 96/225 (42%), Gaps = 13/225 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
++ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 131
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 132 VSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+L + +Y D WS G + + G PF +P + ++
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-80
Identities = 77/214 (35%), Positives = 118/214 (55%), Gaps = 6/214 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 80
+ F+ +GSG F L++ ++T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 141 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYD 198
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL + Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
K D WS GV Y++L G PF + E K F K
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-80
Identities = 77/215 (35%), Positives = 113/215 (52%), Gaps = 5/215 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
K D+W+CGV LY++LVG PF D D+ + + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 9e-80
Identities = 78/214 (36%), Positives = 114/214 (53%), Gaps = 6/214 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHP 79
+ Y IG G++G ++ K T+ A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y- 184
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G D WS GV +YV+L G PF P + + K
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-79
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 16/230 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
R G D+WS GVT Y G PF + P+ ++ +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 6e-79
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 16/230 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
R G D+WS GVT Y G PF + P+ ++ +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-78
Identities = 73/226 (32%), Positives = 106/226 (46%), Gaps = 13/226 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
L+ + D WS GV L++ L G PF + + I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 9e-78
Identities = 74/220 (33%), Positives = 116/220 (52%), Gaps = 10/220 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D Y+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H+ ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G AD+WS GV Y++L G PF + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-77
Identities = 82/215 (38%), Positives = 121/215 (56%), Gaps = 6/215 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D K DVWS GV LY++L G PF +E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-77
Identities = 78/215 (36%), Positives = 114/215 (53%), Gaps = 5/215 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKID-ENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
K D+W+CGV LY++LVG PF D D+ + + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-77
Identities = 72/226 (31%), Positives = 106/226 (46%), Gaps = 13/226 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
L+ + D WS GV L++ L G PF + + I
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-77
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 9/218 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 79
D + F R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 135
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 136 HAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ V H+DLK EN L SP +KI DFG ++ + GT Y+APEV +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ K D+WS GV +Y +L G PF + +K
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 9e-77
Identities = 77/204 (37%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
+D Y+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
I+ K+V ++ +V E GGEL ++I FSE EA + V Y HA V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 141 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRDLK N L ++ICDFG++K + T T ++APEVL R Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 198 DGKIADVWSCGVTLYVMLVGGYPF 221
D D+WS GV LY ML G PF
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-76
Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 17/226 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREI-I 71
+YD IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
VS+ HA + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
L + GK D+W+CGV L+ +L G PF + R
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 4e-76
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI- 70
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 71 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 191 VLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
++ D GK D+WS GV +Y +L G PF + R
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 5e-76
Identities = 74/220 (33%), Positives = 119/220 (54%), Gaps = 10/220 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G AD+WS GV Y++L G PF + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-76
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 10/220 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G AD+WS GV Y++L G PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 1e-75
Identities = 71/220 (32%), Positives = 112/220 (50%), Gaps = 10/220 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
G AD+WS GV Y++L G PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-75
Identities = 83/222 (37%), Positives = 119/222 (53%), Gaps = 9/222 (4%)
Query: 22 SDRYDF---VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLR 77
YD + +G G+F + R K + + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 138 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRH 195
+ V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237
YD + D+WS GV LY ML G PF+ D +++
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-75
Identities = 77/219 (35%), Positives = 114/219 (52%), Gaps = 12/219 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
++ Y ++G G F V R + + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 139 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 193
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+ Y GK D+W+CGV LY++LVG PF D D+ + +++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-75
Identities = 78/213 (36%), Positives = 117/213 (54%), Gaps = 4/213 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
SD ++ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 142 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRK 232
D+WS G+ Y++L G PF D + FR+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-75
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 2/212 (0%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
++Y D+G G FG+ + +K+ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + H+ +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D+WS G +YV+L G PF +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-75
Identities = 47/244 (19%), Positives = 88/244 (36%), Gaps = 39/244 (15%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------GDKIDE 64
+ Y +R + G F L + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 65 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 116
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 117 SEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + +++ SY H +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
+ + GT ++ PE Y+G D+WS G+ LYVM PF +
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 232 KTIQ 235
I+
Sbjct: 263 NNIR 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 4e-75
Identities = 82/215 (38%), Positives = 121/215 (56%), Gaps = 6/215 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D K DVWS GV LY++L G PF +E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 5e-75
Identities = 81/215 (37%), Positives = 115/215 (53%), Gaps = 6/215 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
S+ Y V+ +GSG +G L RDKVT A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL +KI DFG S + K +GT YIAPEVL + Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y 214
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D K DVWS GV L+++L G PF + + RK
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK 248
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-74
Identities = 88/216 (40%), Positives = 122/216 (56%), Gaps = 7/216 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
SDRY R +G G+FG L +DK+T + AVK I + K D E++ RE+ + L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNI++ E + +V E +GGELF+ I + RFSE +A +Q++SG++Y H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
YD K DVWS GV LY++L G PF +E +K
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK 238
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-73
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 3/213 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQ 139
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ H D+K EN + + A +KI DFG + K T T + APE++ R G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D+W+ GV YV+L G PF D+ + +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-73
Identities = 79/226 (34%), Positives = 119/226 (52%), Gaps = 17/226 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--------------GDKIDENVQ 67
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
IAPEVL + Y+ K DVWSCGV +Y++L G PF ++ +K
Sbjct: 215 IAPEVLKKK-YNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 1e-73
Identities = 65/263 (24%), Positives = 106/263 (40%), Gaps = 52/263 (19%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKID-ENVQREIINHRS 75
+Y IG G++GV R+ + T+ + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 116 --------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155
E +Q+ S + Y H +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 156 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGV 209
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 210 TLYVMLVGGYPFEDPDEPKDFRK 232
L+++L+G PF ++ +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-73
Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 34/243 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ + +G G FG R+ + A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 82 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 127
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 172
++ +SY H+ + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
S +GT Y+A EVL + + D++S G+ + M+ YPF E + K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 233 TIQ 235
++
Sbjct: 240 KLR 242
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-73
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 9/219 (4%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREI-INHRSL 76
++ Y +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 134
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D+W+ G+ Y++L PF D + +
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 8e-73
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 5/215 (2%)
Query: 22 SDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRH 78
+ Y + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + +++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D+WS GV Y++L G PF ++ +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-72
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 3/213 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
H DLK EN + + LK+ DFG + K T GT + APEV G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D+WS GV Y++L G PF ++ + R
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-72
Identities = 71/236 (30%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 5 RASLTVGPAMDMPIMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----- 57
S G +DM D Y+ IG G F V R ++ T + AVK ++
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63
Query: 58 -RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 115
E+++RE L+HP+IV E + L +V E+ G +L I
Sbjct: 64 SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 123
Query: 116 ---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171
+SE A + +Q++ + YCH + HRD+K LL + +K+ FG +
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 172 VLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
VGTP ++APEV+ R Y GK DVW CGV L+++L G PF E
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-71
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 23/222 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
+DVWS G LY M G PF+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-70
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 23/222 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
+DVWS G LY M G PF+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-70
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREI-INHRSLRH 78
D Y D +G G + + +T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++ E +V E GG + I F+E EA Q + S + + H
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 188
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPF 221
PEV+ + K D+WS GV LY++L G PF
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-70
Identities = 74/226 (32%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
V + + D Y + +G G G + +K T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 64 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 116
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 175
+E EA + + + Y H++ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
+ TP Y+APEVL +YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPF 263
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-70
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 23/222 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
+DVWS G LY M G PF+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 6e-69
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHP 79
+D Y + +G G G + T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 80 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 133
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 134 YCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 191
+ H+ + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
L +YD K D+WS GV +Y++L G PF
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-67
Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 34/252 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+ + IGSG FG + ++ + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 83 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 124
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
F+Q+ GV Y H+ ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------PKDFRKTI 234
Y++PE + +Y + D+++ G+ L +L + + F K
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE 244
Query: 235 QVFIKPCCHITP 246
+ ++ P
Sbjct: 245 KTLLQKLLSKKP 256
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-67
Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 9/224 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
++Y ++ IG G+FG A L++ +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
Y+ K +D+W+ G LY + + FE K I P
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-66
Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 18/233 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 80 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
+PE + R Y+ K +D+WS G LY + PF + + K + +
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-63
Identities = 59/235 (25%), Positives = 91/235 (38%), Gaps = 23/235 (9%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHP 79
D+ Y F++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 80 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 131
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 181
+ HA HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 182 GTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
T +Y APE+ + H + DVWS G LY M+ G P++ + D
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-63
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 13/223 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSL-RH 78
+ + +G G++G +R K L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
P VR ++ L + E G L + G E + + + + +++ H+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
ADV+S G+T+ + P + +++ Q ++ P
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPP 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 7e-63
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQ 67
P M + + + IG G F + VA+K ++ D +D +
Sbjct: 24 PDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 123
+EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 182
+F QL S + + H+ +V HRD+K N + + +K+ D G + S + S VG
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
TP Y++PE + + Y+ K +D+WS G LY M PF
Sbjct: 199 TPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY 237
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-61
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D + +G G G + +K T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 81 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
+YD K D+WS GV +Y++L G PF
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-59
Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 35/238 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 81
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 134
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 135 CHAMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 178
H++++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 179 STVGTPAYIAPEVLLRHEYD------GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKD 229
+ GT + APE+L + D++S G Y +L G PF D +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-58
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 81
R R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 82 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 131
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 132 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 180
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 181 ----VGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
TP Y PE+ L + G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-58
Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 36/243 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 81 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 125
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 172
Q+ V + H+ + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+++ VGT Y++PE + + Y K D++S G+ L+ +L YPF E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERVRTLT 238
Query: 233 TIQ 235
++
Sbjct: 239 DVR 241
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-58
Identities = 42/259 (16%), Positives = 85/259 (32%), Gaps = 31/259 (11%)
Query: 21 DSDRYDFVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERGDKIDENVQREIIN-HR 74
S +G G F + D K+ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 129
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 180
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 181 V-----GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ T + E+L ++ +I D + T+Y ML G Y + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNE---GGECKPE 296
Query: 236 VFIKPCCHITPFYPLFKLI 254
+ H+ + F ++
Sbjct: 297 GLFRRLPHLDMWNEFFHVM 315
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-56
Identities = 53/217 (24%), Positives = 82/217 (37%), Gaps = 16/217 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 82
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVC 141
R+ I +E L E + E QQ SG+++ H++ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 142 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLR 194
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 195 HEYD--GKIADVWSCGVTLYVMLVGGY-PFEDPDEPK 228
+ D++S G Y ++ G PF + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-55
Identities = 59/263 (22%), Positives = 99/263 (37%), Gaps = 42/263 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSL-R 77
+ + + IGSG FG ++ + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 134 YCHAMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 176
Y H+M + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 177 PKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFED------------ 223
P+ G ++A EVL + + K AD+++ +T+ +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245
Query: 224 PDEPKDFRKTIQVFIKPCCHITP 246
P P+ + +K H P
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDP 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
K +D+W+ G +Y ++ G PF +E F+K
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 243
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-53
Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 16/220 (7%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----S 75
+++ ++ +G G+FG + + + ++L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 192
H++ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
R + + AD WS GV ++ ML G PF+ D +
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-52
Identities = 79/220 (35%), Positives = 112/220 (50%), Gaps = 17/220 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
D ++F+R +G G+FG L R K T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y G D W+ GV LY ML G PFE +E F
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-52
Identities = 76/219 (34%), Positives = 117/219 (53%), Gaps = 16/219 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
+ +D+++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 193
H+ V +RD+KLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
++Y G+ D W GV +Y M+ G PF + D + F
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 73/222 (32%), Positives = 108/222 (48%), Gaps = 21/222 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ + + +G G+FG L K T + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ H+ + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+LL +Y D WS GV LY ML+G PF DE + F
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 21/222 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ F++ IG G+FG L R K + AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H++ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
VL + Y + D W G LY ML G PF + + +
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-51
Identities = 76/222 (34%), Positives = 108/222 (48%), Gaps = 21/222 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
++F+ +G G+FG L K T EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ + + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
++ Y GK D W+ GV LY ML G PFE DE + F+
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-51
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR---- 74
+ ++ +R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
L+R + + D WS G +Y ML G PF + K K
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-51
Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
+ +R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 137 AMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+ + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y K D WS G+ +Y ML G PF D + K + K
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-51
Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 29/239 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
+G G+FG M+DK T AVK + ++ E++ L P IV +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
+ I ME GG L + I G ED A ++ Q + G+ Y H ++ H D+K +N
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 151 LLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
LL R +CDFG++ GT ++APEV++ D K D+
Sbjct: 182 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDI 239
Query: 205 WSCGVTLYVMLVGGYPFED-----------------PDEPKDFRKTIQVFIKPCCHITP 246
WS + ML G +P+ + P I+ P
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEP 298
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-51
Identities = 31/256 (12%), Positives = 62/256 (24%), Gaps = 52/256 (20%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 78 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 106
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLV 216
V + + + PE+ R D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 217 GGYPFEDPDEPKDFRK 232
P
Sbjct: 309 ADLPITKDAALGGSEW 324
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-51
Identities = 65/216 (30%), Positives = 116/216 (53%), Gaps = 13/216 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y K D W+ GV +Y M G PF + + K
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-50
Identities = 75/216 (34%), Positives = 115/216 (53%), Gaps = 9/216 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
+ +++++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y G+ D W GV +Y M+ G PF + D K F
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-49
Identities = 35/255 (13%), Positives = 60/255 (23%), Gaps = 43/255 (16%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
+ V + G+ V L+RD E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 80 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 107
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 108 ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167
G QLI + + + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPD 225
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 226 EPKDFRKTIQVFIKP 240
P
Sbjct: 298 PGIKGSWKRPSLRVP 312
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-49
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229
+L +Y G D W+ GV ++ M+ G PF+ +
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 13/222 (5%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 81
+ +R IG G+FG +++ TK++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V + +V++ GG+L + F E+ + F +L+ + Y ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 142 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ + G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 200 --KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
D WS GVT Y +L G P+ ++ + F
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFET 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 18/240 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 192
Y H + +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR-KTIQVFIKPCCHITPFYPLF 251
+Y G D W+ GV ++ M+ G PF+ + T + P
Sbjct: 226 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-48
Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
++F+ +G G+FG L K T EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRH 195
+ + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y GK D W+ GV LY ML G PFE DE + F+
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
Y+ V+ IG G FG +L+R K T+++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
+M HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 195 HEYD---GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
D G+ D WS GV LY MLVG PF + K
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 23/227 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
D ++ ++ IG G F +++ K T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 133
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 191
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 192 LLRHEYD------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
L G D W+ GV Y M G PF + + K
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-47
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 26 DFVRDIGSGNFG---VARLMRDKVTKELVAVK-----YIERGDKIDENVQRE-----IIN 72
+ ++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 133 SYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 189 PEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
P+++ + K D WS GV +Y +L G PF E + +
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-46
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 90 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 147 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIAD 203
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ + Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEP 227
+WS G T+ M G PF + EP
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
++ ++ IG G FG +++ K ++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 135
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 194 RHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
E G D WS GV +Y ML G PF + + K
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-46
Identities = 32/255 (12%), Positives = 67/255 (26%), Gaps = 45/255 (17%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 78 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 106
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 167 YSKS--SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLVGGYP 220
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 221 FEDPDEPKDFRKTIQ 235
D +
Sbjct: 317 NTDDAALGGSEWIFR 331
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-46
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------SLRH 78
R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
AD +S G L+ +L G PF
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-45
Identities = 66/238 (27%), Positives = 112/238 (47%), Gaps = 22/238 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG D T+++VA+K I E + E++Q+EI P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ ++ L T L I+MEY GG + + G E + ++++ G+ Y H+ +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
HRD+K N LL +K+ DFG + ++T VGTP ++APEV+ + YD
Sbjct: 140 KIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 199 GKIADVWSCGVTLYVMLVGGYPFED---------------PDEPKDFRKTIQVFIKPC 241
K AD+WS G+T + G P + P ++ K ++ F++ C
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 16/226 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 134
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
H + +RDLK EN LLD ++I D G + GTP ++APE+LL
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD----FRKTIQ 235
EY D ++ GVTLY M+ PF E + ++ ++
Sbjct: 363 GEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 9/216 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRH 78
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
Y D W+ G LY M+ G PF+ + +
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-45
Identities = 67/246 (27%), Positives = 113/246 (45%), Gaps = 27/246 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFED---------------P--DEPKDFRKTIQVFIKP 240
+ AD+WS G+T M G P+ D P +P+ + F+K
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 241 CCHITP 246
C +P
Sbjct: 262 CLVKSP 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 9e-45
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
D ++ + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
Y + +D+WS G++L M VG YP PD +
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-44
Identities = 71/249 (28%), Positives = 107/249 (42%), Gaps = 32/249 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D + +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHA 137
IV+ L P + +VMEYA GG L+ + A A + GV+Y H+
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 138 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFED-----------------PDEPKDFRKTIQVF 237
Y K DV+S G+ L+ ++ PF++ P K+ K I+
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 238 IKPCCHITP 246
+ C P
Sbjct: 237 MTRCWSKDP 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV + + L L +VMEY +GG L + + E + ++ + + + H+ Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ R
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFED 223
Y K D+WS G+ M+ G P+ +
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-43
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 30/249 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREI-INHRSLR 77
+ + + + ++GSG G MR + T ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 192
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 193 -LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD------------------EPKDFRKT 233
+ +YD + ADVWS G++L + G +P+++ F
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 234 IQVFIKPCC 242
Q F+K C
Sbjct: 260 FQSFVKDCL 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-43
Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 80
D IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y HA V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ R Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFED 223
+ D+WS G+ + M+ G P+
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS 243
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
+D + + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 134
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 135 CHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
H+ + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 193 L----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
+ Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-42
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 18/242 (7%)
Query: 1 MKMDR-ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--E 57
M ++ L + P ++ + +IG G +G M K + +++AVK I
Sbjct: 1 MSIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 58 RGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA- 113
+K + + ++ + RS P IV+F + I ME S + ++ + +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 114 -GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
E+ + +++ +++ HRD+K N LLD S +K+CDFG S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQL 176
Query: 172 VLHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
V G Y+APE + R YD + +DVWS G+TLY + G +P+ +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
Query: 228 KD 229
D
Sbjct: 236 FD 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-42
Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
++ ++ V ++G G FG ++K T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAM 138
IV+ L I++E+ GG + + +E + + +Q++ +++ H+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRH 195
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 196 E-----YDGKIADVWSCGVTLYVMLVGGYPFED---------------P--DEPKDFRKT 233
YD K AD+WS G+TL M P + P P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 234 IQVFIKPCCHITP 246
+ F+K P
Sbjct: 252 FRDFLKIALDKNP 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-41
Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV F
Sbjct: 45 IGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAM--QVCH 142
+ P +L+IV EY S G L+ + +G E + G++Y H + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
R+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL +
Sbjct: 163 RNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 200 KIADVWSCGVTLYVMLVGGYPFED----------------PDEPKDFRKTIQVFIKPCCH 243
K +DV+S GV L+ + P+ + + P++ + I+ C
Sbjct: 219 K-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 244 ITP 246
P
Sbjct: 278 NEP 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-41
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRH 78
+ D Y+ IGSG V + KE VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 130
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 184
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
++APEV+ + YD K AD+WS G+T + G P+
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 2e-41
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 20/220 (9%)
Query: 21 DSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRS 75
+ Y+ + IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 133
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 185
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 186 YIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 38/253 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+ ++ V +G+G +G R T +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 81 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 132
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 133 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 189
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 190 EVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------EPK 228
EV+ E YD K +D+WS G+T M G P D + K
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257
Query: 229 DFRKTIQVFIKPC 241
+ K Q FI+ C
Sbjct: 258 KWSKKFQSFIESC 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-40
Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 80
IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-- 138
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 139 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+ + +DVWS GV L+ +L G PF
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-40
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 13/219 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 84
IG G+F D T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 85 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VC 141
+ + + +V E + G L + R + +Q++ G+ + H +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
DV++ G+ + M YP+ + + + +KP
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-40
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 35/251 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
+ +R+IG G+FG RD E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 193
+ + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPFED---------------PD-EPKDFRKTIQ 235
+YDGK DVWS G+T + P + P + + + +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283
Query: 236 VFIKPCCHITP 246
F+ C P
Sbjct: 284 NFVDSCLQKIP 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-40
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV--------QREIINHRSLR 77
++ + IG G FG+ R K +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 137 AM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 192 LL-RHE-YDGKIADVWSCGVTLYVMLVGGYPFED 223
+ E Y K AD +S + LY +L G PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 31 IGSGNFGVARLMRDKVTKEL----VAVKYIERGDKIDENVQ---REIINHRSLRHPNIVR 83
IG G FG +V VA++ I+ ++ ++ RE++ +R RH N+V
Sbjct: 41 IGKGRFG-------QVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y HA + H
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL---- 192
+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 154 KDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
+ + +DV++ G Y + +PF+
Sbjct: 211 PDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-38
Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 19/204 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEV 87
+ + G L + + + VK ++ D + + E R HPN++
Sbjct: 18 LNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 88 ILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VC 141
+P H ++ + G L+ + F D+++ F + G+++ H ++ +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
L + ++D +I S Q + PA++APE L + D
Sbjct: 136 RHALNSRSVMIDED--MTARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 202 --ADVWSCGVTLYVMLVGGYPFED 223
AD+WS V L+ ++ PF D
Sbjct: 190 RSADMWSFAVLLWELVTREVPFAD 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
DRY + +G G +G D VT E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CH+
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 139 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 194 RHEYDGKIADVWSCGVTLYVMLVG 217
Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IGSG+FG + + K + VAVK + + +Q E+ R RH NI+ F
Sbjct: 32 IGSGSFG--TVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 88 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T LAIV ++ G L+ + + +F + +Q G+ Y HA + HRDLK
Sbjct: 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 147 LENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGK 200
N L +KI DFG + Q + G+ ++APEV+ + Y +
Sbjct: 148 SNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 201 IADVWSCGVTLYVMLVGGYPFED 223
+DV++ G+ LY ++ G P+ +
Sbjct: 206 -SDVYAFGIVLYELMTGQLPYSN 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE 64
S V + ++Y+ + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 65 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 118
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178
+ + Q+I+G+ +CH+ + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 179 ST-VGTPAYIAPEVLLRHEYDGKIADVWSCG 208
V T Y APE+L+ GK DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-37
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
Y + IG+G+FGV + + ELVA+K + DK +N RE+ R L H NIVR
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 84 FKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ + +L +V++Y + + QL ++Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ +CHRD+K +N LLD A LK+CDFG +K L + + + Y APE++
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELI 228
Query: 193 LR-HEYDGKIADVWSCG 208
+Y I DVWS G
Sbjct: 229 FGATDYTSSI-DVWSAG 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-36
Identities = 38/183 (20%), Positives = 65/183 (35%), Gaps = 22/183 (12%)
Query: 60 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 116
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
F Q+ V + H+ + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 177 PKST-------------VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
++ VGT Y++PE + + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 224 PDE 226
E
Sbjct: 276 QME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 81 IVRFKE 86
IVR+
Sbjct: 66 IVRYFN 71
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-36
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
+ V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPF 221
Y I D+WS G + G P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-36
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y+ + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 193
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 194 RHEYDGKIADVWSCG 208
G DVW+ G
Sbjct: 176 GDTQYGPPVDVWAIG 190
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-36
Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG A + + T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 90 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L + EY GG L I + + + F + + SG++Y H+M + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 149 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 193
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQVFIKPCC 242
YD K DV+S G+ L ++ D DF ++ F+ C
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-36
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSL 76
M S ++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 131
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 190
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
VL+ Y I D+WSCG L M+ G
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITG 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
M + + + RY+ + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 68 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 124
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 181
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 182 GTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG 217
T Y APE+L R Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARM-YGVGV-DMWAVGCILAELLLR 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y + +G G + + K+T LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHE 196
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 197 YDGKIADVWSCGVTLYVMLVG 217
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-34
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 195 HEYDGKIADVWSCGVTLYVMLVG 217
+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
Y + IG+G+FGV + + E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 82 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 132
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+Y H++ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 191 VLLR-HEYDGKIADVWSCGVTLYVMLVG 217
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
+G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 16 VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------- 139
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
+ HRDLK +N L+ + + I D G + ++ L VGT Y+APEVL
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
+ + D+W+ G+ L+ + ++ K
Sbjct: 191 ETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M ++ ++Y + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 63 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 116
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 177 PKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
+ V T Y AP+VL+ +Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
D Y VR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR-H 195
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF 221
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-34
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 23 DRYDFVRD-IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
D +++ +G G +G A+ +D + A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 79 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 128
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 182
+ G+ Y HA V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 183 TPAYIAPEVLL--RHEYDGKIADVWSCG 208
T Y APE+LL RH Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARH-YTKAI-DIWAIG 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----Q 67
+++ P + +Y+ + IG G FG R + T + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 117
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 173
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 174 HSQP-KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCG 208
+ V T Y PE+LL +Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-34
Identities = 55/247 (22%), Positives = 99/247 (40%), Gaps = 30/247 (12%)
Query: 7 SLTVGPAMDMPIMH---DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
S + G +P++ + + V+ IG G +G + K E VAVK ++
Sbjct: 18 SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEAS 75
Query: 64 ENVQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSED 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAK 134
Query: 120 EARFFFQQLISGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
+SG+ + H + HRDLK +N L+ + I D G +
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKF 192
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
++ + P + VGT Y+ PEVL H +AD++S G+ L+ +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 222 EDPDEPK 228
+E +
Sbjct: 253 GIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
IG G FG + R K E VAVK ++ + EI LRH NI+ F +
Sbjct: 50 IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------M 138
T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
+ HRDLK +N L+ + I D G + + + P VGT Y+APEVL
Sbjct: 167 AIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 193 ----LRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
++H E + AD+++ G+ + + ++ +
Sbjct: 225 DSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 71/207 (34%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLR 77
++RY V +G G L D + VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRH 195
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFE 222
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-33
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
RY+ V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 76 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 125
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182
+Q + G+ + HA + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCG 208
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN- 65
SL A D + DR+ R G G FG +L ++K T VA+K + D N
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNR 65
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR--- 115
+ + + L HPNIV+ + T L +VMEY L N R
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 116 -FSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
+ F QLI + H ++ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183
Query: 173 LHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
+ + + Y APE++ Y + D+WS G M++G
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY ++ +G G G+ D + VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 128
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
Y +P +LL + Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 66/250 (26%), Positives = 97/250 (38%), Gaps = 30/250 (12%)
Query: 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---- 66
G M P DRY+ +G G L RD VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 67 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 178
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--------------EDP 224
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 225 DEPKDFRKTI 234
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 9/205 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRHP 79
Y R +G G G D V + +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
++V + L + M +G +L + G + A +Q+ S + HA
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFE 222
+ AD+++ LY L G P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 22/211 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKIDENVQ----REIINHRSL 76
+ +Y+ I G G L D+ V V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 77 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+SY H++ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
+ D+++ G TL + +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRN 277
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-30
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQ----REI---INHR 74
+Y+ V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 127
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
L+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 186 YIAPEVLLRHEYDGKIADVWSCG 208
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-30
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
S + G FG + + ++ E VAVK DK + E+ + ++H N
Sbjct: 22 QSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 81 IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I++F K L ++ + G L + + A S +E + + G++Y H
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138
Query: 137 AMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 183
+ HRD+K +N LL + I DFG + T VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 184 PAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
Y+APEVL + + + D+++ G+ L+ + + P +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 53/238 (22%), Positives = 85/238 (35%), Gaps = 37/238 (15%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D D + IG G +G + + + + VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 136 HAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 177
H + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 178 KSTVGTPAYIAPEVL------LRHEYDGKIADVWSCGVTLYVML---VGGYPFEDPDE 226
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 15/228 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D + + VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
L Y + D+WS G + M+ GG F D + K I+ P
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y ++ +GSG +G D T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y HA + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V+L Y + D+WS G + M+ G
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D V VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+ H+ + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVG 217
V+L Y + D+WS G + M+
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-29
Identities = 66/214 (30%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REIINH 73
RY + IG G +G+ D + K VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 74 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 128
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 185 AYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
Y APE++L Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REII 71
+ S + +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 180
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 181 -----VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y +GSG +G DK + E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V+L Y+ + D+WS G + ML G
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTG 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 47/238 (19%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
S +Y + +G+G+FG+ + D + + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 114
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 115 --------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
+ + QL V + H++ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG 217
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 49/217 (22%), Positives = 78/217 (35%), Gaps = 24/217 (11%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------------ 67
Y R I SG++G D VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 68 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 121
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 182 GTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
Y APE+++ + + D+WS G + M
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNR 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSL 76
DRY+ IG+G++G DK+ K +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 77 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
V Y H+ + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 186 ----------------------YIAPEVLLR-HEYDGKIADVWSCG 208
Y APE++L Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 36/239 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
D Y IG G++G L DK T++ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 185
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 186 ---------------YIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR 74
+ RY VR +G G+F L +D V VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 75 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 122
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 123 FFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 177
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
+++ T Y +PEVLL + D+WS ++ ++ G + FE + +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLR- 77
+Y+ V+ +G G +G+ D+ T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 78 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 180
H+ + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 181 -------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 217
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 20 HDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
H + RY+ ++ IG G+FG V + D + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 79 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 127
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 186
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
APEV+L Y I D+WS G L +L G DE I++ P
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 64/206 (31%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--- 79
DRY+ IG G+FG D+V +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 80 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
+ + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVG 217
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-25
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 133 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 193 LRHEYDGKIADVWSCGVTLY 212
++ +DVWS GV LY
Sbjct: 190 TESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-25
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 193 LRHEYDGKIADVWSCGVTLY 212
++ +DVWS GV LY
Sbjct: 221 TESKFSVA-SDVWSFGVVLY 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 57/206 (27%), Positives = 78/206 (37%), Gaps = 14/206 (6%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 85 KEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
V + IVME GG+ + R +G+ Y + HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYD 198
DL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS G+ L+ +G P+ +
Sbjct: 294 SE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-24
Identities = 32/209 (15%), Positives = 57/209 (27%), Gaps = 35/209 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
RY + G D VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
D+ G +LY +LV +P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-24
Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 21/212 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
+ +G G+FGV VAVK ++ + I SL H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y +
Sbjct: 82 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVL 192
+ HRDL N LL + +KI DFG + L APE L
Sbjct: 141 RFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +D W GVTL+ + G P+
Sbjct: 197 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+RD+G G+FG D T E VAVK + E G ++++EI R+L H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 80 NIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
NIV++K + + ++ME+ G L E + N + + + + Q+ G+ Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APE 190
+ Q HRDL N L+ S ++KI DFG +K + + + TV APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 191 VLLRHEYDGKIADVWSCGVTLY 212
L++ ++ +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
++ +G GNFG + D T LVAVK + G + QREI ++L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV+++ V P L +VMEY G L + + + R + Q+ G+ Y +
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ S A +KI DFG +K + + V P APE L
Sbjct: 146 RRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD 229
+ + + +DVWS GV LY + E
Sbjct: 203 SDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L + T E+VAVK + + G + ++EI R+L H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+++K L +VMEY G L + + + F QQ+ G++Y HA
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
HRDL N LL + +KI DFG +K +V V APE L
Sbjct: 154 HYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 194 RHEYDGKIADVWSCGVTLY 212
+++ +DVWS GVTLY
Sbjct: 211 EYKFYYA-SDVWSFGVTLY 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 8/208 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HR+L N L+ + +K+ DFG S+ + APE L ++
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 10/203 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G +G K VAVK ++ E +E + ++HPN+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V I+ E+ + G L + R CN S + Q+ S + Y HRD
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHEYDGKI 201
L N L+ + +K+ DFG S+ + + G P + APE L +++ K
Sbjct: 137 LAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK- 192
Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
+DVW+ GV L+ + G P+
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-22
Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERGDKIDENVQREIINH----RSLRH 78
++ +GSG FG + + ++ VA+K + +EI++ S+ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDN 76
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLR 194
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y + +DVWS GVT++ +M G P++
Sbjct: 194 RIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 56/222 (25%), Positives = 82/222 (36%), Gaps = 32/222 (14%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP-- 79
+RY+ V ++G G FG V + K VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 80 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 133
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 134 YCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 176
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 177 PKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+T V T Y PEV+L + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 38/227 (16%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
+ + +R +G G FG V + K+ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 171
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 172 VLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 64/223 (28%), Positives = 90/223 (40%), Gaps = 34/223 (15%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR-- 74
RY+ V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 175
++ H+ ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 176 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-21
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 5e-21
Identities = 57/271 (21%), Positives = 94/271 (34%), Gaps = 66/271 (24%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
RY +R +G G+F L D K+ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 78 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 128
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 129 ISGVSYCHA-MQVCHRDLKLENTLLD---------------------------------- 153
+ G+ Y H ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 154 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
AD+WS + + G Y FE + R
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-21
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-21
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
FV++IGSG FG+ +K VA+K I G +E+ E L HP +V+
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L + +V E+ G L + R G F+ + + G++Y V H
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV Y
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVWS GV ++ V G P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ IGSG+ G RL VA+K ++ G ++ + E HPNI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ IV EY G L F R + G+F+ + + + +G+ Y +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLRH 195
HRDL N L+D + K+ DFG S+ +T G I APE +
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GV ++ V+ G P+ +
Sbjct: 230 TFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNI 81
+++GSGNFG KV K VAVK + + + D ++ E++ + L +P I
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKT-VAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 81 VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRH 195
HRDL N LL + KI DFG SK L + K+ P + APE + +
Sbjct: 140 HRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ K +DVWS GV ++ G P+
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + ++ VA+K + K ++ + E S+ +P+
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ R + LT T + ++ + G L + + + + Q+ G++Y +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLRHE 196
+ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 138 LVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
Y + +DVWS GVT++ +M G P++
Sbjct: 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-20
Identities = 56/204 (27%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
++ IG G FG L + K VAVK I + D + E LRH N+V+
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 87 VILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
VI+ L IV EY + G L + R D F + + Y HR
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGK 200
DL N L+ K+ DFG +K + + + APE L ++ K
Sbjct: 314 DLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 366
Query: 201 IADVWSCGVTLY-VMLVGGYPFED 223
+DVWS G+ L+ + G P+
Sbjct: 367 -SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-20
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + + ++ V +K I + G + + V ++ SL H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IVR + + L +V +Y G L + + + G + Q+ G+ Y
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLR 194
+ HR+L N LL SP+ ++++ DFG + +L K + + A A E +
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
+Y + +DVWS GVT++ +M G P+
Sbjct: 192 GKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-20
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ +G+G FG RL + VA+K ++ G +K + E HPNI
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ + IV EY G L F R + +F+ + + + SG+ Y M
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLL 193
HRDL N L++ + K+ DFG + VL P +T G I +PE +
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ L+ VM G P+ +
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-20
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
++++GSG FGV + + + VAVK I+ G ++ +E L HP +V+F
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + IV EY S G L + R + + + G+++ + Q H
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L+D +K+ DFG ++ VL Q S+VGT + APEV +Y
Sbjct: 128 RDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVW+ G+ ++ V +G P++
Sbjct: 185 K-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-20
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+ +G+G FG + + VAVK ++ G E E ++L+H +V+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V+ T + I+ E+ + G L F + + + F Q+ G+++ HRD
Sbjct: 251 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKI 201
L+ N L+ S KI DFG ++ + ++ + G I APE + + K
Sbjct: 310 LRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK- 365
Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
+DVWS G+ L ++ G P+
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPG 388
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 31 IGSGNFG-VAR-LMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 86
+G GNFG V + + R + + VA+K +++G E + RE L +P IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + +VME A GG L + + Q+ G+ Y HRDL
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRHEYDG 199
N LL + KI DFG SK L + + P + APE + ++
Sbjct: 137 AARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GVT++ + G P++
Sbjct: 193 R-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
V +G+G FG VAVK +++G + E + L+H +VR
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V+ T + I+ EY G L F + + + + ++ Q+ G+++ H
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL+ N L+ + + KI DFG ++ + ++ + G I APE + +
Sbjct: 133 RDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +DVWS G+ L ++ G P+
Sbjct: 190 K-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 18/210 (8%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + K VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 81 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLR 194
HRDL N L+ S K+ DFG +K + + + APE L
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
+G GNFG K + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 86 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYD 198
L N LL + KI DFG SK L + + + APE + ++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-19
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
F++++G+G FGV + R + VA+K I+ G ++ E +L H +V+
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD---VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + I+ EY + G L + R RF + + + + Y + Q H
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
RDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL+ ++
Sbjct: 144 RDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
K +D+W+ GV ++ + +G P+E
Sbjct: 201 K-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ IG+G FG L KE+ VA+K ++ G +K + E H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + VI + I+ EY G L F R G FS + + + +G+ Y M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLR 194
HRDL N L++ + K+ DFG S+ + +T G I APE +
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
++ +DVWS G+ ++ VM G P+ +
Sbjct: 225 RKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 15/207 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R +G G FG K K VAVK ++ E E + ++L HP+I
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ +I I+ME GEL + N + Q+ ++Y ++
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEY 197
HRD+ + N L+ +K+ DFG S+ + T I +PE + +
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
+DVW V ++ ++ G PF
Sbjct: 192 TTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V+ VI I+ME + GEL F + + QL + ++Y + +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHE 196
HRD+ N L+ + +K+ DFG S+ + S P ++APE +
Sbjct: 137 FVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVW GV ++ +++ G PF+
Sbjct: 194 FTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 52/216 (24%), Positives = 79/216 (36%), Gaps = 24/216 (11%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I+ME +GG+L + + L+ G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211
Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
PE + + K D WS GV L+ + +G P+
Sbjct: 212 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
++ R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 75 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 127 QLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
L+ G+ Y + HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 180 TVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
G + + A E L + Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ VI I+ME + GEL + + QL + ++Y + +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLRHE 196
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE +
Sbjct: 513 VHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
+ +DVW GV ++ +++ G PF+
Sbjct: 569 FTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-18
Identities = 51/216 (23%), Positives = 79/216 (36%), Gaps = 24/216 (11%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I++E +GG+L + + L+ G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252
Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
PE + + K D WS GV L+ + +G P+
Sbjct: 253 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
R++G G FG + K LVAVK ++ QRE +L+H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLI-- 129
IV+F V L +V EY G+L + I G+ + + Q++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 130 -----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
SG+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGH 194
Query: 185 AYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ PE ++ ++ + +DVWS GV L+ + G P+
Sbjct: 195 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 34/227 (14%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
D + + +G G FG L ++ T VAVK ++ + ++ E +
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 75 SLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
HPN++R + +++ + G+L + R Q
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQT 148
Query: 128 LI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+ G+ Y HRDL N +L + + DFG SK ++S
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYR 204
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
G A + A E L Y K +DVW+ GVT++ + G P+
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 185
Q+ G+ Y + + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 37/218 (16%), Positives = 74/218 (33%), Gaps = 29/218 (13%)
Query: 27 FVRDIGSGNFGV-------ARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRH 78
F +G G F ++ + V +K +++ E+ L H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 136
++V V + +V E+ G L + + N + +QL + + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 137 AMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ H ++ +N LL + K+ D G S + + + + ++ PE
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPE 187
Query: 191 VLLRHEYDGKI----ADVWSCGVTLY-VMLVGGYPFED 223
+ + K D WS G TL+ + G P
Sbjct: 188 CIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-17
Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 32/222 (14%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
++G G FG + + K LVAVK ++ + QRE L+H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQLI--- 129
IVRF V L +V EY G+L AG QL+
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
+G+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRVGGRT 220
Query: 186 YI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ PE +L ++ + +DVWS GV L+ + G P+
Sbjct: 221 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
Q+ G+ + + + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 187 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 28/218 (12%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
R++G G+FG VA+ + + VA+K + + E + E +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFFQQLI 129
++VR V+ ++ME + G+L + R + ++
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 187
G++Y +A + HRDL N ++ + +KI DFG ++ ++ G +
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204
Query: 188 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+PE L + +DVWS GV L+ + + P+
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 70 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 125
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 182
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 183 T-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
P + A E L + + K +DVWS GV L+ ++ G P+
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-16
Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 34/224 (15%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
F+ ++G FG + VA+K ++ + E + E + L+HP
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQLI- 129
N+V V+ L+++ Y S G+L + + ++ +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 130 ------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
+G+ Y + V H+DL N L+ +KI D G + +++ +
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLG 188
Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 54/231 (23%), Positives = 84/231 (36%), Gaps = 47/231 (20%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +G+G FG A + VAVK + ER + E V +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL--- 83
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSEDEAR 122
H NIV ++ EY G+L + +DE
Sbjct: 84 --GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+S G+++ + HRDL N LL KICDFG ++ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKN 197
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
V A + APE + Y + +DVWS G+ L+ + +G P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 60/233 (25%), Positives = 89/233 (38%), Gaps = 47/233 (20%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
D + F IG GNFG AR+ +D + + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 120
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 121 ARFFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 174 HSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
+ T + A E L Y +DVWS GV L+ ++ +GG P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
+++ R IGSG+FG L + T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + + +VM+ S +LF C+ + S Q+I+ V + H+
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 140 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ S G L L G P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-15
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 42/232 (18%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+VRDIG G FG A + +VAVK ++ + + QRE +P
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
NIV+ V + ++ EY + G+L + A S
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 123 FFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ + +G++Y + HRDL N L+ +KI DFG S++ ++S
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYS 226
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
I PE + + Y + +DVW+ GV L+ + G P+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 24/215 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 140 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 188
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 189 PEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ + G L G P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 43/231 (18%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVK-------YIERGDKIDE-NVQRE 69
+ F + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 122
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+ G+++ + HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
V A + APE + Y + +DVWS G+ L+ + +G P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 42/232 (18%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ +G G FG A ++ + VAVK ++ ++ E + + HP
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
++++ L +++EYA G L ++ DE
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
LIS G+ Y M++ HRDL N L+ +KI DFG S+ ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYE 202
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
+ + I A E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 82
+ + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 83 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+ + A+V+E S +LF +C+ FS QLIS + Y H+ +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 141 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 189
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 190 EVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ + G L G P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
+RY R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + +VME S +LF C+ +FS Q+IS + Y H+
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 140 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
L E D D+ S G L +G P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 37/226 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+S G+ Y + + HRDL N L+ + +KI DFG ++ +++
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYK 214
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
T + APE L Y + +DVWS GV ++ + +GG P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 54/235 (22%), Positives = 84/235 (35%), Gaps = 46/235 (19%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
DR + +G G FG A + T VAVK + E + E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 70 IINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL---------FERICNAGRFSED 119
I H N+V P L +++E+ G L
Sbjct: 87 I-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 120 EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
+ + LI G+ + + + HRDL N LL +KICDFG ++
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--D 197
Query: 173 LHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
++ P A + APE + Y + +DVWS GV L+ + +G P+
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
L+S G+ Y + + HRDL N L+ + +KI DFG ++ +++
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYK 260
Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
T + APE L Y + +DVWS GV ++ + +GG P+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 47/231 (20%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYI-------ERGDKIDE-NVQREII 71
+ +G G FG L +DK + VAVK + + D I E + + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEAR 122
+H NI+ L +++EYAS G L + E +
Sbjct: 133 -----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
+ L+S G+ Y + + HRDL N L+ + +KI DFG ++ +H
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHH 243
Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
T + APE L Y + +DVWS GV L+ + +GG P
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 56/236 (23%), Positives = 83/236 (35%), Gaps = 52/236 (22%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +GSG FG A + VAVK + ER + E + ++
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL--- 105
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNAGRFS 117
H NIV + ++ EY G+L
Sbjct: 106 --GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 118 EDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
ED F+ L+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD 221
Query: 171 SVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
+ S V A + APE L Y K +DVWS G+ L+ + +G P
Sbjct: 222 --IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 4e-11
Identities = 37/196 (18%), Positives = 57/196 (29%), Gaps = 52/196 (26%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---------VQREIIN 72
+++ IG G FG VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 73 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 93
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLL 152
L IV+E+ GG E++ S A+ QL + ++ +++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 153 DGSPAPRLKICDFGYS 168
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 50/214 (23%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82
IG G FG KV K VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFG-------KVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLV 98
Query: 83 RF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQ 126
E + ++ +Y G L + + + AR
Sbjct: 99 SLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---- 150
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GT 183
G+ Y H + HRD+K N LLD + P KI DFG SK Q STV GT
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGT 204
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
YI PE ++ K +DV+S GV L+ +L
Sbjct: 205 LGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCA 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 55/217 (25%), Positives = 78/217 (35%), Gaps = 55/217 (25%)
Query: 31 IGSGNFGVARLMRDKVTK-----ELVAVKYIERGDKI-----DENVQREIINHRSLRHPN 80
+G G FG V K VAVK + I + +EI +H N
Sbjct: 39 MGEGGFG-------VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 81 IVRFKEVILTPTHLAIVMEYASGG----ELFER-------------ICNAGRFSEDEARF 123
+V L +V Y G L I + A
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA------QGAAN- 144
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST-- 180
G+++ H HRD+K N LLD + KI DFG ++ S ++
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRI 195
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
VGT AY+APE L K +D++S GV L ++ G
Sbjct: 196 VGTTAYMAPEALRGEITP-K-SDIYSFGVVLLEIITG 230
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 58/216 (26%), Positives = 83/216 (38%), Gaps = 63/216 (29%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDKIDENVQRE------IINHRSLRH 78
+G G FG KV K LVAVK ++ + + + +I+ H
Sbjct: 38 LGRGGFG-------KVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVH 86
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQ 126
N++R + +TPT +V Y + G L ER + AR
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---- 142
Query: 127 QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 181
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 ----GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTT 193
Query: 182 ---GTPAYIAPEVLLRHEYDGKI---ADVWSCGVTL 211
GT +IAPE L GK DV+ GV L
Sbjct: 194 AVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 24/167 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 84 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 122
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 11/118 (9%)
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
+ Q+ G+ + + + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
A + APE + Y + +DVWS GV L+ + +G P+ ++F + ++
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 22/171 (12%), Positives = 55/171 (32%), Gaps = 29/171 (16%)
Query: 24 RYDFVRDIGSGNFGV--------ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS 75
++ N G+ K+ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 76 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 118
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-07
Identities = 36/275 (13%), Positives = 89/275 (32%), Gaps = 66/275 (24%)
Query: 25 YDFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
FV ++ N+ ++ + ++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 83 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 133
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 134 YCH-------AMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
C+ +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 186 YIAPEVL--LRHEYDGKIADVW--SC---------GVTLYVMLVGGYPFEDPDEPKDF-- 230
Y L L + + K + + SC VT ++
Sbjct: 243 Y--ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 231 RKTIQVFIK---------P--CCHITPFYPLFKLI 254
+ + +K P P +I
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPR--RLSII 333
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 26/169 (15%), Positives = 50/169 (29%), Gaps = 25/169 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVK---------------YIERGDKID 63
+ IG G FG L + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 64 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 120
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.61 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.18 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.54 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.19 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=345.61 Aligned_cols=223 Identities=28% Similarity=0.462 Sum_probs=195.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++++.||+|+||+||+|++..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999998643 2334678899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc--
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-- 174 (254)
||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 187 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCC
Confidence 9999999999999999899999999999999999999999999999999999999998887 999999999765332
Q ss_pred -CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhc
Q 025369 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIK 239 (254)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~ 239 (254)
......+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+. +....+.++.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence 22345679999999999988777555 9999999999999999999987654333 3345667888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|++.+|
T Consensus 267 ~lL~~dp 273 (311)
T 4aw0_A 267 KLLVLDA 273 (311)
T ss_dssp HHSCSSG
T ss_pred HHccCCH
Confidence 8888887
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=338.98 Aligned_cols=223 Identities=41% Similarity=0.690 Sum_probs=181.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999986532 2345688999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|||+ +|+|.+.+...+++++.+++.++.||+.||+|||++||+||||||+||++++++. +||+|||+|.........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence 9999 6699999998889999999999999999999999999999999999999988877 999999999766555555
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~~ 243 (254)
...+|++.|+|||++.+..++..++||||+||++|+|++|..||...+... .+...++.++..|++
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 667899999999999888877666999999999999999999998755432 334457778888888
Q ss_pred cCCC
Q 025369 244 ITPF 247 (254)
Q Consensus 244 ~~p~ 247 (254)
.+|.
T Consensus 249 ~dP~ 252 (275)
T 3hyh_A 249 VNPL 252 (275)
T ss_dssp SSGG
T ss_pred CChh
Confidence 8873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=348.67 Aligned_cols=237 Identities=27% Similarity=0.483 Sum_probs=190.1
Q ss_pred cCCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeee
Q 025369 7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVR 83 (254)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~ 83 (254)
|..++-..+...-...++|++++.||+|+||+||+|++..+++.||+|.+.... ...+.+.+|+.++++++||||++
T Consensus 8 ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp -------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 333443344443345689999999999999999999999999999999986543 23466889999999999999999
Q ss_pred eeEEEEcCCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceE
Q 025369 84 FKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 84 ~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~ 161 (254)
+++++.+++.+|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 88 ~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vK 165 (350)
T 4b9d_A 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQ 165 (350)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EE
Confidence 999999999999999999999999999654 35799999999999999999999999999999999999998887 99
Q ss_pred EecccccccccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------
Q 025369 162 ICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------ 228 (254)
Q Consensus 162 l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------ 228 (254)
|+|||+|+....... ....+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+
T Consensus 166 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~ 244 (350)
T 4b9d_A 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244 (350)
T ss_dssp ECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred EcccccceeecCCcccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC
Confidence 999999875543221 234569999999999988777555 999999999999999999998765433
Q ss_pred ---hhHHHHHHhhcCccccCC
Q 025369 229 ---DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ---~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|++.+|
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP 265 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNP 265 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSG
T ss_pred CCccCCHHHHHHHHHHccCCh
Confidence 334457778888888887
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=340.75 Aligned_cols=222 Identities=27% Similarity=0.449 Sum_probs=193.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|+++++||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999999999999999986532 3346688999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 179 (254)
++||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... .....
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccc
Confidence 999999998875 56999999999999999999999999999999999999998887 999999998765433 33456
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~ 242 (254)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+ .+...+..++..|+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 689999999999987777555 999999999999999999997754322 33456778888888
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
+.+|.
T Consensus 309 ~~dP~ 313 (346)
T 4fih_A 309 VRDPA 313 (346)
T ss_dssp CSSTT
T ss_pred CCChh
Confidence 88883
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=339.44 Aligned_cols=226 Identities=29% Similarity=0.517 Sum_probs=189.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
..+.++|++++.||+|+||+||+|++. .+++.||+|.+.... .....+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 345589999999999999999999874 467899999986542 23346788999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999998887 9999999997543
Q ss_pred cc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHh
Q 025369 173 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVF 237 (254)
Q Consensus 173 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~ 237 (254)
.. ......+|++.|+|||++.+..++.+ +||||+||++|+|++|..||...+..+ .+...+..+
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 32 33455689999999999988777655 999999999999999999998765433 334457788
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|++.+|.
T Consensus 257 i~~~L~~dP~ 266 (304)
T 3ubd_A 257 LRMLFKRNPA 266 (304)
T ss_dssp HHHHTCSSGG
T ss_pred HHHHcccCHH
Confidence 8888888884
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=337.44 Aligned_cols=224 Identities=26% Similarity=0.380 Sum_probs=191.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.....+.|++.++||+|+||+||+|++..+++.||+|++..... ..+|+.+++.++||||+++++++.+++.+|+|
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34456789999999999999999999999999999999865432 24699999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC-
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 176 (254)
|||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcc
Confidence 999999999999999899999999999999999999999999999999999999987763 399999999875443221
Q ss_pred -----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHH
Q 025369 177 -----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTI 234 (254)
Q Consensus 177 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~ 234 (254)
....+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.. ..+...+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 123469999999999988777655 99999999999999999999765432 2344567
Q ss_pred HHhhcCccccCCC
Q 025369 235 QVFIKPCCHITPF 247 (254)
Q Consensus 235 ~~~~~~~~~~~p~ 247 (254)
..++..|++.+|.
T Consensus 287 ~~li~~~L~~dP~ 299 (336)
T 4g3f_A 287 AQAIQEGLRKEPV 299 (336)
T ss_dssp HHHHHHHTCSSGG
T ss_pred HHHHHHHccCCHh
Confidence 7888888888883
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=342.84 Aligned_cols=222 Identities=27% Similarity=0.449 Sum_probs=193.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|+++++||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999999999999999986543 3346788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 179 (254)
++||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... .....
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCC
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccc
Confidence 999999998865 46999999999999999999999999999999999999998887 999999998755433 33456
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-----------------hhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------------DFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~ 242 (254)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+ .+...+..++..|+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 385 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 385 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence 689999999999988777555 999999999999999999997754322 33446778888888
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
+.+|.
T Consensus 386 ~~dP~ 390 (423)
T 4fie_A 386 VRDPA 390 (423)
T ss_dssp CSSTT
T ss_pred CCChh
Confidence 88883
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=324.77 Aligned_cols=223 Identities=25% Similarity=0.414 Sum_probs=187.1
Q ss_pred cCCCce-eEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc----C
Q 025369 20 HDSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----P 91 (254)
Q Consensus 20 ~~~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 91 (254)
...++| ++.++||+|+||+||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 344566 78889999999999999999999999999886532 234568899999999999999999999865 3
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecC-CCCCceEEeccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYS 168 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~-~~~~~~~l~df~~~ 168 (254)
+.+++||||+++|+|.+++.....+++..++.++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla 179 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCC
Confidence 568999999999999999999899999999999999999999999998 999999999999974 555 999999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh-----------------hH
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----------------FR 231 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------------~~ 231 (254)
.... .......+|++.|+|||++.+ .+ +.++|||||||++|+|++|..||...+.... ..
T Consensus 180 ~~~~-~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred EeCC-CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 6432 233345679999999998865 45 4559999999999999999999976543222 22
Q ss_pred HHHHHhhcCccccCCC
Q 025369 232 KTIQVFIKPCCHITPF 247 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p~ 247 (254)
..+..++..|++.+|.
T Consensus 257 ~~~~~li~~~L~~dP~ 272 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKD 272 (290)
T ss_dssp HHHHHHHHHHSCSSGG
T ss_pred HHHHHHHHHHccCChh
Confidence 3577888889988883
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=331.98 Aligned_cols=229 Identities=25% Similarity=0.410 Sum_probs=191.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
...++|.+.+.||+|+||+||+|++. .++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45689999999999999999999874 3578899999876433 34678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCce
Q 025369 94 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~ 160 (254)
+++||||+++|+|.+++... ..+++.+++.++.||+.|+.|||+++|+||||||+|||+++++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999754 35899999999999999999999999999999999999998877 9
Q ss_pred EEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC----------
Q 025369 161 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------- 226 (254)
Q Consensus 161 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------- 226 (254)
||+|||+|+....... .....+++.|+|||++.+..++.+ +||||||+++|||+| |+.||...+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999864433221 223458889999999988877655 999999999999998 8999977442
Q ss_pred -----ChhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 -----PKDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 -----~~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+..+...+.+++..||+.+| ..|-+
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~ 277 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNI 277 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 44556678899999999999 44443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=327.03 Aligned_cols=231 Identities=23% Similarity=0.390 Sum_probs=194.1
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
....+++++.++||+|+||+||+|... .++..||||.+.... ...+.+.+|+.++++++||||+++++++.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 345678999999999999999999863 467899999986532 3346789999999999999999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC
Q 025369 92 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~ 155 (254)
+.+++||||+++|+|.+++... ..+++.++..++.||+.|++|||+++|+||||||+|||++++
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999643 358999999999999999999999999999999999999988
Q ss_pred CCCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-----
Q 025369 156 PAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE----- 226 (254)
Q Consensus 156 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~----- 226 (254)
+. +||+|||+++...... ......+++.|+|||++.+..++.+ +||||||+++|||++ |..||...+.
T Consensus 182 ~~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 182 LN--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GC--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CC--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 9999999987543322 2234568899999999988877655 999999999999998 8999976442
Q ss_pred ----------ChhhHHHHHHhhcCccccCC-Cccccc
Q 025369 227 ----------PKDFRKTIQVFIKPCCHITP-FYPLFK 252 (254)
Q Consensus 227 ----------~~~~~~~~~~~~~~~~~~~p-~~~~~~ 252 (254)
++.....+..++..||+.+| ..|-|.
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ 295 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK 295 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence 44555678899999999999 455544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=327.76 Aligned_cols=229 Identities=26% Similarity=0.399 Sum_probs=187.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
...+++.+.++||+|+||+||+|++. .++..||||.+..... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45578999999999999999999864 3688999999876433 34678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 94 LAIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
+++||||+++|+|.+++... .++++.+++.++.|++.|++|||+++|+||||||+|||+++++.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~- 196 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV- 196 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-
Confidence 99999999999999998653 35899999999999999999999999999999999999998877
Q ss_pred ceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
+||+|||+++....... .....+++.|+|||++.+..++.+ +||||||+++|||++ |+.||...+.
T Consensus 197 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 197 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp -EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred -EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999875433221 233468899999999988877655 999999999999998 8999976443
Q ss_pred -------ChhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+..+...+..++..||+.+| ..|-+
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~ 307 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSI 307 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCH
Confidence 34455678899999999999 44444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=321.42 Aligned_cols=228 Identities=27% Similarity=0.407 Sum_probs=185.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
+-.+.+++++.++||+|+||+||++++.. .+|||.+.... ...+.+.+|+.++++++||||+++++++.. +.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 44667899999999999999999998753 48999876533 233668899999999999999999998754 568
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++|+|.+++... .++++.++..++.||+.||+|||+++|+||||||+|||+++++. +||+|||+|.....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence 9999999999999999654 57999999999999999999999999999999999999998877 99999999875432
Q ss_pred c---CCCCCccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------------h
Q 025369 174 H---SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------------K 228 (254)
Q Consensus 174 ~---~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------------~ 228 (254)
. .......|++.|+|||++.+.. .++.++||||||+++|+|++|+.||...+.. .
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 2223457999999999986432 2345599999999999999999999764432 2
Q ss_pred hhHHHHHHhhcCccccCC-Ccccc
Q 025369 229 DFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
.+...+..++..||+.+| ..|-+
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~ 288 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLF 288 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCH
Confidence 344568889999999998 34443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=323.97 Aligned_cols=219 Identities=27% Similarity=0.438 Sum_probs=190.3
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEc------CC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT------PT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 92 (254)
.++|++++.||+|+||+||+|++..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3689999999999999999999999999999999875432 23557789999999999999999999764 35
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+|+||||++ ++|.+++...+.+++..++.+++||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 579999988889999999999999999999999999999999999999998887 9999999987543
Q ss_pred cc-----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccc
Q 025369 173 LH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 173 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (254)
.. ......+|++.|+|||++.+..+++.++||||+||++|+|++|..||...+..+++..++.....+...
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 22 223456799999999999887776777999999999999999999999999888888888877766543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=312.89 Aligned_cols=218 Identities=27% Similarity=0.424 Sum_probs=171.9
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC--------
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 92 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 92 (254)
++|++++.||+|+||+||+|++..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999865432 3456889999999999999999999987543
Q ss_pred ----eEEEEEEccCccchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 93 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 93 ----~~~lv~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
.+|+||||+++++|.+++..... .+...++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37999999999999999987654 455678899999999999999999999999999999998887 999999
Q ss_pred cccccccccCCC-------------CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------
Q 025369 166 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------ 226 (254)
Q Consensus 166 ~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------ 226 (254)
|+|......... ...+|++.|+|||++.+..++.+ +|||||||++|+|++ ||....+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 998754432211 23469999999999988777555 999999999999996 7754221
Q ss_pred -------ChhhH---HHHHHhhcCccccCC
Q 025369 227 -------PKDFR---KTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~---~~~~~~~~~~~~~~p 246 (254)
+.... .....+++.|++.+|
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSG
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCCh
Confidence 11111 124568888888888
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=334.88 Aligned_cols=228 Identities=27% Similarity=0.400 Sum_probs=192.0
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHH---HHHHHHhhcCCCCCeeeeeEEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
......++|+++++||+|+||+||+|++..+++.||+|.+.+.. ...... ..++.+++.++||||+++++++.
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 34566789999999999999999999999999999999986421 112222 33466778889999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
+++.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+++ +||+|||+|.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~ 340 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLAC 340 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceee
Confidence 99999999999999999999999999999999999999999999999999999999999999998887 9999999987
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHH
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRK 232 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~ 232 (254)
.... ......+|++.|+|||++.+...+..++|+|||||++|+|++|..||...+.. ..+..
T Consensus 341 ~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 341 DFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 5433 33455689999999999976554455599999999999999999999754322 22334
Q ss_pred HHHHhhcCccccCCC
Q 025369 233 TIQVFIKPCCHITPF 247 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~ 247 (254)
..+.++..|++.+|.
T Consensus 420 ~a~dLI~~lL~~dP~ 434 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVN 434 (689)
T ss_dssp HHHHHHHHHTCSCGG
T ss_pred HHHHHHHHHccCCHh
Confidence 577788888887774
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=320.18 Aligned_cols=229 Identities=23% Similarity=0.379 Sum_probs=189.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc-----ceeEEEEEccCCcc--chhHHHHHHHHhhcCCC-CCeeeeeEEEEcC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 91 (254)
++.++|++++.||+|+||+||+|.+..+ ++.||+|.+..... ..+.+.+|+.+++++.| |||++++++|..+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4568999999999999999999997643 46899998876432 23568899999999976 8999999998765
Q ss_pred -CeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC
Q 025369 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (254)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~ 154 (254)
+.+++||||+++|+|.+++... ..+++..+..++.||+.|++|||+++|+||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5689999999999999999653 23799999999999999999999999999999999999998
Q ss_pred CCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh-
Q 025369 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD- 229 (254)
Q Consensus 155 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~- 229 (254)
++. +||+|||+|+....... .....+++.|+|||++.+..++.+ +||||||+++|||++ |..||......+.
T Consensus 221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 887 99999999975433322 223457889999999988877655 999999999999998 8999987554333
Q ss_pred ---------------hHHHHHHhhcCccccCC-Ccccc
Q 025369 230 ---------------FRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 230 ---------------~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
....+..++..||+.+| ..|-+
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH
Confidence 33457888999999998 44443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=308.93 Aligned_cols=225 Identities=24% Similarity=0.276 Sum_probs=177.5
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----eEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 97 (254)
..+|.+.++||+|+||+||+|++ +|..||||++............|+..+..++||||+++++++.+++ .+++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35799999999999999999987 4889999998655433333445777778899999999999998653 58999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
|||+++|+|.+++... ++++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++.
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCc
Confidence 9999999999999764 589999999999999999999987 8999999999999998887 9999999987
Q ss_pred cccccCC-----CCCccCCCCccCccccccccC-----CCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------
Q 025369 170 SSVLHSQ-----PKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDE------------- 226 (254)
Q Consensus 170 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------- 226 (254)
....... .....+++.|+|||++.+... ++.++||||||+++|||++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 5443322 223468999999999876431 23459999999999999999765532110
Q ss_pred ------------------C-----hhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 ------------------P-----KDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 ------------------~-----~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+ ....+.+.+++..||+.+| ..|-+
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 285 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH
Confidence 0 1233467889999999999 44443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=330.08 Aligned_cols=225 Identities=30% Similarity=0.516 Sum_probs=195.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|++++.||+|+||+||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4789999999999999999999999999999998876543 346688999999999999999999999999999999999
Q ss_pred cCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
++||+|.+++.. ...+++.+++.+++||+.||+|||++||+||||||+||+++.+..+.+||+|||++...........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998864 4579999999999999999999999999999999999999876545699999999987655555556
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcCc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKPC 241 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~~ 241 (254)
.+|++.|+|||++.+..+... +||||+||++|+|++|..||...+..+ .+......|+..|
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 679999999999988777555 999999999999999999998755332 2344567788888
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
++.+|.
T Consensus 395 L~~dp~ 400 (573)
T 3uto_A 395 LLADPN 400 (573)
T ss_dssp SCSSGG
T ss_pred ccCChh
Confidence 888873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=309.23 Aligned_cols=243 Identities=86% Similarity=1.384 Sum_probs=195.1
Q ss_pred cccccCCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee
Q 025369 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82 (254)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 82 (254)
|++++++.. .+..+.....++|++++.||+|+||+||++++..+++.||+|.+.......+.+.+|+..++.++||||+
T Consensus 1 m~~~~~~~~-p~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTG-PLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCC-CCCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 345555444 3667778889999999999999999999999999999999999987766778889999999999999999
Q ss_pred eeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEE
Q 025369 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (254)
Q Consensus 83 ~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l 162 (254)
++++++..++.+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777767999
Q ss_pred ecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh------------
Q 025369 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF------------ 230 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------------ 230 (254)
+|||++.............+++.|+|||++.+..+..+++||||||+++|+|++|..||.........
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 99999875555555556678999999999988877767689999999999999999999875543322
Q ss_pred --------HHHHHHhhcCccccCC
Q 025369 231 --------RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 --------~~~~~~~~~~~~~~~p 246 (254)
...+..++..|+..+|
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP 263 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADP 263 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCT
T ss_pred CCCCcCCCCHHHHHHHHHHccCCh
Confidence 3456677777787777
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=305.83 Aligned_cols=210 Identities=23% Similarity=0.385 Sum_probs=174.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+..++.+ +||||+++++++.+++.+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 3578999999999999999999875 467899999886543 345678899999988 69999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
||||+++++|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+.. .+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~-~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK-KYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC-eEEECcCCCCcccCCccc
Confidence 999999999999883 5899999999999999999999999999999999999986532 49999999986432211
Q ss_pred ----------------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-C
Q 025369 176 ----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-E 226 (254)
Q Consensus 176 ----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~ 226 (254)
.....+|++.|+|||++.+...++.++||||+||++|+|++|+.||...+ .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 11234689999999999887766666999999999999999999996544 3
Q ss_pred ChhhHHHHH
Q 025369 227 PKDFRKTIQ 235 (254)
Q Consensus 227 ~~~~~~~~~ 235 (254)
.+++.++..
T Consensus 254 ~~~l~~I~~ 262 (361)
T 4f9c_A 254 LTALAQIMT 262 (361)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 444444443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=299.05 Aligned_cols=226 Identities=38% Similarity=0.662 Sum_probs=198.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
....++|++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+..++.++||||+++++++..++..+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345679999999999999999999999999999999986532 23456788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSC
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCC
Confidence 99999999999999988889999999999999999999999999999999999999988877 9999999987665555
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~ 241 (254)
......+++.|+|||.+.+..+...++||||+|+++|+|++|..||...+.... ....+..++..|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 556667999999999998888776669999999999999999999987654332 334567788888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 249 L~~dP 253 (328)
T 3fe3_A 249 LVLNP 253 (328)
T ss_dssp CCSST
T ss_pred CCCCh
Confidence 88887
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=293.71 Aligned_cols=226 Identities=32% Similarity=0.558 Sum_probs=195.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++++.||+|+||.||++++..+++.||+|.+... ......+.+|+.+++.++||+|+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 468999999999999999999999999999999988653 2234567889999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~ 175 (254)
||||+++++|...+.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999998889999999999999999999999999999999999999988887 99999999875322 23
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~~ 241 (254)
.....++++.|+|||++.+..+..+ +|+||||+++|+|++|..||...+.... +...+..++..|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3445678999999999988777655 9999999999999999999987654332 334567788888
Q ss_pred cccCCCcc
Q 025369 242 CHITPFYP 249 (254)
Q Consensus 242 ~~~~p~~~ 249 (254)
++.+|.-+
T Consensus 240 L~~dP~~R 247 (337)
T 1o6l_A 240 LKKDPKQR 247 (337)
T ss_dssp TCSSTTTS
T ss_pred hhcCHHHh
Confidence 88888443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=294.73 Aligned_cols=226 Identities=32% Similarity=0.549 Sum_probs=195.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++++.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 346789999999999999999999999999999999875432 2367889999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC--CceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~--~~~~l~df~~~~~ 170 (254)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||++++++. ..++|+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999988888999999999999999999999999999999999999986662 2499999999876
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHH
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRK 232 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~ 232 (254)
...........+++.|+|||++.+..+..+ +|+||||+++|+|++|..||...+..+. +..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 655555556679999999999977766555 9999999999999999999977554322 233
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..|+..+|
T Consensus 248 ~~~~li~~~L~~dP 261 (361)
T 2yab_A 248 LAKDFIRKLLVKET 261 (361)
T ss_dssp HHHHHHHHHSCSST
T ss_pred HHHHHHHHHCCCCh
Confidence 46778888888888
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=296.73 Aligned_cols=233 Identities=26% Similarity=0.435 Sum_probs=198.1
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
..........++|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp ---CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344556667899999999999999999999999999999999876432 2335678899999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
.+.+.+++|++|+.+++|..++.....+++..++.++.||+.||.|||++||+||||+|+||+++.++. ++|+|||++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a 162 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIA 162 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEecccee
Confidence 999999999999999999999998888999999999999999999999999999999999999988887 999999999
Q ss_pred ccccccCCCCCccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------Chh
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKD 229 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~ 229 (254)
.............+++.|+|||++.+. ...+.++|+||||+++|+|++|..||..... +..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTT
T ss_pred eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCc
Confidence 766555555667899999999998643 2234449999999999999999999975432 223
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..++..|+..+|.
T Consensus 243 ~s~~~~~li~~lL~~dP~ 260 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPD 260 (384)
T ss_dssp SCHHHHHHHHHHSCSSGG
T ss_pred CCHHHHHHHHHHhcCCHh
Confidence 345677888888888883
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=291.74 Aligned_cols=224 Identities=42% Similarity=0.722 Sum_probs=197.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+..++.++||||+++++++..++..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999987543 2234578899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
||||+ +++|.+.+.....+++.+++.++.|++.|+.|||+.|++||||+|+||++++++. ++|+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcc
Confidence 99999 6789999988888999999999999999999999999999999999999998876 99999999876655555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~ 242 (254)
.....+++.|+|||.+.+..+..+++|+||||+++|+|++|..||..... ++.+...+..++..|+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 56677999999999998877766669999999999999999999976432 3445677889999999
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
..+|.
T Consensus 244 ~~dP~ 248 (336)
T 3h4j_B 244 VADPM 248 (336)
T ss_dssp CSSGG
T ss_pred CCChh
Confidence 99983
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=292.25 Aligned_cols=226 Identities=23% Similarity=0.389 Sum_probs=195.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.+.||+|+||.||++.+..++..+++|.+.........+.+|+..++.++||||+++++++.+.+.+++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 36899999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
+++++|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+..+.++|+|||++...........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9999999999765 469999999999999999999999999999999999999874444599999999876544444445
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcCc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKPC 241 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~~ 241 (254)
..+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+... .+...+..++..|
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 568899999999977765554 999999999999999999997755432 2344577888899
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
+..+|.
T Consensus 242 L~~dp~ 247 (321)
T 1tki_A 242 LVKERK 247 (321)
T ss_dssp SCSSGG
T ss_pred cCCChh
Confidence 988883
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=295.54 Aligned_cols=228 Identities=35% Similarity=0.535 Sum_probs=187.4
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (254)
......++|++.+.||+|+||.||++++..+++.||+|.+... ....+...+|..+++.+ +||||+++++++.+.
T Consensus 17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 3345678999999999999999999999999999999988653 22335567888888887 799999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+.+++||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeec
Confidence 999999999999999999998889999999999999999999999999999999999999998887 999999998753
Q ss_pred cc-cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHH
Q 025369 172 VL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQV 236 (254)
Q Consensus 172 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~ 236 (254)
.. .......++++.|+|||++.+..+... +|+||||+++|+|++|..||...+..+.+ ...+..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG 253 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 32 233345578999999999987777555 99999999999999999999876654333 334666
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 254 li~~lL~~dP~ 264 (353)
T 3txo_A 254 ILKSFMTKNPT 264 (353)
T ss_dssp HHHHHTCSSGG
T ss_pred HHHHHhhhCHH
Confidence 77777777773
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=295.98 Aligned_cols=228 Identities=28% Similarity=0.478 Sum_probs=192.2
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
.....++|++++.||+|+||.||++++..+++.||+|.+.... ...+.+.+|..+++++ +||||+++++++.+++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3456789999999999999999999999999999999986532 2335577888888776 8999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc-
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~- 171 (254)
.+++||||+++++|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999998889999999999999999999999999999999999999998887 999999998752
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------------Ch
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------------PK 228 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------------~~ 228 (254)
.........++++.|+|||++.+..+... +|+||||+++|+|++|..||..... +.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 23344455678999999999988777555 9999999999999999999964221 12
Q ss_pred hhHHHHHHhhcCccccCCCc
Q 025369 229 DFRKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p~~ 248 (254)
.+...+..++..|++.+|.-
T Consensus 284 ~~s~~~~~li~~lL~~dP~~ 303 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKE 303 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTT
T ss_pred cCCHHHHHHHHHHhcCCHhH
Confidence 23345677888888888843
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=286.28 Aligned_cols=228 Identities=32% Similarity=0.445 Sum_probs=191.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.....++|++.+.||+|++|.||++.+..++..+|+|.+.... ...+.+.+|+..++.++||||+++++++.+++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 4456789999999999999999999999999999999875432 223567889999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||||+++++|.+++...+++++..++.++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC--
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccc
Confidence 9999999999999999998889999999999999999999999999999999999999988876 99999999865433
Q ss_pred cC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------hhhHH
Q 025369 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------KDFRK 232 (254)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------~~~~~ 232 (254)
.. ......+++.|+|||.+.+...+.+ +|+||||+++|+|++|..||...+.. ..+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred ccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 22 2233468899999999988777555 99999999999999999999765432 22345
Q ss_pred HHHHhhcCccccCCCc
Q 025369 233 TIQVFIKPCCHITPFY 248 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~~ 248 (254)
.+..++..|++.+|.-
T Consensus 243 ~l~~li~~~l~~dp~~ 258 (294)
T 4eqm_A 243 SLSNVILRATEKDKAN 258 (294)
T ss_dssp HHHHHHHHHSCSSGGG
T ss_pred HHHHHHHHHhcCCHhH
Confidence 6888888899888843
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=290.55 Aligned_cols=226 Identities=33% Similarity=0.526 Sum_probs=191.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
.....++|++.+.||+|+||.||++++..+++.||+|.+... ....+....|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999988653 22345567788888776 9999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcc
Confidence 99999999999999999998888999999999999999999999999999999999999998887 9999999987533
Q ss_pred c-cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHh
Q 025369 173 L-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVF 237 (254)
Q Consensus 173 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~ 237 (254)
. .......++++.|+|||++.+..++.. +|+||||+++|+|++|..||...+.... +...+..+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 2 233445678999999999988776555 9999999999999999999987654333 33456777
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|+..+|
T Consensus 249 i~~lL~~dp 257 (345)
T 1xjd_A 249 LVKLFVREP 257 (345)
T ss_dssp HHHHSCSSG
T ss_pred HHHHhcCCH
Confidence 888887777
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=286.78 Aligned_cols=223 Identities=30% Similarity=0.526 Sum_probs=192.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|..+++.++||||+++++++.+.+.++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35689999999999999999999999999999999886532 23456778999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||+++++|.+++.....+++..++.++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++.... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~--~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--D 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--S
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecC--C
Confidence 99999999999999998888999999999999999999999999999999999999988877 9999999987533 2
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~ 241 (254)
......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..... ...+..++..|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 3345578999999999987777665 99999999999999999999775543332 34566777777
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
+..+|.
T Consensus 238 L~~dp~ 243 (318)
T 1fot_A 238 ITRDLS 243 (318)
T ss_dssp TCSCTT
T ss_pred hccCHH
Confidence 777774
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=286.99 Aligned_cols=225 Identities=33% Similarity=0.583 Sum_probs=194.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+..++.++||||+++++++.+++.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45789999999999999999999999999999998865422 34678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC--CceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~--~~~~l~df~~~~~~ 171 (254)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999988888999999999999999999999999999999999999987662 24999999998766
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKT 233 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~ 233 (254)
..........+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+. ....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 55555556678999999999977766555 9999999999999999999976553322 2334
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|+..+|
T Consensus 248 ~~~li~~~L~~dP 260 (326)
T 2y0a_A 248 AKDFIRRLLVKDP 260 (326)
T ss_dssp HHHHHHHHSCSSG
T ss_pred HHHHHHHHccCCh
Confidence 6778888888888
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=284.60 Aligned_cols=222 Identities=28% Similarity=0.505 Sum_probs=192.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+..++.++||||+++++++..++.+++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999886543 334668899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 178 (254)
|+++++|.+++... .+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....... ...
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBC
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccC
Confidence 99999999998765 6899999999999999999999999999999999999988877 9999999876543332 233
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhcCc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIKPC 241 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~ 241 (254)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+. +..+...+..++..|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 4568899999999988777555 9999999999999999999976543 334455688899999
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
++.+|
T Consensus 254 l~~dp 258 (297)
T 3fxz_A 254 LEMDV 258 (297)
T ss_dssp SCSST
T ss_pred ccCCh
Confidence 99988
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=288.91 Aligned_cols=227 Identities=33% Similarity=0.500 Sum_probs=192.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|+||.||++++..+++.||+|.+.... ...+....|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456789999999999999999999999999999999886532 2345677888888887 79999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCccccccc
Confidence 9999999999999999998888999999999999999999999999999999999999998887 99999999875322
Q ss_pred -cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhh
Q 025369 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFI 238 (254)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~ 238 (254)
.......++++.|+|||++.+..+... +|+||||+++|+|++|..||...+..... ...+..++
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 233445678999999999987776555 99999999999999999999876543333 34567788
Q ss_pred cCccccCCCc
Q 025369 239 KPCCHITPFY 248 (254)
Q Consensus 239 ~~~~~~~p~~ 248 (254)
..|+..+|.-
T Consensus 253 ~~lL~~dP~~ 262 (353)
T 2i0e_A 253 KGLMTKHPGK 262 (353)
T ss_dssp HHHTCSCTTS
T ss_pred HHHhhcCHHH
Confidence 8888888743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=289.33 Aligned_cols=225 Identities=36% Similarity=0.612 Sum_probs=192.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
...++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34789999999999999999999999999999999886543 2346688999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc---
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 174 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~--- 174 (254)
|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcc
Confidence 999999999999988888999999999999999999999999999999999999988776 999999998643322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHh
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVF 237 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~ 237 (254)
.......+++.|+|||++.+......++||||||+++|+|++|..||...... ..+...+..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22234568899999999988776566699999999999999999999765442 2344567788
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..|+..+|
T Consensus 242 i~~~L~~dP 250 (323)
T 3tki_A 242 LHKILVENP 250 (323)
T ss_dssp HHHHSCSST
T ss_pred HHHHccCCh
Confidence 888888888
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=287.88 Aligned_cols=226 Identities=29% Similarity=0.493 Sum_probs=191.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
...++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|..+++.+ +||||+++++++.+++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 35689999999999999999999999999999999986542 2234577888898887 899999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-c
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~-~ 173 (254)
++||||+++++|..++.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCC
Confidence 999999999999999988888999999999999999999999999999999999999988877 9999999987532 2
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------------Chhh
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------------PKDF 230 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------------~~~~ 230 (254)
........+++.|+|||.+.+..+... +|+||||+++|+|++|..||..... +..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 233445578999999999988776555 9999999999999999999965211 1123
Q ss_pred HHHHHHhhcCccccCCCc
Q 025369 231 RKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p~~ 248 (254)
...+..++..|+..+|..
T Consensus 243 s~~~~~li~~lL~~dP~~ 260 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKE 260 (345)
T ss_dssp CHHHHHHHHHHTCSSTTT
T ss_pred CHHHHHHHHHHhcCCHhH
Confidence 345677888888888743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=288.78 Aligned_cols=225 Identities=29% Similarity=0.526 Sum_probs=195.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 345689999999999999999999999999999999885432 2345678899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~-- 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK-- 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceecc--
Confidence 999999999999999998888999999999999999999999999999999999999988877 9999999987543
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~ 240 (254)
.......+++.|+|||++.+..+... +|+||||+++|+|++|..||...+... .+...+..++..
T Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 193 GRTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp SCBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred CCcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23345578999999999987776555 999999999999999999998755433 234457788888
Q ss_pred ccccCCCc
Q 025369 241 CCHITPFY 248 (254)
Q Consensus 241 ~~~~~p~~ 248 (254)
|++.+|.-
T Consensus 272 lL~~dp~~ 279 (350)
T 1rdq_E 272 LLQVDLTK 279 (350)
T ss_dssp HSCSCTTT
T ss_pred HhhcCHHh
Confidence 88888843
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=299.53 Aligned_cols=231 Identities=39% Similarity=0.685 Sum_probs=200.5
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
........++|++++.||+|+||.||++.+..++..||+|.+.... .....+.+|+..++.++||||+++++++..
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3445566789999999999999999999999999999999886532 234568899999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
.+.+++|+||+++++|.+++...+.+++..++.++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~ 165 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNM 165 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhh
Confidence 9999999999999999999988888999999999999999999999999999999999999988877 99999999876
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHH
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQV 236 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~ 236 (254)
..........++++.|+|||.+.+..+...++|+||||+++|+|++|..||...+.... +...+..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 55544445667999999999998877766669999999999999999999987654433 3345677
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 246 Li~~~L~~dP~ 256 (476)
T 2y94_A 246 LLKHMLQVDPM 256 (476)
T ss_dssp HHHHHTCSSTT
T ss_pred HHHHHcCCCch
Confidence 88888888883
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=288.95 Aligned_cols=225 Identities=35% Similarity=0.583 Sum_probs=193.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34689999999999999999999999999999999865432 235678899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~~ 176 (254)
|||+.+++|.+.+.....+++..++.++.||+.||.|||++||+|+||+|+||+++.++. ..++|+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 999999999999988888999999999999999999999999999999999999976542 3599999999876654444
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~ 238 (254)
.....+++.|+|||++.+..+..+ +||||||+++|+|++|..||...+.. ..+...+..++
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 455678999999999987766555 99999999999999999999765432 23345677788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 266 ~~~L~~dP 273 (362)
T 2bdw_A 266 DSMLTVNP 273 (362)
T ss_dssp HHHSCSSG
T ss_pred HHHcCCCh
Confidence 88888887
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=279.61 Aligned_cols=199 Identities=28% Similarity=0.477 Sum_probs=171.3
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++++.||+|++|+||++.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++.+++.+++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 3689999999999999999999999999999999865432 2366788999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
||++++.+..+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccc
Confidence 99987555555555678999999999999999999999999999999999999988877 999999998654322 223
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
....++..|+|||.+.+....+.++||||||+++++|++|..||.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 445678899999999877755666999999999999999887753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=282.91 Aligned_cols=225 Identities=27% Similarity=0.455 Sum_probs=190.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.+..++|++++.||+|+||.||++.+..++..+++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 356789999999999999999999999999999999876543 3456788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccc
Confidence 999999999999987 467999999999999999999999999999999999999988777 99999999864433222
Q ss_pred CC---------------CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------
Q 025369 177 PK---------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------- 226 (254)
Q Consensus 177 ~~---------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------- 226 (254)
.. ...+++.|+|||++.+..++.+ +||||||+++|+|++|..||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 3458889999999987776555 9999999999999999999865332
Q ss_pred --ChhhHHHHHHhhcCccccCC
Q 025369 227 --PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 --~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|++.+|
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP 264 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDP 264 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSG
T ss_pred cCCCCCCHHHHHHHHHHccCCh
Confidence 12233457788889999888
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=289.30 Aligned_cols=225 Identities=30% Similarity=0.535 Sum_probs=184.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHH-hhcCCCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|+||.||++++..++..||+|.+..... ....+.+|... ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4566899999999999999999999999999999999865432 22344555555 577899999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~- 172 (254)
+++||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCcccccccc
Confidence 9999999999999999998888999999999999999999999999999999999999998887 9999999987532
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFI 238 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~ 238 (254)
........++++.|+|||++.+..+... +|+||||+++|+|++|..||...+..+.+ ...+..++
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 2333455678999999999987776555 99999999999999999999876543333 33456677
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 271 ~~lL~~dp 278 (373)
T 2r5t_A 271 EGLLQKDR 278 (373)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCH
Confidence 77777666
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=281.50 Aligned_cols=213 Identities=28% Similarity=0.470 Sum_probs=178.1
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..+...++|++++.||+|+||+||++++. +++.||+|.+..... ....+.+|+..+++++||||+++++++.+++.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 55667899999999999999999999996 588999998865422 23567899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFG 170 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETT
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecC
Confidence 9999999976 777777654 45999999999999999999999999999999999999988876 9999999987543
Q ss_pred cc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 173 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 173 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
.. .......+++.|+|||.+.+......++|+||||+++++|++|..||...+..+...++
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22 22334567899999999977655566699999999999999999999877766555444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=288.79 Aligned_cols=225 Identities=30% Similarity=0.485 Sum_probs=193.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||+|+||.||++.+..++..+|+|.+..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 45789999999999999999999999999999998866532 33568899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|+.+++|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+||+++.+....++|+|||++..........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 999999999887553 6999999999999999999999999999999999999986555569999999987654443334
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~ 240 (254)
...+++.|+|||++.+..+..+ +||||||+++|+|++|..||...+..+ .+...+..++..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 287 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred eeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence 4568999999999987766555 999999999999999999997654322 344567888999
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 288 ~L~~dP 293 (387)
T 1kob_A 288 LLQKEP 293 (387)
T ss_dssp TSCSSG
T ss_pred HcCCCh
Confidence 999888
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=277.48 Aligned_cols=208 Identities=30% Similarity=0.472 Sum_probs=173.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++.+.||+|+||.||++++ .+++.+|+|.+..... ..+.+.+|+..++.++||||+++++++..++..++||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 36899999999999999999999 5788999998865432 2367789999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
|++++ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccc
Confidence 99976 888888754 67999999999999999999999999999999999999988877 999999988644322 22
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHH
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 233 (254)
.....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+...++
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 234467889999999977665566699999999999999999999876654444433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=286.09 Aligned_cols=223 Identities=30% Similarity=0.468 Sum_probs=194.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4699999999999999999999999999999998876432 2245678999999999999999999999999
Q ss_pred eEEEEEEccCcc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.+++|++++.++ +|.+++.....+++..++.++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence 999999998665 99999998889999999999999999999999999999999999999988776 999999998765
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CChhhHHHHHHhhcCccc
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------EPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~ 243 (254)
..........+++.|+|||++.+..+...++||||||+++|+|++|..||.... .+..+...+..++..|+.
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 260 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQ 260 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHHTC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHHcc
Confidence 555444556789999999999888776666999999999999999999996522 233456678888888888
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 261 ~dP 263 (335)
T 3dls_A 261 PVP 263 (335)
T ss_dssp SSG
T ss_pred CCh
Confidence 888
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=279.38 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=173.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc---hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++++.||+|++|.||++.+..++..||+|.+...... .+.+.+|+..+++++||||+++++++.+.+..++|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57899999999999999999999999999999988654332 355778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
||+++++|..++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence 99999999999888888999999999999999999999999999999999999988776 999999988654322 222
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
....++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 344678899999999875555666999999999999999999998765443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=282.32 Aligned_cols=226 Identities=28% Similarity=0.469 Sum_probs=184.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
....++|++.+.||+|+||.||++++. .++..+|+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345789999999999999999999985 588999999987542 233457789999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++.+++||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccc
Confidence 9999999999999999999998888999999999999999999999999999999999999988876 99999998864
Q ss_pred cccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHH
Q 025369 171 SVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQ 235 (254)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~ 235 (254)
.... .......+++.|+|||.+.+..+... +|+||||+++|+|++|..||...+.... +...+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 3322 22344568899999999987766554 9999999999999999999987554332 334567
Q ss_pred HhhcCccccCCC
Q 025369 236 VFIKPCCHITPF 247 (254)
Q Consensus 236 ~~~~~~~~~~p~ 247 (254)
.++..|+..+|.
T Consensus 250 ~li~~~L~~dp~ 261 (327)
T 3a62_A 250 DLLKKLLKRNAA 261 (327)
T ss_dssp HHHHHHSCSCGG
T ss_pred HHHHHHHhcCHh
Confidence 788888888773
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=280.39 Aligned_cols=226 Identities=31% Similarity=0.529 Sum_probs=195.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||+|+||.||++.+..++..+|+|.+..... ..+.+.+|+..++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35789999999999999999999999999999998865422 24668899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC--ceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~--~~~l~df~~~~~~ 171 (254)
.++|+||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.. .++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999999988889999999999999999999999999999999999999877621 4999999998765
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKT 233 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~ 233 (254)
..........+++.|+|||.+.+..+..+ +|+||||+++++|++|..||...+..+. ....
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 55444455678999999999977766555 9999999999999999999976543222 2345
Q ss_pred HHHhhcCccccCCC
Q 025369 234 IQVFIKPCCHITPF 247 (254)
Q Consensus 234 ~~~~~~~~~~~~p~ 247 (254)
+..++..|+..+|.
T Consensus 249 ~~~li~~~l~~dp~ 262 (321)
T 2a2a_A 249 AKDFIRKLLVKETR 262 (321)
T ss_dssp HHHHHHTTSCSSTT
T ss_pred HHHHHHHHcCCChh
Confidence 78899999999883
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=284.68 Aligned_cols=226 Identities=27% Similarity=0.393 Sum_probs=185.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC---
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT--- 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 92 (254)
...++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+..+++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 346899999999999999999999999999999999876432 2346788999999999999999999987653
Q ss_pred -eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++||||+++++|.+++...+.+++..++.++.|++.+|+|||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccc
Confidence 34999999999999999998889999999999999999999999999999999999999988877 999999988644
Q ss_pred cccC----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------
Q 025369 172 VLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------ 229 (254)
Q Consensus 172 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------ 229 (254)
.... ......+++.|+|||++.+..+..+ +|+||||+++|+|++|..||...+....
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 3322 1223457899999999987766555 9999999999999999999987654322
Q ss_pred hHHHHHHhhcCccccCCCc
Q 025369 230 FRKTIQVFIKPCCHITPFY 248 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~~ 248 (254)
+...+..++..|++.+|.-
T Consensus 246 ~~~~l~~li~~~l~~dP~~ 264 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPEN 264 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGG
T ss_pred CCHHHHHHHHHHHhcCHhh
Confidence 3345778888999988843
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=291.86 Aligned_cols=226 Identities=34% Similarity=0.562 Sum_probs=190.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
..++|++.+.||+|+||+||++.+..++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999998876432 235678999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~~~~~l~df~~~~~~~~~~~ 176 (254)
|||+.+++|.+.+.....+++..+..++.||+.||.|||++||+||||+|+||+++.+ ..+.++|+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999988899999999999999999999999999999999999999843 223599999999865443322
Q ss_pred -CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHh
Q 025369 177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVF 237 (254)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~ 237 (254)
.....+++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+... .+...+..+
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 234578999999999987776555 999999999999999999997654322 344567788
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|++.+|.
T Consensus 248 i~~~L~~dP~ 257 (444)
T 3soa_A 248 INKMLTINPS 257 (444)
T ss_dssp HHHHSCSSTT
T ss_pred HHHHcCCChh
Confidence 8888888883
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=279.31 Aligned_cols=207 Identities=29% Similarity=0.476 Sum_probs=162.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+..++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4679999999999999999999999999999999886543 23467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 99 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
||+++ +|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 99975 888888654 35899999999999999999999999999999999999988877 9999999986543
Q ss_pred cc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh
Q 025369 173 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (254)
Q Consensus 173 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 230 (254)
.. .......+++.|+|||++.+......++||||||+++|+|++|..||...+..+..
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 22 22234567899999999977655556699999999999999999999876544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=279.87 Aligned_cols=204 Identities=26% Similarity=0.416 Sum_probs=174.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC--eE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 94 (254)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..+++++||||+++++++.... ..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 345789999999999999999999999999999999986543 23466779999999999999999999998765 78
Q ss_pred EEEEEccCccchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe----cCCCCCceEEecccc
Q 025369 95 AIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGY 167 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili----~~~~~~~~~l~df~~ 167 (254)
++||||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||+|+||++ +.++ .++|+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCC
Confidence 999999999999999976543 8999999999999999999999999999999999998 4333 499999999
Q ss_pred cccccccCCCCCccCCCCccCcccccc--------ccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
+.............++..|+|||.+.. ..+ +.++||||||+++|+|++|..||....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876655555556678999999999862 344 444999999999999999999996433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=283.47 Aligned_cols=208 Identities=26% Similarity=0.438 Sum_probs=180.0
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-----CCCeeeeeEEEEc
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILT 90 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~ 90 (254)
..+....++|++.+.||+|+||.||++++..++..||+|.+............|+.+++.+. ||||+++++++..
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 44556678999999999999999999999999999999998766656677788999998886 9999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-------------
Q 025369 91 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS------------- 155 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~------------- 155 (254)
.+..++|||++ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 889999997664 48999999999999999999999999999999999999751
Q ss_pred ----------CCCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 156 ----------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 156 ----------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
....++|+|||++.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCc
Confidence 13349999999986432 23345578899999999988877666 999999999999999999998755
Q ss_pred CC
Q 025369 226 EP 227 (254)
Q Consensus 226 ~~ 227 (254)
..
T Consensus 264 ~~ 265 (360)
T 3llt_A 264 HM 265 (360)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=285.63 Aligned_cols=224 Identities=34% Similarity=0.554 Sum_probs=177.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... ..+.+.+|+..+++++||||+++++++..++..++|+||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4567999999999999999999999999999999886543 345677899999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
+++++|.+++.....+++.+++.++.|++.||.|||+.|++|+||+|+||+++. +..+.++|+|||++...........
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999999999988888999999999999999999999999999999999999975 2233599999999875544444445
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------------hhHHHHHHhhcC
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------------DFRKTIQVFIKP 240 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------------~~~~~~~~~~~~ 240 (254)
..+++.|+|||.+.+..+..+ +||||||+++|+|++|..||....... .+...+..++..
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred ccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 668899999999987776555 999999999999999999997655432 233457788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 289 ~L~~dP 294 (349)
T 2w4o_A 289 LIVLDP 294 (349)
T ss_dssp TSCSSG
T ss_pred HccCCh
Confidence 888888
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=289.84 Aligned_cols=211 Identities=33% Similarity=0.482 Sum_probs=180.3
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|+||.||++++..++..||+|.+... ......+.+|..+++.++||||+++++++.+++.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999988642 22335578899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccC
Confidence 999999999999998865 46899999999999999999999999999999999999998887 999999998654332
Q ss_pred C--CCCCccCCCCccCccccccccC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 175 S--QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
. .....++++.|+|||++.+... ...++|+||||+++|+|++|..||...+....+.+
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~ 284 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH
Confidence 2 2235679999999999876542 34459999999999999999999987664443333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=278.68 Aligned_cols=226 Identities=30% Similarity=0.479 Sum_probs=183.2
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc---hhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.......++|++.+.||+|+||+||++++ ++..||+|.+...... .+.+.+|+..+++++||||+++++++.+.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34456678999999999999999999987 4778999988665322 246778999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEEecccc
Q 025369 93 HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
..++||||+++++|.+++..... +++..++.++.|++.||.|||++| ++||||+|+||+++.++. ++|+|||+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~ 185 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGL 185 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCC
Confidence 99999999999999999976543 899999999999999999999999 999999999999988776 99999998
Q ss_pred ccccccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hhh
Q 025369 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KDF 230 (254)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~ 230 (254)
+...... .......+++.|+|||++.+.....+ +|+||||+++|+|++|..||...+.. ..+
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 8643322 22234568899999999988777666 99999999999999999999875432 234
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+..++..|+..+|
T Consensus 265 ~~~l~~li~~~l~~dP 280 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEP 280 (309)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHccCCh
Confidence 4567889999999888
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=273.63 Aligned_cols=223 Identities=34% Similarity=0.568 Sum_probs=192.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||+|++|.||++.+..++..+++|.+... ....+.+.+|+..++.++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 357899999999999999999999999999999988654 2345678899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe---cCCCCCceEEecccccccccccCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|+++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||++ +.++. ++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSC
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccc
Confidence 99999999999888889999999999999999999999999999999999999 44444 99999999876655555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~ 238 (254)
.....+++.|+|||.+.+. +..+ +|+||||+++++|++|..||...+..+ .+...+..++
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred hhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 5666789999999998654 4444 999999999999999999998755322 2344677888
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..|++.+|.
T Consensus 243 ~~~l~~dp~ 251 (277)
T 3f3z_A 243 RRLLTKSPK 251 (277)
T ss_dssp HHHTCSSTT
T ss_pred HHHccCChh
Confidence 888888883
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=294.41 Aligned_cols=228 Identities=33% Similarity=0.552 Sum_probs=187.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|+||.||++.+..++..||+|.+... ......+.+|+..++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34568999999999999999999999999999999988642 22335567899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|...+.....+++..++.++.|++.||+|||+ .||+||||+|+||+++.++. ++|+|||++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccC
Confidence 9999999999999999988899999999999999999999998 99999999999999988876 99999999865322
Q ss_pred -cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhh
Q 025369 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFI 238 (254)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~ 238 (254)
........+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+... .+...+..++
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 233345678999999999987776555 999999999999999999998765433 2334577888
Q ss_pred cCccccCCCcc
Q 025369 239 KPCCHITPFYP 249 (254)
Q Consensus 239 ~~~~~~~p~~~ 249 (254)
..|+..+|.-+
T Consensus 381 ~~~L~~dP~~R 391 (446)
T 4ejn_A 381 SGLLKKDPKQR 391 (446)
T ss_dssp HHHTCSSTTTS
T ss_pred HHHcccCHHHh
Confidence 88888888543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=286.55 Aligned_cols=215 Identities=23% Similarity=0.380 Sum_probs=180.8
Q ss_pred CCCCCCcccCCCceeEeccccCC--cceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeE
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE 86 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g--~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 86 (254)
+..........++|++++.||+| ++|.||++++..++..||+|.+.... ...+.+.+|+.+++.++||||+++++
T Consensus 14 ~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 14 FQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 33445566778899999999999 99999999999999999999986543 23356778999999999999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
++.+++.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~d 171 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSG 171 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECC
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcc
Confidence 999999999999999999999999776 67999999999999999999999999999999999999987776 99999
Q ss_pred cccccccccc--------CCCCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 165 FGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 165 f~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
||.+...... .......++..|+|||++.+. .....++||||||+++|+|++|..||...+...
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9986432221 111223577889999999773 233445999999999999999999998755443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=277.83 Aligned_cols=211 Identities=29% Similarity=0.450 Sum_probs=176.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc------cchhHHHHHHHHhhcC---CCCCeeeeeEEEEc
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSL---RHPNIVRFKEVILT 90 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~------~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 90 (254)
...++|++.+.||+|+||+||++++..+++.||+|.+.... .......+|+..++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45789999999999999999999999999999999886321 2234566777777666 49999999999987
Q ss_pred CC-----eEEEEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 91 PT-----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 91 ~~-----~~~lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
.. ..+++++++.+ +|.+++..... +++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEEC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEe
Confidence 54 57999999975 99999987654 899999999999999999999999999999999999988876 9999
Q ss_pred cccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHH
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 234 (254)
|||++.............+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+...++.
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999876655555556678999999999988777666 999999999999999999998776655544443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=282.12 Aligned_cols=217 Identities=32% Similarity=0.450 Sum_probs=173.4
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
........++|++.+.||+|+||+||++.+..+++.||+|.+..... ....+.+|+..++.++||||+++++++.++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 34455667899999999999999999999999999999999865432 234567899999999999999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC---CCceEEeccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYS 168 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~---~~~~~l~df~~~ 168 (254)
+.+++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+|+||+|+||+++.++ ...++|+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999975 9999999888899999999999999999999999999999999999995332 234999999988
Q ss_pred cccccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
...... .......++..|+|||++.+......++||||||+++++|++|..||...+..+...+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 654322 2223445788999999998766556669999999999999999999987665444433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=272.78 Aligned_cols=225 Identities=33% Similarity=0.590 Sum_probs=189.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999998865321 346788999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC--CCceEEeccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~--~~~~~l~df~~~~~~~ 172 (254)
++|+|++++++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++ ...++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998765 2249999999987655
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHHH
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKTI 234 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~~ 234 (254)
.........+++.|+|||.+.+.....+ +|+||||+++++|++|..||...+..+. ....+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 4444445568889999999877766555 9999999999999999999977543222 23457
Q ss_pred HHhhcCccccCCC
Q 025369 235 QVFIKPCCHITPF 247 (254)
Q Consensus 235 ~~~~~~~~~~~p~ 247 (254)
..++..|+..+|.
T Consensus 243 ~~li~~~l~~dp~ 255 (283)
T 3bhy_A 243 KDFIRRLLVKDPK 255 (283)
T ss_dssp HHHHHTTSCSSGG
T ss_pred HHHHHHHccCCHh
Confidence 8889999998883
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=291.42 Aligned_cols=211 Identities=26% Similarity=0.457 Sum_probs=179.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.++||+|+||+||++++..+++.||+|.+... ......+.+|..+++.++||||+++++++.+++.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45578999999999999999999999999999999988642 12234478899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhccc
Confidence 999999999999999987 467999999999999999999999999999999999999998887 99999999865433
Q ss_pred cCC--CCCccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH
Q 025369 174 HSQ--PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (254)
Q Consensus 174 ~~~--~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 231 (254)
... ....++++.|+|||++.. ...+..++|+||||+++|+|++|..||...+..+.+.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 222 233578999999999862 2333445999999999999999999998766544333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=272.25 Aligned_cols=225 Identities=35% Similarity=0.594 Sum_probs=194.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
..++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++||||+++++++..++..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999886543 2235677899999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~~ 176 (254)
+||+++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++. ..++|+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999975543 3499999999876655555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~ 238 (254)
.....+++.|+|||.+.+..+..+ +|+||||+++++|++|..||...+... .+...+..++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 455678999999999987776555 999999999999999999997654322 3345677888
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 243 ~~~l~~dp 250 (284)
T 3kk8_A 243 DSMLTVNP 250 (284)
T ss_dssp HHHSCSST
T ss_pred HHHcccCh
Confidence 88888888
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=279.13 Aligned_cols=208 Identities=28% Similarity=0.458 Sum_probs=176.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc---hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.-...++|++.+.||+|++|.||++.+..+++.|++|.+...... .+.+.+|+..++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 334578999999999999999999999999999999988654322 34567899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++++|..+......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCC
Confidence 999999999999988877778999999999999999999999999999999999999988876 999999988644332
Q ss_pred -CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 025369 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227 (254)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 227 (254)
.......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 22334568889999999987655566699999999999999999999876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=284.18 Aligned_cols=208 Identities=24% Similarity=0.443 Sum_probs=173.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc---------
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--------- 90 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 90 (254)
...++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 457899999999999999999999999999999998865432 23479999999999999999999854
Q ss_pred -----------------------------CCeEEEEEEccCccchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Q 025369 91 -----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHA 137 (254)
Q Consensus 91 -----------------------------~~~~~lv~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~LH~ 137 (254)
...+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 6655553 45679999999999999999999999
Q ss_pred cCeeecCCCCCcEEec-CCCCCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh
Q 025369 138 MQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216 (254)
Q Consensus 138 ~~i~h~di~p~nili~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 216 (254)
+||+||||+|+||+++ .++. ++|+|||++.............+++.|+|||.+.+....+.++||||+|+++++|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999997 4554 999999999866655666667789999999998876655666999999999999999
Q ss_pred CCCCCCCCCCChhhHHH
Q 025369 217 GGYPFEDPDEPKDFRKT 233 (254)
Q Consensus 217 g~~pf~~~~~~~~~~~~ 233 (254)
|..||...+..+.+.++
T Consensus 238 g~~pf~~~~~~~~~~~i 254 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRI 254 (383)
T ss_dssp SSCSSCCSSHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHH
Confidence 99999887665554444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=272.26 Aligned_cols=224 Identities=31% Similarity=0.555 Sum_probs=190.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+..++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 456789999999999999999999999999999999875432 2345678899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++++|.+.+.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-
Confidence 999999999999999988888999999999999999999999999999999999999988877 99999998754332
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh--------------hHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--------------FRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~~~~ 240 (254)
.......++..|+|||.+.+.....+ +|+||||+++++|++|..||...+..+. ....+..++..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 22344568899999999987776555 9999999999999999999987554332 33457788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 241 ~l~~~p 246 (279)
T 3fdn_A 241 LLKHNP 246 (279)
T ss_dssp HCCSSG
T ss_pred HhccCh
Confidence 888888
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=278.68 Aligned_cols=224 Identities=33% Similarity=0.492 Sum_probs=193.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|+||.||++.+..+++.+++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45679999999999999999999999999999999876532 23466788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 174 (254)
+||||+++++|.+++.....+++.+++.++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 999999998654322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------hhhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------KDFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~~~ 240 (254)
.......++..|+|||.+.+...... +|+||||+++|+|++|..||...... ..+...+..++..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22334568889999999987766555 99999999999999999999765432 2334557788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|++.+|
T Consensus 275 ~l~~dp 280 (335)
T 2owb_A 275 MLQTDP 280 (335)
T ss_dssp HTCSSG
T ss_pred HccCCh
Confidence 888888
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=285.64 Aligned_cols=228 Identities=29% Similarity=0.506 Sum_probs=189.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC------ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
....++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34467999999999999999999999999999999987532 123567889999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecccc
Q 025369 93 HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGY 167 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df~~ 167 (254)
.+++||||+++++|.+.+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ..++|+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998777543 35899999999999999999999999999999999999976543 3599999999
Q ss_pred cccccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------C----hh
Q 025369 168 SKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------P----KD 229 (254)
Q Consensus 168 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------~----~~ 229 (254)
+........ .....+++.|+|||++.+..+..+ +||||||+++|+|++|..||..... . ..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence 865443322 334568999999999987776555 9999999999999999999976321 0 12
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..++..|+..+|.
T Consensus 259 ~s~~~~~li~~~L~~dP~ 276 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPA 276 (351)
T ss_dssp SCHHHHHHHHHHTCSSTT
T ss_pred CCHHHHHHHHHHCCCChh
Confidence 345677888888888883
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=272.60 Aligned_cols=228 Identities=40% Similarity=0.697 Sum_probs=187.1
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.+....++|++++.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++..++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34556789999999999999999999999999999999875432 23457789999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++|+|++++++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccC
Confidence 99999999999999999988888999999999999999999999999999999999999988776 9999999887654
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFI 238 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~ 238 (254)
.........+++.|+|||.+.+....+.++|+||||+++++|++|..||....... .....+..++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 44434455688899999999877665556999999999999999999997654322 2345677788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 243 ~~~l~~~p 250 (276)
T 2h6d_A 243 MHMLQVDP 250 (276)
T ss_dssp HHHTCSSG
T ss_pred HHHccCCh
Confidence 88888887
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=271.93 Aligned_cols=229 Identities=23% Similarity=0.405 Sum_probs=191.4
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+....++|++.+.||+|+||.||++.+. ++..|++|.+.......+.+.+|+..++.++||||+++++++.+++..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3455677889999999999999999999887 677899999987766778899999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++.. ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccc
Confidence 999999999999999976 457999999999999999999999999999999999999988776 99999998864432
Q ss_pred c--CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 174 H--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 174 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
. .......++..|+|||.+.+..+..+ +|+||||+++++|++ |..||...+. +......+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence 2 12223345667999999987776554 999999999999998 9999976443 233345677
Q ss_pred HhhcCccccCCC
Q 025369 236 VFIKPCCHITPF 247 (254)
Q Consensus 236 ~~~~~~~~~~p~ 247 (254)
.++..|++.+|.
T Consensus 252 ~li~~~l~~~p~ 263 (283)
T 3gen_A 252 TIMYSCWHEKAD 263 (283)
T ss_dssp HHHHHTTCSSGG
T ss_pred HHHHHHccCChh
Confidence 888899988883
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.66 Aligned_cols=225 Identities=26% Similarity=0.430 Sum_probs=188.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|..++..++||+|+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 456789999999999999999999999999999999886432 2334578899999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRA 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccC
Confidence 99999999999999998754 7999999999999999999999999999999999999998887 99999999865443
Q ss_pred cCC--CCCccCCCCccCcccccc------ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh---------------
Q 025369 174 HSQ--PKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------- 230 (254)
Q Consensus 174 ~~~--~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------- 230 (254)
... ....++++.|+|||++.. ...+..++|+||||+++|+|++|..||...+..+.+
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 322 234578999999999873 223345599999999999999999999876543332
Q ss_pred ----HHHHHHhhcCccccCC
Q 025369 231 ----RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ----~~~~~~~~~~~~~~~p 246 (254)
....+.+++.|++ +|
T Consensus 295 ~~~~s~~~~dli~~lL~-~p 313 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PP 313 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CG
T ss_pred ccCCCHHHHHHHHHHcC-Ch
Confidence 3345666777776 55
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=270.37 Aligned_cols=226 Identities=27% Similarity=0.444 Sum_probs=192.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+....++|++.+.||+|++|.||++.+. ++..||+|.+.......+.+.+|+..+++++||||+++++++.+++..++|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3457889999999999999999999887 567799999987776778899999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|||+++++|.+++.... .+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhh
Confidence 99999999999997654 4999999999999999999999999999999999999988876 99999998864432221
Q ss_pred --CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhh
Q 025369 177 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFI 238 (254)
Q Consensus 177 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~ 238 (254)
.....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+. +......+..++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 122334567999999987777666 999999999999998 9999976443 223345678889
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..|++.+|.
T Consensus 239 ~~~l~~~p~ 247 (268)
T 3sxs_A 239 YSCWHELPE 247 (268)
T ss_dssp HHTTCSSGG
T ss_pred HHHcCCChh
Confidence 999998883
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=271.73 Aligned_cols=224 Identities=33% Similarity=0.504 Sum_probs=192.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++||||+++++++.+++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45689999999999999999999999999999999876532 23456788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 174 (254)
+++||+++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 999999988654322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~ 240 (254)
.......++..|+|||.+.+.....+ +|+||||+++++|++|..||..... +......+..++..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22334568889999999977766555 9999999999999999999976542 23344567788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|++.+|
T Consensus 249 ~l~~~p 254 (294)
T 2rku_A 249 MLQTDP 254 (294)
T ss_dssp HTCSSG
T ss_pred HcccCh
Confidence 888888
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=280.65 Aligned_cols=211 Identities=23% Similarity=0.280 Sum_probs=175.3
Q ss_pred CCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 9 ~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
+..........+..++|++.+.||+|+||.||++++. ++.||+|.+...........+|+..+++++||||+++++++
T Consensus 10 ~~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp ----CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhccee
Confidence 3445556667788999999999999999999999876 78999999876655555667789999999999999999999
Q ss_pred EcCC----eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CeeecCCCCCcEEecC
Q 025369 89 LTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------QVCHRDLKLENTLLDG 154 (254)
Q Consensus 89 ~~~~----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------~i~h~di~p~nili~~ 154 (254)
.... .+++||||+++++|.+++... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 8743 479999999999999999764 589999999999999999999999 9999999999999988
Q ss_pred CCCCceEEecccccccccccCC---CCCccCCCCccCccccccccC----CCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 155 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
++. ++|+|||++........ .....+++.|+|||++.+... .+.++||||||+++|+|++|..||...
T Consensus 167 ~~~--~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 167 NLT--ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp TCC--EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred CCe--EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 776 99999999865433322 223468899999999876422 223479999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=279.61 Aligned_cols=225 Identities=24% Similarity=0.400 Sum_probs=187.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEc-------ccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (254)
....++|++++.||+|+||.||++.+. .++..||+|.+..... ..+.+.+|+.+++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 455689999999999999999999874 3466799999876432 235688999999999 899999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili 152 (254)
...+.+++||||+++++|.+++.... .++..+++.++.||+.||+|||++|++||||+|+||++
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999997653 47899999999999999999999999999999999999
Q ss_pred cCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh
Q 025369 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 228 (254)
Q Consensus 153 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 228 (254)
+.++. ++|+|||++........ .....+++.|+|||++.+..+..+ +|+||||+++|+|++ |..||...+..+
T Consensus 237 ~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 88877 99999999864433221 222345678999999987766555 999999999999999 999997654332
Q ss_pred ---------------hhHHHHHHhhcCccccCC
Q 025369 229 ---------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ---------------~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..||+.+|
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 346 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP 346 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 334467888899999888
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=280.21 Aligned_cols=226 Identities=24% Similarity=0.375 Sum_probs=187.2
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccce---eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.....++|++.+.||+|+||.||++.+..++. .||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 44567899999999999999999999975544 59999987642 23456889999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++...
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccccc
Confidence 999999999999999999654 57999999999999999999999999999999999999988776 999999998754
Q ss_pred cccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhH
Q 025369 172 VLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFR 231 (254)
Q Consensus 172 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~ 231 (254)
...... ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+ .+.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 332221 12234567999999977776555 999999999999999 999997654322 344
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+..++..|+..+|
T Consensus 281 ~~l~~li~~~l~~dp 295 (325)
T 3kul_A 281 HALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 567888999999888
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=279.37 Aligned_cols=222 Identities=37% Similarity=0.610 Sum_probs=170.4
Q ss_pred CCceeEe---ccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFV---RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~---~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++. +.||+|+||.||++.+..++..||+|.+... ......+|+..++.+. ||||+++++++.++...++|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 4678886 7899999999999999999999999988543 3466778999999997 99999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEeccccccccccc-C
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-S 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~-~ 175 (254)
|||+++++|.+++.....+++.+++.++.|++.+|.|||++|++||||+|+||+++.++ ...++|+|||++...... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999999999999988999999999999999999999999999999999999997654 224999999998644332 2
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------------hhh
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------------KDF 230 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------------~~~ 230 (254)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. ..+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp -------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 2234467889999999987776555 99999999999999999999764321 124
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+..++..|+..+|
T Consensus 244 s~~~~~li~~~L~~dP 259 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDP 259 (325)
T ss_dssp CHHHHHHHHHHHCCCT
T ss_pred CHHHHHHHHHHCCCCh
Confidence 4567788888888888
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=292.04 Aligned_cols=225 Identities=35% Similarity=0.579 Sum_probs=191.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--------------cchhHHHHHHHHhhcCCCCCeeeeeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFKE 86 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 86 (254)
..++|++++.||+|+||+||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999999999999999986542 23467889999999999999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecc
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDF 165 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df 165 (254)
++.++..+++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||+|+||+++.++. ..++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999999988889999999999999999999999999999999999999987653 25999999
Q ss_pred cccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh----------------
Q 025369 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---------------- 229 (254)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------- 229 (254)
|++.............+++.|+|||++.+ .+ +.++||||+|+++|+|++|..||...+..+.
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 99876655555566779999999999864 34 4459999999999999999999987654322
Q ss_pred --hHHHHHHhhcCccccCCC
Q 025369 230 --FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 --~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..++..|+..+|.
T Consensus 272 ~~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTT
T ss_pred CCCCHHHHHHHHHHcCCChh
Confidence 334577788888888883
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.35 Aligned_cols=226 Identities=36% Similarity=0.595 Sum_probs=191.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
...++|++++.||+|+||+||++.+..++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3568999999999999999999999999999999987542 2345678899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccccccC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~ 175 (254)
|++|+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||+|+||+++..+ ...++|+|||++.......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999999998888999999999999999999999999999999999999996432 2349999999987665555
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHh
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVF 237 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~ 237 (254)
......+++.|+|||++.+. + ..++||||+|+++|+|++|..||...+..+ .+...+..+
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 55566789999999998753 4 455999999999999999999997755432 233457778
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|+..+|.
T Consensus 257 i~~~L~~dp~ 266 (486)
T 3mwu_A 257 IRKMLTFHPS 266 (486)
T ss_dssp HHHHTCSSTT
T ss_pred HHHHcCCChh
Confidence 8888888883
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.08 Aligned_cols=207 Identities=28% Similarity=0.474 Sum_probs=169.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc--hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.++|++++.||+|+||.||++.+..++..||+|.+...... ...+.+|+..++.++||||+++++++..++..++|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 36899999999999999999999999999999988654322 2244578999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
|+++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC-------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCcccc
Confidence 9975 888877665 45899999999999999999999999999999999999988876 9999999886443222 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhH
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 231 (254)
....++..|+|||.+.+....+.++||||||+++++|++|..||...+..+...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 334678899999998875555666999999999999999999998766544333
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=270.62 Aligned_cols=225 Identities=27% Similarity=0.453 Sum_probs=191.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+....++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..+++++||||+++++++.+++..++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456789999999999999999999987 467799999987776778899999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc--
Q 025369 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 174 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-- 174 (254)
|||+++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999999654 45899999999999999999999999999999999999987776 999999988643322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh---------------hHHHHHHhh
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD---------------FRKTIQVFI 238 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~---------------~~~~~~~~~ 238 (254)
.......++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+..+. ....+..++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 240 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence 12233345668999999977776555 999999999999999 9999976554332 334567788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|++.+|
T Consensus 241 ~~~l~~~p 248 (269)
T 4hcu_A 241 NHCWRERP 248 (269)
T ss_dssp HHHTCSSG
T ss_pred HHHccCCc
Confidence 88888888
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.11 Aligned_cols=226 Identities=26% Similarity=0.392 Sum_probs=193.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|+||.||++++..++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5678999999999999999999999999999999988543 223356788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 96 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 99999999999999876543 999999999999999999999999999999999999998877 99999999876554
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQ 235 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~ 235 (254)
........+++.|+|||++.+..++.. +|+||||+++|+|++|..||...... ..+...+.
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 444445678999999999987776555 99999999999999999999875431 12334567
Q ss_pred HhhcCccccCCCc
Q 025369 236 VFIKPCCHITPFY 248 (254)
Q Consensus 236 ~~~~~~~~~~p~~ 248 (254)
.++..|++.+|.-
T Consensus 418 dLI~~lL~~dP~~ 430 (576)
T 2acx_A 418 SLCSQLLCKDPAE 430 (576)
T ss_dssp HHHHHHTCSSGGG
T ss_pred HHHHHhccCCHHH
Confidence 7777788777743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=277.49 Aligned_cols=222 Identities=23% Similarity=0.276 Sum_probs=187.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... ..+.+.+|+..++.+ +||||+++++++..++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3579999999999999999999999999999999876543 345688999999999 99999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC---ceEEecccccccccccC
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLHS 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~---~~~l~df~~~~~~~~~~ 175 (254)
|+ +++|.+++... ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.. .++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 88999999764 679999999999999999999999999999999999999866532 29999999987543322
Q ss_pred C--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------
Q 025369 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------ 229 (254)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------ 229 (254)
. .....+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 2 234568899999999988776544 9999999999999999999987544321
Q ss_pred ----hHHHHHHhhcCccccCC
Q 025369 230 ----FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ----~~~~~~~~~~~~~~~~p 246 (254)
.. .+..++..|+..+|
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCT
T ss_pred HhccCh-HHHHHHHHHHhCCC
Confidence 12 56777888888877
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=274.18 Aligned_cols=225 Identities=35% Similarity=0.561 Sum_probs=184.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------------------------chhHHHHHHHH
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------------------IDENVQREIIN 72 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------------------------~~~~~~~e~~~ 72 (254)
...++|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 346899999999999999999999999999999998865421 12567899999
Q ss_pred hhcCCCCCeeeeeEEEEc--CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcE
Q 025369 73 HRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (254)
Q Consensus 73 l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ni 150 (254)
++.++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 568899999999989877543 35699999999999999999999999999999999999
Q ss_pred EecCCCCCceEEecccccccccccC-CCCCccCCCCccCccccccccC--CCCcccHHHHHHHHHHHHhCCCCCCCCCC-
Q 025369 151 LLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDE- 226 (254)
Q Consensus 151 li~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 226 (254)
+++.++. ++|+|||++....... ......+++.|+|||.+.+... ...++|+||||+++|+|++|..||.....
T Consensus 169 l~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9988876 9999999986543322 1234568899999999876543 34558999999999999999999976432
Q ss_pred ---------------ChhhHHHHHHhhcCccccCCC
Q 025369 227 ---------------PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 ---------------~~~~~~~~~~~~~~~~~~~p~ 247 (254)
...+...+..++..|++.+|.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 282 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChh
Confidence 123445678888888888883
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=279.99 Aligned_cols=224 Identities=30% Similarity=0.482 Sum_probs=184.4
Q ss_pred CceeE--eccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 23 DRYDF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 23 ~~y~~--~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
+.|++ .+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 44555 678999999999999999999999999987654 344678899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||++..+....++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46999999999999999999999999999999999999954444459999999987665555555
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~ 240 (254)
...+++.|+|||.+.+..+..+ +||||||+++++|++|..||...+..+ .+...+..++..
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred cccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 5678999999999876665444 999999999999999999998755432 234567788888
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 326 ~L~~dp~ 332 (373)
T 2x4f_A 326 LLIKEKS 332 (373)
T ss_dssp TSCSSGG
T ss_pred HcCCChh
Confidence 8888883
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=289.91 Aligned_cols=216 Identities=27% Similarity=0.426 Sum_probs=181.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC------
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------ 91 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 91 (254)
..++|++++.||+|+||+||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999998653 23345678899999999999999999999754
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..+++||||+++ ++.+.+.. .+++..++.+++||+.||+|||++||+||||||+||+++.++. ++|+|||++...
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeec
Confidence 467999999976 45555533 4899999999999999999999999999999999999998877 999999998766
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCcc
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCC 242 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (254)
..........+++.|+|||++.+..++.+ +||||||+++++|++|+.||...+..+++.+++..+..++.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 55545556678999999999988877655 99999999999999999999999988888888887776653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=274.93 Aligned_cols=238 Identities=26% Similarity=0.436 Sum_probs=188.4
Q ss_pred ccCCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeee
Q 025369 6 ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRF 84 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 84 (254)
....+...-........++|++.+.||+|++|.||++.+..++..|++|.+.......+.+.+|+..++++ +||||+++
T Consensus 7 ~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp ---------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred CCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeee
Confidence 33334444455666778999999999999999999999999999999999877666678889999999998 79999999
Q ss_pred eEEEEc------CCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC
Q 025369 85 KEVILT------PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (254)
Q Consensus 85 ~~~~~~------~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~ 156 (254)
++++.. .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC
Confidence 999986 46889999999999999999764 4689999999999999999999999999999999999998777
Q ss_pred CCceEEeccccccccccc-CCCCCccCCCCccCccccc-----cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--
Q 025369 157 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-- 228 (254)
Q Consensus 157 ~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-- 228 (254)
. ++|+|||++...... .......++..|+|||.+. +..+ ..++|+||||+++|+|++|..||.......
T Consensus 167 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 167 E--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp C--EEECCCTTTC-------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred C--EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 6 999999987654322 2223446888999999986 3334 444999999999999999999997654322
Q ss_pred --------------hhHHHHHHhhcCccccCC
Q 025369 229 --------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 --------------~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|+..+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 275 (326)
T 2x7f_A 244 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNH 275 (326)
T ss_dssp HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSG
T ss_pred HHhhcCccccCCccccCHHHHHHHHHHhccCh
Confidence 234567888888888888
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=277.55 Aligned_cols=209 Identities=27% Similarity=0.418 Sum_probs=174.2
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc---
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--- 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 90 (254)
+.....++|++++.||+|++|.||++++..++..||+|.+.... .....+.+|+..++.++||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp TTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 33445689999999999999999999999999999999886543 233567789999999999999999999887
Q ss_pred -----CCeEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 91 -----PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 91 -----~~~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
.+..++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~D 167 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLAD 167 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEcc
Confidence 3468999999976 66666654 367999999999999999999999999999999999999988876 99999
Q ss_pred cccccccccc-----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 165 FGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 165 f~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
||++...... .......+++.|+|||++.+....+.++||||||+++++|++|..||...+...
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9998654322 122334578899999999776655666999999999999999999998765443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=289.75 Aligned_cols=224 Identities=35% Similarity=0.568 Sum_probs=189.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++++.||+|+||+||++++..++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 358999999999999999999999999999999886542 33567889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||+|+||+++..+ ...++|+|||++.........
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999998888899999999999999999999999999999999999997543 234999999998766555555
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~ 239 (254)
....+++.|+|||++.+ .+ ..++||||+|+++|+|++|..||...+..+. +...+..++.
T Consensus 196 ~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp CCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred cccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 66779999999998864 44 4459999999999999999999987554322 3345677888
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|++.+|.
T Consensus 274 ~~L~~dp~ 281 (494)
T 3lij_A 274 QMLQFDSQ 281 (494)
T ss_dssp HHTCSSTT
T ss_pred HHCCCChh
Confidence 88888883
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=273.16 Aligned_cols=229 Identities=24% Similarity=0.309 Sum_probs=183.1
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
......++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++||||+++++++..++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 445567899999999999999999999999999999999865432 2366788999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++++|++++++|.+++....++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccc
Confidence 99999999999999999998888999999999999999999999999999999999999988776 9999999876443
Q ss_pred ccC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHH
Q 025369 173 LHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKT 233 (254)
Q Consensus 173 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~ 233 (254)
... ......++..|+|||.+.+.....+ +|+||||+++++|++|..||...+.. ..+...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 322 2234467889999999987776655 99999999999999999999764321 223445
Q ss_pred HHHhhcCccccCCCc
Q 025369 234 IQVFIKPCCHITPFY 248 (254)
Q Consensus 234 ~~~~~~~~~~~~p~~ 248 (254)
+..++..|+..+|..
T Consensus 265 l~~li~~~l~~dP~~ 279 (309)
T 2h34_A 265 FDAVIARGMAKNPED 279 (309)
T ss_dssp HHHHHHHHTCSSGGG
T ss_pred HHHHHHHhccCCHHH
Confidence 778888888888843
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=268.67 Aligned_cols=224 Identities=32% Similarity=0.585 Sum_probs=193.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|+..++.++||||+++++++.+.+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45668999999999999999999999999999999987543 22345688999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++++||+++++|.+++.....+++..++.++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-
Confidence 999999999999999988888999999999999999999999999999999999999988776 99999998754432
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------hhhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------KDFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~~~ 240 (254)
.......++..|+|||.+.+...+.. +|+||||+++++|++|..||...+.. ..+...+..++..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 22344568889999999987777665 99999999999999999999765432 2234567788888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 246 ~l~~~p 251 (284)
T 2vgo_A 246 LLRYHP 251 (284)
T ss_dssp HSCSSG
T ss_pred HhhcCH
Confidence 888887
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=273.85 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=192.1
Q ss_pred ccCCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc--chhHHHHHHHHhhcCCC
Q 025369 6 ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRH 78 (254)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h 78 (254)
.........+....+..++|++.+.||+|+||.||++.+. .++..|++|.+..... ..+.+.+|+..++.++|
T Consensus 6 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 6 SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp --------CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC
T ss_pred eecceeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC
Confidence 3344455555667778899999999999999999999983 4558899998865432 23567889999999999
Q ss_pred CCeeeeeEEEEcCCeEEEEEEccCccchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHH
Q 025369 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSY 134 (254)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~i~~~l~~ 134 (254)
|||+++++++.+.+..++|+||+++++|.+++..... +++.+++.++.|++.||.|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 165 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165 (314)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999976543 8999999999999999999
Q ss_pred HHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHH
Q 025369 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211 (254)
Q Consensus 135 LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 211 (254)
||++|++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++
T Consensus 166 lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il 242 (314)
T 2ivs_A 166 LAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLL 242 (314)
T ss_dssp HHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHH
T ss_pred HHHCCCcccccchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHH
Confidence 99999999999999999987776 9999999886443222 1223345678999999987766555 9999999999
Q ss_pred HHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhcCccccCC
Q 025369 212 YVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 212 ~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~p 246 (254)
++|++ |..||...... ..+...+..++..|+..+|
T Consensus 243 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCCh
Confidence 99999 99999765432 2334567788888888888
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=269.99 Aligned_cols=225 Identities=36% Similarity=0.609 Sum_probs=192.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.+++..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3578999999999999999999999999999999886432 33467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc---C
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~ 175 (254)
||+++++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 162 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchh
Confidence 99999999999987778999999999999999999999999999999999999988776 999999988643322 1
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhh
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFI 238 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~ 238 (254)
......++..|+|||.+.+......++|+||||+++++|++|..||...... ..+...+..++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2234567889999999987776555699999999999999999999765432 23445677888
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..|+..+|.
T Consensus 243 ~~~l~~~p~ 251 (276)
T 2yex_A 243 HKILVENPS 251 (276)
T ss_dssp HHHSCSSTT
T ss_pred HHHCCCCch
Confidence 888888883
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=293.21 Aligned_cols=226 Identities=37% Similarity=0.579 Sum_probs=192.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
....++|++.+.||+|+||.||++.+..++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34567999999999999999999999999999999998653 23456788999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~~~~~l~df~~~~~~~~ 173 (254)
++|+||+.+++|.+.+.....+++..++.++.|++.||.|||++||+||||+|+||+++.. ..+.++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999988899999999999999999999999999999999999999532 223499999999876544
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQ 235 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~ 235 (254)
........+++.|+|||++.+ .+ ..++||||||+++|+|++|..||...+..+ .+...+.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 444445568999999999866 34 445999999999999999999998755322 3345577
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 260 ~li~~~L~~dp 270 (484)
T 3nyv_A 260 DLIRKMLTYVP 270 (484)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHCCCCh
Confidence 78888888887
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=269.45 Aligned_cols=223 Identities=30% Similarity=0.493 Sum_probs=172.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4578999999999999999999999899999999885432 223668899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-
Q 025369 97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 174 (254)
++||+++++|.+++... .++++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCC
Confidence 99999999999999865 56999999999999999999999999999999999999988776 999999988654322
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~ 240 (254)
.......+++.|+|||.+.+.....+ +|+||||+++++|++|..||...+. +..+...+..++..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp -------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 22233457889999999887766555 9999999999999999999976442 23345677888888
Q ss_pred ccccCC
Q 025369 241 CCHITP 246 (254)
Q Consensus 241 ~~~~~p 246 (254)
|+..+|
T Consensus 246 ~l~~dp 251 (278)
T 3cok_A 246 LLRRNP 251 (278)
T ss_dssp HSCSSG
T ss_pred HcccCH
Confidence 998888
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=280.89 Aligned_cols=226 Identities=33% Similarity=0.532 Sum_probs=186.9
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (254)
.....++|++.+.||+|+||.||++.+..++..||+|.+..... ...+|+..+.++ +||||+++++++.+++..++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 33456799999999999999999999999999999999866432 234677777777 79999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-C-CceEEeccccccccccc
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A-PRLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~-~~~~l~df~~~~~~~~~ 174 (254)
||||+++++|.+.+.....+++..++.++.||+.||+|||++|++||||+|+||++.++. . ..++|+|||++......
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999999999888899999999999999999999999999999999999985432 2 24999999998754332
Q ss_pred -CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------------hhhHH
Q 025369 175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------------KDFRK 232 (254)
Q Consensus 175 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------------~~~~~ 232 (254)
.......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...... ..+..
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 22344568899999999877665444 99999999999999999999753211 12345
Q ss_pred HHHHhhcCccccCCC
Q 025369 233 TIQVFIKPCCHITPF 247 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~ 247 (254)
.+..++..|+..+|.
T Consensus 253 ~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPH 267 (342)
T ss_dssp HHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHCCCChh
Confidence 667788888888873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=268.96 Aligned_cols=226 Identities=31% Similarity=0.487 Sum_probs=192.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----------cchhHHHHHHHHhhcCC-CCCeeeeeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEV 87 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 87 (254)
....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345789999999999999999999999999999999986542 12345678999999995 9999999999
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
+..++..++|+||+++++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~ 170 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGF 170 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccc
Confidence 9999999999999999999999998888999999999999999999999999999999999999988776 99999999
Q ss_pred cccccccCCCCCccCCCCccCcccccc-----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------- 227 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------- 227 (254)
+.............++..|+|||.+.+ ....+.++|+||||+++++|++|..||...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 876555444555678899999999852 223345599999999999999999999764432
Q ss_pred ---hhhHHHHHHhhcCccccCC
Q 025369 228 ---KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+..++..|+..+|
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSG
T ss_pred ccccccCHHHHHHHHHHccCCc
Confidence 2344567888888888887
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=297.87 Aligned_cols=226 Identities=34% Similarity=0.512 Sum_probs=192.1
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (254)
....++|++++.||+|+||.||++++..+++.||+|.+... ....+....|..++..+ +||+|+.+++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34568999999999999999999999999999999988642 23345677788888877 78999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc-
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~- 172 (254)
+++||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeecccc
Confidence 9999999999999999998889999999999999999999999999999999999999998887 9999999987532
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh--------------HHHHHHhh
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--------------RKTIQVFI 238 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~~~~ 238 (254)
.........+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+.+ ...+..++
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2333445678999999999987777555 99999999999999999999876654433 33466777
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..+++.+|.
T Consensus 574 ~~lL~~dP~ 582 (674)
T 3pfq_A 574 KGLMTKHPG 582 (674)
T ss_dssp HHHSCSSST
T ss_pred HHHccCCHH
Confidence 777777773
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=282.04 Aligned_cols=222 Identities=33% Similarity=0.544 Sum_probs=177.9
Q ss_pred CCCceeEe-ccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHh-hcCCCCCeeeeeEEEEc----CCeE
Q 025369 21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHL 94 (254)
Q Consensus 21 ~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~ 94 (254)
..++|.+. +.||+|+||+||++.+..+++.||+|.+.. .....+|+..+ +..+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 34678887 789999999999999999999999998853 24566777776 45589999999999875 5678
Q ss_pred EEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccc
Q 025369 95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 171 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~ 171 (254)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||+|+||+++.++ .+.++|+|||++...
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999997653 599999999999999999999999999999999999998632 234999999998765
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------------hh
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------------KD 229 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------------~~ 229 (254)
..........+++.|+|||++.+..++.. +||||||+++|+|++|..||...... ..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 54444455678999999999977766555 99999999999999999999764421 23
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..++..|+..+|.
T Consensus 294 ~s~~~~~li~~~L~~dP~ 311 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPT 311 (400)
T ss_dssp SCHHHHHHHHTTSCSSGG
T ss_pred CCHHHHHHHHHHCCCChh
Confidence 455688899999998883
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=270.66 Aligned_cols=228 Identities=22% Similarity=0.332 Sum_probs=194.6
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
.+....++|++.+.||+|++|.||++.+..++..+++|.+.......+.+.+|+..++.++||||+++++++.+++..++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 44567889999999999999999999999999999999998777677888999999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
|+||+++++|.+++... ..+++..++.++.+++.+|.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 164 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence 99999999999999764 44899999999999999999999999999999999999987776 999999988654322
Q ss_pred CC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHH
Q 025369 175 SQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQV 236 (254)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~ 236 (254)
.. .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+.. ..+...+..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 21 122335668999999977776555 999999999999999 99999765533 233456778
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 244 li~~~l~~dp~ 254 (288)
T 3kfa_A 244 LMRACWQWNPS 254 (288)
T ss_dssp HHHHHTCSSGG
T ss_pred HHHHHhCCChh
Confidence 88888888873
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.00 Aligned_cols=217 Identities=30% Similarity=0.410 Sum_probs=174.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCC--eE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~ 94 (254)
..++|++++.||+|+||.||++.+..+++.||+|++... ........+|+..++.+. ||||+++++++..++ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357999999999999999999999999999999988643 223356778999999997 999999999998654 78
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
++||||+++ +|..++.. ..+++..+..+++|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 87 ~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSC
T ss_pred EEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccc
Confidence 999999975 88888865 47899999999999999999999999999999999999988876 999999998643221
Q ss_pred ----------------------CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 175 ----------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 175 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
.......+++.|+|||++.+...++.++|||||||++++|++|..||...+..+++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1112346888999999998755556669999999999999999999999888888888
Q ss_pred HHHHhhcCc
Q 025369 233 TIQVFIKPC 241 (254)
Q Consensus 233 ~~~~~~~~~ 241 (254)
++..+..+.
T Consensus 243 i~~~~~~p~ 251 (388)
T 3oz6_A 243 IIGVIDFPS 251 (388)
T ss_dssp HHHHHCCCC
T ss_pred HHHhcCCCC
Confidence 776655443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=286.11 Aligned_cols=228 Identities=26% Similarity=0.391 Sum_probs=190.8
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..+....++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 345566789999999999999999999999899999999886542 223567789999999999999999999999899
Q ss_pred EEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.++||||+++++|.+++...+ .++...++.++.|++.|++|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecC
Confidence 999999999999999997653 5899999999999999999999999999999999999988776 9999999886432
Q ss_pred ccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHH
Q 025369 173 LHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKT 233 (254)
Q Consensus 173 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~ 233 (254)
..... ....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+. +......
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 21111 11224567999999987766555 999999999999998 9999976443 2334557
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..||+.+|
T Consensus 344 l~~li~~cl~~dP 356 (377)
T 3cbl_A 344 VFRLMEQCWAYEP 356 (377)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHcCCCc
Confidence 8889999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=276.83 Aligned_cols=223 Identities=31% Similarity=0.507 Sum_probs=190.5
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------chhHHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 92 (254)
++|++.+.||+|++|.||++.+..+|+.||+|.+..... ..+.+.+|+..++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 689999999999999999999998999999998865431 134567899999998 7999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++||||+++++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|.||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999988876 9999999987665
Q ss_pred ccCCCCCccCCCCccCccccccc-----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh-----------------
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----------------- 230 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----------------- 230 (254)
.........+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+.....
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 55555566789999999998643 12344599999999999999999999765432222
Q ss_pred -HHHHHHhhcCccccCCC
Q 025369 231 -RKTIQVFIKPCCHITPF 247 (254)
Q Consensus 231 -~~~~~~~~~~~~~~~p~ 247 (254)
...+..++..|+..+|.
T Consensus 332 ~~~~~~~li~~~L~~dP~ 349 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPE 349 (365)
T ss_dssp SCHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHcCCChh
Confidence 23477888888888883
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=269.68 Aligned_cols=225 Identities=32% Similarity=0.526 Sum_probs=184.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
...++|++.+.||+|+||.||++.+..++..+++|.+.... ...+.+.+|+..++.++||||+++++++.+....++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 34579999999999999999999999999999999886543 3346788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC-CCCceEEeccccccccc
Q 025369 98 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV 172 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~-~~~~~~l~df~~~~~~~ 172 (254)
+||+++++|.+.+... ..+++..++.++.|++.||++||++|++|+||+|+||+++++ ....++|+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998888543 679999999999999999999999999999999999999643 23359999999987655
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh-----------------hHHHHH
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----------------FRKTIQ 235 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------------~~~~~~ 235 (254)
.........++..|+|||.+.+ .. ..++|+||||+++++|++|..||...+..+. ....+.
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred CcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 5554556678899999998853 34 4459999999999999999999976543222 234567
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|++.+|
T Consensus 257 ~li~~~L~~dP 267 (285)
T 3is5_A 257 DLLKQMLTKDP 267 (285)
T ss_dssp HHHHHHTCSCT
T ss_pred HHHHHHccCCh
Confidence 78888888888
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.60 Aligned_cols=226 Identities=20% Similarity=0.258 Sum_probs=189.4
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (254)
.....++|++.+.||+|++|.||++.+..++..||+|.+... ...+.+.+|+..++.+ +|++++.+++++......++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 345578999999999999999999999999999999987543 3445678899999999 79999999999999999999
Q ss_pred EEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC---CceEEeccccccccc
Q 025369 97 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSV 172 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~---~~~~l~df~~~~~~~ 172 (254)
|+||+ +++|.+++.... ++++..++.++.|++.||.|||++|++||||+|+||+++.++. ..++|+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 889999998654 5999999999999999999999999999999999999976542 249999999986544
Q ss_pred ccCC--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------------
Q 025369 173 LHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------- 228 (254)
Q Consensus 173 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------- 228 (254)
.... .....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||...+...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 3322 234458899999999987776444 999999999999999999998754321
Q ss_pred ------hhHHHHHHhhcCccccCC
Q 025369 229 ------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ------~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|+..+|
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp 265 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAF 265 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCc
Confidence 223467788888988888
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=274.57 Aligned_cols=209 Identities=30% Similarity=0.456 Sum_probs=176.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----C
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (254)
...++|++++.||+|+||.||++.+..++..||+|.+.... .....+.+|+..+++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34579999999999999999999999999999999986533 2336678999999999999999999998764 3
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++|++++.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecC
Confidence 68999999975 88888865 46899999999999999999999999999999999999988777 9999999986544
Q ss_pred ccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
.... .....+++.|+|||++.+....+.++|+||||+++++|++|..||...+..+...+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 243 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 3322 23346889999999987666556669999999999999999999987765544433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=279.57 Aligned_cols=228 Identities=25% Similarity=0.394 Sum_probs=189.4
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeee
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFK 85 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~ 85 (254)
..+....++|++++.||+|+||.||+|.+.. .+..||+|.+..... ....+.+|+..++.+ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 3445667899999999999999999999753 346799998876432 235678999999999 999999999
Q ss_pred EEEEcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCc
Q 025369 86 EVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (254)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~n 149 (254)
+++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999997653 48999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 025369 150 TLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD 225 (254)
Q Consensus 150 ili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 225 (254)
|+++.++. ++|+|||++....... ......++..|+|||++.+..++.+ +||||||+++++|++ |..||...+
T Consensus 222 Ill~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99988876 9999999987543322 1223345678999999987766555 999999999999999 999997654
Q ss_pred CCh---------------hhHHHHHHhhcCccccCC
Q 025369 226 EPK---------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ~~~---------------~~~~~~~~~~~~~~~~~p 246 (254)
..+ .....+..++..|+..+|
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCh
Confidence 322 334567788888998888
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=272.01 Aligned_cols=227 Identities=28% Similarity=0.418 Sum_probs=185.7
Q ss_pred cCCCceeEe-ccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEE
Q 025369 20 HDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 20 ~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (254)
...++|++. +.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+..++++ +||||+++++++.+++.+++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 346899995 78999999999999999999999999986653 3356788999999885 79999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecccccccccccC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~ 175 (254)
||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999999998888999999999999999999999999999999999999986653 348999999876433211
Q ss_pred --------CCCCccCCCCccCcccccc-----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------
Q 025369 176 --------QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------- 228 (254)
Q Consensus 176 --------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------- 228 (254)
......++..|+|||.+.+ ..++.+ +||||||+++|+|++|..||......+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1123358889999999865 334444 999999999999999999997654211
Q ss_pred -------------------hhHHHHHHhhcCccccCCC
Q 025369 229 -------------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 -------------------~~~~~~~~~~~~~~~~~p~ 247 (254)
.+...+..++..|+..+|.
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChh
Confidence 1334577888888888883
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=285.16 Aligned_cols=206 Identities=24% Similarity=0.358 Sum_probs=174.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC--eE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HL 94 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 94 (254)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+ ..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 345789999999999999999999999999999999986543 23466779999999999999999999998765 78
Q ss_pred EEEEEccCccchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec--CCCCCceEEecccccc
Q 025369 95 AIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK 169 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~--~~~~~~~~l~df~~~~ 169 (254)
++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||+|+||++. +++...++|+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999975433 89999999999999999999999999999999999981 2233349999999987
Q ss_pred cccccCCCCCccCCCCccCccccccc-------cCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRH-------EYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
............++..|+|||.+.+. ...+.++||||||+++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 66555555566789999999998652 22234499999999999999999999643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=280.49 Aligned_cols=213 Identities=27% Similarity=0.432 Sum_probs=169.0
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 92 (254)
.........++|++.+.||+|+||.||++.+..++..||+|.+...........+++..++.++||||+++++++...+
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3444556678999999999999999999999999999999998776666677788888899999999999999987533
Q ss_pred ------eEEEEEEccCccchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecCCCCCcEEecC-CCCCc
Q 025369 93 ------HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDG-SPAPR 159 (254)
Q Consensus 93 ------~~~lv~~~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~di~p~nili~~-~~~~~ 159 (254)
.+++||||++++ +...+ .....+++..++.++.|++.++.||| +.|++|+||+|+||+++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~-- 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT-- 170 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--
Confidence 378999999874 43333 34567899999999999999999999 999999999999999985 554
Q ss_pred eEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh
Q 025369 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (254)
Q Consensus 160 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 229 (254)
++|+|||++.............+++.|+|||++.+....+.++||||||+++|+|++|..||...+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 9999999987666555555667899999999997776556669999999999999999999987665433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.85 Aligned_cols=201 Identities=30% Similarity=0.401 Sum_probs=169.2
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 91 (254)
......++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 34445789999999999999999999999999999999986532 2235678999999999999999999998766
Q ss_pred ---CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 92 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 92 ---~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
...++|||++. ++|.+++.....+++..++.+++||+.||.|||++||+||||||+||+++.++. ++|+|||++
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla 176 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLA 176 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCc
Confidence 57899999986 499999988888999999999999999999999999999999999999988876 999999998
Q ss_pred ccccccCC-----------------------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC
Q 025369 169 KSSVLHSQ-----------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220 (254)
Q Consensus 169 ~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 220 (254)
........ .....+++.|+|||++.....++.++|||||||++|+|++|..|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 75433221 24456889999999976655556669999999999999984333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=275.29 Aligned_cols=228 Identities=28% Similarity=0.450 Sum_probs=185.0
Q ss_pred CcccCCCceeEeccccCCcceEEEEEE----EcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
+..+..++|++.+.||+|+||.||+++ +..++..||+|.+..... ..+.+.+|+..++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345678999999999999999999998 566899999998876533 335688999999999999999999998654
Q ss_pred --CeEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 92 --THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 92 --~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
..+++||||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccc
Confidence 56899999999999999997654 4999999999999999999999999999999999999987776 999999998
Q ss_pred ccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-------------------
Q 025369 169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD------------------- 225 (254)
Q Consensus 169 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------------------- 225 (254)
........ .....++..|+|||.+.+..++.+ +||||||+++++|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 65433221 122235566999999987776555 999999999999999998875421
Q ss_pred ------------CChhhHHHHHHhhcCccccCCC
Q 025369 226 ------------EPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 226 ------------~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
.+......+..++..||..+|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 274 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVN 274 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChh
Confidence 1233456788899999999883
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=287.50 Aligned_cols=225 Identities=31% Similarity=0.426 Sum_probs=191.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|+||.||++++..+++.||+|.+.... .....+.+|+.+++.++||+|+++++++.+.+.++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999886432 23356788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 96 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+||||++|++|..++... ..+++..++.++.||+.||+|||++||+||||+|+||+++.++. ++|+|||++...
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeec
Confidence 999999999999998764 36999999999999999999999999999999999999998887 999999998755
Q ss_pred cccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------ChhhHH
Q 025369 172 VLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------PKDFRK 232 (254)
Q Consensus 172 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------~~~~~~ 232 (254)
..... .....+++.|+|||++.+..++.. +|+||||+++|+|++|..||..... +..+..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cCCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 43332 233478999999999988776555 9999999999999999999987532 122334
Q ss_pred HHHHhhcCccccCCC
Q 025369 233 TIQVFIKPCCHITPF 247 (254)
Q Consensus 233 ~~~~~~~~~~~~~p~ 247 (254)
.+..++..|+..+|.
T Consensus 419 ~~~~li~~lL~~dP~ 433 (543)
T 3c4z_A 419 ASKDFCEALLQKDPE 433 (543)
T ss_dssp HHHHHHHHHSCSSGG
T ss_pred HHHHHHHHhccCCHh
Confidence 567777788887773
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=279.98 Aligned_cols=204 Identities=31% Similarity=0.491 Sum_probs=178.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
.....++|++.+.||+|++|.||++.+..++..+|+|.+.... ...+.+.+|+..++.++||||+++++++..++..+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 4556789999999999999999999999999999999887642 33467889999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+||||+++++|.+++.....+++..++.++.+++.++.|||++ |++|+||+|+||+++.++. ++|+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc
Confidence 9999999999999999888899999999999999999999996 9999999999999988877 999999987543222
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
......+++.|+|||++.+..++.+ +|+||||+++++|++|..||...+
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred -cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2334568899999999987766555 999999999999999999997644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=268.26 Aligned_cols=232 Identities=28% Similarity=0.501 Sum_probs=195.9
Q ss_pred CCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
.|.+........++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++
T Consensus 10 ~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 10 LPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp ---CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45566666677889999999999999999999999999999999886543 3346788999999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
..+...++|+||+++++|.+++.. .++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~ 166 (303)
T 3a7i_A 90 LKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVA 166 (303)
T ss_dssp EETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccc
Confidence 999999999999999999998865 46899999999999999999999999999999999999988776 999999988
Q ss_pred ccccccC-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------hhhHH
Q 025369 169 KSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------KDFRK 232 (254)
Q Consensus 169 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~~~~ 232 (254)
....... ......++..|+|||.+.+..+..+ +|+||||+++++|++|..||...... ..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T 3a7i_A 167 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK 245 (303)
T ss_dssp EECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCH
T ss_pred eecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCH
Confidence 6543322 2334567889999999987776555 99999999999999999999764432 23344
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..|+..+|
T Consensus 246 ~l~~li~~~l~~dp 259 (303)
T 3a7i_A 246 PLKEFVEACLNKEP 259 (303)
T ss_dssp HHHHHHHHHCCSSG
T ss_pred HHHHHHHHHcCCCh
Confidence 57888888998888
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.17 Aligned_cols=221 Identities=26% Similarity=0.414 Sum_probs=187.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-eEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAI 96 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 96 (254)
+....++|++.+.||+|+||.||++.+. +..||+|.+.... ..+.+.+|+.++++++||||+++++++.... ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4566789999999999999999999886 6789999887654 5677899999999999999999999987765 7899
Q ss_pred EEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
||||+++++|.+++...+. +++..++.++.|++.|++|||++|++||||+|+||+++.++. +||+|||++......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc
Confidence 9999999999999987654 799999999999999999999999999999999999988776 999999998743222
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhh
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFI 238 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~ 238 (254)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+.. ......+..++
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 223356778999999987776555 999999999999998 99999765433 33445688899
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..||..+|
T Consensus 420 ~~cl~~dp 427 (450)
T 1k9a_A 420 KNCWHLDA 427 (450)
T ss_dssp HHHTCSSG
T ss_pred HHHcCCCh
Confidence 99999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=270.19 Aligned_cols=220 Identities=28% Similarity=0.460 Sum_probs=188.2
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.|...+.||+|++|.||++++..+++.||+|.+..... ..+.+.+|+..++.++||||+++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 58889999999999999999999999999998865433 34668899999999999999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCCcc
Q 025369 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV 181 (254)
Q Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 181 (254)
+++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998765 46899999999999999999999999999999999999988776 999999987654332 2234456
Q ss_pred CCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhhcCcccc
Q 025369 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFIKPCCHI 244 (254)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~ 244 (254)
+++.|+|||.+.+..++.+ +|+||||+++++|++|..||...+.. ..+...+..++..|++.
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 8899999999987766555 99999999999999999999764422 22344577888888888
Q ss_pred CCC
Q 025369 245 TPF 247 (254)
Q Consensus 245 ~p~ 247 (254)
+|.
T Consensus 282 dp~ 284 (321)
T 2c30_A 282 DPQ 284 (321)
T ss_dssp STT
T ss_pred Chh
Confidence 883
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=280.18 Aligned_cols=209 Identities=27% Similarity=0.373 Sum_probs=178.9
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC------CCCCeeeeeEEEEcC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILTP 91 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 91 (254)
.....++|++++.||+|+||.||++.+..++..||+|.+...........+|+.+++.+ +|+||+.+++.+...
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 34456789999999999999999999999999999999977665566677788877766 567999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
+.+++|+|++. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++...++|+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 48888887654 4899999999999999999999999999999999999998776569999999986
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 230 (254)
... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+.+
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l 308 (429)
T 3kvw_A 251 YEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQL 308 (429)
T ss_dssp ETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 432 33345578899999999988777555 99999999999999999999876654443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.04 Aligned_cols=202 Identities=30% Similarity=0.442 Sum_probs=158.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 91 (254)
...++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 34589999999999999999999999999999999886532 2235678999999999999999999998543
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..+++|+|++ +++|.+++.....+++..++.+++||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCT
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhc
Confidence 5789999998 4689999988888999999999999999999999999999999999999998877 999999998754
Q ss_pred cccC----------------------------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-------
Q 025369 172 VLHS----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV------- 216 (254)
Q Consensus 172 ~~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~------- 216 (254)
.... ......+++.|+|||++.....++.++|||||||++|+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 3221 12234578899999987655555666999999999999998
Q ss_pred ----CCCCCCCC
Q 025369 217 ----GGYPFEDP 224 (254)
Q Consensus 217 ----g~~pf~~~ 224 (254)
|.++|...
T Consensus 287 ~~~~~~p~f~g~ 298 (458)
T 3rp9_A 287 YHADRGPLFPGS 298 (458)
T ss_dssp SGGGCCCSCC--
T ss_pred ccccccccCCCC
Confidence 66777553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=289.42 Aligned_cols=226 Identities=22% Similarity=0.338 Sum_probs=193.8
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
+....++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++.....+++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 44567799999999999999999999998899999999987766678899999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
|||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||+|+||+++.++. +||+|||++.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCc
Confidence 9999999999999764 45899999999999999999999999999999999999987776 9999999987543221
Q ss_pred --CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHh
Q 025369 176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVF 237 (254)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~ 237 (254)
......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.. ......+..+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122334568999999987776555 999999999999999 99999765432 3344567889
Q ss_pred hcCccccCC
Q 025369 238 IKPCCHITP 246 (254)
Q Consensus 238 ~~~~~~~~p 246 (254)
+..||+.+|
T Consensus 452 i~~cl~~dP 460 (495)
T 1opk_A 452 MRACWQWNP 460 (495)
T ss_dssp HHHHTCSSG
T ss_pred HHHHcCcCh
Confidence 999999988
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=273.37 Aligned_cols=231 Identities=20% Similarity=0.352 Sum_probs=175.4
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccce---eEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEE
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 87 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (254)
.........++|++.+.||+|+||.||++.+..++. .||+|.+... ....+.+.+|+..+++++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 344556778899999999999999999999887665 7999988653 2334678899999999999999999999
Q ss_pred EEcCCeE------EEEEEccCccchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC
Q 025369 88 ILTPTHL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (254)
Q Consensus 88 ~~~~~~~------~lv~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~ 155 (254)
+...... +++++|+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877654 99999999999999986543 58999999999999999999999999999999999999887
Q ss_pred CCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---
Q 025369 156 PAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK--- 228 (254)
Q Consensus 156 ~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~--- 228 (254)
+. ++|+|||++......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+
T Consensus 174 ~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 174 MT--VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp SC--EEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CC--EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 76 999999998654332221 22335668999999987776555 999999999999999 899998654433
Q ss_pred ------------hhHHHHHHhhcCccccCCC
Q 025369 229 ------------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 ------------~~~~~~~~~~~~~~~~~p~ 247 (254)
.....+..++..|+..+|.
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 281 (323)
T 3qup_A 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPK 281 (323)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HHhcCCCCCCCCccCHHHHHHHHHHccCChh
Confidence 3345688899999998883
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=278.31 Aligned_cols=225 Identities=17% Similarity=0.208 Sum_probs=177.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc-----ceeEEEEEccCCccc------------hhHHHHHHHHhhcCCCCCee
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIV 82 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~~~lK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~ 82 (254)
...++|++.+.||+|+||.||++.+..+ +..||+|.+...... .....+++..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4466999999999999999999998764 578999987654321 12233455566778899999
Q ss_pred eeeEEEEcC----CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC
Q 025369 83 RFKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 83 ~~~~~~~~~----~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~ 157 (254)
++++++... ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++.+..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 4589999999 89999999776 67999999999999999999999999999999999999983333
Q ss_pred CceEEecccccccccccCCC--------CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh
Q 025369 158 PRLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (254)
Q Consensus 158 ~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 229 (254)
+.++|+|||++......... ....+++.|+|||++.+..++.+ +||||||+++|+|++|..||........
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 45999999998654332221 22348899999999987776544 9999999999999999999986432211
Q ss_pred -------------------------hHHHHHHhhcCccccCC
Q 025369 230 -------------------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 -------------------------~~~~~~~~~~~~~~~~p 246 (254)
....+..++..||..+|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 311 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDY 311 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCT
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCC
Confidence 13346677778888777
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=270.70 Aligned_cols=198 Identities=24% Similarity=0.454 Sum_probs=174.1
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEc--CCeEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAI 96 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 96 (254)
...++|++.+.||+|++|.||++.+..+++.||+|.+... ..+.+.+|+.+++.++ ||||+++++++.+ ....++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 4467999999999999999999999999999999988653 3467889999999997 9999999999987 567899
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+++|+.+++|.+++.. +++..++.++.|++.||.|||++|++||||+|+||+++.++. .++|+|||++........
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCc
Confidence 9999999999888753 899999999999999999999999999999999999986653 499999999876655555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
.....++..|+|||.+.+....+.++||||||+++++|++|..||..
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 56667889999999998755556669999999999999999999954
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=276.20 Aligned_cols=226 Identities=25% Similarity=0.432 Sum_probs=189.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
.....++|++.+.||+|+||.||++++. .++..||+|.+.... ...+.+.+|+..++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3556789999999999999999999997 356899999987543 234668899999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCC
Q 025369 91 PTHLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~ 146 (254)
++..++||||+++++|.+++... ..+++.+++.++.||+.+|.|||++|++|+||+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999763 568999999999999999999999999999999
Q ss_pred CCcEEecCCCCCceEEeccccccccccc---CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 025369 147 LENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 222 (254)
Q Consensus 147 p~nili~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 222 (254)
|+||+++.++. ++|+|||++...... .......++..|+|||.+.+..+..+ +|+||||+++|+|++ |..||.
T Consensus 202 p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCC
Confidence 99999987776 999999988643322 12233456778999999887776554 999999999999999 999997
Q ss_pred CCCC---------------ChhhHHHHHHhhcCccccCC
Q 025369 223 DPDE---------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 223 ~~~~---------------~~~~~~~~~~~~~~~~~~~p 246 (254)
..+. +..+...+..++..|+..+|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 6543 23344567888889998888
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=273.31 Aligned_cols=229 Identities=25% Similarity=0.370 Sum_probs=188.9
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeE--EEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~--~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (254)
..-.....++|++.+.||+|++|.||++++..++..+ ++|.+... ....+.+.+|+..++++ +||||+++++++.
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 3334466789999999999999999999998888765 88887643 23446688999999999 8999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec
Q 025369 90 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~ 153 (254)
+.+..++||||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997654 689999999999999999999999999999999999998
Q ss_pred CCCCCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC------
Q 025369 154 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE------ 226 (254)
Q Consensus 154 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~------ 226 (254)
.++. ++|+|||++.............++..|+|||.+.+..+..+ +|+||||+++++|++ |..||...+.
T Consensus 177 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 177 ENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp GGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 7776 99999999875444444444556778999999877666555 999999999999998 9999976543
Q ss_pred ---------ChhhHHHHHHhhcCccccCC
Q 025369 227 ---------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ---------~~~~~~~~~~~~~~~~~~~p 246 (254)
+..+...+..++..|+..+|
T Consensus 254 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 254 LPQGYRLEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp GGGTCCCCCCTTBCHHHHHHHHHHTCSSG
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 22344567788888888888
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=283.95 Aligned_cols=225 Identities=32% Similarity=0.518 Sum_probs=179.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 578999999999999999999999999999999876432 11235788999999999999999999975 45
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~ 171 (254)
.+++||||+++++|.+.+.....+++..++.++.|++.||.|||++|++||||+|+||+++.++ ...++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888899999999999999999999999999999999999997543 234999999998765
Q ss_pred cccCCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------------hh
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-------------------DF 230 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------------~~ 230 (254)
..........+++.|+|||++.+ ....+.++|+||||+++|+|++|..||....... .+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 54444455678999999999864 2333445999999999999999999997654322 23
Q ss_pred HHHHHHhhcCccccCCC
Q 025369 231 RKTIQVFIKPCCHITPF 247 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p~ 247 (254)
...+..++..|++.+|.
T Consensus 373 ~~~~~~li~~~L~~dP~ 389 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPK 389 (419)
T ss_dssp CHHHHHHHHHHSCSSTT
T ss_pred CHHHHHHHHHHccCChh
Confidence 34677888889988883
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=267.95 Aligned_cols=225 Identities=28% Similarity=0.484 Sum_probs=187.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
....++|++.+.||+|++|.||++.+..++..|++|.+.... ..+.+.+|+..++.++||||+++++++...+..++|+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345678999999999999999999999999999999886643 4567889999999999999999999999999999999
Q ss_pred EccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
||+++++|.+++. ....+++..++.++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSC
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccc
Confidence 9999999999986 4567999999999999999999999999999999999999988776 999999988654332 22
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIK 239 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~ 239 (254)
.....++..|+|||.+.+..++.+ +|+||||+++++|++|..||..... +..+...+..++.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 234467889999999987776666 9999999999999999999976432 2334567888999
Q ss_pred CccccCCC
Q 025369 240 PCCHITPF 247 (254)
Q Consensus 240 ~~~~~~p~ 247 (254)
.|+..+|.
T Consensus 261 ~~l~~dp~ 268 (314)
T 3com_A 261 QCLVKSPE 268 (314)
T ss_dssp HHTCSCTT
T ss_pred HHccCChh
Confidence 99998883
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=275.12 Aligned_cols=217 Identities=28% Similarity=0.421 Sum_probs=178.9
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC--
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 92 (254)
.....++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+..++.++||||+++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 3345689999999999999999999999999999999986532 22356789999999999999999999997653
Q ss_pred ----eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 93 ----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 93 ----~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
.+++|||++ +++|.+++.. ..+++..++.+++|++.||.|||++|++||||+|+||+++.++. ++|+|||++
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a 175 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLA 175 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTC
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecc
Confidence 469999999 7799988876 57899999999999999999999999999999999999988876 999999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
.... .......+++.|+|||.+.+....+.++|+||+|+++++|++|..||...+..+++.+++..+..+
T Consensus 176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 176 RQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp EECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 7533 233455788999999998874444555999999999999999999999988877777777665544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=278.05 Aligned_cols=226 Identities=20% Similarity=0.226 Sum_probs=180.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcc---cceeEEEEEccCCccc------------hhHHHHHHHHhhcCCCCCeee
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVR 83 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~lK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~ 83 (254)
....++|++.+.||+|+||.||++.+.. ++..+++|........ ...+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3456899999999999999999999987 8889999988654321 123556778888999999999
Q ss_pred eeEEEEc----CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 84 FKEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 84 ~~~~~~~----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
+++++.. ....++||||+ +++|.+++.....+++.+++.++.||+.||.|||++|++||||+|+||+++.++...
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 9999988 67899999999 899999998877899999999999999999999999999999999999998777445
Q ss_pred eEEecccccccccccCCC--------CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----
Q 025369 160 LKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---- 227 (254)
Q Consensus 160 ~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---- 227 (254)
++|+|||++......... ....++..|+|||++.+..++.+ +||||||+++|+|++|..||......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999998654322211 33468889999999987766544 99999999999999999999542211
Q ss_pred ------------h---------hhHHHHHHhhcCccccCC
Q 025369 228 ------------K---------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ------------~---------~~~~~~~~~~~~~~~~~p 246 (254)
. .....+..++..|+..+|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 310 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAY 310 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCT
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCc
Confidence 1 233367888889998888
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=275.42 Aligned_cols=201 Identities=19% Similarity=0.206 Sum_probs=168.9
Q ss_pred cccCCCceeEeccccCCcceEEEEE-----EEcccceeEEEEEccCCccchhHHHHHHHHhhcCC---CCCeeeeeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLM-----RDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~-----~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 89 (254)
.....++|++.+.||+|+||+||+| .+..++..||+|.+... ....+.+|...++.++ |++++.+++++.
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4456789999999999999999999 46778999999988654 3355667777777776 899999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC----------
Q 025369 90 TPTHLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---------- 154 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~---------- 154 (254)
.++..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999973 456999999999999999999999999999999999999986
Q ss_pred -CCCCceEEecccccccccc---cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 025369 155 -SPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223 (254)
Q Consensus 155 -~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 223 (254)
++. ++|+|||++..... ........++..|+|||++.+..++.+ +||||||+++|+|++|..||..
T Consensus 218 ~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 218 LSAG--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -CTT--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCC--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCcccc
Confidence 444 99999999864332 222344568999999999988776555 9999999999999999999853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=273.05 Aligned_cols=222 Identities=24% Similarity=0.353 Sum_probs=180.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-------
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 92 (254)
.++|++.+.||+|+||.||+|++..++..||+|.+.... ...+.+.+|+..+++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 368999999999999999999999999999999986433 34467889999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEccCccchHHHHHhcCC---CCHH
Q 025369 93 --------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSED 119 (254)
Q Consensus 93 --------------------------------------------------~~~lv~~~~~~~~L~~~l~~~~~---~~~~ 119 (254)
..++||||+++++|.+++..... .+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-------------CCCCccCCCCc
Q 025369 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAY 186 (254)
Q Consensus 120 ~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~ 186 (254)
.++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....... ......+++.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999999999999999987776 9999999987544332 22334688999
Q ss_pred cCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC----------CCC---hhhHHHHHHhhcCccccCC
Q 025369 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----------DEP---KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 187 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----------~~~---~~~~~~~~~~~~~~~~~~p 246 (254)
+|||.+.+..++.+ +|+||||+++++|++|..|+... ..+ ......+..++..|+..+|
T Consensus 243 ~aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 243 MSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred cChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence 99999987776555 99999999999999998775321 111 1223456778888888888
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=274.49 Aligned_cols=227 Identities=33% Similarity=0.507 Sum_probs=185.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---------cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
...++|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+..++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34579999999999999999999999999999999886532 122457889999999999999999999876
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEecccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 169 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~df~~~~ 169 (254)
+. +++|+||+++++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ..++|+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 8999999999999999988888999999999999999999999999999999999999976542 349999999886
Q ss_pred cccccCCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------------
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------- 228 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------- 228 (254)
............++..|+|||.+.+ ......++|+||||+++|+|++|..||.......
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 5433222223457889999999742 3334455999999999999999999997654321
Q ss_pred hhHHHHHHhhcCccccCCC
Q 025369 229 DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p~ 247 (254)
.+...+..++..|+..+|.
T Consensus 246 ~~~~~~~~li~~~l~~dP~ 264 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPK 264 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTT
T ss_pred hcCHHHHHHHHHHcccCHh
Confidence 1234577888899988883
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=279.05 Aligned_cols=228 Identities=21% Similarity=0.327 Sum_probs=186.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEE-----EcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
....++|++.+.||+|+||.||++. +..++..||+|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4556899999999999999999999 45577899999986532 2334677899999999999999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC-CceEEe
Q 025369 92 THLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKIC 163 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~-~~~~l~ 163 (254)
+..++||||+++++|.+++.... .++..+++.++.|++.||.|||++||+||||+|+||+++.++. ..++|+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999999997653 4899999999999999999999999999999999999985442 248999
Q ss_pred ccccccccccc---CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC------------
Q 025369 164 DFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP------------ 227 (254)
Q Consensus 164 df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~------------ 227 (254)
|||++...... .......+++.|+|||++.+..+..+ +||||||+++++|++ |..||...+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99998643222 22233456789999999987776555 999999999999998 99999765432
Q ss_pred ---hhhHHHHHHhhcCccccCCC
Q 025369 228 ---KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~p~ 247 (254)
......+..++..||+.+|.
T Consensus 306 ~~~~~~~~~l~~li~~~l~~dP~ 328 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQHQPE 328 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCccCCHHHHHHHHHHcCCCHh
Confidence 23445677889999998883
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.91 Aligned_cols=227 Identities=22% Similarity=0.364 Sum_probs=191.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+....++|++.+.||+|+||.||++.+. .+..||+|.+.......+.+.+|+.+++.++||||+++++++. ....
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 3445667889999999999999999999987 4677999999877666788999999999999999999999986 5678
Q ss_pred EEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 95 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++||||+.+++|.+++... ..++...++.++.|++.||+|||++|++||||+|+||+++.++. +||+|||++....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIE 335 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcC
Confidence 9999999999999999754 36899999999999999999999999999999999999988776 9999999986543
Q ss_pred cc--CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 173 LH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 173 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
.. .......++..|+|||.+....++.+ +||||||+++|+|++ |..||...+. +......+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 414 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 414 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 22 11223345678999999977766555 999999999999999 9999976543 23344567
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..||..+|
T Consensus 415 ~~li~~cl~~dp 426 (454)
T 1qcf_A 415 YNIMMRCWKNRP 426 (454)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHccCCh
Confidence 889999999988
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=271.47 Aligned_cols=230 Identities=29% Similarity=0.455 Sum_probs=170.4
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
..++....++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++...+
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 3456677899999999999999999999999899999999876542 33456778999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 93 HLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
..++|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEe
Confidence 99999999999999999864 355899999999999999999999999999999999999988776 99999
Q ss_pred ccccccccccC------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------
Q 025369 165 FGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------- 228 (254)
Q Consensus 165 f~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------- 228 (254)
||++....... ......+++.|+|||.+.+......++|+||||+++++|++|..||.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99875433221 11234578899999998764444555999999999999999999997644322
Q ss_pred --------------hhHHHHHHhhcCccccCC
Q 025369 229 --------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 --------------~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..|++.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCCh
Confidence 223457778888998888
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.80 Aligned_cols=224 Identities=27% Similarity=0.455 Sum_probs=190.6
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..+.++|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..++.++||||+++++++.+++..++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 456789999999999999999999987 5778999999877666788999999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc--C
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~--~ 175 (254)
|++++++|.+++... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999999765 46899999999999999999999999999999999999987776 999999988644321 1
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhhc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFIK 239 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~~ 239 (254)
......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ......+..++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 2223345678999999977666544 999999999999999 89999765432 223456778888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 240 ~~l~~~p 246 (267)
T 3t9t_A 240 HCWRERP 246 (267)
T ss_dssp HHTCSSG
T ss_pred HHccCCh
Confidence 8888888
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=278.96 Aligned_cols=206 Identities=26% Similarity=0.410 Sum_probs=169.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC------eE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 94 (254)
...+|++.+.||+|+||+||++++..++. +++|++...... ..+|+.+++.++||||+++++++...+ .+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 35689999999999999999999987766 777776543322 236899999999999999999986533 37
Q ss_pred EEEEEccCccchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-CCCCCceEEeccccccc
Q 025369 95 AIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 170 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-~~~~~~~~l~df~~~~~ 170 (254)
++||||++++.+.... .....+++..++.+++||+.||.|||++||+||||+|+||+++ .++. ++|+|||++..
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~ 191 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKI 191 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCccc
Confidence 8999999875443332 2356799999999999999999999999999999999999998 5555 99999999876
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHH
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 232 (254)
...........+++.|+|||.+.+...++.++||||+|+++|+|++|..||...+..+++.+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 65555566677899999999998776556669999999999999999999988765544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=276.97 Aligned_cols=227 Identities=29% Similarity=0.476 Sum_probs=185.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC------ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
..++|++++.||+|+||.||++.+..++..+|+|.+... ....+.+.+|+..++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 357999999999999999999999999999999987542 23446788999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 025369 95 AIVMEYASGGELFERICNA----------------------------------------GRFSEDEARFFFQQLISGVSY 134 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~----------------------------------------~~~~~~~~~~~~~~i~~~l~~ 134 (254)
++||||+++++|.+++... ..+++..++.++.|++.+|.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999988421 113677888999999999999
Q ss_pred HHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-----CCCCccCCCCccCccccccc-cCCCCcccHHHHH
Q 025369 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCG 208 (254)
Q Consensus 135 LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG 208 (254)
||++|++|+||+|+||+++.++...++|+|||++....... ......+++.|+|||.+.+. ...+.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 99999999999999999987775459999999986443221 12345688899999998652 3345559999999
Q ss_pred HHHHHHHhCCCCCCCCCCChh------------------hHHHHHHhhcCccccCCC
Q 025369 209 VTLYVMLVGGYPFEDPDEPKD------------------FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 209 ~~l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~~~~~p~ 247 (254)
+++|+|++|..||...+..+. +...+..++..|++.+|.
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999976544322 345677888888888883
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=277.69 Aligned_cols=227 Identities=23% Similarity=0.385 Sum_probs=187.2
Q ss_pred CcccCCCceeEeccccCCcceEEEEEE-----EcccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (254)
.+....++|++.+.||+|+||.||+++ +..+++.||+|.+..... ..+.+.+|+..++++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 344667899999999999999999999 556779999999876432 235688999999999 789999999999
Q ss_pred EcCC-eEEEEEEccCccchHHHHHhcCC----------------------------------------------------
Q 025369 89 LTPT-HLAIVMEYASGGELFERICNAGR---------------------------------------------------- 115 (254)
Q Consensus 89 ~~~~-~~~lv~~~~~~~~L~~~l~~~~~---------------------------------------------------- 115 (254)
.+.+ .+++||||+++++|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 48999999999999999976533
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC---CCC
Q 025369 116 --------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPK 178 (254)
Q Consensus 116 --------------~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~---~~~ 178 (254)
+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhcc
Confidence 899999999999999999999999999999999999987776 9999999986443222 122
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh----------------hHHHHHHhhcCc
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD----------------FRKTIQVFIKPC 241 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~----------------~~~~~~~~~~~~ 241 (254)
...++..|+|||++.+..++.+ +||||||+++|+|++ |..||........ ....+..++..|
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 3446778999999987776555 999999999999998 9999987654433 333577788888
Q ss_pred cccCC
Q 025369 242 CHITP 246 (254)
Q Consensus 242 ~~~~p 246 (254)
+..+|
T Consensus 333 l~~dP 337 (359)
T 3vhe_A 333 WHGEP 337 (359)
T ss_dssp TCSSG
T ss_pred ccCCh
Confidence 88888
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=274.74 Aligned_cols=224 Identities=26% Similarity=0.401 Sum_probs=181.8
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc------chhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
......++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 344557899999999999999999999999999999999865321 23467889999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.+..++|+||+++ +|...+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~ 160 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAK 160 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGS
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccce
Confidence 9999999999976 787777654 46899999999999999999999999999999999999988876 9999999987
Q ss_pred ccccc-CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccc
Q 025369 170 SSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 170 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (254)
..... .......+++.|+|||.+.+......++|+||||+++|+|++|.+||...+..+.+.+++..+..+...
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 54322 223345688899999999776655666999999999999999999999988888888887776665443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=269.27 Aligned_cols=222 Identities=35% Similarity=0.608 Sum_probs=186.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++.+.||+|++|.||++++..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.+.+..++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 35789999999999999999999999999999999876533 33567899999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe---cCCCCCceEEecccccccccccCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|+++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||++ +.++ .++|+|||++..... ..
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~-~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQN-GI 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCC-BT
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCC-Cc
Confidence 99999999999888889999999999999999999999999999999999999 4444 499999998764322 12
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~ 238 (254)
.....+++.|+|||.+.+..+..+ +|+||||+++++|++|..||...+.. ..+...+..++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 233458889999999977766544 99999999999999999999765432 22345677788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 243 ~~~l~~dp 250 (304)
T 2jam_A 243 CHLLEKDP 250 (304)
T ss_dssp HHHHCSST
T ss_pred HHHcCCCh
Confidence 88888877
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=274.11 Aligned_cols=228 Identities=21% Similarity=0.354 Sum_probs=181.5
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEccccee----EEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
........++|++.+.||+|+||.||++.+..++.. +++|.+.... .....+.+|+..+++++||||+++++++
T Consensus 7 ~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred HHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 344456688999999999999999999998877665 4777765432 3446788999999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
..+. .+++++++.+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||+
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~ 163 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGL 163 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcc
Confidence 8765 67889999999999998764 56999999999999999999999999999999999999988776 99999999
Q ss_pred cccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------h
Q 025369 168 SKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------K 228 (254)
Q Consensus 168 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~ 228 (254)
+......... ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.. .
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence 8654332222 22235668999999987776555 999999999999999 99999765432 2
Q ss_pred hhHHHHHHhhcCccccCC
Q 025369 229 DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..||+.+|
T Consensus 243 ~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp TBCHHHHHHHHHHTCSCG
T ss_pred cCCHHHHHHHHHHcCCCh
Confidence 334457788888998888
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=268.97 Aligned_cols=229 Identities=24% Similarity=0.363 Sum_probs=190.8
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 86 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~ 86 (254)
........++|++.+.||+|+||.||++.+ ..++..|++|.+..... ..+.+.+|+..++++ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 344566778999999999999999999985 45788999999876543 346688999999999 9999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCC
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ 148 (254)
++.+++..++|+||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997654 4899999999999999999999999999999999
Q ss_pred cEEecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 025369 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP 224 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 224 (254)
||+++.++. ++|+|||++........ .....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...
T Consensus 175 Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 175 NILLTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GEEEETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eEEEcCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999987776 99999998865443322 122345678999999877766544 999999999999998 99999876
Q ss_pred CCChh----------------hHHHHHHhhcCccccCC
Q 025369 225 DEPKD----------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 225 ~~~~~----------------~~~~~~~~~~~~~~~~p 246 (254)
..... ....+..++..|+..+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 54433 33457778888888887
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=270.39 Aligned_cols=224 Identities=24% Similarity=0.311 Sum_probs=188.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
....++|++.+.||+|+||.||++.+. ++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345689999999999999999999975 68899999876643 3346788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 98 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccc
Confidence 99999999999886543 4899999999999999999999999999999999999988776 99999998864332
Q ss_pred cCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------------------
Q 025369 174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------------------ 226 (254)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------------------ 226 (254)
... .....++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||.....
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 211 123347889999999987776555 9999999999999999999864321
Q ss_pred -------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p 246 (254)
.......+..++..|++.+|
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP 297 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSS 297 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSG
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCc
Confidence 23445667888889999988
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=273.09 Aligned_cols=219 Identities=28% Similarity=0.454 Sum_probs=184.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+..++.++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3569999999999999999999999999999999865432 224678899999999999999999999999999999
Q ss_pred EEccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|||+.| ++.+.+. ....+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.... .
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~---~ 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---P 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---S
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecC---C
Confidence 999975 7777764 4567999999999999999999999999999999999999987776 9999999886543 2
Q ss_pred CCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hhhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KDFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~ 238 (254)
.....+++.|+|||++.+ ....+.++||||||+++++|++|..||...+.. ..+...+..++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 334578899999999853 223344599999999999999999999764432 23445678888
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|++.+|
T Consensus 287 ~~~l~~dP 294 (348)
T 1u5q_A 287 DSCLQKIP 294 (348)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCh
Confidence 89999888
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=273.61 Aligned_cols=228 Identities=23% Similarity=0.382 Sum_probs=188.3
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEE
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEV 87 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (254)
..+....++|++.+.||+|+||.||++.+ ..++..||+|.+.... ...+.+.+|+..++++ +||||++++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34566778999999999999999999997 3467789999986532 3446788999999999 89999999999
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecC
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~d 144 (254)
+...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997653 278999999999999999999999999999
Q ss_pred CCCCcEEecCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCC
Q 025369 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYP 220 (254)
Q Consensus 145 i~p~nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p 220 (254)
|+|+||+++.++. ++|+|||++......... ....+++.|+|||.+.+..++.+ +||||||+++++|++ |..|
T Consensus 198 ikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCC
Confidence 9999999987776 999999998654332221 22345678999999877766554 999999999999998 9999
Q ss_pred CCCCCCChh----------------hHHHHHHhhcCccccCC
Q 025369 221 FEDPDEPKD----------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 221 f~~~~~~~~----------------~~~~~~~~~~~~~~~~p 246 (254)
|........ ....+..++..|+..+|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 316 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 316 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 987654433 23457778888888888
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=275.97 Aligned_cols=228 Identities=27% Similarity=0.486 Sum_probs=188.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcC-CCCCeeeeeEEEEc
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 90 (254)
...++|++.+.||+|+||.||++++. .++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999984 478999999886432 2335567789999999 69999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++.+++||||+++++|.+++.....+++..++.++.|++.+|.|||++||+|+||+|+||+++.++. ++|+|||++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCee
Confidence 9999999999999999999998888999999999999999999999999999999999999988776 99999998864
Q ss_pred cccc--CCCCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hh
Q 025369 171 SVLH--SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KD 229 (254)
Q Consensus 171 ~~~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~ 229 (254)
.... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...... ..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 3322 2223446899999999987633 3455599999999999999999999754322 22
Q ss_pred hHHHHHHhhcCccccCCCcc
Q 025369 230 FRKTIQVFIKPCCHITPFYP 249 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~~~ 249 (254)
+...+..++..|+..+|..+
T Consensus 289 ~~~~~~~li~~~L~~dP~~R 308 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKR 308 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGS
T ss_pred cCHHHHHHHHHHhhhCHHHh
Confidence 33456778888888888433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=267.67 Aligned_cols=230 Identities=27% Similarity=0.417 Sum_probs=187.7
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEE----EcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
.....+...+|++.+.||+|++|.||+++ +..++..||+|.+.... ...+.+.+|+..++.++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 34455667789999999999999999999 56789999999987543 2346788999999999999999999999
Q ss_pred EcC--CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 89 LTP--THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 89 ~~~--~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
... +.+++||||+++++|.+++... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Df 170 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDF 170 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCC
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcc
Confidence 876 6789999999999999999544 56999999999999999999999999999999999999987776 999999
Q ss_pred cccccccccC----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC-----------------
Q 025369 166 GYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----------------- 224 (254)
Q Consensus 166 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----------------- 224 (254)
|++....... ......++..|+|||.+.+..++.+ +|+||||+++++|++|..|+...
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 9886543332 1223446677999999987776555 99999999999999998875321
Q ss_pred -------------CCChhhHHHHHHhhcCccccCCC
Q 025369 225 -------------DEPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 225 -------------~~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
..+..+...+..++..|++.+|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 285 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPS 285 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCC
Confidence 11223445688899999998883
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=279.22 Aligned_cols=228 Identities=23% Similarity=0.370 Sum_probs=180.1
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
.......++|++.+.||+|+||.||++++. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++..
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 344556789999999999999999999987 467789999987543 234568899999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.+..++||||+++++|.+++.... .+++.+++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 195 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR 195 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccc
Confidence 999999999999999999997654 6999999999999999999999999999999999999988776 9999999986
Q ss_pred cccccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hh
Q 025369 170 SSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KD 229 (254)
Q Consensus 170 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~ 229 (254)
........ ....++..|+|||.+.+..+..+ +||||||+++|+|++ |..||...+.. ..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 54332211 11224567999999987776555 999999999999998 99999765432 23
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|++.+|
T Consensus 275 ~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDR 291 (373)
T ss_dssp CBHHHHHHHHHHTCSSG
T ss_pred ccHHHHHHHHHHhCcCh
Confidence 34567788888998888
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=274.59 Aligned_cols=215 Identities=28% Similarity=0.456 Sum_probs=173.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 92 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+..++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3579999999999999999999999999999999986532 23356778999999999999999999997654
Q ss_pred -eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++...
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccc
Confidence 78999999976 7777775 35899999999999999999999999999999999999988876 999999998765
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
..........+++.|+|||++.+..++.+ +||||||+++++|++|..||...+..+.+.+++..+..+|
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred ccccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 44444445678899999999988776655 9999999999999999999998887776666665544443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=266.26 Aligned_cols=225 Identities=23% Similarity=0.359 Sum_probs=172.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch---hHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
....++|++.+.||+|+||.||++.+..+++.||+|.+....... ..+.++...++.++||||+++++++.+++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 345789999999999999999999999999999999886543222 23445555678889999999999999999999
Q ss_pred EEEEccCccchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 96 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+|+||+++ +|.+++. ....+++..++.++.|++.+|.|||++ |++|+||+|+||+++.++. ++|+|||++..
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGY 159 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC-----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCccc
Confidence 99999975 7766654 356799999999999999999999998 9999999999999988776 99999999876
Q ss_pred ccccCCCCCccCCCCccCccccc---cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhh
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDF 230 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~ 230 (254)
...........+++.|+|||.+. .....+.++|+||||+++++|++|..||.....+ ..+
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 55555555557889999999973 3333445599999999999999999999753321 234
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+..++..|++.+|
T Consensus 240 ~~~~~~li~~~l~~~p 255 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNS 255 (290)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHhhcCh
Confidence 4567788888888887
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=262.90 Aligned_cols=226 Identities=27% Similarity=0.454 Sum_probs=185.6
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch--------hHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
......++|++.+.||+|++|.||++.+..++..||+|.+....... +.+.+|+..++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34566799999999999999999999999999999999886543221 5678999999999999999999998
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCC---CceEE
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPA---PRLKI 162 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~---~~~~l 162 (254)
.+.. ++||||+++++|.+.+... ..+++..++.++.|++.++.|||+.| ++|+||+|+||+++.++. ..++|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7665 6899999999998887654 46999999999999999999999999 999999999999976543 23899
Q ss_pred ecccccccccccCCCCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------
Q 025369 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------- 228 (254)
Q Consensus 163 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------- 228 (254)
+|||++.... .......+++.|+|||.+... ...+.++|+||||+++|+|++|..||.......
T Consensus 171 ~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 171 ADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9999886332 233445688999999998432 223445999999999999999999997654322
Q ss_pred -----hhHHHHHHhhcCccccCC
Q 025369 229 -----DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -----~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|+..+|
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp 271 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDP 271 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCCCcccCHHHHHHHHHHhcCCh
Confidence 334467888889998888
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=263.62 Aligned_cols=223 Identities=31% Similarity=0.459 Sum_probs=177.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|++|.||++.+. +..+++|.+.... ...+.+.+|+..++.++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999985 7889999876542 223668899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecCCCCCcEEecCCC------CCceEEec
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSP------APRLKICD 164 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~di~p~nili~~~~------~~~~~l~d 164 (254)
.++||||+++++|.+++. ...+++..++.++.|++.++.+||++| ++|+||+|+||+++.+. .+.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999998885 457899999999999999999999999 89999999999998521 33499999
Q ss_pred ccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------Ch
Q 025369 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PK 228 (254)
Q Consensus 165 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~ 228 (254)
||++....... .....++..|+|||.+.+..++.+ +|+||||+++++|++|..||...+. +.
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred CCccccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 99886443322 234568889999999977766554 9999999999999999999976443 23
Q ss_pred hhHHHHHHhhcCccccCC
Q 025369 229 DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|+..+|
T Consensus 238 ~~~~~~~~li~~~l~~~p 255 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDP 255 (271)
T ss_dssp TCCHHHHHHHHHHTCSSG
T ss_pred ccCHHHHHHHHHHhcCCc
Confidence 344568889999999888
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=265.11 Aligned_cols=224 Identities=37% Similarity=0.602 Sum_probs=190.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++.+.+..+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3569999999999999999999999999999999886432 3446788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~ 176 (254)
+|++.+++|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++ ...++|+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99999999999998888899999999999999999999999999999999999997644 23599999998876554444
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhh
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFI 238 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~ 238 (254)
.....++..|+|||.+.+. . ..++|+||||+++++|++|..||...+..+ .+...+..++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHH
Confidence 4445678889999988654 4 445999999999999999999997654322 2344567788
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 258 ~~~l~~dp 265 (287)
T 2wei_A 258 RKMLTFHP 265 (287)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCh
Confidence 88888777
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=264.21 Aligned_cols=228 Identities=21% Similarity=0.369 Sum_probs=189.9
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
.+..+....++|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..++.++||||+++++++. .+.
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 81 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence 34556677899999999999999999999976 5677999998776666778899999999999999999999876 456
Q ss_pred EEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.++|+||+++++|.+++.... .+++..++.++.|++.+|.+||++|++|+||+|+||++++++. ++|+|||++...
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccc
Confidence 899999999999999996543 6899999999999999999999999999999999999987776 999999988654
Q ss_pred cccC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHH
Q 025369 172 VLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKT 233 (254)
Q Consensus 172 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~ 233 (254)
.... ......++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence 3221 1123345678999999977666544 999999999999999 89999765432 233456
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|+..+|
T Consensus 239 l~~li~~~l~~~p 251 (279)
T 1qpc_A 239 LYQLMRLCWKERP 251 (279)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHhccCh
Confidence 7788888888888
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=261.44 Aligned_cols=224 Identities=24% Similarity=0.398 Sum_probs=186.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc----
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT---- 90 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 90 (254)
.......|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 3445567999999999999999999999999999999876532 234567889999999999999999999875
Q ss_pred CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEec-CCCCCceEEecccc
Q 025369 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGY 167 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~-~~~~~~~~l~df~~ 167 (254)
...+++|+||+++++|.+++.....+++..++.++.|++.+|.|||+.| ++|+||+|+||+++ .++. ++|+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~ 178 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGL 178 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCC
Confidence 3568999999999999999998888999999999999999999999999 99999999999997 5555 99999998
Q ss_pred cccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh-----------------
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----------------- 230 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----------------- 230 (254)
+..... .......+++.|+|||.+.+. + ..++|+||||+++++|++|..||.........
T Consensus 179 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 179 ATLKRA-SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred cccccc-cccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 854322 222344688899999988643 4 45599999999999999999999774442222
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+..++..|+..+|
T Consensus 256 ~~~l~~li~~~l~~dp 271 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNK 271 (290)
T ss_dssp CHHHHHHHHHHSCSSG
T ss_pred CHHHHHHHHHHccCCh
Confidence 2357788888888888
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=275.04 Aligned_cols=208 Identities=25% Similarity=0.362 Sum_probs=165.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc------------chhHHHHHHHHhhcCCCCCeeeee
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFK 85 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~ 85 (254)
.....++|++.+.||+|+||.||++.+.. +..||+|.+..... ..+.+.+|+..++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34457899999999999999999999875 88999998854221 126688999999999999999999
Q ss_pred EEEEc-----CCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCc
Q 025369 86 EVILT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (254)
Q Consensus 86 ~~~~~-----~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~ 159 (254)
+++.. ...+++||||+.+ +|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-- 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-- 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--
T ss_pred eeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--
Confidence 99854 3468999999975 777766544 46999999999999999999999999999999999999987776
Q ss_pred eEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh
Q 025369 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229 (254)
Q Consensus 160 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 229 (254)
++|+|||++.............+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999987555555555567888999999988755556669999999999999999999987664333
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=276.23 Aligned_cols=203 Identities=27% Similarity=0.413 Sum_probs=171.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC--------CCCeeeeeEEEE-
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL- 89 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~- 89 (254)
....++|++.+.||+|+||+||++.+..++..||+|.+.......+.+.+|+..++.++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34468999999999999999999999999999999999876666677889999998885 788999999987
Q ss_pred ---cCCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCC------
Q 025369 90 ---TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPA------ 157 (254)
Q Consensus 90 ---~~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~------ 157 (254)
....+++||+++.+ ++.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 45688999999955 555555443 4699999999999999999999998 9999999999999986641
Q ss_pred -----------------------------------------CceEEecccccccccccCCCCCccCCCCccCcccccccc
Q 025369 158 -----------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196 (254)
Q Consensus 158 -----------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 196 (254)
..++|+|||++.... .......++..|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCC
Confidence 149999999986543 2334557899999999998877
Q ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 197 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
+..+ +||||||+++|+|++|..||...+
T Consensus 270 ~~~~-~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 270 YNTP-ADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CCTH-HHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCcH-HHHHHHHHHHHHHhhCCCCCCCCc
Confidence 6555 999999999999999999997544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=264.76 Aligned_cols=222 Identities=24% Similarity=0.371 Sum_probs=185.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57899999999999999999999999999999988754 22345677888888888 999999999999999999999
Q ss_pred EEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-----------------
Q 025369 98 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP----------------- 156 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~----------------- 156 (254)
+||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 6689999999999999999999999999999999999998543
Q ss_pred CCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----------
Q 025369 157 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------- 225 (254)
Q Consensus 157 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------- 225 (254)
...++|+|||++..... .....++..|+|||.+.+......++||||||+++++|++|.+++...+
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCC
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCC
Confidence 22489999998765432 2344588899999999876555556999999999999999987764322
Q ss_pred -CChhhHHHHHHhhcCccccCC
Q 025369 226 -EPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~p 246 (254)
.+..+...+..++..|++.+|
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSG
T ss_pred CCCcccCHHHHHHHHHHhCCCc
Confidence 233445678888888988888
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=262.69 Aligned_cols=225 Identities=20% Similarity=0.331 Sum_probs=187.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
........++|++.+.||+|++|.||++.+. +..+++|.+.... ...+.+.+|+..++.++||||+++++++.++
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 2 NKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp --CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCcCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 3445667899999999999999999999986 7889999887643 2235688999999999999999999999887
Q ss_pred --CeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceEEecc
Q 025369 92 --THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 92 --~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~l~df 165 (254)
+..++++||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||+|+||+++.++. +++.||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~ 157 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMA 157 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGG
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEec
Confidence 78899999999999999998765 4899999999999999999999999 999999999999998877 788887
Q ss_pred cccccccccCCCCCccCCCCccCccccccccCCCC--cccHHHHHHHHHHHHhCCCCCCCCCCC----------------
Q 025369 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK--IADVWSCGVTLYVMLVGGYPFEDPDEP---------------- 227 (254)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~~Di~slG~~l~~l~~g~~pf~~~~~~---------------- 227 (254)
|++.. .......+++.|+|||.+.+...... ++|+||||+++|+|++|..||...+..
T Consensus 158 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 158 DVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp GSCCT----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred cceee----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 76543 22234567889999999977655442 599999999999999999999764432
Q ss_pred hhhHHHHHHhhcCccccCCC
Q 025369 228 KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p~ 247 (254)
..+...+..++..|+..+|.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~ 253 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPA 253 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCHHHHHHHHHHcCCChh
Confidence 33455677888889988883
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=283.66 Aligned_cols=222 Identities=13% Similarity=0.105 Sum_probs=177.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHH---HHhhcCCCCCeeeee------
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK------ 85 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~---~~l~~l~h~~i~~~~------ 85 (254)
....++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+ ..++.++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34468999999999999999999999989999999998643 23346778899 555666899999988
Q ss_pred -EEEEcCC-----------------eEEEEEEccCccchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCe
Q 025369 86 -EVILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHAMQV 140 (254)
Q Consensus 86 -~~~~~~~-----------------~~~lv~~~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~LH~~~i 140 (254)
+++.+++ ..+++|||+ +++|.+++.....+++ ..++.++.||+.||+|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7666553 278999999 5699999987655555 7888899999999999999999
Q ss_pred eecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccccc-----------cCCCCcccHHHHHH
Q 025369 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-----------EYDGKIADVWSCGV 209 (254)
Q Consensus 141 ~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~ 209 (254)
+||||||+||+++.++. +||+|||++.... .......+ +.|+|||++.+. .+ +.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGG--VFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCC--EEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCC--EEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHH
Confidence 99999999999998876 9999999987432 22234456 999999999877 45 44599999999
Q ss_pred HHHHHHhCCCCCCCCCCC----------hhhHHHHHHhhcCccccCCC
Q 025369 210 TLYVMLVGGYPFEDPDEP----------KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 210 ~l~~l~~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~p~ 247 (254)
++|+|++|..||...... ..+...+..++..|++.+|.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCch
Confidence 999999999999764421 23456788899999998883
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=266.70 Aligned_cols=224 Identities=26% Similarity=0.436 Sum_probs=178.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45679999999999999999999999999999999886532 23356788999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 96 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+|+||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeee
Confidence 99999999999998864 456899999999999999999999999999999999999987776 999999987644
Q ss_pred cccC-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHH
Q 025369 172 VLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRK 232 (254)
Q Consensus 172 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~ 232 (254)
.... ......++..|+|||.+.+..+..+ +|+||||+++++|++|..||...... ..+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 3322 2233457889999999987766555 99999999999999999999654321 33456
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..|+..+|
T Consensus 266 ~l~~li~~~l~~dp 279 (310)
T 2wqm_A 266 ELRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHcCCCh
Confidence 78888888998888
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.94 Aligned_cols=215 Identities=29% Similarity=0.457 Sum_probs=179.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC------CeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 94 (254)
...+|++.+.||+|+||+||++.+..+++.||+|++..... ...+|+.+++.++||||+++++++... ..+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 34589999999999999999999999999999998865432 234699999999999999999998542 246
Q ss_pred EEEEEccCccchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 95 AIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++|+||+++ ++...+. ....+++..++.+++||+.||.|||++||+||||||+||+++.++. .+||+|||++..
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~ 206 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhh
Confidence 799999976 5555443 3467999999999999999999999999999999999999985543 389999999976
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
...........+++.|+|||++.+...+..++|||||||++|+|++|+.||...+..+++.+++..+..+
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 5555555566789999999999776555566999999999999999999999988888888877765544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=266.58 Aligned_cols=228 Identities=24% Similarity=0.345 Sum_probs=186.8
Q ss_pred CCcccCCCceeEec-cccCCcceEEEEEE--EcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 16 MPIMHDSDRYDFVR-DIGSGNFGVARLMR--DKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 16 ~~~~~~~~~y~~~~-~l~~g~~g~v~~~~--~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
..+..+.++|++.+ .||+|++|.||++. ...++..+++|.+.... ...+.+.+|+..++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 44556778999999 99999999999995 45678899999887543 2246788999999999999999999998
Q ss_pred cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..+..++|+|++++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcce
Confidence 56678999999999999999998888999999999999999999999999999999999999987776 9999999886
Q ss_pred cccccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------Chh
Q 025369 170 SSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKD 229 (254)
Q Consensus 170 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~ 229 (254)
........ ....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 54332211 12234578999999977666544 999999999999999 9999976543 233
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..++..|+..+|.
T Consensus 245 ~~~~l~~li~~~l~~dp~ 262 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVE 262 (291)
T ss_dssp CCHHHHHHHHHHTCSSTT
T ss_pred CCHHHHHHHHHHcCCChh
Confidence 445688899999998883
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=264.78 Aligned_cols=226 Identities=24% Similarity=0.371 Sum_probs=177.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.....++|++.+.||+|+||.||++.+..+ +..+++|...... ...+.+.+|+..++.++||||+++++++ .++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 456678999999999999999999998653 4579999876542 2345688999999999999999999997 456
Q ss_pred eEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++||||+++++|.+++.... .+++..++.++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECcccccccc
Confidence 7889999999999999997654 6899999999999999999999999999999999999987776 999999988654
Q ss_pred cccCC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHHH
Q 025369 172 VLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRKT 233 (254)
Q Consensus 172 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~~ 233 (254)
..... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+ .....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 33221 122345668999999977666554 999999999999996 999997655433 33445
Q ss_pred HHHhhcCccccCCC
Q 025369 234 IQVFIKPCCHITPF 247 (254)
Q Consensus 234 ~~~~~~~~~~~~p~ 247 (254)
+..++..|+..+|.
T Consensus 246 l~~li~~~l~~~p~ 259 (281)
T 1mp8_A 246 LYSLMTKCWAYDPS 259 (281)
T ss_dssp HHHHHHHHTCSSGG
T ss_pred HHHHHHHHccCChh
Confidence 77888888888883
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=268.17 Aligned_cols=221 Identities=21% Similarity=0.267 Sum_probs=176.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc---hhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++.++||+|+||+||++.+..+++.||+|++...... ......|+..+..+ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999987654322 22334444444444 899999999999999999999
Q ss_pred EEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
+|++ +++|.+++... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++. ++|+|||++........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCC
Confidence 9999 55787777654 46999999999999999999999999999999999999988877 99999999876555555
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------ChhhHHHHHHhhcCccc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------~~~~~~~~~~~~~~~~~ 243 (254)
.....+++.|+|||++.+ .+ ..++||||||+++++|++|..|+...+. +..+...+..++..|++
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred CcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 555668999999999876 44 4459999999999999999766543221 11234568888999999
Q ss_pred cCCC
Q 025369 244 ITPF 247 (254)
Q Consensus 244 ~~p~ 247 (254)
.+|.
T Consensus 291 ~dP~ 294 (311)
T 3p1a_A 291 PDPK 294 (311)
T ss_dssp SSTT
T ss_pred CChh
Confidence 8883
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.93 Aligned_cols=205 Identities=31% Similarity=0.409 Sum_probs=175.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEE-cccceeEEEEEccCCccchhHHHHHHHHhhcCCCC------CeeeeeEEEEc
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILT 90 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~-~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 90 (254)
+....++|++.+.||+|+||.||++.+ ..++..||+|.+.......+.+.+|+..++.++|+ +++++++++..
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 344578999999999999999999998 56789999999877665667788899999888654 59999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC------------
Q 025369 91 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP------------ 156 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~------------ 156 (254)
.+..++||||+ +++|.+++.... ++++..++.++.|++.||+|||++|++|+||+|+||+++.++
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 779999887765 689999999999999999999999999999999999998743
Q ss_pred -----CCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 157 -----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 157 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
...++|+|||++.... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 3359999999886432 23345568899999999987776555 9999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=272.42 Aligned_cols=226 Identities=24% Similarity=0.324 Sum_probs=188.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
.....++|++.+.||+|+||.||++.+. ++..||+|.+..... ....+.+|+..++.++||||+++++++..++..+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 4456789999999999999999999865 688999999876432 2346889999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 96 IVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
+|+||+.+++|.+++.... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~ 181 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLA 181 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSC
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccc
Confidence 9999999999999997653 489999999999999999999999 9999999999999988776 999999998
Q ss_pred ccccccCC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCC-----------------------
Q 025369 169 KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED----------------------- 223 (254)
Q Consensus 169 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~----------------------- 223 (254)
........ .....+++.|+|||.+.+..++.+ +||||||+++++|++|..||..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 65432222 223348899999999977776555 9999999999999999999951
Q ss_pred ----------CCCChhhHHHHHHhhcCccccCCC
Q 025369 224 ----------PDEPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 224 ----------~~~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
........+.+..++..|++.+|.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 294 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM 294 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGG
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCc
Confidence 011334456788899999999983
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=271.66 Aligned_cols=225 Identities=22% Similarity=0.332 Sum_probs=182.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEccccee----EEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
..+..++|++.+.||+|+||.||++.+..++.. +++|.+.... .....+.+|+..++.++||||+++++++. +
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 345678999999999999999999999877775 7777664432 22356678999999999999999999885 4
Q ss_pred CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+..++|++|+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccc
Confidence 5688999999999999998764 56899999999999999999999999999999999999988776 99999999875
Q ss_pred ccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChhhHH--------------
Q 025369 171 SVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRK-------------- 232 (254)
Q Consensus 171 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~-------------- 232 (254)
....... ....++..|+|||++.+..++.+ +|+||||+++|+|++ |..||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence 4333221 23346678999999987776554 999999999999999 9999987654433222
Q ss_pred -HHHHhhcCccccCC
Q 025369 233 -TIQVFIKPCCHITP 246 (254)
Q Consensus 233 -~~~~~~~~~~~~~p 246 (254)
.+..++..||..+|
T Consensus 244 ~~~~~li~~~l~~dp 258 (325)
T 3kex_A 244 IDVYMVMVKCWMIDE 258 (325)
T ss_dssp TTTTHHHHHHTCSCT
T ss_pred HHHHHHHHHHcCCCh
Confidence 34557777888877
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=264.46 Aligned_cols=224 Identities=26% Similarity=0.403 Sum_probs=180.5
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-Ce
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-TH 93 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 93 (254)
...+....++|++.+.||+|++|.||++++. +..+++|.+... ...+.+.+|+..++.++|||++++++++... +.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 3345567899999999999999999999875 788999988654 3556788999999999999999999997655 47
Q ss_pred EEEEEEccCccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.++|+||+++++|.+++..... +++..++.++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~ 167 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEA 167 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeeccccccc
Confidence 8999999999999999976543 899999999999999999999999999999999999987776 999999987643
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQ 235 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~ 235 (254)
... .....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ......+.
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ccc--ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 322 223456778999999977666555 999999999999998 99999765432 23345678
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 245 ~li~~~l~~~p 255 (278)
T 1byg_A 245 EVMKNCWHLDA 255 (278)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHhcCCh
Confidence 88899999888
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=265.23 Aligned_cols=219 Identities=25% Similarity=0.358 Sum_probs=186.3
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-----------
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 90 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 90 (254)
.++|++.+.||+|++|.||++.+..++..|++|.+.... +.+.+|+..++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 468999999999999999999999999999999886543 466789999999999999999998864
Q ss_pred -----CCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 91 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 91 -----~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
...+++||||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999754 57999999999999999999999999999999999999987776 9999
Q ss_pred cccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC----------CCChhhHHH
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----------DEPKDFRKT 233 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----------~~~~~~~~~ 233 (254)
|||++.............+++.|+|||.+.+.....+ +|+||||+++++|++|..||... ..+..+...
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKK 243 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSCHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCCHH
Confidence 9999876655555555678899999999987766555 99999999999999999887421 122334456
Q ss_pred HHHhhcCccccCC
Q 025369 234 IQVFIKPCCHITP 246 (254)
Q Consensus 234 ~~~~~~~~~~~~p 246 (254)
+..++..|+..+|
T Consensus 244 ~~~li~~~l~~dp 256 (284)
T 2a19_B 244 EKTLLQKLLSKKP 256 (284)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHccCCh
Confidence 7788888888888
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=270.12 Aligned_cols=228 Identities=23% Similarity=0.392 Sum_probs=187.3
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEc-------ccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeee
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFK 85 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~ 85 (254)
..+....++|++.+.||+|+||.||++.+. .++..||+|.+..... ....+.+|+..++.+ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 344566789999999999999999999975 3567899998875432 335678899999999 899999999
Q ss_pred EEEEcCCeEEEEEEccCccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCc
Q 025369 86 EVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (254)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~n 149 (254)
+++...+..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999997654 38999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 025369 150 TLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD 225 (254)
Q Consensus 150 ili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 225 (254)
|+++.++. ++|+|||++....... ......++..|+|||++.+..++.+ +|+||||+++++|++ |..||...+
T Consensus 188 Ill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99988776 9999999886443322 1223345678999999877666555 999999999999999 999997654
Q ss_pred CC---------------hhhHHHHHHhhcCccccCC
Q 025369 226 EP---------------KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ~~---------------~~~~~~~~~~~~~~~~~~p 246 (254)
.. ......+..++..|+..+|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCCh
Confidence 32 2334467788888888888
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=266.99 Aligned_cols=225 Identities=18% Similarity=0.211 Sum_probs=182.9
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccc-------eeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
....++|++.+.||+|+||.||++.+..++ ..+++|.+.... ...+.+.+|+..++.++||||+++++++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 356789999999999999999999998776 469999886543 344678899999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC------ceEEe
Q 025369 91 PTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKIC 163 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~------~~~l~ 163 (254)
++..++||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||+|+||+++.++.. .++|+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999999977654 9999999999999999999999999999999999999866642 28999
Q ss_pred cccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC-CCCCCCCCChh-------------
Q 025369 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKD------------- 229 (254)
Q Consensus 164 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~------------- 229 (254)
|||++..... .....++..|+|||.+.+....+.++|+||||+++|+|++|. +||...+....
T Consensus 164 Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (289)
T 4fvq_A 164 DPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP 240 (289)
T ss_dssp CCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCC
Confidence 9998754321 123346778999999987454555699999999999999955 44444332111
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|++.+|
T Consensus 241 ~~~~l~~li~~~l~~dp 257 (289)
T 4fvq_A 241 KAAELANLINNCMDYEP 257 (289)
T ss_dssp SSCTTHHHHHHHSCSSG
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 12246677788888877
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=269.64 Aligned_cols=228 Identities=27% Similarity=0.474 Sum_probs=186.5
Q ss_pred cccCCCceeEe-ccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 92 (254)
.....++|.+. +.||+|+||.||++.+..++..||+|.+.... .....+.+|+..++.+. ||||+++++++...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34456789998 89999999999999999999999999886532 23467888999999884 699999999999999
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 169 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~ 169 (254)
..++|+||+.+++|.+++... ..+++..++.++.|++.||++||++|++||||+|+||+++... .+.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999988543 5699999999999999999999999999999999999998621 2349999999987
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhH
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFR 231 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~ 231 (254)
............+++.|+|||.+.+..+..+ +|+||||+++++|++|..||...+..+ .+.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp EC---------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ccCCccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 6655544455678999999999987776555 999999999999999999997655432 233
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+..++..|++.+|
T Consensus 262 ~~~~~li~~~L~~dP 276 (327)
T 3lm5_A 262 QLATDFIQSLLVKNP 276 (327)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHcCCCh
Confidence 457778888888887
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=274.29 Aligned_cols=200 Identities=29% Similarity=0.448 Sum_probs=168.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE--
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL-- 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-- 94 (254)
...++|++.+.||+|+||.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 345799999999999999999999999999999999875422 245678899999999999999999999876654
Q ss_pred ----EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 95 ----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 95 ----~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
++|++|+. ++|.+.+. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~ 193 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARH 193 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC--
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccc
Confidence 99999997 47877763 34899999999999999999999999999999999999988877 99999999864
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.. .......+++.|+|||++.+....+.++|+||||+++++|++|..||...+.
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 194 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 33 2334456789999999998744445559999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=272.61 Aligned_cols=216 Identities=25% Similarity=0.431 Sum_probs=167.1
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC----
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP---- 91 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 91 (254)
....++|++.+.||+|+||.||++.+..++..||+|++.... .....+.+|+..++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 334589999999999999999999999999999999986532 2335677899999999999999999998754
Q ss_pred --CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 92 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 92 --~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..++++++++ +++|.+++.. ..+++..++.+++||+.||.|||++|++||||+|+||+++.++. ++|+|||++.
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccc
Confidence 5679999998 6789888765 57999999999999999999999999999999999999988776 9999999986
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
... .......+++.|+|||.+.+....+.++||||||+++++|++|..||...+..+++..++..+..+
T Consensus 181 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 181 HTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ccc--ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 533 223445788999999998875445555999999999999999999999988877777776655543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=281.44 Aligned_cols=226 Identities=23% Similarity=0.348 Sum_probs=186.3
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
..+....++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 4455677899999999999999999999975 4569999988766666789999999999999999999999866 6789
Q ss_pred EEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++.....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIED 332 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC----
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCC
Confidence 999999999999999643 56899999999999999999999999999999999999987776 99999999865432
Q ss_pred cC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
.. ......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||..... +......+.
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred CceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 21 1122335678999999987766555 999999999999999 9999976543 234455688
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..||..+|
T Consensus 412 ~li~~cl~~dP 422 (452)
T 1fmk_A 412 DLMCQCWRKEP 422 (452)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHccCCh
Confidence 89999999988
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=270.08 Aligned_cols=237 Identities=24% Similarity=0.373 Sum_probs=188.7
Q ss_pred CCCCCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeE
Q 025369 8 LTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKE 86 (254)
Q Consensus 8 ~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 86 (254)
....+..-..+....++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++
T Consensus 14 ~~~~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp --CCSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccceeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 33444444556677899999999999999999999999999999999875543 34467889999999999999999999
Q ss_pred EEEc----CCeEEEEEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 87 VILT----PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 87 ~~~~----~~~~~lv~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
++.. ....++|+||+.+++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~- 172 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ- 172 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC-
Confidence 9873 3478999999999999998875 466999999999999999999999999999999999999988776
Q ss_pred ceEEecccccccccccCCC----------CCccCCCCccCccccccccC--CCCcccHHHHHHHHHHHHhCCCCCCC---
Q 025369 159 RLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFED--- 223 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~--- 223 (254)
++|+|||++......... ....++..|+|||.+.+... ...++||||||+++++|++|..||..
T Consensus 173 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 251 (317)
T 2buj_A 173 -PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251 (317)
T ss_dssp -EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred -EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence 999999987543221111 12235888999999865432 24459999999999999999999843
Q ss_pred --------------CCCChhhHHHHHHhhcCccccCC
Q 025369 224 --------------PDEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 224 --------------~~~~~~~~~~~~~~~~~~~~~~p 246 (254)
......+...+..++..|+..+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp TTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcCh
Confidence 11123445678888888998888
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=265.39 Aligned_cols=210 Identities=31% Similarity=0.426 Sum_probs=166.7
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEE---
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL--- 89 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 89 (254)
|........++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 44556667899999999999999999999999999999999886553 23466789999999999999999999874
Q ss_pred -----------cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 90 -----------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 90 -----------~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
..+..++|+||+. ++|.+++.. .++++..++.++.|++.||++||++|++|+||+|+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~- 158 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL- 158 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT-
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-
Confidence 3467899999997 489888864 56899999999999999999999999999999999999974332
Q ss_pred ceEEeccccccccccc----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 159 RLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.++|+|||++...... .......++..|+|||.+.+......++|+||||+++++|++|..||...+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 4999999988654322 1223345678899999987655556669999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=269.45 Aligned_cols=227 Identities=23% Similarity=0.357 Sum_probs=189.1
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccce-----eEEEEEccCCc--cchhHHHHHHHHhhcC-CCCCeeeeeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 88 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~lK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (254)
......++|++.+.||+|+||.||++.+..++. .+++|.+.... ...+.+.+|+..++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456778899999999999999999999976654 79999886643 2345688999999999 899999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~ 154 (254)
.+++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999998643 35799999999999999999999999999999999999987
Q ss_pred CCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCChh-
Q 025369 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD- 229 (254)
Q Consensus 155 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~- 229 (254)
++. ++|+|||++........ .....++..|+|||.+.+..++.+ +||||||+++++|++ |..||........
T Consensus 200 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 200 GHV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCe--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 776 99999999865433222 122345678999999887766544 999999999999998 9999987554333
Q ss_pred ---------------hHHHHHHhhcCccccCC
Q 025369 230 ---------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ---------------~~~~~~~~~~~~~~~~p 246 (254)
....+..++..|+..+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 308 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccCh
Confidence 23457788888998888
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=270.06 Aligned_cols=224 Identities=25% Similarity=0.385 Sum_probs=181.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCC--CCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRH--PNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|+||.||++.+. ++..||+|.+..... ..+.+.+|+..++.++| +||+++++++..++.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 456789999999999999999999985 688899998865432 23567889999999976 999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
.++|||+ .+++|.+++.....+++.+++.++.|++.||.|||++||+||||+|+||++++ + .++|+|||++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCc
Confidence 9999995 57799999999889999999999999999999999999999999999999973 3 399999999875433
Q ss_pred cCC---CCCccCCCCccCcccccc----------ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------
Q 025369 174 HSQ---PKSTVGTPAYIAPEVLLR----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------- 226 (254)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------- 226 (254)
... .....+++.|+|||++.+ ....+.++||||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 222 234468999999999865 13334459999999999999999999976432
Q ss_pred ---ChhhHHHHHHhhcCccccCCC
Q 025369 227 ---PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~~~p~ 247 (254)
+......+..++..|++.+|.
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~ 263 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPK 263 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred cCCcccCCHHHHHHHHHHcCCChh
Confidence 122234678888899998883
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=269.11 Aligned_cols=226 Identities=29% Similarity=0.453 Sum_probs=190.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCC--CCCeeeeeEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVI 88 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 88 (254)
.....++|++.+.||+|+||.||++.+..++..||+|.+..... ....+.+|+..++.++ |+|++++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34567899999999999999999999999999999999865422 2245667899999986 59999999999
Q ss_pred EcCCeEEEEEEccCc-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-CCCCCceEEeccc
Q 025369 89 LTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFG 166 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-~~~~~~~~l~df~ 166 (254)
..++..+++++++.+ ++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++ +++. ++|+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCc
Confidence 999999999999975 89999999888999999999999999999999999999999999999998 4554 9999999
Q ss_pred ccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CChhhHHHHHHhh
Q 025369 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------EPKDFRKTIQVFI 238 (254)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~ 238 (254)
++..... .......++..|+|||.+.+......++|+||||+++++|++|..||...+ .+..+...+..++
T Consensus 196 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li 274 (320)
T 3a99_A 196 SGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274 (320)
T ss_dssp TCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHH
T ss_pred ccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHHHH
Confidence 8865432 222345688899999999877776666899999999999999999996532 2233456788888
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..|+..+|
T Consensus 275 ~~~l~~dp 282 (320)
T 3a99_A 275 RWCLALRP 282 (320)
T ss_dssp HHHTCSSG
T ss_pred HHHccCCh
Confidence 88998888
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=262.46 Aligned_cols=222 Identities=24% Similarity=0.282 Sum_probs=183.0
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEE-EcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~ 99 (254)
..++|++.+.||+|++|.||++++..+++.||+|.+.... ..+.+.+|+..++.++|++++..+..+ ......++|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3689999999999999999999999999999999876543 345688999999999987766555554 56678899999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec---CCCCCceEEecccccccccccC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~---~~~~~~~~l~df~~~~~~~~~~ 175 (254)
|+ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++ +++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999974 45799999999999999999999999999999999999994 4554 9999999986544332
Q ss_pred C--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------------
Q 025369 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------- 227 (254)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------- 227 (254)
. .....++..|+|||.+.+...+.+ +||||||+++++|++|..||......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2 234568889999999987776544 99999999999999999999864321
Q ss_pred --hhhHHHHHHhhcCccccCCC
Q 025369 228 --KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~p~ 247 (254)
..+...+..++..|++.+|.
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~ 263 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFD 263 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTT
T ss_pred HHhhCCHHHHHHHHHHHhcCcC
Confidence 22345678888999988883
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=268.73 Aligned_cols=229 Identities=21% Similarity=0.357 Sum_probs=182.2
Q ss_pred CCCCcccCCCceeEeccccCCcceEEEEEEEcccceeE----EEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEE
Q 025369 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEV 87 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~----~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (254)
.........++|++.+.||+|+||.||++.+..++..+ ++|.+... ......+.+|+..++.++||||++++++
T Consensus 6 ~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp --CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred hhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 34445567899999999999999999999998777755 66665432 2345678899999999999999999999
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
+..+. .+++++++.+++|.+++... ..+++..++.++.|++.+|.|||++|++||||+|+||+++.++. ++|+|||
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG 162 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFG 162 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTT
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCc
Confidence 98765 77889999999999998764 56999999999999999999999999999999999999987776 9999999
Q ss_pred ccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------
Q 025369 167 YSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP--------------- 227 (254)
Q Consensus 167 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~--------------- 227 (254)
++......... ....++..|+|||.+.+..+..+ +||||||+++|+|++ |..||...+..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 98654332222 22235668999999987776555 999999999999999 99999765432
Q ss_pred hhhHHHHHHhhcCccccCC
Q 025369 228 KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p 246 (254)
......+..++..|+..+|
T Consensus 242 ~~~~~~l~~li~~~l~~dp 260 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDA 260 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSG
T ss_pred ccCCHHHHHHHHHHcCCCh
Confidence 3344567888889998888
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=273.22 Aligned_cols=224 Identities=25% Similarity=0.366 Sum_probs=182.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCC--CCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 93 (254)
.....+|++.+.||+|+||.||++.+.. +..||+|.+..... ..+.+.+|+.+++.++ ||||+++++++..++.
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 3345679999999999999999999875 88999998865432 3366789999999996 4999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||| +.+++|.+++.....+++.+++.++.||+.||.|||+.||+||||+|+||++++ +. ++|+|||++.....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~--~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-SC--EEECCCSSSCCC--
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-Ce--EEEEecCccccccC
Confidence 999999 557799999998888999999999999999999999999999999999999963 44 99999999875433
Q ss_pred cCC---CCCccCCCCccCccccccc----------cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------
Q 025369 174 HSQ---PKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------- 227 (254)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------- 227 (254)
... .....+++.|+|||++.+. ...+.++||||||+++|+|++|..||......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 221 2345689999999998652 23445599999999999999999999764321
Q ss_pred ----hhhHHHHHHhhcCccccCCC
Q 025369 228 ----KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ----~~~~~~~~~~~~~~~~~~p~ 247 (254)
......+..++..|+..+|.
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~ 310 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPK 310 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred CCCCccchHHHHHHHHHHcccChh
Confidence 12234678888899998883
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=269.26 Aligned_cols=228 Identities=28% Similarity=0.463 Sum_probs=188.4
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEE----EcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
....+..++|++.+.||+|++|.||+++ +..++..|++|.+..... ..+.+.+|+..+++++||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3445677899999999999999999999 567899999999876543 33568899999999999999999999874
Q ss_pred --CCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 91 --PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 91 --~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~ 173 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGL 173 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGG
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEccccc
Confidence 46789999999999999999764 56999999999999999999999999999999999999987776 99999999
Q ss_pred cccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------
Q 025369 168 SKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------- 226 (254)
Q Consensus 168 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------- 226 (254)
+........ .....++..|+|||.+.+..+..+ +|+||||+++++|++|..||.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 865433221 223346677999999977766555 9999999999999999999854221
Q ss_pred -------------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------------~~~~~~~~~~~~~~~~~~~p 246 (254)
+..+...+..++..|++.+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCCh
Confidence 22334568888889998888
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.10 Aligned_cols=228 Identities=20% Similarity=0.322 Sum_probs=188.6
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
..+....++|++.+.||+|++|.||++.+. .++..|++|.+..... ....+.+|+..++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344566789999999999999999999886 4678899999875433 234578899999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
.+++..++||||+++++|.+++... ..++...++.++.|++.||.+||++|++||||+|+||+++.++.
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~- 176 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT- 176 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe-
Confidence 9999999999999999999998653 35689999999999999999999999999999999999988776
Q ss_pred ceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--------
Q 025369 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------- 226 (254)
++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+.
T Consensus 177 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 177 -VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp -EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred -EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999998864432221 122345678999999877666554 999999999999999 8899976443
Q ss_pred -------ChhhHHHHHHhhcCccccCC
Q 025369 227 -------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|+..+|
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNP 281 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCc
Confidence 23344567788888888888
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.40 Aligned_cols=229 Identities=25% Similarity=0.383 Sum_probs=175.1
Q ss_pred CCCCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEE
Q 025369 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEV 87 (254)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (254)
.+.-...+....++|++.+.||+|+||.||++.+.. .+++|.+..... ..+.+.+|+..++.++||||++++++
T Consensus 12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp ------CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 455556677889999999999999999999998753 489998765432 23568899999999999999999996
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
. .....++|++|+++++|.+++... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg 165 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFG 165 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccce
Confidence 5 556789999999999999988543 56999999999999999999999999999999999999988776 9999999
Q ss_pred ccccccc---cCCCCCccCCCCccCccccc---cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------
Q 025369 167 YSKSSVL---HSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------ 228 (254)
Q Consensus 167 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------ 228 (254)
++..... ........++..|+|||.+. +..+ +.++||||||+++++|++|..||......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 8864332 12223345888999999986 3333 445999999999999999999997754432
Q ss_pred --------hhHHHHHHhhcCccccCC
Q 025369 229 --------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 --------~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|+..+|
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p 270 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKR 270 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSG
T ss_pred cchhhccccCCHHHHHHHHHHccCCh
Confidence 233557788888888887
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=263.37 Aligned_cols=230 Identities=23% Similarity=0.341 Sum_probs=179.8
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcc---cceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
........++|++.+.||+|++|.||++.+.. ++..||+|.+..... ..+.+.+|+..+++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34455677899999999999999999998765 566899998875432 235678899999999999999999999
Q ss_pred EcCC-----eEEEEEEccCccchHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC
Q 025369 89 LTPT-----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (254)
Q Consensus 89 ~~~~-----~~~lv~~~~~~~~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~ 157 (254)
...+ ..+++++|+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8754 3599999999999999984 3356999999999999999999999999999999999999988776
Q ss_pred CceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh-----
Q 025369 158 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK----- 228 (254)
Q Consensus 158 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~----- 228 (254)
++|+|||++....... ......+++.|+|||.+.+..+..+ +|+||||+++++|++ |..||.......
T Consensus 186 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 186 --VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp --EEECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred --EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999886543321 1123345678999999977666555 999999999999999 889997655433
Q ss_pred ----------hhHHHHHHhhcCccccCCC
Q 025369 229 ----------DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 ----------~~~~~~~~~~~~~~~~~p~ 247 (254)
.+...+..++..|+..+|.
T Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 291 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYEIMYSCWRTDPL 291 (313)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHTTCSSGG
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChh
Confidence 3345688889999988883
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=265.16 Aligned_cols=207 Identities=29% Similarity=0.449 Sum_probs=172.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc-ccceeEEEEEccCCc---cchhHHHHHHHHhhcC---CCCCeeeeeEEEE---
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL--- 89 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 89 (254)
...++|++.+.||+|++|.||++.+. .+++.||+|.+.... .....+.+|+..++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 678899999876432 2234566777766655 8999999999987
Q ss_pred --cCCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 90 --TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 90 --~~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
.....++|+|++. ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecC
Confidence 4567899999997 49999887653 4899999999999999999999999999999999999988776 999999
Q ss_pred cccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh
Q 025369 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (254)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 230 (254)
|++.............++..|+|||.+.+..+..+ +|+||||+++++|++|..||...+..+..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99876554444455678899999999987776555 99999999999999999999876554433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=267.22 Aligned_cols=230 Identities=23% Similarity=0.344 Sum_probs=183.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccc----eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 88 (254)
........++|++.+.||+|++|.||++.+..++ ..|++|.+..... ....+.+|+..++.++||||+++++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3444567889999999999999999999987553 4599998865432 335678899999999999999999999
Q ss_pred EcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 89 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 89 ~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
...+..++||||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~ 193 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGL 193 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCc
Confidence 9999999999999999999999765 57999999999999999999999999999999999999987776 99999998
Q ss_pred cccccccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------C
Q 025369 168 SKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------P 227 (254)
Q Consensus 168 ~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~ 227 (254)
+......... ....++..|+|||.+.+..+..+ +|+||||+++++|++ |..||...+. +
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc
Confidence 8654332211 12234567999999977666554 999999999999998 9999975432 2
Q ss_pred hhhHHHHHHhhcCccccCCC
Q 025369 228 KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p~ 247 (254)
......+..++..||..+|.
T Consensus 273 ~~~~~~l~~li~~~l~~~p~ 292 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERA 292 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTT
T ss_pred ccCCHHHHHHHHHHcCCChh
Confidence 23445678888899998883
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=263.40 Aligned_cols=221 Identities=24% Similarity=0.291 Sum_probs=178.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEE-EcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~~ 99 (254)
..++|++.+.||+|++|.||++.+..+++.||+|.+.... ..+.+.+|+..++.++|++++..+..+ ..++..+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3689999999999999999999999999999999765432 335678899999999887766655555 56778899999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEe---cCCCCCceEEecccccccccccC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
++ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++ ++++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899999874 4579999999999999999999999999999999999999 55555 9999999986544332
Q ss_pred C--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------------
Q 025369 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------------------- 227 (254)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------------- 227 (254)
. .....++..|+|||.+.+..++.+ +||||||+++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 2 234468889999999987776544 99999999999999999999764432
Q ss_pred --hhhHHHHHHhhcCccccCC
Q 025369 228 --KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+..++..|++.+|
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCT
T ss_pred hhccCCHHHHHHHHHHHhcCC
Confidence 1224567888899999888
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=272.72 Aligned_cols=225 Identities=22% Similarity=0.371 Sum_probs=189.2
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc----h--------------hHHHHHHHHhhcCCC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----D--------------ENVQREIINHRSLRH 78 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~----~--------------~~~~~e~~~l~~l~h 78 (254)
......++|++.+.||+|++|.||++.+ ++..||+|.+...... . +.+.+|+..+++++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445568999999999999999999999 8999999987643211 1 778899999999999
Q ss_pred CCeeeeeEEEEcCCeEEEEEEccCccchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCc
Q 025369 79 PNIVRFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLEN 149 (254)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~~~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~n 149 (254)
|||+++++++.+++..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .|++|+||+|+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999988 655 5679999999999999999999999 999999999999
Q ss_pred EEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccccc-cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-
Q 025369 150 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP- 227 (254)
Q Consensus 150 ili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 227 (254)
|+++.++. ++|+|||++...... ......++..|+|||.+.+. .+...++|+||||+++++|++|..||......
T Consensus 183 il~~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99988876 999999988654332 33455688899999999876 44443599999999999999999999765441
Q ss_pred ---------------------------------hhhHHHHHHhhcCccccCC
Q 025369 228 ---------------------------------KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---------------------------------~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+..++..|++.+|
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 311 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCCh
Confidence 2344567788888888887
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=261.30 Aligned_cols=226 Identities=27% Similarity=0.406 Sum_probs=186.2
Q ss_pred CcccCCCceeEec-cccCCcceEEEEEEEc--ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
.+....++|.+.+ .||+|++|.||++.+. .++..|++|.+.... ...+.+.+|+..++.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 4556788999988 9999999999999864 467889999987643 3346688999999999999999999998 55
Q ss_pred CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+..++|+|++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceee
Confidence 6689999999999999998654 45999999999999999999999999999999999999987776 99999998865
Q ss_pred ccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhh
Q 025369 171 SVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDF 230 (254)
Q Consensus 171 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~ 230 (254)
...... .....++..|+|||.+.+...+.+ +|+||||+++++|++ |..||...+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 432221 122335678999999977666555 999999999999998 99999765432 334
Q ss_pred HHHHHHhhcCccccCC
Q 025369 231 RKTIQVFIKPCCHITP 246 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p 246 (254)
...+..++..|+..+|
T Consensus 239 ~~~l~~li~~~l~~~p 254 (287)
T 1u59_A 239 PPELYALMSDCWIYKW 254 (287)
T ss_dssp CHHHHHHHHHTTCSSG
T ss_pred CHHHHHHHHHHcCCCh
Confidence 4567788888998888
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=265.17 Aligned_cols=224 Identities=31% Similarity=0.524 Sum_probs=184.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 94 (254)
...++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++||||+++++++.+ +...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34689999999999999999999999999999999986543 234567889999999999999999998854 5689
Q ss_pred EEEEEccCccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecCCCCCcEEecCCCCCceEEecc
Q 025369 95 AIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~di~p~nili~~~~~~~~~l~df 165 (254)
++|+||+++++|.+++... ..+++..++.++.|++.+|.+||+.| ++|+||+|+||+++.++. ++|+||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~df 160 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDF 160 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecC
Confidence 9999999999999998654 34899999999999999999999999 999999999999987776 999999
Q ss_pred cccccccccCC-CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------------hh
Q 025369 166 GYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------KD 229 (254)
Q Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~ 229 (254)
|++........ .....++..|+|||.+.+..++.. +|+||||+++++|++|..||...+.. ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 98764332211 122357889999999987766544 99999999999999999999775432 23
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
+...+..++..|+..+|
T Consensus 240 ~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKD 256 (279)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred cCHHHHHHHHHHcCCCc
Confidence 34567888888888888
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=268.22 Aligned_cols=227 Identities=29% Similarity=0.437 Sum_probs=181.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcC----CCCCeeeeeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKE 86 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l----~h~~i~~~~~ 86 (254)
.....++|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 44557899999999999999999999999999999999865432 223455688888888 8999999999
Q ss_pred EEEcCCeEEEEEEc-cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec-CCCCCceEEec
Q 025369 87 VILTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICD 164 (254)
Q Consensus 87 ~~~~~~~~~lv~~~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~-~~~~~~~~l~d 164 (254)
++...+..++++++ +.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++. ++|+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEE
Confidence 99998999999999 68899999999888899999999999999999999999999999999999998 5555 99999
Q ss_pred ccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CChhhHHHHHH
Q 025369 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------EPKDFRKTIQV 236 (254)
Q Consensus 165 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~ 236 (254)
||++...... ......++..|+|||.+.+......++|+||||+++++|++|..||.... .+..+...+..
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHH
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHH
Confidence 9988654332 23445688899999998877766656999999999999999999996421 23345567888
Q ss_pred hhcCccccCCC
Q 025369 237 FIKPCCHITPF 247 (254)
Q Consensus 237 ~~~~~~~~~p~ 247 (254)
++..|+..+|.
T Consensus 263 li~~~l~~~p~ 273 (312)
T 2iwi_A 263 LIRRCLAPKPS 273 (312)
T ss_dssp HHHHHTCSSTT
T ss_pred HHHHHccCChh
Confidence 88889988883
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=264.13 Aligned_cols=226 Identities=26% Similarity=0.438 Sum_probs=185.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
....++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++||||+++++++..++..++|
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 345789999999999999999999999999999999886543 3346788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cC
Q 025369 98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~ 175 (254)
+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccc
Confidence 999999999998865 456999999999999999999999999999999999999987776 99999998643221 12
Q ss_pred CCCCccCCCCccCccccc----cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHH
Q 025369 176 QPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTI 234 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~ 234 (254)
......++..|+|||.+. .....+.++|+||||+++++|++|..||...+. +..+...+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 223456788999999984 223334559999999999999999999976442 23344567
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..|+..+|
T Consensus 253 ~~li~~~l~~dp 264 (302)
T 2j7t_A 253 RDFLKIALDKNP 264 (302)
T ss_dssp HHHHHHHSCSCT
T ss_pred HHHHHHHcccCh
Confidence 888888988888
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=266.80 Aligned_cols=202 Identities=31% Similarity=0.447 Sum_probs=170.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----C
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (254)
...++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 357899999999999999999999999999999999865432 335677899999999999999999988754 6
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
..++++|++.+ +|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccc
Confidence 78999999974 88888866 46899999999999999999999999999999999999988776 9999999886543
Q ss_pred ccCC-----------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 173 LHSQ-----------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 173 ~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.... .....++..|+|||++.+....+.++|+||||+++++|++|..||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2211 1223578889999998765555666999999999999999999997655
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=268.37 Aligned_cols=223 Identities=30% Similarity=0.454 Sum_probs=182.5
Q ss_pred CCCce-eEeccccCCcceEEEEEE----EcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcC--
Q 025369 21 DSDRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (254)
Q Consensus 21 ~~~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 91 (254)
..++| ++++.||+|+||.||++. +..++..||+|.+.... ...+.+.+|+..++.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 45566 999999999999998775 34578899999987653 2345688999999999999999999999874
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..+++||||+++++|.+++... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccc
Confidence 6789999999999999998765 4899999999999999999999999999999999999988876 999999998654
Q ss_pred cccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------------
Q 025369 172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---------------------- 225 (254)
Q Consensus 172 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------------------- 225 (254)
..... .....++..|+|||.+.+..++.+ +|+||||+++++|++|..||....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 43221 223346677999999987776555 999999999999999999986432
Q ss_pred --------CChhhHHHHHHhhcCccccCCC
Q 025369 226 --------EPKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 226 --------~~~~~~~~~~~~~~~~~~~~p~ 247 (254)
.+..+...+..++..|++.+|.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 293 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEAS 293 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcc
Confidence 1233445688899999998883
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.26 Aligned_cols=222 Identities=25% Similarity=0.330 Sum_probs=177.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhc--CCCCCeeeeeEEEEcC----C
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----T 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~ 92 (254)
....++|++.+.||+|+||.||++++ ++..||+|.+.... .....+|.+.+.. ++||||+++++++... .
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34578999999999999999999987 58899999886542 3344455555544 7999999999986542 4
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeecCCCCCcEEecCCCCCceEEec
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
..++|+||+++++|.+++.. ..+++..++.++.|++.||.||| +.|++||||||+||+++.++. ++|+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~D 156 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIAD 156 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECC
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEee
Confidence 68999999999999999954 46899999999999999999999 999999999999999988776 99999
Q ss_pred ccccccccccCC-----CCCccCCCCccCccccccccCC-----CCcccHHHHHHHHHHHHhC----------CCCCCCC
Q 025369 165 FGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDP 224 (254)
Q Consensus 165 f~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf~~~ 224 (254)
||++........ .....+++.|+|||.+.+.... +.++||||||+++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 998854332221 2234688999999998766332 2359999999999999999 8888553
Q ss_pred CCC--------------------------hhhHHHHHHhhcCccccCCC
Q 025369 225 DEP--------------------------KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 225 ~~~--------------------------~~~~~~~~~~~~~~~~~~p~ 247 (254)
... ......+.+++..||+.+|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChh
Confidence 211 12445688899999999983
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=264.48 Aligned_cols=223 Identities=23% Similarity=0.379 Sum_probs=177.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC----CeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP----THLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~ 95 (254)
...++|++.+.||+|+||.||++++. +..||+|.+............++.....++||||+++++++... ...+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 34579999999999999999999886 88999998865433222223333333445999999999999877 6889
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
+||||+++++|.+++... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 999999999999999654 689999999999999999999998 9999999999999988776 99999999
Q ss_pred cccccccCCC-----CCccCCCCccCccccccccCCCC-----cccHHHHHHHHHHHHhC----------CCCCCCCCC-
Q 025369 168 SKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVG----------GYPFEDPDE- 226 (254)
Q Consensus 168 ~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~pf~~~~~- 226 (254)
+......... ....+++.|+|||++.+...... ++||||||+++|+|++| ..||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 8644332221 23468899999999977655443 38999999999999999 777754321
Q ss_pred -------------------------ChhhHHHHHHhhcCccccCCC
Q 025369 227 -------------------------PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 -------------------------~~~~~~~~~~~~~~~~~~~p~ 247 (254)
.......+..++..||+.+|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence 124556688899999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=269.07 Aligned_cols=208 Identities=31% Similarity=0.403 Sum_probs=175.5
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CC-----CeeeeeEEEEcCC
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPT 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~ 92 (254)
....++|++.+.||+|+||+||++.+..+++.||+|.+............|+..++.++ |+ +++.+.+++...+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 33468999999999999999999999999999999998766555566777888887774 44 4999999999999
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
..++|||++.+ +|.+++... ..+++..++.++.|++.||.||| +.||+||||||+||+++.+....++|+|||++
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999999965 899888765 45899999999999999999999 57999999999999997554455999999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhh
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 230 (254)
.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+..
T Consensus 209 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~ 267 (382)
T 2vx3_A 209 CQLG--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQM 267 (382)
T ss_dssp EETT--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eecc--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 7543 23345678889999999988776555 99999999999999999999876544433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=265.04 Aligned_cols=227 Identities=23% Similarity=0.379 Sum_probs=186.9
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEE-----cccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 88 (254)
......++|++.+.||+|+||.||++.+ ..+++.|++|.+..... ....+.+|+..++.+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3456678999999999999999999985 45778999999876433 235678899999999 789999999998
Q ss_pred EcCC-eEEEEEEccCccchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEE
Q 025369 89 LTPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (254)
Q Consensus 89 ~~~~-~~~lv~~~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nil 151 (254)
...+ .+++++||+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7754 58999999999999999987654 789999999999999999999999999999999999
Q ss_pred ecCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 025369 152 LDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 227 (254)
Q Consensus 152 i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 227 (254)
++.++. ++|+|||++......... ....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||......
T Consensus 181 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp ECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 987776 999999988654332221 23345678999999987776555 999999999999998 99999775543
Q ss_pred hh----------------hHHHHHHhhcCccccCC
Q 025369 228 KD----------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ~~----------------~~~~~~~~~~~~~~~~p 246 (254)
.. ....+..++..|+..+|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 292 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCCh
Confidence 32 33457778888888887
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=282.97 Aligned_cols=227 Identities=23% Similarity=0.349 Sum_probs=190.1
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...+....++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.+++.++|+||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 34455677899999999999999999999975 4569999988766666789999999999999999999999866 678
Q ss_pred EEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 95 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++||||+.+++|.+++... ..+++.+++.++.||+.+|.|||++|++||||+|+||+++.++. +||+|||++....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecC
Confidence 9999999999999999643 56899999999999999999999999999999999999987776 9999999986543
Q ss_pred cc--CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 173 LH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 173 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
.. .......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||..... +..+...+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 493 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 21 11223345678999999987766555 999999999999999 9999976543 23344568
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..||..+|
T Consensus 494 ~~li~~cl~~dP 505 (535)
T 2h8h_A 494 HDLMCQCWRKEP 505 (535)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHcCCCh
Confidence 889999999988
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.84 Aligned_cols=229 Identities=22% Similarity=0.331 Sum_probs=183.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEE-----EcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
......++|++.+.||+|++|.||++. +..++..||+|.+.... .....+.+|+..++.++||||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 445678999999999999999999999 55678899999986432 23456788999999999999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceE
Q 025369 90 TPTHLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLK 161 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~ 161 (254)
..+..++||||+++++|.+++.... .++...++.++.|++.||.|||++|++|+||+|+||+++.++ ...++
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999998543 23499
Q ss_pred EecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC----------
Q 025369 162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------- 227 (254)
Q Consensus 162 l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------- 227 (254)
|+|||++....... ......++..|+|||.+.+..+..+ +|+||||+++++|++ |..||......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 99999876432221 2223456778999999877766554 999999999999998 99999765432
Q ss_pred -----hhhHHHHHHhhcCccccCC
Q 025369 228 -----KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 -----~~~~~~~~~~~~~~~~~~p 246 (254)
......+..++..|+..+|
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp 286 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQP 286 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCh
Confidence 2334457788888888888
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=270.35 Aligned_cols=221 Identities=14% Similarity=0.161 Sum_probs=181.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc--------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeee--------
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-------- 83 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------- 83 (254)
...++|++.+.||+|++|.||++.+.. .+..||+|.+... +.+.+|+..+++++|||+++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 346899999999999999999999987 4889999987544 56788999999999998887
Q ss_pred -------eeEEEEc-CCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec
Q 025369 84 -------FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (254)
Q Consensus 84 -------~~~~~~~-~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~ 153 (254)
+++++.. ++..++||||+ +++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6777766 67889999999 88999999875 6799999999999999999999999999999999999999
Q ss_pred CCCCCceEEecccccccccccCC--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 154 GSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 154 ~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
.++...++|+|||++........ .....+++.|+|||.+.+..+..+ +|+||||+++|+|++|..||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCC
Confidence 87733499999999865433221 123368889999999987766444 999999999999999999998754
Q ss_pred -CCh------------------------hhHHHHHHhhcCccccCC
Q 025369 226 -EPK------------------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 -~~~------------------------~~~~~~~~~~~~~~~~~p 246 (254)
... .+...+..++..|+..+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 111 124567778888888887
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=265.57 Aligned_cols=206 Identities=26% Similarity=0.368 Sum_probs=172.0
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccc-eeEEEEEccCCccchhHHHHHHHHhhcCCCCC------eeeeeEEEE
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVIL 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~ 89 (254)
......++|++.+.||+|++|.||++.+..++ ..||+|.+.......+.+.+|+..++.++|++ ++.+.+++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 34455789999999999999999999998776 78999998776666677888999998887654 899999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC------------
Q 025369 90 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS------------ 155 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~------------ 155 (254)
..+..++|||++. +++.+.+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999999995 4666666544 369999999999999999999999999999999999999432
Q ss_pred -----CCCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 156 -----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 156 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
....++|+|||++.... .......+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCH
Confidence 23349999999886432 33345578899999999987776555 9999999999999999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=268.08 Aligned_cols=204 Identities=25% Similarity=0.392 Sum_probs=171.3
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-----------CCCeeeeeE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKE 86 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~ 86 (254)
.....++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+..+++++ |+||+++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 345678999999999999999999999999999999998776656677888999888875 789999999
Q ss_pred EEEcCC----eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCC---
Q 025369 87 VILTPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP--- 156 (254)
Q Consensus 87 ~~~~~~----~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~--- 156 (254)
++...+ .++++++++ +++|.+++... ..+++..++.++.||+.||.|||++ |++|+||+|+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 988654 789999999 78999998764 4599999999999999999999998 999999999999995332
Q ss_pred -CCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 025369 157 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225 (254)
Q Consensus 157 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 225 (254)
...++|+|||++.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+
T Consensus 173 ~~~~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred CcceEEEcccccccccC--CCCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCc
Confidence 2259999999986443 23344578899999999988776555 999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=261.98 Aligned_cols=223 Identities=30% Similarity=0.486 Sum_probs=181.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 94 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 94 (254)
.++|++.+.||+|+||.||++.+..++..+++|.+... ......+.+|+..++.++||||+++++++.. .+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 57999999999999999999999999999999988653 2334678899999999999999999999853 4578
Q ss_pred EEEEEccCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++||||+.++ +.+.+.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999875 6666654 356899999999999999999999999999999999999988776 9999999886543
Q ss_pred ccC---CCCCccCCCCccCccccccccC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHH
Q 025369 173 LHS---QPKSTVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTI 234 (254)
Q Consensus 173 ~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~ 234 (254)
... ......++..|+|||.+.+... ...++|+||||+++++|++|..||...+... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 221 1133457889999999876432 2445999999999999999999998754322 233457
Q ss_pred HHhhcCccccCCC
Q 025369 235 QVFIKPCCHITPF 247 (254)
Q Consensus 235 ~~~~~~~~~~~p~ 247 (254)
..++..|+..+|.
T Consensus 241 ~~li~~~l~~dp~ 253 (305)
T 2wtk_C 241 SDLLKGMLEYEPA 253 (305)
T ss_dssp HHHHHHHTCSSTT
T ss_pred HHHHHHHccCChh
Confidence 7888888888883
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=265.31 Aligned_cols=227 Identities=28% Similarity=0.455 Sum_probs=185.3
Q ss_pred CcccCCCceeEeccccCCcceEEEEEE----EcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 91 (254)
...+..++|++++.||+|++|.||+++ +..++..||+|.+..... ..+.+.+|+..++.++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 455677899999999999999999998 456899999999876433 346788999999999999999999998765
Q ss_pred C--eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 92 T--HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 92 ~--~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
+ ..++|+||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcch
Confidence 4 789999999999999999776 45899999999999999999999999999999999999987776 999999988
Q ss_pred ccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC--------------------
Q 025369 169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-------------------- 224 (254)
Q Consensus 169 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------------------- 224 (254)
........ .....++..|+|||.+.+...+.+ +|+||||+++++|++|..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 65433221 122345667999999877766554 99999999999999999887532
Q ss_pred -----------CCChhhHHHHHHhhcCccccCC
Q 025369 225 -----------DEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~~p 246 (254)
..+..+...+..++..|+..+|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCCh
Confidence 1122344567888889998888
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=259.73 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=182.7
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcc---cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.....++|++.+.||+|++|.||++.+.. ++..|++|.+.... ...+.+.+|+..++.++||||+++++++.+ +
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 34567899999999999999999998653 34569999887643 234668889999999999999999999765 4
Q ss_pred eEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..+++++++++++|.+++... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYI 163 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCccc
Confidence 568999999999999999765 45999999999999999999999999999999999999987776 999999988654
Q ss_pred cccCC--CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHH
Q 025369 172 VLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKT 233 (254)
Q Consensus 172 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~ 233 (254)
..... .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||..... +......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 33221 123345678999999977666554 999999999999998 9999965433 2234456
Q ss_pred HHHhhcCccccCCC
Q 025369 234 IQVFIKPCCHITPF 247 (254)
Q Consensus 234 ~~~~~~~~~~~~p~ 247 (254)
+..++..|+..+|.
T Consensus 243 l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 243 LYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHHHHTCSSGG
T ss_pred HHHHHHHHccCCch
Confidence 78888889988883
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=264.59 Aligned_cols=227 Identities=25% Similarity=0.377 Sum_probs=167.9
Q ss_pred CCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc--chhHHHHHHH-HhhcCCCCCeeeeeEEEEcCC
Q 025369 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~--~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~ 92 (254)
.......++|++.+.||+|+||.||++.+..+++.||+|.+..... .......|+. .++.++||||+++++++..++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 3455678999999999999999999999999999999999876432 2233444554 677889999999999999999
Q ss_pred eEEEEEEccCccchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 93 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
..++||||+++ +|.+++.. ...+++..++.++.+++.+|.+||+. |++|+||+|+||+++.++. ++|+|||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg 171 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFG 171 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCC
Confidence 99999999976 77777653 46789999999999999999999999 9999999999999987776 9999999
Q ss_pred ccccccccCCCCCccCCCCccCccccc----cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------
Q 025369 167 YSKSSVLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------- 226 (254)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------- 226 (254)
++.............++..|+|||.+. +..+ +.++|+||||+++++|++|..||.....
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSCC------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 987654444444456888999999984 3334 4559999999999999999999975321
Q ss_pred ----ChhhHHHHHHhhcCccccCC
Q 025369 227 ----PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ----~~~~~~~~~~~~~~~~~~~p 246 (254)
...+...+..++..|+..+|
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp 274 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDE 274 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSG
T ss_pred CCcccccCCHHHHHHHHHHhhCCh
Confidence 12345678889999998888
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=261.17 Aligned_cols=219 Identities=32% Similarity=0.519 Sum_probs=177.8
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..+.++|++.+.||+|+||.||++++. +..+++|.+... ...+.+.+|+..+++++||||+++++++.+ ..++||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 456789999999999999999999885 678999988643 345678899999999999999999998764 478999
Q ss_pred EccCccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 99 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
||+++++|.+++.... .++...++.++.|++.+|.|||+ +|++|+||+|+||+++.++. .++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc
Confidence 9999999999997654 37899999999999999999999 89999999999999986664 37999999886433
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHH
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQ 235 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~ 235 (254)
. ......++..|+|||.+.+..+..+ +||||||+++++|++|..||...... ..+...+.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 158 T--HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred c--ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 2 2234468899999999987766555 99999999999999999999754332 23345678
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..|+..+|
T Consensus 235 ~li~~~l~~dp 245 (307)
T 2eva_A 235 SLMTRCWSKDP 245 (307)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHhcCCh
Confidence 88889998888
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=261.39 Aligned_cols=220 Identities=28% Similarity=0.439 Sum_probs=176.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-----------
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 90 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 90 (254)
.++|++.+.||+|++|.||++.+..++..|++|.+.......+.+.+|+..++.++|||++++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999986655555778899999999999999999998865
Q ss_pred --CCeEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 91 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 91 --~~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
.+..++|+||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356799999999999999997543 5788999999999999999999999999999999999988776 99999998
Q ss_pred ccccccc---------------CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC--------
Q 025369 168 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-------- 224 (254)
Q Consensus 168 ~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------- 224 (254)
+...... .......++..|+|||.+.+....+.++|+||||+++|+|++ ||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 8654321 112234578899999999776555566999999999999998 44321
Q ss_pred -----------CCChhhHHHHHHhhcCccccCC
Q 025369 225 -----------DEPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~~p 246 (254)
.-.......+..++..|+..+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 272 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSG
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCc
Confidence 1112233456778888888887
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=272.14 Aligned_cols=219 Identities=15% Similarity=0.150 Sum_probs=165.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHH---HHhhcCCCCCeeeee-------EE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EV 87 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~---~~l~~l~h~~i~~~~-------~~ 87 (254)
..+|++.+.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+ ..++. +|||+++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 4469999999999999999999999999999999877542 234566774 45555 799977744 55
Q ss_pred EEcC-----------------CeEEEEEEccCccchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCeeec
Q 025369 88 ILTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHAMQVCHR 143 (254)
Q Consensus 88 ~~~~-----------------~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~------~~~~~~i~~~l~~LH~~~i~h~ 143 (254)
+..+ ..+++||||++ ++|.+++... ..++...+ +.++.||+.||+|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 34799999998 7999999764 33455555 6778999999999999999999
Q ss_pred CCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCC
Q 025369 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 144 di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf 221 (254)
||||+||+++.++. ++|+|||++..... ......+++.|+|||++.+ ..+ +.++||||||+++|+|++|..||
T Consensus 219 Dikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence 99999999998876 99999999874432 2224455699999999976 445 45599999999999999999999
Q ss_pred CCCCC-----------------------ChhhHHHHHHhhcCccccCCC
Q 025369 222 EDPDE-----------------------PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 222 ~~~~~-----------------------~~~~~~~~~~~~~~~~~~~p~ 247 (254)
..... ...+...+..++..|++.+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 342 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChh
Confidence 76521 124567888999999999983
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.28 Aligned_cols=227 Identities=31% Similarity=0.473 Sum_probs=184.6
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
....++|.....||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++...+..++|
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344445555569999999999999999999999999886643 3346788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccc
Q 025369 98 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~ 173 (254)
+|++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++. ++. ++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCC
Confidence 99999999999997652 4678999999999999999999999999999999999986 555 99999998865433
Q ss_pred c-CCCCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHH
Q 025369 174 H-SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTI 234 (254)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~ 234 (254)
. .......++..|+|||.+.+.. ....++|+||||+++++|++|..||..... +..+...+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 2 2223446788999999987643 234559999999999999999999965332 23345567
Q ss_pred HHhhcCccccCCC
Q 025369 235 QVFIKPCCHITPF 247 (254)
Q Consensus 235 ~~~~~~~~~~~p~ 247 (254)
..++..|+..+|.
T Consensus 256 ~~li~~~l~~dp~ 268 (295)
T 2clq_A 256 KAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHHTTCSSTT
T ss_pred HHHHHHHccCChh
Confidence 8889999998883
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=260.02 Aligned_cols=217 Identities=27% Similarity=0.358 Sum_probs=180.0
Q ss_pred ceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-----cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.|..++.||+|++|.||++.+ ++..+++|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355668999999999999987 47789999886532 23467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 99 EYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+|+++++|.+++.. ..++++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFA 187 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCS
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeeccccccccccc
Confidence 99999999999863 346899999999999999999999999999999999999987776 9999999876443322
Q ss_pred C---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------------
Q 025369 176 Q---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------------ 228 (254)
Q Consensus 176 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------------ 228 (254)
. .....++..|+|||.+.+. . +.++|+||||+++++|++|..||.......
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 1 2334678899999988653 3 445999999999999999999997654322
Q ss_pred -----hhHHHHHHhhcCccccCC
Q 025369 229 -----DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 -----~~~~~~~~~~~~~~~~~p 246 (254)
.....+..++..|++.+|
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSST
T ss_pred cccchHHHHHHHHHHHHHcCCCc
Confidence 233457788899999988
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=259.31 Aligned_cols=229 Identities=28% Similarity=0.410 Sum_probs=183.2
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccc---eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
+.......-.|++.+.||+|+||.||++.+..++ ..+++|.+..... ..+.+.+|+..++.++||||+++++++.
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML 92 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 3344455567888899999999999999975443 3799998875433 3356789999999999999999999998
Q ss_pred cCCeE-EEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 90 TPTHL-AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 90 ~~~~~-~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
+.+.. +++++|+.+++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~ 170 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGL 170 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTS
T ss_pred cCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCC
Confidence 76655 999999999999999976 456899999999999999999999999999999999999988776 99999998
Q ss_pred ccccccc-----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC-CCCCCC---------------
Q 025369 168 SKSSVLH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDE--------------- 226 (254)
Q Consensus 168 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~--------------- 226 (254)
+...... .......++..|+|||.+.+..++.+ +|+||||+++++|++|..| |...+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC
Confidence 8643221 12233446678999999987776555 9999999999999996555 443332
Q ss_pred ChhhHHHHHHhhcCccccCC
Q 025369 227 PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~p 246 (254)
+......+..++..|+..+|
T Consensus 250 ~~~~~~~l~~li~~~l~~~p 269 (298)
T 3pls_A 250 PEYCPDSLYQVMQQCWEADP 269 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSG
T ss_pred CccchHHHHHHHHHHccCCh
Confidence 22334567888888998888
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=263.19 Aligned_cols=227 Identities=25% Similarity=0.396 Sum_probs=166.1
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCC-CCCeeeeeEEEE-----
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL----- 89 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----- 89 (254)
.+.....+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34455679999999999999999999999999999999875543 33456788999999996 999999999984
Q ss_pred ---cCCeEEEEEEccCccchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecCCCCCceE
Q 025369 90 ---TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLK 161 (254)
Q Consensus 90 ---~~~~~~lv~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~~~~~~~~ 161 (254)
....++++++|+. ++|.+++.. ...+++..++.++.|++.+|.|||+.| ++|+||+|+||+++.++. ++
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~k 178 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IK 178 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EE
Confidence 2346899999996 588887754 456999999999999999999999999 999999999999988776 99
Q ss_pred EecccccccccccCCC-------------CCccCCCCccCccccc--cccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 162 ICDFGYSKSSVLHSQP-------------KSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 162 l~df~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
|+|||++......... ....+++.|+|||++. .......++||||||+++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999998654332221 1334788899999983 222234459999999999999999999975433
Q ss_pred Ch------------hhHHHHHHhhcCccccCC
Q 025369 227 PK------------DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 ~~------------~~~~~~~~~~~~~~~~~p 246 (254)
.. .....+..++..|++.+|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 290 (337)
T 3ll6_A 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNP 290 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSG
T ss_pred HHhhcCcccCCcccccchHHHHHHHHHccCCh
Confidence 21 122346677788888777
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=265.07 Aligned_cols=198 Identities=29% Similarity=0.460 Sum_probs=166.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe-----
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (254)
.++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+..++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 5799999999999999999999999999999999865422 23567889999999999999999999987653
Q ss_pred -EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 -~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
++++|+++.+ +|.+.+.. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 4999999974 78776643 4899999999999999999999999999999999999988776 9999999886433
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.......+++.|+|||.+.+......++|+||||+++++|++|..||...+.
T Consensus 178 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 178 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred --CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2233456788999999988744445559999999999999999999987553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=267.83 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=176.6
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc-C
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-P 91 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 91 (254)
+.....+|++.+.||+|+||.||++.+..+ +..+++|.+.... ...+.+.+|+.++++++||||+++++++.. +
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 334556799999999999999999987543 3468899876532 234668899999999999999999998765 4
Q ss_pred CeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~ 241 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARD 241 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccc
Confidence 5789999999999999999765 45899999999999999999999999999999999999988776 99999999864
Q ss_pred ccccCC-----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hh
Q 025369 171 SVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KD 229 (254)
Q Consensus 171 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~ 229 (254)
...... .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |.+||...+.. ..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~ 320 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 432211 122345678999999987766555 999999999999999 67788654432 33
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
....+..++..||..+|.
T Consensus 321 ~~~~l~~li~~cl~~dp~ 338 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAE 338 (373)
T ss_dssp CCHHHHHHHHHHTCSSGG
T ss_pred CCHHHHHHHHHHcCCChh
Confidence 445688899999998883
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=264.47 Aligned_cols=227 Identities=29% Similarity=0.449 Sum_probs=164.2
Q ss_pred CCCcccCCCceeEec-cccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc---
Q 025369 15 DMPIMHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--- 90 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 90 (254)
........++|++.+ .||+|++|.||++.+..+++.||+|.+.... ....+....++.++|||++++++++..
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 334445678999965 6999999999999999999999999886532 222333344577799999999999876
Q ss_pred -CCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEeccc
Q 025369 91 -PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFG 166 (254)
Q Consensus 91 -~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~ 166 (254)
....++||||+++++|.+++.... .+++.+++.++.|++.||.|||++|++|+||+|+||+++.++ ...++|+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 446899999999999999998664 699999999999999999999999999999999999997643 3359999999
Q ss_pred ccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------
Q 025369 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------- 227 (254)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------- 227 (254)
++..... .......+++.|+|||++.+..+..+ +|+||||+++++|++|..||......
T Consensus 177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp TCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred cceeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 8864432 22234567889999999876666554 99999999999999999999654322
Q ss_pred ---hhhHHHHHHhhcCccccCC
Q 025369 228 ---KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ---~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+..++..|+..+|
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP 276 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDP 276 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSG
T ss_pred hhhccCCHHHHHHHHHHCCCCh
Confidence 2345567888888888888
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=265.69 Aligned_cols=199 Identities=25% Similarity=0.305 Sum_probs=158.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-----CCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 93 (254)
....++|++.+.||+|+||.||++++ ++..||+|.+............++..++.++||||+++++.+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 45678999999999999999999976 57899999886544333333445555567899999999976542 236
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CeeecCCCCCcEEecCCCCCceEEec
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICD 164 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------~i~h~di~p~nili~~~~~~~~~l~d 164 (254)
+++||||+++++|.+++.... .++..++.++.|++.||.|||+. |++||||||+||+++.++. ++|+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEee
Confidence 789999999999999997654 48899999999999999999999 9999999999999988776 99999
Q ss_pred cccccccccc---------CCCCCccCCCCccCccccccc------cCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 165 FGYSKSSVLH---------SQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 165 f~~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
||++...... .......+++.|+|||++.+. ...+.++||||||+++|+|++|..||.
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 9998654321 111234588999999998763 122344899999999999999976653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=260.06 Aligned_cols=231 Identities=27% Similarity=0.436 Sum_probs=176.7
Q ss_pred CCCCCCcccCCCceeEeccccCCcceEEEEEEEcc-cc--eeEEEEEccCCc----cchhHHHHHHHHhhcCCCCCeeee
Q 025369 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TK--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRF 84 (254)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~--~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~ 84 (254)
|..........++|++.+.||+|++|.||++.+.. ++ ..|++|.+.... ...+.+.+|+..++.++||||+++
T Consensus 7 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp ----CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 33344456678899999999999999999998643 22 368999876532 234677899999999999999999
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEe
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~ 163 (254)
++++..+. .+++++++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~ 163 (291)
T 1u46_A 87 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIG 163 (291)
T ss_dssp EEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEEC
T ss_pred EEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEc
Confidence 99987765 78999999999999998764 56899999999999999999999999999999999999987776 9999
Q ss_pred cccccccccccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC-----------
Q 025369 164 DFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP----------- 227 (254)
Q Consensus 164 df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~----------- 227 (254)
|||++........ .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC
Confidence 9998865433221 122345667999999877666544 999999999999999 99999764432
Q ss_pred -----hhhHHHHHHhhcCccccCC
Q 025369 228 -----KDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 -----~~~~~~~~~~~~~~~~~~p 246 (254)
..+...+..++..|+..+|
T Consensus 243 ~~~~~~~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 243 RLPRPEDCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCCcCcCHHHHHHHHHHccCCc
Confidence 2344567788888888888
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=271.52 Aligned_cols=221 Identities=24% Similarity=0.301 Sum_probs=183.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC-CCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++++.||+|+||.||++.+..++..||+|++.... ....+.+|+.+++.++| +++..+..++......++|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3689999999999999999999999999999999765543 33457889999999987 566666666677888999999
Q ss_pred ccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEec---CCCCCceEEecccccccccccC
Q 025369 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~---~~~~~~~~l~df~~~~~~~~~~ 175 (254)
|+ +++|.+++.. ...+++..++.++.||+.+|.|||++||+||||+|+|||++ .++. ++|+|||++.......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCc
Confidence 99 8899999975 46799999999999999999999999999999999999994 4554 9999999986544332
Q ss_pred C--------CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh-------------------
Q 025369 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------- 228 (254)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------- 228 (254)
. .....++..|+|||.+.+..+..+ +||||||+++|+|++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2 124568899999999988776555 999999999999999999998755421
Q ss_pred ---hhHHHHHHhhcCccccCC
Q 025369 229 ---DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 ---~~~~~~~~~~~~~~~~~p 246 (254)
.+...+..++..||..+|
T Consensus 240 l~~~~p~~l~~li~~cl~~dP 260 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRF 260 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCT
T ss_pred HhcCCcHHHHHHHHHHhcCCh
Confidence 223457888889998888
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=254.84 Aligned_cols=207 Identities=15% Similarity=0.134 Sum_probs=173.7
Q ss_pred CCCCCCcc-cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch----hHHHHHHHHhhcCCCCCeeeeeE
Q 025369 12 PAMDMPIM-HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86 (254)
Q Consensus 12 ~~~~~~~~-~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~ 86 (254)
+.....+. ...++|++.+.||+|+||.||++.+..+++.||+|.+....... ..+.+|+..++.++||||+++++
T Consensus 19 ~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 98 (286)
T 3uqc_A 19 DVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98 (286)
T ss_dssp -CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence 33334444 66789999999999999999999999999999999987654332 67888999999999999999999
Q ss_pred EEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 87 ~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
++.+++..++||||+++++|.+++... ....++..++.|++.+|+|||++||+|+||||+||+++.++. ++|++++
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~ 174 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA 174 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc
Confidence 999999999999999999999998553 466788999999999999999999999999999999998887 8888554
Q ss_pred ccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------------------
Q 025369 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------- 227 (254)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------- 227 (254)
. ++| .+.++||||||+++|+|++|..||...+..
T Consensus 175 ~-------------------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 T-------------------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227 (286)
T ss_dssp C-------------------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHH
T ss_pred c-------------------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhh
Confidence 2 121 244599999999999999999999765432
Q ss_pred --hhhHHHHHHhhcCccccCCCcc
Q 025369 228 --KDFRKTIQVFIKPCCHITPFYP 249 (254)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~p~~~ 249 (254)
..+...+..++..|++.+|-.+
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R 251 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR 251 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC
T ss_pred cccCCCHHHHHHHHHHcccCCccC
Confidence 2345678999999999999554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.01 Aligned_cols=228 Identities=25% Similarity=0.313 Sum_probs=181.9
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEc-
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT- 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 90 (254)
.......+|++.+.||+|+||.||++.+..+ ...+++|.+..... ..+.+.+|+..+++++||||+++++++..
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3445567899999999999999999997543 34688998765432 33567899999999999999999999654
Q ss_pred CCeEEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++..++++||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~ 176 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccc
Confidence 56789999999999999999754 45899999999999999999999999999999999999987776 9999999986
Q ss_pred cccccCC-----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------h
Q 025369 170 SSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------K 228 (254)
Q Consensus 170 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~ 228 (254)
....... .....+++.|+|||.+.+..++.+ +|+||||+++++|++ |.+||...+.. .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 4432221 122345678999999977776555 999999999999999 56666654432 2
Q ss_pred hhHHHHHHhhcCccccCCC
Q 025369 229 DFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 229 ~~~~~~~~~~~~~~~~~p~ 247 (254)
.....+..++..|+..+|.
T Consensus 256 ~~~~~l~~li~~~l~~~p~ 274 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAE 274 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGG
T ss_pred cCCHHHHHHHHHHcCCChh
Confidence 3345688888889988883
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=257.35 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=169.2
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccch---hHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
......++|++.+.||+|++|.||++.+..+++.|++|.+....... +.+.++...++.++||||+++++++..++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 44566789999999999999999999999999999999987653322 233445556788899999999999999999
Q ss_pred EEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.++||||+ ++.+..+... ...+++..++.++.|++.+|.|||++ |++|+||+|+||+++.++. ++|+|||++...
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~ 175 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRL 175 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC---
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhc
Confidence 99999999 5566555543 46799999999999999999999996 9999999999999988776 999999988655
Q ss_pred cccCCCCCccCCCCccCcccccc----ccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------h
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------D 229 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~ 229 (254)
..........+++.|+|||.+.. ......++|+||||+++++|++|..||....... .
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 44444445568899999999852 2233455999999999999999999997643211 2
Q ss_pred hHHHHHHhhcCccccCC
Q 025369 230 FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p 246 (254)
+...+..++..|++.+|
T Consensus 256 ~~~~l~~li~~~l~~dp 272 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDH 272 (318)
T ss_dssp CCHHHHHHHHHHTCSCT
T ss_pred CCHHHHHHHHHHccCCh
Confidence 34567788888888888
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=265.98 Aligned_cols=218 Identities=28% Similarity=0.419 Sum_probs=163.1
Q ss_pred CCceeE-eccccCCcceEEEEEEEc--ccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeEEE
Q 025369 22 SDRYDF-VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 96 (254)
Q Consensus 22 ~~~y~~-~~~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (254)
.+.|++ +++||+|+||.||++++. .++..||+|.+... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 356777 558999999999999965 56889999988654 344678899999999999999999999964 678999
Q ss_pred EEEccCccchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC--CCCCceEEecc
Q 025369 97 VMEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDF 165 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~--~~~~~~~l~df 165 (254)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||++.. +..+.++|+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999975 777766422 24899999999999999999999999999999999999932 12234999999
Q ss_pred ccccccccc----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------ChhhHH
Q 025369 166 GYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------PKDFRK 232 (254)
Q Consensus 166 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~ 232 (254)
|++...... .......+++.|+|||++.+....+.++||||||+++|+|++|..||..... .+++.+
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 998654332 2223456789999999998766556669999999999999999999976554 255555
Q ss_pred HHHHhhcCc
Q 025369 233 TIQVFIKPC 241 (254)
Q Consensus 233 ~~~~~~~~~ 241 (254)
++..+..+.
T Consensus 257 i~~~~g~p~ 265 (405)
T 3rgf_A 257 IFNVMGFPA 265 (405)
T ss_dssp HHHHHCCCC
T ss_pred HHHhhCCCC
Confidence 555555443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=277.68 Aligned_cols=224 Identities=26% Similarity=0.400 Sum_probs=182.2
Q ss_pred ccCCCceeEec-cccCCcceEEEEEEEc--ccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
....+++.+.+ .||+|+||.||++.+. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 34556677777 8999999999999875 356679999987642 345778899999999999999999999876 56
Q ss_pred EEEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||+|+||+++.++. +||+|||++....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~ 487 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALG 487 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCccccc
Confidence 89999999999999998654 45999999999999999999999999999999999999987776 9999999987543
Q ss_pred ccCCC----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCh---------------hhHH
Q 025369 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK---------------DFRK 232 (254)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~---------------~~~~ 232 (254)
..... ....++..|+|||++.+..++.+ +||||||+++|+|++ |..||...+..+ ....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 22211 11234578999999977776555 999999999999998 999998755433 3445
Q ss_pred HHHHhhcCccccCC
Q 025369 233 TIQVFIKPCCHITP 246 (254)
Q Consensus 233 ~~~~~~~~~~~~~p 246 (254)
.+..++..||..+|
T Consensus 567 ~l~~li~~cl~~dP 580 (613)
T 2ozo_A 567 ELYALMSDCWIYKW 580 (613)
T ss_dssp HHHHHHHHTTCSST
T ss_pred HHHHHHHHHcCCCh
Confidence 78889999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.99 Aligned_cols=221 Identities=24% Similarity=0.362 Sum_probs=180.0
Q ss_pred CCceeEe-ccccCCcceEEEEEEE--cccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 22 SDRYDFV-RDIGSGNFGVARLMRD--KVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 22 ~~~y~~~-~~l~~g~~g~v~~~~~--~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
...+.+. +.||+|+||.||++.+ ..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 3344443 4899999999999954 4567899999886542 234678899999999999999999999865 4578
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||+|+||+++.++. ++|+|||++.......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADE 523 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC--
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCc
Confidence 99999999999999998888999999999999999999999999999999999999987776 9999999986543322
Q ss_pred C----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 176 Q----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 176 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
. .....++..|+|||++.+..++.+ +||||||+++|+|++ |..||...+. +..+...+.
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 602 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 602 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 122234577999999977776555 999999999999998 9999977553 233445678
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..||..+|
T Consensus 603 ~li~~cl~~dP 613 (635)
T 4fl3_A 603 DLMNLCWTYDV 613 (635)
T ss_dssp HHHHHHTCSST
T ss_pred HHHHHHcCCCH
Confidence 89999999988
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=256.53 Aligned_cols=226 Identities=25% Similarity=0.385 Sum_probs=181.5
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCC--CCCeeeeeEEEEcC
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR--HPNIVRFKEVILTP 91 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 91 (254)
......++|++.+.||+|++|.||++.+. ++..||+|.+.... ...+.+.+|+..+++++ |+||+++++++..+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34556778999999999999999999986 58889999886543 23366788999999997 59999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+..+++|| +.+++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++++ + .++|+|||++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC-
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccc
Confidence 99999999 457799999998888999999999999999999999999999999999999964 3 4999999988654
Q ss_pred cccCC---CCCccCCCCccCccccccc----------cCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------------
Q 025369 172 VLHSQ---PKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 226 (254)
Q Consensus 172 ~~~~~---~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------ 226 (254)
..... .....++..|+|||.+.+. .....++|+||||+++++|++|..||.....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 33221 1234578899999998652 2334459999999999999999999976432
Q ss_pred -----ChhhHHHHHHhhcCccccCCC
Q 025369 227 -----PKDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 -----~~~~~~~~~~~~~~~~~~~p~ 247 (254)
+......+..++..|+..+|.
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred cccCCcccchHHHHHHHHHHccCCcc
Confidence 122345678888889988883
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=254.48 Aligned_cols=220 Identities=25% Similarity=0.324 Sum_probs=180.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhc--CCCCCeeeeeEEEEcCC----eE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~ 94 (254)
..++|++.+.||+|++|.||++.+. ++.||+|.+... ....+.+|..+++. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3579999999999999999999884 889999988543 33556677777766 79999999999998875 78
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeecCCCCCcEEecCCCCCceEEeccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~i~h~di~p~nili~~~~~~~~~l~df~ 166 (254)
++|+||+++++|.+++... .+++..++.++.|++.+|.||| +.|++|+||+|+||+++.++. ++|+|||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg 192 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLG 192 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCT
T ss_pred EEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECC
Confidence 9999999999999999764 6899999999999999999999 899999999999999988876 9999999
Q ss_pred ccccccccC-----CCCCccCCCCccCccccccccCCC-----CcccHHHHHHHHHHHHhC----------CCCCCCCCC
Q 025369 167 YSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDG-----KIADVWSCGVTLYVMLVG----------GYPFEDPDE 226 (254)
Q Consensus 167 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~l~~l~~g----------~~pf~~~~~ 226 (254)
++....... ......++..|+|||.+.+..... .++|+||||+++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 986544332 223446888999999987653321 458999999999999999 788865321
Q ss_pred ---------------------C-----hhhHHHHHHhhcCccccCCC
Q 025369 227 ---------------------P-----KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 227 ---------------------~-----~~~~~~~~~~~~~~~~~~p~ 247 (254)
+ ....+.+..++..||..+|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChh
Confidence 0 12345678899999988883
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=276.87 Aligned_cols=225 Identities=28% Similarity=0.370 Sum_probs=188.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEc------CC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 92 (254)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3589999999999999999999999999999999886542 234568889999999999999999998765 56
Q ss_pred eEEEEEEccCccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC-ceEEeccccc
Q 025369 93 HLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYS 168 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~-~~~l~df~~~ 168 (254)
..++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++||||+|+||+++.++.. .++|+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999997654 58999999999999999999999999999999999999866532 4899999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----------------------
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------------- 225 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------------------- 225 (254)
.............++..|+|||.+.+..++.+ +|+||||+++|+|++|..||....
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 76655555556678999999999987777666 999999999999999999995421
Q ss_pred ---------------CChhhHHHHHHhhcCccccCC
Q 025369 226 ---------------EPKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 226 ---------------~~~~~~~~~~~~~~~~~~~~p 246 (254)
-...+...+..++..|+..+|
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 123467788999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=258.51 Aligned_cols=228 Identities=25% Similarity=0.353 Sum_probs=182.0
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEE
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 89 (254)
..........++|++.+.||+|++|.||++.+.. .+++|.+.... ...+.+.+|+..++.++||||+++++++.
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 3445566778999999999999999999998864 48899876532 23355778999999999999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccc
Q 025369 90 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~ 168 (254)
+++..++++||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++ ++. ++|+|||++
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~ 176 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLF 176 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCC
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCc
Confidence 9999999999999999999997654 689999999999999999999999999999999999997 344 899999987
Q ss_pred cccccc------CCCCCccCCCCccCccccccc--------cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh-----
Q 025369 169 KSSVLH------SQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD----- 229 (254)
Q Consensus 169 ~~~~~~------~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----- 229 (254)
...... .......++..|+|||.+.+. .....++||||||+++++|++|..||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 543211 111233477889999998652 2234559999999999999999999976543322
Q ss_pred -----------hHHHHHHhhcCccccCC
Q 025369 230 -----------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 -----------~~~~~~~~~~~~~~~~p 246 (254)
+...+..++..|+..+|
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSST
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCCh
Confidence 23456777888888877
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.35 Aligned_cols=224 Identities=24% Similarity=0.381 Sum_probs=182.2
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
....++|++.+.||+|+||.||++.+..+ +..+++|...... ...+.+.+|+..++.++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 44567899999999999999999998643 4679999876533 23367889999999999999999999984 456
Q ss_pred EEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYME 542 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecC
Confidence 899999999999999997654 6899999999999999999999999999999999999987776 9999999987543
Q ss_pred ccCCC--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 173 LHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 173 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
..... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+. +..+...+
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 32211 22335578999999977766554 999999999999997 9999976543 23344567
Q ss_pred HHhhcCccccCC
Q 025369 235 QVFIKPCCHITP 246 (254)
Q Consensus 235 ~~~~~~~~~~~p 246 (254)
..++..||..+|
T Consensus 622 ~~li~~~l~~dP 633 (656)
T 2j0j_A 622 YSLMTKCWAYDP 633 (656)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHcCCCh
Confidence 888999999888
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.78 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=179.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe---
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH--- 93 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 93 (254)
...++|++.+.||+|+||.||++.+.. +++.|++|.+.... .....+.+|+..+++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 345899999999999999999999976 78999999886542 233567889999999999999999999987654
Q ss_pred --EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 94 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 94 --~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.++||||+++++|.+++.. .+++.+++.++.||+.+|.|||++||+|+||||+||+++.+ .++|+|||++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEET
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhc
Confidence 7999999999999887755 68999999999999999999999999999999999999864 3999999988654
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------ChhhHHHHHHhhcCccc
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~ 243 (254)
... ....+++.|+|||++.+.. +.++||||||+++++|++|..||..... .......+..++..|++
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 306 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTC
T ss_pred ccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhcc
Confidence 322 4556899999999986654 4559999999999999999988764221 11123567889999999
Q ss_pred cCCCc
Q 025369 244 ITPFY 248 (254)
Q Consensus 244 ~~p~~ 248 (254)
.+|.-
T Consensus 307 ~dP~~ 311 (681)
T 2pzi_A 307 PDPRQ 311 (681)
T ss_dssp SSGGG
T ss_pred CChhh
Confidence 98843
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=261.07 Aligned_cols=228 Identities=25% Similarity=0.306 Sum_probs=175.7
Q ss_pred CCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCe
Q 025369 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (254)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 93 (254)
.........+|++.+.||+|+||+|+. ....+++.||+|.+..... ....+|+.+++.+ +||||+++++++.+...
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 344556667899999999999998764 4445788999998865432 3456899999998 79999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC---CCCCceEEecccccc
Q 025369 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSK 169 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~---~~~~~~~l~df~~~~ 169 (254)
.++|||++.+ +|.+++.... ..++..++.++.||+.||.|||++||+||||+|+||+++. ++..+++|+|||++.
T Consensus 93 ~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999999965 8998887653 4556677899999999999999999999999999999953 344458899999987
Q ss_pred cccccC----CCCCccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC----------------
Q 025369 170 SSVLHS----QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------- 226 (254)
Q Consensus 170 ~~~~~~----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------- 226 (254)
...... ......+++.|+|||++.+. ...+.++||||||+++++|++ |..||.....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC
Confidence 554332 22345689999999998742 233445999999999999999 8899864322
Q ss_pred -ChhhHHHHHHhhcCccccCC
Q 025369 227 -PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -~~~~~~~~~~~~~~~~~~~p 246 (254)
.......+..++..|++.+|
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSG
T ss_pred ccccccHHHHHHHHHHHhCCH
Confidence 12234457789999999888
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=245.03 Aligned_cols=208 Identities=31% Similarity=0.520 Sum_probs=169.2
Q ss_pred CCCCcccCCCceeEe-ccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHh-hcCCCCCeeeeeEEEEc-
Q 025369 14 MDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT- 90 (254)
Q Consensus 14 ~~~~~~~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~- 90 (254)
.........++|.+. +.||+|++|.||++.+..++..||+|.+.. .....+|+..+ +.++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 333444556788888 789999999999999999999999998854 34566777777 66699999999999876
Q ss_pred ---CCeEEEEEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEec
Q 025369 91 ---PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICD 164 (254)
Q Consensus 91 ---~~~~~lv~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~d 164 (254)
...+++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ ...++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 667899999999999999998764 699999999999999999999999999999999999998732 23499999
Q ss_pred ccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------
Q 025369 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------- 227 (254)
Q Consensus 165 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------- 227 (254)
||++.... +..+ ..++|+||||+++|+|++|..||......
T Consensus 164 fg~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 164 FGFAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp CTTCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred cccccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 99875321 1122 34499999999999999999999653321
Q ss_pred -----hhhHHHHHHhhcCccccCCC
Q 025369 228 -----KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 -----~~~~~~~~~~~~~~~~~~p~ 247 (254)
..+...+..++..|+..+|.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~ 246 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPT 246 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred CchhcccCCHHHHHHHHHHcccChh
Confidence 23466788999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=256.78 Aligned_cols=223 Identities=25% Similarity=0.297 Sum_probs=171.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...+.|.+.+.||+|+||+||.+. ..+++.||+|.+... ..+...+|+..++++ +||||+++++++.+++..++|+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 346678888999999999998654 457899999987543 235567899999876 8999999999999999999999
Q ss_pred EccCccchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-----------CCce
Q 025369 99 EYASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------APRL 160 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-----------~~~~ 160 (254)
|++. ++|.+++...... ++..++.++.||+.||+|||++||+||||+|+||+++.++ ...+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9996 5999999765432 2334578999999999999999999999999999997542 3359
Q ss_pred EEecccccccccccCC-----CCCccCCCCccCccccccc------cCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC--
Q 025369 161 KICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-- 226 (254)
Q Consensus 161 ~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-- 226 (254)
+|+|||++........ .....+++.|+|||++.+. ...+.++||||||+++|+|++ |..||.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999875443321 1234688999999998652 334556999999999999999 9999965422
Q ss_pred -----------------ChhhHHHHHHhhcCccccCC
Q 025369 227 -----------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 -----------------~~~~~~~~~~~~~~~~~~~p 246 (254)
...+...+..++..|++.+|
T Consensus 248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred HHHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence 12345678889999999888
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=259.11 Aligned_cols=217 Identities=20% Similarity=0.229 Sum_probs=171.7
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------chhHHHHHHHHhhcCC---------CCCe
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 81 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~i 81 (254)
...++|++.+.||+|+||+||++++ ++..||+|.+..... ..+.+.+|+.+++.++ |||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4568999999999999999999998 579999999875421 2266788888888775 7788
Q ss_pred eeeeEEEE------------------------------cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHH
Q 025369 82 VRFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131 (254)
Q Consensus 82 ~~~~~~~~------------------------------~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 131 (254)
+++.+++. .++..++||||++++++.+.+.. ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77777643 26789999999988866555533 568999999999999999
Q ss_pred HHHHH-hcCeeecCCCCCcEEecCCCC------------------CceEEecccccccccccCCCCCccCCCCccCcccc
Q 025369 132 VSYCH-AMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (254)
Q Consensus 132 l~~LH-~~~i~h~di~p~nili~~~~~------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 192 (254)
|+||| ++||+||||||+|||++.++. ..+||+|||++..... ....+++.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 999999999999999987751 1499999999875432 244788999999999
Q ss_pred ccccCCCCcccHHHHHHH-HHHHHhCCCCCCCC-------------------CC---ChhhHHHHHHhhcCccccC
Q 025369 193 LRHEYDGKIADVWSCGVT-LYVMLVGGYPFEDP-------------------DE---PKDFRKTIQVFIKPCCHIT 245 (254)
Q Consensus 193 ~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~~-------------------~~---~~~~~~~~~~~~~~~~~~~ 245 (254)
.+.. ..++||||++++ .+++++|..||... .. ...+...+..+++.|++.+
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 8666 445999998777 67788899888531 01 2245667888888888765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=252.46 Aligned_cols=219 Identities=14% Similarity=0.105 Sum_probs=166.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHHHHHHHHhhcCCC-CC---------eeeeeEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH-PN---------IVRFKEV 87 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~~~e~~~l~~l~h-~~---------i~~~~~~ 87 (254)
...|++.+.||+|+||+||++.+..+++.||||++.... ...+.+.+|+..++.++| ++ ++...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346899999999999999999999999999999887322 224678899999999877 22 1111111
Q ss_pred ------------EEc-----CCeEEEEEEccCccchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeec
Q 025369 88 ------------ILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143 (254)
Q Consensus 88 ------------~~~-----~~~~~lv~~~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~ 143 (254)
+.. ...++++++.. +++|.+++.. ...+++..++.++.|++.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111 12457777776 5688888741 2236778899999999999999999999999
Q ss_pred CCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccc----------cccCCCCcccHHHHHHHHHH
Q 025369 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----------RHEYDGKIADVWSCGVTLYV 213 (254)
Q Consensus 144 di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~----------~~~~~~~~~Di~slG~~l~~ 213 (254)
||||+||+++.++. +||+|||++...... .....+ +.|+|||++. +..+ +.++||||||+++|+
T Consensus 236 DiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 99999999998887 999999997644332 344456 9999999983 2233 445999999999999
Q ss_pred HHhCCCCCCCCCCC----------hhhHHHHHHhhcCccccCCC
Q 025369 214 MLVGGYPFEDPDEP----------KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 214 l~~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~p~ 247 (254)
|++|+.||...+.. ..+...+..++..|++.+|.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChh
Confidence 99999999764321 23456788899999998883
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=236.63 Aligned_cols=182 Identities=14% Similarity=0.053 Sum_probs=130.8
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCc-----------cchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeEEEE
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (254)
..+.|+.|....++....|+.+++|.+.... ...+.+.+|+++|+++ .|+||+++++++.+++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3556777777777777889999999886532 1225688899999999 799999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
|||++|++|.+.+...+++++. .++.||+.||+|+|++||+||||||+|||+++++. +||+|||+++..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999998888875 47899999999999999999999999999998887 999999998754332 22
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 218 (254)
....++++.|+|||++.+.. ... +|+||+|++++.+.++.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~~~-~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-SWN-GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCceechhhccHHHhCCCC-CCc-ccccccccchhhhcccc
Confidence 33456899999999987643 334 89999999877765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=206.04 Aligned_cols=181 Identities=20% Similarity=0.117 Sum_probs=137.3
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
-.+.||+|+||.||++.. .+..+++|....... ..+.+.+|+.++++++||||+++..++...+..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 356899999999999944 467788887543211 123468999999999999999666666677778999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|||+++++|.+++.. +..++.|++.+|.|||++||+||||||+||+++. . ++|+|||++.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCcccc
Confidence 999999999998865 5689999999999999999999999999999987 4 999999998755432211
Q ss_pred --------CCccCCCCccCcccccc--ccCCCCcccHHHHHHHHHHHHhCCCCCC
Q 025369 178 --------KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 178 --------~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 222 (254)
....+++.|+|||++.. ..+... .|+||..+-..+-..++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 23468899999999876 334333 799999988888877776664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=173.88 Aligned_cols=140 Identities=18% Similarity=0.161 Sum_probs=110.9
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------------------chhHHHHHHHHhhcCCCCCeeeeeEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFKEV 87 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~~~ 87 (254)
+++.||+|++|.||++.+ .++..+|+|.+..... ....+.+|+..++.++ | +++.++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 449999999999999999 7899999998864321 2345789999999998 4 555554
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
+.. +..++||||+++++|.+ +. ......++.|++.++.+||+.|++|+||+|+||+++ ++. ++|+|||+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DFG~ 238 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDFPQ 238 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCCTT
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEECCC
Confidence 433 45699999999999987 41 133457999999999999999999999999999999 555 99999998
Q ss_pred cccccccCCCCCccCCCCccCccccc
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLL 193 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~ 193 (254)
+... ..+.|||.+.
T Consensus 239 a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVEV------------GEEGWREILE 252 (282)
T ss_dssp CEET------------TSTTHHHHHH
T ss_pred CeEC------------CCCCHHHHHH
Confidence 7632 2357788763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=154.40 Aligned_cols=136 Identities=15% Similarity=0.100 Sum_probs=105.6
Q ss_pred ceeEeccccCCcceEEEEEEEccccee--EEEEEccCCccc-------------------------hhHHHHHHHHhhcC
Q 025369 24 RYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 76 (254)
Q Consensus 24 ~y~~~~~l~~g~~g~v~~~~~~~~~~~--~~lK~~~~~~~~-------------------------~~~~~~e~~~l~~l 76 (254)
-|++.+.||+|++|.||++.+..+|.. ||+|.+...... ...+.+|+..++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999778888 999986443111 12577899999999
Q ss_pred CCCCe--eeeeEEEEcCCeEEEEEEccCc-c----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecCCCCC
Q 025369 77 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLE 148 (254)
Q Consensus 77 ~h~~i--~~~~~~~~~~~~~~lv~~~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~di~p~ 148 (254)
.|+++ +.+++. +..++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++||||+|.
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 333332 345899999942 2 66665433 234567889999999999999 999999999999
Q ss_pred cEEecCCCCCceEEeccccccc
Q 025369 149 NTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~ 170 (254)
||++++ . ++|+|||++..
T Consensus 201 NILl~~--~--~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--K--VYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--S--EEECCCTTCEE
T ss_pred HEEEcC--c--EEEEECccccc
Confidence 999986 3 99999998763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=144.03 Aligned_cols=136 Identities=15% Similarity=0.109 Sum_probs=98.1
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---------------ch--------hHHHHHHHHhhcCCCCCe
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------ID--------ENVQREIINHRSLRHPNI 81 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---------------~~--------~~~~~e~~~l~~l~h~~i 81 (254)
|+++++||+|++|.||+|.+. +|+.||||++..... .. -...+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999986 688999998643210 00 012346666777755444
Q ss_pred eeeeEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC---
Q 025369 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--- 158 (254)
Q Consensus 82 ~~~~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~--- 158 (254)
....-+.... .++||||++|.+|..+.. ......++.|++.++.+||+.|++||||||.|||+++++.+
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 3222222222 379999999988865432 22345678999999999999999999999999999876632
Q ss_pred -----ceEEecccccc
Q 025369 159 -----RLKICDFGYSK 169 (254)
Q Consensus 159 -----~~~l~df~~~~ 169 (254)
.+.++||+-+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 27899998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-13 Score=107.56 Aligned_cols=138 Identities=16% Similarity=0.126 Sum_probs=108.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.|++...++.|+.+.||++... +..+++|...... .....+.+|+..++.+. +..+.++++++.+.+..|+||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 57999999999999999999764 5789999875421 22356888999998884 56677888888888899999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA------------------------------------------- 137 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~------------------------------------------- 137 (254)
++|.++.+.+. +......++.++..++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999876531 122334678899999999998
Q ss_pred ----------------cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 138 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 ----------------~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..++|||++|.||+++++.. +.++||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 45899999999999975432 5699998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-11 Score=97.84 Aligned_cols=138 Identities=14% Similarity=0.126 Sum_probs=99.0
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEEEEcCCeEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAI 96 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~l 96 (254)
......|.+....+.|..+.||++... ++..+++|..... ....+.+|+..++.+.+.+ +.+++.+...++..++
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 334556777666556667999999653 5677999986543 3356778888888885444 4568888877778899
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------------------------------------- 139 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------------------------------- 139 (254)
||++++|.++. .. ..+. ..++.+++..+..||+..
T Consensus 93 v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998874 21 1122 256667777777777643
Q ss_pred ---------------------eeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 140 ---------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 140 ---------------------i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++|||++|.||+++++.. +.++||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999975532 5699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.2e-11 Score=99.85 Aligned_cols=142 Identities=14% Similarity=0.192 Sum_probs=104.6
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEcc--CCc--cchhHHHHHHHHhhcCCC--CCeeeeeEEEEcC---CeEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 95 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~ 95 (254)
....+.|+.|.++.+|++... +..+++|+.. ... .....+.+|...++.+.. ..+++++.++.+. +..|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345678899999999999875 4578888765 332 234567889999988864 4467788877665 4579
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------- 137 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------------------------------- 137 (254)
+||++++|.++.+.. ...++..+...++.++...|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999987764311 1236788888999999999999997
Q ss_pred --------------------cCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 138 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 138 --------------------~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..++|||+++.||+++.++...+.++||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 369999999999999866543358999997753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2.8e-10 Score=92.04 Aligned_cols=186 Identities=15% Similarity=0.094 Sum_probs=116.8
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCC--eeeeeEEEEcCC---eEEEEEEcc
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 101 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~~~~ 101 (254)
.+.++.|....+|++. ..+++|.... ......+.+|...++.+. +.. +..++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458889999999874 4588887533 234567888999988773 333 334444433332 348899999
Q ss_pred CccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 025369 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (254)
Q Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------------------------------------- 137 (254)
+|.++..... ..++..+...++.+++..+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865433 236777778888888888888885
Q ss_pred --------------cCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCccCCCCccCccccc----cccCCC
Q 025369 138 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----RHEYDG 199 (254)
Q Consensus 138 --------------~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~ 199 (254)
..++|||++|.||+++++....+.++||+.+.......+.........-..|+... ......
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 23799999999999987422237899999765432211110000000002232211 111111
Q ss_pred ---------CcccHHHHHHHHHHHHhCCCCC
Q 025369 200 ---------KIADVWSCGVTLYVMLVGGYPF 221 (254)
Q Consensus 200 ---------~~~Di~slG~~l~~l~~g~~pf 221 (254)
.-.+.|+++.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0148899999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=8.3e-08 Score=75.94 Aligned_cols=154 Identities=18% Similarity=0.204 Sum_probs=94.4
Q ss_pred cCCCCCCCCCCcccCCCceeEeccccCCcce-EEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC-CCeeee
Q 025369 7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRF 84 (254)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g-~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~ 84 (254)
..+..|............|+.. .+..|..+ .||++.....+..+++|..... ....+.+|...++.+.. --+.++
T Consensus 9 ~~~~~p~l~~~l~~~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v 85 (272)
T 4gkh_A 9 TSCSRPRLNSNLDADLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTI 85 (272)
T ss_dssp ----------CHHHHHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCE
T ss_pred hhcchhhhhHHHhccccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeE
Confidence 3344444444444434444433 33334444 6899988877888999975432 33567788888877742 226678
Q ss_pred eEEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------
Q 025369 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------------------------- 137 (254)
Q Consensus 85 ~~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~--------------------------- 137 (254)
+.++.+++..++||++++|.++.+..... ......+..++...+..||+
T Consensus 86 ~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (272)
T 4gkh_A 86 KHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL 161 (272)
T ss_dssp EEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTC
T ss_pred EEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhh
Confidence 88888888999999999998876654332 11222344444444444442
Q ss_pred -------------------------------cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 138 -------------------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 -------------------------------~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..++|||+++.||++++++. +-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 162 VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp CCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred hhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 12789999999999986543 5699998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.7e-07 Score=75.65 Aligned_cols=135 Identities=19% Similarity=0.134 Sum_probs=88.9
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCC---CeeeeeEEEE-cCCeEEEEEEccCc
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 103 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~~~~~~ 103 (254)
.+.++.|....+|++ +..+++|+. ........+.+|...++.+.+. .+.+++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455788888899988 456888874 3233456788999999888642 2455666654 34567899999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------------- 137 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~---------------------------------------------- 137 (254)
.++...... .++..+...++.++...+..||+
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 887653211 23444444444444444444442
Q ss_pred --------------cCeeecCCCCCcEEecC---CCCCceEEecccccccc
Q 025369 138 --------------MQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 171 (254)
Q Consensus 138 --------------~~i~h~di~p~nili~~---~~~~~~~l~df~~~~~~ 171 (254)
..++|||++|.||+++. ++. .+.++||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCCC
Confidence 14699999999999986 232 2479999976543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.8e-06 Score=72.20 Aligned_cols=76 Identities=17% Similarity=0.086 Sum_probs=48.5
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCc--------cchhHHHHHHHHhhcCCC--CC-eeeeeEEEEcCCeEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------KIDENVQREIINHRSLRH--PN-IVRFKEVILTPTHLA 95 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~ 95 (254)
-.+.+|.|..+.||++....+++.+++|...... ...++...|...++.+.. +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4568899999999999876667789999754321 123456778888877632 33 3344443 344568
Q ss_pred EEEEccCcc
Q 025369 96 IVMEYASGG 104 (254)
Q Consensus 96 lv~~~~~~~ 104 (254)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=9e-07 Score=72.86 Aligned_cols=82 Identities=9% Similarity=0.082 Sum_probs=54.4
Q ss_pred eeEeccc-cCCcceEEEEEEEcc------cceeEEEEEccCCc---c-chhHHHHHHHHhhcCCC---CCeeeeeEEEEc
Q 025369 25 YDFVRDI-GSGNFGVARLMRDKV------TKELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILT 90 (254)
Q Consensus 25 y~~~~~l-~~g~~g~v~~~~~~~------~~~~~~lK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~ 90 (254)
....+.| +.|....+|++.... ++..+++|...... . ....+.+|...++.+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456777 888889999987641 25678899764432 1 13567778888877732 245667776655
Q ss_pred C---CeEEEEEEccCccch
Q 025369 91 P---THLAIVMEYASGGEL 106 (254)
Q Consensus 91 ~---~~~~lv~~~~~~~~L 106 (254)
. +..+++|++++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 356899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.6e-05 Score=64.69 Aligned_cols=30 Identities=27% Similarity=0.442 Sum_probs=25.6
Q ss_pred cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 138 ~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
.+++|||+++.||+++.++. +.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 57999999999999975554 8999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.8e-05 Score=63.57 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=43.2
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEEEcc-Cccc
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 105 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~-~~~~ 105 (254)
.+.|+.|....+|++ ..+++|.............+|...++.+...++ .+++.. ++..-+++++|+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 778888999999998 458888765532222233557766666533233 344443 343447899999 6654
Q ss_pred h
Q 025369 106 L 106 (254)
Q Consensus 106 L 106 (254)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00013 Score=61.35 Aligned_cols=33 Identities=18% Similarity=0.253 Sum_probs=27.1
Q ss_pred HhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 136 H~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
+...++|||++|.||+++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccccC
Confidence 456799999999999997554 899999877544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00024 Score=57.29 Aligned_cols=76 Identities=18% Similarity=0.135 Sum_probs=57.3
Q ss_pred eEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC---CCCeeeeeEEEEcCCeEEEEEEccC
Q 025369 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 102 (254)
Q Consensus 26 ~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~~ 102 (254)
.-.+.|+.|....+|++... +..+++|..... ....+..|...++.+. ...+++++.+....+..++||++++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34567899999999999863 567888976432 2456778888887773 3557778888777788999999998
Q ss_pred ccc
Q 025369 103 GGE 105 (254)
Q Consensus 103 ~~~ 105 (254)
+..
T Consensus 115 G~~ 117 (312)
T 3jr1_A 115 KSK 117 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0003 Score=58.26 Aligned_cols=142 Identities=14% Similarity=0.135 Sum_probs=78.5
Q ss_pred CceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHL 94 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~ 94 (254)
+..++ +.|..|-...+|++.... ++..+++|..-..........+|..+++.+...++ .+++..+. +
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~-- 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E-- 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--
Confidence 34443 456667778899998742 35689999764332334566688888877743233 44555443 3
Q ss_pred EEEEEccCccchH--------------HHHH---hc-C----CCC--HHHHHHHHHHHHH-------------------H
Q 025369 95 AIVMEYASGGELF--------------ERIC---NA-G----RFS--EDEARFFFQQLIS-------------------G 131 (254)
Q Consensus 95 ~lv~~~~~~~~L~--------------~~l~---~~-~----~~~--~~~~~~~~~~i~~-------------------~ 131 (254)
.+|++|++|.++. ..+. .. . +.. ..++..+..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999875442 1111 10 0 111 2344444433321 2
Q ss_pred HHHHH----h----cCeeecCCCCCcEEecCC--CCCceEEecccccc
Q 025369 132 VSYCH----A----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 169 (254)
Q Consensus 132 l~~LH----~----~~i~h~di~p~nili~~~--~~~~~~l~df~~~~ 169 (254)
++.|. + ..++|+|+.+.||+++.+ ....+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 23332 2 359999999999999865 12248999999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00093 Score=53.96 Aligned_cols=74 Identities=9% Similarity=0.060 Sum_probs=45.6
Q ss_pred cccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEE-----EEcCCeEEEEEEccC
Q 025369 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYAS 102 (254)
Q Consensus 30 ~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~~~~~ 102 (254)
.++ |....+|++... +|+.+++|.........+.+..|...++.+...+ +++++.. ....+..++++++++
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 777789988654 4557999987644334456667777776663222 2333322 122456688999998
Q ss_pred ccc
Q 025369 103 GGE 105 (254)
Q Consensus 103 ~~~ 105 (254)
|.+
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0015 Score=52.89 Aligned_cols=35 Identities=29% Similarity=0.359 Sum_probs=26.8
Q ss_pred hcCeeecCCCCCcEEecCCC--CCceEEecccccccc
Q 025369 137 AMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 171 (254)
Q Consensus 137 ~~~i~h~di~p~nili~~~~--~~~~~l~df~~~~~~ 171 (254)
...++|||+.+.||+++.+. ...+.++||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 34699999999999997641 124899999977544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0011 Score=54.65 Aligned_cols=74 Identities=14% Similarity=0.027 Sum_probs=42.4
Q ss_pred eccccCCcceEEEEEEEccc--------ceeEEEEEccCCccchhHHHHHHHHhhcCCCCC-eeeeeEEEEcCCeEEEEE
Q 025369 28 VRDIGSGNFGVARLMRDKVT--------KELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~--------~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 98 (254)
.+.++.|....+|++..... +..+++|..............|...++.+...+ ..+++... ++ ++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 45677787789999987531 267889976543222223456777776664333 33455433 22 6899
Q ss_pred EccCccc
Q 025369 99 EYASGGE 105 (254)
Q Consensus 99 ~~~~~~~ 105 (254)
+|++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00078 Score=54.29 Aligned_cols=140 Identities=15% Similarity=0.120 Sum_probs=74.3
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEE------EEcCCeEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 96 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~l 96 (254)
..-.+.|+.|....+|++... +..+++|..... ...+.+..|...++.+...+ +.+++.. ....+..++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEEECC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeeccCCCcccceEEEEeC--CccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 344567777888899999765 336889977652 12344556666665553212 2222211 122456789
Q ss_pred EEEccCccchH-----------HHH----HhcCCC--------CHHHHHH---------------HHHHHHHHHHHHH--
Q 025369 97 VMEYASGGELF-----------ERI----CNAGRF--------SEDEARF---------------FFQQLISGVSYCH-- 136 (254)
Q Consensus 97 v~~~~~~~~L~-----------~~l----~~~~~~--------~~~~~~~---------------~~~~i~~~l~~LH-- 136 (254)
++++++|..+. ..+ .....+ ....-.. +...+...++.+.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999875421 111 110010 1100000 0011333445554
Q ss_pred -----hcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 137 -----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 137 -----~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
..+++|+|+++.||+++++.. +.++||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 246999999999999986532 4799998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0033 Score=49.80 Aligned_cols=78 Identities=12% Similarity=0.053 Sum_probs=52.8
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCC-C--eeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHP-N--IVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~-~--i~~~~~~~~~~~~~~lv~ 98 (254)
.+..-.+.+|.|..+.||+++.. +|+.+++|+...... ....+..|...|+.|... . +++++.+ +. .+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 35566788999999999999876 678899997654432 234567888888877422 2 3334433 22 36888
Q ss_pred EccCccc
Q 025369 99 EYASGGE 105 (254)
Q Consensus 99 ~~~~~~~ 105 (254)
+++++..
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00086 Score=56.54 Aligned_cols=74 Identities=12% Similarity=0.100 Sum_probs=47.2
Q ss_pred EeccccCCcceEEEEEEEcc-------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 98 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 98 (254)
-.+.|+.|-...+|++.... .+..+++|+.... ...+.+.+|...++.+...++ .++++.+. + .+|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35667878889999998753 2567899977332 121455578888877743333 45555432 2 3789
Q ss_pred EccCccc
Q 025369 99 EYASGGE 105 (254)
Q Consensus 99 ~~~~~~~ 105 (254)
+|++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9997643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0022 Score=54.48 Aligned_cols=75 Identities=16% Similarity=0.103 Sum_probs=46.5
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEEEccCccch
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
.+.|+.|-...+|++.....+..+++|.........-...+|...++.|...++ .++++.+ .+. .|++|++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCccC
Confidence 456777888899999876545788999764432221223578888887765444 4555554 332 49999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.007 Score=49.22 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=25.7
Q ss_pred cCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 138 ~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..++|||+.+.||++++++. +.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCee
Confidence 36999999999999986554 89999986643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0074 Score=50.68 Aligned_cols=75 Identities=16% Similarity=0.063 Sum_probs=46.0
Q ss_pred EeccccCCcceEEEEEEEccc-------ceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCCeEEEEE
Q 025369 27 FVRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 98 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 98 (254)
-.+.+..|-...+|++..... +..+++|.........-...+|...++.+...++ .++++.+ .+ ++|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 345666677789999987621 5778999765433222234567777776643233 3444432 22 6889
Q ss_pred EccCccc
Q 025369 99 EYASGGE 105 (254)
Q Consensus 99 ~~~~~~~ 105 (254)
+|++|.+
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998755
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.025 Score=42.72 Aligned_cols=116 Identities=16% Similarity=0.081 Sum_probs=69.3
Q ss_pred ccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCCc
Q 025369 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (254)
Q Consensus 103 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 180 (254)
..+|.+++... .+++++++|.+++|.+.+|..+- ++.-...=+.|..|++..+|+ +-..+ ..+ .
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~ 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------D 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------c
Confidence 35789988654 68999999999999999987762 222224445678899988887 55443 111 0
Q ss_pred cCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC-CCCCCCChhhHHHH
Q 025369 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTI 234 (254)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~ 234 (254)
.....+.+||... .....+.=|||||.++|.-+--..| -....-.+.+.+.+
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL 150 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLI 150 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHH
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHH
Confidence 1122456777652 1222336899999999999975444 33333334444444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.18 E-value=0.087 Score=43.79 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.7
Q ss_pred eeecCCCCCcEEecC----CCCCceEEecccccc
Q 025369 140 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 169 (254)
Q Consensus 140 i~h~di~p~nili~~----~~~~~~~l~df~~~~ 169 (254)
++|+|+.+.||++.. +....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999943 223359999999874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.54 E-value=1.8 Score=32.43 Aligned_cols=115 Identities=10% Similarity=0.083 Sum_probs=75.2
Q ss_pred CCCCCeeeeeEEEEcCCeEEEEEEccC-ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC
Q 025369 76 LRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (254)
Q Consensus 76 l~h~~i~~~~~~~~~~~~~~lv~~~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~ 154 (254)
..+|++++. .+...++.+.+.++..+ +-++.. + ...+....++++.+|+....++++ =+|--++|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 368999877 46666676666666543 223332 2 246889999999999987754443 367889999999998
Q ss_pred CCCCceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHH-HHHHHHHHHHhCCCCCC
Q 025369 155 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW-SCGVTLYVMLVGGYPFE 222 (254)
Q Consensus 155 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~-slG~~l~~l~~g~~pf~ 222 (254)
++. +++.=.|+... ++|..+ .+ .|.+ ..=+++..+++++..|.
T Consensus 115 ~~~--p~i~~RGik~~----------------l~P~~~------~e-e~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGL--PIAKTRGLQNV----------------VDPLPV------SE-AEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSC--EEESCCEETTT----------------BSCCCC------CH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCC--EEEEEccCccC----------------CCCCCC------CH-HHHHHHHHHHHHHHHcCCCCHH
Confidence 887 77776664221 122211 12 3444 57777888888877763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.19 E-value=4.1 Score=30.63 Aligned_cols=82 Identities=12% Similarity=0.025 Sum_probs=58.7
Q ss_pred CCCCCeeeeeEEEEcCCeEEEEEEccCc-cchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhcCeeecCCCCCcEEec
Q 025369 76 LRHPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVS-YCHAMQVCHRDLKLENTLLD 153 (254)
Q Consensus 76 l~h~~i~~~~~~~~~~~~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~LH~~~i~h~di~p~nili~ 153 (254)
..||++ -..+..+++.+.+.++..++ -++..+ ...+....++++.+|+.... +++ .-+|--++|+|++++
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 367888 45555677777777776533 344432 24689999999999988766 443 347788999999999
Q ss_pred CCCCCceEEecccc
Q 025369 154 GSPAPRLKICDFGY 167 (254)
Q Consensus 154 ~~~~~~~~l~df~~ 167 (254)
.++. +++.=.|+
T Consensus 119 ~~~~--p~i~hRGi 130 (219)
T 4ano_A 119 RALE--PFFLHVGV 130 (219)
T ss_dssp TTCC--EEESCCEE
T ss_pred CCCc--EEEEEcCC
Confidence 8887 78776664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 254 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-65 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 209 bits (534), Expect = 3e-67
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 3/229 (1%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
D+W+ GV YV+L G PF D+ + + + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-65
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 8/230 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
D ++ + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ- 139
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
+ +D+WS G++L M VG YP P + K+ ++ TP P
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPI-PPPDAKELELMFGCQVEGDAAETPPRP 230
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 204 bits (520), Expect = 3e-65
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 3/238 (1%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIIN 72
+++ H D YD ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 131
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
D+WS GV Y++L G PF ++ + R
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-65
Identities = 71/228 (31%), Positives = 116/228 (50%), Gaps = 8/228 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
K D+WS GV Y LVG PFE + +++ +V +T
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-65
Identities = 82/233 (35%), Positives = 129/233 (55%), Gaps = 10/233 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ +D V+ +G G +G +L ++VT+E VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEY 197
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L R E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYPL 250
+ DVWSCG+ L ML G P+ D+P D + + + ++ P+ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKI 232
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 2e-63
Identities = 79/231 (34%), Positives = 119/231 (51%), Gaps = 4/231 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
D YDF +G+G F L DK T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 140 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
D WS GV Y++L G PF D ++ K F + ++ +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-63
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 2/228 (0%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y D+G G FG+ + +K+ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
E + L ++ E+ SG ++FERI +A +E E + Q+ + + H+ +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
D+WS G +YV+L G PF + +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-62
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 9/221 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D ++ + ++G G FG ++K T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 199 GKI----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ ADVWS G+TL M P + + + K +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-61
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 10/231 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRH 78
+ + F + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
+D+W+ G +Y ++ G PF +E F+K I++ P
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-60
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 6/216 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV + + L L +VMEY +GG L + + E + ++ + + + H+ QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
K D+WS G+ M+ G P+ + + +
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 4e-60
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR 77
+ +R+IG G+FG RD E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPN ++++ L +VMEY G + E E + G++Y H+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-- 195
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 196 -EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+YDGK DVWS G+T + P + + Q
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 184 bits (467), Expect = 4e-58
Identities = 70/243 (28%), Positives = 106/243 (43%), Gaps = 18/243 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREIIN 72
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 73 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
+ D GK D+WS GV +Y +L G PF + R + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 247 FYP 249
Y
Sbjct: 241 DYS 243
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-58
Identities = 74/237 (31%), Positives = 120/237 (50%), Gaps = 10/237 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
AD+WS GV Y++L G PF + + V +
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (460), Expect = 4e-57
Identities = 59/240 (24%), Positives = 91/240 (37%), Gaps = 11/240 (4%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRS 75
H SDRY+ +G G L RD VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 76 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 189
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
E D + +DV+S G LY +L G PF + ++ P
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 6e-57
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 80 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
+PE + R Y+ K +D+WS G LY + PF + + K
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-56
Identities = 71/230 (30%), Positives = 112/230 (48%), Gaps = 9/230 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLR 77
+ + + +G G+FG L K T + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + H+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL +
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
Y+ D WS GV LY ML+G PF DE + F +
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-55
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 13/244 (5%)
Query: 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR 74
+ +D F +IG G+F D T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 75 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 131 GVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
G+ + H + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFY 248
PE+ +YD DV++ G+ + M YP+ + + + +KP
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 249 PLFK 252
P K
Sbjct: 240 PEVK 243
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-55
Identities = 73/227 (32%), Positives = 109/227 (48%), Gaps = 14/227 (6%)
Query: 23 DRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D Y +G G G + +K T+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66
Query: 81 IVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 135 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
+YD D+WS GV +Y++L G PF
Sbjct: 187 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-54
Identities = 68/242 (28%), Positives = 104/242 (42%), Gaps = 20/242 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------VQREIINHRS 75
+Y +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 76 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+CH V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------PKDFRKTIQVFIKPCCHI 244
H Y G+ A VWS G+ LY M+ G PFE +E + Q I+ C +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 245 TP 246
P
Sbjct: 242 RP 243
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (445), Expect = 8e-54
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 11/234 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------S 75
+ + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
H V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
AD +S G L+ +L G PF + KD + ++ + + +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSFS 233
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-52
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 15/224 (6%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLR 77
+ + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 136
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
A + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 194 RHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ + +DV++ G+ LY ++ G P+ + + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 2e-51
Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 9/228 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ +R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
D WS G+ +Y ML G PF D + K + K + ++
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-51
Identities = 70/258 (27%), Positives = 104/258 (40%), Gaps = 20/258 (7%)
Query: 9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR 68
T G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 69 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 119
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ + QL ++Y H+ +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239
+ + Y APE++ DVWS G L +L+G F + I+V
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 240 P----CCHITPFYPLFKL 253
P + P Y FK
Sbjct: 242 PTREQIREMNPNYTEFKF 259
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-51
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 9/223 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRF 84
+G G F RDK T ++VA+K I+ G D I+ REI + L HPNI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ +++++V ++ N+ + + + + G+ Y H + HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
LK N LLD + LK+ DFG +KS + V T Y APE+L G D
Sbjct: 126 LKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
+W+ G L +L+ + + + P P
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-51
Identities = 59/223 (26%), Positives = 87/223 (39%), Gaps = 11/223 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 81 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRDL N L+ K+ DFG +K S + + APE L ++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
K +DVWS G+ L+ + G KD ++ K
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-50
Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 8/230 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D F++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + I+ EY + G L + RF + + + + Y + Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY 197
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 198 DGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQVFIKPCCHITP 246
K +D+W+ GV ++ + G P+E + Q H+
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (415), Expect = 8e-50
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 9/216 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
D Y VR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ ++
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
D+WS G L M+ PF + D I
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-49
Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 18/256 (7%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREI 70
++ P + +Y+ + IG G FG R + T + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 71 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 122
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 177
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVF 237
+ V T Y PE+LL G D+W G + M + E Q+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 238 IKPCCHITPFYPLFKL 253
+ P ++L
Sbjct: 239 GSITPEVWPNVDNYEL 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 76/229 (33%), Positives = 119/229 (51%), Gaps = 8/229 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
+ +D+++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEY 197
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL ++Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
D W GV +Y M+ G PF + D + F + I+ ++P
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 2e-49
Identities = 65/228 (28%), Positives = 120/228 (52%), Gaps = 9/228 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
D W+ GV +Y M G PF + + K + ++ H +
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-49
Identities = 66/240 (27%), Positives = 96/240 (40%), Gaps = 13/240 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G +G+ D V K VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 81 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 192
+ V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYPLFK 252
L + K D+WS G L ML F + + P K
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-49
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 7/223 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D FV++IGSG FG+ L K+ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
K +DVWS GV ++ + G + + + I +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-48
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 15/235 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
Y ++ +GSG +G D T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFY 248
+ D+WS G + M+ G F+ D ++ ++V P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 5e-48
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 7/219 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL N L+ + +K+ DFG S+ + ++ + APE L ++
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ K +DVW+ GV L+ + G + + ++
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-47
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 7/229 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + V IG G +GV R+K+T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NIV+ +VI T L +V E+ + F + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
D+WS G M+ F E + + P + P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-47
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 9/219 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ K +DVWS G+ L + G ++ ++
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-46
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 9/219 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ V +G+G FG + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ K +DVWS G+ L ++ G + + ++
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (388), Expect = 3e-46
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 7/228 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITP 246
D+WS G M+ G F E + ++ P P
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 4e-46
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 15/246 (6%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH 73
M++ + +RY R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 74 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 133 SYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 183
Y H+ HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243
Y + L E + D+ S G L +G P++ +K ++ K
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 244 ITPFYP 249
Sbjct: 236 PIEVLC 241
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-46
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 6/216 (2%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + + + + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIVR +V+ + L +V E+ G + + F QL+ G+ +CH+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
D+WS G + G P ++ D K I
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 1e-45
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 16/234 (6%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRS 75
D + IG+G FG K+ + VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 134
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 188
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQVFIKPC 241
PE + ++ +DVWS G+ ++ ++ G P+ D Q + P
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (382), Expect = 3e-45
Identities = 44/230 (19%), Positives = 85/230 (36%), Gaps = 14/230 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 142 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240
L E + D+ + G L G P++ + +K ++ K
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-45
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 17/223 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARLMRDKVTKE--LVAVKYIERGDKID--ENVQREIINHRS 75
R + + ++G GNFG R ++ K+ VA+K +++G + E + RE
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSY 134
L +P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 190
HRDL N LL + I DFG SK ++ + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRK 232
+ ++ + +DVWS GVT++ L G P++ P+
Sbjct: 183 CINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-45
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 12/223 (5%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRS 75
+R + R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 134
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
+ + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ +DVW GV ++ +L+ G + D I+
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-44
Identities = 63/242 (26%), Positives = 96/242 (39%), Gaps = 16/242 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYI---ERGDKIDENVQREIINHRSL-- 76
+Y+ V +IG G +G RD VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 77 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
EVLL+ Y D+WS G M F + K + V P P
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 250 LF 251
Sbjct: 244 AL 245
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-44
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 15/229 (6%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQR 68
+ + + +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 127
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 184
+ G+ Y + + HRDL N LL +KI DFG + + H + P
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRK 232
L+ +D W GVTL+ M G P+ + + K
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-44
Identities = 55/250 (22%), Positives = 90/250 (36%), Gaps = 38/250 (15%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL-----VAVKYI--ERGDKIDENVQREIINH 73
+ +F + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 110
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 111 -CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPD 225
S + + ++APE L Y K +DVWS G+ L+ + G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 226 EPKDFRKTIQ 235
+F K IQ
Sbjct: 272 VDANFYKLIQ 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-44
Identities = 47/229 (20%), Positives = 89/229 (38%), Gaps = 13/229 (5%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQRE 69
+ I+ +++ + ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 186
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+A E +L Y + +DVWS GVT++ ++ G D + ++
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-44
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 16/225 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARL--MRDKVTKELVAVKYIERG---DKIDENVQREIINHR 74
DR +++GSGNFG + + K + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 190
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
+ +++ K +DVWS GV ++ G + + ++
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-44
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 13/235 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y H+ + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFY 248
+ + D+WS G + +L G F D + +++ P +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-43
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 15/232 (6%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDE--NVQRE 69
+ I S F IG G+FG L+ + K AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 70 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 127
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
+ G+ + + + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
++A E L ++ K +DVWS GV L+ ++ G P D +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-43
Identities = 55/236 (23%), Positives = 85/236 (36%), Gaps = 24/236 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKID--ENVQREIINHRSL 76
D + F IG GNFG R K A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 77 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 119
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
++A E L Y +DVWS GV L+ ++ G + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 1e-42
Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 37/247 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYI--ERGDKIDENVQREIINHRS 75
+ ++VRDIG G FG R +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 116 ----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 170 -SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
S+ + + ++ PE + + Y + +DVW+ GV L+ + G +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 229 DFRKTIQ 235
+ ++
Sbjct: 250 EVIYYVR 256
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-42
Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 10/237 (4%)
Query: 23 DRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHR 74
+ ++ ++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 75 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 194 RHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
+ K D WS GV +Y +L G PF E + + +K
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-41
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 15/228 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
RY ++ IGSG G+ D V VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241
Y + D+WS G + M+ F D + K I+ PC
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-41
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 14/245 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHR 74
+ IG+G FG K + VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 133
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 189
Y M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHITPFYP 249
E + ++ +DVWS G+ ++ ++ G + K I + +
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 250 LFKLI 254
+++L+
Sbjct: 242 IYQLM 246
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-41
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 27/229 (11%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ IG G FG + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 82 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 138 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 184
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 185 AYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
Y+APEVL ++H K AD+++ G+ + + ++ +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-40
Identities = 54/272 (19%), Positives = 89/272 (32%), Gaps = 49/272 (18%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
+R F + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 114
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
++ F Q+ G+++ + HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 175 SQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED-------- 223
S ++APE + Y + +DVWS G+ L+ + G
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 224 ---------PDEPKDFRKTIQVFIKPCCHITP 246
P+ + +K C P
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-38
Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 44/269 (16%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-------LVAVKYI--ERGDKIDENVQREII 71
DR + +G G FG L + VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 72 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 114
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 173
+ S + Q+ G+ Y + + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFED--------- 223
+ + + ++APE L Y + +DVWS GV L+ + G P+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 224 ------PDEPKDFRKTIQVFIKPCCHITP 246
D+P + + + ++ C H P
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVP 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-36
Identities = 44/236 (18%), Positives = 91/236 (38%), Gaps = 24/236 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKIDE--NVQREIINH 73
++ R++G G+FG+ K + VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 123
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQ 235
+ +++PE L + DVWS GV L+ + P++ + R ++
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-35
Identities = 52/249 (20%), Positives = 93/249 (37%), Gaps = 32/249 (12%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKIDEN---VQREIIN 72
DR + +G G FG A + T VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 73 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 115
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 116 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + + Q+ G+ + + + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFR 231
+ + ++APE + Y + +DVWS GV L+ + G P+ ++F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 232 KTIQVFIKP 240
+ ++ +
Sbjct: 248 RRLKEGTRM 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 6e-33
Identities = 50/248 (20%), Positives = 89/248 (35%), Gaps = 20/248 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
RY VR +G G+F L +D V VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 84 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 127
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 128 LISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHI 244
Y +PEVLL + AD+WS ++ ++ G + FE + + +
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 245 TPFYPLFK 252
L +
Sbjct: 253 ELPSYLLR 260
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 1e-13
Identities = 22/155 (14%), Positives = 43/155 (27%), Gaps = 26/155 (16%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG-----------DKIDENVQREIINHRSLRHP 79
+G G + VK+ + G D D + I
Sbjct: 8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 80 NIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ + + + + + A++ME R + ++ V+
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
+ + H DL N L+ + I DF S
Sbjct: 120 YHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 254 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.74 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.35 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=332.04 Aligned_cols=225 Identities=36% Similarity=0.609 Sum_probs=194.4
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
..++|++++.||+|+||+||+|++..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 4689999999999999999999999999999999986543 23456889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc---C
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~ 175 (254)
||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+||++++++. +||+|||+|...... .
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 160 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccc
Confidence 99999999999988888999999999999999999999999999999999999988876 999999998754332 2
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHhh
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVFI 238 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~ 238 (254)
......|++.|+|||++.+..++++++||||+|+++|+|++|..||...... ..+.....+++
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 2344578999999999988887766699999999999999999999764432 23445677888
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
..|++.+|.
T Consensus 241 ~~~L~~dP~ 249 (271)
T d1nvra_ 241 HKILVENPS 249 (271)
T ss_dssp HHHSCSSTT
T ss_pred HHHcCCChh
Confidence 899998883
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=326.38 Aligned_cols=224 Identities=31% Similarity=0.544 Sum_probs=195.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
+..++|++++.||+|+||+||+|++..+++.||+|.+... ......+.+|+.+++.++||||+++++++.+++.++
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 3467999999999999999999999999999999987642 234466889999999999999999999999999999
Q ss_pred EEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC
Q 025369 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 175 (254)
+||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-S 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-C
Confidence 99999999999999998889999999999999999999999999999999999999998877 99999999865433 2
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------hhhHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------KDFRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~ 241 (254)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.. +.+.+.+..++..|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 2344568999999999988777555 99999999999999999999875532 33445677888888
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
++.+|.
T Consensus 239 L~~dp~ 244 (263)
T d2j4za1 239 LKHNPS 244 (263)
T ss_dssp TCSSGG
T ss_pred ccCCHh
Confidence 888883
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=324.77 Aligned_cols=222 Identities=28% Similarity=0.501 Sum_probs=193.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 468999999999999999999999999999999886543 3446788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 179 (254)
+++++|.+++.. ..+++.+++.+++||+.||+|||++||+||||||+||+++.++. +||+|||++...... .....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999987765 46999999999999999999999999999999999999988876 999999998765433 33345
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHHhhcCcc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQVFIKPCC 242 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~ 242 (254)
..+++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+. +..+...++.++..|+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 579999999999988777555 9999999999999999999976442 2344567888999999
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
+.+|.
T Consensus 255 ~~dP~ 259 (293)
T d1yhwa1 255 DMDVE 259 (293)
T ss_dssp CSSTT
T ss_pred cCChh
Confidence 99984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=325.40 Aligned_cols=223 Identities=29% Similarity=0.486 Sum_probs=193.0
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++++.||+|+||+||+|++..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999988643 23346688999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC--
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-- 175 (254)
|||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||++++++. ++|+|||++.......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcc
Confidence 999999999999999999999999999999999999999999999999999999998887 9999999987544322
Q ss_pred -CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcC
Q 025369 176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~ 240 (254)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. ++.+...+..+++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 2234568999999999988776554 9999999999999999999986543 33445568889999
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 244 ~L~~dP~ 250 (288)
T d1uu3a_ 244 LLVLDAT 250 (288)
T ss_dssp TSCSSGG
T ss_pred HccCCHh
Confidence 9999983
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=330.22 Aligned_cols=203 Identities=31% Similarity=0.509 Sum_probs=180.5
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
...++|++.+.||+|+||+||++++..++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4578999999999999999999999999999999998654 33346788999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+||++++++. +||+|||+|...... .
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-T
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-c
Confidence 99999999999999888999999999999999999999975 9999999999999998877 999999998754332 2
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.....|++.|+|||++.+..++.+ +||||+||++|+|++|+.||...+.
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred cccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 345689999999999998887666 9999999999999999999976543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-50 Score=330.11 Aligned_cols=226 Identities=31% Similarity=0.521 Sum_probs=195.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
...++|++++.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345799999999999999999999999999999999876543 3456789999999999999999999999999999999
Q ss_pred EccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.+..+.+||+|||++.........
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 9999999999885 445799999999999999999999999999999999999997655556999999998766555555
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHHHHHhhc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKTIQVFIK 239 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~ 239 (254)
....+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+. +.+.+..++.
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred ceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 56678999999999988777555 9999999999999999999986553332 3345677888
Q ss_pred CccccCC
Q 025369 240 PCCHITP 246 (254)
Q Consensus 240 ~~~~~~p 246 (254)
.|+..+|
T Consensus 262 ~~L~~dP 268 (350)
T d1koaa2 262 KLLLADP 268 (350)
T ss_dssp HHCCSSG
T ss_pred HHccCCh
Confidence 8888888
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=325.38 Aligned_cols=226 Identities=32% Similarity=0.564 Sum_probs=198.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++++.||+|+||.||+|++..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 467999999999999999999999999999999998643 2234667889999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc-cC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~ 175 (254)
||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|..... ..
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999875443 33
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~ 241 (254)
.....+|++.|+|||++.+..++.+ +|+|||||++|+|++|..||...+... .+...+..++..|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhh
Confidence 3445679999999999988888665 999999999999999999998766433 3444577888888
Q ss_pred cccCCCcc
Q 025369 242 CHITPFYP 249 (254)
Q Consensus 242 ~~~~p~~~ 249 (254)
++.+|.-+
T Consensus 240 L~~dP~~R 247 (337)
T d1o6la_ 240 LKKDPKQR 247 (337)
T ss_dssp TCSSTTTS
T ss_pred ccCCchhh
Confidence 88888544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-50 Score=324.86 Aligned_cols=225 Identities=36% Similarity=0.611 Sum_probs=178.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.++|++.+.||+|+||+||+|++..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999986543 233567789999999999999999999999999999999
Q ss_pred ccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC-CCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|++|++|.+++...+.+++.++..++.||+.||+|||++||+||||||+||++.. +..+.+||+|||++..........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999998889999999999999999999999999999999999999964 223359999999987655555555
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~~~ 240 (254)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||...... ..+...+..++..
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 6679999999999988777555 99999999999999999999764432 2344567788888
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 247 ~L~~dP~ 253 (307)
T d1a06a_ 247 LMEKDPE 253 (307)
T ss_dssp HSCSSGG
T ss_pred HccCCHh
Confidence 8888883
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=318.95 Aligned_cols=226 Identities=33% Similarity=0.576 Sum_probs=197.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-------cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|+++++||+|+||+||+|++..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3578999999999999999999999999999999886432 234678899999999999999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCC--CceEEecccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 171 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~--~~~~l~df~~~~~~ 171 (254)
+++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+|++|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999998889999999999999999999999999999999999999986653 24999999998876
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHH
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKT 233 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~ 233 (254)
..........+++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+..+ .+...
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 66666666788999999999987776555 999999999999999999998755322 23345
Q ss_pred HHHhhcCccccCCC
Q 025369 234 IQVFIKPCCHITPF 247 (254)
Q Consensus 234 ~~~~~~~~~~~~p~ 247 (254)
+.++++.|++.+|.
T Consensus 247 ~~~li~~~L~~dP~ 260 (293)
T d1jksa_ 247 AKDFIRRLLVKDPK 260 (293)
T ss_dssp HHHHHHTTSCSSGG
T ss_pred HHHHHHHHccCChh
Confidence 77899999999983
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=319.35 Aligned_cols=224 Identities=28% Similarity=0.432 Sum_probs=191.4
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC-ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.+.|++++.||+|+||+||+|++..++..||+|.+... ....+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35799999999999999999999999999999998654 34457788999999999999999999999999999999999
Q ss_pred cCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCCC
Q 025369 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (254)
Q Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 178 (254)
+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... ....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHT
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccc
Confidence 999999998765 456999999999999999999999999999999999999998887 999999998644322 2234
Q ss_pred CccCCCCccCccccccc----cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----------------hhhHHHHHHh
Q 025369 179 STVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------------KDFRKTIQVF 237 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~ 237 (254)
...|++.|+|||++... ..++.++||||+||++|+|++|..||...+.. ..+...+..+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 56789999999998532 22345599999999999999999999765432 3445567888
Q ss_pred hcCccccCCC
Q 025369 238 IKPCCHITPF 247 (254)
Q Consensus 238 ~~~~~~~~p~ 247 (254)
+..|++.+|.
T Consensus 249 i~~~L~~dp~ 258 (288)
T d2jfla1 249 LKKCLEKNVD 258 (288)
T ss_dssp HHHHSCSSTT
T ss_pred HHHHccCChh
Confidence 8899998883
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-49 Score=326.84 Aligned_cols=226 Identities=30% Similarity=0.472 Sum_probs=195.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
..++|++++.||+|+||+||+|.+..+++.||+|.+..... ....+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35789999999999999999999999999999999876543 33567889999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
|+++++|.+.+... .++++.+++.++.||+.||.|||++||+||||||+|||++....+.+||+|||++..........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99999998877654 46999999999999999999999999999999999999985555569999999998766555555
Q ss_pred CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~~~~~~~~~~ 240 (254)
...+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+ .+...+.+++..
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 265 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred eccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 6678999999999988777655 999999999999999999997754322 344567888889
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 266 ~L~~dp~ 272 (352)
T d1koba_ 266 LLQKEPR 272 (352)
T ss_dssp TSCSSGG
T ss_pred HccCChh
Confidence 9988883
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=323.59 Aligned_cols=226 Identities=23% Similarity=0.387 Sum_probs=198.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
..+||++++.||+|+||+||+|.+..+++.||+|.+.........+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999999999999999999987765566788999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCCC
Q 025369 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 179 (254)
++|++|.+.+...+ .+++.+++.++.||+.||+|||++||+||||+|+||+++.++...++|+|||++...........
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999999997664 79999999999999999999999999999999999999877766799999999876554444455
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh------------------hHHHHHHhhcCc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD------------------FRKTIQVFIKPC 241 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~ 241 (254)
..+++.|+|||.+.+..++.+ +||||+|+++|+|++|..||...+..+. +...+.+++..|
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 678999999999887777555 9999999999999999999987664332 233567889999
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
+..+|.
T Consensus 242 L~~dp~ 247 (321)
T d1tkia_ 242 LVKERK 247 (321)
T ss_dssp SCSSGG
T ss_pred ccCChh
Confidence 998884
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-49 Score=320.98 Aligned_cols=222 Identities=30% Similarity=0.522 Sum_probs=194.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
..++|++++.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 357899999999999999999999999999999998642 2334678899999999999999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
||||+.|+++...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.... ..
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~--~~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--DV 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--SC
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEec--cc
Confidence 9999999999999999999999999999999999999999999999999999999998877 9999999987543 33
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------------hhhHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--------------KDFRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~~ 242 (254)
.....|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.. ..+...+..++..|+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 345679999999999988877665 99999999999999999999775532 334445777777777
Q ss_pred ccCCC
Q 025369 243 HITPF 247 (254)
Q Consensus 243 ~~~p~ 247 (254)
+.+|.
T Consensus 237 ~~dp~ 241 (316)
T d1fota_ 237 TRDLS 241 (316)
T ss_dssp CSCTT
T ss_pred hhCHH
Confidence 77774
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=318.94 Aligned_cols=225 Identities=22% Similarity=0.327 Sum_probs=193.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
-.+.++|++.+.||+|+||+||+|.+..++..||+|.+.......+.+.+|+.++++++||||+++++++.+++.++++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 45678999999999999999999999999999999998877666778999999999999999999999999999999999
Q ss_pred EccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC
Q 025369 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 176 (254)
||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+++++. +||+|||++........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY 170 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCc
Confidence 999999999998654 56899999999999999999999999999999999999988877 99999999875433222
Q ss_pred C--CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC----------------ChhhHHHHHHhh
Q 025369 177 P--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------------PKDFRKTIQVFI 238 (254)
Q Consensus 177 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~~~~ 238 (254)
. ....++..|+|||++.+..++.+ +||||+|+++|+|++|+.||..... ++.+...+.+++
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 1 22346788999999988777555 9999999999999997766543322 233445688899
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..||+.+|
T Consensus 250 ~~cl~~dP 257 (287)
T d1opja_ 250 RACWQWNP 257 (287)
T ss_dssp HHHTCSSG
T ss_pred HHHcCCCH
Confidence 99999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=318.75 Aligned_cols=220 Identities=28% Similarity=0.430 Sum_probs=190.1
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccc----hhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.+|++.+.||+|+||+||+|++..++..||+|.+...... .+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999998764322 245778999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 178 (254)
||+.++++..++....++++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... ...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~---~~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PAN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccC---CCC
Confidence 99999999888888888999999999999999999999999999999999999998876 9999999987543 234
Q ss_pred CccCCCCccCccccccc--cCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------hhhHHHHHHhhcC
Q 025369 179 STVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------------KDFRKTIQVFIKP 240 (254)
Q Consensus 179 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~~~ 240 (254)
...|++.|+|||++.+. ..++.++||||||+++|+|++|..||...+.. ..+...+..++..
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56799999999998653 22345599999999999999999999765432 2344568888889
Q ss_pred ccccCCC
Q 025369 241 CCHITPF 247 (254)
Q Consensus 241 ~~~~~p~ 247 (254)
|++.+|.
T Consensus 250 ~L~~dP~ 256 (309)
T d1u5ra_ 250 CLQKIPQ 256 (309)
T ss_dssp HTCSSGG
T ss_pred HCcCChh
Confidence 9988883
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=315.24 Aligned_cols=223 Identities=31% Similarity=0.539 Sum_probs=178.9
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEc--CCeEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 96 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (254)
.++|++.+.||+|+||+||++++..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+ ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4789999999999999999999999999999999866432 23567889999999999999999999875 456899
Q ss_pred EEEccCccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecCCCCCcEEecCCCCCceEEecccc
Q 025369 97 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence 9999999999998853 356999999999999999999999976 999999999999998877 99999999
Q ss_pred cccccccC-CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC---------------ChhhH
Q 025369 168 SKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFR 231 (254)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~ 231 (254)
+....... ......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+. +..+.
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 239 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 87544332 2344578999999999987776554 9999999999999999999976543 23344
Q ss_pred HHHHHhhcCccccCCC
Q 025369 232 KTIQVFIKPCCHITPF 247 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p~ 247 (254)
+.+..++..|++.+|.
T Consensus 240 ~~l~~li~~~L~~dp~ 255 (269)
T d2java1 240 DELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHcCCChh
Confidence 5678888888888873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=309.81 Aligned_cols=222 Identities=25% Similarity=0.423 Sum_probs=185.5
Q ss_pred cCCCce-eEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc----C
Q 025369 20 HDSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----P 91 (254)
Q Consensus 20 ~~~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 91 (254)
...+|| ++.++||+|+||+||++.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 345566 78889999999999999999999999999876532 233567899999999999999999999865 3
Q ss_pred CeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecCCCCCcEEecC-CCCCceEEeccccc
Q 025369 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYS 168 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~di~p~nili~~-~~~~~~~l~df~~~ 168 (254)
..+++||||+++++|.+++.....+++..++.++.||+.||+|||+++ |+||||||+||++++ ++. +||+|||++
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcc
Confidence 568999999999999999998889999999999999999999999998 999999999999964 455 999999998
Q ss_pred ccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChh-----------------hH
Q 025369 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----------------FR 231 (254)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------------~~ 231 (254)
.... ........|++.|+|||++.+ .+ ..++||||||+++|+|++|+.||........ ..
T Consensus 163 ~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKR-ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred eecc-CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 6432 223345579999999998865 34 4559999999999999999999976543322 22
Q ss_pred HHHHHhhcCccccCC
Q 025369 232 KTIQVFIKPCCHITP 246 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p 246 (254)
..+.+++..|++.+|
T Consensus 240 ~~~~~li~~~l~~dp 254 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNK 254 (270)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHccCCH
Confidence 357788888888888
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-49 Score=322.12 Aligned_cols=222 Identities=30% Similarity=0.541 Sum_probs=195.2
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (254)
.++|++++.||+|+||.||+|++..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47999999999999999999999999999999988642 23345678999999999999999999999999999999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
++|+.+++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... ...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~--~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecc--ccc
Confidence 999999999999999889999999999999999999999999999999999999998876 9999999987543 233
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------------ChhhHHHHHHhhcCccc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~~~~~ 243 (254)
....|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+. +..+...+..+++.|++
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhh
Confidence 45678999999999988777655 9999999999999999999987543 23344568888888888
Q ss_pred cCCCc
Q 025369 244 ITPFY 248 (254)
Q Consensus 244 ~~p~~ 248 (254)
.+|.-
T Consensus 275 ~dP~k 279 (350)
T d1rdqe_ 275 VDLTK 279 (350)
T ss_dssp SCTTT
T ss_pred hCHHh
Confidence 88843
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-48 Score=309.64 Aligned_cols=224 Identities=31% Similarity=0.477 Sum_probs=194.2
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----------chhHHHHHHHHhhcCC-CCCeeeeeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----------IDENVQREIINHRSLR-HPNIVRFKEVIL 89 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 89 (254)
+.++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 36899999999999999999999999999999999865421 1235778999999997 999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
+++..++||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||+|+||+++.++. +||+|||++.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~ 158 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC 158 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchhee
Confidence 99999999999999999999998899999999999999999999999999999999999999988877 9999999998
Q ss_pred cccccCCCCCccCCCCccCcccccccc-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------------
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------------- 228 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------- 228 (254)
............++..|+|||.+.+.. ..+.++||||+|+++|+|++|+.||...+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 766555556677899999999986432 23456999999999999999999998765322
Q ss_pred --hhHHHHHHhhcCccccCC
Q 025369 229 --DFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 229 --~~~~~~~~~~~~~~~~~p 246 (254)
.+...+.+++..|++.+|
T Consensus 239 ~~~~s~~~~~li~~~L~~~p 258 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQP 258 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSG
T ss_pred cccCCHHHHHHHHHHccCCh
Confidence 344467778888888887
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=310.46 Aligned_cols=228 Identities=27% Similarity=0.453 Sum_probs=184.9
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 99 (254)
.+.++|++.+.||+|+||+||++.+. ++..||||++.......+.+.+|+..+++++||||+++++++..++..++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 35689999999999999999999987 56789999998777677889999999999999999999999999999999999
Q ss_pred ccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC-
Q 025369 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (254)
Q Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 177 (254)
|+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+||++++++. +||+|||++.........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988655 56899999999999999999999999999999999999998887 999999998754433222
Q ss_pred -CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhC-CCCCCCCCC---------------ChhhHHHHHHhhcC
Q 025369 178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE---------------PKDFRKTIQVFIKP 240 (254)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~---------------~~~~~~~~~~~~~~ 240 (254)
....++..|+|||.+.+..++.+ +||||||+++|+|+++ .+||...+. +......+..++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 23457889999999988777555 9999999999999995 555554332 23334568889999
Q ss_pred ccccCC-Ccccc
Q 025369 241 CCHITP-FYPLF 251 (254)
Q Consensus 241 ~~~~~p-~~~~~ 251 (254)
||+.+| ..|-+
T Consensus 238 cl~~~p~~Rps~ 249 (263)
T d1sm2a_ 238 CWKERPEDRPAF 249 (263)
T ss_dssp HTCSSGGGSCCH
T ss_pred HccCCHhHCcCH
Confidence 999998 44444
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-48 Score=321.10 Aligned_cols=225 Identities=27% Similarity=0.415 Sum_probs=191.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc----cchhHH---HHHHHHhhcCCCCCeeeeeEEEEcCCe
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTH 93 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~----~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~ 93 (254)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ...... .+++..++.++||||+++++++.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4679999999999999999999999999999999875421 111222 334677788899999999999999999
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999875433
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----------------ChhhHHHHHH
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------------PKDFRKTIQV 236 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~~~~~ 236 (254)
.......|++.|+|||++.....++.++|||||||++|+|++|..||..... +..+...+..
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 2344567999999999997665555669999999999999999999976443 2234556888
Q ss_pred hhcCccccCCCc
Q 025369 237 FIKPCCHITPFY 248 (254)
Q Consensus 237 ~~~~~~~~~p~~ 248 (254)
++..|++.+|--
T Consensus 239 li~~~L~~dP~~ 250 (364)
T d1omwa3 239 LLEGLLQRDVNR 250 (364)
T ss_dssp HHHHHTCSSTTT
T ss_pred HHHHHcccCHHH
Confidence 999999988843
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=308.36 Aligned_cols=228 Identities=24% Similarity=0.444 Sum_probs=195.6
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.++|+++++||+|+||+||+++++ ++..||||.+.......+.+.+|+..+++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4689999999999999999999986 778899999988777778899999999999999999999999999999999999
Q ss_pred cCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC--CC
Q 025369 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (254)
Q Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--~~ 177 (254)
+++|+|..++.. ...+++..++.++.|+++|+.|||+.||+||||+|+||++++++. +||+|||++....... ..
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 456899999999999999999999999999999999999998877 9999999986443322 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~ 241 (254)
....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+. +......+.+++..|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 23457889999999988777555 999999999999998 8999987554 334445688999999
Q ss_pred cccCC-Cccccc
Q 025369 242 CHITP-FYPLFK 252 (254)
Q Consensus 242 ~~~~p-~~~~~~ 252 (254)
|..+| ..|-+.
T Consensus 238 l~~dP~~RPt~~ 249 (258)
T d1k2pa_ 238 WHEKADERPTFK 249 (258)
T ss_dssp TCSSGGGSCCHH
T ss_pred ccCCHhHCcCHH
Confidence 99999 455443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=314.04 Aligned_cols=223 Identities=33% Similarity=0.524 Sum_probs=190.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC----ccchhHHHHHHHHh-hcCCCCCeeeeeEEEEcCCeEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAI 96 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~----~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~l 96 (254)
.++|+++++||+|+||+||+|.+..+++.||+|.+.+. ....+....|...+ +.++||||+++++++.+++.+++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999999999999999998643 22233445555555 57899999999999999999999
Q ss_pred EEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-C
Q 025369 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~ 175 (254)
||||+++|+|.+++.....+++.+++.++.||+.||+|||++|++||||||+||++++++. ++|+|||++...... .
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccc
Confidence 9999999999999999999999999999999999999999999999999999999998877 999999998754433 3
Q ss_pred CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------hhHHHHHHhhcCc
Q 025369 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQVFIKPC 241 (254)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~ 241 (254)
......|++.|+|||++.+..++.+ +||||+||++|+|++|+.||...+... .+...+..+++.|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 3344578999999999998887655 999999999999999999998755433 3345677888888
Q ss_pred cccCCC
Q 025369 242 CHITPF 247 (254)
Q Consensus 242 ~~~~p~ 247 (254)
++.+|.
T Consensus 238 L~~dP~ 243 (320)
T d1xjda_ 238 FVREPE 243 (320)
T ss_dssp SCSSGG
T ss_pred cccCCC
Confidence 888883
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=309.03 Aligned_cols=234 Identities=21% Similarity=0.340 Sum_probs=192.7
Q ss_pred CCCCCcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
--+..+-.+.++|++.+.||+|+||.||+|.++ ++..||||.+.......+.+.+|+.++++++||||+++++++. ++
T Consensus 3 ~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~ 80 (272)
T d1qpca_ 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (272)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence 344555567789999999999999999999986 5678999999877666788999999999999999999999875 45
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..++||||+++|+|.+.+... .++++..++.++.||+.||.|||++||+||||||+||++++++. +||+|||++..
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~ 158 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARL 158 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEE
Confidence 678999999999999877433 35899999999999999999999999999999999999998877 99999999875
Q ss_pred ccccC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCC-CCCCC---------------CChhhHH
Q 025369 171 SVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPD---------------EPKDFRK 232 (254)
Q Consensus 171 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~---------------~~~~~~~ 232 (254)
..... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|+.| |...+ .++.+.+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 43322 2234457889999999987776555 9999999999999996554 44322 2344556
Q ss_pred HHHHhhcCccccCC-Ccccc
Q 025369 233 TIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 233 ~~~~~~~~~~~~~p-~~~~~ 251 (254)
.+..++..||+.+| ..|-+
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHcCCCHhHCcCH
Confidence 78899999999998 34433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-48 Score=313.07 Aligned_cols=229 Identities=24% Similarity=0.403 Sum_probs=181.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccce---eEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.+.++|++.+.||+|+||+||+|.+..+++ .+|+|.+.... ...+.+.+|+.++++++||||+++++++..++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 456899999999999999999999976654 58888876542 2335688999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++... +.+++.+++.++.||+.||.|||++|++||||||+|||++.++. +||+|||++.....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED 180 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence 9999999999999988764 56999999999999999999999999999999999999998877 99999999875443
Q ss_pred cCCCC------CccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhH
Q 025369 174 HSQPK------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFR 231 (254)
Q Consensus 174 ~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~ 231 (254)
..... ...+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+. +....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 32221 1246788999999987776555 999999999999998 8999976543 33445
Q ss_pred HHHHHhhcCccccCC-Ccccc
Q 025369 232 KTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+.+..++..||+.+| ..|-+
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~ 280 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKF 280 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHHHHHcCCCHhHCcCH
Confidence 678899999999998 44433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=307.84 Aligned_cols=227 Identities=26% Similarity=0.384 Sum_probs=183.3
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (254)
-.+.++|++++.||+|+||+||+++... .||+|.+.... ...+.+.+|+.++++++||||+++++++. ++.++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 3567899999999999999999997653 49999886532 33467889999999999999999999875 45689
Q ss_pred EEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 96 lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+||||+++++|.+++... .++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeecccc
Confidence 999999999999999654 56999999999999999999999999999999999999998877 999999998654332
Q ss_pred C---CCCCccCCCCccCcccccccc--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh--------------------h
Q 025369 175 S---QPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--------------------D 229 (254)
Q Consensus 175 ~---~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------------~ 229 (254)
. ......+++.|+|||++.+.. .++.++||||||+++|+|++|+.||...+... .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2 223446889999999986533 23455999999999999999999998754322 2
Q ss_pred hHHHHHHhhcCccccCC-Ccccc
Q 025369 230 FRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+.+.+..++..||..+| ..|.+
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chHHHHHHHHHHcCCCHhHCcCH
Confidence 34568889999999988 44433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-47 Score=302.95 Aligned_cols=224 Identities=27% Similarity=0.396 Sum_probs=184.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc----chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----e
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H 93 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 93 (254)
.++|++.+.||+|+||+||+|.+..+++.||+|.+..... ....+.+|+..++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999999999999999999865432 2356789999999999999999999987643 4
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+|+||||++|++|.+.+...+++++.+++.++.||+.||+|||++||+||||||+||+++.++. .+++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 7999999999999999999899999999999999999999999999999999999999998887 89999998754332
Q ss_pred cC----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh------------------hhH
Q 025369 174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------------DFR 231 (254)
Q Consensus 174 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------~~~ 231 (254)
.. ......|++.|+|||++.+..++.+ +||||+|+++|+|++|..||...+..+ .+.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 22 2234468999999999987766555 999999999999999999998755322 234
Q ss_pred HHHHHhhcCccccCCCc
Q 025369 232 KTIQVFIKPCCHITPFY 248 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p~~ 248 (254)
..+..++..|++.+|.-
T Consensus 243 ~~l~~li~~~L~~dp~~ 259 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPEN 259 (277)
T ss_dssp HHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHccCCHhH
Confidence 56778888888888843
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=311.88 Aligned_cols=229 Identities=24% Similarity=0.389 Sum_probs=188.8
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccce-----eEEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (254)
++.++|+++++||+|+||+||+|++..+++ .||+|.+... ......+.+|+..++++ +||||+++++++.++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 456899999999999999999999875543 6899987543 23346788899999988 899999999999999
Q ss_pred CeEEEEEEccCccchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCC
Q 025369 92 THLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (254)
Q Consensus 92 ~~~~lv~~~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ 148 (254)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999996542 4789999999999999999999999999999999
Q ss_pred cEEecCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 025369 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP 224 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 224 (254)
||+++.++. +||+|||+|+........ ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...
T Consensus 194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCC
Confidence 999988876 999999998754443322 23456889999999987777555 999999999999997 89999875
Q ss_pred CCCh----------------hhHHHHHHhhcCccccCC-Ccccc
Q 025369 225 DEPK----------------DFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 225 ~~~~----------------~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+... ...+.+..++..||+.+| ..|.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 5433 334467888999999888 44443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=304.75 Aligned_cols=224 Identities=29% Similarity=0.462 Sum_probs=190.5
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------chhHHHHHHHHhhcCC--CCCeeeeeEEEEcC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTP 91 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 91 (254)
..++|++++.||+|+||+||+|.+..++..||+|.+..... ....+.+|+.++++++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46899999999999999999999999999999998864321 1234568999999886 89999999999999
Q ss_pred CeEEEEEEccCc-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 92 THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 92 ~~~~lv~~~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
+..++||+++.+ +++.+++.....+++.+++.++.||+.||+|||++||+||||||+||+++.+.. .++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECcccccee
Confidence 999999999975 688888888889999999999999999999999999999999999999985532 499999999864
Q ss_pred ccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CChhhHHHHHHhhcCcc
Q 025369 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------EPKDFRKTIQVFIKPCC 242 (254)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~ 242 (254)
... .......|++.|+|||++.+..+++.++||||+||++|+|++|..||...+ -+..+...+.+++..|+
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L 239 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHc
Confidence 332 233456789999999999888777676899999999999999999997532 23445667888999999
Q ss_pred ccCC
Q 025369 243 HITP 246 (254)
Q Consensus 243 ~~~p 246 (254)
..+|
T Consensus 240 ~~dp 243 (273)
T d1xwsa_ 240 ALRP 243 (273)
T ss_dssp CSSG
T ss_pred cCCH
Confidence 9888
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=310.95 Aligned_cols=224 Identities=32% Similarity=0.510 Sum_probs=189.2
Q ss_pred ccCCCceeEec-cccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhc-CCCCCeeeeeEEEEc----CC
Q 025369 19 MHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT----PT 92 (254)
Q Consensus 19 ~~~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~ 92 (254)
....++|++.+ .||+|+||+||+|++..+++.||+|++.. .....+|+..+.+ ++||||+++++++.+ +.
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 34467999875 59999999999999999999999998854 3556788887654 589999999999875 45
Q ss_pred eEEEEEEccCccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccc
Q 025369 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 169 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~ 169 (254)
.+++||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||+++++. .+.+||+|||++.
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 789999999999999999764 3699999999999999999999999999999999999998643 3459999999998
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC----------------------
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------------------- 227 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------------- 227 (254)
............+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 7666666677789999999999988777555 99999999999999999999654321
Q ss_pred hhhHHHHHHhhcCccccCCC
Q 025369 228 KDFRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~p~ 247 (254)
..+...+..++..|++.+|.
T Consensus 242 ~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTT
T ss_pred ccCCHHHHHHHHHHccCChh
Confidence 13445688899999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=302.16 Aligned_cols=227 Identities=27% Similarity=0.388 Sum_probs=187.0
Q ss_pred cCCCceeEecc-ccCCcceEEEEEEEcc--cceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRD-IGSGNFGVARLMRDKV--TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~-l~~g~~g~v~~~~~~~--~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
...++|.+.+. ||+|+||+||+|.+.. ++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 45678999985 9999999999998754 45579999986543 334678899999999999999999999865 457
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccc
Confidence 8999999999999987554 57999999999999999999999999999999999999988776 99999999875433
Q ss_pred cCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHH
Q 025369 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKT 233 (254)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~ 233 (254)
... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...+.. ..+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 221 123357789999999987776555 999999999999998 89999875532 344456
Q ss_pred HHHhhcCccccCC-Cccc
Q 025369 234 IQVFIKPCCHITP-FYPL 250 (254)
Q Consensus 234 ~~~~~~~~~~~~p-~~~~ 250 (254)
+..++..||..+| -.|-
T Consensus 241 l~~li~~cl~~~p~~RPs 258 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPD 258 (285)
T ss_dssp HHHHHHHTTCSSGGGSCC
T ss_pred HHHHHHHHcCCCHhHCcC
Confidence 8899999999998 3443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=304.61 Aligned_cols=216 Identities=26% Similarity=0.369 Sum_probs=185.2
Q ss_pred EeccccCCcceEEEEEEEcccceeEEEEEccCCcc------chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEc
Q 025369 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 27 ~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++.||+|+||+||+|++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999865322 235688999999999999999999999999999999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CCCC
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 179 (254)
+.++++.........+++..+..+++||+.||+|||++|++||||||+||+++.++. +||+|||++....... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 999888877777778999999999999999999999999999999999999998877 9999999986544332 3344
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCcccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCHI 244 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 244 (254)
..+++.|+|||++.....++.++||||+||++|+|++|..||...+..+++.++...+..+..+.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 56899999999998776666669999999999999999999999988888888887776655443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=301.17 Aligned_cols=223 Identities=24% Similarity=0.325 Sum_probs=183.4
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++.++|++.+.||+|+||.||++.+..+ ..||+|.+.......+.+.+|+..+++++||||+++++++. ++.+++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 35678999999999999999999999755 56999999877666788999999999999999999999985 45678999
Q ss_pred EccCccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-
Q 025369 99 EYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 99 ~~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 175 (254)
||+++|+|..++.. ...+++.+++.++.||+.||.|||++|++||||||+||++++++. +||+|||++.......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCc
Confidence 99999999888754 356999999999999999999999999999999999999988877 9999999987543322
Q ss_pred -CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------CChhhHHHHHHhh
Q 025369 176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------EPKDFRKTIQVFI 238 (254)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------------~~~~~~~~~~~~~ 238 (254)
......+++.|+|||++.+..++.+ +||||||+++|+|++|..||.... .+..+.+.+.+++
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 2233457889999999988777655 999999999999999665554322 2344455788999
Q ss_pred cCccccCC
Q 025369 239 KPCCHITP 246 (254)
Q Consensus 239 ~~~~~~~p 246 (254)
..||+.+|
T Consensus 248 ~~cl~~dP 255 (285)
T d1fmka3 248 CQCWRKEP 255 (285)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCH
Confidence 99999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=303.21 Aligned_cols=214 Identities=25% Similarity=0.373 Sum_probs=178.4
Q ss_pred ccccCCcceEEEEEEEc--ccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEEEccCc
Q 025369 29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (254)
Q Consensus 29 ~~l~~g~~g~v~~~~~~--~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 103 (254)
++||+|+||+||+|.+. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 456789999886532 2346788999999999999999999998654 56899999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCC----CCC
Q 025369 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS 179 (254)
Q Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~----~~~ 179 (254)
++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++........ ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence 999999999889999999999999999999999999999999999999988776 99999999875433222 123
Q ss_pred ccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHHHhhcCccc
Q 025369 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~ 243 (254)
..+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+. +..+...+.+++..||+
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcC
Confidence 357889999999987776555 999999999999998 8999976442 33445678899999999
Q ss_pred cCC
Q 025369 244 ITP 246 (254)
Q Consensus 244 ~~p 246 (254)
.+|
T Consensus 249 ~dp 251 (277)
T d1xbba_ 249 YDV 251 (277)
T ss_dssp SST
T ss_pred CCH
Confidence 998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=298.74 Aligned_cols=219 Identities=29% Similarity=0.433 Sum_probs=185.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|+++++||+|+||+||+|.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 379999999999999999999999999999999986542 23567889999999999999999999999999999999
Q ss_pred EccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CC
Q 025369 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (254)
Q Consensus 99 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 176 (254)
||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCccc
Confidence 99976544433333 356999999999999999999999999999999999999988776 999999998654432 23
Q ss_pred CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCcc
Q 025369 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCC 242 (254)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (254)
.....+++.|+|||.+......+.++|+||+|+++|+|++|+.||...+..+...++......+..
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 344578999999999888887777799999999999999999999988877777777766655443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=300.07 Aligned_cols=228 Identities=24% Similarity=0.326 Sum_probs=181.9
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccc----eeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
..++|++.+.||+|+||.||+|.+..++ ..||||.+..... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4578999999999999999999987554 4799998865432 334678999999999999999999999999999
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++++||+.++++.+.+... ..+++.++..++.|++.|++|||+++|+||||||+|||++.++. +||+|||++.....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLED 162 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccC
Confidence 9999999999998877655 57999999999999999999999999999999999999998887 99999999875433
Q ss_pred cCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC-C---------------CChhhHHH
Q 025369 174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-D---------------EPKDFRKT 233 (254)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~---------------~~~~~~~~ 233 (254)
... .....+++.|+|||++.+..++.+ +||||||+++|+|++|..|+... + .+......
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 222 123356788999999987776655 99999999999999966554332 2 23345567
Q ss_pred HHHhhcCccccCC-Ccccc
Q 025369 234 IQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 234 ~~~~~~~~~~~~p-~~~~~ 251 (254)
+..++..||+.+| -.|-+
T Consensus 242 l~~li~~cl~~~p~~RPt~ 260 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKF 260 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHHHCcCCHhHCcCH
Confidence 8999999999999 44433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-45 Score=292.21 Aligned_cols=217 Identities=29% Similarity=0.439 Sum_probs=185.8
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|++.++||+|+||+||+|+++ +++.||+|++.... ...+.+.+|+.++++++||||+++++.+.+++..++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 379999999999999999999986 78899999986543 23467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc-CCC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 177 (254)
+++.++.+.........+++..++.++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+...... ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence 99988777777777788999999999999999999999999999999999999998877 999999998654332 223
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCc
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPC 241 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 241 (254)
....+++.|+|||.+.+....+.++|+||||+++++|++|+.||...+..+.+.++...+..+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 4446888999999998877767779999999999999999999998887777777776665543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=294.61 Aligned_cols=223 Identities=24% Similarity=0.390 Sum_probs=177.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
.+.++|++++.||+|+||+||+|.+..+ +..||+|.+.... ...+.+.+|+..+++++||||+++++++. ++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 4568999999999999999999998654 3568888876533 23466889999999999999999999985 5678
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
++||||++++++.+++... ..+++..++.++.||+.||.|||++|++||||||+||++++++. +||+|||++.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence 9999999999999887554 56899999999999999999999999999999999999998876 99999999875433
Q ss_pred cC--CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHHH
Q 025369 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTIQ 235 (254)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~~ 235 (254)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |.+||...+. +..+...+.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 22 2233457889999999987776555 999999999999998 8899976543 334455788
Q ss_pred HhhcCccccCC
Q 025369 236 VFIKPCCHITP 246 (254)
Q Consensus 236 ~~~~~~~~~~p 246 (254)
.++..||..+|
T Consensus 240 ~li~~cl~~dp 250 (273)
T d1mp8a_ 240 SLMTKCWAYDP 250 (273)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHcCCCH
Confidence 89999999988
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=292.27 Aligned_cols=222 Identities=26% Similarity=0.405 Sum_probs=180.8
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC-CeEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAI 96 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 96 (254)
+..+.++|++.+.||+|+||.||+++++ +..||+|.+..+ ...+.+.+|+..+++++||||+++++++.++ +.+++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 3467789999999999999999999985 678999998654 4557789999999999999999999998654 56899
Q ss_pred EEEccCccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 97 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
||||+++++|.+++.... .+++..++.++.||+.|+.|||+.+++||||+|+||+++.++. ++++|||++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~-- 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-- 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--
Confidence 999999999999986543 4899999999999999999999999999999999999998887 9999999886433
Q ss_pred CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC---------------hhhHHHHHHhh
Q 025369 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP---------------KDFRKTIQVFI 238 (254)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~---------------~~~~~~~~~~~ 238 (254)
.......++..|+|||.+.+..++.+ +||||||+++|+|++ |.+||...+.. ......+.+++
T Consensus 155 ~~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 155 STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred CCCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 23334467789999999988776544 999999999999998 67887664432 23345788999
Q ss_pred cCccccCCC
Q 025369 239 KPCCHITPF 247 (254)
Q Consensus 239 ~~~~~~~p~ 247 (254)
+.||..+|.
T Consensus 234 ~~cl~~dP~ 242 (262)
T d1byga_ 234 KNCWHLDAA 242 (262)
T ss_dssp HHHTCSSGG
T ss_pred HHHcccCHh
Confidence 999999993
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=297.79 Aligned_cols=229 Identities=26% Similarity=0.366 Sum_probs=189.4
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccccee--EEEEEccCC--ccchhHHHHHHHHhhcC-CCCCeeeeeEEEEcCCeE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~--~~lK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (254)
.+.++|++.++||+|+||+||+|.+..++.. |+||.+... ....+.+.+|+..++++ +||||+++++++.+++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4678999999999999999999999887764 667776432 23446789999999998 799999999999999999
Q ss_pred EEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCC
Q 025369 95 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~ 158 (254)
++||||+++|+|.+++... ..+++..+..++.||+.|+.|||++|++||||+|+|||++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998643 46899999999999999999999999999999999999988876
Q ss_pred ceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC-CCCCCCCC-----------
Q 025369 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDE----------- 226 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~----------- 226 (254)
+||+|||++.............++..|+|||.+.+..++.+ +||||||+++|+|++|. +||...+.
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999876655555556678899999999988777555 99999999999999965 56765332
Q ss_pred ----ChhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 ----PKDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 ----~~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+..+...+..++..||+.+| -+|.+
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 273 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSF 273 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 33455678999999999998 44433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=297.89 Aligned_cols=227 Identities=23% Similarity=0.379 Sum_probs=181.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccce----eEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (254)
..++|++++.||+|+||+||+|.+..+++ .||+|.+... ....+.+.+|+.++++++||||+++++++.+++ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 34689999999999999999999987765 5788877543 234567899999999999999999999998654 5
Q ss_pred EEEEEccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
+++++++.+++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccc
Confidence 6777888888888777654 57999999999999999999999999999999999999988876 99999999875443
Q ss_pred cCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC---------------ChhhHHHH
Q 025369 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE---------------PKDFRKTI 234 (254)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~---------------~~~~~~~~ 234 (254)
.... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |.+||...+. +......+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 3222 22347889999999988776555 999999999999998 7889876432 33455678
Q ss_pred HHhhcCccccCC-Ccccc
Q 025369 235 QVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 235 ~~~~~~~~~~~p-~~~~~ 251 (254)
..++..||..+| ..|.+
T Consensus 243 ~~li~~cl~~dP~~RPs~ 260 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKF 260 (317)
T ss_dssp HHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHhCCCChhhCcCH
Confidence 889999999998 34433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=298.61 Aligned_cols=217 Identities=29% Similarity=0.413 Sum_probs=181.7
Q ss_pred ccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcC------C
Q 025369 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (254)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 92 (254)
....-+|+.+++||+|+||+||+|++..+++.||+|++..... ...+|+.++++++||||+++++++... .
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3334489999999999999999999999999999999866543 234799999999999999999998643 3
Q ss_pred eEEEEEEccCccchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 93 HLAIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
++++||||++++.+..+. .....+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~ 171 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchh
Confidence 578999999876433332 34567999999999999999999999999999999999999987653 38999999987
Q ss_pred cccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhc
Q 025369 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIK 239 (254)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 239 (254)
............++..|+|||.+.+...+..++||||+||++|+|++|..||...+..+++.+++..+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 6665566666789999999999877666566699999999999999999999988887777777665544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=294.22 Aligned_cols=226 Identities=25% Similarity=0.410 Sum_probs=184.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcccc-------eeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 87 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~ 87 (254)
+.++.++|++++.||+|+||.||+|++..++ ..||+|.+..... ....+.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 5577899999999999999999999976544 4799998866443 335677788888887 79999999999
Q ss_pred EEcCCeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEE
Q 025369 88 ILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (254)
Q Consensus 88 ~~~~~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nil 151 (254)
+.+++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+.|++||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999644 24899999999999999999999999999999999999
Q ss_pred ecCCCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC-
Q 025369 152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE- 226 (254)
Q Consensus 152 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~- 226 (254)
++.++. +||+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.
T Consensus 168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 998887 99999999875544332 233457789999999988777555 999999999999998 7888875443
Q ss_pred --------------ChhhHHHHHHhhcCccccCC
Q 025369 227 --------------PKDFRKTIQVFIKPCCHITP 246 (254)
Q Consensus 227 --------------~~~~~~~~~~~~~~~~~~~p 246 (254)
+..+...+.+++..||+.+|
T Consensus 245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP 278 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278 (299)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCH
Confidence 23344568889999999988
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=292.37 Aligned_cols=220 Identities=28% Similarity=0.406 Sum_probs=182.7
Q ss_pred CCCceeEeccccCCcceEEEEEEEccc-ceeEEEEEccCC---ccchhHHHHHHHHhhcC---CCCCeeeeeEEEEc---
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERG---DKIDENVQREIINHRSL---RHPNIVRFKEVILT--- 90 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~--- 90 (254)
..++|++++.||+|+||+||+|++..+ ++.||+|++... ........+|+..++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357999999999999999999999655 677999987542 22334556677766655 89999999999863
Q ss_pred --CCeEEEEEEccCccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccc
Q 025369 91 --PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (254)
Q Consensus 91 --~~~~~lv~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~ 167 (254)
....+++++++.++++..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++. ++|+|||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~ 162 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 162 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence 346899999998877654443 3356899999999999999999999999999999999999988877 99999999
Q ss_pred cccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCccc
Q 025369 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCCH 243 (254)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 243 (254)
+.............+++.|+|||++.+..++.+ +||||+||++|+|++|..||...+..+.+.+++..+..+...
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 876666666677789999999999988877665 999999999999999999999988888888877776655433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-45 Score=294.19 Aligned_cols=228 Identities=25% Similarity=0.430 Sum_probs=188.6
Q ss_pred cCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc--chhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
++.++|++.+.||+|+||+||+|+.. .++..||||++..... ..+.+.+|+.++++++|||++++++++...+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 45689999999999999999999975 3567899999875432 2456889999999999999999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCC
Q 025369 93 HLAIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~ 148 (254)
..+++++++.+++|.+++.... .++...++.++.|++.|++|||+++++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999986432 3788999999999999999999999999999999
Q ss_pred cEEecCCCCCceEEecccccccccccC---CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCC-CCCCCC
Q 025369 149 NTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDP 224 (254)
Q Consensus 149 nili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~ 224 (254)
||+++.++. +||+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|. +||...
T Consensus 170 NILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 170 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCC
Confidence 999998777 9999999986443322 2223457788999999988777655 99999999999999985 677664
Q ss_pred CC---------------ChhhHHHHHHhhcCccccCC-Cccc
Q 025369 225 DE---------------PKDFRKTIQVFIKPCCHITP-FYPL 250 (254)
Q Consensus 225 ~~---------------~~~~~~~~~~~~~~~~~~~p-~~~~ 250 (254)
+. ++.+...+..++..||+.+| -.|-
T Consensus 247 ~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcC
Confidence 43 33445568889999999998 3443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=292.15 Aligned_cols=228 Identities=28% Similarity=0.440 Sum_probs=178.2
Q ss_pred cCCCceeEeccccCCcceEEEEEEEccc---ceeEEEEEccCC----ccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~lK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 92 (254)
...++|++.+.||+|+||.||+|+.... ...||+|.+... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3467899999999999999999986532 346899987653 2233578899999999999999999999965 4
Q ss_pred eEEEEEEccCccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
..++|+||++++++.+.+.. ..++++..++.++.|++.|+.|||++||+||||||+||+++.++. +||+|||++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhc
Confidence 67899999999999877754 456999999999999999999999999999999999999998776 999999998754
Q ss_pred cccCC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCC----------------CChhh
Q 025369 172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD----------------EPKDF 230 (254)
Q Consensus 172 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~----------------~~~~~ 230 (254)
..... .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+ .+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 33322 123346778999999988776555 999999999999998 899996543 23455
Q ss_pred HHHHHHhhcCccccCC-Ccccc
Q 025369 231 RKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 231 ~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
...+.++++.||..+| -.|.+
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~ 262 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTF 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCH
T ss_pred cHHHHHHHHHHcCCChhHCcCH
Confidence 6678999999999999 44443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=293.33 Aligned_cols=201 Identities=32% Similarity=0.484 Sum_probs=167.5
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc--cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----eE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 94 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 94 (254)
.++|++++.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++|||++++++++.... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 578999999999999999999999999999999986543 23456789999999999999999999987643 34
Q ss_pred EEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccccc
Q 025369 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (254)
Q Consensus 95 ~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 174 (254)
+++ +++.+++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 555 556688999998654 6999999999999999999999999999999999999998776 999999998654333
Q ss_pred CC----CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 175 SQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 175 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
.. .....+++.|+|||.+.....+..++||||+|+++++|++|..||...+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 22 23445888999999987776666769999999999999999999976553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=289.53 Aligned_cols=223 Identities=25% Similarity=0.342 Sum_probs=183.8
Q ss_pred CcccCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCC---ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc---
Q 025369 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT--- 90 (254)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 90 (254)
+.....+||+++++||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++|||++++++++..
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 3345579999999999999999999999999999999987543 2334668899999999999999999999865
Q ss_pred -----CCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 91 -----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 91 -----~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
++..+++||++.++.+.........+++..++.+++|++.||.|||++||+||||||+||+++.++. ++++||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeec
Confidence 3467999999988777766666778999999999999999999999999999999999999998887 999999
Q ss_pred ccccccccc-----CCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 166 GYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 166 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
|++...... .......+++.|+|||.+.+...++.++||||+|+++++|++|+.||...+.......+...+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 998543321 122334689999999999877655666999999999999999999998877766666666655544
Q ss_pred c
Q 025369 241 C 241 (254)
Q Consensus 241 ~ 241 (254)
.
T Consensus 242 ~ 242 (318)
T d3blha1 242 T 242 (318)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=294.78 Aligned_cols=201 Identities=29% Similarity=0.429 Sum_probs=167.8
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC-----
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 92 (254)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4789999999999999999999999999999999987543 22356788999999999999999999997654
Q ss_pred -eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccc
Q 025369 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (254)
Q Consensus 93 -~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~ 171 (254)
.+++||||+ +.+|..... ...+++..++.++.||+.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 579999999 556766654 457999999999999999999999999999999999999998887 999999998744
Q ss_pred cccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 025369 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227 (254)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 227 (254)
. .......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+..
T Consensus 172 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 172 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 3 33455678999999999987766666699999999999999999999876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=282.11 Aligned_cols=215 Identities=26% Similarity=0.456 Sum_probs=183.2
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEcCCeEEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (254)
.++|+++++||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+....++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 379999999999999999999999999999999986543 33467889999999999999999999999999999999
Q ss_pred EccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccC-CC
Q 025369 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 177 (254)
+++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccc
Confidence 99999999998888889999999999999999999999999999999999999988776 9999999987554433 22
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-ChhhHHHHHHhh
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQVFI 238 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~ 238 (254)
....+...|+|||.+.+....+.++||||+||++++|++|+.||..... .+...+......
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 220 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence 3345677899999988777666669999999999999999988655444 444444433333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=290.99 Aligned_cols=225 Identities=28% Similarity=0.502 Sum_probs=190.2
Q ss_pred CCceeEeccccCCcceEEEEEEEc---ccceeEEEEEccCCc-----cchhHHHHHHHHhhcCCC-CCeeeeeEEEEcCC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRH-PNIVRFKEVILTPT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~~~lK~~~~~~-----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 92 (254)
.++|++++.||+|+||+||+|.+. .+|+.||+|.+.... ...+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 488999999999999999999873 468899999886432 234667889999999977 89999999999999
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++++||+.+++|.+.+.....+++..++.++.||+.|++|||++|++||||+|+||+++.++. ++|+|||++....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999998876 9999999986543
Q ss_pred c--cCCCCCccCCCCccCcccccccc-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------------------hhhH
Q 025369 173 L--HSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------------------KDFR 231 (254)
Q Consensus 173 ~--~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~ 231 (254)
. ........+++.|++||.+.+.. ....++||||+||++|+|++|..||...... ....
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 23334567899999999997654 3455699999999999999999999765432 2344
Q ss_pred HHHHHhhcCccccCCCc
Q 025369 232 KTIQVFIKPCCHITPFY 248 (254)
Q Consensus 232 ~~~~~~~~~~~~~~p~~ 248 (254)
..+..++..|++.+|.-
T Consensus 261 ~~~~~li~~~l~~dP~~ 277 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKK 277 (322)
T ss_dssp HHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHcccCHHH
Confidence 45778888888888843
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=289.74 Aligned_cols=224 Identities=23% Similarity=0.365 Sum_probs=174.0
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 91 (254)
++.++|++++.||+|+||.||+|.+.. +++.||+|.+..... ....+.+|...+.++ +|++|+.+.+++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 456899999999999999999999754 457899998865432 234566677777666 689999999988765
Q ss_pred -CeEEEEEEccCccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecC
Q 025369 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (254)
Q Consensus 92 -~~~~lv~~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~ 154 (254)
..+++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||++++
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4689999999999999998643 24889999999999999999999999999999999999988
Q ss_pred CCCCceEEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCChh-
Q 025369 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKD- 229 (254)
Q Consensus 155 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~- 229 (254)
++. +||+|||+++....... .....+++.|+|||.+.+..++.+ +||||+|+++|+|++| ..||......+.
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 877 99999999865433222 233467889999999988776555 9999999999999986 567876554333
Q ss_pred ---------------hHHHHHHhhcCccccCC
Q 025369 230 ---------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 230 ---------------~~~~~~~~~~~~~~~~p 246 (254)
....+.+++..||+.+|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 278 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 278 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCCh
Confidence 33467788889999888
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=287.70 Aligned_cols=226 Identities=23% Similarity=0.357 Sum_probs=188.0
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEc-----ccceeEEEEEccCCcc--chhHHHHHHHHhhcC-CCCCeeeeeEEEE
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~lK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 89 (254)
+-.+.++|+++++||+|+||.||+|++. .++..||+|.+..... ....+.+|+..++++ +||||+++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3356689999999999999999999863 4678999999876433 334678899999998 6999999999999
Q ss_pred cCCeEEEEEEccCccchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEE
Q 025369 90 TPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (254)
Q Consensus 90 ~~~~~~lv~~~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nil 151 (254)
++..++++|||+++++|.+++.... .+++..+..++.||+.|+.|||++|++||||||+||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999986543 4899999999999999999999999999999999999
Q ss_pred ecCCCCCceEEecccccccccccCCC---CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 025369 152 LDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 227 (254)
Q Consensus 152 i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 227 (254)
++.++. ++++|||.+......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |.+||......
T Consensus 178 ~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 178 LTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 988776 999999998754432222 23467889999999987776555 999999999999998 56666665543
Q ss_pred hh----------------hHHHHHHhhcCccccCC
Q 025369 228 KD----------------FRKTIQVFIKPCCHITP 246 (254)
Q Consensus 228 ~~----------------~~~~~~~~~~~~~~~~p 246 (254)
+. ....+.+++..||+.+|
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCCh
Confidence 33 33468889999999988
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=286.88 Aligned_cols=231 Identities=20% Similarity=0.339 Sum_probs=191.1
Q ss_pred cccCCCceeEeccccCCcceEEEEEEEcc-----cceeEEEEEccCCccch--hHHHHHHHHhhcCCCCCeeeeeEEEEc
Q 025369 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILT 90 (254)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~lK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~ 90 (254)
+-++.++|++++.||+|+||.||+|.+.. ++..||||++....... ..+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 44667999999999999999999998853 45789999987543322 457899999999999999999999999
Q ss_pred CCeEEEEEEccCccchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCce
Q 025369 91 PTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (254)
Q Consensus 91 ~~~~~lv~~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~ 160 (254)
+...++||||+++|+|.+++... ..++...+..++.+++.|+.|||+++|+||||||+|||+++++. +
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--V 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--E
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--E
Confidence 99999999999999999988543 24688999999999999999999999999999999999998877 9
Q ss_pred EEecccccccccccCC---CCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhC-CCCCCCCCC----------
Q 025369 161 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE---------- 226 (254)
Q Consensus 161 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~---------- 226 (254)
||+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++| .+||...+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999999864433222 233357889999999988777655 9999999999999997 477866443
Q ss_pred -----ChhhHHHHHHhhcCccccCC-Ccccc
Q 025369 227 -----PKDFRKTIQVFIKPCCHITP-FYPLF 251 (254)
Q Consensus 227 -----~~~~~~~~~~~~~~~~~~~p-~~~~~ 251 (254)
+......+..++..||+.+| ..|.+
T Consensus 252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~ 282 (308)
T d1p4oa_ 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282 (308)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCcccchHHHHHHHHHHcCCChhHCcCH
Confidence 33444678999999999998 44443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-43 Score=286.58 Aligned_cols=202 Identities=24% Similarity=0.458 Sum_probs=176.1
Q ss_pred CCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-CCCeeeeeEEEEcC--CeEEEE
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 97 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 97 (254)
..++|+++++||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++... ...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 457899999999999999999999999999999998654 3467889999999995 99999999999754 568999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
|||+.+++|.... ..+++..++.+++||+.||.|||++||+||||||+|||++.++. .++|+|||++.........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999987653 46999999999999999999999999999999999999986553 4899999998766666666
Q ss_pred CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh
Q 025369 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228 (254)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 228 (254)
....+++.|+|||.+.+....+.++||||+|+++++|++|..||.......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 677789999999998877766666999999999999999999998766543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=284.69 Aligned_cols=225 Identities=24% Similarity=0.321 Sum_probs=181.0
Q ss_pred eeEeccccCCcceEEEEEEEcccc---eeEEEEEccCC--ccchhHHHHHHHHhhcCCCCCeeeeeEEEEc-CCeEEEEE
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVM 98 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~---~~~~lK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 98 (254)
+...++||+|+||+||+|.+..++ ..||+|.+... ....+++.+|+.++++++||||+++++++.. ++.+++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 344788999999999999986543 36899988643 2234678999999999999999999999875 56899999
Q ss_pred EccCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccccCCC
Q 025369 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (254)
Q Consensus 99 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 177 (254)
||+++++|.+++... ..++...++.++.|++.||.|||+.+|+||||+|+|||+++++. +||+|||++.........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccc
Confidence 999999999988755 45788899999999999999999999999999999999988776 999999998754433222
Q ss_pred -----CCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------CChhhHHHHHH
Q 025369 178 -----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----------------EPKDFRKTIQV 236 (254)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----------------~~~~~~~~~~~ 236 (254)
....++..|+|||.+.+..++.+ +||||||+++|+|++|+.||.... .++.....+.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 22346789999999987776555 999999999999999877775432 22344557899
Q ss_pred hhcCccccCC-Cccccc
Q 025369 237 FIKPCCHITP-FYPLFK 252 (254)
Q Consensus 237 ~~~~~~~~~p-~~~~~~ 252 (254)
++..||+.+| .+|-++
T Consensus 266 li~~cl~~dP~~RPs~~ 282 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFS 282 (311)
T ss_dssp HHHHHTCSSGGGSCCHH
T ss_pred HHHHHcCCCHhHCcCHH
Confidence 9999999999 444443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-43 Score=281.43 Aligned_cols=224 Identities=23% Similarity=0.250 Sum_probs=178.5
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC-eeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|++++.||+|+||+||+|++..+++.||+|...... ..+.+..|+.+++.++|++ ++.+...+.+++..++||++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 468999999999999999999999999999999876543 3456788999999998765 55556666778889999999
Q ss_pred cCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCC-CCceEEecccccccccccC----
Q 025369 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS---- 175 (254)
Q Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~---- 175 (254)
+.++...........+++..+..++.|++.||+|||++||+||||||+||+++..+ ...++++|||++.......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 96544444444556799999999999999999999999999999999999986432 2359999999987544322
Q ss_pred ----CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCh----------------------h
Q 025369 176 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------D 229 (254)
Q Consensus 176 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------------~ 229 (254)
......+++.|+|||++.+..++.+ +||||||+++|+|++|..||....... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence 2234468999999999988776555 999999999999999999997644321 1
Q ss_pred hHHHHHHhhcCccccCCC
Q 025369 230 FRKTIQVFIKPCCHITPF 247 (254)
Q Consensus 230 ~~~~~~~~~~~~~~~~p~ 247 (254)
+...+..+++.||..+|.
T Consensus 244 ~p~~~~~li~~cl~~~p~ 261 (299)
T d1ckia_ 244 YPSEFATYLNFCRSLRFD 261 (299)
T ss_dssp SCHHHHHHHHHHHHSCTT
T ss_pred CCHHHHHHHHHHccCChh
Confidence 234577888899988883
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=287.79 Aligned_cols=215 Identities=27% Similarity=0.401 Sum_probs=172.7
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc---cchhHHHHHHHHhhcCCCCCeeeeeEEEEc------CC
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT------PT 92 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 92 (254)
.++|+++++||+|+||+||+|++..++..||+|++.... ....++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999999999999999987543 223467899999999999999999999864 36
Q ss_pred eEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEeccccccccc
Q 025369 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (254)
Q Consensus 93 ~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~ 172 (254)
.+++||||+.++++. .+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||++....
T Consensus 96 ~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence 889999999775544 34 346899999999999999999999999999999999999998877 9999999887666
Q ss_pred ccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcCcc
Q 025369 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKPCC 242 (254)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 242 (254)
.........+++.|+|||++.+..++.+ +||||+||++++|++|..||...+......+++..+..++.
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 6666666778999999999988777666 99999999999999999999988877777777766655433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=284.77 Aligned_cols=225 Identities=23% Similarity=0.263 Sum_probs=177.6
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCeeeeeEEEEcCC----eEEEE
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIV 97 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 97 (254)
..+|.+.+.||+|+||.||+|+. +|..||||.+............|+..++.++||||+++++++.+++ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46899999999999999999986 5789999988655433333445666677889999999999998653 67999
Q ss_pred EEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCeeecCCCCCcEEecCCCCCceEEecccccc
Q 025369 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (254)
Q Consensus 98 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~--------~~i~h~di~p~nili~~~~~~~~~l~df~~~~ 169 (254)
|||+++++|.+++... ++++..++.++.+++.++.|||+ +||+||||||+||++++++. +||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccc
Confidence 9999999999999765 68999999999999999999996 59999999999999988877 9999999886
Q ss_pred cccccC-----CCCCccCCCCccCccccccccC-----CCCcccHHHHHHHHHHHHhCCCCCCCCCC-------------
Q 025369 170 SSVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDE------------- 226 (254)
Q Consensus 170 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------- 226 (254)
...... ......+++.|+|||++.+... .+.++||||||+++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 544332 2234568999999999866532 23348999999999999999877632110
Q ss_pred -----------------------ChhhHHHHHHhhcCccccCCC-cccc
Q 025369 227 -----------------------PKDFRKTIQVFIKPCCHITPF-YPLF 251 (254)
Q Consensus 227 -----------------------~~~~~~~~~~~~~~~~~~~p~-~~~~ 251 (254)
.....+.+..++..||..+|. .|-+
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 285 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence 112234588899999999993 4433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-42 Score=279.38 Aligned_cols=202 Identities=22% Similarity=0.282 Sum_probs=171.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCC-CCeeeeeEEEEcCCeEEEEEEc
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
.++|++++.||+|+||+||+|++..+++.||+|..... ...+.+.+|+..++.++| ++++.+.+++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 47999999999999999999999999999999977543 234567888999999976 8999999999999999999999
Q ss_pred cCccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCC---CCCceEEecccccccccccC-
Q 025369 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLHS- 175 (254)
Q Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~---~~~~~~l~df~~~~~~~~~~- 175 (254)
+ +++|.+++... ..++..++..++.|++.+|++||++||+||||||+||+++.+ ..+.++|+|||++.......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 56888888655 469999999999999999999999999999999999999753 23359999999986543221
Q ss_pred -------CCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 025369 176 -------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226 (254)
Q Consensus 176 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 226 (254)
......|++.|+|||++.+..++.+ +||||||+++|+|++|..||.....
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccc
Confidence 2233468999999999988776555 9999999999999999999976543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=285.20 Aligned_cols=214 Identities=25% Similarity=0.421 Sum_probs=178.1
Q ss_pred CCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc---chhHHHHHHHHhhcCCCCCeeeeeEEEEcC-----Ce
Q 025369 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 93 (254)
Q Consensus 22 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 93 (254)
.+||++.+.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 6899999999999999999999999999999999875432 235678999999999999999999998643 33
Q ss_pred EEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecccccccccc
Q 025369 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (254)
Q Consensus 94 ~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~~~~ 173 (254)
.+++++++.+++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 4566677778999998854 46999999999999999999999999999999999999998877 9999999876432
Q ss_pred cCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCCCCChhhHHHHHHhhcC
Q 025369 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQVFIKP 240 (254)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 240 (254)
.......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+......+
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 333455678899999998887766666999999999999999999999888777777766655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-37 Score=252.55 Aligned_cols=202 Identities=26% Similarity=0.420 Sum_probs=161.3
Q ss_pred cCCCceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCC-----------CCCeeeeeEEE
Q 025369 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVI 88 (254)
Q Consensus 20 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~ 88 (254)
+..+||+++++||+|+||+||+|++..+++.||||++.......+...+|+.+++.++ |+|++++++++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3457899999999999999999999999999999999876656677788888887774 57899999887
Q ss_pred Ec--CCeEEEEEEccCcc-chHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecCCCCCcEEecCCCC----C
Q 025369 89 LT--PTHLAIVMEYASGG-ELFERI--CNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA----P 158 (254)
Q Consensus 89 ~~--~~~~~lv~~~~~~~-~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~di~p~nili~~~~~----~ 158 (254)
.. ....++++.+.... ...... .....+++..++.++.|++.|++|||+ .||+||||||+||+++.++. .
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 64 34556666555433 333222 233568999999999999999999997 89999999999999975543 2
Q ss_pred ceEEecccccccccccCCCCCccCCCCccCccccccccCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 025369 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224 (254)
Q Consensus 159 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 224 (254)
.++++|||.+... ........+++.|+|||++.+..++.+ +|+||+|+++++|++|+.||...
T Consensus 170 ~~kl~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 170 QIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeEeeccccccc--ccccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCC
Confidence 4899999987643 233455678999999999988777655 99999999999999999999643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.2e-25 Score=166.48 Aligned_cols=131 Identities=17% Similarity=0.160 Sum_probs=103.4
Q ss_pred eeEeccccCCcceEEEEEEEcccceeEEEEEccCCcc-------------------chhHHHHHHHHhhcCCCCCeeeee
Q 025369 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 85 (254)
Q Consensus 25 y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~ 85 (254)
+.++++||+|+||+||+|.+. +|+.||+|++..... ......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999986 688999997643210 012334577888899999988877
Q ss_pred EEEEcCCeEEEEEEccCccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeecCCCCCcEEecCCCCCceEEecc
Q 025369 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (254)
Q Consensus 86 ~~~~~~~~~~lv~~~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~di~p~nili~~~~~~~~~l~df 165 (254)
+.. . .+++|+++++..+.. ++......++.|++.++.+||++|++||||||+||++++++ ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 653 2 268999998866543 45556678999999999999999999999999999998543 899999
Q ss_pred ccccc
Q 025369 166 GYSKS 170 (254)
Q Consensus 166 ~~~~~ 170 (254)
|.|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=1.6e-07 Score=72.06 Aligned_cols=85 Identities=15% Similarity=0.062 Sum_probs=58.3
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCc-cchhHHHHHHHHhhcCC-CCCeeeeeEEEEcCCeEEEEEEc
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~ 100 (254)
+.|+..+..+.++.+.||++.. ++..+++|...... .....+.+|...+..+. +--+.+++.+..+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 4677777766555678998864 45567788765432 23445677887776663 22256677777788889999999
Q ss_pred cCccchHHH
Q 025369 101 ASGGELFER 109 (254)
Q Consensus 101 ~~~~~L~~~ 109 (254)
++|.++.+.
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 998776543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.47 E-value=9.3e-07 Score=71.88 Aligned_cols=76 Identities=18% Similarity=0.120 Sum_probs=47.7
Q ss_pred eccccCCcceEEEEEEEcccceeEEEEEccC------C--ccchhHHHHHHHHhhcCC-C-C-CeeeeeEEEEcCCeEEE
Q 025369 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER------G--DKIDENVQREIINHRSLR-H-P-NIVRFKEVILTPTHLAI 96 (254)
Q Consensus 28 ~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~------~--~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~l 96 (254)
.+.||.|....||++++..+++.+++|.-.. . ....++...|...++.+. + | .+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5568999999999999887888999996432 1 122345666777776552 2 3 34445443 4555688
Q ss_pred EEEccCccc
Q 025369 97 VMEYASGGE 105 (254)
Q Consensus 97 v~~~~~~~~ 105 (254)
+||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=7.2e-06 Score=62.12 Aligned_cols=73 Identities=14% Similarity=0.087 Sum_probs=49.6
Q ss_pred ccCCcc-eEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCC--eeeeeEEEEcCCeEEEEEEccCccch
Q 025369 31 IGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGEL 106 (254)
Q Consensus 31 l~~g~~-g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~~~~~~~L 106 (254)
+..|.. +.||++... .+..+++|...... ...+..|...++.+...+ +.+++.+..+++..+++|++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 578988775 56668888755443 345667777777664322 56677777788888999999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.74 E-value=9e-05 Score=58.21 Aligned_cols=68 Identities=10% Similarity=0.063 Sum_probs=45.0
Q ss_pred ceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCee--ee-----eEEEEcCCeEEEEEEccCcc
Q 025369 36 FGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV--RF-----KEVILTPTHLAIVMEYASGG 104 (254)
Q Consensus 36 ~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i~--~~-----~~~~~~~~~~~lv~~~~~~~ 104 (254)
.-.||+++.. +|..+++|+........+.+.+|+..+..|...++. .. ...+...+..+.++++..|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3689999875 678899998776666667788888888776432221 11 11123356678889988763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.42 E-value=0.00037 Score=56.08 Aligned_cols=80 Identities=13% Similarity=0.119 Sum_probs=50.3
Q ss_pred CCCceeEeccccCCcceEEEEEEEcc-------cceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe-eeeeEEEEcCC
Q 025369 21 DSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPT 92 (254)
Q Consensus 21 ~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~ 92 (254)
+.+..++ +.|+.|-.-.+|++.... .+..+++++.-. ........+|..+++.+.-.++ .++++++. +
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~ 116 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G 116 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C
Confidence 3445555 567778888999998753 245677776653 2233455678888877743343 45666553 2
Q ss_pred eEEEEEEccCccch
Q 025369 93 HLAIVMEYASGGEL 106 (254)
Q Consensus 93 ~~~lv~~~~~~~~L 106 (254)
+.|++|++|.++
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 578898887543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.35 E-value=0.00051 Score=53.35 Aligned_cols=143 Identities=15% Similarity=0.077 Sum_probs=72.4
Q ss_pred CceeEeccccCCcceEEEEEEEcccceeEEEEEccCCccchhHHHHHHHHhhcCCCCCe--eeeeE------EEEcCCeE
Q 025369 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI--VRFKE------VILTPTHL 94 (254)
Q Consensus 23 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~lK~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~------~~~~~~~~ 94 (254)
++..-.+.|..|-.-+.|+++.. +..+++|++... ...+.+..++..+..|...++ ..... +.......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 34444556667777889999876 345899987543 234555666666666532221 11110 01123344
Q ss_pred EEEEEccCccch-----------HHHH---Hhc-C--------CC------------------CHHHHHHHHHHHHHHHH
Q 025369 95 AIVMEYASGGEL-----------FERI---CNA-G--------RF------------------SEDEARFFFQQLISGVS 133 (254)
Q Consensus 95 ~lv~~~~~~~~L-----------~~~l---~~~-~--------~~------------------~~~~~~~~~~~i~~~l~ 133 (254)
+.++.+..+... ...+ ... . .. ........+......+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 555555544221 0000 000 0 00 01111222333333333
Q ss_pred HHH----hcCeeecCCCCCcEEecCCCCCceEEeccccccc
Q 025369 134 YCH----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (254)
Q Consensus 134 ~LH----~~~i~h~di~p~nili~~~~~~~~~l~df~~~~~ 170 (254)
..+ ..|++|+|+.+.|++++.+.. .-++||+.++.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~~ 213 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFACN 213 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCEE
T ss_pred ccCccccccccccCCcchhhhhcccccc--eeEeccccccc
Confidence 333 357999999999999986654 68999998753
|